PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hochwagen, A; Tham, WH; Brar, GA; Amon, A				Hochwagen, A; Tham, WH; Brar, GA; Amon, A			The FK506 binding protein Fpr3 counteracts protein phosphatase 1 to maintain meiotic recombination checkpoint activity	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; SISTER-CHROMATID RECOMBINATION; SACCHAROMYCES-CEREVISIAE; YEAST MEIOSIS; FK506-BINDING PROTEIN; CDC14 PHOSPHATASE; PACHYTENE CHECKPOINT; CHROMOSOME SYNAPSIS; PROLINE ISOMERASES; RAPAMYCIN-BINDING	The meiotic recombination checkpoint delays gamete precursors in G2 until DNA breaks created during recombination are repaired and chromosome structure has been restored. Here, we show that the FK506 binding protein Fpr3 prevents premature adaptation to damage and thus serves to maintain recombination checkpoint activity. Impaired checkpoint function is observed both in cells lacking FPR3 and in cells treated with rapamycin, a small molecule inhibitor that binds to the proline isomerase (PPlase) domain of Fpr3. FPR3 functions in the checkpoint through controlling protein phosphatase 1 (PP1). Fpr3 interacts with PP1 through its PPlase domain, regulates PP1 localization, and counteracts the activity of PP1 in vivo. Our findings define a branch of the recombination checkpoint involved in the adaptation to persistent chromosomal damage and a critical function for FK506 binding proteins during meiosis.	MIT, Howard Hughes Med Inst, Ctr Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Howard Hughes Med Inst, Ctr Canc Res, E17-233,40 Ames St, Cambridge, MA 02139 USA.	angelika@mit.edu	Tham, Wai-Hong/P-6474-2019; Tham, Wai-Hong/L-3173-2018	Tham, Wai-Hong/0000-0001-7950-8699; Tham, Wai-Hong/0000-0001-7950-8699; Hochwagen, Andreas/0000-0002-6184-443X; Amon, Angelika/0000-0001-9837-0314	NIGMS NIH HHS [R01 GM062207, GM62207] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Baarends WM, 2001, REPRODUCTION, V121, P31, DOI 10.1530/rep.0.1210031; Bailis JM, 2000, CELL, V101, P211, DOI 10.1016/S0092-8674(00)80831-4; BENTON BM, 1994, J CELL BIOL, V127, P623, DOI 10.1083/jcb.127.3.623; Bishop DK, 1999, GENES CELLS, V4, P425, DOI 10.1046/j.1365-2443.1999.00273.x; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bloecher A, 2000, J CELL BIOL, V149, P125, DOI 10.1083/jcb.149.1.125; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Breiman A, 2002, TRANSGENIC RES, V11, P321, DOI 10.1023/A:1016331814412; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Crackower MA, 2003, SCIENCE, V300, P1291, DOI 10.1126/science.1083022; Davey M, 2000, MOL GEN GENET, V263, P520, DOI 10.1007/s004380051197; DeCenzo MT, 1996, PROTEIN ENG, V9, P173, DOI 10.1093/protein/9.2.173; DEMASSY B, 1994, P NATL ACAD SCI USA, V91, P11929, DOI 10.1073/pnas.91.25.11929; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Grushcow JM, 1999, GENETICS, V153, P607; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamilton GS, 1998, J MED CHEM, V41, P5119, DOI 10.1021/jm980307x; HEITMAN J, 1992, NEW BIOL, V4, P448; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; KOSER PL, 1993, GENE, V129, P159, DOI 10.1016/0378-1119(93)90264-4; Kuzuhara T, 2004, NAT STRUCT MOL BIOL, V11, P275, DOI 10.1038/nsmb733; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; MANNINGKRIEG UC, 1994, FEBS LETT, V352, P98, DOI 10.1016/0014-5793(94)00927-9; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Munn K, 2000, GENETICS, V156, P245; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Pak J, 2002, MOL CELL BIOL, V22, P6430, DOI 10.1128/MCB.22.18.6430-6440.2002; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Petes TD, 1995, ADV GENET, V33, P41, DOI 10.1016/S0065-2660(08)60330-2; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SHAN XY, 1994, J CELL BIOL, V126, P853, DOI 10.1083/jcb.126.4.853; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Thompson DA, 1999, GENETICS, V153, P621; TIMERMAN AP, 1995, J BIOL CHEM, V270, P2451, DOI 10.1074/jbc.270.6.2451; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tung KS, 2000, P NATL ACAD SCI USA, V97, P12187, DOI 10.1073/pnas.220464597; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; WAGSTAFF JE, 1982, P NATL ACAD SCI-BIOL, V79, P2986, DOI 10.1073/pnas.79.9.2986; White EJ, 2004, GENETICS, V167, P51, DOI 10.1534/genetics.167.1.51; Wilson LK, 1997, J BIOL CHEM, V272, P12961, DOI 10.1074/jbc.272.20.12961; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	63	99	104	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					861	873		10.1016/j.cell.2005.07.010	http://dx.doi.org/10.1016/j.cell.2005.07.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179256	Bronze			2022-12-28	WOS:000232130200011
J	Sharkis, SJ				Sharkis, SJ			Canadian stem cell scientists take the prize	CELL			English	Editorial Material							BONE-MARROW CELLS	This year, the recipients of the Lasker Award for Basic Medical Research are Ernest A. McCulloch and James E. Till. The landmark studies of McCulloch and Till in the 1960s defined the hallmark properties of stem cells: the ability to self-renew and differentiate.	Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Med Inst, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Sharkis, SJ (corresponding author), Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Med Inst, Baltimore, MD 21231 USA.	ssharkis@jhmi.edu						BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; JONES RJ, 1990, NATURE, V347, P188, DOI 10.1038/347188a0; MCCULLOCH EA, 1960, RADIAT RES, V13, P115, DOI 10.2307/3570877; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810	5	3	3	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 23	2005	122	6					817	819		10.1016/j.cell.2005.09.008	http://dx.doi.org/10.1016/j.cell.2005.09.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179246	Bronze			2022-12-28	WOS:000232130200001
J	Simmons, LW; Roberts, B				Simmons, LW; Roberts, B			Bacterial immunity traded for sperm viability in male crickets	SCIENCE			English	Article							PARASITES; COSTS; OFFS		Univ Western Australia, Sch Anim Biol M092, Evolutionary Biol Res Grp, Crawley, WA 6009, Australia	University of Western Australia	Simmons, LW (corresponding author), Univ Western Australia, Sch Anim Biol M092, Evolutionary Biol Res Grp, Crawley, WA 6009, Australia.	lsimmons@cyllene.uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474				Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Folstad I, 1997, BEHAV ECOL, V8, P109, DOI 10.1093/beheco/8.1.109; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Liljedal S, 1999, P ROY SOC B-BIOL SCI, V266, P1893, DOI 10.1098/rspb.1999.0863; REZNICK D, 1992, TRENDS ECOL EVOL, V7, P42, DOI 10.1016/0169-5347(92)90104-J; SCHNEIDER PM, 1985, INSECT BIOCHEM, V15, P463, DOI 10.1016/0020-1790(85)90058-7; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Skau PA, 2005, BEHAV ECOL, V16, P410, DOI 10.1093/beheco/ari004	10	89	92	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2031	2031		10.1126/science.1114500	http://dx.doi.org/10.1126/science.1114500			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179472				2022-12-28	WOS:000232181900042
J	Berg, P				Berg, P			Reflections on the Lasker Prize for basic biomedical research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Beckman Ctr, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University	Berg, P (corresponding author), Stanford Univ, Beckman Ctr, Dept Biochem, Sch Med, B-062, Stanford, CA 94305 USA.	pberg@cmgm.stanford.edu						Kamen M. D., 1985, RADIANT SCI DARK POL; MEDAWAR P, 1980, SEARCH SOLUTIONS, P5	2	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1419	1420		10.1001/jama.294.11.1419	http://dx.doi.org/10.1001/jama.294.11.1419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174707				2022-12-28	WOS:000231987800022
J	Gerberding, JL				Gerberding, JL			Protecting health - The new research imperative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Gerberding, JL (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA.	Jgerberding@cdc.gov						Crowley WF, 2004, JAMA-J AM MED ASSOC, V291, P1120, DOI 10.1001/jama.291.9.1120; *CTR MED MED SERV, 2004, NAT HLTH EXP SEL EC; *I MED, 1998, SCI OPP PUBL NEEDS I; *I MED, 2000, PROM HLTH INT STRAT; Institute of Medicine, 2002, FUT PUBL HLTH 21 CEN; KHOURY MJ, 2004, MONOGRAPHS EPIDEMIOL; Lurie N, 2002, HEALTH AFFAIR, V21, P94, DOI 10.1377/hlthaff.21.2.94; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Scrimshaw SC, 2001, PUBLIC HEALTH REP, V116, P4, DOI 10.1093/phr/116.S1.4; Zaza S, 2005, GUIDE COMMUNITY PREV	10	28	28	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1403	1406		10.1001/jama.294.11.1403	http://dx.doi.org/10.1001/jama.294.11.1403			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965YW	16174702				2022-12-28	WOS:000231987800017
J	Wolff, JL; Boult, C				Wolff, JL; Boult, C			Moving beyond round pegs and square holes: Restructuring medicare to improve chronic care	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH MAINTENANCE ORGANIZATION; RANDOMIZED CONTROLLED-TRIAL; OUTPATIENT GERIATRIC EVALUATION; CONGESTIVE-HEART-FAILURE; NURSE CASE-MANAGEMENT; LATE-LIFE DEPRESSION; ADVERSE DRUG EVENTS; QUALITY-OF-CARE; CHRONIC ILLNESS; CLINICAL-TRIAL	Chronic disease is the norm rather than the exception among Medicare beneficiaries, yet Medicare's benefit structure and reimbursement mechanisms are poorly aligned with high-quality chronic care. This disconnect is thought to undermine the quality of chronic care, thereby contributing to excess program spending and placing beneficiaries at risk foe undesirable health outcomes. Despite widespread recognition of this mismatch, there is little compelling evidence to suggest that successful quality improvement initiatives would reduce the costs of the Medicare program. This paper describes state-of-the-art chronic care innovations to date, discusses ongoing and planned efforts by the Centers for Medicare & Medicaid Services to test related changes to Medicare's benefit structure and provider reimbursement, and suggests opportunities for future progress in this area.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Lipitz Ctr Integrated Hlth Care, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Wolff, JL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Lipitz Ctr Integrated Hlth Care, 624 N Broadway,Room 692, Baltimore, MD 21205 USA.	jwolff@jhsph.edu						Anderson G, 2001, HEALTH AFFAIR, V20, P146, DOI 10.1377/hlthaff.20.6.146; Anderson G, 2002, CHRONIC CONDITIONS M; Asch SM, 2000, JAMA-J AM MED ASSOC, V284, P2325, DOI 10.1001/jama.284.18.2325; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Badamgarav E, 2003, AM J PSYCHIAT, V160, P2080, DOI 10.1176/appi.ajp.160.12.2080; BERENSON RA, 2003, HLTH AFF MILLWOOD S; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Boult C, 2000, J AM GERIATR SOC, V48, P996; Boult C, 2001, J AM GERIATR SOC, V49, P351, DOI 10.1046/j.1532-5415.2001.49076.x; Boyd CM, 2005, J AM GERIATR SOC, V53, pS205; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; *C BUDG OFF, 2004, AN LIT DIS; Callahan CM, 2001, MED CARE, V39, P772, DOI 10.1097/00005650-200108000-00004; Cassel CK, 1999, HEALTH AFFAIR, V18, P118, DOI 10.1377/hlthaff.18.1.118; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; *COUNC GRAD MED ED, 2000, FIN GRAD MED ED CHAN; Darer JD, 2004, ACAD MED, V79, P541, DOI 10.1097/00001888-200406000-00009; Eng C, 1997, J AM GERIATR SOC, V45, P223, DOI 10.1111/j.1532-5415.1997.tb04513.x; Ferguson JA, 1998, J GEN INTERN MED, V13, P123, DOI 10.1046/j.1525-1497.1998.00029.x; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Fillenbaum GG, 2000, J GERONTOL A-BIOL, V55, pM84; Gagnon AJ, 1999, J AM GERIATR SOC, V47, P1118; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; GOLD M, 2005, HLTH AFF W, V5, P199; Goldman DP, 2003, HEALTH AFFAIR, V22, P194, DOI 10.1377/hlthaff.22.3.194; Gross DJ, 1999, HEALTH SERV RES, V34, P241; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kane RL, 1997, J AM GERIATR SOC, V45, P101, DOI 10.1111/j.1532-5415.1997.tb00987.x; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; MedPAC, 2004, REP C NEW APPR MED; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Newcomer R, 2000, J AM GERIATR SOC, V48, P829; Ofman JJ, 2004, AM J MED, V117, P182, DOI 10.1016/j.amjmed.2004.03.018; Omoigui NA, 1996, CIRCULATION, V93, P27, DOI 10.1161/01.CIR.93.1.27; *PARTN SOL, 2002, MED COST PREV CHRON; *PARTN SOL, 2001, MED 5 PERC STAND AN; Phelan EA, 2002, J AM GERIATR SOC, V50, P1519, DOI 10.1046/j.1532-5415.2002.50407.x; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Reuben DB, 1999, J AM GERIATR SOC, V47, P269, DOI 10.1111/j.1532-5415.1999.tb02988.x; Reuben DB, 2002, MED CARE, V40, P416, DOI 10.1097/00005650-200205000-00007; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Rothman AA, 2003, ANN INTERN MED, V138, P256, DOI 10.7326/0003-4819-138-3-200302040-00034; *S HMO MED PAYM AD, 2003, REC FUT DEM; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; Selden TM, 2003, MED CARE, V41, P13; Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; VLADECK BC, 2002, MEDICARE CHRONIC CAR; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; WHITE AJ, 2000, EVALUATION PROGRAM A; Williams MV, 2002, FAM MED, V34, P383; Windham BG, 2003, AM J MANAG CARE, V9, P447; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	66	48	48	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2005	143	6					439	445		10.7326/0003-4819-143-6-200509200-00008	http://dx.doi.org/10.7326/0003-4819-143-6-200509200-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967OG	16172442				2022-12-28	WOS:000232099900005
J	Jankowski, J; Boulton, E				Jankowski, J; Boulton, E			10-minute consultation - Cancer prevention	BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford, Dept Clin Pharmacol, Oxford OX2 6HE, England	University of Oxford	Jankowski, J (corresponding author), Univ Oxford, Dept Clin Pharmacol, Oxford OX2 6HE, England.	janusz.jankowski@clinpharm.ox.ac.uk	Jankowski, Janusz/H-2706-2012; Boyle, Peter/A-4380-2014	Jankowski, Janusz/0000-0003-2130-9181; Boyle, Peter/0000-0001-6251-0610				AUSTOKER J, 1995, CANC PREVENTION PRIM; HOBBS R, 2001, ABC COLORECTAL CANC; Key T, 2004, PUBLIC HEALTH NUTR, V7, P187, DOI 10.1079/PHN2003588	3	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 17	2005	331	7517					618	618		10.1136/bmj.331.7517.618	http://dx.doi.org/10.1136/bmj.331.7517.618			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967EK	16166132	Green Published, Bronze			2022-12-28	WOS:000232074100023
J	Patterson, TF				Patterson, TF			Advances and challenges in management of invasive mycoses	LANCET			English	Review							LINKED-IMMUNOSORBENT-ASSAY; CELL TRANSPLANT RECIPIENTS; LIPOSOMAL AMPHOTERICIN-B; EXPERIMENTAL PULMONARY ASPERGILLOSIS; BLOOD-STREAM INFECTIONS; PROSPECTIVE CLINICAL-EVALUATION; EMPIRICAL ANTIFUNGAL THERAPY; NEUTROPENIC CANCER-PATIENTS; IN-VITRO SUSCEPTIBILITIES; GUINEA-PIG MODEL	Invasive mycoses pose a major diagnostic and therapeutic challenge. Advances in antifungal agents and diagnostic methods offer the potential for improved outcomes in patients with these infections, which are often lethal. Many fungal pathogens occur almost exclusively in opportunistic settings-in the immunocompromised host-and these infections are the focus of this review. Several areas of ongoing challenge remain, including the emergence of resistant organisms and the absence of reliable markers for early identification of patients at risk of developing invasive fungal disease. This Seminar reviews the changing epidemiology of invasive mycoses, new diagnostic methods, and recent therapeutic options and current management strategies for these opportunistic pathogens.	Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Patterson, TF (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	patterson@uthscsa.edu			NIAID NIH HHS [N01-AI-30041] Funding Source: Medline; NIDCR NIH HHS [R01-DE-11381] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011381] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AbiSaid D, 1997, CLIN INFECT DIS, V24, P1122, DOI 10.1086/513663; Aliff TB, 2003, CANCER-AM CANCER SOC, V97, P1025, DOI 10.1002/cncr.11115; Ally R, 2001, CLIN INFECT DIS, V33, P1447, DOI 10.1086/322653; ANAISSIE E, 1997, 37 INT C ANT AG CHEM; Anaissie EJ, 2001, BLOOD, V98, p207A; Anaissie EJ, 2001, CLIN INFECT DIS, V33, P1546, DOI 10.1086/322967; Anaissie EJ, 2001, CLIN INFECT DIS, V33, P1871, DOI 10.1086/324501; Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530; Andes D, 2001, ANTIMICROB AGENTS CH, V45, P922, DOI 10.1128/AAC.45.3.922-926.2001; Andresen D, 2005, LANCET, V365, P876, DOI 10.1016/S0140-6736(05)71046-1; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002; Bachmann SP, 2003, ANTIMICROB AGENTS CH, V47, P3657, DOI 10.1128/AAC.47.11.3657-3659.2003; Barrett JP, 2003, CLIN THER, V25, P1295, DOI 10.1016/S0149-2918(03)80125-X; Bartizal K, 1997, ANTIMICROB AGENTS CH, V41, P2326, DOI 10.1128/AAC.41.11.2326; Bates DW, 2001, CLIN INFECT DIS, V32, P686, DOI 10.1086/319211; Becker MJ, 2000, J CLIN MICROBIOL, V38, P1434, DOI 10.1128/JCM.38.4.1434-1438.2000; Becker MJ, 2003, BRIT J HAEMATOL, V121, P448, DOI 10.1046/j.1365-2141.2003.04308.x; Boogaerts M, 2001, ANN INTERN MED, V135, P412, DOI 10.7326/0003-4819-135-6-200109180-00010; BOUCHER HW, 2003, 43 INT C ANT AG CHEM, P446; Bowden R, 2002, CLIN INFECT DIS, V35, P359, DOI 10.1086/341401; Bowman JC, 2002, ANTIMICROB AGENTS CH, V46, P3001, DOI 10.1128/AAC.46.9.3001-3012.2002; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Buchheidt D, 2004, BRIT J HAEMATOL, V125, P196, DOI 10.1111/j.1365-2141.2004.04904.x; Caillot D, 2001, J CLIN ONCOL, V19, P253, DOI 10.1200/JCO.2001.19.1.253; Caillot D, 2001, CLIN INFECT DIS, V33, pE83, DOI 10.1086/323020; Castiglioni B, 2002, MEDICINE, V81, P333, DOI 10.1097/00005792-200209000-00001; Costa C, 2001, J MICROBIOL METH, V44, P263, DOI 10.1016/S0167-7012(01)00212-3; Costa C, 2002, J CLIN MICROBIOL, V40, P2224, DOI 10.1128/JCM.40.6.2224-2227.2002; Dannaoui E, 2003, ANTIMICROB AGENTS CH, V47, P3647, DOI 10.1128/AAC.47.11.3647-3650.2003; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Denning DW, 2002, CLIN INFECT DIS, V34, P563, DOI 10.1086/324620; DENNING DW, 1992, DIAGN MICR INFEC DIS, V15, P21, DOI 10.1016/0732-8893(92)90053-V; Denning DW, 2000, LANCET, V355, P423, DOI 10.1016/S0140-6736(00)82003-6; DENNING DW, 1990, REV INFECT DIS, V12, P1147; Diekema DJ, 2002, J CLIN MICROBIOL, V40, P1298, DOI 10.1128/JCM.40.4.1298-1302.2002; DOUGLAS CM, 2002, 42 INT C ANT AG CHEM; EDWARDS JE, 1991, NEW ENGL J MED, V324, P1060, DOI 10.1056/NEJM199104113241511; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; GEORGE D, 1993, J INFECT DIS, V168, P692, DOI 10.1093/infdis/168.3.692; Gonzalez CE, 1997, CLIN INFECT DIS, V24, P192, DOI 10.1093/clinids/24.2.192; Graybill JR, 2001, CLIN INFECT DIS, V33, P1545, DOI 10.1086/323596; GREENBERG RN, 2003, 43 INT C ANT AG CHEM, P476; GREENE RE, 2003, 13 EUR C CLIN MICR I; Groll AH, 1996, J INFECTION, V33, P23, DOI 10.1016/S0163-4453(96)92700-0; Guarro J, 1999, J CLIN MICROBIOL, V37, P2493, DOI 10.1128/JCM.37.8.2493-2497.1999; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; HACHEM R, 2000, 40 INT C ANT AG CHEM; Hajjeh RA, 2001, CLIN INFECT DIS, V33, P1549, DOI 10.1086/322970; Herbrecht R, 2001, EUR J CLIN MICROBIOL, V20, P460, DOI 10.1007/s10096-001-8152-2; Herbrecht R, 2002, J CLIN ONCOL, V20, P1898, DOI 10.1200/JCO.2002.07.004; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Imhof A, 2003, CLIN INFECT DIS, V36, P943, DOI 10.1086/368312; Imhof A, 2004, CLIN INFECT DIS, V39, P743, DOI 10.1086/423274; Iwen PC, 1998, CLIN INFECT DIS, V26, P1092, DOI 10.1086/520297; Jantunen E, 1997, BONE MARROW TRANSPL, V19, P801, DOI 10.1038/sj.bmt.1700737; Kauffman CA, 2004, CLIN INFECT DIS, V39, P588, DOI 10.1086/422729; Kawazu M, 2004, J CLIN MICROBIOL, V42, P2733, DOI 10.1128/JCM.42.6.2733-2741.2004; Kirkpatrick WR, 2002, J ANTIMICROB CHEMOTH, V49, P353, DOI 10.1093/jac/49.2.353; Kirkpatrick WR, 2000, ANTIMICROB AGENTS CH, V44, P780, DOI 10.1128/AAC.44.3.780-782.2000; Kirkpatrick WR, 2002, ANTIMICROB AGENTS CH, V46, P2564, DOI 10.1128/AAC.46.8.2564-2568.2002; KIRKPATRICK WR, 2003, TRENDS INV FUNG INF, V7; Klont RR, 2004, CLIN INFECT DIS, V39, P1467, DOI 10.1086/425317; Kobayashi Kazuhiko, 2004, Haematologica, V89, pECR42; KOHNO S, 2000, 40 INT C ANT AG CHEM; Kontoyiannis DP, 2003, CANCER, V98, P292, DOI 10.1002/cncr.11479; Kontoyiannis DP, 2005, J INFECT DIS, V191, P1350, DOI 10.1086/428780; Krause DS, 2004, ANTIMICROB AGENTS CH, V48, P2021, DOI 10.1128/AAC.48.6.2021-2024.2004; KULLBERG BJ, 2004, 14 EUR C CLIN MICR I; Leenders ACAP, 1998, BRIT J HAEMATOL, V103, P205, DOI 10.1046/j.1365-2141.1998.00944.x; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Linden PK, 2003, CLIN INFECT DIS, V37, P17, DOI 10.1086/375219; Loeffler J, 2001, J CLIN MICROBIOL, V39, P1626, DOI 10.1128/JCM.39.4.1626-1629.2001; Loeffler J, 2000, J CLIN MICROBIOL, V38, P3830, DOI 10.1128/JCM.38.10.3830-3833.2000; Maertens J, 2004, BRIT J HAEMATOL, V126, P852, DOI 10.1111/j.1365-2141.2004.05140.x; Maertens J, 2001, BLOOD, V97, P1604, DOI 10.1182/blood.V97.6.1604; Maertens J, 2004, CLIN INFECT DIS, V39, P1563, DOI 10.1086/423381; Marr K A, 2004, Transpl Infect Dis, V6, P110, DOI 10.1111/j.1399-3062.2004.00065.x; Marr KA, 2004, BLOOD, V103, P1527, DOI 10.1182/blood-2003-08-2644; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; Marr KA, 2000, J INFECT DIS, V181, P309, DOI 10.1086/315193; Marr KA, 2004, CLIN INFECT DIS, V39, P797, DOI 10.1086/423380; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Marty FM, 2003, BLOOD, V102, P2768, DOI 10.1182/blood-2003-01-0267; Marty FM, 2004, NEW ENGL J MED, V350, P950, DOI 10.1056/NEJM200402263500923; Mattei D, 2004, J CLIN MICROBIOL, V42, P5362, DOI 10.1128/JCM.42.11.5362-5363.2004; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Mennink-Kersten MASH, 2004, LANCET, V363, P325, DOI 10.1016/S0140-6736(03)15393-7; Mennink-Kersten MASH, 2004, LANCET INFECT DIS, V4, P349, DOI 10.1016/S1473-3099(04)01045-X; MENNINKKERSTEN MAS, 2004, 44 INT C ANT AG CHEM; MIYAZAKI T, 1995, J CLIN MICROBIOL, V33, P3115, DOI 10.1128/JCM.33.12.3115-3118.1995; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Musher B, 2004, J CLIN MICROBIOL, V42, P5517, DOI 10.1128/JCM.42.12.5517-5522.2004; NAKAJIMA M, 2000, 40 INT C ANT AG CHEM; Nucci M, 2001, J CLIN MICROBIOL, V39, P514, DOI 10.1128/JCM.39.2.514-518.2001; Nucci M, 2004, CLIN INFECT DIS, V38, P1237, DOI 10.1086/383319; Nucci M, 2002, CLIN INFECT DIS, V35, P909, DOI 10.1086/342328; Odabasi Z, 2004, CLIN INFECT DIS, V39, P199, DOI 10.1086/421944; Oren H, 2005, CLIN INFECT DIS, V40, P770, DOI 10.1086/427759; Ostrosky-Zeichner L, 2003, CLIN INFECT DIS, V37, P415, DOI 10.1086/376634; Ostrosky-Zeichner L, 2003, CURR OPIN INFECT DIS, V16, P533, DOI 10.1097/00001432-200312000-00004; Ostrosky-Zeichner L, 2003, EUR J CLIN MICROBIOL, V22, P651, DOI 10.1007/s10096-003-1014-3; Ostrosky-Zeichner L, 2003, ANTIMICROB AGENTS CH, V47, P3149, DOI 10.1128/AAC.47.10.3149-3154.2003; Palmer SM, 2001, TRANSPLANTATION, V72, P545, DOI 10.1097/00007890-200108150-00036; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; PAPPAS PG, 2003, 43 ICAAC ABSTR AM SO, P458; Patterson TF, 1999, J CHEMOTHERAPY, V11, P504, DOI 10.1179/joc.1999.11.6.504; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; Pazos C, 2005, J CLIN MICROBIOL, V43, P299, DOI 10.1128/JCM.43.1.299-305.2005; Peleg AY, 2004, J ANTIMICROB CHEMOTH, V54, P803, DOI 10.1093/jac/dkh403; Penack O, 2004, CLIN INFECT DIS, V39, P1401, DOI 10.1086/425131; Perfect JR, 2001, CLIN INFECT DIS, V33, P1824, DOI 10.1086/323900; Perfect JR, 2003, CLIN INFECT DIS, V36, P1122, DOI 10.1086/374557; Petraitiene R, 2001, ANTIMICROB AGENTS CH, V45, P857, DOI 10.1128/AAC.45.3.857-869.2001; Petraitiene R, 2002, ANTIMICROB AGENTS CH, V46, P12, DOI 10.1128/AAC.46.1.12-23.2002; Petraitis V, 2002, ANTIMICROB AGENTS CH, V46, P1857, DOI 10.1128/AAC.46.6.1857-1869.2002; Petraitis V, 2003, J INFECT DIS, V187, P1834, DOI 10.1086/375420; Petraitis V, 2001, ANTIMICROB AGENTS CH, V45, P471, DOI 10.1128/AAC.45.2.471-479.2001; Pfaller MA, 1997, ANTIMICROB AGENTS CH, V41, P763, DOI 10.1128/AAC.41.4.763; Pfaller MA, 2002, J CLIN MICROBIOL, V40, P1694, DOI 10.1128/JCM.40.5.1694-1697.2002; Pfaller MA, 2002, ANTIMICROB AGENTS CH, V46, P1723, DOI 10.1128/AAC.46.6.1723-1727.2002; Pfaller MA, 1998, J CLIN MICROBIOL, V36, P1886, DOI 10.1128/JCM.36.7.1886-1889.1998; Pfaller MA, 1998, DIAGN MICR INFEC DIS, V30, P121, DOI 10.1016/S0732-8893(97)00192-2; Pfaller MA, 2002, ANTIMICROB AGENTS CH, V46, P1032, DOI 10.1128/AAC.46.4.1032-1037.2002; Pfaller MA, 2001, J CLIN MICROBIOL, V39, P3254, DOI 10.1128/JCM.39.9.3254-3259.2001; Pham AS, 2003, AM J CLIN PATHOL, V119, P38, DOI 10.1309/RQ05PP9NEG6DADXR; Pinel C, 2003, J CLIN MICROBIOL, V41, P2184, DOI 10.1128/JCM.41.5.2184-2186.2003; Raad I., 2004, 44 INT C ANT AG CHEM; Ramage G, 2001, Am Clin Lab, V20, P42; Rangel-Frausto MS, 1999, CLIN INFECT DIS, V29, P253, DOI 10.1086/520194; Revankar SG, 2002, CLIN INFECT DIS, V34, P467, DOI 10.1086/338636; Rex JH, 1997, CLIN INFECT DIS, V24, P235, DOI 10.1093/clinids/24.2.235; Rex JH, 2003, CLIN INFECT DIS, V36, P1221, DOI 10.1086/374850; Roling EE, 2002, DIAGN MICR INFEC DIS, V43, P13, DOI 10.1016/S0732-8893(02)00361-9; Rubin MA, 2002, CLIN INFECT DIS, V34, P1160, DOI 10.1086/339755; Saag MS, 2000, CLIN INFECT DIS, V30, P710, DOI 10.1086/313757; SCHAFFNER A, 1985, J INFECT DIS, V151, P902, DOI 10.1093/infdis/151.5.902; Sendid B, 2002, J MED MICROBIOL, V51, P433, DOI 10.1099/0022-1317-51-5-433; Sigler L, 2003, MANUAL CLIN MICROBIO, P1726; Siwek GT, 2004, CLIN INFECT DIS, V39, P584, DOI 10.1086/422723; Steinbach WJ, 2003, J CLIN MICROBIOL, V41, P3981, DOI 10.1128/JCM.41.8.3981-3985.2003; Steinbach WJ, 2004, CLIN INFECT DIS, V39, P192, DOI 10.1086/421950; Steinhart H, 2003, CHEM UNSERER ZEIT, V37, P3, DOI 10.1002/ciuz.200390003; Stevens DA, 2000, CLIN INFECT DIS, V30, P696, DOI 10.1086/313756; Strahilevitz J, 2005, CLIN INFECT DIS, V40, P781, DOI 10.1086/428045; Sulahian A, 1996, EUR J CLIN MICROBIOL, V15, P139, DOI 10.1007/BF01591487; Sulahian A, 2003, NEW ENGL J MED, V349, P2366, DOI 10.1056/NEJM200312113492424; Sutton D. A., 1998, GUIDE CLIN SIGNIFICA; Sutton DA, 2002, CURR OPIN INFECT DIS, V15, P575, DOI 10.1097/00001432-200212000-00004; Swanink CMA, 1997, J CLIN MICROBIOL, V35, P257, DOI 10.1128/JCM.35.1.257-260.1997; Tortorano AM, 2002, J HOSP INFECT, V51, P297, DOI 10.1053/jhin.2002.1261; TROKE PF, 2003, 43 INT C ANT AG CHEM, P476; *US FDA, 2003, FDA CLEARS RAP TEST; van Burik JAH, 2004, CLIN INFECT DIS, V39, P1407, DOI 10.1086/422312; Verweij PE, 1998, MED MYCOL, V36, P146; Verweij PE, 2004, BRIT J HAEMATOL, V127, P235, DOI 10.1111/j.1365-2141.2004.05181.x; Vigouroux S, 2005, CLIN INFECT DIS, V40, pE35, DOI 10.1086/427752; VILLARREAL NC, 2004, 44 INT C ANT AG CHEM; Viscoli C, 2004, CLIN INFECT DIS, V39, P803, DOI 10.1086/423389; Viscoli C, 2004, CLIN INFECT DIS, V38, P913, DOI 10.1086/382224; Viscoli C, 2002, J CLIN MICROBIOL, V40, P1496, DOI 10.1128/JCM.40.4.1496-1499.2002; Viscoli C, 1999, CLIN INFECT DIS, V28, P1071, DOI 10.1086/514731; Viudes A, 2002, EUR J CLIN MICROBIOL, V21, P767, DOI 10.1007/s10096-002-0822-1; Wald A, 1997, J INFECT DIS, V175, P1459, DOI 10.1086/516480; WALSH TJ, 1991, NEW ENGL J MED, V324, P1026, DOI 10.1056/NEJM199104113241504; Walsh TJ, 2003, J INFECT DIS, V188, P305, DOI 10.1086/377210; Walsh TJ, 2002, PEDIATR INFECT DIS J, V21, P240, DOI 10.1097/00006454-200203000-00015; Walsh TJ, 2001, ANTIMICROB AGENTS CH, V45, P3487, DOI 10.1128/AAC.45.12.3487-3496.2001; Walsh TJ, 2004, J CLIN MICROBIOL, V42, P4744, DOI 10.1128/JCM.42.10.4744-4748.2004; Walsh TJ, 2002, NEW ENGL J MED, V346, P225, DOI 10.1056/NEJM200201243460403; Walsh TJ, 1998, CLIN INFECT DIS, V26, P1383, DOI 10.1086/516353; Warris A, 2001, NEW ENGL J MED, V344, P1099, DOI 10.1056/NEJM200104053441415; Warris A, 2002, CLIN INFECT DIS, V34, P1159, DOI 10.1086/339754; WEY SB, 1988, ARCH INTERN MED, V148, P2642, DOI 10.1001/archinte.148.12.2642; Wheat J, 1999, J CLIN MICROBIOL, V37, P2387; Wingard JR, 1999, CLIN INFECT DIS, V29, P1402, DOI 10.1086/313498; Wingard JR, 2000, CLIN INFECT DIS, V31, P1155, DOI 10.1086/317451; Winston DJ, 2003, ANN INTERN MED, V138, P705, DOI 10.7326/0003-4819-138-9-200305060-00006	181	172	188	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					1013	1025		10.1016/S0140-6736(05)67381-3	http://dx.doi.org/10.1016/S0140-6736(05)67381-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168784				2022-12-28	WOS:000231955900037
J	Sharp, D				Sharp, D			Genetic epidemiology: strengths, weaknesses, and opportunities	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Keavney B, 2000, LANCET, V355, P434; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; WOLPERT L, 1984, LANCET, V2, P853	3	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 10	2005	366	9489					880	880		10.1016/S0140-6736(05)67299-6	http://dx.doi.org/10.1016/S0140-6736(05)67299-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154001				2022-12-28	WOS:000231770000009
J	Chipuk, JE; Bouchier-Hayes, L; Kuwana, T; Newmeyer, DD; Green, DR				Chipuk, JE; Bouchier-Hayes, L; Kuwana, T; Newmeyer, DD; Green, DR			PUMA couples the nuclear and cytoplasmic proapoptotic function of p53	SCIENCE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; CELL-DEATH; APOPTOTIC RESPONSE; DNA-DAMAGE; BAX; ACTIVATION; PROTEINS; COMPLEX; BCL-2; GENE	The Trp53 tumor suppressor gene product (p53) functions in the nucleus to regulate proapoptotic genes, whereas cytoplasmic p53 directly activates proapoptotic Bcl-2 proteins to permeabilize mitochondria and initiate apoptosis. Here, we demonstrate that a tripartite nexus between Bcl-xL, cytoplasmic p53, and PUMA coordinates these distinct p53 functions. After genotoxic stress, Bcl-xL sequestered cytoplasmic p53. Nuclear p53 caused expression of PUMA, which then displaced p53 from Bcl-xL, allowing p53 to induce mitochondria) permeabilization. Mutant Bcl-xL that bound p53, but not PUMA, rendered cells resistant to p53-induced apoptosis irrespective of PUMA expression. Thus, PUMA couples the nuclear and cytoplasmic proapoptotic functions of p53.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA	La Jolla Institute for Immunology; University of Iowa	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	dgreen5240@aol.com	Bouchier-Hayes, Lisa/T-9491-2019; Green, Douglas R/N-8083-2018	Bouchier-Hayes, Lisa/0000-0003-3886-5977; Green, Douglas R/0000-0002-7332-1417; Chipuk, Jerry Edward/0000-0002-1337-842X				CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Klockel BJ, 2002, CELL DEATH DIFFER, V9, P1063, DOI 10.1038/sj.cdd.4401067; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100	27	445	472	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2005	309	5741					1732	1735		10.1126/science.1114297	http://dx.doi.org/10.1126/science.1114297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151013				2022-12-28	WOS:000231836700047
J	Ogawa, S; Lozach, J; Benner, C; Pascual, G; Tangirala, RK; Westin, S; Hoffmann, A; Subramaniam, S; David, M; Rosenfeld, MG; Glass, CK				Ogawa, S; Lozach, J; Benner, C; Pascual, G; Tangirala, RK; Westin, S; Hoffmann, A; Subramaniam, S; David, M; Rosenfeld, MG; Glass, CK			Molecular determinants of crosstalk between nuclear receptors and toll-like receptors	CELL			English	Article							NF-KAPPA-B; OXIDE SYNTHASE GENE; GLUCOCORTICOID-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; MACROPHAGE ACTIVATION; FUNCTIONAL ANTAGONISM; REGULATORY FACTOR-3; SIGNALING PATHWAYS; RESPONSE ELEMENT; P65 SUBUNIT	Nuclear receptors (NRs) repress transcriptional responses to diverse signaling pathways as an essential aspect of their biological activities, but mechanisms determining the specificity and functional consequences of transrepression remain poorly understood. Here, we report signal- and gene-specific repression of transcriptional responses initiated by engagement of toll-like receptors (TLR) 3, 4, and 9 in macrophages. The glucocorticoid receptor (GR) represses a large set of functionally related inflammatory response genes by disrupting p65/interferon regulatory factor (IRF) complexes required for TLR4- or TLR9-dependent, but not TLR3-dependent, transcriptional activation. This mechanism requires signaling through MyD88 and enables the GR to differentially regulate pathogen-specific programs of gene expression. PPAR gamma and LXRs repress overlapping transcriptional targets by p65/IRF3-independent mechanisms and cooperate with the GR to synergistically transrepress distinct subsets of TLR-responsive genes. These findings reveal combinatorial control of homeostasis and immune responses by nuclear receptors and suggest new approaches for treatment of inflammatory diseases.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Exelixis Inc, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Chem & Biochem, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Exelixis, Inc.; Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	cglass@ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Benner, Christopher/0000-0002-4618-0719	NCI NIH HHS [CA52599, R01 CA052599] Funding Source: Medline; NIAID NIH HHS [R01 AI047182] Funding Source: Medline; NIDDK NIH HHS [R01 DK091183, DK063491] Funding Source: Medline; NIGMS NIH HHS [GM069338, U54 GM069338] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA052599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091183, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ashburner M, 2001, GENOME RES, V11, P1425; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bladh LG, 2005, MOL PHARMACOL, V67, P815, DOI 10.1124/mol.104.005801; Caelles C, 1997, GENE DEV, V11, P3351, DOI 10.1101/gad.11.24.3351; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Halees AS, 2003, NUCLEIC ACIDS RES, V31, P3554, DOI 10.1093/nar/gkg549; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kanehisa M., 1996, SCI TECHNOL JAPAN, V59, P34; Kassel O, 2004, GENE DEV, V18, P2518, DOI 10.1101/gad.322404; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Liden J, 1997, J BIOL CHEM, V272, P21467, DOI 10.1074/jbc.272.34.21467; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Nagpal S, 2001, CURR MED CHEM, V8, P1661, DOI 10.2174/0929867013371950; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Pitha PM, 2004, P NATL ACAD SCI USA, V101, P695, DOI 10.1073/pnas.0307303101; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Ricote M, 2004, ARTERIOSCL THROM VAS, V24, P230, DOI 10.1161/01.ATV.0000103951.67680.B1; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SEGAL E, 2002, P 6 INT C RES COMP M, P263; Servant MJ, 2002, BIOCHEM PHARMACOL, V64, P985, DOI 10.1016/S0006-2952(02)01165-6; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Wietek C, 2003, J BIOL CHEM, V278, P50923, DOI 10.1074/jbc.M308135200	50	527	546	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					707	721		10.1016/j.cell.2005.06.029	http://dx.doi.org/10.1016/j.cell.2005.06.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143103	Green Accepted, Bronze			2022-12-28	WOS:000231844300011
J	Nelson, HD; Huffman, LH; Fu, RW; Harris, EL				Nelson, HD; Huffman, LH; Fu, RW; Harris, EL			Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Systematic evidence review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							BILATERAL PROPHYLACTIC MASTECTOMY; INTERPRETING FAMILY HISTORIES; SURGICAL ADJUVANT BREAST; POPULATION-BASED SAMPLE; ASHKENAZI JEWISH WOMEN; PSYCHOLOGICAL IMPACT; HEREDITARY BREAST; INHERITED MUTATIONS; GERMLINE MUTATIONS; RANDOMIZED-TRIAL	Background: Clinically significant mutations of BRCA1 and BRCA2 genes are associated with increased susceptibility for breast and ovarian cancer. Although these mutations are uncommon, public interest in testing for them is growing. Purpose: To determine benefits and harms of screening for in-herited breast and ovarian cancer susceptibility in the general population of women without cancer presenting for primary health care in the United States. Data Sources: MEDLINE (1966 to 1 October 2004), Cochrane Library databases, reference lists, reviews, Web sites, and experts. Study Selection: Eligibility was determined by inclusion criteria specific to key questions about risk assessment, genetic counseling, mutation testing, prevention interventions, and potential adverse effects. Data Extraction: After review of studies, data were extracted, entered into evidence tables, and summarized by using descriptive or statistical methods. Study quality was rated by using predefined criteria. Data Synthesis: Tools assessing risks for mutations and referral guidelines have been developed; their accuracy, effectiveness, and adverse effects in primary care settings are unknown. Risk assessment, genetic counseling, and mutation testing did not cause adverse psychological outcomes, and counseling improved distress and risk perception in the highly selected populations studied. Intensive cancer screening studies are inconclusive. Chemoprevention trials indicate risk reduction for breast cancer in women with varying levels of risk, as well as increased adverse effects. observational studies of prophylactic surgeries report reduced risks for breast and ovarian cancer in mutation carriers. Limitations: No data describe the range of risk associated with BRCA mutations, genetic heterogeneity, and moderating factors; studies conducted in highly selected populations contain biases; and information on adverse effects is incomplete. Conclusions: A primary care approach to screening for inherited breast and ovarian cancer susceptibility has not been evaluated, and evidence is lacking to determine benefits and harms for the general population.	Oregon Hlth & Sci Univ, Portland, OR 97239 USA; Kaiser Permanente Ctr Hlth Res, Portland, OR USA	Oregon Health & Science University; Kaiser Permanente	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Mail Code BICC 504,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu			PHS HHS [290-02-0024] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM COLL MED GE PR, 1999, GEN SUSC BREAST OV C; [Anonymous], 1975, Am J Hum Genet, V27, P240; [Anonymous], 1995, JAMA, V273, P491; [Anonymous], 1996, J CLIN ONCOL, V14, P1737; Anton-Culver H, 2000, EUR J CANCER, V36, P1200, DOI 10.1016/S0959-8049(00)00110-6; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Arason A, 1998, J MED GENET, V35, P446, DOI 10.1136/jmg.35.6.446; Aziz S, 2001, GYNECOL ONCOL, V80, P341, DOI 10.1006/gyno.2000.6095; Bandera CA, 1998, OBSTET GYNECOL, V92, P596, DOI 10.1016/S0029-7844(98)00223-3; Begg CB, 2002, J NATL CANCER I, V94, P1221; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Berg AO, 2002, ANN INTERN MED, V137, P56, DOI 10.7326/0003-4819-137-1-200207020-00016; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Berry DA, 2002, J CLIN ONCOL, V20, P2701, DOI 10.1200/JCO.2002.05.121; Berry DA, 1997, J NATL CANCER I, V89, P227, DOI 10.1093/jnci/89.3.227; Bish A, 2002, GENET MED, V4, P353, DOI 10.1097/00125817-200209000-00006; Blackwood A, 2001, BREAST CANCER RES TR, V69, P223; BOURNE TH, 1993, BRIT MED J, V306, P1025, DOI 10.1136/bmj.306.6884.1025; Bowen DJ, 2004, PATIENT EDUC COUNS, V53, P79, DOI 10.1016/S0738-3991(03)00122-8; Bowen DJ, 2002, GENET MED, V4, P359, DOI 10.1097/00125817-200209000-00007; Bowen DJ, 1998, J CLIN PSYCHOL MED S, V5, P365, DOI 10.1023/A:1026262321756; Brain K, 2002, BRIT J CANCER, V86, P233, DOI 10.1038/sj.bjc.6600051; Brekelmans CTM, 2001, J CLIN ONCOL, V19, P924, DOI 10.1200/JCO.2001.19.4.924; BRINTON LA, 1988, CANCER INVEST, V6, P245, DOI 10.3109/07357908809080645; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Burke W, 2000, AM J MED GENET, V90, P361, DOI 10.1002/(SICI)1096-8628(20000228)90:5<361::AID-AJMG4>3.0.CO;2-8; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Cauley JA, 1999, ANN INTERN MED, V130, P270, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00004; Chart PL, 1997, CAN MED ASSOC J, V157, P1235; Contant CME, 2002, EUR J SURG ONCOL, V28, P627, DOI 10.1053/ejso.2002.1279; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Coulson AS, 2001, METHOD INFORM MED, V40, P315, DOI 10.1055/s-0038-1634427; Cull A, 1998, BRIT J CANCER, V77, P830, DOI 10.1038/bjc.1998.135; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cuzick J, 2002, LANCET, V360, P817; DAY NE, 1989, BRIT J CANCER, V59, P954, DOI 10.1038/bjc.1989.203; Day R, 2001, ANN NY ACAD SCI, V949, P143; de Bock GH, 1999, FAM PRACT, V16, P71, DOI 10.1093/fampra/16.1.71; DENNERSTEIN L, 1977, OBSTET GYNECOL, V49, P92; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Domchek SM, 2003, J CLIN ONCOL, V21, P593, DOI 10.1200/JCO.2003.07.007; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; Eccles DM, 2000, J MED GENET, V37, P203, DOI 10.1136/jmg.37.3.203; Eccles DM, 1999, DIS MARKERS, V15, P187, DOI 10.1155/1999/809015; Einbeigi Z, 2001, EUR J CANCER, V37, P1904, DOI 10.1016/S0959-8049(01)00223-4; Eisen A, 2000, J CLIN ONCOL, V18, P1980, DOI 10.1200/JCO.2000.18.9.1980; Eisinger F, 1997, J NATL CANCER I, V89, P731, DOI 10.1093/jnci/89.10.731; Elwyn G, 2002, FAM PRACT, V19, P65, DOI 10.1093/fampra/19.1.65; Emery J, 2000, BMJ-BRIT MED J, V321, P28, DOI 10.1136/bmj.321.7252.28; Emery J, 1999, BRIT MED J, V319, P32, DOI 10.1136/bmj.319.7201.32; Eng C, 2001, J MED GENET, V38, P824, DOI 10.1136/jmg.38.12.824; Euhus David, 2004, Breast J, V10 Suppl 1, pS10, DOI 10.1111/j.1524-4741.2004.101S4.x; Euhus DM, 2002, J NATL CANCER I, V94, P844, DOI 10.1093/jnci/94.11.844; Evans DGR, 2004, J MED GENET, V41, P474, DOI 10.1136/jmg.2003.017996; EVERSON SA, 1995, HEALTH PSYCHOL, V14, P435, DOI 10.1037/0278-6133.14.5.435; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FORD D, 1995, BRIT J CANCER, V72, P805, DOI 10.1038/bjc.1995.417; Fracheboud J, 1998, INT J CANCER, V75, P694, DOI 10.1002/(SICI)1097-0215(19980302)75:5<694::AID-IJC6>3.0.CO;2-U; FRANCESCHI S, 1991, INT J CANCER, V49, P61, DOI 10.1002/ijc.2910490112; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Friedman LC, 1999, GENET MED, V1, P74; Fries MH, 2002, MIL MED, V167, P93, DOI 10.1093/milmed/167.2.93; Frost MH, 2000, JAMA-J AM MED ASSOC, V284, P319, DOI 10.1001/jama.284.3.319; Fry A, 2001, PSYCHO-ONCOL, V10, P231, DOI 10.1002/pon.512; Gabrick DM, 2000, JAMA-J AM MED ASSOC, V284, P1791, DOI 10.1001/jama.284.14.1791; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; Gilpin CA, 2000, CLIN GENET, V58, P299, DOI 10.1034/j.1399-0004.2000.580408.x; GOODNIGHT JE, 1984, J SURG ONCOL, V26, P198, DOI 10.1002/jso.2930260313; Grana G., 1994, Breast Cancer Research and Treatment, V32, P72; Green MJ, 2004, JAMA-J AM MED ASSOC, V292, P442, DOI 10.1001/jama.292.4.442; Gui GPH, 2001, EUR J CANCER, V37, P1668, DOI 10.1016/S0959-8049(01)00207-6; GWINN ML, 1990, J CLIN EPIDEMIOL, V43, P559, DOI 10.1016/0895-4356(90)90160-Q; Hampel H, 2004, J MED GENET, V41, P81, DOI 10.1136/jmg.2003.010918; HANKINSON SE, 1993, JAMA-J AM MED ASSOC, V270, P2813, DOI 10.1001/jama.270.23.2813; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Hatcher MB, 2001, BRIT MED J, V322, P76, DOI 10.1136/bmj.322.7278.76; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Hopwood P, 1998, PSYCHO-ONCOL, V7, P402, DOI 10.1002/(SICI)1099-1611(1998090)7:5<402::AID-PON317>3.3.CO;2-O; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kerber RA, 1997, AM J EPIDEMIOL, V146, P244; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Klaren HM, 2003, J NATL CANCER I, V95, P941, DOI 10.1093/jnci/95.13.941; Kollias J, 1998, EUR J CANCER, V34, P878, DOI 10.1016/S0959-8049(97)00365-1; Komenaka IK, 2004, CANCER, V100, P2079, DOI 10.1002/cncr.20221; Lai MS, 1998, INT J CANCER, V78, P21, DOI 10.1002/(SICI)1097-0215(19980925)78:1<21::AID-IJC5>3.0.CO;2-Z; Lakhani SR, 1997, LANCET, V349, P1505; Lalloo F, 1998, EUR J CANCER, V34, P937, DOI 10.1016/S0959-8049(98)00005-7; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; Law J, 1997, BRIT J RADIOL, V70, P62, DOI 10.1259/bjr.70.829.9059297; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Lerman C, 1996, HEALTH PSYCHOL, V15, P75; LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259; Lerman C, 1998, J CLIN ONCOL, V16, P1650, DOI 10.1200/JCO.1998.16.5.1650; LERMAN C, 1995, J NATL CANCER I, V87, P286, DOI 10.1093/jnci/87.4.286; Lerman C, 1999, CANCER EPIDEM BIOMAR, V8, P361; LERMAN C, 1998, J HLTH CARE LAW POLI, V1, P353; Liede A, 2004, J CLIN ONCOL, V22, P735, DOI 10.1200/JCO.2004.05.055; Lindor NM, 1998, JNCI-J NATL CANCER I, V90, P1039, DOI 10.1093/jnci/90.14.1039; Lobb E, 2002, J MED GENET, V39, P697, DOI 10.1136/jmg.39.9.697; Lobb EA, 2004, BRIT J CANCER, V90, P321, DOI 10.1038/sj.bjc.6601502; Lucassen A, 2001, FAM PRACT, V18, P135, DOI 10.1093/fampra/18.2.135; Malone KE, 2000, CANCER, V88, P1393, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P; McGuire V, 2004, AM J EPIDEMIOL, V160, P613, DOI 10.1093/aje/kwh284; MEIJER WJ, 1992, EUR J OBSTET GYN R B, V47, P59, DOI 10.1016/0028-2243(92)90215-K; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Meiser B, 2002, SOC SCI MED, V54, P1463, DOI 10.1016/S0277-9536(01)00133-2; Meiser B, 2002, EUR J CANCER, V38, P2025, DOI 10.1016/S0959-8049(02)00264-2; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moller P, 1996, ACTA ONCOL, V35, P7, DOI 10.3109/02841869609098515; Moller P, 1999, DIS MARKERS, V15, P207, DOI 10.1155/1999/920109; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; Mouchawar J, 2003, GENET MED, V5, P444, DOI 10.1097/01.GIM.0000093979.08524.86; Murff HJ, 2004, JAMA-J AM MED ASSOC, V292, P1480, DOI 10.1001/jama.292.12.1480; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Narod SA, 2001, LANCET, V357, P1467, DOI 10.1016/S0140-6736(00)04642-0; *NAT BREAST CANC C, ADV FAM ASP BREAST C; NATHORSTBOOS J, 1993, J PSYCHOSOM OBST GYN, V14, P283; NELSON HD, 2005, IN PRESS GENETIC RIS; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Paley PJ, 2001, GYNECOL ONCOL, V80, P176, DOI 10.1006/gyno.2000.6071; Parazzini F, 1997, OBSTET GYNECOL, V90, P453, DOI 10.1016/S0029-7844(97)00295-0; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Peelen T, 1997, AM J HUM GENET, V60, P1041; PENNISI VR, 1989, AESTHET PLAST SURG, V13, P15, DOI 10.1007/BF01570320; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P2751, DOI 10.1002/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Powles T, 1998, LANCET, V352, P98; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Rebbeck TR, 2002, EUR J CANCER, V38, pS15; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Ries L, 2004, SEER CANC STAT REV 1; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Rosenblatt KA, 1996, CANCER EPIDEM BIOMAR, V5, P933; Saetersdal A, 1996, ANTICANCER RES, V16, P1989; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Schairer C, 1997, INT J CANCER, V70, P150, DOI 10.1002/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; Skinner CS, 2002, GENET TEST, V6, P93, DOI 10.1089/10906570260199348; Smith KR, 1999, CANCER EPIDEM BIOMAR, V8, P385; Srivastava A, 2001, ONCOLOGY-NY, V15, P889; Stefanek M E, 1995, J Natl Cancer Inst Monogr, P37; Stratton JF, 1997, NEW ENGL J MED, V336, P1125, DOI 10.1056/NEJM199704173361602; Struewing J P, 1995, J Natl Cancer Inst Monogr, P33; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Tilanus-Linthorst MMA, 2000, EUR J CANCER, V36, P514, DOI 10.1016/S0959-8049(99)00337-8; Tiller K, 2002, GYNECOL ONCOL, V86, P212, DOI 10.1006/gyno.2002.6737; TOBACMAN JK, 1982, LANCET, V2, P795; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; Unger MA, 2000, AM J HUM GENET, V67, P841, DOI 10.1086/303076; Ursin G, 1997, CANCER RES, V57, P3678; *US PREV SERV TASK, REC RAT SCREEN OV CA; Veronesi U, 1998, LANCET, V352, P93; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317; Watson M, 1999, BRIT J CANCER, V79, P868, DOI 10.1038/sj.bjc.6690139; Watson M, 1998, J MED GENET, V35, P731, DOI 10.1136/jmg.35.9.731; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1184, DOI 10.1093/oxfordjournals.aje.a116427; Wickerham DL, 2002, EUR J CANCER, V38, pS20; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; 2004, MMWR MORB MORTAL WKL, V53, P603; 2004, PHASE 3 RANDOMIZED S	180	259	270	1	35	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2005	143	5					362	379		10.7326/0003-4819-143-5-200509060-00012	http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00012			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961TE	16144895				2022-12-28	WOS:000231683900006
J	Beauchamp, GK; Keast, RSJ; Morel, D; Lin, JM; Pika, J; Han, Q; Lee, CH; Smith, AB; Breslin, PAS				Beauchamp, GK; Keast, RSJ; Morel, D; Lin, JM; Pika, J; Han, Q; Lee, CH; Smith, AB; Breslin, PAS			Phytochemistry - Ibuprofen-like activity in extra-virgin olive oil	NATURE			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HYDROXYTYROSOL		Univ Sci Philadelphia, Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; Univ Sci Philadelphia, Dept Pharmacol & Toxicol, Philadelphia, PA 19104 USA; Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; Konkuk Univ, Anim Resources Res Ctr, Seoul 143130, South Korea; Firmenich Co, Princeton, NJ 08543 USA	Monell Chemical Senses Center; University of Pennsylvania; Konkuk University; Firmenich	Breslin, PAS (corresponding author), Univ Sci Philadelphia, Monell Chem Senses Ctr, Philadelphia, PA 19104 USA.	breslin@monell.org	Keast, Russell S/P-1899-2017	Keast, Russell S/0000-0003-2147-7687; Breslin, Paul/0000-0001-5988-8401				Andrewes P, 2003, J AGR FOOD CHEM, V51, P1415, DOI 10.1021/jf026042j; Breslin PAS, 2001, CHEM SENSES, V26, P55, DOI 10.1093/chemse/26.1.55; FISCHER R, 1965, NATURE, V207, P1049, DOI 10.1038/2071049a0; Harris RE, 2005, ONCOL REP, V13, P559; Hennekens CH, 2002, AM J MANAG CARE, V8, pS691; Hu FB, 2003, NEW ENGL J MED, V348, P2595, DOI 10.1056/NEJMp030069; LEFER AM, 1984, BRIT J PHARMACOL, V83, P125, DOI 10.1111/j.1476-5381.1984.tb10126.x; Miro-Casas E, 2003, CLIN CHEM, V49, P945, DOI 10.1373/49.6.945; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; Togna GI, 2003, J NUTR, V133, P2532, DOI 10.1093/jn/133.8.2532; Tuck KL, 2001, J NUTR, V131, P1993, DOI 10.1093/jn/131.7.1993; VANE JR, 1995, INFLAMM RES, V44, P1, DOI 10.1007/BF01630479; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	13	637	659	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					45	46		10.1038/437045a	http://dx.doi.org/10.1038/437045a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136122				2022-12-28	WOS:000231560400033
J	Ostriker, JP				Ostriker, JP			John Norris Bahcall 1935-2005 - Obituary	NATURE			English	Biographical-Item									Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	Princeton University	Ostriker, JP (corresponding author), Princeton Univ, Dept Astrophys Sci, Peyton Hall,Ivy Lane, Princeton, NJ 08544 USA.	ostriker@princeton.edu						BAHCALL JN, PUBLICATION LIST	1	1	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					43	43		10.1038/437043a	http://dx.doi.org/10.1038/437043a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136121	Bronze			2022-12-28	WOS:000231560400032
J	Ray, A				Ray, A			Plant genetics - RNA cache genome trash?	NATURE			English	Editorial Material									Keck Grad Inst, Claremont, CA 91711 USA	Claremont Colleges; Keck Graduate Institute	Ray, A (corresponding author), Keck Grad Inst, Claremont, CA 91711 USA.	aray@kgi.edu		Ray, Animesh/0000-0002-0120-5820				BALTIMORE D, 1985, CELL, V40, P481, DOI 10.1016/0092-8674(85)90190-4; CHAUDHURY A, 2005, NATURE; DOWNS DM, 1987, GENETICS, V117, P367; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; NICOLAS A, 1994, EXPERIENTIA, V50, P242, DOI 10.1007/BF01924007; STEBBINS GL, 1971, CHROMOSOMAL EVOLUTIO, P67	6	14	14	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					E1	E2		10.1038/nature04063	http://dx.doi.org/10.1038/nature04063			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136081	hybrid			2022-12-28	WOS:000231560400036
J	Kapp, C				Kapp, C			Hamilton Naki - Obituary	LANCET			English	Biographical-Item												nulliskapp@mweb.co.za							0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2005	366	9479					22	22		10.1016/S0140-6736(05)66811-0	http://dx.doi.org/10.1016/S0140-6736(05)66811-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942JB	16127806	Bronze			2022-12-28	WOS:000230277600015
J	Skjaerven, R; Vatten, LJ; Wilcox, AJ; Ronning, T; Irgens, LM; Lie, RT				Skjaerven, R; Vatten, LJ; Wilcox, AJ; Ronning, T; Irgens, LM; Lie, RT			Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort	BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; GESTATIONAL HYPERTENSION; ABRUPTIO PLACENTAE; ECLAMPSIA; FAMILY; PREDISPOSITION; PREGNANCIES; MORTALITY; GROWTH; WOMEN	Objectives To assess the impact on risk of pre-eclampsia of genes that work through the mother, and genes of paternal origin that work through the fetus. Design Population based cohort study. Setting Registry data from Norway. Participants Linked generational data from the medical birth registry of Norway (1967-2003): 438 597 mother-offspring units and 286 945 father-offspring units. Main outcome measures Pre-eclampsia in the second generation. Results The daughters of women who had pre-eclampsia during pregnancy had more than twice the risk of pre-eclampsia themselves (odds ratio 2.2, 95% confidence interval 2.0 to 2.4) compared with other women. Men born after a pregnancy complicated by pre-eclampsia had a moderately increased risk of fathering a pre-eclamptic pregnancy (1.5, 1.3 to 1.7). Sisters of affected men or women who were themselves born after pregnancies not complicated by pre-eclampsia, also had an increased risk (2.0, 1.7 to 2.3). Women and men born after pre-eclamptic pregnancies were more likely to trigger severe pre-eclampsia in their own pregnancy (3.0, 2.4 to 3.7, for mothers and 1.9, 1.4 to 2.5, for fathers). Conclusion Maternal genes and fetal genes from either the mother or father may trigger pre-eclampsia. The maternal association is stronger than the fetal association. The familial association predicts more severe pre-eclampsia.	Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5020 Bergen, Norway; Norwegian Univ Sci & Technol, Fac Med, N-7034 Trondheim, Norway; NIEHS, Res Triangle Pk, NC 27709 USA; Norwegian Inst Publ Hlth, Div Genes & Environm, Oslo, Norway; Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway	University of Bergen; Norwegian University of Science & Technology (NTNU); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH)	Skjaerven, R (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5020 Bergen, Norway.	Rolv.Skjaerven@smis.uib.no	Vatten, Lars/AFK-2073-2022; Wilcox, Allen J/C-7723-2019; Vatten, Lars/AAF-9380-2022	Wilcox, Allen J/0000-0002-3376-1311; 				ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; CHESLEY LC, 1986, BRIT J OBSTET GYNAEC, V93, P898, DOI 10.1111/j.1471-0528.1986.tb08006.x; Cincotta RB, 1998, INT J GYNECOL OBSTET, V60, P23, DOI 10.1016/S0020-7292(97)00241-5; Cnattingius S, 1997, AM J OBSTET GYNECOL, V177, P156, DOI 10.1016/S0002-9378(97)70455-1; COOPER DW, 1988, BRIT J OBSTET GYNAEC, V95, P644, DOI 10.1111/j.1471-0528.1988.tb06524.x; Dalaker K, 1999, CLIN GUIDELINES OBST; Dekker G A, 1998, Obstet Gynecol Surv, V53, P377, DOI 10.1097/00006254-199806000-00023; Engeland A, 2004, EPIDEMIOLOGY, V15, P79, DOI 10.1097/01.ede.0000100148.40711.59; Esplin MS, 2001, NEW ENGL J MED, V344, P867, DOI 10.1056/NEJM200103223441201; Ghidini A, 1997, OBSTET GYNECOL, V90, P542, DOI 10.1016/S0029-7844(97)00360-8; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Mogren I, 1999, EPIDEMIOLOGY, V10, P518, DOI 10.1097/00001648-199909000-00009; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Nilsson E, 2004, BJOG-INT J OBSTET GY, V111, P200, DOI 10.1111/j.1471-0528.2004.00042x.x; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Odegard RA, 2000, BRIT J OBSTET GYNAEC, V107, P1410, DOI 10.1111/j.1471-0528.2000.tb11657.x; Pawitan Y, 2004, STAT MED, V23, P449, DOI 10.1002/sim.1603; Pipkin FB, 2001, NEW ENGL J MED, V344, P925, DOI 10.1056/NEJM200103223441209; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; TEASDALE F, 1985, AM J OBSTET GYNECOL, V152, P25, DOI 10.1016/S0002-9378(85)80170-8; VATTEN LJ, 2004, BJOG, V11, P298; Xiong X, 2002, AM J EPIDEMIOL, V155, P203, DOI 10.1093/aje/155.3.203	25	195	200	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 15	2005	331	7521					877	879		10.1136/bmj.38555.462685.8F	http://dx.doi.org/10.1136/bmj.38555.462685.8F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975SX	16169871	Green Published, Bronze			2022-12-28	WOS:000232683300021
J	Coller, J; Parker, R				Coller, J; Parker, R			General translational repression by activators of mRNA decapping	CELL			English	Article							DEAD BOX PROTEIN; BINDING-PROTEIN; INITIATION; COMPLEX; OVEREXPRESSION; RCK/P54; EXPRESSION; HELICASE; DECAY; IDENTIFICATION	Translation and mRNA degradation are affected by a key transition where eukaryotic mRNAs exit translation and assemble an mRNP state that accumulates into processing bodies (P bodies), cytoplasmic sites of mRNA degradation containing nontranslating mRNAs, and mRNA degradation machinery. We identify the decapping activators Dhh1p and Pat1p as functioning as translational repressors and facilitators of P body formation. Strains lacking both Dhh1p and Pat1p show strong defects in mRNA decapping and P body formation and are blocked in translational repression. Contrastingly, overexpression of Dhh1p or Pat1p causes translational repression, P body formation, and arrests cell growth. Dhh1p, and its human homolog, RCK/p54, repress translation in vitro, and Dhh1p function is bypassed in vivo by inhibition of translational initiation. These results identify a broadly acting mechanism of translational repression that targets mRNAs for decapping and functions in translational control. We propose this mechanism is competitively balanced with translation, and shifting this balance is an important basis of translational control.	Univ Arizona, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu		Coller, Jeff/0000-0001-5662-8110	NIGMS NIH HHS [R37 GM045443, R01 GM045443, GM45443] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, R37GM045443] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akao Y, 1998, FEBS LETT, V429, P279, DOI 10.1016/S0014-5793(98)00605-X; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Hashimoto K, 2001, CARCINOGENESIS, V22, P1965, DOI 10.1093/carcin/22.12.1965; Holmes LEA, 2004, MOL CELL BIOL, V24, P2998, DOI 10.1128/MCB.24.7.2998-3010.2004; Iizuka N, 1997, METHODS, V11, P353, DOI 10.1006/meth.1996.0433; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Miyaji K, 2003, J VIRAL HEPATITIS, V10, P241, DOI 10.1046/j.1365-2893.2003.00447.x; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; MURRAY MT, 1991, J CELL BIOL, V112, P1, DOI 10.1083/jcb.112.1.1; Nakagawa Y, 1999, BRIT J CANCER, V80, P914, DOI 10.1038/sj.bjc.6690441; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Otero LJ, 2001, RNA, V7, P1753; ROTHER RP, 1992, EUR J BIOCHEM, V206, P673, DOI 10.1111/j.1432-1033.1992.tb16973.x; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; Tseng-Rogenski SSI, 2003, NUCLEIC ACIDS RES, V31, P4995, DOI 10.1093/nar/gkg712; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Westmoreland TJ, 2003, J SURG RES, V113, P62, DOI 10.1016/S0022-4804(03)00155-0; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wyers F, 2000, MOL CELL BIOL, V20, P3538, DOI 10.1128/MCB.20.10.3538-3549.2000	46	464	472	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					875	886		10.1016/j.cell.2005.07.012	http://dx.doi.org/10.1016/j.cell.2005.07.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179257	Green Accepted, Bronze			2022-12-28	WOS:000232130200012
J	Hansen, RA; Gartlehner, G; Lohr, KN; Gaynes, BN; Carey, TS				Hansen, RA; Gartlehner, G; Lohr, KN; Gaynes, BN; Carey, TS			Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder	ANNALS OF INTERNAL MEDICINE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; BUPROPION SUSTAINED-RELEASE; VENLAFAXINE EXTENDED-RELEASE; TRIAL COMPARING SERTRALINE; LONG-TERM TREATMENT; QUALITY-OF-LIFE; DOUBLE-BLIND; PRIMARY-CARE; REMISSION RATES; CLINICAL-TRIALS	Background: Reviews have compared the efficacy and tolerability of newer second-generation antidepressants with those of placebo or older treatments, but comparative evidence for use of second-generation antidepressants to treat major depressive disorder has not been evaluated. Purpose: To systematically evaluate comparative data on the efficacy, effectiveness, and tolerability of commonly prescribed second-generation antidepressants (selective serotonin reuptake inhibitors, bupropion, duloxetine, mirtazapine, and venlafaxine) in the treatment of major depressive disorder. Data Sources: MEDLINE, EMBASE, and PsychLit; the Cochrane Library; and the International Pharmaceutical Abstracts were searched from January 1980 through February 2005 for reviews; randomized, controlled trials; meta-analyses; and observational studies. Study Selection: The authors reviewed 46 head-to-head randomized, controlled trials comparing one second-generation antidepressant with another. Twenty-four observational studies and placebo-controlled trials were also included for assessment of safety and tolerability. Data Extraction: Two researchers independently reviewed titles and abstracts. Trained reviewers abstracted data from each study and assigned an initial quality rating. A second reviewer verified the data extraction and quality rating. Data Synthesis: According to fair to good evidence, the second-generation antidepressants that were compared had only minimal differences in efficacy, and 88% of comparative efficacy studies reported no statistically significant difference in any outcome measure at the end of the study. One effectiveness trial rated good and 2 effectiveness trials rated fair reported no statistically significant differences in primary outcome measures for compared drugs. Meta-analyses showed a modest but statistically significant additional treatment effect for sertraline and venlafaxine compared with fluoxetine. About 96% of comparative trials were sponsored by or had at least 1 author affiliated with a pharmaceutical company; the remaining trials did not report funding sources. Adverse event profiles differed among drugs; however, the degree and quality of adverse event assessment varied and only 13% of trials used a standardized scale to assess adverse events. Limitations: Quantitative analyses could not be done for many drug comparisons because the quantity and quality of the evidence were inadequate. Most published evidence was from trials sponsored by pharmaceutical companies, and publication bias may have occurred. Conclusions: Overall, second-generation antidepressants probably do not differ substantially for treatment of major depressive disorder. Choosing the agent that is most appropriate for a given patient is difficult.	Univ N Carolina, Div Pharmaceut Policy & Evaluat Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Hansen, RA (corresponding author), Univ N Carolina, Div Pharmaceut Policy & Evaluat Sci, Room 205M,Beard Hall,Campus Box 7360, Chapel Hill, NC 27599 USA.	rahansen@unc.edu	Gartlehner, Gerald/AAY-2801-2021	Gartlehner, Gerald/0000-0001-5531-3678; Gaynes, Bradley/0000-0002-8283-5030; Lohr, Kathleen/0000-0002-3825-0713; Hansen, Richard/0000-0002-4578-6698	NIMH NIH HHS [K23 MH01951-03] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH001951] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aberg-Wistedt A, 2000, J CLIN PSYCHOPHARM, V20, P645, DOI 10.1097/00004714-200012000-00010; AGUGLIA E, 1993, INT CLIN PSYCHOPHARM, V8, P197, DOI 10.1097/00004850-199300830-00010; ALVES C, 1999, PRIMARY CARE PSYCHIA, V5, P57; Anderson IM, 2001, BRIT MED BULL, V57, P161, DOI 10.1093/bmb/57.1.161; Ballus C, 2000, INT CLIN PSYCHOPHARM, V15, P43, DOI 10.1097/00004850-200015010-00007; BEASLEY CM, 1991, BMJ-BRIT MED J, V303, P685, DOI 10.1136/bmj.303.6804.685; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Behnke K, 2003, J CLIN PSYCHOPHARM, V23, P358, DOI 10.1097/01.jcp.0000085408.08426.05; Benkert O, 2000, J CLIN PSYCHIAT, V61, P656, DOI 10.4088/JCP.v61n0911; BENNIE EH, 1995, J CLIN PSYCHIAT, V56, P229; Bielski RJ, 2004, J CLIN PSYCHIAT, V65, P1190, DOI 10.4088/JCP.v65n0906; Boyer P, 1998, PHARMACOECONOMICS, V13, P157, DOI 10.2165/00019053-199813010-00015; Burke WJ, 2002, J CLIN PSYCHIAT, V63, P331, DOI 10.4088/JCP.v63n0410; Cassano GB, 2002, J CLIN PSYCHIAT, V63, P396, DOI 10.4088/JCP.v63n0504; Centre for Reviews Disseminations, 2001, 4 CRD; Chouinard G, 1999, J AFFECT DISORDERS, V54, P39, DOI 10.1016/S0165-0327(98)00188-8; Clayton AH, 2002, J CLIN PSYCHIAT, V63, P357, DOI 10.4088/JCP.v63n0414; Coleman C C, 1999, Ann Clin Psychiatry, V11, P205, DOI 10.3109/10401239909147072; Coleman CC, 2001, CLIN THER, V23, P1040, DOI 10.1016/S0149-2918(01)80090-4; COSTA E, 1998, J CLIN PSYCHIAT, V59, P352; Croft H, 1999, CLIN THER, V21, P643, DOI 10.1016/S0149-2918(00)88317-4; Croft H, 2002, CLIN THER, V24, P662, DOI 10.1016/S0149-2918(02)85141-4; Dalery J, 2003, HUM PSYCHOPHARM CLIN, V18, P379, DOI 10.1002/hup.490; Davidson JRT, 2002, DEPRESS ANXIETY, V16, P4, DOI 10.1002/da.10045; De Nayer A, 2002, INT J NEUROPSYCHOPH, V5, P115, DOI 10.1017/S1461145702002857; *DEPR GUID PAN, AHCPR PUBL; Detke MJ, 2004, EUR NEUROPSYCHOPHARM, V14, P457, DOI 10.1016/j.euroneuro.2004.01.002; DEWILDE J, 1993, ACTA PSYCHIAT SCAND, V87, P141; Dierick M, 1996, PROG NEURO-PSYCHOPH, V20, P57, DOI 10.1016/0278-5846(95)00292-8; Doraiswamy PM, 2001, AM J GERIAT PSYCHIAT, V9, P423; Dunner DL, 1998, J CLIN PSYCHIAT, V59, P366, DOI 10.4088/JCP.v59n0705; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2001, SYSTEMATIC REV HLTH; Ekselius L, 1997, INT CLIN PSYCHOPHARM, V12, P323, DOI 10.1097/00004850-199711000-00005; Entsuah AR, 2001, J CLIN PSYCHIAT, V62, P869, DOI 10.4088/JCP.v62n1106; Fava M, 2000, J CLIN PSYCHIAT, V61, P863, DOI 10.4088/JCP.v61n1109; Fava M, 1998, Ann Clin Psychiatry, V10, P145; Fava M, 2002, J CLIN PSYCHOPHARM, V22, P137, DOI 10.1097/00004714-200204000-00006; Feiger A, 1996, J CLIN PSYCHIAT, V57, P53; Feiger AD, 2003, INT CLIN PSYCHOPHARM, V18, P203, DOI 10.1097/00004850-200307000-00002; FEIGHNER JP, 1991, J CLIN PSYCHIAT, V52, P329; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Fox DM, 2005, HEALTH AFFAIR, V24, P114, DOI 10.1377/hlthaff.24.1.114; Franchini L, 1997, J CLIN PSYCHIAT, V58, P104, DOI 10.4088/JCP.v58n0303; GAGIANO CA, 1993, BR J CLIN RES, V4, P145; Gartlehner G, 2005, INT CLIN PSYCHOPHARM, V20, P59, DOI 10.1097/00004850-200503000-00001; GEDDES JR, 2000, COCHRANE DB SYST REV; Goldstein DJ, 2002, J CLIN PSYCHIAT, V63, P225, DOI 10.4088/JCP.v63n0309; Gorman JM, 2002, CNS SPECTRUMS, V7, P40, DOI 10.1017/S1092852900028595; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hong CJ, 2003, J CLIN PSYCHIAT, V64, P921, DOI 10.4088/JCP.v64n0810; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; JOHNSTON A, 1991, J CLIN PSYCHIAT, V52, P450; Karasu TB, 2000, AM J PSYCHIAT, V157, P1; Kavoussi RJ, 1997, J CLIN PSYCHIAT, V58, P532, DOI 10.4088/JCP.v58n1204; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Kiev A, 1997, J CLIN PSYCHIAT, V58, P146, DOI 10.4088/JCP.v58n0402; Kroenke K, 2001, JAMA-J AM MED ASSOC, V286, P2947, DOI 10.1001/jama.286.23.2947; Lepola UM, 2003, INT CLIN PSYCHOPHARM, V18, P211, DOI 10.1097/00004850-200307000-00003; Liu BA, 1996, CAN MED ASSOC J, V155, P519; MCPARTLIN GM, 1998, PRIMARY CARE PSYCHIA, V4, P127, DOI DOI 10.1016/J.BIOPSYCH.2007.04.040; Mehtonen OP, 2000, J CLIN PSYCHIAT, V61, P95, DOI 10.4088/JCP.v61n0204; Montgomery SA, 2004, NEUROPSYCHOBIOLOGY, V50, P57, DOI 10.1159/000078225; MONTGOMERY SA, 1994, INT CLIN PSYCHOPHARM, V9, P47, DOI 10.1097/00004850-199400910-00008; Mulrow CD, 2000, AM J MED, V108, P54, DOI 10.1016/S0002-9343(99)00316-2; Nemeroff CB, 1995, DEPRESSION, V3, P163, DOI 10.1002/depr.3050030402; Newhouse Paul A., 2000, Journal of Clinical Psychiatry, V61, P559; Nieuwstraten CE, 2001, ANN PHARMACOTHER, V35, P1608; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Olfson M, 2002, JAMA-J AM MED ASSOC, V287, P203, DOI 10.1001/jama.287.2.203; Oslin DW, 2003, J CLIN PSYCHIAT, V64, P875, DOI 10.4088/JCP.v64n0804; Patris M, 1996, INT CLIN PSYCHOPHARM, V11, P129, DOI 10.1097/00004850-199611020-00007; Rapaport M, 1996, J CLIN PSYCHOPHARM, V16, P373, DOI 10.1097/00004714-199610000-00005; Rudolph RL, 1999, J AFFECT DISORDERS, V56, P171, DOI 10.1016/S0165-0327(99)00067-1; Schatzberg AF, 2002, AM J GERIAT PSYCHIAT, V10, P541, DOI 10.1176/appi.ajgp.10.5.541; SCHONE W, 1993, J CLIN PSYCHOPHARM, V13, pS34; Sechter D, 1999, EUR PSYCHIAT, V14, P41, DOI 10.1016/S0924-9338(99)80714-7; Segraves RT, 2000, J CLIN PSYCHOPHARM, V20, P122, DOI 10.1097/00004714-200004000-00002; Silverstone PH, 1999, J CLIN PSYCHIAT, V60, P22, DOI 10.4088/JCP.v60n0105; SONG FJ, 1993, BMJ-BRIT MED J, V306, P683, DOI 10.1136/bmj.306.6879.683; Stahl SM, 2000, BIOL PSYCHIAT, V48, P894, DOI 10.1016/S0006-3223(00)00957-4; Stahl SM, 2002, BIOL PSYCHIAT, V52, P1166, DOI 10.1016/S0006-3223(02)01425-7; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stewart DE, 2002, CAN J PSYCHIAT, V47, P375, DOI 10.1177/070674370204700409; Thase ME, 1998, J CLIN PSYCHIAT, V59, P502, DOI 10.4088/JCP.v59n1002; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; TOLLEFSON GD, 1994, J CLIN PSYCHOPHARM, V14, P163; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; TYLEE A, 1997, PRIMARY CARE PSYCHIA, V3, P51; Wade A, 2003, INT CLIN PSYCHOPHARM, V18, P133, DOI 10.1097/01.yic.0000068045.82050.00; Weihs KL, 2000, J CLIN PSYCHIAT, V61, P196, DOI 10.4088/JCP.v61n0309; Williams JW, 2000, ANN INTERN MED, V132, P743, DOI 10.7326/0003-4819-132-9-200005020-00011	95	185	188	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2005	143	6					415	426		10.7326/0003-4819-143-6-200509200-00006	http://dx.doi.org/10.7326/0003-4819-143-6-200509200-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967OG	16172440				2022-12-28	WOS:000232099900003
J	Glasier, A; Gulmezoglu, AM				Glasier, A; Gulmezoglu, AM			Sexual and reproductive health: call for papers	LANCET			English	Editorial Material									NHS Lothian Family Planning & Well Women Serv, Edinburgh EH4 1NL, Midlothian, Scotland; Univ Edinburgh, Edinburgh EH4 1NL, Midlothian, Scotland; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of Edinburgh; World Health Organization	Glasier, A (corresponding author), NHS Lothian Family Planning & Well Women Serv, Edinburgh EH4 1NL, Midlothian, Scotland.	Anna.Glasier@lpct.scot.nhs.uk						Adler M, 2003, BRIT MED J, V327, P62, DOI 10.1136/bmj.327.7406.62; [Anonymous], [No title captured]; *AVERT, 2005, STD STAT WORLDW; *DEP REPR HLTH RES, WHO MON EV; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Goto A, 1999, JAMA-J AM MED ASSOC, V282, P2173, DOI 10.1001/jama.282.22.2173; *UN POP INF NETW, 1994, REP INT C POP DEV; *WHO, 2000, UNS AB GLOB REG EST; Zwillich T, 2005, LANCET, V365, P1677	9	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					969	970		10.1016/S0140-6736(05)67354-0	http://dx.doi.org/10.1016/S0140-6736(05)67354-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168762				2022-12-28	WOS:000231955900010
J	Evans, WJ; Kozimor, SA; Ziller, JW				Evans, WJ; Kozimor, SA; Ziller, JW			Molecular octa-uranium rings with alternating nitride and azide bridges	SCIENCE			English	Article							CRYSTAL-STRUCTURES; COMPLEXES; METALLOCENES; CHEMISTRY	Uranium nitrides offer potential as future nuclear fuels and as probes of metal ligand multiple bonding involving the f-block actinide metals. However, few molecular examples are available for study owing to the difficulties in synthesis. Recent advances in organoactinide chemistry have provided a route to uranium nitride complexes that expands the options for developing UN chemistry.. Several 24-membered uranium nitrogen rings, (UNUN3)(4) have been synthesized by reduction of sodium azide with organometaltic metallocene derivatives, [(C5Me4R)(2)U][(mu-Ph)(2)BPh2] (R = Me, H; Me = methyl, Ph = phenyl). The nanometer-sized rings contain unusual UNU nitride linkages that have short U-N distances within the double-bond range.	Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Evans, WJ (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.	wevans@uci.edu	Evans, William J/L-2005-2016	Evans, William J/0000-0002-0651-418X				ARNEY DSJ, 1995, J AM CHEM SOC, V117, P9448, DOI 10.1021/ja00142a011; BERTHET JC, 1991, J ORGANOMET CHEM, V420, pC9, DOI 10.1016/0022-328X(91)80271-K; Black L, 2001, J ALLOY COMPD, V315, P36, DOI 10.1016/S0925-8388(00)01307-4; BRENNAN JG, 1988, J AM CHEM SOC, V110, P4554, DOI 10.1021/ja00222a011; BRENNAN JG, 1986, INORG CHEM, V25, P1761, DOI 10.1021/ic00231a008; Bunzli JCG, 2002, CHEM REV, V102, P1897, DOI 10.1021/cr010299j; Castro-Rodriguez I, 2004, SCIENCE, V305, P1757, DOI 10.1126/science.1102602; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P4565, DOI 10.1021/ja028342n; DEHNICKE K, 1992, ANGEW CHEM INT EDIT, V31, P955, DOI 10.1002/anie.199209551; Duval PB, 2001, ANGEW CHEM INT EDIT, V40, P3358; Evans WJ, 2005, J AM CHEM SOC, V127, P3894, DOI 10.1021/ja045064e; Evans WJ, 2005, J AM CHEM SOC, V127, P1068, DOI 10.1021/ja044529y; Evans WJ, 2004, POLYHEDRON, V23, P2689, DOI 10.1016/j.poly.2004.08.007; Evans WJ, 2004, J AM CHEM SOC, V126, P14533, DOI 10.1021/ja0463886; Evans WJ, 2002, CHEM REV, V102, P2119, DOI 10.1021/cr010298r; Evans WJ, 2002, ORGANOMETALLICS, V21, P1050, DOI 10.1021/om010831t; Evans WJ, 2000, ANGEW CHEM INT EDIT, V39, P240, DOI 10.1002/(SICI)1521-3773(20000103)39:1<240::AID-ANIE240>3.3.CO;2-Q; Evans WJ, 2000, J AM CHEM SOC, V122, P12019, DOI 10.1021/ja002486p; EVANS WJ, IN PRESS ORGANOMETAL; EVANS WJ, IN PRESS CHEM COMMUN; Gagliardi L, 2004, ANGEW CHEM INT EDIT, V43, P1573, DOI 10.1002/anie.200353261; GRIFFITH WP, 1972, COORDIN CHEM REV, V8, P369, DOI 10.1016/S0010-8545(00)80003-X; Kaltsoyannis N, 2000, INORG CHEM, V39, P6009, DOI 10.1021/ic000891b; KEMPTER CP, 1959, ANAL CHEM, V31, P156, DOI 10.1021/ac60145a601; Korobkov I, 2002, ANGEW CHEM INT EDIT, V41, P3433, DOI 10.1002/1521-3773(20020916)41:18<3433::AID-ANIE3433>3.0.CO;2-V; Krivovichev SV, 2005, J AM CHEM SOC, V127, P1072, DOI 10.1021/ja0436289; Kushto GP, 1997, J CHEM PHYS, V106, P5894, DOI 10.1063/1.473254; LE TN, 1991, J NUCL MATER, V184, P230, DOI 10.1016/0022-3115(91)90544-H; Obora Y, 1997, J AM CHEM SOC, V119, P3745, DOI 10.1021/ja963775+; Reshetnikov FG, 2001, ATOM ENERGY+, V91, P998, DOI 10.1023/A:1014811604126; SCHUMANN H, 1988, J ORGANOMET CHEM, V349, P117, DOI 10.1016/0022-328X(88)80442-X; Singh UP, 2002, J CHEM SOC DALTON, P4464, DOI 10.1039/b205053f; Thuery P, 2004, J AM CHEM SOC, V126, P6838, DOI 10.1021/ja0485964; URABE T, 1993, J ALLOY COMPD, V193, P122, DOI 10.1016/0925-8388(93)90328-K; WHEELER RA, 1986, J AM CHEM SOC, V108, P2222, DOI 10.1021/ja00269a018; WHEELER RA, 1986, J AM CHEM SOC, V108, P5381, DOI 10.1021/ja00278a001	36	184	186	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1835	1838		10.1126/science.1116452	http://dx.doi.org/10.1126/science.1116452			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166511				2022-12-28	WOS:000231989500043
J	Aylin, P; Williams, S; Jarman, B; Bottle, A				Aylin, P; Williams, S; Jarman, B; Bottle, A			Dr Foster's case notes	BRITISH MEDICAL JOURNAL			English	Article									Univ London Imperial Coll Sci & Technol, Dr Foster Unit, London, England	Imperial College London	Aylin, P (corresponding author), Univ London Imperial Coll Sci & Technol, Dr Foster Unit, London, England.		Aylin, Paul/A-1073-2014	Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743					0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 10	2005	331	7516					539	539		10.1136/bmj.331.7516.539	http://dx.doi.org/10.1136/bmj.331.7516.539			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965GX	16150763	Green Published			2022-12-28	WOS:000231939700014
J	Gao, PX; Ding, Y; Mai, WJ; Hughes, WL; Lao, CS; Wang, ZL				Gao, PX; Ding, Y; Mai, WJ; Hughes, WL; Lao, CS; Wang, ZL			Conversion of zinc oxide nanobelts into superlattice-structured nanohelices	SCIENCE			English	Article							SINGLE-CRYSTAL NANORINGS	A previously unknown rigid helical structure of zinc oxide consisting of a superlattice-structured nanobelt was formed spontaneously in a vapor-solid growth process. Starting from a single-crystal stiff nanoribbon dominated by the c-plane polar surfaces, an abrupt structural transformation into the superlattice-structured nanobelt led to the formation of a uniform nanohelix due to a rigid lattice rotation or twisting. The nanohelix was made of two types of alternating and periodically distributed long crystal stripes, which were oriented with their c axes perpendicular to each other. The nanohelix terminated by transforming into a single-crystal nanobelt dominated by nonpolar (01 (1) over bar0) surfaces. The nanohelix could be manipulated, and its elastic properties were measured, which suggests possible uses in electromechanically coupled sensors, transducers, and resonators.	Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; Peking Univ, Coll Engn, Beijing 100871, Peoples R China; Natl Ctr Nanosci & Technol China, Beijing 100080, Peoples R China	University System of Georgia; Georgia Institute of Technology; Peking University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Wang, ZL (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	zhong.wang@mse.gatech.edu	Mai, Wenjie/Y-4781-2019; wang, jie/GRS-0942-2022; Mai, Wenjie/S-2681-2017; Ding, Yong/F-3705-2017; Gao, Puxian/E-1461-2011; Wang, Zhong Lin/E-2176-2011; Dee, Chang Fu/G-4842-2010	Mai, Wenjie/0000-0003-4363-2799; Mai, Wenjie/0000-0003-4363-2799; Ding, Yong/0000-0001-5805-347X; Wang, Zhong Lin/0000-0002-5530-0380; Dee, Chang Fu/0000-0003-1015-9181				AMELINCKX S, 1994, SCIENCE, V265, P635, DOI 10.1126/science.265.5172.635; Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878; Dai Y, 2003, SOLID STATE COMMUN, V126, P629, DOI 10.1016/S0038-1098(03)00277-1; GAO PX, IN PRESS SMALL; Gao RP, 2000, J PHYS CHEM B, V104, P1227, DOI 10.1021/jp9937611; Hughes WL, 2004, J AM CHEM SOC, V126, P6703, DOI 10.1021/ja049266m; Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356; Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Schmidt OG, 2001, NATURE, V410, P168, DOI 10.1038/35065525; Volodin A, 2000, PHYS REV LETT, V84, P3342, DOI 10.1103/PhysRevLett.84.3342; Wang ZL, 2004, ADV FUNCT MATER, V14, P943, DOI 10.1002/adfm.200400180; Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971; Zhang HF, 2003, NANO LETT, V3, P577, DOI 10.1021/nl0341180; Zhang HF, 2002, NANO LETT, V2, P941, DOI 10.1021/nl025667t	15	786	844	10	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1700	1704		10.1126/science.1116495	http://dx.doi.org/10.1126/science.1116495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151005				2022-12-28	WOS:000231836700037
J	Bellamy, PH; Loveland, PJ; Bradley, RI; Lark, RM; Kirk, GJD				Bellamy, PH; Loveland, PJ; Bradley, RI; Lark, RM; Kirk, GJD			Carbon losses from all soils across England and Wales 1978-2003	NATURE			English	Article							ORGANIC-CARBON; CLIMATE-CHANGE; LAND-USE; TEMPERATURE; ATMOSPHERE; EXCHANGE; MATTER; MODEL	More than twice as much carbon is held in soils as in vegetation or the atmosphere(1), and changes in soil carbon content can have a large effect on the global carbon budget. The possibility that climate change is being reinforced by increased carbon dioxide emissions from soils owing to rising temperature is the subject of a continuing debate(2-9). But evidence for the suggested feedback mechanism has to date come solely from small-scale laboratory and field experiments and modelling studies(2-9). Here we use data from the National Soil Inventory of England and Wales obtained between 1978 and 2003 to show that carbon was lost from soils across England and Wales over the survey period at a mean rate of 0.6% yr(-1) ( relative to the existing soil carbon content). We find that the relative rate of carbon loss increased with soil carbon content and was more than 2% yr(-1) in soils with carbon contents greater than 100 g kg(-1). The relationship between rate of carbon loss and carbon content is irrespective of land use, suggesting a link to climate change. Our findings indicate that losses of soil carbon in England and Wales - and by inference in other temperate regions - are likely to have been offsetting absorption of carbon by terrestrial sinks.	Cranfield Univ, Natl Soil Resources Inst, Bedford MK45 4DT, England; Rothamsted Res, Harpenden AL5 2JQ, Herts, England	Cranfield University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Kirk, GJD (corresponding author), Cranfield Univ, Natl Soil Resources Inst, Bedford MK45 4DT, England.	g.kirk@cranfield.ac.uk	Kirk, Guy J.D./A-4855-2011; Lark, Richard/G-6744-2012	Kirk, Guy J.D./0000-0002-7739-9772; Lark, Richard/0000-0003-2571-8521; Bellamy, Patricia/0000-0003-4116-3837				Avery B.W., 1974, SOIL SURVEY TECHNICA, V6; Avery B. W., 1980, SOIL SURVEY TECHNICA, V14; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; BRADLEY RI, IN PRESS SOIL USE MA; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Freeman C, 2004, NATURE, V430, P195, DOI 10.1038/nature02707; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Gilmour A. R., 2002, ASREML USER GUIDE RE; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; HOWARD PJA, 1995, SOIL USE MANAGE, V11, P9, DOI 10.1111/j.1475-2743.1995.tb00488.x; HULME JM, 2002, CLIMATE CHANGE SCENA; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Lark RM, 2004, EUR J SOIL SCI, V55, P777, DOI 10.1111/j.1365-2389.2004.00630.x; LOVELAND PJ, 1990, ELEMENT CONCENTRATION CADASTERS IN ECOSYSTEMS, P73; Powlson D, 2005, NATURE, V433, P204, DOI 10.1038/433204a; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Smith KA, 2003, EUR J SOIL SCI, V54, P779, DOI 10.1046/j.1351-0754.2003.0567.x; WEBSTER R, 1984, J SOIL SCI, V35, P127, DOI 10.1111/j.1365-2389.1984.tb00267.x; Worrall F, 2003, BIOGEOCHEMISTRY, V64, P165, DOI 10.1023/A:1024924216148	25	838	883	13	351	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					245	248		10.1038/nature04038	http://dx.doi.org/10.1038/nature04038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148931	Green Submitted			2022-12-28	WOS:000231696900053
J	Oliveira, RF; Carneiro, LA; Canario, AVM				Oliveira, RF; Carneiro, LA; Canario, AVM			No hormonal response in tied fights	NATURE			English	Article							CICHLID FISH; CHALLENGE HYPOTHESIS; SOCIAL MODULATION; ANDROGENS		Inst Super Psicol Aplicada, Unidade Invest Ecoetol, P-1149041 Lisbon, Portugal; Univ Algarve, CCMar, P-8005139 Faro, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Universidade do Algarve	Oliveira, RF (corresponding author), Inst Super Psicol Aplicada, Unidade Invest Ecoetol, P-1149041 Lisbon, Portugal.	ruiol@ispa.pt	Oliveira, Rui/A-3581-2013; Canario, Adelino/C-7942-2009	Oliveira, Rui/0000-0003-1528-618X; Canario, Adelino/0000-0002-6244-6468				BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Hirschenhauser K, 2004, ANIM BEHAV, V68, P741, DOI 10.1016/j.anbehav.2003.12.015; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Oliveira RF, 2004, ADV STUD BEHAV, V34, P165, DOI 10.1016/S0065-3454(04)34005-2; Oliveira RF, 1996, HORM BEHAV, V30, P2, DOI 10.1006/hbeh.1996.0002; Oliveira RF, 2001, NATURE, V409, P475, DOI 10.1038/35054128; Rowland WJ, 1999, ENVIRON BIOL FISH, V56, P285, DOI 10.1023/A:1007517720723; SCOTT AP, 1989, GEN COMP ENDOCR, V73, P46, DOI 10.1016/0016-6480(89)90054-3; SCOTT AP, 1984, GEN COMP ENDOCR, V56, P349, DOI 10.1016/0016-6480(84)90077-7; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	10	129	132	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					207	208		10.1038/437207a	http://dx.doi.org/10.1038/437207a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148924	Green Published			2022-12-28	WOS:000231696900041
J	Fordis, M; King, JE; Ballantyne, CM; Jones, PH; Schneider, KH; Spann, SJ; Greenberg, SB; Greisinger, AJ				Fordis, M; King, JE; Ballantyne, CM; Jones, PH; Schneider, KH; Spann, SJ; Greenberg, SB; Greisinger, AJ			Comparison of the instructional efficacy of Internet-based CME with live interactive CME workshops - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTINUING MEDICAL-EDUCATION; PHYSICIANS; CARE; PERFORMANCE; EXPERIENCE; TUTORIAL; QUALITY	Context Despite evidence that a variety of continuing medical education (CME) techniques can foster physician behavioral change, there have been no randomized trials comparing performance outcomes for physicians participating in Internet-based CME with physicians participating in a live CME intervention using approaches documented to be effective. Objective To determine if Internet-based CME can produce changes comparable to those produced via live, small-group, interactive CME with respect to physician knowledge and behaviors that have an impact on patient care. Design, Setting, and Participants Randomized controlled trial conducted from August 2001 to July 2002. Participants were 97 primary care physicians drawn from 21 practice sites in Houston, Tex, including 7 community health centers and 14 private group practices. A control group of 18 physicians from these same sites received no intervention. Interventions Physicians were randomly assigned to an Internet-based CME intervention that could be completed in multiple sessions over 2 weeks, or to a single live, small-group, interactive CME workshop. Both incorporated similar multifaceted instructional approaches demonstrated to be effective in live settings. Content was based on the National Institutes of Health National Cholesterol Education Program-Adult Treatment Panel III guidelines. Main Outcome Measures Knowledge was assessed immediately before the intervention, immediately after the intervention, and 12 weeks later. The percentage of high-risk patients who had appropriate lipid panel screening and pharmacotherapeutic treatment according to guidelines was documented with chart audits conducted over a 5-month period before intervention and a 5-month period after intervention. Results Both interventions produced similar and significant immediate and 12-week knowledge gains, representing large increases in percentage of items correct (pretest to posttest: 31.0% [95% confidence interval {CI}, 27.0%-35.0%]; pretest to 12 weeks: 36.4% [95% Cl, 32.2%-40.6%]; P<.001 for all comparisons). Chart audits revealed high baseline screening rates in all study groups (>= 93%) with no significant postintervention change. However, the Internet-based intervention was associated with a significant increase in the percentage of high-risk patients treated with pharmacotherapeutics according to guidelines (preintervention, 85.3%; postintervention, 90.3%; P.=.04). Conclusions Appropriately designed, evidence-based online CME can produce objectively measured changes in behavior as well as sustained gains in knowledge that are comparable or superior to those realized from effective live activities.	Baylor Coll Med, Ctr Collaborat & Interact Technol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Sect Atherosclerosis & Lipoprot Res, Houston, TX 77030 USA; Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA; Methodist DeBakey Heart Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX USA; Kelsey Res Fdn, Houston, TX USA; Kelsey Seybold Clin, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Fordis, M (corresponding author), Baylor Coll Med, Ctr Collaborat & Interact Technol, 1 Baylor Plaza,BCM-MS155, Houston, TX 77030 USA.	fordis@bcm.tmc.edu	Ballantyne, Christie/A-6599-2008	King, Jason/0000-0001-8168-9599; Ballantyne, Christie/0000-0002-6432-1730				*ACCR COUNC CONT M, 2004, ACCME ANN REP DAT 20; *ACCR COUNC CONT M, 2000, ACCME ANN REP DAT 19; Allison JJ, 2005, AM J PREV MED, V28, P285, DOI 10.1016/j.amepre.2004.12.013; *AM MED ASS, 2002, 2002 AMA STUD PHYS U; Barnes BE, 1998, ACAD MED, V73, P278, DOI 10.1097/00001888-199803000-00016; BEDNAR A, 1993, CONSTRUCTIVISM TECHN, P17; Bennett Nancy L, 2004, J Contin Educ Health Prof, V24, P31, DOI 10.1002/chp.1340240106; Casebeer LL, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.3.e20; Chan DH, 1999, M D COMPUT, V16, P54; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Chumley-Jones HS, 2002, ACAD MED, V77, pS86, DOI 10.1097/00001888-200210001-00028; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36; Cobb Susan Copley, 2004, J Contin Educ Health Prof, V24, P171, DOI 10.1002/chp.1340240308; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COHEN J, 2002, WORD PRESIDENT TRANS; Curran V R, 2000, J Contin Educ Health Prof, V20, P97, DOI 10.1002/chp.1340200206; Curran V R, 2000, J Contin Educ Health Prof, V20, P106, DOI 10.1002/chp.1340200207; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Davis DA, 1997, CAN MED ASSOC J, V157, P408; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; Dennis M.L., 1997, SCI PREVENTION METHO; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Furr RM, 2003, PSYCHOL METHODS, V8, P275, DOI 10.1037/1082-989X.8.3.275; Gerbert B, 2002, J CANCER EDUC, V17, P7; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Harris JM, 2002, FAM MED, V34, P287; Harris JM, 2001, J GEN INTERN MED, V16, P50, DOI 10.1046/j.1525-1497.2001.00615.x; Hinkka H, 2002, J CANCER EDUC, V17, P12; HOLM S, 1979, SCAND J STAT, V6, P65; Horton W., 2000, DESIGNING WEB BASED; *I MED, 2004, PAT SAF ACH NEW STAN; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2003, HLTH PROF ED BRIDG Q; KEARSLEY G, EXPLORATION LEARNING; Kemper KJ, 2002, ACAD MED, V77, P882, DOI 10.1097/00001888-200209000-00014; KNOWLES M, 1988, SELF DIRECTED LEARNI; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; Kronz JD, 2000, CANCER, V89, P1818, DOI 10.1002/1097-0142(20001015)89:8<1818::AID-CNCR23>3.3.CO;2-A; Massing MW, 2003, DIABETES CARE, V26, P991, DOI 10.2337/diacare.26.4.991; Mazmanian PE, 2002, JAMA-J AM MED ASSOC, V288, P1057, DOI 10.1001/jama.288.9.1057; *NAT CHOL ED PROGR, 2002, 3 NCEP EXP PAN DET E; Olejnik S, 1997, J EDUC BEHAV STAT, V22, P389, DOI 10.3102/10769986022004389; Pagnanelli G, 2003, BRIT J DERMATOL, V148, P698, DOI 10.1046/j.1365-2133.2003.05168.x; Sargeant Joan, 2004, J Contin Educ Health Prof, V24, P227, DOI 10.1002/chp.1340240406; Smith-Gratto K, 2000, INSTRUCTIONAL AND COGNITIVE IMPACTS OF WEB-BASED EDUCATION, P227; SPIRO R, 1993, CONSTRUCTIVISM TECHN, P57; Stewart M, 2005, FAM MED, V37, P131; THOMPSON B, 1988, MEAS EVAL COUNS DEV, V21, P99, DOI 10.1080/07481756.1988.12022889; *US DEP ED, 2003, ED477483; Whitcomb ME, 2002, ACAD MED, V77, P943, DOI 10.1097/00001888-200210000-00001; Wutoh Rita, 2004, J Contin Educ Health Prof, V24, P20, DOI 10.1002/chp.1340240105	53	280	285	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2005	294	9					1043	1051		10.1001/jama.294.9.1043	http://dx.doi.org/10.1001/jama.294.9.1043			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XU	16145024	Bronze			2022-12-28	WOS:000231627300004
J	Otten, M; Kezaala, R; Fall, A; Masresha, B; Martin, R; Cairns, L; Eggers, R; Biellik, R; Grabowsky, M; Strebel, P; Okwo-Bele, JM; Nshimirimana, D				Otten, M; Kezaala, R; Fall, A; Masresha, B; Martin, R; Cairns, L; Eggers, R; Biellik, R; Grabowsky, M; Strebel, P; Okwo-Bele, JM; Nshimirimana, D			Public-health impact of accelerated measles control in the WHO African Region 2000-03	LANCET			English	Article								Background In 2000, the WHO African Region adopted a plan to accelerate efforts to lower measles mortality with the goal of decreasing the number of measles deaths to near zero. By June, 2003, 19 African countries had completed measles supplemental immunisation activities (SIA) in children aged 9 months to 14 years as part of a comprehensive measles-control strategy.. We assessed the public-health impact of these control measures by use of available surveillance data. Methods We calculated percentage decline in reported measles cases during 1-2 years after SIA, compared with 6 years before SIA. On the basis of data from 13 of the 19 countries, we assumed that the percentage decline in measles deaths equalled that in measles cases. We also examined data on routine and SIA measles vaccine coverage, measles case-based surveillance, and suspected measles outbreaks. Findings Between 2000 and June, 2003, 82.1 million children were targeted for vaccination during initial SIA in 12 countries and follow-up SIA in seven countries. The average decline in the number of reported measles cases was 91%. In 17 of the 19 countries, measles case-based surveillance confirmed that transmission of measles virus, and therefore measles deaths, had been reduced to low or very low rates. The total estimated number of deaths averted in the year 2003 was 90 043. Between 2000 and 2003 in the African Region as a whole, we estimated that the percentage decline in annual measles deaths was around 20% (90 043 of 454 000). Interpretation The burden of measles in sub-Saharan Africa can be reduced to very low levels by means of appropriate strategies, resources, and personnel.	Ctr Dis Control & Prevent, Global Measles Branch, Global Immunizat Div, Atlanta, GA 30333 USA; WHO, Reg Off Africa, Harare, Zimbabwe; WHO, Reg Off Africa, Abidjan, Cote Ivoire; WHO, Reg Off Africa, Nairobi, Kenya; Amer Red Cross, Washington, DC 20006 USA; WHO, CH-1211 Geneva, Switzerland	Centers for Disease Control & Prevention - USA; World Health Organization; World Health Organization; World Health Organization; American Red Cross; World Health Organization	Otten, M (corresponding author), Ctr Dis Control & Prevent, Global Measles Branch, Global Immunizat Div, MS E05,1600 Clifton, Atlanta, GA 30333 USA.	motten@cdc.gov						[Anonymous], 2004, Wkly Epidemiol Rec, V79, P20; Biellik R, 2002, LANCET, V359, P1564, DOI 10.1016/S0140-6736(02)08517-3; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P581; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P28; de Quadros C A, 1998, Bull World Health Organ, V76 Suppl 2, P47; Dietz V, 1997, INT J HEALTH SERV, V27, P767, DOI 10.2190/QPCQ-FBF8-6ABX-2TB5; Hersh BS, 2000, LANCET, V355, P1943, DOI 10.1016/S0140-6736(00)02325-4; Loevinsohn B, 2002, AM J PUBLIC HEALTH, V92, P19, DOI 10.2105/AJPH.92.1.19; Otten MW, 2003, J INFECT DIS, V187, pS36, DOI 10.1086/368272; *WHO, 2000, WORLD HLTH REP 2001, P145; *WHO UN CHILDR FUN, JOINT STAT STRAT RED; YAMEOGO RK, 2002, INT J EPIDEMIOL, V34, P556	12	77	79	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2005	366	9488					832	839		10.1016/S0140-6736(05)67216-9	http://dx.doi.org/10.1016/S0140-6736(05)67216-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139658	Green Submitted			2022-12-28	WOS:000231627000028
J	Carninci, P; Kasukawa, T; Katayama, S; Gough, J; Frith, MC; Maeda, N; Oyama, R; Ravasi, T; Lenhard, B; Wells, C; Kodzius, R; Shimokawa, K; Bajic, VB; Brenner, SE; Batalov, S; Forrest, ARR; Zavolan, M; Davis, MJ; Wilming, LG; Aidinis, V; Allen, JE; Ambesi-Impiombato, X; Apweiler, R; Aturaliya, RN; Bailey, TL; Bansal, M; Baxter, L; Beisel, KW; Bersano, T; Bono, H; Chalk, AM; Chiu, KP; Choudhary, V; Christoffels, A; Clutterbuck, DR; Crowe, ML; Dalla, E; Dalrymple, BP; de Bono, B; Della Gatta, G; di Bernardo, D; Down, T; Engstrom, P; Fagiolini, M; Faulkner, G; Fletcher, CF; Fukushima, T; Furuno, M; Futaki, S; Gariboldi, M; Georgii-Hemming, P; Gingeras, TR; Gojobori, T; Green, RE; Gustincich, S; Harbers, M; Hayashi, Y; Hensch, TK; Hirokawa, N; Hill, D; Huminiecki, L; Iacono, M; Ikeo, K; Iwama, A; Ishikawa, T; Jakt, M; Kanapin, A; Katoh, M; Kawasawa, Y; Kelso, J; Kitamura, H; Kitano, H; Kollias, G; Krishnan, SPT; Kruger, A; Kummerfeld, SK; Kurochkin, IV; Lareau, LF; Lazarevic, D; Lipovich, L; Liu, J; Liuni, S; McWilliam, S; Babu, MM; Madera, M; Marchionni, L; Matsuda, H; Matsuzawa, S; Miki, H; Mignone, F; Miyake, S; Morris, K; Mottagui-Tabar, S; Mulder, N; Nakano, N; Nakauchi, H; Ng, P; Nilsson, R; Nishiguchi, S; Nishikawa, S; Nori, F; Ohara, O; Okazaki, Y; Orlando, V; Pang, KC; Pavan, WJ; Pavesi, G; Pesole, G; Petrovsky, N; Piazza, S; Reed, J; Reid, JF; Ring, BZ; Ringwald, M; Rost, B; Ruan, Y; Salzberg, SL; Sandelin, A; Schneider, C; Schonbach, C; Sekiguchi, K; Semple, CAM; Seno, S; Sessa, L; Sheng, Y; Shibata, Y; Shimada, H; Shimada, K; Silva, D; Sinclair, B; Sperling, S; Stupka, E; Sugiura, K; Sultana, R; Takenaka, Y; Taki, K; Tammoja, K; Tan, SL; Tang, S; Taylor, MS; Tegner, J; Teichmann, SA; Ueda, HR; van Nimwegen, E; Verardo, R; Wei, CL; Yagi, K; Yamanishi, H; Zabarovsky, E; Zhu, S; Zimmer, A; Hide, W; Bult, C; Grimmond, SM; Teasdale, RD; Liu, ET; Brusic, V; Quackenbush, J; Wahlestedt, C; Mattick, JS; Hume, DA; Kai, C; Sasaki, D; Tomaru, Y; Fukuda, S; Kanamori-Katayama, M; Suzuki, M; Aoki, J; Arakawa, T; Iida, J; Imamura, K; Itoh, M; Kato, T; Kawaji, H; Kawagashira, N; Kawashima, T; Kojima, M; Kondo, S; Konno, H; Nakano, K; Ninomiya, N; Nishio, T; Okada, M; Plessy, C; Shibata, K; Shiraki, T; Suzuki, S; Tagami, M; Waki, K; Watahiki, A; Okamura-Oho, Y; Suzuki, H; Kawai, J; Hayashizaki, Y				Carninci, P; Kasukawa, T; Katayama, S; Gough, J; Frith, MC; Maeda, N; Oyama, R; Ravasi, T; Lenhard, B; Wells, C; Kodzius, R; Shimokawa, K; Bajic, VB; Brenner, SE; Batalov, S; Forrest, ARR; Zavolan, M; Davis, MJ; Wilming, LG; Aidinis, V; Allen, JE; Ambesi-Impiombato, X; Apweiler, R; Aturaliya, RN; Bailey, TL; Bansal, M; Baxter, L; Beisel, KW; Bersano, T; Bono, H; Chalk, AM; Chiu, KP; Choudhary, V; Christoffels, A; Clutterbuck, DR; Crowe, ML; Dalla, E; Dalrymple, BP; de Bono, B; Della Gatta, G; di Bernardo, D; Down, T; Engstrom, P; Fagiolini, M; Faulkner, G; Fletcher, CF; Fukushima, T; Furuno, M; Futaki, S; Gariboldi, M; Georgii-Hemming, P; Gingeras, TR; Gojobori, T; Green, RE; Gustincich, S; Harbers, M; Hayashi, Y; Hensch, TK; Hirokawa, N; Hill, D; Huminiecki, L; Iacono, M; Ikeo, K; Iwama, A; Ishikawa, T; Jakt, M; Kanapin, A; Katoh, M; Kawasawa, Y; Kelso, J; Kitamura, H; Kitano, H; Kollias, G; Krishnan, SPT; Kruger, A; Kummerfeld, SK; Kurochkin, IV; Lareau, LF; Lazarevic, D; Lipovich, L; Liu, J; Liuni, S; McWilliam, S; Babu, MM; Madera, M; Marchionni, L; Matsuda, H; Matsuzawa, S; Miki, H; Mignone, F; Miyake, S; Morris, K; Mottagui-Tabar, S; Mulder, N; Nakano, N; Nakauchi, H; Ng, P; Nilsson, R; Nishiguchi, S; Nishikawa, S; Nori, F; Ohara, O; Okazaki, Y; Orlando, V; Pang, KC; Pavan, WJ; Pavesi, G; Pesole, G; Petrovsky, N; Piazza, S; Reed, J; Reid, JF; Ring, BZ; Ringwald, M; Rost, B; Ruan, Y; Salzberg, SL; Sandelin, A; Schneider, C; Schonbach, C; Sekiguchi, K; Semple, CAM; Seno, S; Sessa, L; Sheng, Y; Shibata, Y; Shimada, H; Shimada, K; Silva, D; Sinclair, B; Sperling, S; Stupka, E; Sugiura, K; Sultana, R; Takenaka, Y; Taki, K; Tammoja, K; Tan, SL; Tang, S; Taylor, MS; Tegner, J; Teichmann, SA; Ueda, HR; van Nimwegen, E; Verardo, R; Wei, CL; Yagi, K; Yamanishi, H; Zabarovsky, E; Zhu, S; Zimmer, A; Hide, W; Bult, C; Grimmond, SM; Teasdale, RD; Liu, ET; Brusic, V; Quackenbush, J; Wahlestedt, C; Mattick, JS; Hume, DA; Kai, C; Sasaki, D; Tomaru, Y; Fukuda, S; Kanamori-Katayama, M; Suzuki, M; Aoki, J; Arakawa, T; Iida, J; Imamura, K; Itoh, M; Kato, T; Kawaji, H; Kawagashira, N; Kawashima, T; Kojima, M; Kondo, S; Konno, H; Nakano, K; Ninomiya, N; Nishio, T; Okada, M; Plessy, C; Shibata, K; Shiraki, T; Suzuki, S; Tagami, M; Waki, K; Watahiki, A; Okamura-Oho, Y; Suzuki, H; Kawai, J; Hayashizaki, Y		FANTOM Consortium; RIKEN Genome Explorat Res Grp S	The transcriptional landscape of the mammalian genome	SCIENCE			English	Article							GENE-EXPRESSION; IDENTIFICATION; HUMAN-CHROMOSOME-21	This study describes comprehensive polling of transcription start and termination sites and analysis of previously unidentified full-length complementary DNAs derived from the mouse genome. We identify the 5' and 3' boundaries of 181,047 transcripts with extensive variation in transcripts arising from alternative promoter usage, splicing, and polyadenylation. There are 16,247 new mouse protein-coding transcripts, including 5154 encoding previously unidentified proteins. Genomic mapping of the transcriptome reveals transcriptional forests, with overlapping transcription on both strands, separated by deserts in which few transcripts are observed. The data provide a comprehensive platform for the comparative analysis of mammalian transcriptional regulation in differentiation and development.				yosihide@gsc.riken.jp	Itoh, Masayoshi/N-5363-2015; Sugiura, Koji/AAE-2966-2019; Zavolan, Mihaela/S-3888-2016; Mohan, Babu P./I-7362-2019; Liuni, Sabino/O-2441-2015; Kawai, Jun/A-6451-2016; Pesole, Graziano/C-1408-2009; Kanapin, Alexander A/Q-7590-2016; Carninci, Piero/K-1568-2014; Hide, Winston/R-3815-2019; Jakt, Lars/A-6290-2009; Liu, Edison/C-4141-2008; Martinez, Octavio/B-7375-2009; Hide, Winston A/V-2727-2017; di Bernardo, Diego/I-9440-2012; Chalk, Alistair/O-3522-2019; Hume, David A/C-7695-2013; Hayashizaki, Yoshihide/N-6590-2015; Nori, Franco/B-1222-2009; Taylor, Martin S/C-3825-2009; Salzberg, Steven L/F-6162-2011; Mattick, John S/I-7789-2012; Pesole, Graziano/K-5283-2019; Konno, Hideaki/A-9191-2012; Wells, Christine A/A-5071-2010; Ohara, Osamu/G-5448-2015; Brusic, Vladimir/B-1478-2008; Ohara, Osamu/A-9119-2012; Ganesh, Dunna Sai/AGX-5170-2022; di Bernardo, Diego/AAF-5881-2021; McWilliam, Sean M/H-8978-2013; Christoffels, Alan/C-3269-2014; Katayama, Shintaro/F-2958-2010; Koort, Kairi/C-7575-2017; Dalrymple, Brian P/F-8721-2010; Konno, Hideaki/N-4366-2014; Kurochkin, Igor/Q-5646-2019; Nilsson, Roland/AAJ-3519-2021; Kollias, George/A-7079-2012; Pavesi, Giulio/AAB-3230-2022; Grimmond, Sean M/J-5304-2016; Hensch, Takao/L-4182-2019; Hide, Winston Hide/C-7217-2009; Sandelin, Albin/G-2881-2011; Lazarevic, Dejan/AAN-1861-2020; Schönbach, Christian/B-1998-2009; Salzberg, Steven/Q-6514-2019; Forrest, Alistair/A-6597-2008; tegner, jesper N/R-5095-2017; Seno, Shigeto/W-1426-2019; Petrovsky, Nikolai/P-1912-2017; Brenner, Steven E/A-8729-2008; Kasukawa, Takeya/N-5070-2015; Grimmond, Sean/K-3246-2019; Davis, Melissa/B-9168-2013; Hayashi, Yoshitaka/I-6168-2014; Lipovich, Leonard/B-2355-2019; Kelso, Janet/N-1812-2019; van Nimwegen, Erik/ABF-1085-2021; Teasdale, Rohan/AAD-6698-2019; Semple, Colin A M/A-5613-2009; Aidinis, Vassilis/AAF-5380-2021; Zimmer, Andreas/B-8357-2009; Oyama, Rieko/AAA-3346-2020; Rost, Burkhard/A-1908-2016; Marchionni, Luigi/S-6774-2017; Stupka, Elia/J-6279-2012; Faulkner, Geoffrey J/M-3168-2014; Ravasi, Timothy/B-8777-2008; Zabarovsky, Eugene R/A-6645-2010; Pesole, Graziano/E-9051-2014; Wahlestedt, Claes/A-7039-2009; Plessy, Charles/N-5054-2015; Ueda, Hiroki R/C-5037-2014; Kawaji, Hideya/N-5116-2015; Dalla, Emiliano/AAH-3039-2020; Chiu, Kuo-Ping/AAG-8855-2020; Mattick, John/ABH-6130-2020; Reid, James/G-2496-2010; Teasdale, Rohan D/B-2538-2009; Kanapin, Alexander/E-7632-2013; K, Rimantas/H-4512-2019; Bono, Hidemasa/AAF-3649-2020; Waki, Kazunori/T-6444-2019; Bajic, Vladimir/D-2810-2009; Gariboldi, Manuela/K-4744-2016	Itoh, Masayoshi/0000-0002-1772-318X; Sugiura, Koji/0000-0001-8945-3353; Pesole, Graziano/0000-0003-3663-0859; Kanapin, Alexander A/0000-0001-9802-5297; Carninci, Piero/0000-0001-7202-7243; Hide, Winston/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; di Bernardo, Diego/0000-0002-1911-7407; Chalk, Alistair/0000-0002-9630-6236; Nori, Franco/0000-0003-3682-7432; Taylor, Martin S/0000-0001-7656-330X; Salzberg, Steven L/0000-0002-8859-7432; Mattick, John S/0000-0002-7680-7527; Wells, Christine A/0000-0003-3133-3628; Ohara, Osamu/0000-0002-3328-9571; Brusic, Vladimir/0000-0003-0523-5266; di Bernardo, Diego/0000-0002-1911-7407; McWilliam, Sean M/0000-0002-3148-0428; Christoffels, Alan/0000-0002-0420-2916; Katayama, Shintaro/0000-0001-7581-5157; Koort, Kairi/0000-0001-7831-8973; Dalrymple, Brian P/0000-0003-3891-5233; Konno, Hideaki/0000-0002-8470-4835; Kollias, George/0000-0003-1867-3150; Grimmond, Sean M/0000-0002-8102-7998; Hide, Winston Hide/0000-0002-8621-3271; Sandelin, Albin/0000-0002-7109-7378; Schönbach, Christian/0000-0002-0693-7617; Salzberg, Steven/0000-0002-8859-7432; Forrest, Alistair/0000-0003-4543-1675; tegner, jesper N/0000-0002-9568-5588; Seno, Shigeto/0000-0003-3861-6444; Petrovsky, Nikolai/0000-0002-1580-5245; Brenner, Steven E/0000-0001-7559-6185; Kasukawa, Takeya/0000-0001-5085-0802; Grimmond, Sean/0000-0002-8102-7998; Hayashi, Yoshitaka/0000-0002-7557-4303; Lipovich, Leonard/0000-0002-0531-3570; Kelso, Janet/0000-0002-3618-322X; van Nimwegen, Erik/0000-0001-6338-1312; Teasdale, Rohan/0000-0001-7455-5269; Semple, Colin A M/0000-0003-1765-4118; Rost, Burkhard/0000-0003-0179-8424; Marchionni, Luigi/0000-0002-7336-8071; Stupka, Elia/0000-0003-3154-4011; Faulkner, Geoffrey J/0000-0001-5769-4494; Pesole, Graziano/0000-0003-3663-0859; Plessy, Charles/0000-0001-7410-6295; Ueda, Hiroki R/0000-0001-8342-9176; Kawaji, Hideya/0000-0002-0575-0308; Dalla, Emiliano/0000-0002-4687-6011; Chiu, Kuo-Ping/0000-0001-9144-0674; Mattick, John/0000-0002-7680-7527; Teasdale, Rohan D/0000-0001-7455-5269; K, Rimantas/0000-0001-9417-8894; Bono, Hidemasa/0000-0003-4413-0651; Jakt, Lars Martin/0000-0002-3787-8138; Apweiler, Rolf/0000-0001-7078-200X; Piazza, Silvano/0000-0002-7156-5434; Lenhard, Boris/0000-0002-1114-1509; Ravasi, Timothy/0000-0002-9950-465X; Quackenbush, John/0000-0002-2702-5879; Fukuda, Shiro/0000-0002-0065-662X; Waki, Kazunori/0000-0001-7311-7208; Matsuda, Hideo/0000-0002-4701-3779; Aidinis, Vassilis/0000-0001-9531-7729; Huminiecki, Lukasz/0000-0003-1943-4450; Gustincich, Stefano/0000-0002-2749-2514; Pang, Ken/0000-0002-6881-775X; Liu, Jinfeng/0000-0002-0343-8222; lazarevic, dejan/0000-0003-4527-290X; Reid, James/0000-0001-6997-2850; Crowe, Mark/0000-0002-9514-2487; Gingeras, Thomas/0000-0001-9106-3573; Wilming, Laurens/0000-0002-4154-7358; Frith, Martin/0000-0003-0998-2859; Harbers, Matthias/0000-0002-5613-7220; Hume, David/0000-0002-2615-1478; fagiolini, michela/0000-0003-2807-803X; Bajic, Vladimir/0000-0001-5435-4750; Davis, Melissa/0000-0003-4864-7033; Kummerfeld, Sarah/0000-0002-0089-2358; Kurochkin, Igor V/0000-0002-6231-9004; Baxter, Laura/0000-0001-7941-1088; Rickert-Sperling, Silke/0000-0002-7135-3298; Zavolan, Mihaela/0000-0002-8832-2041; Green, Richard/0000-0003-0516-5827; Batalov, Sergey/0000-0002-0925-0554; Gariboldi, Manuela/0000-0001-8406-165X; Mulder, Nicola J/0000-0003-4905-0941; de Bono, Bernard/0000-0003-0638-5274; Engstrom, Par/0000-0001-5265-2121	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000136, Z01HG000070] Funding Source: NIH RePORTER; Telethon [TGM03P17, TGM06S01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Telethon(Fondazione Telethon)		BAJIC V, UNPUB; Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; CARNINCI P, UNPUB; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; GOUGH JE, UNPUB; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kelso J, 2003, GENOME RES, V13, P1222, DOI 10.1101/gr.985203; MAEDA N, UNPUB; Marshall E, 2004, SCIENCE, V306, P630, DOI 10.1126/science.306.5696.630; MATTICK JS, IN PRESS HUM MOL GEN; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Okazaki Y, 2003, GENOME RES, V13, P1267, DOI 10.1101/gr.1445603; RAVASI T, IN PRESS ENCY GENETI; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Watahiki A, 2004, NAT METHODS, V1, P233, DOI 10.1038/NMETH719; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	23	2637	13414	22	768	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1559	1563		10.1126/science.1112014	http://dx.doi.org/10.1126/science.1112014			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141072				2022-12-28	WOS:000231715000049
J	Stahley, MR; Strobel, SA				Stahley, MR; Strobel, SA			Structural evidence for a two-metal-ion mechanism of group I intron splicing	SCIENCE			English	Article							TETRAHYMENA RIBOZYME REACTION; CATALYTIC METAL-ION; CRYSTAL-STRUCTURE; ACTIVE-SITE; ANGSTROM RESOLUTION; RNA; IDENTIFICATION; POLYMERASE; GUANOSINE; PRECURSOR	We report the 3.4 angstrom crystal structure of a catalytically active group I intron splicing intermediate containing the complete intron, both exons, the scissile phosphate, and aft of the functional groups implicated in catalytic meta[ ion coordination, including the 2'-OH of the terminal guanosine. This structure suggests that, like protein phosphoryltransferases, an RNA phosphoryltransferase can use a two-metal-ion mechanism. Two Mg2+ ions are positioned 3.9 angstroms apart and are directly coordinated by all six of the biochemically predicted ligands. The evolutionary convergence of RNA and protein active sites on the same inorganic architecture highlights the intrinsic chemical capacity of the two-metal-ion catalytic mechanism for phosphoryl transfer.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	scott.strobel@yale.edu						Adams PL, 2004, RNA, V10, P1867, DOI 10.1261/rna.7140504; Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; BASS BL, 1986, BIOCHEMISTRY-US, V25, P4473, DOI 10.1021/bi00364a001; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CECH TR, 1981, CELL, V27, P487, DOI 10.1016/0092-8674(81)90390-1; Dismukes GC, 1996, CHEM REV, V96, P2909, DOI 10.1021/cr950053c; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; Fedor MJ, 2002, CURR OPIN STRUC BIOL, V12, P289, DOI 10.1016/S0959-440X(02)00324-X; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8312, DOI 10.1021/bi00083a035; Horton NC, 2001, NAT STRUCT BIOL, V8, P290, DOI 10.1038/86149; Hougland JL, 2005, PLOS BIOL, V3, P1536, DOI 10.1371/journal.pbio.0030277; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Mei R, 1996, BIOCHEMISTRY-US, V35, P5796, DOI 10.1021/bi9527653; MORAN S, 1993, BIOCHEMISTRY-US, V32, P5247, DOI 10.1021/bi00070a037; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; Shan S, 2001, BIOCHEMISTRY-US, V40, P5161, DOI 10.1021/bi002887h; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; Sjogren AS, 1997, NUCLEIC ACIDS RES, V25, P648, DOI 10.1093/nar/25.3.648; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Strater N, 1996, ANGEW CHEM INT EDIT, V35, P2024, DOI 10.1002/anie.199620241; Strobel SA, 1999, CHEM BIOL, V6, P153, DOI 10.1016/S1074-5521(99)89007-3; Szewczak AA, 2002, BIOCHEMISTRY-US, V41, P2516, DOI 10.1021/bi011973u; Weinstein LB, 1997, NATURE, V388, P805, DOI 10.1038/42076; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822; Yoshida A, 1999, NAT STRUCT BIOL, V6, P318; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	32	164	177	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1587	1590		10.1126/science.1114994	http://dx.doi.org/10.1126/science.1114994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141079				2022-12-28	WOS:000231715000057
J	Greely, HT				Greely, HT			Banning genetic discrimination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFORMATION		Stanford Univ, Stanford, CA 94305 USA	Stanford University	Greely, HT (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							BILLINGS PR, 1992, AM J HUM GENET, V50, P476; Greely HT, 2001, U PENN LAW REV, V149, P1483, DOI 10.2307/3312966; Hall MA, 2000, AM J HUM GENET, V66, P293, DOI 10.1086/302714; Rothenberg K, 1997, SCIENCE, V275, P1755, DOI 10.1126/science.275.5307.1755	4	31	31	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					865	867		10.1056/NEJMp058116	http://dx.doi.org/10.1056/NEJMp058116			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135828				2022-12-28	WOS:000231551100001
J	Wang, X; Zhuang, J; Peng, Q; Li, YD				Wang, X; Zhuang, J; Peng, Q; Li, YD			A general strategy for nanocrystal synthesis	NATURE			English	Article							SINGLE-CRYSTAL NANOWIRES; QUANTUM DOTS; NANOPARTICLES; NANOTUBES; SUPERLATTICES; OXIDES	New strategies for materials fabrication are of fundamental importance in the advancement of science and technology(1-12). Organometallic(13,14) and other organic solution phase(15-17) synthetic routes have enabled the synthesis of functional inorganic quantum dots or nanocrystals. These nanomaterials form the building blocks for new bottom-up approaches to materials assembly for a range of uses; such materials also receive attention because of their intrinsic size-dependent properties and resulting applications(18-21). Here we report a unified approach to the synthesis of a large variety of nanocrystals with different chemistries and properties and with low dispersity; these include noble metal, magnetic/ dielectric, semiconducting, rare-earth fluorescent, biomedical, organic optoelectronic semiconducting and conducting polymer nanoparticles. This strategy is based on a general phase transfer and separation mechanism occurring at the interfaces of the liquid, solid and solution phases present during the synthesis. We believe our methodology provides a simple and convenient route to a variety of building blocks for assembling materials with novel structure and function in nanotechnology(13-29).	Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China; Natl Ctr Nanosci & Nanotechnol, Beijing 100084, Peoples R China	Tsinghua University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Li, YD (corresponding author), Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China.	ydli@tsinghua.edu.cn	Wang, Xun/C-7638-2013					BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; HUO QS, 1994, NATURE, V368, P317, DOI 10.1038/368317a0; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Jovin TM, 2003, NAT BIOTECHNOL, V21, P32, DOI 10.1038/nbt0103-32; Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Law M, 2004, SCIENCE, V305, P1269, DOI 10.1126/science.1100999; Li YD, 2001, J AM CHEM SOC, V123, P9904, DOI 10.1021/ja016435j; Li YDD, 2002, J AM CHEM SOC, V124, P1411, DOI 10.1021/ja012055m; MOALES AM, 1998, SCIENCE, V279, P208; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Peng Q, 2003, ANGEW CHEM INT EDIT, V42, P3027, DOI 10.1002/anie.200250695; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Sun XM, 2004, ANGEW CHEM INT EDIT, V43, P3827, DOI 10.1002/anie.200353212; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; TENNE R, 1992, NATURE, V360, P444, DOI 10.1038/360444a0; Wang X, 2004, ANGEW CHEM INT EDIT, V43, P2017, DOI 10.1002/anie.200353507; Wang X, 2003, ANGEW CHEM INT EDIT, V42, P3497, DOI 10.1002/anie.200351006; Wang X, 2002, ANGEW CHEM INT EDIT, V41, P4790, DOI 10.1002/anie.200290049; Wang X, 2002, J AM CHEM SOC, V124, P2880, DOI 10.1021/ja0177105; Yang PD, 1998, NATURE, V396, P152	29	2329	2450	87	4002	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					121	124		10.1038/nature03968	http://dx.doi.org/10.1038/nature03968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136139				2022-12-28	WOS:000231560400053
J	Loeb, M; Brazil, K; Lohfeld, L; McGeer, A; Simor, A; Stevenson, K; Zoutman, D; Smith, S; Liu, XW; Walter, SD				Loeb, M; Brazil, K; Lohfeld, L; McGeer, A; Simor, A; Stevenson, K; Zoutman, D; Smith, S; Liu, XW; Walter, SD			Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							TERM-CARE FACILITIES; ANTIBIOTIC USE; ASYMPTOMATIC BACTERIURIA; RISK-FACTORS; ASSOCIATION; RESISTANCE; THERAPY; WOMEN	Objective To assess whether a multifaceted intervention can reduce the number of prescriptions for antimicrobials for suspected urinary tract infections in residents of nursing homes. Design Cluster randomised controlled trial. Setting 24 nursing homes in Ontario, Canada, and Idaho, United States. Participants 12 nursing homes allocated to a multifaceted intervention and 12 allocated to usual care. Outcomes were measured in 4217 residents. Interventions Diagnostic and treatment algorithm for urinary tract infections implemented at the nursing home level using a multifaceted approach-small group interactive sessions for nurses, videotapes, written material, outreach visits, and one on one interviews with physicians. Main outcome measures number of antimicrobials prescribed for suspected urinary tract infections, total use of antimicrobials, admissions to hospital, and deaths. Results Fewer courses of antimicrobials for suspected urinary tract infections per 1000 resident days were prescribed in the intervention nursing homes than in the usual care homes (1.17 v 1.59 courses; weighted mean difference -0.49, 95% confidence intervals -0.93 to -0.06). Antimicrobials for suspected urinary tract infection represented 28.4% of all courses of drugs prescribed in the intervention nursing homes compared with 38.6% prescribed in the usual care homes (weighted mean difference -9.6%, -16.9% to -2.4%). The difference in total antimicrobial use per 1000 resident days between intervention and usual care groups was not significantly different (3.52 v 3.93; weighed mean difference -0.37, -1.17 to 0.44). No significant difference was found in admissions to hospital or mortality between the study arms. Conclusion A multifaceted intervention using algorithms can reduce the number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes.	McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; Univ Toronto, Toronto Med Labs, Dept Microbiol, Toronto, ON, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Microbiol, Toronto, ON, Canada; Qualis Hlth, Boise, ID USA; Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada	McMaster University; McMaster University; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; Queens University - Canada	Loeb, M (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	loebm@mcmaster.ca	McGeer, Allison/AAB-6885-2020; mcgeer, allison/H-7747-2014; Walter, Stephen/AAB-5548-2022	McGeer, Allison/0000-0001-5647-6137; mcgeer, allison/0000-0001-5647-6137; Walter, Stephen/0000-0003-4157-8928				ABRUTYN E, 1994, ANN INTERN MED, V120, P827, DOI 10.7326/0003-4819-120-10-199405150-00003; BOSCIA JA, 1986, AM J MED, V81, P979, DOI 10.1016/0002-9343(86)90391-8; DONNER A, 1985, INT J EPIDEMIOL, V14, P322, DOI 10.1093/ije/14.2.322; FLORTOP S, 2002, BRIT MED J, V325, P1; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; JACOBSON C, 1990, AM J INFECT CONTROL, V18, P151, DOI 10.1016/0196-6553(90)90180-Z; Loeb M, 2001, INFECT CONT HOSP EP, V22, P120, DOI 10.1086/501875; Loeb M, 2001, J GEN INTERN MED, V16, P376, DOI 10.1046/j.1525-1497.2001.016006376.x; Loeb MB, 2003, AM J EPIDEMIOL, V157, P40, DOI 10.1093/aje/kwf173; Lundborg CS, 1999, J CLIN EPIDEMIOL, V52, P801, DOI 10.1016/S0895-4356(99)00036-0; Merlo J, 1996, EUR J CLIN PHARMACOL, V50, P27, DOI 10.1007/s002280050064; Montgomery P., 1995, Journal of Geriatric Drug Therapy, V9, P55, DOI 10.1300/J089v09n03_05; MUDER RR, 1991, ANTIMICROB AGENTS CH, V35, P256, DOI 10.1128/AAC.35.2.256; Muder RR, 1997, INFECT CONT HOSP EP, V18, P809; Nicolle LE, 1996, INFECT CONT HOSP EP, V17, P119; NICOLLE LE, 1983, NEW ENGL J MED, V309, P1420, DOI 10.1056/NEJM198312083092304; NICOLLE LE, 1987, AM J MED, V83, P27, DOI 10.1016/0002-9343(87)90493-1; Orr PH, 1996, AM J MED, V100, P71, DOI 10.1016/S0002-9343(96)90014-5; OUSLANDER JG, 1995, ANN INTERN MED, V122, P749, DOI 10.7326/0003-4819-122-10-199505150-00003; Walker S, 2000, CAN MED ASSOC J, V163, P273; WARREN JW, 1991, J AM GERIATR SOC, V39, P963, DOI 10.1111/j.1532-5415.1991.tb04042.x; Wiener J, 1999, JAMA-J AM MED ASSOC, V281, P517, DOI 10.1001/jama.281.6.517; ZIMMER JG, 1986, J AM GERIATR SOC, V34, P703, DOI 10.1111/j.1532-5415.1986.tb04301.x	23	199	201	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 24	2005	331	7518					669	672A		10.1136/bmj.38602.586343.55	http://dx.doi.org/10.1136/bmj.38602.586343.55			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970HH	16150741	Green Published, Bronze			2022-12-28	WOS:000232295400018
J	Ghavidel, A; Cagney, G; Emili, A				Ghavidel, A; Cagney, G; Emili, A			A skeleton of the human protein interactome	CELL			English	Editorial Material							INTERACTION NETWORK; MAP	In this issue of Cell, Wanker and colleagues (Stelzl et al., 2005) present a large-scale two-hybrid map of more than 3000 putative human protein-protein interactions. These new data will serve as an important source of information regarding individual protein partners and offer preliminary insight into the global molecular organization of human cells.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Coll Dublin, Conway Inst, Dublin 2, Ireland	University of Toronto; University College Dublin	Ghavidel, A (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.		Cagney, Gerard/A-4648-2009	Cagney, Gerard/0000-0001-7189-9496				Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750	13	16	18	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 23	2005	122	6					830	832		10.1016/j.cell.2005.09.006	http://dx.doi.org/10.1016/j.cell.2005.09.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179252	Bronze			2022-12-28	WOS:000232130200007
J	Kappers, IF; Aharoni, A; van Herpen, TWJM; Luckerhoff, LLP; Dicke, M; Bouwmeester, HJ				Kappers, IF; Aharoni, A; van Herpen, TWJM; Luckerhoff, LLP; Dicke, M; Bouwmeester, HJ			Genetic engineering of terpenoid metabolism attracts, bodyguards to Arabidopsis	SCIENCE			English	Article							PLANT VOLATILES; JASMONIC ACID; SYNTHASE; BIOSYNTHESIS; EXPRESSION; THALIANA; MITE; IDENTIFICATION; HOMOTERPENES; INVOLVEMENT	Herbivore-damaged plants release complex mixtures of volatites that attract natural enemies of the herbivore. To study the relevance of individual components of these mixtures for predator attraction, we manipulated herbivory-induced volatiles through genetic engineering. Metabolic engineering of terpenoids, which dominate the composition of many induced plant volatile bouquets, holds particular promise. By switching the subcellular localization of the introduced sesquiterpene synthase to the mitochondria, we obtained transgenic Arabidopsis thaliana plants emitting two new isoprenoids. These altered plants attracted carnivorous predatory mites (Phytoseiulus persimilis) that aid the plants' defense mechanisms.	Univ Wageningen & Res Ctr, Plant Res Int, NL-6700 AA Wageningen, Netherlands; Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 EH Wageningen, Netherlands; Weizmann Inst Sci, IL-76100 Rehovot, Israel	Wageningen University & Research; Wageningen University & Research; Weizmann Institute of Science	Bouwmeester, HJ (corresponding author), Univ Wageningen & Res Ctr, Plant Res Int, POB 16, NL-6700 AA Wageningen, Netherlands.	harro.bouwmeester@wur.nl	Bouwmeester, Harro J/C-1414-2008; Dicke, Marcel/B-2300-2010; Kappers, Iris/GWY-2792-2022; aharoni, asaph/W-6670-2019	Dicke, Marcel/0000-0001-8565-8896; kappers, iris/0000-0003-3349-3473; Bouwmeester, Harro/0000-0003-0907-2732				Aharoni A, 2004, PLANT CELL, V16, P3110, DOI 10.1105/tpc.104.023895; Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Ament K, 2004, PLANT PHYSIOL, V135, P2025, DOI 10.1104/pp.104.048694; Arimura G, 2004, PLANT J, V37, P603, DOI 10.1111/j.1365-313X.2003.01987.x; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; BOLAND W, 1995, ANGEW CHEM INT EDIT, V34, P1600, DOI 10.1002/anie.199516001; BOLAND W, 1992, NATURWISSENSCHAFTEN, V79, P368, DOI 10.1007/BF01140183; Bouwmeester HJ, 1999, PLANT PHYSIOL, V121, P173, DOI 10.1104/pp.121.1.173; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; Cunillera N, 1996, J BIOL CHEM, V271, P7774, DOI 10.1074/jbc.271.13.7774; De Boer JG, 2004, J CHEM ECOL, V30, P2215, DOI 10.1023/B:JOEC.0000048784.79031.5e; Degenhardt J, 2000, PLANTA, V210, P815, DOI 10.1007/s004250050684; DICKE M, 1994, J PLANT PHYSIOL, V143, P465, DOI 10.1016/S0176-1617(11)81808-0; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; Dicke M., 1989, CAUSES CONSEQUENCES, P341; DONATH J, 1994, J PLANT PHYSIOL, V143, P473, DOI 10.1016/S0176-1617(11)81809-2; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; FRITZSCHEHOBALL.ME, 2001, EVOL ECOL RES, V3, P553; HOHN TM, 1991, PLANT PHYSIOL, V97, P460, DOI 10.1104/pp.97.1.460; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kohler RH, 1997, PLANT J, V11, P613, DOI 10.1046/j.1365-313X.1997.11030613.x; Pare PW, 1997, NATURE, V385, P30, DOI 10.1038/385030a0; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; van Loon JJA, 2000, ENTOMOL EXP APPL, V97, P219, DOI 10.1046/j.1570-7458.2000.00733.x; Van Poecke RMP, 2001, J CHEM ECOL, V27, P1911, DOI 10.1023/A:1012213116515; van Poecke RMP, 2002, J EXP BOT, V53, P1793, DOI 10.1093/jxb/erf022; VANPOECKE RMP, UNPUB; Wallaart TE, 2001, PLANTA, V212, P460, DOI 10.1007/s004250000428	30	355	402	6	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2070	2072		10.1126/science.1116232	http://dx.doi.org/10.1126/science.1116232			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179482				2022-12-28	WOS:000232181900055
J	Raser, JM; O'Shea, EK				Raser, JM; O'Shea, EK			Noise in gene expression: Origins, consequences, and control	SCIENCE			English	Review							ESCHERICHIA-COLI; SINGLE-CELL; STOCHASTICITY; TRANSCRIPTION; NETWORKS; HAPLOINSUFFICIENCY; ASSIMILATION; PROPAGATION; INITIATION; ALLELES	Genetically identical cells and organisms exhibit remarkable diversity even when they have identical histories of environmental exposure. Noise, or variation, in the process of gene expression may contribute to this phenotypic variability. Recent studies suggest that this noise has multiple sources, including the stochastic or inherently random nature of the biochemical reactions of gene expression. In this review, we summarize noise terminology and comment on recent investigations into the sources, consequences, and control of noise in gene expression.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Med Sci Training Program, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, 7 Divin Ave,Bauer 307, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu			NIGMS NIH HHS [R01 GM051377, GM51377] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051377] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; Arkin A, 1998, GENETICS, V149, P1633; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Jain AK, 2002, PATTERN RECOGN, V35, P2653, DOI 10.1016/S0031-3203(01)00218-7; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kemkemer R, 2002, P NATL ACAD SCI USA, V99, P13783, DOI 10.1073/pnas.212386999; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kierzek AM, 2001, J BIOL CHEM, V276, P8165, DOI 10.1074/jbc.M006264200; KO MSH, 1991, J THEOR BIOL, V153, P181, DOI 10.1016/S0022-5193(05)80421-7; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pigliucci M, 2003, EVOLUTION, V57, P1455; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shin T, 2002, NATURE, V415, P859, DOI 10.1038/nature723; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Van Kampen NG, 1992, STOCHASTIC PROCESSES; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0	38	1208	1236	1	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2010	2013		10.1126/science.1105891	http://dx.doi.org/10.1126/science.1105891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179466	Green Accepted			2022-12-28	WOS:000232181900035
J	Fowler, JH				Fowler, JH			Human cooperation - Second-order free-riding problem solved?	NATURE			English	Editorial Material							INDIRECT RECIPROCITY; REPUTATION; EVOLUTION		Univ Calif Davis, Dept Polit Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Fowler, JH (corresponding author), Univ Calif Davis, Dept Polit Sci, 1 Shields Ave, Davis, CA 95616 USA.	jhfowler@ucdavis.edu	Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638				Alexander R., 1987, BIOL MORAL SYSTEMS; Fehr E, 2004, NATURE, V432, P449, DOI 10.1038/432449a; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Panchanathan K, 2003, J THEOR BIOL, V224, P115, DOI 10.1016/S0022-5193(03)00154-1	7	53	53	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2005	437	7058					E8	E8		10.1038/nature04201	http://dx.doi.org/10.1038/nature04201			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177738	Bronze			2022-12-28	WOS:000232004800037
J	Conn, J; Gillam, L; Conway, GS				Conn, J; Gillam, L; Conway, GS			Ethics in practice - Revealing the diagnosis of androgen insensitivity syndrome in adulthood	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TESTICULAR FEMINIZATION; SEX		Middlesex Hosp, Dept Endocrinol, London W1T 3AA, England; Univ Melbourne, Fac Med Dent & Hlth Sci, Fac Educ Unit, Melbourne, Vic 3010, Australia; Univ Melbourne, Dept Publ Hlth, Ctr Study Hlth & Soc, Parkville, Vic 3010, Australia	University of London; University College London; University of Melbourne; University of Melbourne	Conway, GS (corresponding author), Middlesex Hosp, Dept Endocrinol, London W1T 3AA, England.	g.conway@ucl.ac.uk		Gillam, Lynn/0000-0001-6481-5004				AHLQUIST JO, 1994, BRIT MED J, V308, P1042; BANGSBOLL S, 1992, ACTA OBSTET GYN SCAN, V71, P63, DOI 10.3109/00016349209007950; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Blackless M, 2000, AM J HUM BIOL, V12, P151, DOI 10.1002/(SICI)1520-6300(200003/04)12:2<151::AID-AJHB1>3.0.CO;2-F; Dreger AD, 1998, HASTINGS CENT REP, V28, P24, DOI 10.2307/3528648; JAGIELLO G, 1962, LANCET, V1, P329; Kemp BD, 1996, CAN MED ASSOC J, V154, P1829; KERRIDGE I, 2005, ETHICS LAW HLTH PROF; KITCHENER KS, 2000, FDN PRINCIPLES ETHIC; MINOGUE BP, 1988, HASTINGS CENT REP, V18, P34, DOI 10.2307/3562221; MORRIS JM, 1953, AM J OBSTET GYNECOL, V65, P1192, DOI 10.1016/0002-9378(53)90359-7; Pettersson G, 1937, HEREDITAS, V23, P49; SHAH R, 1992, J PEDIATR SURG, V27, P757, DOI 10.1016/S0022-3468(05)80110-1; WEINER JS, 1997, J UROLOGY, V157, P1377	14	40	46	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2005	331	7517					628	630		10.1136/bmj.331.7517.628	http://dx.doi.org/10.1136/bmj.331.7517.628			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967EK	16166136	Green Published			2022-12-28	WOS:000232074100031
J	Mashburn, LM; Whiteley, M				Mashburn, LM; Whiteley, M			Membrane vesicles traffic signals and facilitate group activities in a prokaryote	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA; VIRULENCE FACTORS; IDENTIFICATION; GENES; GENTAMICIN; MECHANISM; BACTERIA; GROWTH	Many bacteria use extracellular signals to communicate and coordinate social activities, a process referred to as quorum sensing(1). Many quorum signals have significant hydrophobic character, and how these signals are trafficked between bacteria within a population is not understood. Here we show that the opportunistic human pathogen Pseudomonas aeruginosa packages the signalling molecule 2-heptyl-3-hydroxy-4-quinolone ( pseudomonas quinolone signal; PQS)(2) into membrane vesicles that serve to traffic this molecule within a population. Removal of these vesicles from the bacterial population halts cell - cell communication and inhibits PQS-controlled group behaviour. We also show that PQS actively mediates its own packaging and the packaging of other antimicrobial quinolines produced by P. aeruginosa into vesicles. These findings illustrate that a prokaryote possesses a signal trafficking system with features common to those used by higher organisms and outlines a novel mechanism for delivery of a signal critical for coordinating group behaviour in P. aeruginosa.	Univ Oklahoma, Hlth Sci Ctr, Dept Periodont, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Whiteley, M (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Periodont, Oklahoma City, OK 73104 USA.	marvin-whiteley@ouhsc.edu						Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; Chun CK, 2004, P NATL ACAD SCI USA, V101, P3587, DOI 10.1073/pnas.0308750101; Ciofu O, 2000, J ANTIMICROB CHEMOTH, V45, P9, DOI 10.1093/jac/45.1.9; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Kadurugamuwa JL, 1998, J BACTERIOL, V180, P2306, DOI 10.1128/JB.180.9.2306-2311.1998; Kadurugamuwa JL, 1997, J ANTIMICROB CHEMOTH, V40, P615, DOI 10.1093/jac/40.5.615; Kadurugamuwa JL, 1996, J BACTERIOL, V178, P2767, DOI 10.1128/jb.178.10.2767-2774.1996; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; KADURUGAMUWA JL, 1993, J BACTERIOL, V175, P5798, DOI 10.1128/JB.175.18.5798-5805.1993; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Nguyen TT, 2003, J ELECTRON MICROSC, V52, P465, DOI 10.1093/jmicro/52.5.465; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wang YJ, 2005, APPL ENVIRON MICROB, V71, P1291, DOI 10.1128/AEM.71.3.1291-1299.2005; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627	26	528	551	7	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					422	425		10.1038/nature03925	http://dx.doi.org/10.1038/nature03925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163359				2022-12-28	WOS:000231849100056
J	Souibri, K; Grollier, G				Souibri, K; Grollier, G			Infarction due to myocardial bridging	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Hosp Univ Caen, F-14033 Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie	Souibri, K (corresponding author), Ctr Hosp Univ Caen, F-14033 Caen, France.								0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1147	1147		10.1056/NEJMicm1050647	http://dx.doi.org/10.1056/NEJMicm1050647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963YG	16162885				2022-12-28	WOS:000231841900009
J	Tzima, E; Irani-Tehrani, M; Kiosses, WB; Dejana, E; Schultz, DA; Engelhardt, B; Cao, GY; DeLisser, H; Schwartz, MA				Tzima, E; Irani-Tehrani, M; Kiosses, WB; Dejana, E; Schultz, DA; Engelhardt, B; Cao, GY; DeLisser, H; Schwartz, MA			A mechanosensory complex that mediates the endothelial cell response to fluid shear stress	NATURE			English	Article							NF-KAPPA-B; NITRIC-OXIDE; AFFINITY MODULATION; ACTIVATION; ATHEROSCLEROSIS; TRANSDUCTION; CADHERIN; MECHANOTRANSDUCTION; PROLIFERATION; PERMEABILITY	Shear stress is a fundamental determinant of vascular homeostasis, regulating vascular remodelling, cardiac development and atherogenesis(1), but the mechanisms of transduction are poorly understood. Previous work showed that the conversion of integrins to a high-affinity state mediates a subset of shear responses, including cell alignment and gene expression(2-4). Here we investigate the pathway upstream of integrin activation. PECAM-1 ( which directly transmits mechanical force), vascular endothelial cell cadherin ( which functions as an adaptor) and VEGFR2 ( which activates phosphatidylinositol-3-OH kinase) comprise a mechanosensory complex. Together, these receptors are sufficient to confer responsiveness to flow in heterologous cells. In support of the relevance of this pathway in vivo, PECAM-1-knockout mice do not activate NF-kappa B and downstream inflammatory genes in regions of disturbed flow. Therefore, this mechanosensing pathway is required for the earliest-known events in atherogenesis.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Milan, Mario Negri Inst Pharmacol Res, I-20139 Milan, Italy; Univ Milan, Fac Sci, Dept Biomol & Biotechnol Sci, FIRC Inst Mol Oncol, I-20139 Milan, Italy; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland; Univ Penn, Med Ctr, Dept Med, Div Pulm & Crit Care, Philadelphia, PA 19104 USA; Univ Virginia, Mellon Prostate Canc Res Ctr, Cardiovasc Res Ctr, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Mellon Prostate Canc Res Ctr, Cardiovasc Res Ctr, Dept Biomed Engn, Charlottesville, VA 22908 USA	Scripps Research Institute; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; IFOM - FIRC Institute of Molecular Oncology; University of Milan; University of California System; University of California San Diego; University of Bern; University of Pennsylvania; University of Virginia; University of Virginia	Schwartz, MA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	maschwartz@virginia.edu	DeLisser, Horace/AFM-1942-2022; Tzima, Ellie/L-9256-2017; Engelhardt, Britta/K-7267-2014	Tzima, Ellie/0000-0002-3437-0902; Engelhardt, Britta/0000-0003-3059-9846; DEJANA, ELISABETTA/0000-0002-0007-0426; schwartz, martin/0000-0002-2071-1243				Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Davies PF, 1997, J VASC RES, V34, P208, DOI 10.1159/000159224; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Elrayess MA, 2003, ATHEROSCLEROSIS, V168, P131, DOI 10.1016/S0021-9150(03)00089-3; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Hajra L, 2000, P NATL ACAD SCI USA, V97, P9052, DOI 10.1073/pnas.97.16.9052; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Jalali S, 1998, ARTERIOSCL THROM VAS, V18, P227, DOI 10.1161/01.ATV.18.2.227; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; Khachigian LM, 1997, ARTERIOSCL THROM VAS, V17, P2280, DOI 10.1161/01.ATV.17.10.2280; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Lampugnani MG, 2002, MOL BIOL CELL, V13, P1175, DOI 10.1091/mbc.01-07-0368; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; LU TT, 1997, J BIOL CHEM, V272, P14444; Masuda Michitaka, 1993, Frontiers of Medical and Biological Engineering, V5, P79; Mohan S, 1997, AM J PHYSIOL-CELL PH, V273, pC572, DOI 10.1152/ajpcell.1997.273.2.C572; Monaco C, 2004, CARDIOVASC RES, V61, P671, DOI 10.1016/j.cardiores.2003.11.038; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Smalt R, 1997, ADV EXP MED BIOL, V433, P311; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; van der Pauw MTM, 2000, J PERIODONTAL RES, V35, P335, DOI 10.1034/j.1600-0765.2000.035006335.x; Wong CWY, 2000, MOL BIOL CELL, V11, P3109, DOI 10.1091/mbc.11.9.3109	30	1169	1208	5	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					426	431		10.1038/nature03952	http://dx.doi.org/10.1038/nature03952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163360				2022-12-28	WOS:000231849100057
J	McManus, IC; Powis, DA; Wakeford, R; Ferguson, E; James, D; Richards, P				McManus, IC; Powis, DA; Wakeford, R; Ferguson, E; James, D; Richards, P			Intellectual aptitude tests and A levels for selecting UK school leaver entrants for medical school	BRITISH MEDICAL JOURNAL			English	Article							CRITICAL THINKING; PERFORMANCE; INTELLIGENCE; PERSONALITY; PREDICTORS; SUCCESS		UCL, Dept Psychol, London WC1E 6BT, England; Univ Newcastle, Newcastle, NSW 2308, Australia; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge CB2 2QQ, England; Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; Univ Nottingham, Queens Med Ctr, Nottingham NG7 2UH, England; Univ Cambridge, Cambridge CB1 2EW, England	University of London; University College London; University of Newcastle; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Nottingham; University of Nottingham; University of Cambridge	McManus, IC (corresponding author), UCL, Dept Psychol, Gower St, London WC1E 6BT, England.	i.mcmanus@ucl.ac.uk	Powis, David A/C-1956-2008	McManus, Ian/0000-0003-3510-4814; Ferguson, Eamonn/0000-0002-7678-1451				Ackerman PL, 1996, INTELLIGENCE, V22, P227, DOI 10.1016/S0160-2896(96)90016-1; Admissions to Higher Education Steering Group, 2004, FAIR ADM HIGH ED REC; Bekhradnia B, 2002, WHO DOES BEST U; BROWN P, 2004, ADMISSIONS TESTING E, V1, P27; CHOPPIN BHL, 1973, PREDICTION ACAD SUCC; Deary IJ, 1998, BRIT MED J, V317, P1701, DOI 10.1136/bmj.317.7174.1701; Department of Health, 2004, MED SCH DEL DOCT FUT; Ferguson E, 2003, BRIT MED J, V326, P429, DOI 10.1136/bmj.326.7386.429; Ferguson E, 2002, BMJ-BRIT MED J, V324, P952, DOI 10.1136/bmj.324.7343.952; Giddens J, 2005, J NURS EDUC, V44, P85; Gray Sarah A, 2002, J Dent Educ, V66, P1241; Grey M R, 2001, Educ Health (Abingdon), V14, P87, DOI 10.1080/13576280010015083; James D, 2001, MED EDUC, V35, P1056, DOI 10.1046/j.1365-2923.2001.01042.x; James W, 2004, OXFORD REV EDUC, V30, P241, DOI 10.1080/0305498042000215548; Lievens F, 2002, INT J SELECT ASSESS, V10, P245, DOI 10.1111/1468-2389.00215; Lumb AB, 2004, MED EDUC, V38, P1002, DOI 10.1111/j.1365-2929.2004.01912.x; McManus IC, 2003, BRIT MED J, V327, P139, DOI 10.1136/bmj.327.7407.139; MCMANUS IC, 1986, BRIT MED J, V293, P124, DOI 10.1136/bmj.293.6539.124; McManus IC, 1993, MED ACCIDENTS, P80; MONTAGUE W, 1990, MED EDUC, V24, P151, DOI 10.1111/j.1365-2923.1990.tb02514.x; Perkins D, 2000, EDUC PSYCHOL REV, V12, P269, DOI 10.1023/A:1009031605464; Pithers RT, 2000, EDUC RES-UK, V42, P237, DOI 10.1080/001318800440579; *U CAMBR LOC EX SY, FAQS BMAT TSA DO YOU; *WORK GROUP 14 19, 2004, 14 19 CURR QUAL REF; CURRICULUM EVALUATIO	25	104	105	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 10	2005	331	7516					555	559		10.1136/bmj.331.7516.555	http://dx.doi.org/10.1136/bmj.331.7516.555			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965GX	16150766	Bronze, Green Published			2022-12-28	WOS:000231939700019
J	Emery, G; Hutterer, A; Berdnik, D; Mayer, B; Wirtz-Peitz, F; Gaitan, MG; Knoblich, JA				Emery, G; Hutterer, A; Berdnik, D; Mayer, B; Wirtz-Peitz, F; Gaitan, MG; Knoblich, JA			Asymmetric Rab11 endosomes regulate delta recycling and specify cell fate in the Drosophila nervous system	CELL			English	Article							MESSENGER-RNA LOCALIZATION; NUCLEAR-FALLOUT; SENSORY ORGAN; UBIQUITIN LIGASE; IN-VITRO; DIVISION; PROTEIN; NOTCH; NUMB; MEMBRANE	Drosophila sensory organ precursor (SOP) cells are a well-studied model system for asymmetric cell division. During SOP division, the determinants Numb and Neuralized segregate into the pIIb daughter cell and establish a distinct cell fate by regulating Notch/Delta signaling. Here, we describe a Numb- and Neuralized-independent mechanism that acts redundantly in cell-fate specification. We show that trafficking of the Notch ligand Delta is different in the two daughter cells. In pIIb, Delta passes through the recycling endosome which is marked by Rab11. In pIIa, however, the recycling endosome does not form because the centrosome fails to recruit Nuclear fallout, a Rab11 binding partner that is essential for recycling endosome formation. Using a mammalian cell culture system, we demonstrate that recycling endosomes are essential for Delta activity. Our results suggest that cells can regulate signaling pathways and influence their developmental fate by inhibiting the formation of individual endocytic compartments.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Res Inst Mol Pathol, A-1030 Vienna, Austria; Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Max Planck Inst Mol Zellbiol & Genet, D-01307 Dresden, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Stanford University; Max Planck Society	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404; Hutterer, Andrea/0000-0002-5208-6008; Emery, Gregory/0000-0002-6874-6875; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321				Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bellaiche Y, 2001, CURR OPIN GENET DEV, V11, P418, DOI 10.1016/S0959-437X(00)00212-4; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHRISTEN B, 1994, MECH DEVELOP, V48, P255, DOI 10.1016/0925-4773(94)90064-7; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Dollar G, 2002, DEVELOPMENT, V129, P517; Duman JG, 1999, AM J PHYSIOL-CELL PH, V277, pC361, DOI 10.1152/ajpcell.1999.277.3.C361; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gho M, 1999, DEVELOPMENT, V126, P3573; Gonzalez-Gaitan M, 2003, MECH DEVELOP, V120, P1265, DOI 10.1016/j.mod.2003.06.002; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Huppert SS, 1997, DEVELOPMENT, V124, P3283; JAFARNEJAD H, 2002, IN PRESS DEV CELL; Jankovics F, 2001, GENETICS, V158, P1177; Klueg KM, 1999, J CELL SCI, V112, P3289; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Meyers JM, 2002, J BIOL CHEM, V277, P49003, DOI 10.1074/jbc.M205728200; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pelissier A, 2003, CURR BIOL, V13, P1848, DOI 10.1016/j.cub.2003.10.023; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Piddini E, 2003, CURR OPIN CELL BIOL, V15, P474, DOI 10.1016/S0955-0674(03)00072-3; Prekeris R, 2001, J BIOL CHEM, V276, P38966, DOI 10.1074/jbc.M106133200; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Roegiers F, 2001, P NATL ACAD SCI USA, V98, P14469, DOI 10.1073/pnas.261555598; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rothwell WF, 1999, J CELL SCI, V112, P2885; Rothwell WF, 1998, DEVELOPMENT, V125, P1295; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz P, 2004, SCAND J MED SCI SPOR, V14, P1, DOI 10.1111/j.1600-0838.2003.00373.x; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	63	235	239	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					763	773		10.1016/j.cell.2005.08.017	http://dx.doi.org/10.1016/j.cell.2005.08.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16137758	Bronze			2022-12-28	WOS:000231844300015
J	Schwab, SR; Pereira, JP; Matloubian, M; Xu, Y; Huang, Y; Cyster, JG				Schwab, SR; Pereira, JP; Matloubian, M; Xu, Y; Huang, Y; Cyster, JG			Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients	SCIENCE			English	Article							SPHINGOSINE 1-PHOSPHATE; T-CELLS; AMMONIA PROCESS; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; THYMUS; EMIGRATION; METABOLISM; PYRIDOXINE; MIGRATION	Lymphocyte egress from the thymus and from peripheral lymphoid organs depends on sphingosine 1-phosphate (S1P) receptor-1 and is thought to occur in response to circulatory S1P. However, the existence of an S1P gradient between lymphoid organs and blood or lymph has not been established. To further define egress requirements, we addressed why treatment with the food colorant 2-acetyl-4-tetrahydroxybutylimidazole (THI) induces lymphopenia. We found that S1P abundance in lymphoid tissues of mice is normally low but increases more than 100-fold after THI treatment and that this treatment inhibits the S1P-degrading enzyme Slip lyase. We conclude that lymphocyte egress is mediated by S1P gradients that are established by S1P lyase activity and that the lyase may represent a novel immunosuppressant drug target.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biopharmaceut Sci, Drug Studies Unit, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	cyster@itsa.ucsf.edu		Pereira, Joao/0000-0002-5694-4938; Schwab, Susan/0000-0002-0834-0822	NIAID NIH HHS [AI40098, AI45073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073, R01AI040098, R37AI040098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Bradbury MG, 1996, IMMUNOLOGY, V87, P80; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; COBURN SP, 1981, CHEM METABOLISM 4 DE; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; EVANS JG, 1977, FOOD COSMET TOXICOL, V15, P523, DOI 10.1016/0015-6264(77)90066-9; GAUNT IF, 1977, FOOD COSMET TOXICOL, V15, P509, DOI 10.1016/0015-6264(77)90065-7; GOBIN SJP, 1992, THYMUS, V20, P17; Gugasyan R, 1998, IMMUNOLOGY, V93, P398; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Renault AD, 2004, SCIENCE, V305, P1963, DOI 10.1126/science.1102421; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; SINKELDAM EJ, 1988, FOOD CHEM TOXICOL, V26, P195, DOI 10.1016/0278-6915(88)90119-6; Trakatellis A, 1997, POSTGRAD MED J, V73, P617, DOI 10.1136/pgmj.73.864.617; Van Veldhoven PP, 2000, METHOD ENZYMOL, V311, P244; Yatomi Y, 2001, PROSTAG OTH LIPID M, V64, P107, DOI 10.1016/S0090-6980(01)00103-4	21	622	643	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1735	1739		10.1126/science.1113640	http://dx.doi.org/10.1126/science.1113640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151014				2022-12-28	WOS:000231836700048
J	Moseler, M; Gumbsch, P; Casiraghi, C; Ferrari, AC; Robertson, J				Moseler, M; Gumbsch, P; Casiraghi, C; Ferrari, AC; Robertson, J			The ultrasmoothness of diamond-like carbon surfaces	SCIENCE			English	Article							MOLECULAR-DYNAMICS SIMULATION; CROSS-SECTIONAL STRUCTURE; SUBPLANTATION MODEL; FILM GROWTH; COATINGS; DENSITY; STATE	The ultrasmoothness of diamond-like carbon coatings is explained by an atomistic/continuum multiscale model. At the atomic scale, carbon ion impacts induce downhill currents in the top layer of a growing film. At the continuum scale, these currents cause a rapid smoothing of initially rough substrates by erosion of hills into neighboring hollows. The predicted surface evolution is in excellent agreement with atomic force microscopy measurements. This mechanism is general, as shown by similar simulations for amorphous silicon. It explains the recently reported smoothing of multilayers and amorphous transition metal oxide films and underlines the general importance of impact-induced downhill currents for ion deposition, polishing, and nanopattering.	Fraunhofer Inst Mech Mat, D-79108 Freiburg, Germany; Freiburg Mat Res Ctr, D-79104 Freiburg, Germany; Univ Karlsruhe, IZBS, Inst Reliabil Syst & Components, D-76131 Karlsruhe, Germany; Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England	Fraunhofer Gesellschaft; Helmholtz Association; Karlsruhe Institute of Technology; University of Cambridge	Moseler, M (corresponding author), Fraunhofer Inst Mech Mat, Wohlerstr 11, D-79108 Freiburg, Germany.	mos@iwm.fhg.de	Moseler, Michael/AAV-4925-2021; Gumbsch, Peter/E-5879-2012	Moseler, Michael/0000-0002-7064-1351; Gumbsch, Peter/0000-0001-7995-228X				AllonAlaluf M, 1997, THIN SOLID FILMS, V303, P273, DOI 10.1016/S0040-6090(97)00093-X; Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; Brand J, 2002, IND LUBR TRIBOL, V54, P291, DOI 10.1108/00368790210697868; BRENNER DW, 1990, PHYS REV B, V42, P9458, DOI 10.1103/PhysRevB.42.9458; Casiraghi C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.226104; Davis CA, 1998, PHYS REV LETT, V80, P3280, DOI 10.1103/PhysRevLett.80.3280; EDWARDS SF, 1982, P ROY SOC LOND A MAT, V381, P17, DOI 10.1098/rspa.1982.0056; Ferrari AC, 2004, SURF COAT TECH, V180, P190, DOI 10.1016/j.surfcoat.2003.10.146; Ferrari AC, 2000, PHYS REV B, V62, P11089, DOI 10.1103/PhysRevB.62.11089; Frauenheim T, 2002, J PHYS-CONDENS MAT, V14, P3015, DOI 10.1088/0953-8984/14/11/313; Goglia PR, 2001, DIAM RELAT MATER, V10, P271, DOI 10.1016/S0925-9635(00)00589-6; Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5; Jager HU, 2000, J APPL PHYS, V88, P1129, DOI 10.1063/1.373787; Li D, 2002, APPL PHYS LETT, V81, P2088, DOI 10.1063/1.1506412; LIFSHITZ Y, 1989, PHYS REV LETT, V62, P1290, DOI 10.1103/PhysRevLett.62.1290; LIFSHITZ Y, 1994, PHYS REV LETT, V72, P2753, DOI 10.1103/PhysRevLett.72.2753; Moseler M, 2000, NUCL INSTRUM METH B, V164, P522, DOI 10.1016/S0168-583X(99)01081-2; MULLINS WW, 1959, J APPL PHYS, V30, P77, DOI 10.1063/1.1734979; Pearce GK, 2005, DIAM RELAT MATER, V14, P921, DOI 10.1016/j.diamond.2004.12.042; Peng XL, 2001, SURF COAT TECH, V138, P23, DOI 10.1016/S0257-8972(00)01139-7; Rattunde O, 2001, J APPL PHYS, V90, P3226, DOI 10.1063/1.1398067; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Robertson J, 2001, THIN SOLID FILMS, V383, P81, DOI 10.1016/S0040-6090(00)01786-7; Schwan J, 1996, J APPL PHYS, V79, P1416, DOI 10.1063/1.360979; Shi X, 1999, J PHYS-CONDENS MAT, V11, P185, DOI 10.1088/0953-8984/11/1/015; Spiller E, 2003, APPL OPTICS, V42, P4049, DOI 10.1364/AO.42.004049; Sullivan JP, 2001, MRS BULL, V26, P309, DOI 10.1557/mrs2001.68; TERSOFF J, 1989, PHYS REV B, V39, P5566, DOI 10.1103/PhysRevB.39.5566; Uhlmann S, 1998, PHYS REV LETT, V81, P641, DOI 10.1103/PhysRevLett.81.641; Yamamoto T, 2001, FUJITSU SCI TECH J, V37, P201; Zhao ZW, 2004, J PHYS D APPL PHYS, V37, P1701, DOI 10.1088/0022-3727/37/12/016	31	270	275	5	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1545	1548		10.1126/science.1114577	http://dx.doi.org/10.1126/science.1114577			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141070				2022-12-28	WOS:000231715000045
J	Lister, AM; Edwards, CJ; Nock, DAW; Bunce, M; van Pijlen, IA; Bradley, DG; Thomas, MG; Barnes, I				Lister, AM; Edwards, CJ; Nock, DAW; Bunce, M; van Pijlen, IA; Bradley, DG; Thomas, MG; Barnes, I			The phylogenetic position of the 'giant deer' Megaloceros giganteus	NATURE			English	Article							FALLOW-DEER; EVOLUTIONARY; PLEISTOCENE; EXTINCTION; DYNAMICS	The giant deer, or 'Irish elk', has featured extensively in debates on adaptation, sexual selection, and extinction. Its huge antlers - the largest of any deer species, living or extinct - formed a focus of much past work(1-4). Yet the phylogenetic position of the giant deer has remained an enigma. On the basis of its flattened antlers, the species was previously regarded as closely related to the living fallow deer(5-7). Recent morphological studies(8), however, have challenged that view and placed the giant deer closer to the living red deer or wapiti. Here we present a new phylogenetic analysis encompassing morphological and DNA sequence evidence, and find that both sets of data independently support a sister-group relationship of giant and fallow deer. Our results include the successful extraction and sequencing of DNA from this extinct species, and highlight the value of a joint molecular and morphological approach.	UCL, Dept Biol, London WC1E 6BT, England; Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland; Univ Oxford, Dept Zool, Ancient Biomol Ctr, Oxford OX1 3PS, England; Univ Leicester, Dept Zool, Leicester LE1 7RH, Leics, England	University of London; University College London; Trinity College Dublin; University of Oxford; University of Leicester	Barnes, I (corresponding author), UCL, Dept Biol, Mortimer St, London WC1E 6BT, England.	I.Barnes@ucl.ac.uk	Bradley, Daniel G/A-3240-2012; Thomas, Mark G/A-2219-2012; Barnes, Ian C/B-8081-2008; Edwards, Ceiridwen/F-8855-2010	Thomas, Mark G/0000-0002-2452-981X; Barnes, Ian C/0000-0001-8322-6918; Edwards, Ceiridwen/0000-0001-9126-1377; Bunce, Michael/0000-0002-0302-4206; Bradley, Daniel G/0000-0001-7335-7092; Lister, Adrian/0000-0002-7985-138X				Abbazzi L., 2004, REMARKS VALIDITY GEN, V15, P115, DOI 10.1007/BF02904712; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Croitor Roman, 2004, Palaeontologische Zeitschrift, V78, P137; GEIST V, 1999, DEER WORLD EVOLUTION; GOULD SJ, 1974, EVOLUTION, V28, P191, DOI 10.1111/j.1558-5646.1974.tb00740.x; Groves C.P., 1987, P21; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; IUCN, 2004, IUCN RED LIST THREAT; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Lister A.M., 1987, P81; LISTER AM, 1984, P ROY SOC EDINB B, V82, P205, DOI 10.1017/S0269727000003754; LISTER AM, 1996, INT J OSTEOARCHAEOL, V6, P119, DOI 10.1002/(SICI)1099-1212(199603)6:2<119::AID-OA265>3.0.CO;2-8; LYDEKKER R, 1898, DEER ALL LANDS; MacHugh DE., 2000, ANCIENT BIOMOLECULES, V3, P81; MILLAIS JG, 2006, MAMMALS GREAT BRITAI; Moen RA, 1999, EVOL ECOL RES, V1, P235; Pfeiffer Thekla, 2002, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V5, P289; Pfeiffer Thekla, 1999, Courier Forschungsinstitut Senckenberg, V211, P1; Pitra C, 2004, MOL PHYLOGENET EVOL, V33, P880, DOI 10.1016/j.ympev.2004.07.013; Randi E, 1998, P ROY SOC B-BIOL SCI, V265, P793, DOI 10.1098/rspb.1998.0362; REYNOLDS SH, 1929, MONOGRAPH BRIT MAMMA, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Soergel W., 1927, Abhandlungen der Senckenbergischen Gesellschaft, V39, P365; Stuart AJ, 2004, NATURE, V431, P684, DOI 10.1038/nature02890; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; van der Made J, 1999, J HUM EVOL, V37, P389, DOI 10.1006/jhev.1998.0264; Vislobokova I., 1990, Vertebrata Palasiatica, V28, P150; Vogler U, 1997, TIERARZTL PRAX, V25, P100; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; [No title captured]	30	63	69	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					850	853		10.1038/nature04134	http://dx.doi.org/10.1038/nature04134			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16148942				2022-12-28	WOS:000233777800050
J	Harker, DE; Woodward, CE; Wooden, DH				Harker, DE; Woodward, CE; Wooden, DH			The dust grains from 9P/Tempel 1 before and after the encounter with deep impact	SCIENCE			English	Article							TELESCOPE OBSERVATIONS; INFRARED OBSERVATIONS; KUIPER-BELT; COMETS; SPECTRA; SILICATE	Gemini-N observed the properties of dust ejected from the nucleus of comet 9P/Tempel 1 before and after its encounter with Deep Impact. Marked changes were seen in the 7.8- to 13-micrometer spectral energy distribution and derived grain properties of the inner coma. A strong, broad silicate feature dominated by emission from amorphous pyroxene, amorphous olivine, and magnesium-rich crystalline olivine had developed by 1 hour after impact. The ejected dust mass is congruent to 10(4) to 10(6) kilograms on the basis of our models. Twenty-six hours later the silicate feature had faded, leaving a smooth featureless spectrum, similar to that observed before the impact, suggesting that the impact did not produce a new active region releasing small particles on the nucleus.	Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; Univ Minnesota, Dept Astron, Minneapolis, MN 55455 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Harker, DE (corresponding author), Univ Calif San Diego, Ctr Astrophys & Space Sci, 9500 Gilman Dr,Dept 0424, La Jolla, CA 92093 USA.	dharker@ucsd.edu		Harker, David/0000-0001-6397-9082				A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; Bradley JP, 1999, SCIENCE, V285, P1716, DOI 10.1126/science.285.5434.1716; BRADLEY JP, 1998, LPS, V29, P1737; Crovisier J, 2000, ASTR SOC P, V196, P109; Delbo M, 2002, METEORIT PLANET SCI, V37, P1929, DOI 10.1111/j.1945-5100.2002.tb01174.x; Gomes RS, 2003, ICARUS, V161, P404, DOI 10.1016/S0019-1035(02)00056-8; HANNER MS, 1994, ASTROPHYS J, V425, P274, DOI 10.1086/173984; HANNER MS, 1983, P INT C COMETARY EXP, V2, P1; Harker DE, 2002, ASTROPHYS J, V580, P579, DOI 10.1086/343091; Harker DE, 2004, ASTROPHYS J, V615, P1081, DOI 10.1086/424592; JEWITT D, 1991, ASTROPHYS SPACE SC L, V167, P19; Keller LP, 2000, J GEOPHYS RES-SPACE, V105, P10397, DOI 10.1029/1999JA900395; Koike C, 2003, ASTRON ASTROPHYS, V399, P1101, DOI 10.1051/0004-6361:20021831; Levison HF, 2003, NATURE, V426, P419, DOI 10.1038/nature02120; Lisse CM, 2005, ASTROPHYS J, V625, pL139, DOI 10.1086/431238; Lisse CM, 1998, ASTROPHYS J, V496, P971, DOI 10.1086/305397; MOLSTER FJ, 2001, LUNAR PLANET SCI, V32, P1391; REACH W, 2004, 36 ANN DIV PLAN SCI; Stern SA, 2003, NATURE, V424, P639, DOI 10.1038/nature01725; Sugita S, 2005, SCIENCE, V310, P274, DOI 10.1126/science.1119091; Wooden DH, 2004, ASTROPHYS J, V612, pL77, DOI 10.1086/424593; Wooden DH, 2002, EARTH MOON PLANETS, V89, P247; WOODEN DH, 2005, IAU S, V229; WOODEN DH, 2005, CHONDRITES PROTOPLAN; WOPENKA B, 1988, EARTH PLANET SC LETT, V88, P221, DOI 10.1016/0012-821X(88)90079-9; [No title captured]	26	97	97	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					278	280		10.1126/science.1119143	http://dx.doi.org/10.1126/science.1119143			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16166478				2022-12-28	WOS:000232670100041
J	Sugita, S; Ootsubo, T; Kadono, T; Honda, M; Sako, S; Miyata, T; Sakon, I; Yamashita, T; Kawakita, H; Fujiwara, H; Fujiyoshi, T; Takato, N; Fuse, T; Watanabe, J; Furusho, R; Hasegawa, S; Kasuga, T; Sekiguchi, T; Kinoshita, D; Meech, KJ; Wooden, DH; Ip, WH; A'Hearn, MF				Sugita, S; Ootsubo, T; Kadono, T; Honda, M; Sako, S; Miyata, T; Sakon, I; Yamashita, T; Kawakita, H; Fujiwara, H; Fujiyoshi, T; Takato, N; Fuse, T; Watanabe, J; Furusho, R; Hasegawa, S; Kasuga, T; Sekiguchi, T; Kinoshita, D; Meech, KJ; Wooden, DH; Ip, WH; A'Hearn, MF			Subaru telescope observations of Deep Impact	SCIENCE			English	Article							VELOCITY DISTRIBUTIONS	The impact cratering process on a comet is controversial but holds the key for interpreting observations of the Deep Impact collision with comet 9P/Tempel 1. Midinfrared data from the Cooled Mid-Infrared Camera and Spectrometer (COMICS) of the Subaru Telescope indicate that the large-scale dust plume ejected by the impact contained a large mass (similar to 10(6) kilograms) of dust and formed two wings approximately +/- 45 degrees from the symmetric center, both consistent with gravity as the primary control on the impact and its immediate aftermath. The dust distribution in the inner part of the plume, however, is inconsistent with a pure gravity control and implies that evaporation and expansion of volatiles accelerated dust.	Univ Tokyo, Dept Complex Sci & Engn, Chiba, Japan; Univ Tokyo, Inst Astron, Tokyo 113, Japan; Univ Tokyo, Dept Astron, Tokyo 113, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Kanagawa, Japan; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Nagoya Univ, Div Particle & Astrophys Sci, Aichi, Japan; Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Kanagawa, Japan; Natl Astron Observ Japan, Natl Inst Nat Sci, Subaru Telescope, Hilo, HI USA; Kyoto Sangyo Univ, Dept Phys, Kamigamo, Kyodo, Japan; Natl Astron Observ Japan, Tokyo, Japan; Waseda Univ, Tokyo, Japan; Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University of Tokyo; University of Tokyo; University of Tokyo; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Brown University; Nagoya University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kyoto Sangyo University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Waseda University; National Central University; University of Hawaii System; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University System of Maryland; University of Maryland College Park	Sugita, S (corresponding author), Univ Tokyo, Dept Complex Sci & Engn, Chiba, Japan.	sugita@k.u-tokyo.ac.jp	Meech, Karen/CAH-1412-2022; Sugita, Seiji/GQI-1142-2022; Hasegawa, Sunao/R-4768-2017	Sugita, Seiji/0000-0001-6076-3614; Meech, Karen/0000-0002-2058-5670; Hasegawa, Sunao/0000-0001-6366-2608				A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; Cintala MJ, 1999, METEORIT PLANET SCI, V34, P605, DOI 10.1111/j.1945-5100.1999.tb01367.x; Croft S. K., 1980, P LUNAR PLANET SCI, P2347; Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904; GAULT DE, 1963, 6 P HYP IMP S CLEV 2, V2, P419; Gladman B, 2005, SCIENCE, V307, P71, DOI 10.1126/science.1100553; Hampton DL, 2005, SPACE SCI REV, V117, P43, DOI 10.1007/s11214-005-3390-8; HANNER MS, 1994, ASTROPHYS J, V425, P274, DOI 10.1086/173984; HANNER MS, 1983, P INT C COMETARY EXP, V2, P1; Harker DE, 2004, ASTROPHYS J, V615, P1081, DOI 10.1086/424592; Harker DE, 2005, SCIENCE, V310, P278, DOI 10.1126/science.1119143; HARTMANN WK, 1985, ICARUS, V63, P69, DOI 10.1016/0019-1035(85)90021-1; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; Housen KR, 2003, ICARUS, V163, P102, DOI 10.1016/S0019-1035(03)00024-1; Meech KJ, 2005, SCIENCE, V310, P265, DOI 10.1126/science.1118978; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Schultz PH, 2005, SPACE SCI REV, V117, P207, DOI 10.1007/s11214-005-3383-7; SWAMY KS, 1997, PHYS COMETS; Watanabe J., 2005, IAU S AST COM MET RI, P47; Wooden DH, 2004, ASTROPHYS J, V612, pL77, DOI 10.1086/424593; YAMAMOTO S, 2005, IN PRESS ICARUS 0525	21	79	79	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2005	310	5746					274	278		10.1126/science.1119091	http://dx.doi.org/10.1126/science.1119091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16166476				2022-12-28	WOS:000232670100040
J	Crocker, JT; Polisson, RP; Mueller, PR; Harris, NL; Duncan, LM				Crocker, JT; Polisson, RP; Mueller, PR; Harris, NL; Duncan, LM			Case 29-2005: A 68-year-old man with periorbital swelling, rash, and weakness - Dermatomyositis, due to diffuse large-B-cell lymphoma of the spleen.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MALIGNANT-LYMPHOMA; POLYMYOSITIS; DISEASE; MYOPATHIES; DISORDERS; CANCER		Massachusetts Gen Hosp, Arthrit Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Crocker, JT (corresponding author), Massachusetts Gen Hosp, Arthrit Unit, Boston, MA 02114 USA.							Arber DA, 1997, MODERN PATHOL, V10, P18; BARNES BE, 1976, ANN INTERN MED, V84, P68, DOI 10.7326/0003-4819-84-1-68; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; BOHAN A, 1977, MEDICINE, V56, P255, DOI 10.1097/00005792-197707000-00001; Buchbinder R, 2001, ANN INTERN MED, V134, P1087, DOI 10.7326/0003-4819-134-12-200106190-00008; Chan WC, 1997, BLOOD, V89, P3909; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; FALK S, 1990, CANCER-AM CANCER SOC, V66, P2612, DOI 10.1002/1097-0142(19901215)66:12<2612::AID-CNCR2820661225>3.0.CO;2-Q; GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504; HARRIS NL, 1984, CANCER, V54, P2460, DOI 10.1002/1097-0142(19841201)54:11<2460::AID-CNCR2820541125>3.0.CO;2-K; Hill CL, 2001, LANCET, V357, P96, DOI 10.1016/S0140-6736(00)03540-6; KRAEMER BB, 1984, CANCER-AM CANCER SOC, V54, P1606, DOI 10.1002/1097-0142(19841015)54:8<1606::AID-CNCR2820540823>3.0.CO;2-5; LINDFORS KK, 1984, J NUCL MED, V25, P969; Lucey BC, 2002, AM J ROENTGENOL, V179, P1591, DOI 10.2214/ajr.179.6.1791591; MEYER JE, 1983, RADIOLOGY, V148, P199, DOI 10.1148/radiology.148.1.6856834; Mollejo M, 2003, AM J SURG PATHOL, V27, P895, DOI 10.1097/00000478-200307000-00004; NIMELSTEIN SH, 1980, MEDICINE, V59, P239, DOI 10.1097/00005792-198007000-00001; Odeh M, 2002, POSTGRAD MED J, V78, P114, DOI 10.1136/pmj.78.916.114; PARK JH, 1995, ARTHRITIS RHEUM, V38, P68, DOI 10.1002/art.1780380111; PLOTZ PH, 1989, ANN INTERN MED, V111, P143, DOI 10.7326/0003-4819-111-2-143; Reimers Carl D., 1997, Current Opinion in Rheumatology, V9, P475, DOI 10.1097/00002281-199711000-00002; RINGEL RA, 1990, ARCH INTERN MED, V150, P2550, DOI 10.1001/archinte.150.12.2550; SCHNIPPER LE, 1982, NEW ENGL J MED, V306, P918; SEAMAN WB, 1976, NEW ENGL J MED, V295, P1242; SIGURGEIRSSON B, 1992, NEW ENGL J MED, V326, P363, DOI 10.1056/NEJM199202063260602; SPIER CM, 1985, ARCH PATHOL LAB MED, V109, P1076; *THOM PDR, 2004, PHYS DESK REF; TYMMS KE, 1985, J RHEUMATOL, V12, P1140; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; ZUCKNER J, 1990, SEMIN ARTHRITIS RHEU, V19, P259, DOI 10.1016/0049-0172(90)90048-K	30	7	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1275	1284		10.1056/NEJMcpc059025	http://dx.doi.org/10.1056/NEJMcpc059025			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	966DS	16177254				2022-12-28	WOS:000232000400013
J	Bishop, JM				Bishop, JM			Mary Lasker and her prizes - An appreciation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bishop, JM (corresponding author), Univ Calif San Francisco, HSW 1542, San Francisco, CA 94143 USA.	bishop@cgl.ucsf.edu							0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1418	1419		10.1001/jama.294.11.1418	http://dx.doi.org/10.1001/jama.294.11.1418			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174706				2022-12-28	WOS:000231987800021
J	Hatun, H; Sando, AB; Drange, H; Hansen, B; Valdimarsson, H				Hatun, H; Sando, AB; Drange, H; Hansen, B; Valdimarsson, H			Influence of the Atlantic subpolar gyre on the thermohaline circulation	SCIENCE			English	Article							WATER; OCEAN	During the past decade, record-high salinities have been observed in the Atlantic Inflow to the Nordic Seas and the Arctic Ocean, which feeds the North Atlantic thermohaline circulation (THC). This may counteract the observed long-term increase in freshwater supply to the area and tend to stabilize the North Atlantic THC. Here we show that the salinity of the Atlantic Inflow is tightly linked to the dynamics of the North Atlantic subpolar gyre circulation. Therefore, when assessing the future of the North Atlantic THC, it is essential that the dynamics of the subpolar gyre and its influence on the salinity are taken into account.	Faroese Fisheries Lab, Torshavn, Faroe Isl, Denmark; Univ Washington, Seattle, WA 98195 USA; Nansen Environm & Remote Sensing Ctr, N-5006 Bergen, Norway; Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; Univ Bergen, Inst Geophys, N-5007 Bergen, Norway; Chinese Acad Sci, Inst Atmospher Phys, Nansen Zhu Int Res Ctr, Beijing 100029, Peoples R China; Marine Res Inst, IS-121 Reykjavik, Iceland	University of Washington; University of Washington Seattle; Nansen Environmental & Remote Sensing Center (NERSC); Bjerknes Centre for Climate Research; University of Bergen; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Marine & Freshwater Research Institute (MFRI)	Hatun, H (corresponding author), Faroese Fisheries Lab, Box 3051,FO-110, Torshavn, Faroe Isl, Denmark.	hjalmarh@ocean.washington.edu		Hatun, Hjalmar/0000-0002-9312-7355				Bentsen M, 2004, CLIM DYNAM, V22, P701, DOI 10.1007/s00382-004-0397-x; Bersch M, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000901; BLECK R, 1992, J PHYS OCEANOGR, V22, P1486, DOI 10.1175/1520-0485(1992)022<1486:SDTTIA>2.0.CO;2; Blindheim J, 2000, DEEP-SEA RES PT I, V47, P655, DOI 10.1016/S0967-0637(99)00070-9; Boyer TP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021791; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Curry R, 2003, NATURE, V426, P826, DOI 10.1038/nature02206; Curry R, 2005, SCIENCE, V308, P1772, DOI 10.1126/science.1109477; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; Drange H, 2005, GEOPH MONOG SERIES, V158, P199; Drange H, 2005, GEOPH MONOG SERIES, V158, P1; ELLETT DJ, 1973, DEEP-SEA RES, V20, P585, DOI 10.1016/0011-7471(73)90030-2; ELLETT DJ, 1994, 36 MIN AGR FISH FOOD; Hakkinen S, 2004, SCIENCE, V304, P555, DOI 10.1126/science.1094917; Hansen B, 2000, PROG OCEANOGR, V45, P109, DOI 10.1016/S0079-6611(99)00052-X; Hansen B, 2004, SCIENCE, V305, P953, DOI 10.1126/science.1100085; Hatun H, 2005, GEOPH MONOG SERIES, V158, P239; Holliday NP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001344; Holliday NP, 2000, DEEP-SEA RES PT I, V47, P1303, DOI 10.1016/S0967-0637(99)00109-0; Joyce TM, 1996, J CLIMATE, V9, P3121, DOI 10.1175/1520-0442(1996)009<3121:TLTHRA>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Latif M, 2000, J CLIMATE, V13, P1809, DOI 10.1175/1520-0442(2000)013<1809:L>2.0.CO;2; Nilsen JEO, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016597; OSTERHUS S, COMMUNICATION; Peterson BJ, 2002, SCIENCE, V298, P2171, DOI 10.1126/science.1077445	25	511	516	0	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1841	1844		10.1126/science.1114777	http://dx.doi.org/10.1126/science.1114777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166513				2022-12-28	WOS:000231989500045
J	Holmes, KV				Holmes, KV			Adaptation of SARS coronavirus to humans	SCIENCE			English	Editorial Material							RESPIRATORY-SYNDROME-CORONAVIRUS; RECEPTOR-BINDING; SPIKE PROTEIN; IDENTIFICATION; SUBSTITUTION; SPECIFICITY; ANTIBODIES; EVOLUTION		Univ Colorado, Hlth Sci Ctr, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Holmes, KV (corresponding author), Univ Colorado, Hlth Sci Ctr, Mail Stop 8333,POB 6211, Aurora, CO 80045 USA.	kathryn.holmes@uchsc.edu			NIAID NIH HHS [AI59578] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babcock GJ, 2004, J VIROL, V78, P4552, DOI 10.1128/JVI.78.9.4552-4560.2004; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Hueffer K, 2003, J VIROL, V77, P10099, DOI 10.1128/JVI.77.18.10099-10105.2003; Lai MM, 2001, FIELDS VIROLOGY; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Qu XX, 2005, J BIOL CHEM, V280, P29588, DOI 10.1074/jbc.M500662200; Smits SL, 2005, J BIOL CHEM, V280, P6933, DOI 10.1074/jbc.M409683200; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Tu CC, 2004, EMERG INFECT DIS, V10, P2244, DOI 10.3201/eid1012.040520; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024	15	44	49	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2005	309	5742					1822	1823		10.1126/science.1118817	http://dx.doi.org/10.1126/science.1118817			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166506				2022-12-28	WOS:000231989500036
J	Qi, JH; Asano, T; Jinno, M; Matsui, K; Atsumi, K; Sakagami, Y; Ojika, M				Qi, JH; Asano, T; Jinno, M; Matsui, K; Atsumi, K; Sakagami, Y; Ojika, M			Characterization of a Phytophthora mating hormone	SCIENCE			English	Article							SEXUAL REPRODUCTION		Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University	Ojika, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	ojika@agr.nagoya-u.ac.jp		Matsui, Kouhei/0000-0002-9315-3203				ASHBY S. F., 1929, Trains. Brit. Mycol. Soc., V14, P18; Fry WE, 1997, BIOSCIENCE, V47, P363, DOI 10.2307/1313151; Jee HJ, 2002, BOT BULL ACAD SINICA, V43, P203; KO WH, 1978, J GEN MICROBIOL, V107, P15, DOI 10.1099/00221287-107-1-15; Lane CR, 2003, PLANT PATHOL, V52, P414, DOI 10.1046/j.1365-3059.2003.00835.x; SAVAGE EJ, 1968, PHYTOPATHOLOGY, V58, P1004	6	48	51	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1828	1828		10.1126/science.1114756	http://dx.doi.org/10.1126/science.1114756			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166510				2022-12-28	WOS:000231989500040
J	Kadison, R				Kadison, R			Getting an edge - Use of stimulants and antidepressants in college	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Univ Hlth Serv, Cambridge, MA 02138 USA	Harvard University	Kadison, R (corresponding author), Harvard Univ, Univ Hlth Serv, Cambridge, MA 02138 USA.							*NAT COLL HLTH ASS, 2004, REF GROUP REP; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713	2	38	38	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1089	1091		10.1056/NEJMp058047	http://dx.doi.org/10.1056/NEJMp058047			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	963YG	16162878				2022-12-28	WOS:000231841900002
J	Korgel, BA				Korgel, BA			Nanosprings take shape	SCIENCE			English	Editorial Material									Univ Texas, Dept Chem Engn, Texas Mat Inst, Ctr Nano & Mol Sci & Technol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Korgel, BA (corresponding author), Univ Texas, Dept Chem Engn, Texas Mat Inst, Ctr Nano & Mol Sci & Technol, Austin, TX 78712 USA.	korget@mail.che.utexas.edu	Korgel, Brian A/I-5771-2013					BAKER RTK, 1975, NATURE, V253, P37, DOI 10.1038/253037b0; Chen XQ, 2003, NANO LETT, V3, P1299, DOI 10.1021/nl034367o; Davidson FM, 2005, CHEM MATER, V17, P230, DOI 10.1021/cm0486262; Gao PX, 2005, SCIENCE, V309, P1700, DOI 10.1126/science.1116495; Hanrath T, 2005, SMALL, V1, P717, DOI 10.1002/smll.200500033; Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356; McIlroy DN, 2001, APPL PHYS LETT, V79, P1540, DOI 10.1063/1.1400079; MOTOJIMA S, 1989, APPL PHYS LETT, V54, P1001, DOI 10.1063/1.101422; Poggi MA, 2004, NANO LETT, V4, P1009, DOI 10.1021/nl0497023; Seto MW, 1999, J VAC SCI TECHNOL B, V17, P2172, DOI 10.1116/1.590887; Singh JP, 2004, APPL PHYS LETT, V84, P3657, DOI 10.1063/1.1738935; Tang YH, 1999, J APPL PHYS, V85, P7981, DOI 10.1063/1.369389; Zhang HF, 2003, NANO LETT, V3, P577, DOI 10.1021/nl0341180; Zhang HF, 2002, NANO LETT, V2, P941, DOI 10.1021/nl025667t	14	32	35	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1683	1684		10.1126/science.1118125	http://dx.doi.org/10.1126/science.1118125			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16150999				2022-12-28	WOS:000231836700030
J	Vousden, KH				Vousden, KH			p53 and PUMA: A deadly duo	SCIENCE			English	Editorial Material							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; BH3 DOMAINS; APOPTOSIS; PROTEINS; DEATH; ACTIVATION; EXPRESSION; GENE; BAX		Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Vousden, KH (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vous-den@beatson.gla.ac.uk						Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chittenden T, 2002, CANCER CELL, V2, P165, DOI 10.1016/S1535-6108(02)00128-9; Erster S, 2005, BIOCHEM BIOPH RES CO, V331, P843, DOI 10.1016/j.bbrc.2005.03.187; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yee KS, 2005, CARCINOGENESIS, V26, P1317, DOI 10.1093/carcin/bgi122; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6	15	67	77	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2005	309	5741					1685	1686		10.1126/science.1118232	http://dx.doi.org/10.1126/science.1118232			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151000				2022-12-28	WOS:000231836700031
J	Crommie, MF				Crommie, MF			Manipulating magnetism in a single molecule	SCIENCE			English	Editorial Material							KONDO RESONANCE; ATOM; TRANSISTORS		Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Crommie, MF (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	crom-mie@berkeley.edu						Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Hewson A C, 1993, KONDO PROBLEM HEAVY; Himpsel FJ, 1998, ADV PHYS, V47, P511, DOI 10.1080/000187398243519; Knorr N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.096804; Li JT, 1998, PHYS REV LETT, V80, P2893, DOI 10.1103/PhysRevLett.80.2893; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; Long J. R., 2003, CHEM NANOSTRUCTURED, P291; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; Moresco F, 2001, PHYS REV LETT, V86, P672, DOI 10.1103/PhysRevLett.86.672; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Yamachika R, 2004, SCIENCE, V304, P281, DOI 10.1126/science.1095069; Yu LH, 2004, NANO LETT, V4, P79, DOI 10.1021/nl034893f; Zhao AD, 2005, SCIENCE, V309, P1542, DOI 10.1126/science.1113449; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	17	22	23	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1501	1502		10.1126/science.1117039	http://dx.doi.org/10.1126/science.1117039			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141055				2022-12-28	WOS:000231715000031
J	Krushelnick, K; Cowley, S				Krushelnick, K; Cowley, S			Reduced turbulence and new opportunities for fusion	SCIENCE			English	Editorial Material							TRANSPORT; ITER; PHYSICS		Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	Imperial College London; University of California System; University of California Los Angeles	Krushelnick, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England.	kmkr@imperial.ac.uk; steve.cowley@imperial.ac.uk	Krushelnick, Karl/AAZ-3028-2020	Cowley, Steven/0000-0002-1112-6392				Aymar R, 2002, PLASMA PHYS CONTR F, V44, P519, DOI 10.1088/0741-3335/44/5/304; Candy J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.045001; Clery D, 2005, SCIENCE, V309, P28; Dimits AM, 1996, PHYS REV LETT, V77, P71, DOI 10.1103/PhysRevLett.77.71; Dorland W, 2000, PHYS REV LETT, V85, P5579, DOI 10.1103/PhysRevLett.85.5579; Garbet X, 2004, PLASMA PHYS CONTR F, V46, pB557, DOI 10.1088/0741-3335/46/12B/045; Haines MG, 1996, PLASMA PHYS CONTR F, V38, P643, DOI 10.1088/0741-3335/38/5/001; Horton W, 1999, REV MOD PHYS, V71, P735, DOI 10.1103/RevModPhys.71.735; King D, 2004, NATURE, V428, P891, DOI 10.1038/428891c; KOIDE Y, 1994, PHYS REV LETT, V72, P3662, DOI 10.1103/PhysRevLett.72.3662; Lin Z, 1998, SCIENCE, V281, P1835, DOI 10.1126/science.281.5384.1835; Litaudon X, 2004, PLASMA PHYS CONTR F, V46, pA19, DOI 10.1088/0741-3335/46/5A/002; Nazikian R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.135002; Rhodes TL, 2002, PHYS PLASMAS, V9, P2141, DOI 10.1063/1.1464544; WAGNER F, 1982, PHYS REV LETT, V49, P1408, DOI 10.1103/PhysRevLett.49.1408	15	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1502	1503		10.1126/science.1113477	http://dx.doi.org/10.1126/science.1113477			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141056				2022-12-28	WOS:000231715000032
J	Natowicz, M				Natowicz, M			Newborn screening - Setting evidence-based policy for protection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cleveland Clin Fdn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Natowicz, M (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Holtzman NA, 2003, JAMA-J AM MED ASSOC, V290, P2606, DOI 10.1001/jama.290.19.2606; KOLATA G, 2005, NY TIMES        1027, pA1; *MAT CHILD HLTH BU, 2005, NEWB SCREEN UN SCREE; Therrell BL, 2001, MOL GENET METAB, V74, P64, DOI 10.1006/mgme.2001.3238; Tonniges TF, 2000, PEDIATRICS, V106, P389	5	34	35	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					867	870		10.1056/NEJMp058060	http://dx.doi.org/10.1056/NEJMp058060			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135829				2022-12-28	WOS:000231551100002
J	Gravina, B; Mellars, P; Ramsey, CB				Gravina, B; Mellars, P; Ramsey, CB			Radiocarbon dating of interstratified Neanderthal and early modern human occupations at the Chatelperronian type-site	NATURE			English	Article							ICE; CALIBRATION; AURIGNACIAN; RECORDS; AMS	The question of the coexistence and potential interaction between the last Neanderthal and the earliest intrusive populations of anatomically modern humans in Europe has recently emerged as a topic of lively debate in the archaeological and anthropological literature. Here we report the results of radiocarbon accelerator dating for what has been reported as an interstratified sequence of late Neanderthal and early anatomically modern occupations at the French type-site of the Chatelperronian, the Grotte des Fees de Chatelperron, in east-central France. The radiocarbon measurements seem to provide the earliest secure dates for the presence of Aurignacian technology - and from this, we infer the presence of anatomically modern human populations - in France.	Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England; Univ Oxford, Oxford Radiocarbon Accelerator Unit, Oxford OX1 3QJ, England	University of Cambridge; University of Oxford	Mellars, P (corresponding author), Univ Cambridge, Dept Archaeol, Downing St, Cambridge CB2 3DZ, England.	pam59@cam.ac.uk	Ramsey, Christopher Bronk/AAQ-2227-2021; Ramsey, Christopher Bronk/A-3277-2012	Ramsey, Christopher Bronk/0000-0002-8641-9309; Ramsey, Christopher Bronk/0000-0002-8641-9309				Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Bordes J.-G., 2003, TRABALHOS ARQUEOLOGI, V33, P223; BREUIL H, 1910, REV ECOLE ANTHR PARI, V29, P29; Bronk Ramsey C, 2000, ARCHAEOMETRY, V42, P459; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; COMBIER J, 1990, PALEOLITHIQUE MOYEN, P267; Conard NJ, 2003, J HUM EVOL, V44, P331, DOI 10.1016/S0047-2484(02)00202-6; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; David F., 2001, B SOC PREHIST FR, V98, P207; DELPORTE MH, 1955, GALLIA, V13, P79; DELPORTE MH, 1957, C PREHIST FR, V15, P452; DELPORTE MH, 1999, CHATELPERRON GRAND G; DELPORTE MH, 1964, UNPUB EXCAVATIONS CH; DELPORTE MH, 2005, C PREHIST FR, V14, P233; Farizy C., 1990, PALEOLITHIQUE MOYEN, P281; GAMBIER D, 1989, HUMAN REVOLUTION, P194; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Haesaerts P., 2003, CHRONOLOGY AURIGNACI, V33, P133; HARROLD FB, 1978, THESIS U CHICAGO; Hublin J. -J., 2000, GEOGRAPHY NEANDERTHA, V8, P157; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Leroi-Gourhan A, 1961, GALLIA PREHISTOIRE, V4, P3, DOI DOI 10.3406/GALIP.1961.1182; LEVEQUE F, 1980, CR ACAD SCI D NAT, V291, P187; Lucas G, 2003, COLL INT SERIES, P289; Meese DA, 1997, J GEOPHYS RES-OCEANS, V102, P26411, DOI 10.1029/97JC00269; Mellars P, 1999, CURR ANTHROPOL, V40, P341, DOI 10.1086/200024; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; MELLARS P, 2000, GEOGRAPHY NEANDERTAL, P35; Pelegrin J., 1995, CAHIERS QUATERNAIRE, V20, P297; Ramsey CB, 2004, RADIOCARBON, V46, P17, DOI 10.1017/S0033822200039308; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; RAMSEY CB, 1999, NUCL INSTRUMENTS M B, V123, P539; Richter D, 2000, J ARCHAEOL SCI, V27, P71, DOI 10.1006/jasc.1999.0458; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; van Andel T. H., 2003, NEANDERTHALS MODERN; Voelker AHL, 2002, QUATERNARY SCI REV, V21, P1185, DOI 10.1016/S0277-3791(01)00139-1; White R., 2001, ATHENA REV, V2, P41, DOI DOI 10.1016/J.JHEVOL.2008.08.017; Zilhao J, 1999, J WORLD PREHIST, V13, P1, DOI 10.1023/A:1022348410845; Zilhao J, 2003, CHRONOLOGY AURIGNACI	46	72	73	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2005	438	7064					51	56		10.1038/nature04006	http://dx.doi.org/10.1038/nature04006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979XS	16136079				2022-12-28	WOS:000232979000038
J	Smock, RG; Gierasch, LM				Smock, RG; Gierasch, LM			Finding the fittest fold: Using the evolutionary record to design new proteins	CELL			English	Editorial Material							FAMILIES	For many years, the holy grail of protein engineering has been the design of artificial amino acid sequences that fold into stable proteins with desired functions. In the current issue of Nature, two papers from the Ranganathan group (Russ et al., 2005; Socolich et al., 2005) report remarkable success in the design of artificial WW domains. Their method, termed statistical coupling analysis (Lockless and Ranganathan, 1999), does not use structural or physicochemical information but instead extracts information about essential patterns of amino acids from the evolutionary record.	Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Smock, RG (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.		Gierasch, Lila M/D-1494-2009		NIGMS NIH HHS [T32 GM008515] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cordes MHJ, 1996, CURR OPIN STRUC BIOL, V6, P3, DOI 10.1016/S0959-440X(96)80088-1; Kuhlman B, 2004, CURR OPIN STRUC BIOL, V14, P89, DOI 10.1016/j.sbi.2004.01.002; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; RUSS W, 2005, IN PRESS NATURE; SOCOLICH M, 2005, IN PRESS NATURE; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805	11	3	3	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 23	2005	122	6					832	834		10.1016/j.cell.2005.09.005	http://dx.doi.org/10.1016/j.cell.2005.09.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179253	Bronze			2022-12-28	WOS:000232130200008
J	Covert, MW; Leung, TH; Gaston, JE; Baltimore, D				Covert, MW; Leung, TH; Gaston, JE; Baltimore, D			Achieving stability of lipopolysaccharide-induced NF-kappa B activation	SCIENCE			English	Article							SIGNALING PATHWAY; ALPHA; BETA; EXPRESSION; INHIBITOR; PROTEINS; CANCER; TRIF	The activation dynamics of the transcription factor NF-kappa B exhibit damped oscillatory behavior when cells are stimulated by tumor necrosis factor-alpha (TNF alpha) but stable behavior when stimulated by lipopolysaccharide (LPS). LPS binding to Toll-like receptor 4 (TLR4) causes activation of NF-kappa B that requires two downstream pathways, each of which when isolated exhibits damped oscillatory behavior. Computational modeling of the two TLR4-dependent signaling pathways suggests that one pathway requires a time delay to establish early antiphase activation of NF-kappa B by the two pathways. The MyD88-independent pathway required Inferon regulatory factor 3-dependent expression of TNF alpha to activate NF-kappa B, and the time required for TNF alpha synthesis established the delay.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu		Covert, Markus/0000-0002-5993-8912	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039458] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM039458-21] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Cho KH, 2003, GENOME RES, V13, P2413, DOI 10.1101/gr.1195703; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; SEBORG DE, 1989, WILEY SERIES CHEM EN, P7; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	26	480	500	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2005	309	5742					1854	1857		10.1126/science.1112304	http://dx.doi.org/10.1126/science.1112304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166516				2022-12-28	WOS:000231989500049
J	Aleon, J; Robert, F; Duprat, J; Derenne, S				Aleon, J; Robert, F; Duprat, J; Derenne, S			Extreme oxygen isotope ratios in the early Solar System	NATURE			English	Article							EVOLVED STARS; ABUNDANCES; CARBON; METEORITES; GRAINS; ATMOSPHERES; STARDUST; ELEMENTS; GIANTS; O-18	The origins of the building blocks of the Solar System can be studied using the isotopic composition of early planetary and meteoritic material. Oxygen isotopes in planetary materials show variations at the per cent level that are not related to the mass of the isotopes(1,2); rather, they result from the mixture of components having different nucleosynthetic or chemical origins(1-3). Isotopic variations reaching orders of magnitude in minute meteoritic grains are usually attributed to stellar nucleosynthesis before the birth of the Solar System, whereby different grains were contributed by different stars(4,5). Here we report the discovery of abundant silica-rich grains embedded in meteoritic organic matter, having the most extreme O-18/O-16 and O-17/O-16 ratios observed (both similar to 10(-1)) together with a solar silicon isotopic composition. Both O and Si isotopes indicate a single nucleosynthetic process. These compositions can be accounted for by one of two processes: a single exotic evolved star seeding the young Solar System(6), or irradiation of the circumsolar gas by high energy particles accelerated during an active phase of the young Sun. We favour the latter interpretation, because the observed compositions are usually not expected from nucleosynthetic processes in evolved stars, whereas they are predicted by the selective trapping of irradiation products.	Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; Museum Natl Hist Nat, Lab Etud Mat Extraterr, F-75005 Paris, France; Ctr Spectrometrie Nucl & Spectrometrie Masse, F-91405 Orsay, France; Ecole Natl Super Chim Paris, Lab Chim Bioorgan & Organ Phys, F-75231 Paris, France	Universite de Lorraine; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech	Aleon, J (corresponding author), Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, POB 808,L-231, Livermore, CA 94550 USA.	aleon2@llnl.gov	Derenne, Sylvie/I-9853-2014	Derenne, Sylvie/0000-0002-3446-9312				AMARI S, 1995, ASTROPHYS J, V447, pL147, DOI 10.1086/309573; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Busso M, 2003, PUBL ASTRON SOC AUST, V20, P356, DOI 10.1071/AS03035; CAFFEE MW, 1987, ASTROPHYS J, V313, pL31, DOI 10.1086/184826; CARNI J, 2001, ASTRON ASTROPHYS, V367, pL1; Clayton DD, 2004, ANNU REV ASTRON ASTR, V42, P39, DOI 10.1146/annurev.astro.42.053102.134022; Clayton GC, 2005, ASTROPHYS J, V623, pL141, DOI 10.1086/430110; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; DOMINY JF, 1986, ASTROPHYS J, V300, P325, DOI 10.1086/163806; Feigelson ED, 2002, ASTROPHYS J, V572, P335, DOI 10.1086/340340; Gardinier A, 2000, EARTH PLANET SC LETT, V184, P9, DOI 10.1016/S0012-821X(00)00300-9; Gounelle M, 2001, ASTROPHYS J, V548, P1051, DOI 10.1086/319019; HARRIS MJ, 1985, ASTROPHYS J, V299, P375, DOI 10.1086/163707; HARRIS MJ, 1987, ASTROPHYS J, V316, P294, DOI 10.1086/165201; HARRIS MJ, 1984, ASTROPHYS J, V285, P674, DOI 10.1086/162544; HARRIS MJ, 1988, ASTROPHYS J, V325, P768, DOI 10.1086/166047; HARRIS MJ, 1985, ASTROPHYS J, V292, P620, DOI 10.1086/163195; Jose J, 2004, ASTROPHYS J, V612, P414, DOI 10.1086/422569; KAHANE C, 1992, ASTRON ASTROPHYS, V256, P235; McKeegan KD, 2000, SCIENCE, V289, P1334, DOI 10.1126/science.289.5483.1334; McKeegan KD, 2001, REV MINERAL GEOCHEM, V43, P279, DOI 10.2138/gsrmg.43.1.279; Nagashima K, 2004, NATURE, V428, P921, DOI 10.1038/nature02510; Nguyen AN, 2004, SCIENCE, V303, P1496, DOI 10.1126/science.1094389; Nisini B, 2002, ASTRON ASTROPHYS, V395, pL25, DOI 10.1051/0004-6361:20021472; NITTLER LR, 1994, NATURE, V370, P443, DOI 10.1038/370443a0; Prantzos N, 1996, ASTRON ASTROPHYS, V309, P760; Reames DV, 1997, ASTROPHYS J, V483, P515, DOI 10.1086/304229; SMITH VV, 1990, ASTROPHYS J SUPPL S, V72, P387, DOI 10.1086/191421; Zinner E, 2003, GEOCHIM COSMOCHIM AC, V67, P5083, DOI 10.1016/S0016-7037(03)00261-8	30	29	29	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					385	388		10.1038/nature03947	http://dx.doi.org/10.1038/nature03947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163350				2022-12-28	WOS:000231849100047
J	Heimann, M				Heimann, M			Charles David Keeling 1928-2005 - Pioneer in the modern science of climate change. Obituary	NATURE			English	Biographical-Item									Max Planck Inst Biogeochem, D-07701 Jena, Germany	Max Planck Society	Heimann, M (corresponding author), Max Planck Inst Biogeochem, PF 100164, D-07701 Jena, Germany.	martin.heimann@bgc-jena.mpg.de	Heimann, Martin/H-7807-2016	Heimann, Martin/0000-0001-6296-5113				KEELING CD, PUBLICATION LIST	1	4	4	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2005	437	7057					331	331		10.1038/437331a	http://dx.doi.org/10.1038/437331a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163339	Bronze			2022-12-28	WOS:000231849100033
J	Burton, PR; Tobin, MD; Hopper, JL				Burton, PR; Tobin, MD; Hopper, JL			Key concepts in genetic epidemiology	LANCET			English	Review							MIXED MODELS GLMMS; VARIANCE-COMPONENTS ANALYSIS; POPULATION STRATIFICATION; MENDELIAN RANDOMIZATION; COMPLEX TRAITS; LINKAGE DISEQUILIBRIUM; CANCER; DISEASE; ASCERTAINMENT; RELATIVES	This article is the first in a series of seven that will provide an overview of central concepts and topical issues in modem genetic epidemiology. In this article, we provide an overall framework for investigating the role of familial factors, especially genetic determinants, in the causation of complex diseases such as diabetes. The discrete steps of the framework to be outlined integrate the biological science underlying modem genetics and the population science underpinning mainstream epidemiology. In keeping with the broad readership of The Lancet and the diverse background of today's genetic epidemiologists, we provide introductory sections to equip readers with basic concepts and vocabulary. We anticipate that, depending on their professional background and specialist knowledge, some readers will wish to skip some of this article.	Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; Univ Leicester, Dept Genet, Leicester LE1 6TP, Leics, England; Univ Melbourne, Ctr Genet Epidemiol, Melbourne, Vic, Australia	University of Leicester; University of Leicester; University of Melbourne	Burton, PR (corresponding author), Univ Leicester, Dept Hlth Sci, 22-28 Princess Rd W, Leicester LE1 6TP, Leics, England.	pb51@ie.ac.uk	Burton, Paul R/H-7527-2016	Tobin, Martin/0000-0002-3596-7874				Balding DJ, 2003, HDB STAT GENETICS; BLANGERO J, 2002, BIOSTATISTICAL GENET, P696; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Breslow NE., 1987, STAT METHODS CANC RE, P81; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Burton P, 2002, LANCET, V359, P1155, DOI 10.1016/S0140-6736(02)08138-2; Burton P, 2001, AM J HUM GENET, V69, P672; Burton PR, 2000, AM J HUM GENET, V67, P1505, DOI 10.1086/316899; Burton PR, 1999, GENET EPIDEMIOL, V17, P118, DOI 10.1002/(SICI)1098-2272(1999)17:2<118::AID-GEPI3>3.0.CO;2-V; Burton PR, 2003, GENET EPIDEMIOL, V24, P24, DOI 10.1002/gepi.10206; BURTON PR, 2003, HDB STAT GENETICS; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; CHAKRAVARTI A, 2002, BIOSTATISTICAL GENET, P472; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; CLAYTON DG, 2001, HDB STAT GENETICS; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Cookson WOCM, 1998, CLIN EXP ALLERGY, V28, P88; CORDELL HJ, IN PRESS LANCET; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DUFFY DL, 1994, GENET EPIDEMIOL, V11, P483, DOI 10.1002/gepi.1370110606; ELSTON R, 2002, WILEY REFERENCE SERI; Elston R.C., 1981, ADV HUM GENET, V11, P372; ELSTON RC, 1995, CLIN EXP ALLERGY, V25, P103, DOI 10.1111/j.1365-2222.1995.tb00434.x; ELSTON RC, 1979, AM J HUM GENET, V31, P62; EWENS WJ, 1986, ANN HUM GENET, V50, P399, DOI 10.1111/j.1469-1809.1986.tb01760.x; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fisher R. A., 1951, BR AGR B, V4, P217; Fisher RA, 1934, ANN EUGENIC, V6, P13, DOI 10.1111/j.1469-1809.1934.tb02105.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Galton F., 1877, P ROYAL I GREAT BRIT, V8, P282; Galton F., 1865, MACMILLANS MAGAZINE, V12; Galton Francis, 1886, P ROY SOC LONDON, V40, P42; GAUDERMAN WJ, 1994, GENET EPIDEMIOL, V11, P171, DOI 10.1002/gepi.1370110207; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Goldstein H., 1987, MULTILEVEL MODELS ED; Guo SW, 1998, AM J HUM GENET, V63, P252, DOI 10.1086/301928; HATTERSLEY AT, IN PRESS LANCET; Hodge S.E., 2002, BIOSTATISTICAL GENET, P20; HOLMANS P, 2001, HDB STAT GENETICS, P487; HOOPER JL, 2002, BIOSTATISTICAL GENET, P778; Hoover RN, 2000, NEW ENGL J MED, V343, P135, DOI 10.1056/NEJM200007133430210; Hopper J L, 1993, Stat Methods Med Res, V2, P199, DOI 10.1177/096228029300200302; HOPPER JL, 1992, GENET EPIDEMIOL, V9, P225, DOI 10.1002/gepi.1370090402; HOPPER JL, 1992, AM J EPIDEMIOL, V136, P1138, DOI 10.1093/oxfordjournals.aje.a116580; Hopper JL, 2003, INT J EPIDEMIOL, V32, P48, DOI 10.1093/ije/dyg114; HOPPER JL, 1992, ACTA GENET MED GEMEL, V41, P261, DOI 10.1017/S0001566000002129; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; HOPPER JL, 2002, BIOSTATISTICAL GENET, P371; HOPPER JL, IN PRESS LANCET; JINKS JL, 1970, PSYCHOL BULL, V73, P311, DOI 10.1037/h0029135; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Khoury M, 1993, FUNDAMENTALS GENETIC; KING MC, 1984, ANNU REV PUBL HEALTH, V5, P1; KOLODNER RD, 1994, GENOMICS, V24, P516, DOI 10.1006/geno.1994.1661; KOLODNER RD, 1995, CANCER RES, V55, P242; KOPCIUK KA, 2002, BIOSTATISTICAL GENET, P687; Kraft P, 2000, AM J HUM GENET, V66, P1119, DOI 10.1086/302808; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANGE ES, 1987, PROGRAMS PEDIGREE AN; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lynch HT, 2000, J CLIN ONCOL, V18, p19S; MAJUMDER PP, 2002, BIOSTATISTICAL GENET, P693; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mathew CG, 2004, HUM MOL GENET, V13, pR161, DOI 10.1093/hmg/ddh079; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Minelli C, 2004, AM J EPIDEMIOL, V160, P445, DOI 10.1093/aje/kwh228; Morton N. E., 1982, OUTLINE GENETIC EPID; Morton N. E., 1978, GENETIC EPIDEMIOLOGY; MORTON NE, 1959, AM J HUM GENET, V11, P1; Neale MC, 1992, METHODOLOGY GENETIC; NEALE MC, 2002, BIOSTATISTICAL GENET, P743; Neale MC, 2002, MX STAT MODELING; Neel JV, 1954, HUMAN HEREDITY; OLSON JM, 2002, BIOSTATISTICAL GENET, P461; Palmer LJ, 2001, GENET EPIDEMIOL, V20, P356, DOI 10.1002/gepi.6; PALMER LJ, 2002, BIOSTATISTICAL GENET, P141; PALMER LJ, IN PRESS LANCET; Pearson K., 1896, PHILOS T ROYAL SOC A, V187, P253, DOI [DOI 10.1098/RSTA.1896.0007, 10.1098/rsta.1896.0007]; PETO J, 1980, BANBURY REPORT, V4, P203; Pritchard JK, 2000, GENETICS, V155, P945; Rasbash J, 1999, USERS GUIDE MLWIN; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROBERTS DF, 1985, DIS COMPLEX ETIOLOGY, P9; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P29; SCHAID DJ, 2002, BIOSTATISTICAL GENET, P206; Scurrah KJ, 2000, GENET EPIDEMIOL, V19, P127, DOI 10.1002/1098-2272(200009)19:2<127::AID-GEPI2>3.0.CO;2-S; Sham P., 1998, STAT HUMAN GENETICS; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2001, INT J EPIDEMIOL, V30, P1, DOI 10.1093/ije/30.1.1; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; SMITH GD, IN PRESS LANCET; Spector N, 2000, NEW ENGL J MED, V343, P1494; Spiegelhalter D. J., 2000, WINBUGS VERSION 1 3; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STRACHAN T, 2003, HUMAN MOL GENETICS, V3; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; TEARE MD, IN PRESS LANCET; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; TERWILLIGER JD, 2002, BIOSTATISTICAL GENET, P448; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; THOMPSON EA, 2001, HDB STAT GENETICS, P541; Tobin MD, 2004, INT J EPIDEMIOL, V33, P26, DOI 10.1093/ije/dyh016; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; WEINBERG W, 1927, Z INDUKT ABSTAMM VER, V48, P179; Weiss ST, 2004, HUM MOL GENET, V13, pR83, DOI 10.1093/hmg/ddh080; WIJSMAN EM, 2002, BIOSTATISTICAL GENET, P527; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wright S, 1920, J AGRIC RES, V20, P0557; ZEGER SL, 1992, STAT MED, V11, P1825, DOI 10.1002/sim.4780111406; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270; [No title captured]	124	163	174	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					941	951		10.1016/S0140-6736(05)67322-9	http://dx.doi.org/10.1016/S0140-6736(05)67322-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154023				2022-12-28	WOS:000231770000034
J	Mikeladze-Dvali, T; Wernet, MF; Pistillo, D; Mazzoni, EO; Teleman, AA; Chen, YW; Cohen, S; Desplan, C				Mikeladze-Dvali, T; Wernet, MF; Pistillo, D; Mazzoni, EO; Teleman, AA; Chen, YW; Cohen, S; Desplan, C			The growth regulators warts/lats and melted interact in a bistable loop to specify opposite fates in Drosophila R8 photoreceptors	CELL			English	Article						n	DOUBLE-NEGATIVE FEEDBACK; CELL-CYCLE EXIT; TUMOR-SUPPRESSOR; PROMOTES APOPTOSIS; RHODOPSIN GENE; PROLIFERATION; HIPPO; R7; ENCODES; SALVADOR	Color vision in Drosophila relies on the comparison between two color-sensitive photoreceptors, R7 and R8. Two types of ommatidia in which R7 and R8 contain different rhodopsins are distributed stochastically in the retina and appear to discriminate short (p-subset) or long wavelengths (y-subset). The choice between p and y fates is made in R7, which then instructs R8 to follow the corresponding fate, thus leading to a tight coupling between rhodopsins expressed in R7 and R8. Here, we show that warts, encoding large tumor suppressor (Lats) and melted encoding a PH-domain protein, play opposite roles in defining the yR8 or pR8 fates. By interacting antagonistically at the transcriptional level, they form a bistable loop that insures a robust commitment of R8 to a single fate, without allowing ambiguity. This represents an unexpected postmitotic role for genes controlling cell proliferation (warts and its partner hippo and salvador) and cell growth (melted).	NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA; European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany	New York University; European Molecular Biology Laboratory (EMBL)	Desplan, C (corresponding author), NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA.	cd38@nyu.edu	Cohen, Stephen M/G-9930-2011; Pistillo, Daniela/AAC-2367-2020; Mikeladze-Dvali, Tamara/K-4398-2014; Teleman, Aurelio A/E-6864-2013; Teleman, Aurelio/V-8470-2019	Cohen, Stephen M/0000-0003-2858-9163; Pistillo, Daniela/0000-0002-7665-3783; Teleman, Aurelio A/0000-0002-4237-9368; Teleman, Aurelio/0000-0002-4237-9368; Mikeladze-Dvali, Tamara/0000-0002-9449-3218; Desplan, Claude/0000-0002-6914-1413; mazzoni, esteban/0000-0001-8994-681X	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015518] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013012] Funding Source: NIH RePORTER; NCRR NIH HHS [C03 RR-15518-01] Funding Source: Medline; NEI NIH HHS [R01 EY13012] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akhmedov NB, 2005, BBA-GENE STRUCT EXPR, V1728, P11, DOI 10.1016/j.bbaexp.2005.01.003; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Cook T, 2001, SEMIN CELL DEV BIOL, V12, P509, DOI 10.1006/scdb.2001.0275; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hisaoka M, 2002, LAB INVEST, V82, P1427, DOI 10.1097/01.LAB.0000032381.68634.CA; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Huber A, 1997, FEBS LETT, V406, P6, DOI 10.1016/S0014-5793(97)00210-X; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; KIRSCHFELD K, 1978, J COMP PHYSIOL, V125, P275, DOI 10.1007/BF00656606; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Mazzoni EO, 2004, DEV NEUROSCI-BASEL, V26, P388, DOI 10.1159/000082281; Mikeladze-Dvali T, 2005, CURR TOP DEV BIOL, V69, P1, DOI 10.1016/S0070-2153(05)69001-1; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; MONTELL C, 1987, J NEUROSCI, V7, P1558; Muto E, 2004, BIOCHIMIE, V86, P523, DOI 10.1016/j.biochi.2004.07.010; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; Pichaud F, 2001, DEVELOPMENT, V128, P815; Salzberg A, 1997, GENETICS, V147, P1723; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wolff Tanya, 1993, P1277; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; WUNDERER H, 1982, TISSUE CELL, V14, P341, DOI 10.1016/0040-8166(82)90032-5; XU TA, 1995, DEVELOPMENT, V121, P1053; ZUKER CS, 1987, J NEUROSCI, V7, P1550; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	48	131	134	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					775	787		10.1016/j.cell.2005.07.026	http://dx.doi.org/10.1016/j.cell.2005.07.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143107	Bronze			2022-12-28	WOS:000231844300016
J	Sambashivan, S; Liu, YS; Sawaya, MR; Gingery, M; Eisenberg, D				Sambashivan, S; Liu, YS; Sawaya, MR; Gingery, M; Eisenberg, D			Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure	NATURE			English	Article							DISULFIDE BRIDGES; CORE STRUCTURE; CYSTATIN-C; PROTEIN; AGGREGATION; FIBERS; MODEL	Amyloid or amyloid-like fibrils are elongated, insoluble protein aggregates, formed in vivo(1) in association with neurodegenerative diseases or in vitro(2) from soluble native proteins, respectively. The underlying structure of the fibrillar or 'cross-beta' state has presented long-standing, fundamental puzzles of protein structure. These include whether fibril-forming proteins have two structurally distinct stable states, native and fibrillar, and whether all or only part of the native protein refolds as it converts to the fibrillar state. Here we show that a designed amyloid-like fibril of the well-characterized enzyme RNase A contains native-like molecules capable of enzymatic activity. In addition, these functional molecular units are formed from a core RNase A domain and a swapped complementary domain. These findings are consistent with the zipper-spine model(3) in which a cross-beta spine is decorated with three-dimensional domain-swapped functional units, retaining native-like structure.	Univ Calif Los Angeles, Howard Hughes Med Inst, UCLA DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, UCLA DOE Inst Genom & Proteom, Box 951570, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Sawaya, Michael/0000-0003-0874-9043				ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P2421; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Gotte G, 1999, EUR J BIOCHEM, V265, P680, DOI 10.1046/j.1432-1327.1999.00761.x; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Pickersgill RW, 2003, STRUCTURE, V11, P137, DOI 10.1016/S0969-2126(03)00009-1; Sanders A, 2004, J MOL BIOL, V336, P165, DOI 10.1016/j.jmb.2003.12.011; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; SELA M, 1957, SCIENCE, V125, P691, DOI 10.1126/science.125.3250.691; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Wetzel R, 2002, STRUCTURE, V10, P1031, DOI 10.1016/S0969-2126(02)00809-2	26	219	223	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					266	269		10.1038/nature03916	http://dx.doi.org/10.1038/nature03916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148936				2022-12-28	WOS:000231696900058
J	Kobayashi, T; Ganley, ARD				Kobayashi, T; Ganley, ARD			Recombination regulation by transcription-induced cohesin dissociation in rDNA repeats	SCIENCE			English	Article							RIBOSOMAL DNA REPEATS; SACCHAROMYCES-CEREVISIAE; YEAST; REPLICATION; ELEMENTS; IDENTIFICATION; EXPANSION; PROTEIN; GENOME; REGION	Organisms maintain ribosomal RNA gene repeats (rDNA) at stable copy numbers by recombination; the loss of repeats results in gene amplification. Here we report a mechanism of amplification regulation. We show that amplification is dependent on transcription from a noncoding bidirectional promoter (E-pro) within the rDNA spacer. E-pro transcription stimulates the dissociation of cohesin, a DNA binding protein complex that suppresses sister-chromatid-based changes in rDNA copy number. This transcription is regulated by the silencing gene, SIR2, and by copy number. Transcription-induced cohesin dissociation may be a general mechanism of recombination regulation.	Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, SOKENDAI, Sch Life Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Kobayashi, T (corresponding author), Natl Inst Basic Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	koba@nibb.ac.jp	Ganley, Austen/L-8120-2013	Ganley, Austen/0000-0002-1917-7522				Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Ganley ARD, 2005, P NATL ACAD SCI USA, V102, P11787, DOI 10.1073/pnas.0504905102; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HAWLEY RS, 1989, ANNU REV GENET, V23, P87, DOI 10.1146/annurev.genet.23.1.87; Kobayashi T, 2001, MOL CELL BIOL, V21, P136, DOI 10.1128/MCB.21.1.136-147.2001; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; RODLAND KD, 1982, BIOCHIM BIOPHYS ACTA, V697, P162, DOI 10.1016/0167-4781(82)90072-0; SANTANGELO GM, 1988, MOL CELL BIOL, V8, P4217, DOI 10.1128/MCB.8.10.4217; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SMITH GP, 1973, COLD SPRING HARB SYM, V38, P507, DOI 10.1101/SQB.1974.038.01.055; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	24	220	224	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1581	1584		10.1126/science.1116102	http://dx.doi.org/10.1126/science.1116102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141077				2022-12-28	WOS:000231715000055
J	Haney, MM; Snieder, R; Sheiman, J; Losh, S				Haney, MM; Snieder, R; Sheiman, J; Losh, S			Geophysics - A moving fluid pulse in a fault zone	NATURE			English	Editorial Material							330 FIELD		Colorado Sch Mines, Dept Geophys, Golden, CO 80401 USA; Colorado Sch Mines, Ctr Wave Phenomena, Golden, CO 80401 USA; Shell Int Explorat & Prod BV, Houston, TX 77025 USA; Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA; Minnesota State Univ, Dept Chem & Geol, Mankato, MN 56001 USA	Colorado School of Mines; Colorado School of Mines; Royal Dutch Shell; Cornell University; Minnesota State Colleges & Universities; Minnesota State University Mankato	Haney, MM (corresponding author), Sandia Natl Labs, Dept Geophys, POB 5800 MS 0750, Albuquerque, NM 87185 USA.	mmhaney@sandia.gov						ANDERSON RN, 1991, LEADING EDGE, V10, P12; DOBRIN MB, 1976, INTRO GEOPHYSICAL PR; Finkbeiner T, 2001, AAPG BULL, V85, P1007; HANEY M, 2004, P EAGE SPEC SESS FAU; HOLLAND DS, 1990, STRUCTURAL TRAPS, V3, P103; HOOPER ECD, 1991, J PETROL GEOL, V14, P161, DOI 10.1111/j.1747-5457.1991.tb00360.x; Losh S, 1999, AAPG BULL, V83, P244; Rice J., 1992, FAULT MECH TRANSPORT, P475, DOI DOI 10.1016/S0074-6142(08)62835-1; Whelan JK, 2001, GEOCHIM COSMOCHIM AC, V65, P3529, DOI 10.1016/S0016-7037(01)00684-6	9	41	43	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					46	46		10.1038/437046a	http://dx.doi.org/10.1038/437046a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136123	Bronze			2022-12-28	WOS:000231560400034
J	Hauser, M				Hauser, M			Our chimpanzee mind	NATURE			English	Article							REPRESENTATIONS; CONSPECIFICS; COGNITION; LANGUAGE	Some might consider the title of this piece preposterous. Bishop Wilberforce would no doubt have shaken his fist at it, just as he disputed Huxley's championing of darwinian continuity. But the title of this essay is no more outrageous than one entitled 'The chimpanzee's bird brain', for there has been extensive evolutionary conservation of many neural and psychological functions across species. We share with chimpanzees some - but not all - mental functions, some of which are shared with other species as well. As the publication of the chimpanzee genome reveals, we also share a good deal of our DNA. Unfortunately, we are virtually in the dark when it comes to understanding how genes build minds. If comparative genomics is to enlighten our understanding of human origins, it must be accompanied by an equally rich description of animal psychology, both in terms of its underlying neural signatures and the evolutionary processes that led to convergence and divergence with other species.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Biol Anthropol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Hauser, M (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	mdh@wjh.harvard.edu						Beran MJ, 2001, J COMP PSYCHOL, V115, P181, DOI 10.1037//0735-7036.115.2.181; Beran MJ., 2001, ANIM COGN, V4, P81, DOI DOI 10.1007/S100710100098; Biro D, 1999, J COMP PSYCHOL, V113, P178, DOI 10.1037/0735-7036.113.2.178; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Butterworth B., 1999, WHAT COUNTS EVERY BR; Call J, 2004, DEVELOPMENTAL SCI, V7, P488, DOI 10.1111/j.1467-7687.2004.00368.x; Carey S, 2001, MIND LANG, V16, P37, DOI 10.1111/1468-0017.00155; Cheney D.L., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Chomsky N., 2000, NATURE LANGUAGE; Dehaene S., 1997, NUMBER SENSE; Emery NJ, 2001, NATURE, V414, P443, DOI 10.1038/35106560; FLOMBAUM JI, 2005, CURR BIOL, V15, P1, DOI DOI 10.1016/J.CUB.2004.12.076; Gallistel C. R., 1990, ORG LEARNING; Gelman R, 2004, SCIENCE, V306, P441, DOI 10.1126/science.1105144; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; Hare B, 2004, ANIM BEHAV, V68, P571, DOI 10.1016/j.anbehav.2003.11.011; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Hauser MD, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P853; Hauser MD, 2003, COGNITIVE PSYCHOL, V47, P367, DOI 10.1016/S0010-0285(03)00050-1; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hauser MD, 1996, P NATL ACAD SCI USA, V93, P1514, DOI 10.1073/pnas.93.4.1514; HAUSER MD, 2000, WILD MINDS WHAT ANIM; Kawai N, 2000, NATURE, V403, P39, DOI 10.1038/47405; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; PLATT J R, 1971, Learning and Motivation, V2, P386, DOI 10.1016/0023-9690(71)90020-8; Povinelli DJ, 1996, MONOGR SOC RES CHILD, V61, P1, DOI 10.1111/j.1540-5834.1996.tb00481.x; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; PREMACK D, 2002, ORIGINAL INTELLIGENC; Spelke ES, 2000, AM PSYCHOL, V55, P1233, DOI 10.1037/0003-066X.55.11.1233; Tomasello M, 1997, PRIMATE COGNITION; Tomonaga M, 2000, ANIM COGN, V3, P1, DOI 10.1007/s100710050045; Uller C, 2001, J COMP PSYCHOL, V115, P248, DOI 10.1037/0735-7036.115.3.248; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Wrangham R., 1996, DEMONIC MALES; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0	39	16	18	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					60	63		10.1038/nature03917	http://dx.doi.org/10.1038/nature03917			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	960AC	16136129				2022-12-28	WOS:000231560400043
J	Nguyen, T; Sutton, AD; Brynda, M; Fettinger, JC; Long, GJ; Power, PP				Nguyen, T; Sutton, AD; Brynda, M; Fettinger, JC; Long, GJ; Power, PP			Synthesis of a stable compound with fivefold bonding between two chromium(I) centers	SCIENCE			English	Article							SCMEH-MO CALCULATIONS; DENSITY FUNCTIONALS; TERPHENYL LIGANDS; CHEMISTRY; ENERGIES; ADDUCTS; CR	Although in principle transition metals can form bonds with six shared electron pairs, only quadruply bonded compounds can be isolated as stable species at room temperature. Here we show that the reduction of [Cr(mu-Cl)Ar)(2) [where Ar' indicates C6H3-2,6(C6H3-2,6-Pr-2(i))(2) and Pr-i indicates isopropyl] with a slight excess of potassium graphite has produced a stable compound with fivefold chromium-chromium (Cr-Cr) bonding. The very air- and moisture-sensitive dark red crystals of Ar'CrCrAr' were isolated with greater than 40% yield. X-ray diffraction revealed a Cr-Cr bond length of 1.8351(4) angstroms (where the number in parentheses indicates the standard deviation) and a planar transbent core geometry. These data, the structure's temperature-independent paramagnetism, and computational studies support the sharing of five electron pairs in five bonding molecular orbitals between two US chromium(l) ions.	Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; Univ Missouri, Dept Chem, Rolla, MO 65409 USA	University of California System; University of California Davis; University of Missouri System; Missouri University of Science & Technology	Power, PP (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	pppower@ucdavis.edu	Sutton, Andrew D/D-1047-2015	Sutton, Andrew D/0000-0001-7984-1715				Barden CJ, 2000, J CHEM PHYS, V113, P690, DOI 10.1063/1.481916; BILGRIEN CJ, 1988, INORG CHEM, V27, P1410, DOI 10.1021/ic00281a023; Boudreaux EA, 2004, INT J QUANTUM CHEM, V100, P1170, DOI 10.1002/qua.20254; Boudreaux EA, 2001, INT J QUANTUM CHEM, V85, P509, DOI 10.1002/qua.1539; BURSTEN BE, 1980, J AM CHEM SOC, V102, P6349; Clerac R, 2000, INORG CHEM, V39, P2581, DOI 10.1021/ic991370v; Clyburne JAC, 2000, COORDIN CHEM REV, V210, P73, DOI 10.1016/S0010-8545(00)00317-9; Cotton F. A., 2005, MULTIPLE BONDS METAL; COTTON FA, 1964, SCIENCE, V145, P1305, DOI 10.1126/science.145.3638.1305; COTTON FA, 1978, INORG CHEM, V17, P2084, DOI 10.1021/ic50186a010; COTTON FA, 1992, J AM CHEM SOC, V114, P8980, DOI 10.1021/ja00049a031; FORD PD, 1983, POLYHEDRON, V2, P1317, DOI 10.1016/S0277-5387(00)84393-4; Gagliardi L, 2005, NATURE, V433, P848, DOI 10.1038/nature03249; Gutsev GL, 2003, J PHYS CHEM A, V107, P4755, DOI 10.1021/jp030146v; HALL MB, 1987, POLYHEDRON, V6, P679, DOI 10.1016/S0277-5387(00)86875-8; Jules JL, 2003, J PHYS CHEM A, V107, P1268, DOI 10.1021/jp027493+; KLOTZBUCHER W, 1977, INORG CHEM, V16, P984, DOI 10.1021/ic50171a003; KUNDIG EP, 1975, NATURE, V254, P503, DOI 10.1038/254503a0; MORSE MD, 1986, CHEM REV, V86, P1049, DOI 10.1021/cr00076a005; NORMAN JG, 1977, INORG CHEM, V16, P987, DOI 10.1021/ic50171a004; Roos BO, 2003, COLLECT CZECH CHEM C, V68, P265, DOI 10.1135/cccc20030265; Salahub D.R., 1987, ADV CHEM PHYS, V69, P447; Schiemenz B, 1996, ANGEW CHEM INT EDIT, V35, P2150, DOI 10.1002/anie.199621501; Schultz NE, 2005, J PHYS CHEM A, V109, P4388, DOI 10.1021/jp0504468; Twamley B, 1999, ADV ORGANOMET CHEM, V44, P1, DOI 10.1016/S0065-3055(08)60619-X; WEINHOLD F, 2005, VALENCY BONDING, P355; Weinhold F., 2001, CHEM EDUC RES PRACT, V2, P91, DOI [DOI 10.1039/B1RP90011K, 10.1039/B1RP90011K]; Yanagisawa S, 2000, J CHEM PHYS, V112, P545, DOI 10.1063/1.480546	28	430	433	3	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2005	310	5749					844	847		10.1126/science.1116789	http://dx.doi.org/10.1126/science.1116789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16179432				2022-12-28	WOS:000233121800043
J	Mailand, N; Diffley, JFX				Mailand, N; Diffley, JFX			CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis	CELL			English	Article							PRE-RC FORMATION; CYCLIN-A; PREREPLICATION COMPLEXES; CHROMATIN ASSOCIATION; UBIQUITIN LIGASE; MAMMALIAN CDC6; IN-VIVO; MITOSIS; PROTEINS; PHOSPHORYLATION	Cyclin-dependent kinases (CDKs) restrict DNA replication origin firing to once per cell cycle by preventing the assembly of prereplicative complexes (preRCs; licensing) outside of G1 phase. Paradoxically, under certain circumstances, CDKs such as cyclin E-cdk2 are also required to promote licensing. Here, we show that CDK phosphorylation of the essential licensing factor Cdc6 stabilizes it by preventing its association with the anaphase promoting complex/ cyclosome (APC/C). APC/C-dependent Cdc6 proteolysis prevents pre-RC assembly in quiescent cells and, when cells reenter the cell cycle from quiescence, CDK-dependent Cdc6 stabilization allows Cdc6 to accumulate before the licensing inhibitors geminin and cyclin A which are also APC/C substrates. This novel mechanism for regulating protein stability establishes a window of time prior to S phase when preRCs can assemble which we propose represents a critical function of cyclin E.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	john.diffley@cancer.org.uk		Diffley, John/0000-0001-5184-7680				Alexandrow MG, 2004, MOL CELL BIOL, V24, P1614, DOI 10.1128/MCB.24.4.1614-1627.2004; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bermejo R, 2002, MOL BIOL CELL, V13, P3989, DOI 10.1091/mbc.E02-04-0217; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Coverley D, 1998, EXP CELL RES, V238, P63, DOI 10.1006/excr.1997.3829; Coverley D, 1996, EXP CELL RES, V225, P294, DOI 10.1006/excr.1996.0179; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Herbig U, 2000, MOL BIOL CELL, V11, P4117, DOI 10.1091/mbc.11.12.4117; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Laronne A, 2003, MOL BIOL CELL, V14, P3730, DOI 10.1091/mbc.E02-12-0850; Listovsky T, 2000, EXP CELL RES, V255, P184, DOI 10.1006/excr.1999.4788; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002; Tikhmyanova N, 2003, DEV BIOL, V260, P362, DOI 10.1016/S0012-1606(03)00253-7; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932	43	270	270	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					915	926		10.1016/j.cell.2005.08.013	http://dx.doi.org/10.1016/j.cell.2005.08.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16153703	Bronze			2022-12-28	WOS:000232130200015
J	Walsh, JP; Cho, C; Cohen, WM				Walsh, JP; Cho, C; Cohen, WM			View from the bench: Patents and material transfers	SCIENCE			English	Editorial Material							ECONOMICS; SCIENCE; LAW		Univ Illinois, Dept Sociol, Chicago, IL 60607 USA; Univ Tokyo, Tokyo, Japan; Duke Univ, Durham, NC 27708 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Tokyo; Duke University; National Bureau of Economic Research	Walsh, JP (corresponding author), Univ Illinois, Dept Sociol, Chicago, IL 60607 USA.	jwalsh@uic.edu						Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; COLE JR, 1972, SCIENCE, V178, P368, DOI 10.1126/science.178.4059.368; DASGUPTA P, 1987, ECON J, V97, P581, DOI 10.2307/2232925; EISENBERG R, 2001, EXPANDING BOUNDARIES; Eisenberg RS, 2003, SCIENCE, V299, P1018, DOI 10.1126/science.1081790; ELLICKSON RC, 1991, ORDER WITHOUT LAWS; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; MERGES RP, 1990, COLUMBIA LAW REV, V90, P839, DOI 10.2307/1122920; Merges RP, 1996, SOC PHILOS POLICY, V13, P145, DOI 10.1017/S0265052500003496; Merz JF, 2002, NATURE, V415, P577, DOI 10.1038/415577a; National Research Council, 2003, SHAR PUBL REL DAT MA; Rynes SL, 2004, HUM RESOUR MANAGE-US, V43, P381, DOI 10.1002/hrm.20031; SCOTCHMER S, 1991, J ECON PERSPECT, V5, P29, DOI 10.1257/jep.5.1.29; Shapiro C, 2001, INNOV POLICY EC, V1, P119, DOI DOI 10.1086/ipe.1.25056143; Walsh J.P., 2005, PATENTS MAT TRANSFER; Walsh JP, 2003, NATURE, V422, P801, DOI 10.1038/422801c; Walsh JP, 2003, SCIENCE, V299, P1021, DOI 10.1126/science.299.5609.1021; 1999, FED REG, V64, P72090	19	149	152	4	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2002	2003		10.1126/science.1115813	http://dx.doi.org/10.1126/science.1115813			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968SF	16179461				2022-12-28	WOS:000232181900030
J	Carillio, G; Longo, R				Carillio, G; Longo, R			Relapsed colon cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Catanese Oncol, I-95125 Catania, Italy		Carillio, G (corresponding author), Ctr Catanese Oncol, I-95125 Catania, Italy.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1274	1274		10.1056/NEJMicm041152	http://dx.doi.org/10.1056/NEJMicm041152			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	966DS	16177253				2022-12-28	WOS:000232000400011
J	Wassen, MJ; Venterink, HO; Lapshina, ED; Tanneberger, F				Wassen, MJ; Venterink, HO; Lapshina, ED; Tanneberger, F			Endangered plants persist under phosphorus limitation	NATURE			English	Article							SPECIES RICHNESS; NUTRIENT LIMITATION; NITROGEN; RESTORATION; DIVERSITY; BIODIVERSITY; CONSTRAINTS; GRASSLAND; CAPACITY; WETLANDS	Nitrogen enrichment is widely thought to be responsible for the loss of plant species from temperate terrestrial ecosystems. This view is based on field surveys and controlled experiments showing that species richness correlates negatively with high productivity(1,2) and nitrogen enrichment(3). However, as the type of nutrient limitation has never been examined on a large geographical scale the causality of these relationships is uncertain. We investigated species richness in herbaceous terrestrial ecosystems, sampled along a transect through temperate Eurasia that represented a gradient of declining levels of atmospheric nitrogen deposition - from similar to 50 kg ha(-1) yr(-1) in western Europe to natural background values of less than 5 kg ha(-1) yr(-1) in Siberia(4). Here we show that many more endangered plant species persist under phosphorus- limited than under nitrogen- limited conditions, and we conclude that enhanced phosphorus is more likely to be the cause of species loss than nitrogen enrichment. Our results highlight the need for a better understanding of the mechanisms of phosphorus enrichment, and for a stronger focus on conservation management to reduce phosphorus availability.	Univ Utrecht, Copernicus Inst Sustainable Dev & Innovat, NL-3508 TC Utrecht, Netherlands; ETH, Geobot Inst, CH-8044 Zurich, Switzerland; Tomsk State Univ, Dept Bot, Tomsk 634050, Russia; Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, D-17487 Greifswald, Germany	Utrecht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Tomsk State University; Ernst Moritz Arndt Universitat Greifswald	Wassen, MJ (corresponding author), Univ Utrecht, Copernicus Inst Sustainable Dev & Innovat, POB 80115, NL-3508 TC Utrecht, Netherlands.	m.wassen@geo.uu.nl	Lapshina, Elena/AAC-5538-2019; Wassen, Martin J./L-9228-2013; Lapshina, Elena Dmitrievna/A-4792-2014; olde Venterink, Harry/K-9547-2015	Lapshina, Elena/0000-0001-5571-7787; Wassen, Martin J./0000-0002-9735-2103; olde Venterink, Harry/0000-0002-8963-1153; Tanneberger, Franziska/0000-0002-4184-9671				[Anonymous], 2001, PLANT STRATEGIES VEG; Bakker J.P., 1989, NATURE MANAGEMENT GR; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; BERENDSE F, 1992, BIOL CONSERV, V62, P59, DOI 10.1016/0006-3207(92)91152-I; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Giles J, 2005, NATURE, V433, P791, DOI 10.1038/433791a; GOUGH MW, 1990, BIOL CONSERV, V51, P83, DOI 10.1016/0006-3207(90)90104-W; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; Gusewell S, 2005, OIKOS, V109, P71, DOI 10.1111/j.0030-1299.2005.13587.x; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Holland EA, 1999, BIOGEOCHEMISTRY, V46, P7, DOI 10.1007/BF01007572; Jansen AJM, 1996, ECOL ENG, V7, P279, DOI 10.1016/S0925-8574(96)00022-5; Lamers LPM, 1998, ENVIRON SCI TECHNOL, V32, P199, DOI 10.1021/es970362f; Meijden R. van der, 1991, Gorteria, V17, P75; MOORE DRJ, 1989, BIOL CONSERV, V47, P203, DOI 10.1016/0006-3207(89)90065-7; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; RICHARDSON CJ, 1985, SCIENCE, V228, P1424, DOI 10.1126/science.228.4706.1424; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schlesinger WH., 1997, BIOGEOCHEMISTRY; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; TAYLOR DR, 1990, OIKOS, V58, P239, DOI 10.2307/3545432; Turner BL, 2001, NATURE, V411, P258, DOI 10.1038/35077146; Venterink HO, 2003, ECOLOGY, V84, P2191, DOI 10.1890/01-0639; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wassen MJ, 1996, VEGETATIO, V126, P5; WHEELER BD, 1991, J ECOL, V79, P285, DOI 10.2307/2260713	30	386	413	14	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					547	550		10.1038/nature03950	http://dx.doi.org/10.1038/nature03950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177790	Green Published			2022-12-28	WOS:000232004800049
J	Jemal, A; Ward, E; Hao, YP; Thun, M				Jemal, A; Ward, E; Hao, YP; Thun, M			Trends in the leading causes of death in the United States, 1970-2002	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPEED LIMIT; FATALITIES; MORTALITY; CANCER	Context The decrease in overall death rates in the United States may mask changes in death rates from specific conditions. Objective To examine temporal trends in the age-standardized death rates and in the number of deaths from the 6 leading causes of death in the United States. Design and Setting Analyses of vital statistics data on mortality in the United States from 1970 to 2002. Main Outcome Measure The age-standardized death rate and number of deaths (coded as underlying cause) from each of the 6 leading causes of death: heart disease, stroke, cancer, chronic obstructive pulmonary disease, accidents (ie, related to transportation [motor vehicle, other land vehicles, and water, air, and space] and not related to transportation [falls, fire, and accidental posioning]), and diabetes mellitus. Results The age-standardized death rate (per 100000 per year) from all causes combined decreased from 1242 in 1970 to 845 in 2002. The largest percentage decreases were in death rates from stroke (63%), heart disease (52%), and accidents (41%). The largest absolute decreases in death rates were from heart disease (262 deaths per 100 000), stroke (96 deaths per 100 000), and accidents (26 deaths per 100 000). The death rate from all types of cancer combined increased between 1970 and 1990 and then decreased through 2002, yielding a net decline of 2.7%. In contrast, death rates doubled from chronic obstructive pulmonary disease over the entire time interval and increased by 45% for diabetes since 1987. Despite decreases in age-standardized death rates from 4 of the 6 leading causes of death, the absolute number of deaths from these conditions continues to increase, although these deaths occur at older ages. Conclusions The absolute number of deaths and age at death continue to increase in the United States. These temporal trends have major implications for health care and health care costs in an aging population.	Amer Canc Soc, Epidemiol & Surveillance Res, Atlanta, GA 30329 USA	American Cancer Society	Jemal, A (corresponding author), Amer Canc Soc, Epidemiol & Surveillance Res, 1599 Clifton Rd, Atlanta, GA 30329 USA.	ajemal@cancer.org						Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; [Anonymous], INT CLASSIFICATION D, V3rd; Farmer CM, 1999, ACCIDENT ANAL PREV, V31, P537, DOI 10.1016/S0001-4575(99)00010-X; GARBER S, 1990, ACCIDENT ANAL PREV, V22, P137, DOI 10.1016/0001-4575(90)90065-S; GITTELSOHN A, 1982, VITAL HLTH STAT 2, V2, P1; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V53, P1; Mannino David M, 2002, Respir Care, V47, P1184; Mokdad AH, 2001, DIABETES CARE, V24, P412, DOI 10.2337/diacare.24.2.412; *NAT CANC I, UND MORT DAT PROV NA; *NAT CTR HLTH STAT, VIT STAT INSTR CL 2A; Sarti C, 2000, STROKE, V31, P1588, DOI 10.1161/01.STR.31.7.1588; *SEER STAT DAT, MORT COD PUBL US STA; Surveillance Epidemiology and End Results (SEER) Program, SEER CAUS DEATH REC; SUTHERLAND JE, 1990, JAMA-J AM MED ASSOC, V264, P3178, DOI 10.1001/jama.264.24.3178; THROPE KE, HLTH AFF MILLWOOD; *US DHEW, 1967, MAN INT STAT CLASS D; WAGENAAR AC, 1986, PUBLIC HEALTH REP, V101, P505; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; 2004, MMWR MORB MORTAL WKL, V53, P257	22	707	734	1	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2005	294	10					1255	1259		10.1001/jama.294.10.1255	http://dx.doi.org/10.1001/jama.294.10.1255			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963UI	16160134				2022-12-28	WOS:000231831200023
J	Poulter, NR; Wedel, H; Dahlof, B; Sever, PS; Beevers, DG; Caulfield, M; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Pocock, S				Poulter, NR; Wedel, H; Dahlof, B; Sever, PS; Beevers, DG; Caulfield, M; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Pocock, S		ASCOT Investigators	Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)	LANCET			English	Article							MORTALITY; CHOLESTEROL; PREVENTION; PREDICTOR; CORONARY; DISEASE; COHORT; ADULTS; RISK; MEN	Background Results of the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) show significantly lower rates of coronary and stroke events in individuals allocated an amlodipine-based combination drug regimen than in those allocated an atenolol-based combination drug regimen (HR 0.86 and 0.77, respectively). Our aim was to assess to what extent these differences were due to significant differences in blood pressures and in other variables noted after randomisation. Methods We used data from ASCOT-BPLA (n=19257) and compared differences in accumulated mean blood pressure levels at sequential times in the trial with sequential differences in coronary and stroke events. Serial mean matching for differences in systolic blood pressure was used to adjust HRs for differences in these events. We used an updated Cox-regression model to assess the effects of differences in accumulated mean levels of various measures of blood pressure, serum HDL-cholesterol, triglycerides and potassium, fasting blood glucose, heart rate, and bodyweight on differences in event rates. Findings We noted no temporal link between size of differences in blood pressure and different event rates. Serial mean matching for differences in systolic blood-pressure attenuated HRs for coronary and stroke events to a similar extent as did adjustments for systolic blood-pressure differences in Cox-regression analyses. HRs for coronary events and stroke adjusted for blood pressure rose from 0.86 (0.77-0.96) to 0.88 (0.79-0.98) and from 0.77 (0.66-0.89) to 0.83 (0.72-0.96), respectively. Multivariate adjustment gave HRs of 0.94 (0.81-1.08) for coronary events (HDL cholesterol being the largest contributor) and 0.87 (0.73-1.05) for stroke events. Interpretation Multivariate adjustment accounted for about half of the differences in coronary events and for about 40% of the differences in stroke events between the treatment regimens tested in ASCOT-BPLA, but residual differences were no longer significant. These residual differences could indicate inadequate statistical adjustment but it remains possible that differential effects of the two treatment regimens on other variables also contributed to the different rates noted, particularly for stroke.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1PG, England; Nord Sch Publ Hlth, Gothenburg, Sweden; Sahlgrenska Univ Hosp Ostra, Gothenburg, Sweden; City Hosp, Birmingham, W Midlands, England; Barts & London Queen Marys Sch Med, London, England; Ulleval Hosp, Oslo, Norway; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Hosp Reykjavik, Reykjavik, Iceland; Univ Glasgow, Glasgow, Lanark, Scotland; HS Frederiksberg Hosp, Frederiksberg, Denmark; Univ Helsinki, Cent Hosp, Helsinki, Finland; Beaumont Hosp, Dublin 9, Ireland; Royal Coll Surg, Dublin, Ireland; Karolinska Hosp, S-10401 Stockholm, Sweden; London Sch Hyg & Trop Med, London WC1, England	Imperial College London; Sahlgrenska University Hospital; University of Birmingham; University of London; Queen Mary University London; University of Oslo; University of Michigan System; University of Michigan; Landspitali National University Hospital; University of Glasgow; University of Helsinki; Helsinki University Central Hospital; Royal College of Surgeons - Ireland; Karolinska Institutet; Karolinska University Hospital; University of London; London School of Hygiene & Tropical Medicine	Poulter, NR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1PG, England.	n.poulter@imperial.ac.uk	Mehlsen, Jesper/AAA-5848-2022; Stanton, Alice V/F-4697-2012	Caulfield, Mark/0000-0001-9295-3594				Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; COHEN JD, 1987, AM J CARDIOL, V60, P548, DOI 10.1016/0002-9149(87)90303-1; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; HOKANSON JE, 1996, J CARDIOVASC RISK, V3, P21; JACOBS DR, 1990, AM J EPIDEMIOL, V131, P32, DOI 10.1093/oxfordjournals.aje.a115483; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; SAFAR ME, 2005, HYPERTENSION, V46, P1; Sever PS, 2001, J HYPERTENS, V19, P1139, DOI 10.1097/00004872-200106000-00020; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Sleight P, 2001, LANCET, V358, P2130, DOI 10.1016/S0140-6736(01)07186-0; Staessen JA, 2004, LANCET, V364, P931, DOI 10.1016/S0140-6736(04)17010-4; Staessen JA, 2004, J HYPERTENS, V22, P847, DOI 10.1097/00004872-200404000-00029; Turnbull F, 2003, LANCET, V362, P1527; Verdecchia P, 2005, HYPERTENSION, V46, P386, DOI 10.1161/01.HYP.0000174591.42889.a2; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8	18	243	266	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 10	2005	366	9489					907	913		10.1016/S0140-6736(05)67186-3	http://dx.doi.org/10.1016/S0140-6736(05)67186-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154017				2022-12-28	WOS:000231770000028
J	Uncini, A; Caulo, M; Caporale, CM; Perfetti, B; Colosimo, C				Uncini, A; Caulo, M; Caporale, CM; Perfetti, B; Colosimo, C			The "electrocuted" hippocampus	LANCET			English	Editorial Material							STATUS EPILEPTICUS; EPILEPSY		Univ Fdn G dAnnunzio, Dept Oncol Neurosci, I-66013 Chieti, Italy; Univ Fdn G dAnnunzio, Ageing Res Ctr, I-66013 Chieti, Italy; Univ Fdn G dAnnunzio, Dept Clin Sci, Bioimaging & ITAB Inst Adv Biomed Technol, I-66013 Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Uncini, A (corresponding author), Univ Fdn G dAnnunzio, Dept Oncol Neurosci, Via Vestini, I-66013 Chieti, Italy.	uncini@unich.it		Colosimo, Cesare/0000-0003-3800-3648				DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; DUNCAN R, 1987, LANCET, V2, P625; PRINGLE CE, 1993, CAN J NEUROL SCI, V20, P184; Wasterlain C G, 1993, Epilepsia, V34, P137; Wieshmann UC, 1997, EPILEPSIA, V38, P1238, DOI 10.1111/j.1528-1157.1997.tb01222.x	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 10	2005	366	9489					956	956		10.1016/S0140-6736(05)67324-2	http://dx.doi.org/10.1016/S0140-6736(05)67324-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154025				2022-12-28	WOS:000231770000036
J	Mekel-Bobrov, N; Gilbert, SL; Evans, PD; Vallender, EJ; Anderson, JR; Hudson, RR; Tishkoff, SA; Lahn, BT				Mekel-Bobrov, N; Gilbert, SL; Evans, PD; Vallender, EJ; Anderson, JR; Hudson, RR; Tishkoff, SA; Lahn, BT			Ongoing adaptive evolution of ASPM, a brain size determinant in Homo sapiens	SCIENCE			English	Article							CEREBRAL CORTICAL SIZE; MAJOR DETERMINANT; GENETIC-STRUCTURE; MODERN HUMANS	The gene ASPM (abnormal spindle-like microcephaly associated) is a specific regulator of brain size, and its evolution in the lineage leading to Homo sapiens was driven by strong positive selection. Here, we show that one genetic variant of ASPM in humans arose merely about 5800 years ago and has since swept to high frequency under strong positive selection. These findings, especially the remarkably young age of the positively selected variant, suggest that the human brain is still undergoing rapid adaptive evolution.	Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University System of Maryland; University of Maryland College Park	Lahn, BT (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, 5841 S Maryland Ave, Chicago, IL 60637 USA.	blahn@bsd.uchicago.edu	Vallender, Eric/A-2450-2008	Vallender, Eric/0000-0003-3506-0540				Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; HOUSTON S.D., 2004, 1 WRITING SCRIPT INV; Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Wright S., 1978, EVOLUTION GENETICS P; Zhang JZ, 2003, GENETICS, V165, P2063; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	13	283	294	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2005	309	5741					1720	1722		10.1126/science.1116815	http://dx.doi.org/10.1126/science.1116815			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151010				2022-12-28	WOS:000231836700043
J	Varga, Z; Pavlu, J				Varga, Z; Pavlu, J			Roth's spots	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hillington Hosp, Uxbridge UB8 3NN, Middx, England		Varga, Z (corresponding author), Hillington Hosp, Uxbridge UB8 3NN, Middx, England.			Varga, Zsolt/0000-0001-9167-8084					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					1041	1041		10.1056/NEJMicm040783	http://dx.doi.org/10.1056/NEJMicm040783			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148289				2022-12-28	WOS:000231698200009
J	Campo, R				Campo, R			"The medical humanities," for lack of a better term	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE PHYSICIANS; MANAGED-CARE; EXPERIENCE; EDUCATION					rcampo@bidmc.harvard.edu						Behrman RE, 1996, PEDIATRICS, V98, P1249; Cykert S, 1997, J GEN INTERN MED, V12, P192; Dittrich LR, 2003, ACAD MED, V78, P951, DOI 10.1097/00001888-200310000-00001; Feldman DS, 1998, ARCH INTERN MED, V158, P1626, DOI 10.1001/archinte.158.15.1626; Grumbach K, 1998, NEW ENGL J MED, V339, P1516, DOI 10.1056/NEJM199811193392106; Howell JD, 1999, ACAD MED, V74, P244, DOI 10.1097/00001888-199903000-00013; Mechanic D, 1996, JAMA-J AM MED ASSOC, V275, P1693, DOI 10.1001/jama.275.21.1693; PACHTER LM, 1994, JAMA-J AM MED ASSOC, V271, P690, DOI 10.1001/jama.271.9.690; Rothschild SK, 1998, DM-DIS MON, V44, P293, DOI 10.1016/S0011-5029(98)90010-4; Simon SR, 1999, NEW ENGL J MED, V340, P928, DOI 10.1056/NEJM199903253401206; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; THERNSTROM M, 2004, NY TIMES MAGAZI 0418, P44	12	43	43	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2005	294	9					1009	1011		10.1001/jama.294.9.1009	http://dx.doi.org/10.1001/jama.294.9.1009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XU	16145021				2022-12-28	WOS:000231627300001
J	Berg, AO; Allan, JD; Calonge, N; Frame, PS; Gordis, L; Gregory, KD; Harris, R; Johnson, MS; Klein, JD; Loveland-Cherry, C; Moyer, VA; Ockene, JK; Petitti, DB; Siu, AL; Teutsch, SM; Yawn, BP				Berg, AO; Allan, JD; Calonge, N; Frame, PS; Gordis, L; Gregory, KD; Harris, R; Johnson, MS; Klein, JD; Loveland-Cherry, C; Moyer, VA; Ockene, JK; Petitti, DB; Siu, AL; Teutsch, SM; Yawn, BP		US Prevent Serv Task Force	Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article							BILATERAL PROPHYLACTIC MASTECTOMY; INTERPRETING FAMILY HISTORIES; ASHKENAZI JEWISH CARRIERS; SURGICAL ADJUVANT BREAST; INHERITED MUTATIONS; PREVENTION TRIAL; COMPUTER SUPPORT; PRIMARY-CARE; WOMEN; PREVALENCE	This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility, along with the supporting scientific evidence. The complete information on which this statement is based, including evidence tables and references, is included in the evidence synthesis available through the USPSTF Web site (www.preventiveservices.ahrq.gov). The recommendation is also posted on the Web site of the National Guideline Clearinghouse (www.guideline.gov).	Agcy Healthcare & Res & Qual, US Prevent Serv Task Force, Rockville, MD USA	Agency for Healthcare Research & Quality	Berg, AO (corresponding author), Agcy Healthcare & Res & Qual, US Prevent Serv Task Force, Rockville, MD USA.							*ACOG COMM OP, 2001, INT J GYNECOL OBSTET, V75, P339; *AM SOC CLIN ONC P, 2003, GEN TEST CANC SUSC; American College of Medical Genetics, 1996, STAT POP SCREEN BRCA; American College of Medical Genetics Foundation, 1998, GEN SUSC BREAST OV C; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; BOURNE TH, 1993, BRIT MED J, V306, P1025, DOI 10.1136/bmj.306.6884.1025; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; COLDITZ GA, 1993, JAMA-J AM MED ASSOC, V270, P338, DOI 10.1001/jama.270.3.338; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Cuzick J, 2002, LANCET, V360, P817; Domchek SM, 2003, J CLIN ONCOL, V21, P593, DOI 10.1200/JCO.2003.07.007; Emery J, 2000, BMJ-BRIT MED J, V321, P28, DOI 10.1136/bmj.321.7252.28; Emery J, 1999, BRIT MED J, V319, P32, DOI 10.1136/bmj.319.7201.32; Evans DGR, 2004, J MED GENET, V41, P474, DOI 10.1136/jmg.2003.017996; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Gilpin CA, 2000, CLIN GENET, V58, P299, DOI 10.1034/j.1399-0004.2000.580408.x; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hartmann LC, 1990, NEW ENGL J MED, V340, P77; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; JOHNSON N, 1995, FAM PRACT, V12, P287, DOI 10.1093/fampra/12.3.287; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Klaren HM, 2003, J NATL CANCER I, V95, P941, DOI 10.1093/jnci/95.13.941; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Meiser B, 2002, SOC SCI MED, V54, P1463, DOI 10.1016/S0277-9536(01)00133-2; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; National Comprehensive Cancer Network, 2005, CLIN PRACT GUID ONC; Nelson HD, 2005, GENETIC RISK ASSESSM; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Rebbeck TR, 2002, EUR J CANCER, V38, pS15; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Satagopan JM, 2002, CLIN CANCER RES, V8, P3776; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; SLATTERY ML, 1993, JAMA-J AM MED ASSOC, V270, P1563, DOI 10.1001/jama.270.13.1563; Srivastava A, 2001, ONCOLOGY-NY, V15, P889; Srivastava A., 2001, ONCOLOGY, V15, P902; Srivastava A., 2001, ONCOLOGY, V15, P905; Srivastava A., 2001, ONCOLOGY, V15, P911; Struewing J P, 1995, J Natl Cancer Inst Monogr, P33; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Unger MA, 2000, AM J HUM GENET, V67, P841, DOI 10.1086/303076; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yang QH, 1998, AM J EPIDEMIOL, V147, P652	58	309	311	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2005	143	5					355	361		10.7326/0003-4819-143-5-200509060-00011	http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961TE	16144894				2022-12-28	WOS:000231683900005
J	Dorff, EN				Dorff, EN			End-of-life: Jewish perspectives	LANCET			English	Editorial Material									Univ Judaism, Bel Air, CA 90077 USA		Dorff, EN (corresponding author), Univ Judaism, 15600 Mulholland Dr, Bel Air, CA 90077 USA.	edorff@uj.edu						ADDRESS RF, 1992, TIME PREPARE PRACTIC; BLEICH JD, 1981, JUDAISM HEALING, P162; BLEICH JD, 1995, CONTEMP HALAKHIC PRO, V4, P273; BLEICH JD, 1981, JUDAISM HEALING, P134; BLEICH JD, 1981, JUDAISM HEALING, P146; BLEICH JD, 1981, JUDAISM HEALING, P129; Dorff Elliot N., 1988, LIVING TREE ROOTS GR; Dorff Elliot N., 1998, MATTERS LIFE DEATH J, P176; DORFF EN, 1998, MATTERS LIFE DEATH J, P221; DORFF EN, 1998, MATTERS LIFE DEATH J, P14; DORFF EN, 1991, UNITED SYNAGOGUE REV, V44, P21; Ellenson David H., 1995, CONT JEWISH ETHICS M, P129; FELDMAN DM, 1986, HLTH MED JEWISH TRAD; FELDMAN DM, 1984, COMPENDIUM MED ETHIC; FREEHOF SB, 1960, REFORM RESPONSA, P130; FREEHOF SB, 1974, CONT REFORM RESPONSA, P216; GOLDFARB DC, 1976, CONSERVATIVE JUDAISM, V30, P10; GOLDMAN AJ, 1978, JUDAISM CONFRONTS CO, P223; JACOB W, 1983, AM REFORM RESPONSA, P273; Jakobovits I, 1975, JEWISH MED ETHICS; JAKOBOVITS Y, 1989, TRADITION, V24, P1; KLEIN I, 2000, LIFE DEATH RESPONSIB, P435; Klein I., 1975, RESPONSA HALAKHIC ST; *RABB ASS, 1990, P CONS RABB ASS, V52; REISNER AI, 2000, LIFE DEATH RESPONSBI, P233; ROSNER F, 1979, JEWISH BIOETHICS, P358; SIEGEL S, 1976, CONSERVATIVE JUDAISM, V30, P23	27	45	47	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 3	2005	366	9488					862	865		10.1016/S0140-6736(05)67219-4	http://dx.doi.org/10.1016/S0140-6736(05)67219-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139662				2022-12-28	WOS:000231627000032
J	Reader, JS; Ordoukhanian, PT; Kim, JG; de Crecy-Lagard, V; Hwang, I; Farrand, S; Schimmel, P				Reader, JS; Ordoukhanian, PT; Kim, JG; de Crecy-Lagard, V; Hwang, I; Farrand, S; Schimmel, P			Major biocontrol of plant tumors targets tRNA synthetase	SCIENCE			English	Editorial Material							AGROCIN 84; BACTERIOCIN		Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151921, South Korea; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	Scripps Research Institute; Seoul National University (SNU); University of Illinois System; University of Illinois Urbana-Champaign	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	schimmel@scripps.edu	de Crecy-Lagard, Valerie/AAN-8995-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R01GM052465, R01GM023562, R37GM015539] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23562, GM15539, GM52465] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		MURPHY PJ, 1981, EUR J BIOCHEM, V115, P539; READER J, UNPUB; ROBERTS WP, 1977, NATURE, V265, P379, DOI 10.1038/265379a0; RYDER MH, 1987, J BACTERIOL, V169, P4184, DOI 10.1128/jb.169.9.4184-4189.1987; SHIM JS, 1987, PHYTOPATHOLOGY, V77, P463, DOI 10.1094/Phyto-77-463; TATE ME, 1979, NATURE, V280, P697, DOI 10.1038/280697a0	6	70	77	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1533	1533		10.1126/science.1116841	http://dx.doi.org/10.1126/science.1116841			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141066				2022-12-28	WOS:000231715000041
J	Reid, IR; Miller, P; Lyles, K; Fraser, W; Brown, JP; Saidi, Y; Mesenbrink, P; Su, GQ; Pak, J; Zelenakas, K; Luchi, M; Richardson, P; Hosking, D				Reid, IR; Miller, P; Lyles, K; Fraser, W; Brown, JP; Saidi, Y; Mesenbrink, P; Su, GQ; Pak, J; Zelenakas, K; Luchi, M; Richardson, P; Hosking, D			Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; BISPHOSPHONATE THERAPY; BONE-RESORPTION; TILUDRONATE; ETIDRONATE; RESPONSES; PHARMACOLOGY; MULTICENTER; ALENDRONATE; PREVALENCE	Background: The advent of bisphosphonates advanced therapy for Paget's disease, but more effective and convenient agents are needed to increase adherence. Zoledronic acid, a bisphosphonate administered as a single intravenous infusion, might meet these needs. Methods: In two identical, randomized, double-blind, actively controlled trials of 6 months' duration, we compared one 15-minute infusion of 5 mg of zoledronic acid with 60 days of oral risedronate (30 mg per day). The primary efficacy end point was the rate of therapeutic response at six months, defined as a normalization of alkaline phosphatase levels or a reduction of at least 75 percent in the total alkaline phosphatase excess. The results of the studies were pooled. Results: At six months, 96.0 percent of patients receiving zoledronic acid had a therapeutic response (169 of 176), as compared with 74.3 percent of patients receiving risedronate (127 of 171, P < 0.001). Alkaline phosphatase levels normalized in 88.6 percent of patients in the zoledronic acid group and 57.9 percent of patients in the risedronate group (P < 0.001). Zoledronic acid was associated with a shorter median time to a first therapeutic response (64 vs. 89 days, P < 0.001). Higher response rates in the zoledronic acid group were consistent across all demographic, disease-severity, and treatment-history subgroups and with changes in other bone-turnover markers. The physical-component summary score of the Medical Outcomes Study 36-item Short-Form General Health Survey, a measure of the quality of life, increased significantly from baseline at both three and six months in the zoledronic acid group and differed significantly from those in the risedronate group at three months. Pain scores improved in both groups. During post-trial follow-up (median, 190 days), 21 of 82 patients in the risedronate group had a loss of therapeutic response, as compared with 1 of 113 patients in the zoledronic acid group (P < 0.001). Conclusions: A single infusion of zoledronic acid produces more rapid, more complete, and more sustained responses in Paget's disease than does daily treatment with risedronate.	Univ Auckland, Dept Med, Auckland 1, New Zealand; Colorado Ctr Bone Res, Lakewood, CO USA; Duke Univ, Vet Affairs Med Ctr, Durham, NC USA; Royal Liverpool Univ Hosp, Liverpool, Merseyside, England; Le Ctr Hosp Univ Quebec, Ste Foy, PQ, Canada; Novartis Pharma, Basel, Switzerland; Novartis Pharmaceut, E Hanover, NJ USA; City Hosp Nottingham, Nottingham, England	University of Auckland; Colorado Center For Bone Research; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Novartis; Novartis; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Reid, IR (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland 1, New Zealand.	i.reid@auckland.ac.nz		Brown, Jacques/0000-0003-1910-788X				Altman RD, 2000, J BONE MINER RES, V15, P461, DOI 10.1359/jbmr.2000.15.3.461; ArdenCordone M, 1997, CALCIFIED TISSUE INT, V60, P415, DOI 10.1007/s002239900255; Bauss F, 2004, OSTEOPOROSIS INT, V15, P423, DOI 10.1007/s00198-004-1612-7; Buckler H, 1999, BONE, V24, p81S, DOI 10.1016/S8756-3282(99)00071-X; Cooper C, 1999, J BONE MINER RES, V14, P192, DOI 10.1359/jbmr.1999.14.2.192; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; FENTON AJ, 1991, CLIN ENDOCRINOL, V34, P197, DOI 10.1111/j.1365-2265.1991.tb00294.x; Fraser WD, 1997, POSTGRAD MED J, V73, P496, DOI 10.1136/pgmj.73.862.496; Garnero P, 1998, ARTHRITIS RHEUM, V41, P354, DOI 10.1002/1529-0131(199802)41:2<354::AID-ART20>3.0.CO;2-5; GREEN JR, 1994, J BONE MINER RES, V9, P745; Green JR, 2002, DRUG DEVELOP RES, V55, P210, DOI 10.1002/ddr.10071; HARINCK HIJ, 1987, BRIT MED J, V295, P1301, DOI 10.1136/bmj.295.6609.1301; Miller PD, 1999, AM J MED, V106, P513, DOI 10.1016/S0002-9343(99)00062-5; Nancollas GH, 2002, J BONE MINER RES, V17, pS368; REGINSTER JY, 1992, ARTHRITIS RHEUM, V35, P967, DOI 10.1002/art.1780350819; REGINSTER JY, 1993, ARTHRITIS RHEUM, V36, P134; Reid IR, 1996, AM J MED, V101, P341, DOI 10.1016/S0002-9343(96)00227-6; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Reid IR, 2004, BONE, V35, P224, DOI 10.1016/j.bone.2004.03.023; REID IR, 1997, AM J MED, V102, P322; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; Rosen CJ, 2003, NEW ENGL J MED, V348, P1503, DOI 10.1056/NEJM200304103481521; ROUX C, 1995, ARTHRITIS RHEUM, V38, P851, DOI 10.1002/art.1780380620; Russell RGG, 1999, J BONE MINER RES, V14, P53, DOI 10.1002/jbmr.5650140212; Singer FR, 1998, J CLIN ENDOCR METAB, V83, P1906, DOI 10.1210/jc.83.6.1906; Siris E, 1996, J CLIN ENDOCR METAB, V81, P961, DOI 10.1210/jc.81.3.961; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994	27	262	310	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					898	908		10.1056/NEJMoa044241	http://dx.doi.org/10.1056/NEJMoa044241			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135834				2022-12-28	WOS:000231551100007
J	Chapin, FS; Sturm, M; Serreze, MC; McFadden, JP; Key, JR; Lloyd, AH; McGuire, AD; Rupp, TS; Lynch, AH; Schimel, JP; Beringer, J; Chapman, WL; Epstein, HE; Euskirchen, ES; Hinzman, LD; Jia, G; Ping, CL; Tape, KD; Thompson, CDC; Walker, DA; Welker, JM				Chapin, FS; Sturm, M; Serreze, MC; McFadden, JP; Key, JR; Lloyd, AH; McGuire, AD; Rupp, TS; Lynch, AH; Schimel, JP; Beringer, J; Chapman, WL; Epstein, HE; Euskirchen, ES; Hinzman, LD; Jia, G; Ping, CL; Tape, KD; Thompson, CDC; Walker, DA; Welker, JM			Role of land-surface changes in Arctic summer warming	SCIENCE			English	Article							CLIMATE-CHANGE; SEWARD PENINSULA; CARBON STORAGE; TUNDRA SOILS; VEGETATION; TRENDS; TEMPERATURE; TREELINE; ALASKA; VARIABILITY	A major challenge in predicting Earth's future climate state is to understand feedbacks that alter greenhouse-gas forcing. Here we synthesize field data from arctic Alaska, showing that terrestrial changes in summer albedo contribute substantially to recent high-latitude warming trends. Pronounced terrestrial summer warming in. arctic Alaska correlates with a lengthening of the snow-free season that has increased atmospheric heating locally by about 3 watts per square meter per decade (similar in magnitude to the regional heating expected over multiple decades from a doubling of atmospheric CO2). The continuation of current trends in shrub and tree expansion could further amplify this atmospheric heating by two to seven times.	Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; Univ Alaska, US Geol Survey, Fairbanks, AK 99775 USA; Univ Alaska, Alaska Cooperat Fish & Wildlife Res Unit, Fairbanks, AK 99775 USA; Univ Alaska, Dept Forest Sci, Fairbanks, AK 99775 USA; Univ Alaska, Inst No Engn, Fairbanks, AK 99775 USA; USA, Cold Reg Res & Engn Lab, Ft Wainwright, AK 99703 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; NOAA, Natl Environm Satellite Data & Informat Serv, Madison, WI 53706 USA; Middlebury Coll, Dept Biol, Middlebury, VT 05443 USA; Monash Univ, Sch Geog & Environm Sci, Clayton, Vic 3800, Australia; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; Colorado State Univ, Dept Forest Rangeland & Watershed Stewardship, Ft Collins, CO 80523 USA; Univ Alaska Fairbanks, Palmer Res Stn, Palmer, AK 99645 USA; Univ Alaska Anchorage, Environm & Nat Resources Inst, Anchorage, AK 99501 USA	University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); University of Colorado System; University of Colorado Boulder; University of Minnesota System; University of Minnesota Twin Cities; National Oceanic Atmospheric Admin (NOAA) - USA; Monash University; University of California System; University of California Santa Barbara; University of Illinois System; University of Illinois Urbana-Champaign; University of Virginia; Colorado State University; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Anchorage	Chapin, FS (corresponding author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA.	terry.chapin@uaf.edu	Jia, Gensuo/AAL-2681-2020; Beringer, Jason/B-8528-2008; Chapin, F Stuart/AAZ-3931-2020; Schimel, Joshua/AAE-7380-2019; Sturm, Matthew/GXF-6926-2022; Hinzman, Larry/B-3309-2013; Key, Jeffrey R./AAB-7248-2020; Welker, Jeffrey/C-9493-2013; Lynch, Amanda/B-4278-2011	Jia, Gensuo/0000-0001-5950-9555; Beringer, Jason/0000-0002-4619-8361; Chapin, F Stuart/0000-0002-2558-9910; Schimel, Joshua/0000-0002-1022-6623; Hinzman, Larry/0000-0002-5878-6814; Lynch, Amanda/0000-0003-2990-1016				Arctic Climate Impact Assessment, 2004, IMP WARM ARCT; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Beringer J, 2005, AGR FOREST METEOROL, V131, P143, DOI 10.1016/j.agrformet.2005.05.006; Bret-Harte MS, 2002, J ECOL, V90, P251, DOI 10.1046/j.1365-2745.2001.00657.x; BRUBAKER LB, 1995, ECOL STU AN, V113, P111; Chapin FS, 2000, J CLIMATE, V13, P2002, DOI 10.1175/1520-0442(2000)013<2002:SDAAEI>2.0.CO;2; CHAPIN FS, 1988, OECOLOGIA, V77, P506, DOI 10.1007/BF00377266; CHAPIN FS, UNPUB; CHAPMAN WL, 1993, B AM METEOROL SOC, V74, P33, DOI 10.1175/1520-0477(1993)074<0033:RVOSIA>2.0.CO;2; Comiso JC, 2003, J CLIMATE, V16, P3498, DOI 10.1175/1520-0442(2003)016<3498:WTITAF>2.0.CO;2; Corti S, 1999, NATURE, V398, P799, DOI 10.1038/19745; Dingman S. L., 1980, ARCTIC ECOSYSTEM COA, P30; Dye DG, 2002, HYDROL PROCESS, V16, P3065, DOI 10.1002/hyp.1089; Epstein HE, 2004, J BIOGEOGR, V31, P1917, DOI 10.1111/j.1365-2699.2004.01140.x; Eugster W, 2000, GLOBAL CHANGE BIOL, V6, P84, DOI 10.1046/j.1365-2486.2000.06015.x; Fahnestock JT, 1998, J GEOPHYS RES-ATMOS, V103, P29023, DOI 10.1029/98JD00805; FOLEY JA, 1994, NATURE, V371, P52, DOI 10.1038/371052a0; HARTMANN B, IN PRESS J CLIM; Hobbie SE, 1998, J ECOL, V86, P449, DOI 10.1046/j.1365-2745.1998.00278.x; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Jia GSJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018268; Keyser AR, 2000, GLOBAL CHANGE BIOL, V6, P185, DOI 10.1046/j.1365-2486.2000.06020.x; Liu HP, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005158; Lloyd AH, 2003, PERMAFROST PERIGLAC, V14, P93, DOI 10.1002/ppp.446; LLOYD AH, IN PRESS ECOLOGY; LLOYD AH, 2003, J GEOPHYS RES, V107, P8110; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; McFadden JP, 1998, J GEOPHYS RES-ATMOS, V103, P28947, DOI 10.1029/98JD02400; Michaelson GJ, 1996, ARCTIC ALPINE RES, V28, P414, DOI 10.2307/1551852; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Rupp TS, 2001, CLIMATIC CHANGE, V48, P399, DOI 10.1023/A:1010738502596; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; Silapaswan CS, 2001, CAN J REMOTE SENS, V27, P542, DOI 10.1080/07038992.2001.10854894; Smith NV, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004472; Stone RS, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000286; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Sturm M, 2001, J CLIMATE, V14, P336, DOI 10.1175/1520-0442(2001)014<0336:SSIIAT>2.0.CO;2; STURM M, 2005, BIOGEOSCIENCES, V110, DOI DOI 10.1029/2005JG000013; SZEICZ JM, 1995, J ECOL, V83, P873, DOI 10.2307/2261424; TAPE K, 2004, THESIS U ALASKA FAIR; Thorpe N, 2002, EARTH IS FASTER NOW, P201; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Wang XJ, 2003, SCIENCE, V299, P1725, DOI 10.1126/science.1078065	48	961	997	15	471	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					657	660		10.1126/science.1117368	http://dx.doi.org/10.1126/science.1117368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16179434				2022-12-28	WOS:000232997700036
J	Dar, AC; Dever, TE; Sicheri, F				Dar, AC; Dever, TE; Sicheri, F			Higher-order substrate recognition of elF2 alpha by the RNA-dependent protein kinase PKR	CELL			English	Article							DOUBLE-STRANDED-RNA; INITIATION-FACTOR 2-ALPHA; CRYSTAL-STRUCTURE; PEPTIDE SUBSTRATE; ALPHA-SUBUNIT; EIF2 ALPHA; TRANSLATION; EIF2-ALPHA; ACTIVATION; BINDING	In response to binding viral double-stranded RNA by products within a cell, the RNA-dependent protein kinase PKR phosphorylates the a subunit of the translation initiation factor eIF2 on a regulatory site, Ser51. This triggers the general shutdown of protein synthesis and inhibition of viral propagation. To understand the basis for substrate recognition by and the regulation of PKR, we determined X-ray crystal structures of the catalytic domain of PKR in complex with eIF2 alpha. The structures reveal that eIF2a binds to the C-terminal catalytic lobe while catalytic-domain dimerization is mediated by the N-terminal lobe. In addition to inducing a local unfolding of the Ser51 acceptor site in eIF2 alpha, its mode of binding to PKR affords the Ser51 site full access to the catalytic cleft of PKR. The generality and implications of the structural mechanisms uncovered for PKR to the larger family of four human eIF2 alpha protein kinases are discussed.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sicheri, F (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sicheri@mshri.on.ca	Dever, Thomas/GSE-0966-2022; Sicheri, Frank/F-8856-2013	Dever, Thomas/0000-0001-7120-9678	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bauer BN, 2001, BIOCHEMISTRY-US, V40, P11543, DOI 10.1021/bi010983s; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clemens MJ, 2004, ONCOGENE, V23, P3180, DOI 10.1038/sj.onc.1207544; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; DAR AC, 2005, MODULAR PROTEIN DOMA, P181; DeLano WL, 2004, PYMOL USERS MANUAL; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Dey M, 2005, MOL CELL BIOL, V25, P3063, DOI 10.1128/MCB.25.8.3063-3075.2005; Dhaliwal S, 2003, J MOL BIOL, V334, P187, DOI 10.1016/j.jmb.2003.09.045; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ito T, 2004, STRUCTURE, V12, P1693, DOI 10.1016/j.str.2004.07.010; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198; MELLOR H, 1991, BIOCHEM BIOPH RES CO, V178, P430, DOI 10.1016/0006-291X(91)90125-Q; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nonato MC, 2002, J BIOL CHEM, V277, P17057, DOI 10.1074/jbc.M111804200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; THOMIS DC, 1995, J VIROL, V69, P5195, DOI 10.1128/JVI.69.8.5195-5198.1995; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200	36	286	298	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					887	900		10.1016/j.cell.2005.06.044	http://dx.doi.org/10.1016/j.cell.2005.06.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179258	Bronze			2022-12-28	WOS:000232130200013
J	Gillett, NP				Gillett, NP			Climate modelling - Northern Hemisphere circulation	NATURE			English	Editorial Material									Univ E Anglia, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Gillett, NP (corresponding author), Univ E Anglia, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England.	n.gillett@uea.ac.uk						Gillett NP, 2003, NATURE, V422, P292, DOI 10.1038/nature01487; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Osborn TJ, 2004, CLIM DYNAM, V22, P605, DOI 10.1007/s00382-004-0405-1; Selten FM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020739; Thompson DWJ, 2000, J CLIMATE, V13, P1018, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2	5	36	37	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2005	437	7058					496	496		10.1038/437496a	http://dx.doi.org/10.1038/437496a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177779				2022-12-28	WOS:000232004800036
J	He, J; Gu, DF; Wu, XG; Reynolds, K; Duan, XF; Yao, CH; Wang, JL; Chen, C; Chen, J; Wildman, RP; Klag, MJ; Whelton, PK				He, J; Gu, DF; Wu, XG; Reynolds, K; Duan, XF; Yao, CH; Wang, JL; Chen, C; Chen, J; Wildman, RP; Klag, MJ; Whelton, PK			Major causes of death among men and women in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EMERGING TOBACCO HAZARDS; GLOBAL BURDEN; CIGARETTE-SMOKING; HYPERTENSION; PREVALENCE; MORTALITY; PREVENTION; AWARENESS; DISEASES	BACKGROUND: With China's rapid economic development, the disease burden may have changed in the country. We studied the major causes of death and modifiable risk factors in a nationally representative cohort of 169,871 men and women 40 years of age and older in China. METHODS: Baseline data on the participants' demographic characteristics, medical history, lifestyle-related risk factors, blood pressure, and body weight were obtained in 1991 with the use of a standard protocol. The follow-up evaluation was conducted in 1999 and 2000, with a follow-up rate of 93.4 percent. RESULTS: We documented 20,033 deaths in 1,239,191 person-years of follow-up. The mortality from all causes was 1480.1 per 100,000 person-years among men and 1190.2 per 100,000 person-years among women. The five leading causes of death were malignant neoplasms (mortality, 374.1 per 100,000 person-years), diseases of the heart (319.1), cerebrovascular disease (310.5), accidents (54.0), and infectious diseases (50.5) among men and diseases of the heart (268.5), cerebrovascular disease (242.3), malignant neoplasms (214.1), pneumonia and influenza (45.9), and infectious diseases (35.3) among women. The multivariate-adjusted relative risk of death and the population attributable risk for preventable risk factors were as follows: hypertension, 1.48 (95 percent confidence interval, 1.44 to 1.53) and 11.7 percent, respectively; cigarette smoking, 1.23 (95 percent confidence interval, 1.18 to 1.27) and 7.9 percent; physical inactivity, 1.20 (95 percent confidence interval, 1.16 to 1.24) and 6.8 percent; and underweight (body-mass index [the weight in kilograms divided by the square of the height in meters] below 18.5), 1.47 (95 percent confidence interval, 1.42 to 1.53) and 5.2 percent. CONCLUSIONS: Vascular disease and cancer have become the leading causes of death among Chinese adults. Our findings suggest that control of hypertension, smoking cessation, increased physical activity, and improved nutrition should be important strategies for reducing the burden of premature death among adults in China.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; Chinese Acad Sci, Fuwai Hosp, Cardiovasc Inst, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China; Natl Ctr Cardiovasc Dis Control & Res, Beijing, Peoples R China; Capital Univ Med Sci, Anzhen Hosp, Beijing, Peoples R China; Sichuan Univ, W China Coll Med, Chengdu, Peoples R China; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Tulane University; Tulane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Sichuan University; Johns Hopkins University	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1430 Tulane Ave,Mail Stop SL18, New Orleans, LA 70112 USA.	jhe@tulane.edu	Reynolds, Kristi/AAN-1434-2021; He, Jiang/AAF-5303-2020	Reynolds, Kristi/0000-0001-7619-1649; He, Jiang/0000-0002-8286-9652	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1999, WORLD HLTH REPORT 19; Chen ZM, 1997, JAMA-J AM MED ASSOC, V278, P1500, DOI 10.1001/jama.278.18.1500; Chen ZM, 1999, JAMA-J AM MED ASSOC, V281, P1893; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FROHLICH ED, 1988, CIRCULATION, V77, pA502; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gu DF, 2004, AM J PUBLIC HEALTH, V94, P1972, DOI 10.2105/AJPH.94.11.1972; Gwatkin DR, 1999, LANCET, V354, P586, DOI 10.1016/S0140-6736(99)02108-X; HAYS JT, 1996, PREVENTION MYOCARDIA, P99; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; HUANG ZD, 1994, J HYPERTENS, V12, P1103; KAHN HA, 1989, STAT METHODS EPIDEMI, P73; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KOCHANEK KD, 2004, NATL VITAL STAT REPO, V52; Lam TH, 1998, JAMA-J AM MED ASSOC, V279, P1350; Li YJ, 2002, J MATER SCI TECHNOL, V18, P21; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; *MIN PUBL HLTH PEO, 1990, HLTH STAT INF CHIN 1; *NIH, 1998, OBES RES S2, V6, pS51, DOI DOI 10.1001/JAMA.2012.39; Niu SR, 1998, BRIT MED J, V317, P1423, DOI 10.1136/bmj.317.7170.1423; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Sen K, 2000, LANCET, V356, P577, DOI 10.1016/S0140-6736(00)02590-3; *UNDP, MILL DEV GOALS; WHO, 2002, RED RISKS PROM HLTH; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; ZHANG B, 1991, MOL BIOL MED, V8, P39	31	979	1198	4	163	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1124	1134		10.1056/NEJMsa050467	http://dx.doi.org/10.1056/NEJMsa050467			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963YG	16162883	Bronze			2022-12-28	WOS:000231841900007
J	Rossiter, SJ; Ransome, RD; Faulkes, CG; Le Comber, SC; Jones, G				Rossiter, SJ; Ransome, RD; Faulkes, CG; Le Comber, SC; Jones, G			Mate fidelity and intra-lineage polygyny in greater horseshoe bats	NATURE			English	Article							GENE DIVERSITY; DISPERSAL; BEHAVIOR; BIRDS	Mating strategies that lead to increased kinship within socially cooperative groups may offer inclusive fitness benefits to individuals(1-3), but can also result in higher levels of inbreeding(4-6). Here we show in a sexually segregated bat species that females avoid this conflict through two mating behaviours. First, most females revisit and breed with specific, individual males across years, so that their single offspring born in different years are full siblings. Second, relatives in the maternal line, including mothers and daughters, share breeding partners (intra-lineage polygyny) more often than expected by chance. Although these behaviours increased levels of co-ancestry among colony members, there was no concomitant rise in inbreeding. We suggest that when females engage in mate fidelity and intra-lineage polygyny, kin ties among female roost mates will be strengthened, thereby potentially contributing to social group cohesiveness. Our findings reveal the hidden complexity that can underlie polygynous breeding, and highlight a new potential route by which female mate choice could influence social evolution.	Univ London, Queen Mary, Sch Biol Sci, London E1 4NS, England; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of London; Queen Mary University London; University of Bristol	Rossiter, SJ (corresponding author), Univ London, Queen Mary, Sch Biol Sci, London E1 4NS, England.	s.j.rossiter@qmul.ac.uk	Faulkes, Chris/B-8377-2008; Faulkes, Chris/O-8101-2019; Le Comber, Steven/B-8315-2008; Rossiter, Stephen J/E-2111-2011	Rossiter, Stephen/0000-0002-3881-4515; Jones, Gareth/0000-0002-1904-3735; Faulkes, Christopher/0000-0002-5228-9075	Natural Environment Research Council [NER/I/S/2002/00732] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		AMOS B, 1995, SCIENCE, V268, P1897, DOI 10.1126/science.268.5219.1897; Andersson Malte, 1994; BUSH GL, 1977, P NATL ACAD SCI USA, V74, P3942, DOI 10.1073/pnas.74.9.3942; Chapais B., 2004, KINSHIP BEHAV PRIMAT; CHESSER RK, 1991, GENETICS, V129, P573; CHESSER RK, 1991, GENETICS, V127, P437; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Dawson DA, 2004, MOL ECOL NOTES, V4, P96, DOI 10.1046/j.1471-8286.2003.00580.x; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HEPPER PG, 1991, KIN RECOGNITION, P1; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MARSHALL TC, 2002, P ROY SOC LOND B BIO, V266, P1533; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Ransome R.D., 1991, P88; Ransome RD, 1995, PHILOS T ROY SOC B, V350, P153, DOI 10.1098/rstb.1995.0149; REEVE HK, 1990, P NATL ACAD SCI USA, V87, P2496, DOI 10.1073/pnas.87.7.2496; Rossiter SJ, 2000, MOL ECOL, V9, P1131, DOI 10.1046/j.1365-294x.2000.00982.x; Rossiter SJ, 2000, P ROY SOC B-BIOL SCI, V267, P545, DOI 10.1098/rspb.2000.1035; Rossiter SJ, 2002, BEHAV ECOL SOCIOBIOL, V51, P510, DOI 10.1007/s00265-002-0467-1; Rossiter SJ, 1999, MOL ECOL, V8, P1959, DOI 10.1046/j.1365-294x.1999.00778-2.x; Sandercock BK, 2000, CAN J ZOOL, V78, P1948, DOI 10.1139/cjz-78-11-1948; Shields WM, 1982, PHILOPATRY INBREEDIN; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0	29	52	53	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					408	411		10.1038/nature03965	http://dx.doi.org/10.1038/nature03965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163356				2022-12-28	WOS:000231849100053
J	Faxen, K; Gilderson, G; Adelroth, P; Brzezinski, P				Faxen, K; Gilderson, G; Adelroth, P; Brzezinski, P			A mechanistic principle for proton pumping by cytochrome c oxidase	NATURE			English	Article							HEME-COPPER OXIDASES; ELECTRON-TRANSFER; RHODOBACTER-SPHAEROIDES; MOLECULAR-DYNAMICS; OXYGEN REDUCTION; COUPLED PROTON; TRANSLOCATION; MODEL	In aerobic organisms, cellular respiration involves electron transfer to oxygen through a series of membrane-bound protein complexes. The process maintains a transmembrane electrochemical proton gradient that is used, for example, in the synthesis of ATP. In mitochondria and many bacteria, the last enzyme complex in the electron transfer chain is cytochrome c oxidase (CytcO), which catalyses the four-electron reduction of O-2 to H2O using electrons delivered by a water-soluble donor, cytochrome c(1-7). The electron transfer through CytcO, accompanied by proton uptake to form H2O drives the physical movement ( pumping) of four protons across the membrane(8) per reduced O-2. So far, the molecular mechanism of such proton pumping driven by electron transfer has not been determined in any biological system. Here we show that proton pumping in CytcO is mechanistically coupled to proton transfer to O-2 at the catalytic site, rather than to internal electron transfer. This scenario suggests a principle by which redox-driven proton pumps might operate and puts considerable constraints on possible molecular mechanisms by which CytcO translocates protons.	Stockholm Univ, Arrhenius Lab, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	Brzezinski, P (corresponding author), Stockholm Univ, Arrhenius Lab, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	peterb@dbb.su.se						Adelroth P, 1998, BBA-BIOENERGETICS, V1367, P107, DOI 10.1016/S0005-2728(98)00142-X; Babcock GT, 1999, P NATL ACAD SCI USA, V96, P12971, DOI 10.1073/pnas.96.23.12971; Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; Brzezinski P, 2004, TRENDS BIOCHEM SCI, V29, P380, DOI 10.1016/j.tibs.2004.05.008; Brzezinski P, 2003, BBA-BIOENERGETICS, V1605, P1, DOI 10.1016/S0005-2728(03)00079-3; Gennis RB, 2004, FRONT BIOSCI, V9, P581, DOI 10.2741/1237; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karpefors M, 1998, P NATL ACAD SCI USA, V95, P13606, DOI 10.1073/pnas.95.23.13606; Lanyi JK, 2001, CURR OPIN STRUC BIOL, V11, P415, DOI 10.1016/S0959-440X(00)00226-8; Michel H, 1998, P NATL ACAD SCI USA, V95, P12819, DOI 10.1073/pnas.95.22.12819; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Mills DA, 2003, FEBS LETT, V545, P47, DOI 10.1016/S0014-5793(03)00392-2; Namslauer A, 2003, P NATL ACAD SCI USA, V100, P15543, DOI 10.1073/pnas.2432106100; OLIVEBERG M, 1991, BIOCHEMISTRY-US, V30, P436, DOI 10.1021/bi00216a019; Papa S, 1998, FEBS LETT, V439, P1, DOI 10.1016/S0014-5793(98)01305-2; Paula S, 1999, BIOCHEMISTRY-US, V38, P3025, DOI 10.1021/bi981351h; Popovic DM, 2004, FEBS LETT, V566, P126, DOI 10.1016/j.febslet.2004.04.016; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; Rich PR, 1998, J BIOENERG BIOMEMBR, V30, P131, DOI 10.1023/A:1020524014920; Siegbahn PEM, 2003, J PHYS CHEM B, V107, P10946, DOI 10.1021/jp035486v; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Verkhovsky MI, 1997, BBA-BIOENERGETICS, V1318, P6, DOI 10.1016/S0005-2728(96)00147-8; Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013; Wikstrom M, 2003, BBA-BIOENERGETICS, V1604, P61, DOI 10.1016/S0005-2728(03)00041-0; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; ZASLAVSKY D, 1993, FEBS LETT, V336, P389, DOI 10.1016/0014-5793(93)80843-J; Zhen YJ, 2002, BIOCHEMISTRY-US, V41, P2288, DOI 10.1021/bi0114628	30	221	226	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					286	289		10.1038/nature03921	http://dx.doi.org/10.1038/nature03921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148937				2022-12-28	WOS:000231696900062
J	Niewoehner, DE; Rice, K; Cote, C; Paulson, D; Cooper, JAD; Korducki, L; Cassino, C; Kesten, S				Niewoehner, DE; Rice, K; Cote, C; Paulson, D; Cooper, JAD; Korducki, L; Cassino, C; Kesten, S			Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator - A Randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							COPD; MULTICENTER; MANAGEMENT; THERAPY; CELLS	Background: Patients with chronic obstructive pulmonary disease (COPD) frequently develop exacerbations, leading to major clinical and health resource use ramifications. Objective: To prospectively evaluate the effectiveness of a long-acting inhaled anticholinergic bronchodilator, tiotropium, in reducing COPD exacerbations and exacerbation-related health care utilization. Design: Randomized, double-blind study. Setting: 26 Veterans Affairs medical centers. Patients: 1829 patients with moderate to severe COPD (mean baseline FEV1, 36% predicted). Intervention: once-daily tiotropium (18 mu g) or placebo for 6 months. Patients otherwise received usual care, except for other anticholinergic bronchodilators. Measurements: The coprimary end points were the percentage of patients with a COPD exacerbation and the percentage of patients with a COPD-related hospitalization. Results: Tiotropium significantly reduced the percentage of patients experiencing 1 or more exacerbations compared with placebo (27.9% vs. 32.3%, respectively; difference, -5.7 percentage points [95% CI, -10.4 to -1.0 percentage points]; P = 0.037). Fewer tiotropium patients were hospitalized because of COPD exacerbation (7.0% vs. 9.5%, respectively; difference, -3.0 percentage points [CI, -5.9 to -0.1 percentage points]; P = 0.056), although this difference was of borderline statistical significance. Analysis of secondary outcomes indicates that tiotropium may lengthen the time to first COPD exacerbation (P = 0.028) and reduce health care utilization for exacerbations, including the frequency of hospitalizations (P = 0.047), unscheduled clinic visits (P = 0.019), and days of antibiotic treatment (P = 0.015). Tiotropium did not statistically significantly reduce all-cause hospitalization rates. Limitations: Trial participants were enrolled from 1 health care system, and 99% were men. The follow-up period extended for only 6 months. Conclusions: Tiotropium reduces COPD exacerbations and may reduce related health care utilization in patients with moderate to severe COPD.	Vet Adm Med Ctr, Pulm Sect 111N, Minneapolis, MN 55417 USA; Bay Pines Vet Affairs Med Ctr, Bay Pines, FL USA; Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Hunter Holmes McGuire Veterinary Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; Boehringer Ingelheim	Niewoehner, DE (corresponding author), Vet Adm Med Ctr, Pulm Sect 111N, 1 Vet Dr, Minneapolis, MN 55417 USA.	niewo001@umn.edu		Kesten, Steven/0000-0002-5522-7910				[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bohning D, 2000, BIOMETRICS, V56, P304, DOI 10.1111/j.0006-341X.2000.00304.x; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Celli B, 2003, CHEST, V124, P1743, DOI 10.1378/chest.124.5.1743; Chodosh S, 2001, J AEROSOL MED, V14, P309, DOI 10.1089/089426801316970268; Croxton TL, 2003, AM J RESP CRIT CARE, V167, P1142, DOI 10.1164/rccm.200207-756WS; Disse B, 1999, LIFE SCI, V64, P457, DOI 10.1016/S0024-3205(98)00588-8; *GLOB IN CHRON OBS, 2003, NHLBI WHO WORKSH BET; Hilleman DE, 2000, CHEST, V118, P1278, DOI 10.1378/chest.118.5.1278; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; KOYAMA S, 1992, AM J PHYSIOL, V262, pL466, DOI 10.1152/ajplung.1992.262.4.L466; MORRIS JF, 1988, CHEST, V93, P123, DOI 10.1378/chest.93.1.123; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Nomura J, 2003, LIFE SCI, V72, P2121, DOI 10.1016/S0024-3205(03)00071-7; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Paggiaro PL, 1998, LANCET, V351, P773, DOI 10.1016/S0140-6736(97)03471-5; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; TAMAOKI J, 1994, THORAX, V49, P545, DOI 10.1136/thx.49.6.545; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702	25	345	352	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2005	143	5					317	326		10.7326/0003-4819-143-5-200509060-00007	http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961TE	16144890				2022-12-28	WOS:000231683900001
J	McConkey, EH; Varki, A				McConkey, EH; Varki, A			Thoughts on the future of great ape research	SCIENCE			English	Editorial Material							CHIMPANZEE GENOME; PROJECT; EVOLUTION		Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92039 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92039 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego; University of California System; University of California San Diego	McConkey, EH (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	mcconkey@colorado.edu; a1vark@ucsd.edu						KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; McConkey E, 2002, TRENDS GENET, V18, P446, DOI 10.1016/S0168-9525(02)02748-8; McConkey EH, 2000, SCIENCE, V289, P1295; McConkey EH, 1997, TRENDS GENET, V13, P350, DOI 10.1016/S0168-9525(97)01226-2; McConkey EH, 2004, CYTOGENET GENOME RES, V105, P157, DOI 10.1159/000078022; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Olson MV, 2004, SCIENCE, V305, P191, DOI 10.1126/science.1100975; Varki A, 2000, GENOME RES, V10, P1065, DOI 10.1101/gr.10.8.1065; Varki A, 1998, SCIENCE, V282, P239	9	14	14	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1499	1501		10.1126/science.1113863	http://dx.doi.org/10.1126/science.1113863			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141054				2022-12-28	WOS:000231715000030
J	Ashen, MD; Blumenthal, RS				Ashen, MD; Blumenthal, RS			Clinical practice: Low HDL cholesterol levels	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; ESTER TRANSFER PROTEIN; MODERATE ALCOHOL INTAKE; A-I; PRIMARY-PREVENTION; RISK-FACTORS; ATHEROSCLEROSIS PROGRESSION; SECONDARY PREVENTION; CIGARETTE-SMOKING		Johns Hopkins Univ Hosp, Johns Hopkins Ciccarone Prevent Cardiol Ctr, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Blumenthal, RS (corresponding author), Johns Hopkins Univ Hosp, Johns Hopkins Ciccarone Prevent Cardiol Ctr, Blalock 524C,600 N Wolfe St, Baltimore, MD 21287 USA.	rblument@jhmi.edu	Blumenthal, Roger S/H-3223-2018	Blumenthal, Roger S/0000-0003-1910-3168				ALDERMAN JD, 1989, AM J CARDIOL, V64, P725, DOI 10.1016/0002-9149(89)90754-6; Benoit P, 1999, CIRCULATION, V99, P105, DOI 10.1161/01.CIR.99.1.105; Berglund L, 1999, AM J CLIN NUTR, V70, P992; Blumenthal RS, 2000, AM HEART J, V139, P577, DOI 10.1016/S0002-8703(00)90033-4; Brewer HB, 2004, ARTERIOSCL THROM VAS, V24, P387, DOI 10.1161/01.ATV.0000121505.88326.d2; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Couillard C, 2001, ARTERIOSCL THROM VAS, V21, P1226, DOI 10.1161/hq0701.092137; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; DENKE MA, 1993, ARCH INTERN MED, V153, P1093, DOI 10.1001/archinte.153.9.1093; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Ellison RC, 2004, AM HEART J, V147, P529, DOI 10.1016/j.ahj.2003.10.033; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; GERASIMOVA E, 1991, LIPIDS, V26, P261, DOI 10.1007/BF02537134; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; GORDON DJ, 1986, CIRCULATION, V74, P1217, DOI 10.1161/01.CIR.74.6.1217; Gotto AM, 2004, J AM COLL CARDIOL, V43, P717, DOI 10.1016/j.jacc.2003.08.061; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; GUPTA AK, 1993, METABOLISM, V42, P684, DOI 10.1016/0026-0495(93)90233-E; Haffner Steven M, 2003, Diabetes Care, V26 Suppl 1, pS83; Halverstadt A, 2003, METABOLISM, V52, P1505, DOI 10.1016/S0026-0495(03)00284-1; IKEWAKI K, 1995, J CLIN INVEST, V96, P1573, DOI 10.1172/JCI118196; Imamura H, 2002, METABOLISM, V51, P1313, DOI 10.1053/meta.2002.34040; Kastelein, 2000, AM J CARDIOL, V86, P812; Kastelein JJP, 2000, AM J CARDIOL, V86, P221, DOI 10.1016/S0002-9149(00)00942-5; Kelley GA, 2004, PREV MED, V38, P651, DOI 10.1016/j.ypmed.2003.12.012; KING AC, 1995, CIRCULATION, V91, P2596, DOI 10.1161/01.CIR.91.10.2596; Kuvin JT, 2002, AM HEART J, V144, P165, DOI 10.1067/mhj.2002.123145; Li XR, 2004, CIRCULATION, V110, P3488, DOI 10.1161/01.CIR.0000149713.48317.27; Maeda K, 2003, PREV MED, V37, P283, DOI 10.1016/S0091-7435(03)00110-5; Meksawan K, 2004, J AM COLL NUTR, V23, P131, DOI 10.1080/07315724.2004.10719353; Mero N, 1998, J LIPID RES, V39, P1493; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Pelkman CL, 2004, AM J CLIN NUTR, V79, P204; Piepho RW, 2000, AM J CARDIOL, V86, p35L; Rigotti NA, 2002, NEW ENGL J MED, V346, P506, DOI 10.1056/NEJMcp012279; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Saad MF, 2004, DIABETES CARE, V27, P1324, DOI 10.2337/diacare.27.6.1324; Schaefer JR, 1999, ATHEROSCLEROSIS, V144, P177, DOI 10.1016/S0021-9150(99)00053-2; SHAH PK, 1992, CIRCULATION, V85, P1279, DOI 10.1161/01.CIR.85.4.1279; Shah PK, 2001, CIRCULATION, V104, P2376, DOI 10.1161/hc4401.098467; Slyper A, 2005, AM J CLIN NUTR, V81, P376; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Stefanick ML, 1998, NEW ENGL J MED, V339, P12, DOI 10.1056/NEJM199807023390103; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; van der Gaag MS, 2001, J LIPID RES, V42, P2077; Wakabayashi I, 2004, AGING CLIN EXP RES, V16, P461, DOI 10.1007/BF03327402; WEISWEILER P, 1987, J CLIN ENDOCR METAB, V65, P969, DOI 10.1210/jcem-65-5-969; Williams PT, 2004, METABOLISM, V53, P700, DOI 10.1016/j.metabol.2004.01.004; WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737; Wilund KR, 2002, METABOLISM, V51, P774, DOI 10.1053/meta.2002.32730	56	128	139	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1252	1260		10.1056/NEJMcp044370	http://dx.doi.org/10.1056/NEJMcp044370			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	966DS	16177251				2022-12-28	WOS:000232000400009
J	Schorlemmer, D; Wiemer, S; Wyss, M				Schorlemmer, D; Wiemer, S; Wyss, M			Variations in earthquake-size distribution across different stress regimes	NATURE			English	Article							FREQUENCY-MAGNITUDE DISTRIBUTION; B-VALUE; RECURRENCE TIMES; CALIFORNIA; VALUES; FAULTS; DEPTH; ROCK	The earthquake size distribution follows, in most instances, a power law(1,2), with the slope of this power law, the ' b value', commonly used to describe the relative occurrence of large and small events ( a high b value indicates a larger proportion of small earthquakes, and vice versa). Statistically significant variations of b values have been measured in laboratory experiments, mines and various tectonic regimes such as subducting slabs, near magma chambers, along fault zones and in aftershock zones(3). However, it has remained uncertain whether these differences are due to differing stress regimes, as it was questionable that samples in small volumes ( such as in laboratory specimens, mines and the shallow Earth's crust) are representative of earthquakes in general. Given the lack of physical understanding of these differences, the observation that b values approach the constant 1 if large volumes are sampled(4) was interpreted to indicate that b = 1 is a universal constant for earthquakes in general(5). Here we show that the b value varies systematically for different styles of faulting. We find that normal faulting events have the highest b values, thrust events the lowest and strike- slip events intermediate values. Given that thrust faults tend to be under higher stress than normal faults we infer that the b value acts as a stress meter that depends inversely on differential stress.	Swiss Fed Inst Technol, ETH Honggerberg, Swiss Seismol Serv, CH-8093 Zurich, Switzerland; World Agcy Planetary Monitoring & Earthquake Risk, CH-1207 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Schorlemmer, D (corresponding author), Swiss Fed Inst Technol, ETH Honggerberg, Swiss Seismol Serv, Schafmattstr 30, CH-8093 Zurich, Switzerland.	danijel@sed.ethz.ch	Wiemer, Stefan/E-5033-2015	Wyss, Max/0000-0002-7250-3649; Wiemer, Stefan/0000-0002-4919-3283				Amelung F, 1997, GEOPHYS RES LETT, V24, P507, DOI 10.1029/97GL00287; Amitrano D, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000680; [Anonymous], 1992, REPORT JOINT RES I S; [Anonymous], 1939, B EARTHQ RES I; BENDER B, 1983, B SEISMOL SOC AM, V73, P831; FROHLICH C, 1993, J GEOPHYS RES-SOL EA, V98, P631, DOI 10.1029/92JB01891; Gerstenberger M, 2001, GEOPHYS RES LETT, V28, P57, DOI 10.1029/2000GL012026; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; HAUKSSON E, 1990, J GEOPHYS RES-SOLID, V95, P15365, DOI 10.1029/JB095iB10p15365; Hauksson E, 2000, J GEOPHYS RES-SOL EA, V105, P13875, DOI 10.1029/2000JB900016; HUANG J, 1988, EARTH PLANET SC LETT, V91, P223, DOI 10.1016/0012-821X(88)90164-1; Kagan YY, 1999, PURE APPL GEOPHYS, V155, P537, DOI 10.1007/s000240050277; Kagan YY, 2002, GEOPHYS J INT, V148, P520, DOI 10.1046/j.1365-246x.2002.01594.x; Lei XL, 2004, J STRUCT GEOL, V26, P247, DOI 10.1016/S0191-8141(03)00095-6; Mogi K., 1962, B EARTHQ RES I TOKYO, V40, P831; Mori J, 1997, J GEOPHYS RES-SOL EA, V102, P15081, DOI 10.1029/97JB01356; Oglesby DD, 2000, J GEOPHYS RES-SOL EA, V105, P13643, DOI 10.1029/2000JB900055; SCHOLZ CH, 1968, B SEISMOL SOC AM, V58, P399; Schorlemmer D, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003234; Schorlemmer D, 2005, NATURE, V434, P1086, DOI 10.1038/4341086a; SHI Y, 1982, B SEISMOL SOC AM, V72, P1677; SMITH WD, 1981, NATURE, V289, P136, DOI 10.1038/289136a0; URBANCIC TI, 1992, PURE APPL GEOPHYS, V139, P449, DOI 10.1007/BF00879946; Wiemer S, 1998, GEOPHYS J INT, V134, P409, DOI 10.1046/j.1365-246x.1998.00561.x; Wiemer S, 1997, J GEOPHYS RES-SOL EA, V102, P15115, DOI 10.1029/97JB00726; Wiemer S, 2002, ADV GEOPHYS, V45, P259; WYSS M, 1973, GEOPHYS J ROY ASTR S, V31, P341, DOI 10.1111/j.1365-246X.1973.tb06506.x; Wyss M, 2002, PHYS EARTH PLANET IN, V131, P173, DOI 10.1016/S0031-9201(02)00036-5	28	619	647	4	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					539	542		10.1038/nature04094	http://dx.doi.org/10.1038/nature04094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177788				2022-12-28	WOS:000232004800047
J	Quon, BS; Firszt, R; Eisenberg, MJ				Quon, BS; Firszt, R; Eisenberg, MJ			A comparison of brand-name drug prices between Canadian-based Internet pharmacies and major US drug chain pharmacies	ANNALS OF INTERNAL MEDICINE			English	Article								Background: many Americans have been purchasing their medications from online Canadian pharmacies. Although it is commonly perceived that medications are less expensive in Canada than in the United States, little research has been done to quantify this difference. Objective: To compare the prices of retail brand-name medications between Canadian Internet pharmacies and major U.S. drug chain pharmacies with online pricing. Design: Cross-sectional study. Setting: 12 Canadian Internet pharmacies and 3 major online U.S. drug chain pharmacies. Measurements: The authors calculated the per unit and annual savings (in U.S. dollars) for an American if he or she were to buy the 44 brand-name medications most commonly purchased through the Internet from Canadian Internet pharmacies instead of from an online U.S. drug chain pharmacy. Results: Americans can save a mean of approximately 24% per unit of drug if they purchase their medications from Canadian Internet pharmacies instead of from major online U.S. drug chain pharmacies. Forty-one of the 44 brand-name medications examined were less expensive in Canada. The medications offering the largest mean yearly savings were Zyprexa (olanzapine) (Eli Lilly, Indianapolis, Indiana) ($1159), Actos (pioglitazone) (Eli Lilly, Indianapolis, Indiana) ($852), and Nexium (esomeprazole) (AstraZeneca, Wilmington, Delaware) ($772). Only 3 medications, all in the erectile dysfunction category, were more expensive in Canada. Limitations: Potential savings may vary because of temporal fluctuations in drug prices. Conclusions: Brand-name medications are often substantially less expensive when purchased from Canadian Internet pharmacies instead of from major online U.S. drug chain pharmacies.	McGill Univ, Jewish Gen Hosp, Div Cardiol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; Univ British Columbia, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Montreal Childrens Hosp, Vancouver, BC, Canada	McGill University; McGill University; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; McGill University	Eisenberg, MJ (corresponding author), McGill Univ, Jewish Gen Hosp, Div Cardiol, 3755 Cote Ste Catherine Rd,Suite A-118, Montreal, PQ H3T 1E2, Canada.	meisenberg@epid.jgh.mcgill.ca						*CAN PHARM ASS, 2004, 2004 COMP PHARM SPEC; *CTR STUD SERV, 2004, CONSUMERS CHECKBOOK, V1, P64; DAVEY M, 2004, NY TIMES        0817, pA15; *HARR INT POLL, 2004, HARR INT SURV PRESCR; *HLTH CAN, ITS YOUR HLTH BUYING; *INT MARK SERV, 2003, MED CTR RET PRESCR G; Lybecker Kristina M, 2004, Manag Care, V13, P10; *NAT LEG ASS PRESC, 2003, DRUG PRIC COMP; *P DANG CONS INC, 2002, PDCI REP SER; *PAT MED PRIC REV, ANN REP 2003; *US HR, 1998, PRESCR DRUG PRIC 1 C; *US HR, 1998, PRESCR DRUG PRIC VER; Zuger A, 2003, NEW ENGL J MED, V349, P2188, DOI 10.1056/NEJMp038196; MEDICARE FREQUENTLY; NEW HAMPSHIRES MED C; 2004, DRUG STORE NEWS 0419	16	29	32	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2005	143	6					397	403		10.7326/0003-4819-143-6-200509200-00004	http://dx.doi.org/10.7326/0003-4819-143-6-200509200-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967OG	16172438				2022-12-28	WOS:000232099900001
J	Engelhardt, HT; Iltis, AS				Engelhardt, HT; Iltis, AS			End-of-life: the traditional Christian view	LANCET			English	Editorial Material									Rice Univ, Dept Philosophy MS14, Houston, TX 77005 USA; St Louis Univ, Ctr Hlth Care Eth, St Louis, MO 63103 USA	Rice University; Saint Louis University	Engelhardt, HT (corresponding author), Rice Univ, Dept Philosophy MS14, 6100 Main St, Houston, TX 77005 USA.	htengelh@rice.edu						*BISH PA, 1992, ORIGINS, V21, P541; *BISH TX, 1990, ORIGINS, V20, P53; *CHRIST MED DENT A, ETH STAT PAT REF THE; CRONIN D, 1958, THESIS PONTIFICAL GR; *DIV CHURCH SOC, 1992, MESS END OF LIF DEC; ENGELHARDT HT, 1999, CHRIST BIOET, V4, P231; ENGELHARDT HT, 2000, FDN CHRISTIAN BIOETH, P369; HAMEL R, 1991, ACTIVE EUTHANASIA RE; HARAKAS SS, 1990, HLTH MED E ORTHODOX, P145; HOLIFIELD EB, 1986, HLTH MED METHODIST T, P85; KILNER J, 1992, LIFE LINE; MARTY ME, 1983, HLTH MED LUTHERAN TR, P157; MCCORMICK RA, 1984, HLTH MED CATHOLIC TR, P107; MEILAENDER G, 1984, HASTINGS CENT REP, P11; *MENN CHURCH CAN, 1995, LIF WORTH LIV ISS EU; *MO SYN LUTH CHURC, 1993, CHRIST CAR LIF END; PEEL R, 1988, HLTH MED CHRISTIAN S, P71; *PRESB CHURCH US, 1974, 1974 STAT, P199; SCHAFF P, 1994, NICENE POSTNICENE FA, V14, P549; SCHAFF P, 1994, NICENE POSTNICENE FA, V8, P78; SCHAFF P, 1994, NICENE POSTNICENE FA, V14, P613; SMITH DH, 1986, HLTH MED ANGLICAN TR, P45; Thomasma David C, 1998, Christ Bioeth, V4, P122, DOI 10.1076/chbi.4.2.122.6905; *UN UN GEN ASS, 1988, STAT EUTH; VAUX KL, 1984, HLTH MED REFORMED TR, P131; WAGNER M, 1962, ST BASIL LONG RULES, P330; Wildes KW, 1996, THEOL STUD, V57, P500, DOI 10.1177/004056399605700306; 1947, RITUALE ROMANUM, P103; 1989, DIVINE LITURGY, P281	29	41	42	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					1045	1049						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	965MZ	16168787				2022-12-28	WOS:000231955900040
J	Johnston, G; Sladden, M				Johnston, G; Sladden, M			Scabies: diagnosis and treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Leicester Royal Infirm, Leicester, Leics, England	University of Leicester	Johnston, G (corresponding author), Leicester Royal Infirm, Leicester, Leics, England.	graham.johnston@uhl-tr.nhs.uk	Johnston, Graham/Y-2348-2019	Johnston, Graham/0000-0001-7494-0765				*BRIT MED ASS ROYA, 2005, BRIT NAT FORM, P589; Develoux M, 2004, ANN DERMATOL VENER, V131, P561, DOI 10.1016/S0151-9638(04)93668-X; Johnston Graham A, 2004, Expert Rev Anti Infect Ther, V2, P439, DOI 10.1586/14787210.2.3.439; McCarthy JS, 2004, POSTGRAD MED J, V80, P382, DOI 10.1136/pgmj.2003.014563; *NHS NAT EL LIB HL, SPEC LIB SKIN COND; PRENDIVILLE JS, 2000, TXB PEDIAT DERMATOLO, P555; Sladden MJ, 2004, BMJ-BRIT MED J, V329, P95, DOI 10.1136/bmj.329.7457.95; Strong M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000320.pub2; Usha V, 2000, J AM ACAD DERMATOL, V42, P236, DOI 10.1016/S0190-9622(00)90131-2; 2002, DRUG THER B, V40, P43	10	56	63	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2005	331	7517					619	622		10.1136/bmj.331.7517.619	http://dx.doi.org/10.1136/bmj.331.7517.619			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967EK	16166133	Green Published			2022-12-28	WOS:000232074100024
J	Li, F; Li, WH; Farzan, M; Harrison, SC				Li, F; Li, WH; Farzan, M; Harrison, SC			Structure of SARS coronavirus spike receptor-binding domain complexed with receptor	SCIENCE			English	Article							ACUTE-RESPIRATORY-SYNDROME; ANGIOTENSIN-CONVERTING ENZYME-2; MOUSE HEPATITIS-VIRUS; POTENT NEUTRALIZING ANTIBODIES; PROTEIN FUSION CORE; CRYSTAL-STRUCTURE; MEMBRANE-FUSION; AMINO-ACIDS; IDENTIFICATION; GLYCOPROTEIN	The spike protein (S) of SARS coronavirus (SARS-CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The crystal structure at 2.9 angstrom resolution of the RBD bound with the peptidase domain of human ACE2 shows that the RBD presents a gently concave surface, which cradles the N-terminal lobe of the peptidase. The atomic details at the interface between the two proteins clarify the importance of residue changes that facilitate efficient cross-species infection and human-to-human transmission. The structure of the RBD suggests ways to make truncated disulfide-stabilized RBD variants for use in the design of coronavirus vaccines.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 320 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Li, Fang/ABE-9129-2021	Li, Wenhui/0000-0003-1305-7404; Farzan, Michael/0000-0002-2990-5319	NATIONAL CANCER INSTITUTE [R01CA013202, R37CA013202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061601] Funding Source: NIH RePORTER; NCI NIH HHS [CA13202] Funding Source: Medline; NIAID NIH HHS [AI061601] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babcock GJ, 2004, J VIROL, V78, P4552, DOI 10.1128/JVI.78.9.4552-4560.2004; Bonavia A, 2003, J VIROL, V77, P2530, DOI 10.1128/JVI.77.4.2530-2538.2003; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; KUBO H, 1994, J VIROL, V68, P5403, DOI 10.1128/JVI.68.9.5403-5410.1994; Lai MM, 2001, FIELDS VIROLOGY; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Li WH, 2004, J VIROL, V78, P11429, DOI 10.1128/JVI.78.20.11429-11433.2004; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sainz B, 2005, J VIROL, V79, P7195, DOI 10.1128/JVI.79.11.7195-7206.2005; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Sui JH, 2005, J VIROL, V79, P5900, DOI 10.1128/JVI.79.10.5900-5906.2005; Supekar VM, 2004, P NATL ACAD SCI USA, V101, P17958, DOI 10.1073/pnas.0406128102; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; van den Brink EN, 2005, J VIROL, V79, P1635, DOI 10.1128/JVI.79.3.1635-1644.2005; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Xu YH, 2004, BIOCHEMISTRY-US, V43, P14064, DOI 10.1021/bi049101q; Xu YH, 2004, J BIOL CHEM, V279, P30514, DOI 10.1074/jbc.M403760200	33	1244	1334	13	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1864	1868		10.1126/science.1116480	http://dx.doi.org/10.1126/science.1116480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166518				2022-12-28	WOS:000231989500052
J	Fu, LN; Patel, MS; Bradley, A; Wagner, EF; Karsenty, G				Fu, LN; Patel, MS; Bradley, A; Wagner, EF; Karsenty, G			The molecular clock mediates leptin-regulated bone formation	CELL			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; CIRCADIAN CLOCK; IN-VIVO; OSTEOBLAST; MICE; BIOLOGY; GENE; PROLIFERATION; EXPRESSION; CYCLIN-D1	The hormone leptin is a regulator of bone remodeling, a homeostatic function maintaining bone mass constant. Mice lacking molecular-clock components (Per and Cry), or lacking Per genes in osteoblasts, display high bone mass, suggesting that bone remodeling may also be subject to circadian regulation. Moreover, Per-deficient mice experience a paradoxical increase in bone mass following leptin intracerebroventricular infusion. Thus, clock genes may mediate the leptin-dependent sympathetic regulation of bone formation. We show that expression of clock genes in osteoblasts is regulated by the sympathetic nervous system and leptin. Clock genes mediate the antiproliferative function of sympathetic signaling by inhibiting G1 cyclin expression. Partially antagonizing this inhibitory loop, leptin also upregulates AP-1 gene expression, which promotes cyclin D1 expression, osteoblast proliferation, and bone formation. Thus, leptin determines the extent of bone formation by modulating, via sympathetic signaling, osteoblast proliferation through two antagonistic pathways, one of which involves the molecular clock.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Bone Dis Program, Houston, TX 77030 USA; Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Res Inst Mol Pathol, A-1030 Vienna, Austria	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Wellcome Trust Sanger Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Karsenty, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	karsenty@bcm.tmc.edu		Bradley, Allan/0000-0002-2349-8839; Wagner, Erwin F/0000-0001-7872-0196; /0000-0001-7061-6837				BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; GRIGORIADIS AE, 1995, TRENDS GENET, V11, P436, DOI 10.1016/S0168-9525(00)89142-8; GUNDBERG CM, 1985, J CLIN ENDOCR METAB, V60, P736, DOI 10.1210/jcem-60-4-736; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Perreau-Lenz S, 2004, CHRONOBIOL INT, V21, P1, DOI 10.1081/CBI-120027984; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; SIMMONS DJ, 1966, AM J PHYSIOL, V210, P411, DOI 10.1152/ajplegacy.1966.210.2.411; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	36	420	443	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					803	815		10.1016/j.cell.2005.06.028	http://dx.doi.org/10.1016/j.cell.2005.06.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143109	Bronze			2022-12-28	WOS:000231844300018
J	Kuiken, T; Leighton, FA; Fouchier, RAM; LeDuc, JW; Peiris, JSM; Schudel, A; Stohr, K; Osterhaus, ADME				Kuiken, T; Leighton, FA; Fouchier, RAM; LeDuc, JW; Peiris, JSM; Schudel, A; Stohr, K; Osterhaus, ADME			Public health - Pathogen surveillance in animals	SCIENCE			English	Article							SARS CORONAVIRUS; WILDLIFE		Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands; Univ Saskatchewan, Canadian Cooperat Wildlife Hlth Ctr, Saskatoon, SK S7N 5B4, Canada; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; World Org Anim Hlth, Paris, France; World Hlth Org, Dept Communicable Dis Surveillance & Response, Geneva, Switzerland	Erasmus University Rotterdam; Erasmus MC; University of Saskatchewan; Centers for Disease Control & Prevention - USA; University of Hong Kong; World Health Organization	Osterhaus, ADME (corresponding author), Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands.	a.osterhaus@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Kuiken, Thijs/0000-0001-5501-9049				[Anonymous], 2004, 2004 REP GLOB AIDS E; Bell D, 2004, PHILOS T R SOC B, V359, P1107, DOI 10.1098/rstb.2004.1492; *ENV CAN, 2004, CAN NAT WILDL DIS ST; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; KOCH G, 2003, INFECT ZIEKTEN B, V14, P112; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; LEIGHTON FA, 1995, REV SCI TECH OIE, V14, P819; Morner T, 2002, REV SCI TECH OIE, V21, P67, DOI 10.20506/rst.21.1.1321; *OIE, 2005, UPD AV INFL AN AS TY; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; World Health Organization, CUM NUMB CONF HUM CA; World Organisation for Animal Health (OIE), 2004, TERR AN HLTH COD	15	172	185	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1680	1681		10.1126/science.1113310	http://dx.doi.org/10.1126/science.1113310			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16150997				2022-12-28	WOS:000231836700028
J	Wagers, AJ; Conboy, IM				Wagers, AJ; Conboy, IM			Cellular and molecular signatures of muscle regeneration: Current concepts and controversies in adult myogenesis	CELL			English	Review							HEMATOPOIETIC STEM-CELLS; GROWTH-FACTOR-I; SKELETAL-MUSCLE; SATELLITE CELL; BONE-MARROW; OXIDATIVE STRESS; CLONAL ANALYSIS; MOUSE MUSCLE; EXPRESSION; TRANSPLANTATION	Adult skeletal muscle generates force in a controlled and directed manner through the contraction of highly specialized, postmitotic, multinucleated myofibers. Lifelong muscle function relies on maintenance and regeneration of myofibers through a highly regulated process beginning with activation of normally quiescent muscle precursor cells and proceeding with formation of proliferating progenitors that fuse to generate differentiated myofibers. In this review, we describe the historical basis and current evidence for the identification of satellite cells as adult muscle stem cells, critically evaluate contributions of other cells to adult myogenesis, and summarize existing data regarding the origins, genetic markers, and molecular regulation of satellite cells in normal, diseased, and aged muscle.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94702 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; University of California System; University of California Berkeley	Wagers, AJ (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02215 USA.	amywagers@joslin.harvard.edu; iconboy@berkeley.edu			NATIONAL INSTITUTE ON AGING [K01AG025652] Funding Source: NIH RePORTER; NIA NIH HHS [K01-AG25652] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abedi M, 2004, EXP HEMATOL, V32, P426, DOI 10.1016/j.exphem.2004.02.007; Alzghoul MB, 2004, FASEB J, V18, P221, DOI 10.1096/fj.03-0293fje; Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073; ARMAND O, 1983, ARCH ANAT MICROSC MO, V72, P163; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; BINTLIFF S, 1960, AM J ANAT, V106, P233, DOI 10.1002/aja.1001060304; Birchmeier C, 2000, CURR OPIN CELL BIOL, V12, P725, DOI 10.1016/S0955-0674(00)00159-9; BISCHOFF R, 1975, ANAT REC, V182, P215, DOI 10.1002/ar.1091820207; Blaveri K, 1999, DEV DYNAM, V216, P244, DOI 10.1002/(SICI)1097-0177(199911)216:3<244::AID-DVDY3>3.0.CO;2-9; Bondesen BA, 2004, AM J PHYSIOL-CELL PH, V287, pC475, DOI 10.1152/ajpcell.00088.2004; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Cao BH, 2003, NAT CELL BIOL, V5, P640, DOI 10.1038/ncb1008; CARDASIS CA, 1975, J EXP ZOOL, V191, P347, DOI 10.1002/jez.1401910305; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; CLARK WEL, 1946, J ANAT, V80, P24; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins M, 2003, MED SCI SPORT EXER, V35, P1524, DOI 10.1249/01.MSS.0000084522.14168.49; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Cossu G, 1996, DEVELOPMENT, V122, P429; Cossu G, 1996, TRENDS GENET, V12, P218, DOI 10.1016/0168-9525(96)10025-1; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Di Donna S, 2003, MOL CANCER RES, V1, P643; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Doyonnas R, 2004, P NATL ACAD SCI USA, V101, P13507, DOI 10.1073/pnas.0405361101; Ferrari G, 2001, NATURE, V411, P1014, DOI 10.1038/35082631; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; GOULDING M, 1994, DEVELOPMENT, V120, P957; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Gussoni E, 2002, J CLIN INVEST, V110, P807, DOI 10.1172/JCI200216098; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Heslop L, 2001, GENE THER, V8, P778, DOI 10.1038/sj.gt.3301463; Heszele MFC, 2004, ENDOCRINOLOGY, V145, P4803, DOI 10.1210/en.2004-1037; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jockusch H, 2003, J CELL SCI, V116, P1611, DOI 10.1242/jcs.00364; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; KONIGSBERG IR, 1963, SCIENCE, V140, P1273, DOI 10.1126/science.140.3573.1273; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lawlor MA, 2000, J CELL BIOL, V151, P1131, DOI 10.1083/jcb.151.6.1131; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lescaudron L, 1999, NEUROMUSCULAR DISORD, V9, P72, DOI 10.1016/S0960-8966(98)00111-4; LIPTON BH, 1979, SCIENCE, V205, P1292, DOI 10.1126/science.472747; Luz MAM, 2002, BRAZ J MED BIOL RES, V35, P691, DOI 10.1590/S0100-879X2002000600009; MALEY MAL, 1994, EXP CELL RES, V211, P99, DOI 10.1006/excr.1994.1064; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Melone MAB, 2000, J CELL PHYSIOL, V185, P143, DOI 10.1002/1097-4652(200010)185:1<143::AID-JCP14>3.0.CO;2-U; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; MOSS FP, 1970, J CELL BIOL, V44, P459, DOI 10.1083/jcb.44.2.459; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; RANTANEN J, 1995, LAB INVEST, V72, P341; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Renault V, 2002, EXP GERONTOL, V37, P1229, DOI 10.1016/S0531-5565(02)00129-8; ROBERTSON TA, 1993, EXP CELL RES, V207, P321, DOI 10.1006/excr.1993.1199; Rouger K, 2004, CELL TISSUE RES, V317, P319, DOI 10.1007/s00441-004-0911-9; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; SCHULTZ E, 1978, J EXP ZOOL, V206, P451, DOI 10.1002/jez.1402060314; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2004, DEV BIOL, V275, P287, DOI 10.1016/j.ydbio.2004.07.034; Shavlakadze T, 2005, NEUROMUSCULAR DISORD, V15, P139, DOI 10.1016/j.nmd.2004.10.013; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Sherwood RI, 2004, STEM CELLS, V22, P1292, DOI 10.1634/stemcells.2004-0090; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SLOPER JC, 1980, BRIT MED BULL, V36, P153, DOI 10.1093/oxfordjournals.bmb.a071631; SNOW MH, 1978, CELL TISSUE RES, V186, P535; STAUBER WT, 1988, MED SCI SPORT EXER, V20, P345, DOI 10.1249/00005768-198808000-00004; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Volkmann R., 1893, BEITR PATHOL, V12, P233; WALTON JN, 1956, J PATHOL BACTERIOL, V72, P273, DOI 10.1002/path.1700720134; Washabaugh CH, 2004, GENE THER, V11, P1724, DOI 10.1038/sj.gt.3302353; WEBER CO, 1963, ZBL MED WISS, V1, P529; YABLONKAREUVENI Z, 1987, DEV BIOL, V119, P252, DOI 10.1016/0012-1606(87)90226-0; Yaffe D, 1969, Curr Top Dev Biol, V4, P37, DOI 10.1016/S0070-2153(08)60480-9; ZACKS SI, 1982, MUSCLE NERVE, V5, P152, DOI 10.1002/mus.880050213; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	105	315	336	3	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					659	667		10.1016/j.cell.2005.08.021	http://dx.doi.org/10.1016/j.cell.2005.08.021			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143100	Bronze			2022-12-28	WOS:000231844300007
J	Katayama, S; Tomaru, Y; Kasukawa, T; Waki, K; Nakanishi, M; Nakamura, M; Nishida, H; Yap, CC; Suzuki, M; Kawai, J; Suzuki, H; Carninci, P; Hayashizaki, Y; Wells, C; Frith, M; Ravasi, T; Pang, KC; Hallinan, J; Mattick, J; Hume, DA; Lipovich, L; Batalov, S; Engstrom, PG; Mizuno, Y; Faghihi, MA; Sandelin, A; Chalk, AM; Mottagui-Tabar, S; Liang, Z; Lenhard, B; Wahlestedt, C				Katayama, S; Tomaru, Y; Kasukawa, T; Waki, K; Nakanishi, M; Nakamura, M; Nishida, H; Yap, CC; Suzuki, M; Kawai, J; Suzuki, H; Carninci, P; Hayashizaki, Y; Wells, C; Frith, M; Ravasi, T; Pang, KC; Hallinan, J; Mattick, J; Hume, DA; Lipovich, L; Batalov, S; Engstrom, PG; Mizuno, Y; Faghihi, MA; Sandelin, A; Chalk, AM; Mottagui-Tabar, S; Liang, Z; Lenhard, B; Wahlestedt, C		RIKEN Genome Network Project Core; Genome Sci Grp; FANTOM Consortium	Antisense transcription in the mammalian transcriptome	SCIENCE			English	Article							IMPRINTED GENES; NONCODING RNAS; HUMAN GENOME; HUMAN-CELLS; COMPLEX; AIR	Antisense transcription (transcription from the opposite strand to a protein-coding or sense strand) has been ascribed roles in gene regulation involving degradation of the corresponding sense transcripts (RNA interference), as well as gene silencing at the chromatin level. Global transcriptome analysis provides evidence that a large proportion of the genome can produce transcripts from both strands, and that antisense transcripts commonly link neighboring "genes" in complex loci into chains of linked transcriptional units. Expression profiling reveals frequent concordant regulation of sense/antisense pairs. We present experimental evidence that perturbation of an antisense RNA can alter the expression of sense messenger RNAs, suggesting that antisense transcription contributes to control of transcriptional outputs in mammals.	Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Scripps Florida, Jupiter, FL 33458 USA; RIKEN Yokohama Inst, RIKEN Genome Sci Ctr, Lab Genome Explorat Res Grp, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Discovery & Res Inst, Genome Sci Lab, Wako, Saitama 3510198, Japan; Univ Queensland, Australian Res Council Special Res Ctr Func & App, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Austin & Repatriat Med Ctr, T Cell Lab, Ludwig Inst Canc Res, Heidelberg, Vic 3084, Australia; Genome Inst Singapore, Singapore 138672, Singapore; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Karolinska Institutet; State University System of Florida; University of Florida; RIKEN; University of Queensland; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Novartis	Wahlestedt, C (corresponding author), Karolinska Inst, Ctr Genom & Bioinformat, Berzelius v 35, S-17177 Stockholm, Sweden.		Chalk, Alistair/O-3522-2019; Lipovich, Leonard/B-2355-2019; Kasukawa, Takeya/N-5070-2015; Mattick, John/ABH-6130-2020; Hume, David A/C-7695-2013; Nishida, Hiromi/B-1635-2008; Wahlestedt, Claes/A-7039-2009; Mattick, John S/I-7789-2012; Katayama, Shintaro/F-2958-2010; Wells, Christine A/A-5071-2010; Ravasi, Timothy/B-8777-2008; Liang, Zicai/A-2646-2013; Sandelin, Albin/G-2881-2011; Faghihi, Mohammad Ali/AAD-7159-2020; Kawai, Jun/A-6451-2016; Faghihi, Mohammad Ali/AAH-3139-2019; Hayashizaki, Yoshihide/N-6590-2015; Suzuki, Harukazu/N-9553-2015; Carninci, Piero/K-1568-2014; Waki, Kazunori/T-6444-2019	Chalk, Alistair/0000-0002-9630-6236; Lipovich, Leonard/0000-0002-0531-3570; Kasukawa, Takeya/0000-0001-5085-0802; Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527; Katayama, Shintaro/0000-0001-7581-5157; Wells, Christine A/0000-0003-3133-3628; Sandelin, Albin/0000-0002-7109-7378; Faghihi, Mohammad Ali/0000-0002-8330-9067; Suzuki, Harukazu/0000-0002-8087-0836; Carninci, Piero/0000-0001-7202-7243; Waki, Kazunori/0000-0001-7311-7208; Ravasi, Timothy/0000-0002-9950-465X; Lenhard, Boris/0000-0002-1114-1509; Hume, David/0000-0002-2615-1478; Frith, Martin/0000-0003-0998-2859; Batalov, Sergey/0000-0002-0925-0554; Pang, Ken/0000-0002-6881-775X; Engstrom, Par/0000-0001-5265-2121				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen AA, 2003, CURR OPIN CELL BIOL, V15, P281, DOI 10.1016/S0955-0674(03)00041-3; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Holmes R, 2003, GENOME RES, V13, P1410, DOI 10.1101/gr.955503; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; RAVASI T, IN PRESS ENCY GENETI; Shendure J, 2002, GENOME BIOL, V3; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2003, EMBO J, V22, P3696, DOI 10.1093/emboj/cdg341; Tagoh H, 2004, EMBO J, V23, P4275, DOI 10.1038/sj.emboj.7600421; Veeramachaneni V, 2004, GENOME RES, V14, P280, DOI 10.1101/gr.1590904; Wells Christine A, 2003, BMC Immunol, V4, P5, DOI 10.1186/1471-2172-4-5; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	27	1297	1420	2	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1564	1566		10.1126/science.1112009	http://dx.doi.org/10.1126/science.1112009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141073				2022-12-28	WOS:000231715000050
J	Noller, HF				Noller, HF			RNA structure: Reading the ribosome	SCIENCE			English	Review							PHENYLALANINE TRANSFER-RNA; SECONDARY STRUCTURE MODEL; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; HAMMERHEAD RIBOZYME; 70S RIBOSOME; 16 S; SUBUNIT; PROTEINS; COMPLEX	The crystal structures of the ribosome and its subunits have increased the amount of information about RNA structure by about two orders of magnitude. This is leading to an understanding of the principles of RNA folding and of the molecular interactions that underlie the functional capabilities of the ribosome and other RNA systems. Nearly all of the possible types of RNA tertiary interactions have been found in ribosomal RNA. One of these, an abundant tertiary structural motif called the A-minor interaction, has been shown to participate in both aminoacyl-transfer RNA selection and in peptidyl transferase; it may also play an important role in the structural dynamics of the ribosome.	Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.							Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Atkins J.F, 1999, RNA WORLD; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BRIMACOMBE R, 1983, PROG NUCLEIC ACID RE, V28, P1, DOI 10.1016/S0079-6603(08)60081-1; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Burkard M. E., 1999, RNA WORLD, P675; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CRICK FHC, 1966, COLD SPRING HARB SYM, V31, P3, DOI 10.1101/SQB.1966.031.01.007; DABBS ER, 1979, J BACTERIOL, V140, P734, DOI 10.1128/JB.140.2.734-737.1979; Doherty EA, 2000, ANNU REV BIOCHEM, V69, P597, DOI 10.1146/annurev.biochem.69.1.597; DOUDNA JA, 1993, P NATL ACAD SCI USA, V90, P7829, DOI 10.1073/pnas.90.16.7829; Elgavish T, 2001, J MOL BIOL, V310, P735, DOI 10.1006/jmbi.2001.4807; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; FOX GE, 1975, NATURE, V256, P505, DOI 10.1038/256505a0; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2003, BIOPOLYMERS, V68, P223, DOI 10.1002/bip.10210; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; GREEN R, 1990, NATURE, V347, P406, DOI 10.1038/347406a0; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; GUTELL RR, 1986, EMBO J, V5, P1111, DOI 10.1002/j.1460-2075.1986.tb04330.x; GUTELL RR, 1985, PROG NUCLEIC ACID RE, V32, P155, DOI 10.1016/S0079-6603(08)60348-7; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hoang L, 2004, P NATL ACAD SCI USA, V101, P12439, DOI 10.1073/pnas.0405227101; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Klein DJ, 2004, RNA, V10, P1366, DOI 10.1261/rna.7390804; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Leontis NB, 2003, CURR OPIN STRUC BIOL, V13, P300, DOI 10.1016/S0959-440X(03)00076-9; Lescoute A, 2005, NUCLEIC ACIDS RES, V33, P2395, DOI 10.1093/nar/gki535; LEVITT M, 1969, NATURE, V224, P759, DOI 10.1038/224759a0; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Noller HF, 2004, RNA, V10, P1833, DOI 10.1261/rna.7142404; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; Noller HF, 2002, BIOCHEM SOC T, V30, P1159, DOI 10.1042/BST0301159; Noller HF, 2002, FEBS LETT, V514, P11, DOI 10.1016/S0014-5793(02)02327-X; NOLLER HF, 1981, SCIENCE, V212, P403, DOI 10.1126/science.6163215; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Orr JW, 1998, J MOL BIOL, V275, P453, DOI 10.1006/jmbi.1997.1489; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Saenger W., 1984, PRINCIPLES NUCL ACID; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; SZEWCZAK AA, 1993, P NATL ACAD SCI USA, V90, P9581, DOI 10.1073/pnas.90.20.9581; Uhlenbeck OC, 1997, CELL, V90, P833, DOI 10.1016/S0092-8674(00)80348-7; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	67	258	270	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1508	1514		10.1126/science.1111771	http://dx.doi.org/10.1126/science.1111771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141058				2022-12-28	WOS:000231715000034
J	Liu, P; Huang, XH; Zhou, RH; Berne, BJ				Liu, P; Huang, XH; Zhou, RH; Berne, BJ			Observation of a dewetting transition in the collapse of the melittin tetramer	NATURE			English	Article							HYDROPHOBIC HYDRATION; WATER; SIMULATION; PLATES	Marked hydration changes occur during the self-assembly of the melittin protein tetramer in water. Hydrophobicity induces a drying transition in the gap between simple sufficiently large ( more than 1 nm(2)) strongly hydrophobic surfaces as they approach each other(1-6), resulting in the subsequent collapse of the system, as well as a depletion of water next to single surfaces(7-10). Here we investigate whether the hydrophobic induced collapse of multidomain proteins or the formation of protein oligimers exhibits a similar drying transition. We performed computer simulations to study the collapse of the tetramer of melittin in water, and observed a marked water drying transition inside a nanoscale channel of the tetramer ( with a channel size of up to two or three water-molecule diameters). This transition, although occurring on a microscopic length scale, is analogous to a first-order phase transition from liquid to vapour. We find that this drying is very sensitive to single mutations of the three isoleucines to less hydrophobic residues and that such mutations in the right locations can switch the channel from being dry to being wet. Thus, quite subtle changes in hydrophobic surface topology can profoundly influence the drying transition. We show that, even in the presence of the polar protein backbone, sufficiently hydrophobic protein surfaces can induce a liquid - vapour transition providing an enormous driving force towards further collapse. This behaviour was unexpected because of the absence of drying in the collapse of the multidomain protein 2,3-dihydroxybiphenyl dioxygenase (BphC).	Columbia Univ, Dept Chem, New York, NY 10027 USA; IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA	Columbia University; International Business Machines (IBM)	Zhou, RH (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	ruhongz@us.ibm.com; berne@chem.columbia.edu	Huang, Xuhui/ABE-3207-2021	Huang, Xuhui/0000-0002-7119-9358; Zhou, Ruhong/0000-0001-8624-5591				Ball P, 2003, NATURE, V423, P25, DOI 10.1038/423025a; Chandler D, 2002, NATURE, V417, P491, DOI 10.1038/417491a; Cheng YK, 1998, NATURE, V392, P696, DOI 10.1038/33653; Cheung MS, 2002, P NATL ACAD SCI USA, V99, P685, DOI 10.1073/pnas.022387699; Huang X, 2003, P NATL ACAD SCI USA, V100, P11953, DOI 10.1073/pnas.1934837100; Huang XH, 2005, J PHYS CHEM B, V109, P3546, DOI 10.1021/jp045520l; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Jensen TR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.086101; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Leung K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.065502; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Sansom MSP, 2001, NATURE, V414, P156, DOI 10.1038/35102651; Shea JE, 2002, P NATL ACAD SCI USA, V99, P16064, DOI 10.1073/pnas.242293099; Steitz R, 2003, LANGMUIR, V19, P2409, DOI 10.1021/la026731p; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6010; WALLQVIST A, 1995, J PHYS CHEM-US, V99, P2893, DOI 10.1021/j100009a053; WOLDE PRT, 2002, P NATL ACAD SCI USA, V99, P6539; Zhou RH, 2004, SCIENCE, V305, P1605, DOI 10.1126/science.1101176	20	337	344	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					159	162		10.1038/nature03926	http://dx.doi.org/10.1038/nature03926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136146				2022-12-28	WOS:000231560400061
J	Wolgemuth, CW; Charon, NW				Wolgemuth, CW; Charon, NW			The kinky propulsion of Spiroplasma	CELL			English	Editorial Material							MELLIFERUM; MOTILITY; MOTOR	Bacteria have evolved many different means of generating movement. In this issue of Cell, Shaevitz et al. (2005) describe the swimming movement of a helical bacterium called Spiroplasma. They discover that Spiroplasma propels itself by generating two temporally distinct kinks that travel the length of the bacterium. These results point to the existence of a contractile apparatus that drives cell movement.	Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA; W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA	University of Connecticut; West Virginia University	Wolgemuth, CW (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA.			Wolgemuth, Charles/0000-0002-3588-3136				Armitage JP, 1997, MICROBIOL-UK, V143, P3671, DOI 10.1099/00221287-143-12-3671; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Gilad R, 2003, MOL MICROBIOL, V47, P657, DOI 10.1046/j.1365-2958.2003.03200.x; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Moller-Jensen J, 2005, CURR OPIN CELL BIOL, V17, P75, DOI 10.1016/j.ceb.2004.11.002; Shaevitz JW, 2005, CELL, V122, P941, DOI 10.1016/j.cell.2005.07.004; Trachtenberg S, 2004, J MOL MICROB BIOTECH, V7, P78, DOI 10.1159/000077872; Wolgemuth CW, 2003, BIOPHYS J, V85, P828, DOI 10.1016/S0006-3495(03)74523-8	10	5	5	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 23	2005	122	6					827	828		10.1016/j.cell.2005.09.003	http://dx.doi.org/10.1016/j.cell.2005.09.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179250	Bronze			2022-12-28	WOS:000232130200005
J	Frederickson, ME; Greene, MJ; Gordon, DM				Frederickson, ME; Greene, MJ; Gordon, DM			'Devil's gardens' bedevilled by ants	NATURE			English	Editorial Material							DUROIA-HIRSUTA; ALLELOPATHIC TREE; IRIDOID LACTONE; AMAZON		Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Colorado, Dept Biol, Denver, CO 80217 USA; Hlth Sci Ctr, Denver, CO 80217 USA	Stanford University; University of Colorado System; University of Colorado Denver	Frederickson, ME (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	meganf@stanford.edu		Frederickson, Megan/0000-0002-9058-7137				Aquino R, 1999, J NAT PROD, V62, P560, DOI 10.1021/np9803631; CAMPBELL DG, 1989, BIOCHEM SYST ECOL, V17, P403, DOI 10.1016/0305-1978(89)90057-4; DAVIDSON DW, 1993, TRENDS ECOL EVOL, V8, P326, DOI 10.1016/0169-5347(93)90240-P; MORAWETZ W, 1992, BIODIVERS CONSERV, V1, P19, DOI 10.1007/BF00700248; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; PAGE JE, 1994, EXPERIENTIA, V50, P840, DOI 10.1007/BF01956467; Pfannes KR, 2002, REV BIOL TROP, V50, P293; Renner SS, 1998, BIOTROPICA, V30, P324, DOI 10.1111/j.1744-7429.1998.tb00067.x; Revis HC, 2004, AUK, V121, P1262, DOI 10.1642/0004-8038(2004)121[1262:BAFAOA]2.0.CO;2	9	73	81	2	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					495	496		10.1038/437495a	http://dx.doi.org/10.1038/437495a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177778				2022-12-28	WOS:000232004800035
J	Raine, R; Sanderson, C; Black, N				Raine, R; Sanderson, C; Black, N			Developing clinical guidelines: a challenge to current methods	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY REVASCULARIZATION; APPROPRIATENESS; SPECIALTY		Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Raine, R (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, Keppel St, London WC1E 7HT, England.	rosalind.raine@lshtm.ac.uk	Sanderson, Colin F/O-9877-2014	Raine, Rosalind/0000-0003-0904-749X; Sanderson, Colin/0000-0002-4838-6112				Bayley E W, 1994, Am J Crit Care, V3, P208; Bernstein SJ, 2001, MED CARE, V39, P513, DOI 10.1097/00005650-200105000-00011; Brook R. H., 1994, AHCPR PUB, P59; Burgers JS, 2004, LANCET, V364, P392, DOI 10.1016/S0140-6736(04)16778-0; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Fitch K, 1999, EUR J PUBLIC HEALTH, V9, P181, DOI 10.1093/eurpub/9.3.181; Herrin J, 1997, HEALTH POLICY, V42, P67, DOI 10.1016/S0168-8510(97)00055-9; Hume D., 1978, TREATISE HUMAN NATUR, V2nd; Janis I. L, 1982, GROUPTHINK, V2nd; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; Raine R, 2004, LANCET, V364, P429, DOI 10.1016/S0140-6736(04)16766-4; Rawlins MD, 2004, NEW ENGL J MED, V351, P1383, DOI 10.1056/NEJMp048221; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Savoie I, 2000, J Health Serv Res Policy, V5, P76; SCOTT EA, 1991, J PUBLIC HEALTH MED, V13, P35, DOI 10.1093/oxfordjournals.pubmed.a042575; Shekelle P, 2004, MED DECIS MAKING, V24, P228, DOI 10.1177/0272989X04264212; Taffe P, 2004, MED DECIS MAKING, V24, P122, DOI 10.1177/0272989X04263153; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	18	103	110	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2005	331	7517					631	633		10.1136/bmj.331.7517.631	http://dx.doi.org/10.1136/bmj.331.7517.631			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967EK	16166137	Green Published, Green Accepted			2022-12-28	WOS:000232074100032
J	Moreno-Herrero, F; de Jager, M; Dekker, NH; Kanaar, R; Wyman, C; Dekker, C				Moreno-Herrero, F; de Jager, M; Dekker, NH; Kanaar, R; Wyman, C; Dekker, C			Mesoscale conformational changes in the DNA-repair complex Rad50/Mre11/Nbs1 upon binding DNA	NATURE			English	Article							STRAND BREAK REPAIR; MRE11 COMPLEX; HOOK	The human Rad50/Mre11/Nbs1 complex (hR/M/N) functions as an essential guardian of genome integrity by directing the proper processing of DNA ends, including DNA breaks(1). This biological function results from its ability to tether broken DNA molecules(2,3). hR/M/N's dynamic molecular architecture consists of a globular DNA-binding domain from which two 50-nm-long coiled coils protrude. The coiled coils are flexible(4) and their apices can self-associate(5). The flexibility of the coiled coils allows their apices to adopt an orientation favourable for interaction. However, this also allows interaction between the tips of two coiled coils within the same complex, which competes with and frustrates the intercomplex interaction required for DNA tethering. Here we show that the dynamic architecture of hR/M/N is markedly affected by DNA binding. DNAbinding by the hR/M/N globular domain leads to parallel orientation of the coiled coils; this prevents intracomplex interactions and favours intercomplex associations needed for DNA tethering. The hR/M/N complex thus is an example of a biological nanomachine in which binding to its ligand, in this case DNA, affects the functional conformation of a domain located 50 nm distant.	Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands; Erasmus MC, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Radiat Oncol, NL-3000 DR Rotterdam, Netherlands	Delft University of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	c.wyman@erasmusmc.nl; dekker@mb.tn.tudelft.nl	Moreno-Herrero, Fernando/N-2967-2013	Moreno-Herrero, Fernando/0000-0003-4083-1709; Dekker, Cees/0000-0001-6273-071X; Dekker, Nynke/0000-0003-4029-0973				Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; de Jager M, 2004, J MOL BIOL, V339, P937, DOI 10.1016/j.jmb.2004.04.014; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; van Noort J, 2003, P NATL ACAD SCI USA, V100, P7581, DOI 10.1073/pnas.1330706100; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Wyman C, 2002, CURR BIOL, V12, pR446, DOI 10.1016/S0960-9822(02)00941-7	11	200	205	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					440	443		10.1038/nature03927	http://dx.doi.org/10.1038/nature03927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163361				2022-12-28	WOS:000231849100060
J	Rund, D; Rachmilewitz, E				Rund, D; Rachmilewitz, E			Medical progress: beta-thalassemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BONE-MARROW-TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; SICKLE-CELL-ANEMIA; PREIMPLANTATION GENETIC DIAGNOSIS; IRON-CHELATION-THERAPY; INEFFECTIVE ERYTHROPOIESIS; LENTIVIRAL VECTOR; ALPHA-THALASSEMIA; PERIPHERAL-BLOOD; FETAL HEMOGLOBIN		Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Hematol, Jerusalem, Israel; E Wolfson Med Ctr, Dept Hematol, Holon, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Rund, D (corresponding author), Hadassah Univ Hosp, Dept Hematol, POB 12000, IL-91120 Jerusalem, Israel.	rund@cc.huji.ac.il	Rund, Deborah/AFK-2621-2022	Rund, Deborah/0000-0002-4507-7306				ADVANI R, 1992, BLOOD, V79, P1058; Ahmed S, 2002, NEW ENGL J MED, V347, P1162, DOI 10.1056/NEJMsa013234; Alwan A, 2003, NAT REV GENET, V4, P61, DOI 10.1038/nrg978; Amer J, 2004, THROMB HAEMOSTASIS, V92, P1052, DOI 10.1160/TH04-04-0234; Anderson LJ, 2002, LANCET, V360, P516, DOI 10.1016/S0140-6736(02)09740-4; Andreani M, 2000, BONE MARROW TRANSPL, V25, P401, DOI 10.1038/sj.bmt.1702151; Angastiniotis M, 1998, ANN NY ACAD SCI, V850, P251, DOI 10.1111/j.1749-6632.1998.tb10482.x; Angelucci E, 2002, HAEMATOLOGICA, V87, P578; Anie, 2001, COCHRANE DB SYST REV, V3; Atweh GF, 2001, SEMIN HEMATOL, V38, P367, DOI 10.1053/shem.2001.27566; Bhanu NV, 2004, BLOOD, V103, P1929, DOI 10.1182/blood-2003-05-1624; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Bradai M, 2003, BLOOD, V102, P1529, DOI 10.1182/blood-2003-01-0117; Braude P, 2003, NAT REV GENET, V4, P157, DOI 10.1038/nrg1017; BRITTENHAM GM, 1993, AM J HEMATOL, V42, P81, DOI 10.1002/ajh.2830420116; Cao A, 2002, NEW ENGL J MED, V347, P1200, DOI 10.1056/NEJMe020086; Cappellini M, 2004, BLOOD, V104, p984A, DOI 10.1182/blood.V104.11.3619.3619; Cappellini MD, 2000, BRIT J HAEMATOL, V111, P467, DOI 10.1046/j.1365-2141.2000.02376.x; Ceci A, 2002, BRIT J HAEMATOL, V118, P330, DOI 10.1046/j.1365-2141.2002.03554.x; Centis F, 2000, BLOOD, V96, P3624; Cighetti G, 2002, EUR J CLIN INVEST, V32, P55, DOI 10.1046/j.1365-2362.2002.0320s1055.x; Cohen Alan R, 2004, Hematology Am Soc Hematol Educ Program, P14; Cunningham MJ, 2004, BLOOD, V104, P34, DOI 10.1182/blood-2003-09-3167; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; De Sanctis V, 2002, HORM RES, V58, P72, DOI 10.1159/000064766; Di Naro E, 2000, MOL HUM REPROD, V6, P571, DOI 10.1093/molehr/6.6.571; Ding CM, 2004, P NATL ACAD SCI USA, V101, P10762, DOI 10.1073/pnas.0403962101; Dzik WH, 2002, CURR OPIN HEMATOL, V9, P521, DOI 10.1097/00062752-200211000-00010; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; Emery DW, 2002, BLOOD, V100, P2012, DOI 10.1182/blood-2002-01-0219; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Fang XP, 2004, J PEDIAT HEMATOL ONC, V26, P185, DOI 10.1097/00043426-200403000-00008; Fibach E, 2001, SEMIN HEMATOL, V38, P374, DOI 10.1053/shem.2001.27573; Fiorentino F, 2004, MOL HUM REPROD, V10, P445, DOI 10.1093/molehr/gah055; Franchini M, 2004, HEMATOL J, V5, P287, DOI 10.1038/sj.thj.6200407; Fucharoen S, 1996, BLOOD, V87, P887, DOI 10.1182/blood.V87.3.887.bloodjournal873887; Galanello R, 2003, J CLIN PHARMACOL, V43, P565, DOI 10.1177/0091270003253350; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Giardina PJ, 2001, SEMIN HEMATOL, V38, P360, DOI 10.1053/shem.2001.27576; GILMAN JG, 1985, BLOOD, V66, P783; Hall JG, 2004, J PEDIAT HEMATOL ONC, V26, P382, DOI 10.1097/00043426-200406000-00010; Hanawa H, 2004, BLOOD, V104, P2281, DOI 10.1182/blood-2004-03-0863; HERSHKO C, 1978, BRIT J HAEMATOL, V40, P255, DOI 10.1111/j.1365-2141.1978.tb03662.x; Hershko Chaim M, 2005, Curr Hematol Rep, V4, P110; Higgs D.R., 2001, THALASSAEMIA SYNDROM, P133; HIGGS DR, 2001, THALASSAEMIA SYNDROM, V192, P236; Hoffbrand AV, 2003, BLOOD, V102, P17, DOI 10.1182/blood-2002-06-1867; Hongeng S, 2002, BONE MARROW TRANSPL, V30, P409, DOI 10.1038/sj.bmt.1703655; Iannone R, 2003, BIOL BLOOD MARROW TR, V9, P519, DOI 10.1016/S1083-8791(03)00192-7; Imren S, 2004, J CLIN INVEST, V114, P953, DOI 10.1172/JCI200421838; Karnon J, 1999, CLIN LAB HAEMATOL, V21, P377, DOI 10.1046/j.1365-2257.1999.00262.x; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Krishnamurti L, 2003, BONE MARROW TRANSPL, V31, P547, DOI 10.1038/sj.bmt.1703887; Kuypers FA, 2004, CELL MOL BIOL, V50, P147; La Nasa G, 2002, BLOOD, V99, P4350, DOI 10.1182/blood.V99.12.4350; Lacerra G, 2000, P NATL ACAD SCI USA, V97, P9591, DOI 10.1073/pnas.97.17.9591; Li CK, 2004, PEDIATR HEMAT ONCOL, V21, P411, DOI 10.1080/08880010490457132; Link G, 2001, J LAB CLIN MED, V138, P130, DOI 10.1067/mlc.2001.116487; Locatelli F, 2003, BLOOD, V101, P2137, DOI 10.1182/blood-2002-07-2090; Lucarelli G, 1996, BLOOD, V87, P2082, DOI 10.1182/blood.V87.5.2082.bloodjournal8752082; Lung H Y, 2000, Blood Cells Mol Dis, V26, P613, DOI 10.1006/bcmd.2000.0343; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Moreau-Gaudry F, 2001, BLOOD, V98, P2664, DOI 10.1182/blood.V98.9.2664; Mourad FH, 2003, BRIT J HAEMATOL, V121, P187, DOI 10.1046/j.1365-2141.2003.04240.x; Nisbet-Brown E, 2003, LANCET, V361, P1597, DOI 10.1016/S0140-6736(03)13309-0; Old J.M., 2001, THALASSAEMIA SYNDROM, P630; Olivieri NF, 1999, NEW ENGL J MED, V341, P1407; Pace BS, 2003, AM J HEMATOL, V73, P26, DOI 10.1002/ajh.10321; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Persons Derek A, 2003, Curr Hematol Rep, V2, P348; Piga A, 2003, HAEMATOLOGICA, V88, P489; Piyamongkol W, 2003, MOL HUM REPROD, V9, P411, DOI 10.1093/molehr/gag051; Pootrakul P, 2003, BRIT J HAEMATOL, V122, P305, DOI 10.1046/j.1365-2141.2003.04412.x; Pootrakul P, 2000, BLOOD, V96, P2606, DOI 10.1182/blood.V96.7.2606.h8002606_2606_2612; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; Puthenveetil Geetha, 2004, Curr Hematol Rep, V3, P298; RACHMILEWITZ EA, 1995, BRIT J HAEMATOL, V90, P341, DOI 10.1111/j.1365-2141.1995.tb05156.x; Rachmilewitz EA, 2001, DISORDERS HEMOGLOBIN, P233; RACHMILEWITZ EA, 2005, ANN NY ACAD SCI, V1054, P1; Raiola G, 2003, J PEDIATR ENDOCR MET, V16, P259; Rivella S, 2000, J VIROL, V74, P4679, DOI 10.1128/JVI.74.10.4679-4687.2000; Rivella S, 2002, CURR OPIN MOL THER, V4, P505; Rund D, 2001, SEMIN HEMATOL, V38, P343, DOI 10.1053/shem.2001.27579; SHALEV O, 1995, BLOOD, V86, P2008, DOI 10.1182/blood.V86.5.2008.bloodjournal8652008; SHINAR E, 1989, J CLIN INVEST, V83, P404, DOI 10.1172/JCI113898; Singer ST, 2003, BLOOD, V102, p268A; Sodani P, 2004, BLOOD, V104, P1201, DOI 10.1182/blood-2003-08-2800; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V290, P756; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Tan PHC, 2004, AM J HEMATOL, V75, P209, DOI 10.1002/ajh.20015; Tavazzi D, 2001, BRIT J HAEMATOL, V112, P48, DOI 10.1046/j.1365-2141.2001.02482.x; Tesoriere L, 2001, FREE RADICAL RES, V34, P529, DOI 10.1080/10715760100300461; Testa U, 2004, LEUKEMIA, V18, P1176, DOI 10.1038/sj.leu.2403383; Vacek MM, 2003, BLOOD, V101, P104, DOI 10.1182/blood-2002-06-1869; Van de Velde H, 2004, HUM REPROD, V19, P700, DOI 10.1093/humrep/deh153; Voskaridou E, 2004, BRIT J HAEMATOL, V127, P127, DOI 10.1111/j.1365-2141.2004.05143.x; Voskaridou E, 2004, BRIT J HAEMATOL, V126, P736, DOI 10.1111/j.1365-2141.2004.05104.x; Wanless, 2003, BLOOD, V101, P2460; Wanless IR, 2002, BLOOD, V100, P1566, DOI 10.1182/blood-2002-01-0306; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Zoueva OP, 2004, EXP HEMATOL, V32, P700, DOI 10.1016/j.exphem.2004.05.024	104	742	798	1	246	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1135	1146		10.1056/NEJMra050436	http://dx.doi.org/10.1056/NEJMra050436			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963YG	16162884				2022-12-28	WOS:000231841900008
J	Zietman, AL; DeSilvio, ML; Slater, JD; Rossi, CJ; Miller, DW; Adams, JA; Shipley, WU				Zietman, AL; DeSilvio, ML; Slater, JD; Rossi, CJ; Miller, DW; Adams, JA; Shipley, WU			Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXTERNAL-BEAM RADIOTHERAPY; RADICAL PROSTATECTOMY; ANTIGEN LEVELS; CANCER; IRRADIATION; CARCINOMA; GY; ESCALATION; GUIDELINES; BIOPSY	Context Clinically localized prostate cancer is very prevalent among US men, but recurrence after treatment with conventional radiation therapy is common. Objective To evaluate the hypothesis that increasing the radiation dose delivered to men with clinically localized prostate cancer improves disease outcome. Design, Setting, and Patients Randomized controlled trial of 393 patients with stage T1b through T2b prostate cancer and prostate-specific antigen (PSA) levels less than 15 ng/mL randomized between January 1996 and December 1999 and treated at 2 US academic institutions. Median age was 67 years and median PSA level was 6.3 ng/mL. Median follow-up was 5.5 (range, 1.2-8.2) years. Intervention Patients were randomized to receive external beam radiation to a total dose of either 70.2 Gy (conventional dose) or 79.2 Gy (high dose). This was delivered using a combination of conformal photon and proton beams. Main Outcome Measure Increasing PSA level (ie, biochemical failure) 5 years after treatment. Results The proportions of men free from biochemical failure at 5 years were 61.4% (95% confidence interval, 54.6%-68.3%) for conventional-dose and 80.4% (95% confidence interval, 74.7%-86.1%) for high-dose therapy (P<.001), a 49% reduction in the risk of failure. The advantage to high-dose therapy was observed in both the low-risk and the higher-risk subgroups (risk reduction, 51% [P<.001] and 44% [P=.03], respectively). There has been no significant difference in overall survival rates between the treatment groups. Only 1% of patients receiving conventional-dose and 2% receiving high-dose radiation experienced acute urinary or rectal morbidity of Radiation Therapy Oncology Group (RTOG) grade 3 or greater. So far, only 2% and 1%, respectively, have experienced late morbidity of RTOG grade 3 or greater. Conclusions Men with clinically localized prostate cancer have a lower risk of biochemical failure if they receive high-dose rather than conventional-dose conformal radiation. This advantage was achieved without any associated increase in RTOG grade 3 acute or late urinary or rectal morbidity.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA; Loma Linda Univ, Med Ctr, Loma Linda, CA USA; Amer Coll Radiol, Philadelphia, PA USA; Radiat Therapy Oncol Grp, Philadelphia, PA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Loma Linda University; American College of Radiology; Radiation Therapy Oncology Group (RTOG)	Zietman, AL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA.	azietman@partners.org			NCI NIH HHS [P01 CA21239] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA021239] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; Cox JD, 1999, J CLIN ONCOL, V17, P1155; Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035; Crook JM, 1997, CANCER, V79, P81, DOI 10.1002/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.3.CO;2-I; D'Amico AV, 2002, INT J RADIAT ONCOL, V54, P436, DOI 10.1016/S0360-3016(02)02940-1; DUGAN TC, 1991, J UROLOGY, V146, P1313, DOI 10.1016/S0022-5347(17)38077-1; Gottschalk AR, 2004, BRIT J CANCER, V90, P950, DOI 10.1038/sj.bjc.6601625; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Gretzer MB, 2002, J UROLOGY, V168, P1419, DOI 10.1016/S0022-5347(05)64464-3; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KUPELIAN P, 2002, INT J RADIAT ONCOL, V58, P25; Kupelian PA, 2004, INT J RADIAT ONCOL, V58, P25, DOI 10.1016/S0360-3016(03)00784-3; LAWTON CA, 1991, INT J RADIAT ONCOL, V21, P935, DOI 10.1016/0360-3016(91)90732-J; Lukka H., 2003, International Journal of Radiation Oncology Biology Physics, V57, pS126, DOI 10.1016/S0360-3016(03)00827-7; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Pollack A, 2000, J CLIN ONCOL, V18, P3904, DOI 10.1200/JCO.2000.18.23.3904; Pollack A, 2004, J UROLOGY, V171, P1132, DOI 10.1097/01.ju.0000111844.95024.74; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; Ryu JK, 2002, INT J RADIAT ONCOL, V54, P1036, DOI 10.1016/S0360-3016(02)03006-7; SHIPLEY WU, 1979, JAMA-J AM MED ASSOC, V241, P1912, DOI 10.1001/jama.241.18.1912; SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5; Slater JD, 1998, INT J RADIAT ONCOL, V42, P299, DOI 10.1016/S0360-3016(98)00225-9; Vicini FA, 1999, INT J RADIAT ONCOL, V45, P553, DOI 10.1016/S0360-3016(99)00235-7; Zelefsky MJ, 2004, INT J RADIAT ONCOL, V59, P1053, DOI 10.1016/j.ijrobp.2003.12.011; Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7; Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1; Zietman AL, 2004, J UROLOGY, V171, P210, DOI 10.1097/01.ju.0000100980.13364.a6	27	982	998	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2005	294	10					1233	1239		10.1001/jama.294.10.1233	http://dx.doi.org/10.1001/jama.294.10.1233			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963UI	16160131	Bronze			2022-12-28	WOS:000231831200020
J	Salvi, VS; Damania, KR				Salvi, VS; Damania, KR			Neural tube defects in India - time for action	LANCET			English	Editorial Material							FOLIC-ACID		Seth GS Med Coll, Bombay 400012, Maharashtra, India; King Edward Mem Hosp, Bombay 400012, Maharashtra, India; Nowrosjee Wadia Matern Hosp, Bombay, Maharashtra, India	Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	Salvi, VS (corresponding author), Seth GS Med Coll, Bombay 400012, Maharashtra, India.	vinitasalvi@gsmc.edu						Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Chakravarty I, 2002, NUTR REV, V60, pS53, DOI 10.1301/00296640260130740; Cherian A, 2005, LANCET, V366, P930, DOI 10.1016/S0140-6736(05)67319-9; CHIDAMBARAM P, 2005, COMMUNICATION   0228; Oakley GP, 2004, BIRTH DEFECTS RES A, V70, P835, DOI 10.1002/bdra.20058; *PLANN COMM GOV IN, 2005, 10 5 YEAR PLAN 2002	7	10	10	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 10	2005	366	9489					871	872		10.1016/S0140-6736(05)67294-7	http://dx.doi.org/10.1016/S0140-6736(05)67294-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16153996				2022-12-28	WOS:000231770000004
J	Hayakawa, T; Angata, T; Lewis, AL; Mikkelsen, TS; Varki, NM; Varki, A				Hayakawa, T; Angata, T; Lewis, AL; Mikkelsen, TS; Varki, NM; Varki, A			A human-specific gene in microglia	SCIENCE			English	Article							BRAIN		Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Cambridge, MA 02141 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu		Lewis, Amanda/0000-0001-6195-3030	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM32373] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angata T, 2002, J BIOL CHEM, V277, P24466, DOI 10.1074/jbc.M202833200; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; *CHIMP SEQ AN CONS, IN PRESS NATURE; Varki A, 2004, NAT GENET, V36, P1034, DOI 10.1038/ng1004-1034; VARKI A, IN PRESS GLYCOBIOLOG	5	76	77	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1693	1693		10.1126/science.1114321	http://dx.doi.org/10.1126/science.1114321			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151003				2022-12-28	WOS:000231836700034
J	Shayeghi, M; Latunde-Dada, GO; Oakhill, JS; Laftah, AH; Takeuchi, K; Halliday, N; Khan, Y; Warley, A; McCann, FE; Hider, RC; Frazer, DM; Anderson, GJ; Vulpe, CD; Simpson, RJ; McKie, AT				Shayeghi, M; Latunde-Dada, GO; Oakhill, JS; Laftah, AH; Takeuchi, K; Halliday, N; Khan, Y; Warley, A; McCann, FE; Hider, RC; Frazer, DM; Anderson, GJ; Vulpe, CD; Simpson, RJ; McKie, AT			Identification of an intestinal heme transporter	CELL			English	Article							HEMOGLOBIN-IRON ABSORPTION; RAT HEPATOCYTES; HEPCIDIN; EXPRESSION; HEMOPEXIN; RECEPTOR; DUODENUM; BINDING; INVIVO; ANEMIA	Dietary heme iron is an important nutritional source of iron in carnivores and omnivores that is more readily absorbed than non-heme iron derived from vegetables and grain. Most heme is absorbed in the proximal intestine, with absorptive capacity decreasing distally. We utilized a subtractive hybridization approach to isolate a heme transporter from duodenum by taking advantage of the intestinal gradient for heme absorption. Here we show a membrane protein named HCP1 (heme carrier protein 1), with homology to bacterial metal-tetracycIine transporters, mediates heme uptake by cells in a temperature-dependent and saturable manner. HCP1 mRNA was highly expressed in duodenum and regulated by hypoxia. HCP1 protein was iron regulated and localized to the brush-border membrane of duodenal enterocytes in iron deficiency.	Kings Coll London, Dept Life Sci, Nutr Sci Res Div, London SE1 9NN, England; St Thomas Hosp, Rayne Inst, GKT Dept Ophthalmol, London SE1 7EH, England; Univ London Imperial Coll Sci Technol & Med, Dept Sci Biol, London SW7 2AZ, England; Kings Coll London, Dept Pharm, London SE1 9NN, England; Queensland Inst Med Res, Iron Metab Lab, Brisbane, Qld, Australia; Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London; University of London; King's College London; QIMR Berghofer Medical Research Institute; University of California System; University of California Berkeley	McKie, AT (corresponding author), Kings Coll London, Dept Life Sci, Nutr Sci Res Div, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NN, England.	andrew.t.mckie@kcl.ac.uk	Anderson, Gregory J/G-4148-2013; Vulpe, Chris/AAF-9170-2020; Oakhill, Jonathan S/F-5724-2011; Frazer, David M/L-3570-2014; Simpson, Robert J/A-8776-2013	Anderson, Gregory J/0000-0002-8814-5866; Vulpe, Chris/0000-0001-5134-8929; Oakhill, Jonathan S/0000-0002-9475-1440; Frazer, David M/0000-0003-4098-1379; Simpson, Robert J/0000-0002-2196-5368; Halliday, Neil/0000-0001-8220-9139; Hider, Robert/0000-0003-1330-5797; McCann, Fiona/0000-0001-8151-8781	MRC [G0400485] Funding Source: UKRI; Medical Research Council [G0400485] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; BANNERMAN RM, 1965, J LAB CLIN MED, V65, P944; Canonne-Hergaux F, 2000, BLOOD, V96, P3964; CONRAD ME, 1966, AM J PHYSIOL, V211, P1123, DOI 10.1152/ajplegacy.1966.211.5.1123; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; DITCHBURN RW, 1956, NATURE, V177, P434, DOI 10.1038/177434a0; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Frazer DM, 2003, GUT, V52, P340, DOI 10.1136/gut.52.3.340; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; GALBRAITH RA, 1985, J BIOL CHEM, V260, P2198; Gburek J, 2002, J AM SOC NEPHROL, V13, P423, DOI 10.1681/ASN.V132423; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; GRASBECK R, 1982, BIOCHIM BIOPHYS ACTA, V700, P137, DOI 10.1016/0167-4838(82)90089-9; Hahn PF, 1943, J EXP MED, V78, P169, DOI 10.1084/jem.78.3.169; HUGGENVIK JI, 1989, BLOOD, V74, P482; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LABBE RF, 1957, BIOCHIM BIOPHYS ACTA, V26, P437, DOI 10.1016/0006-3002(57)90033-1; LIGHT WR, 1990, J BIOL CHEM, V265, P15623; LYNCH SR, 1989, BLOOD, V74, P2187; MCEWAN GTA, 1988, PROC R SOC SER B-BIO, V234, P219, DOI 10.1098/rspb.1988.0045; McKie AT, 1996, AM J PHYSIOL-GASTR L, V271, pG772, DOI 10.1152/ajpgi.1996.271.5.G772; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; MULLEREBERHARD U, 1988, METHOD ENZYMOL, V163, P536; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Noyer CM, 1998, HEPATOLOGY, V28, P150, DOI 10.1002/hep.510280120; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; PARMLEY RT, 1981, EXP MOL PATHOL, V34, P131, DOI 10.1016/0014-4800(81)90070-8; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P1753, DOI 10.1021/bi00277a002; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; RAFFIN SB, 1974, J CLIN INVEST, V54, P1344, DOI 10.1172/JCI107881; RAJA KB, 1988, BRIT J HAEMATOL, V68, P373, DOI 10.1111/j.1365-2141.1988.tb04217.x; RAJA KB, 1987, BIOCHIM BIOPHYS ACTA, V901, P52, DOI 10.1016/0005-2736(87)90255-0; ROBERTS SK, 1993, AM J PHYSIOL, V265, pG712, DOI 10.1152/ajpgi.1993.265.4.G712; SIEVERS G, 1987, CHEM-BIOL INTERACT, V63, P105, DOI 10.1016/0009-2797(87)90091-3; SMITH A, 1981, J BIOL CHEM, V256, P902; SMITH A, 1984, J BIOL CHEM, V259, P2049; TENHUNEN R, 1987, J PHARM PHARMACOL, V39, P780, DOI 10.1111/j.2042-7158.1987.tb05119.x; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Trinder D, 2000, GUT, V46, P270, DOI 10.1136/gut.46.2.270; TURNBULL A, 1962, J CLIN INVEST, V41, P1897, DOI 10.1172/JCI104646; Uc A, 2004, AM J PHYSIOL-GASTR L, V287, pG1150, DOI 10.1152/ajpgi.00157.2004; Uzel C, 1998, SEMIN HEMATOL, V35, P27; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; WEINTRAUB LR, 1965, P SOC EXP BIOL MED, V120, P840, DOI 10.3181/00379727-120-30670; WHEBY MS, 1970, GASTROENTEROLOGY, V58, P647; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172; WYLLIE JC, 1982, LAB INVEST, V47, P471; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P4809; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P19155	54	495	529	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					789	801		10.1016/j.cell.2005.06.025	http://dx.doi.org/10.1016/j.cell.2005.06.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143108	Bronze			2022-12-28	WOS:000231844300017
J	Surani, MA				Surani, MA			Nuclear reprogramming by human embryonic stem cells	CELL			English	Editorial Material							SOMATIC-CELLS	Embryonic stem cells have two unique properties. They are capable of indefinite self-renewal and, being pluripotent, they can differentiate into all possible cell types, including germ cells. A new study by Cowan et al. (2005) published in Science shows that human embryonic stem cells are able to reprogram the nuclei of fully differentiated human somatic cells, apparently conferring on them a pluripotent state.	Univ Cambridge, Wellcome Trust Canc Res UK, Gurdon Inst, Cambridge CB2 1QN, England	Cancer Research UK; University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.			Surani, Azim/0000-0002-8640-4318				Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Blau HM, 1999, SEMIN CELL DEV BIOL, V10, P267, DOI 10.1006/scdb.1999.0311; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; LEE MG, 2005, IN PRESS NATURE; METZGER E, 2005, IN PRESS NATURE; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	10	15	15	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 9	2005	122	5					653	654		10.1016/j.cell.2005.08.023	http://dx.doi.org/10.1016/j.cell.2005.08.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143098	Bronze			2022-12-28	WOS:000231844300005
J	Pisano, ED; Gatsonis, C; Hendrick, E; Yaffe, M; Baum, JK; Acharyya, S; Conant, EF; Fajardo, LL; Bassett, L; D'Orsi, C; Jong, R; Rebner, M				Pisano, ED; Gatsonis, C; Hendrick, E; Yaffe, M; Baum, JK; Acharyya, S; Conant, EF; Fajardo, LL; Bassett, L; D'Orsi, C; Jong, R; Rebner, M		DMIST Investigators Grp	Diagnostic performance of digital versus film mammography for breast-cancer screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WOMEN; SENSITIVITY; DENSITY; RISK; AGE; ACCURACY; TRIAL; TIME	BACKGROUND: Film mammography has limited sensitivity for the detection of breast cancer in women with radiographically dense breasts. We assessed whether the use of digital mammography would avoid some of these limitations. METHODS: A total of 49,528 asymptomatic women presenting for screening mammography at 33 sites in the United States and Canada underwent both digital and film mammography. All relevant information was available for 42,760 of these women (86.3 percent). Mammograms were interpreted independently by two radiologists. Breast-cancer status was ascertained on the basis of a breast biopsy done within 15 months after study entry or a follow-up mammogram obtained at least 10 months after study entry. Receiver-operating-characteristic (ROC) analysis was used to evaluate the results. RESULTS: In the entire population, the diagnostic accuracy of digital and film mammography was similar (difference between methods in the area under the ROC curve, 0.03; 95 percent confidence interval, -0.02 to 0.08; P=0.18). However, the accuracy of digital mammography was significantly higher than that of film mammography among women under the age of 50 years (difference in the area under the curve, 0.15; 95 percent confidence interval, 0.05 to 0.25; P=0.002), women with heterogeneously dense or extremely dense breasts on mammography (difference, 0.11; 95 percent confidence interval, 0.04 to 0.18; P=0.003), and premenopausal or perimenopausal women (difference, 0.15; 95 percent confidence interval, 0.05 to 0.24; P=0.002). CONCLUSIONS: The overall diagnostic accuracy of digital and film mammography as a means of screening for breast cancer is similar, but digital mammography is more accurate in women under the age of 50 years, women with radiographically dense breasts, and premenopausal or perimenopausal women. (ClinicalTrials.govnumber, NCT00008346.).	Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA; Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA; Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; Univ Penn, Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA; Emory Univ, Dept Radiol, Atlanta, GA 30322 USA; William Beaumont Hosp, Dept Radiol, Royal Oak, MI 48072 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Brown University; Northwestern University; Feinberg School of Medicine; University of Toronto; University of Toronto; Harvard University; Beth Israel Deaconess Medical Center; University of Pennsylvania; University of Iowa; University of California System; University of California Los Angeles; Emory University; Beaumont Health	Pisano, ED (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA.	etta_pisano@med.unc.edu	SALAZAR, ANTONIO/A-5806-2013	SALAZAR, ANTONIO/0000-0003-2639-2340	NATIONAL CANCER INSTITUTE [U01CA079778, U01CA080098] Funding Source: NIH RePORTER; NCI NIH HHS [U01CA80098-S1, U01CA80098, U01CA79778] Funding Source: Medline; PHS HHS [U0179778-S1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		American College of Radiology, 2003, BREAST IM REP DAT SY; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Banks E, 2004, BMJ-BRIT MED J, V329, P477, DOI 10.1136/bmj.329.7464.477; BLOOMQUIST AK, IN PRESS MED PHYS; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Carney PA, 2003, ANN INTERN MED, V138, P771, DOI 10.7326/0003-4819-138-3-200302040-00008; Cole E, 2004, ACAD RADIOL, V11, P879, DOI 10.1016/j.acra.2004.04.003; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Duffy SW, 1996, INT J EPIDEMIOL, V25, P1139, DOI 10.1093/ije/25.6.1139; Fletcher SW, 2003, NEW ENGL J MED, V348, P1672, DOI 10.1056/NEJMcp021804; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Ghate SV, 2005, RADIOLOGY, V235, P31, DOI 10.1148/radiol.2351040699; Hendrick RE, 2001, IWDM 2000: 5TH INTERNATIONAL WORKSHOP ON DIGITAL MAMMOGRAPHY, P475; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; *I MED, 2005, SAV WOM LIV INT INN; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Lewin JM, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790671; Metz CE, 1984, INFORMATION PROCESSI; Pisano ED, 2000, RADIOLOGY, V216, P820, DOI 10.1148/radiology.216.3.r00se48820; Pisano ED, 2005, RADIOLOGY, V236, P404, DOI 10.1148/radiol.2362050440; Pisano ED, 2005, RADIOLOGY, V234, P353, DOI 10.1148/radiol.2342030897; Pisano ED, 2000, RADIOGRAPHICS, V20, P1479, DOI 10.1148/radiographics.20.5.g00se311479; Pisano ED, 2000, ACAD RADIOL, V7, P266, DOI 10.1016/S1076-6332(00)80478-X; Poplack SP, 2000, RADIOLOGY, V217, P832, DOI 10.1148/radiology.217.3.r00dc33832; Rosenberg RD, 2000, ACAD RADIOL, V7, P1058, DOI 10.1016/S1076-6332(00)80057-4; SHTERN F, 1992, RADIOLOGY, V183, P629, DOI 10.1148/radiology.183.3.1584908; Skaane P, 2004, RADIOLOGY, V232, P197, DOI 10.1148/radiol.2321031624; Skaane P, 2003, RADIOLOGY, V229, P877, DOI 10.1148/radiol.2293021171; Smith-Bindman R, 2005, J MED SCREEN, V12, P50, DOI 10.1258/0969141053279130; Smith-Bindman R, 2005, JNCI-J NATL CANCER I, V97, P358, DOI 10.1093/jnci/dji060; Toledano AY, 1999, BIOMETRICS, V55, P488, DOI 10.1111/j.0006-341X.1999.00488.x; WOLFE JN, 1976, CANCER, V37, P2486, DOI 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	36	1218	1262	2	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2005	353	17					1773	1783		10.1056/NEJMoa052911	http://dx.doi.org/10.1056/NEJMoa052911			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977OL	16169887				2022-12-28	WOS:000232813000005
J	Meylan, E; Curran, J; Hofmann, K; Moradpour, D; Binder, M; Bartenschlager, R; Tschopp, R				Meylan, E; Curran, J; Hofmann, K; Moradpour, D; Binder, M; Bartenschlager, R; Tschopp, R			Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus	NATURE			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; INTERFERON REGULATORY FACTOR-3; MEMBRANE ASSOCIATION; IKK-EPSILON; ACTIVATION; HELICASE; IDENTIFICATION; CLEAVAGE; DETERMINANTS	Antiviral immunity against a pathogen is mounted upon recognition by the host of virally associated structures. One of these viral 'signatures', double-stranded (ds) RNA, is a replication product of most viruses within infected cells and is sensed by Toll-like receptor 3 (TLR3) and the recently identified cytosolic RNA helicases RIG-I (retinoic acid inducible gene I, also known as Ddx58) and Mda5 (melanoma differentiation-associated gene 5, also known as Ifih1 or Helicard)(1). Both helicases detect dsRNA, and through their protein-interacting CARD domains, relay an undefined signal resulting in the activation of the transcription factors interferon regulatory factor 3 (IRF3) and NF-kappa B. Here we describe Cardif, a new CARD-containing adaptor protein that interacts with RIG-I and recruits IKK alpha, IKK beta and IKK epsilon kinases by means of its C-terminal region, leading to the activation of NF-kappa B and IRF3. Overexpression of Cardif results in interferon-beta and NF-kappa B promoter activation, and knockdown of Cardif by short interfering RNA inhibits RIG-I-dependent antiviral responses. Cardif is targeted and inactivated by NS3-4A, a serine protease from hepatitis C virus known to block interferon-beta production. Cardif thus functions as an adaptor, linking the cytoplasmic dsRNA receptor RIG-I to the initiation of antiviral programmes.	Univ Lausanne, Dept Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland; Univ Geneva, Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; MEMOREC Biotec GmbH, D-50829 Cologne, Germany; CHU Vaudois, Div Gastroenterol & Hepatol, CH-1011 Lausanne, Switzerland; Heidelberg Univ, Dept Mol Virol, D-69120 Heidelberg, Germany	University of Lausanne; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ruprecht Karls University Heidelberg	Tschopp, R (corresponding author), Univ Lausanne, Dept Biochem, BIL Biomed Res Ctr, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Binder, Marco/E-9717-2011; Hofmann, Kay/D-6714-2011; Moradpour, Darius/G-7918-2017; Bartenschlager, Ralf/L-2582-2015	Binder, Marco/0000-0002-5805-6109; Hofmann, Kay/0000-0002-2289-9083; Moradpour, Darius/0000-0003-1977-6792; Bartenschlager, Ralf/0000-0001-5601-9307; Meylan, Etienne/0000-0002-0899-2230				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Conzelmann KK, 2005, J VIROL, V79, P5241, DOI 10.1128/JVI.79.9.5241-5248.2005; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Levy DE, 2004, NAT IMMUNOL, V5, P699, DOI 10.1038/ni0704-699; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun Y.W., 1997, THESIS SHANGHAI 2 ME; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	32	1851	1961	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2005	437	7062					1167	1172		10.1038/nature04193	http://dx.doi.org/10.1038/nature04193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16177806	Green Published			2022-12-28	WOS:000232660500047
J	Mumma, MJ; DiSanti, MA; Magee-Sauer, K; Bonev, BP; Villanueva, GL; Kawakita, H; Dello Russo, N; Gibb, EL; Blake, GA; Lyke, JE; Campbell, RD; Aycock, J; Conrad, A; Hill, GM				Mumma, MJ; DiSanti, MA; Magee-Sauer, K; Bonev, BP; Villanueva, GL; Kawakita, H; Dello Russo, N; Gibb, EL; Blake, GA; Lyke, JE; Campbell, RD; Aycock, J; Conrad, A; Hill, GM			Parent volatiles in comet 9P/Tempel 1: Before and after impact	SCIENCE			English	Article								We quantified eight parent votatiles (H(2)O, C(2)H(6), HCN, CO, CH(3)OH, H(2)CO, C(2)H(2), and CH(4)) in the Jupiter-family comet Tempel 1 using high-dispersion infrared spectroscopy in the wavelength range 2.8 to 5.0 micrometers. The abundance ratio for ethane was significantly higher after impact, whereas those for methanol and hydrogen cyanide were unchanged. The abundance ratios in the ejecta are similar to those for most Oort cloud comets, but methanol and acetylene are tower in Tempel 1 by a factor of about 2. These results suggest that the volatile ices in Tempel 1 and in most Oort cloud comets originated in a common region of the protoplanetary disk.	NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; Rowan Univ, Dept Phys & Astron, Glassboro, NJ 08028 USA; Univ Toledo, Dept Phys & Astron, Ritter Astrophys Res Ctr, Toledo, OH 43606 USA; Kyoto Sangyo Univ, Dept Phys, Kita Ku, Kyoto 6038555, Japan; Johns Hopkins Univ, Appl Phys Lab, Space Dept, Planetary Explorat Grp, Laurel, MD 20723 USA; Univ Missouri, Dept Phys & Astron, St Louis, MO 63121 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; WM Keck Observ, Kamuela, HI 96743 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Rowan University; University System of Ohio; University of Toledo; Kyoto Sangyo University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Missouri System; University of Missouri Saint Louis; California Institute of Technology	Mumma, MJ (corresponding author), NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA.	michael.j.mumma@nasa.gov	mumma, michael j/I-2764-2013; Magee-Sauer, Karen/K-6061-2015; Russo, Neil Dello/G-2727-2015	mumma, michael j/0000-0003-4627-750X; Magee-Sauer, Karen/0000-0002-4979-9875; Russo, Neil Dello/0000-0002-8379-7304				A'Hearn MF, 2005, SPACE SCI REV, V117, P1, DOI 10.1007/s11214-005-3387-3; AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Bernstein GM, 2004, ASTRON J, V128, P1364, DOI 10.1086/422919; Biver N, 2002, EARTH MOON PLANETS, V90, P323, DOI 10.1023/A:1021530316352; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Bocklelee-Morvan D., 2004, COMETS, P391; Delsemme AH, 2000, ICARUS, V146, P313, DOI 10.1006/icar.2000.6404; Dones L., 2005, COMETS, P153; ESPINASSE S, 1993, PLANET SPACE SCI, V41, P409, DOI 10.1016/0032-0633(93)90001-I; Gladman B, 2005, SCIENCE, V307, P71, DOI 10.1126/science.1100553; Irvine W. M., 2000, Protostars and planets 4, P1159; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; Levison HF, 1996, ASTR SOC P, V107, P173; McLean IS, 1998, P SOC PHOTO-OPT INS, V3354, P566, DOI 10.1117/12.317283; MORBIDELLI A, 2005, COMETS, V2, P175; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; Mumma MJ, 2003, ADV SPACE RES-SERIES, V31, P2563, DOI 10.1016/S0273-1177(03)00578-7; WEIDENSCHILLING SJ, 2004, COMETS, V2, P97	19	140	143	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2005	310	5746					270	274		10.1126/science.1119337	http://dx.doi.org/10.1126/science.1119337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16166477				2022-12-28	WOS:000232670100039
J	Bolton-Maggs, P; Flavin, A				Bolton-Maggs, P; Flavin, A			Epirubicin for breast cancer may cause considerable venous sclerosis	BRITISH MEDICAL JOURNAL			English	Article							EXTRAVASATION		Manchester Royal Infirm, Dept Clin Haematol, Manchester M13 9WL, Lancs, England; Clatterbridge Ctr Oncol, Wirral CH63 4JY, Merseyside, England	University of Manchester; Clatterbridge Cancer Centre	Bolton-Maggs, P (corresponding author), Manchester Royal Infirm, Dept Clin Haematol, Manchester M13 9WL, Lancs, England.	paula.bolton-maggs@manchester.ac.uk						BERTELLI G, 1995, DRUG SAFETY, V12, P245, DOI 10.2165/00002018-199512040-00004; POOLE CJ, 2003, P AN M AM SOC CLIN, V22, P4; Schrijvers DL, 2003, ANN ONCOL, V14, P26, DOI 10.1093/annonc/mdg744	3	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 8	2005	331	7520					816	816		10.1136/bmj.38574.659225.79	http://dx.doi.org/10.1136/bmj.38574.659225.79			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	974BC	16155047	Green Published, Bronze			2022-12-28	WOS:000232565300021
J	Hupp, JT; Poeppelmeier, KR				Hupp, JT; Poeppelmeier, KR			Better living through nanopore chemistry	SCIENCE			English	Editorial Material									Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University	Hupp, JT (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	j-hupp@northwestern.edu; krp@northwestern.edu	Hupp, Joseph T/K-8844-2012	Hupp, Joseph T/0000-0003-3982-9812				Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Halper SR, 2005, INORG CHEM, V44, P486, DOI 10.1021/ic048289z; WEISZ PB, 1973, CHEMTECH, P498; Wu CD, 2005, J AM CHEM SOC, V127, P8940, DOI 10.1021/ja052431t; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650	5	146	151	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2005	309	5743					2008	2009		10.1126/science.1117808	http://dx.doi.org/10.1126/science.1117808			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179465				2022-12-28	WOS:000232181900034
J	Adem, PV; Montgomery, CP; Husain, AN; Koogler, TK; Arangelovich, V; Humilier, M; Boyle-Vavra, S; Daum, RS				Adem, PV; Montgomery, CP; Husain, AN; Koogler, TK; Arangelovich, V; Humilier, M; Boyle-Vavra, S; Daum, RS			Brief report: Staphylococcus aureus sepsis and the waterhouse-friderichsen syndrome in children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PANTON-VALENTINE LEUKOCIDIN; FIELD GEL-ELECTROPHORESIS; METHICILLIN-RESISTANT; PURPURA FULMINANS; NECROTIZING PNEUMONIA; COMMUNITY; INFECTIONS; MENINGOCOCCEMIA; SEPTICEMIA; VIRULENCE	Staphylococcus aureus has increasingly been recognized as a cause of severe invasive illness. We describe three children who died at our institution after rapidly progressive clinical deterioration from this infection, with necrotizing pneumonia and multiple-organ-system involvement. The identification of bilateral adrenal hemorrhage at autopsy was characteristic of the Waterhouse - Friderichsen syndrome, a constellation of findings usually associated with fulminant meningococcemia. The close genetic relationship among the three responsible isolates of S. aureus, one susceptible to methicillin and two resistant to methicillin, underscores the close relationship between virulent methicillin-susceptible S. aureus and methicillin-resistant S. aureus isolates now circulating in the community.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Sect Crit Care Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA; Cook Cty Off Med Examiner, Chicago, IL USA	University of Chicago; University of Chicago; University of Chicago	Adem, PV (corresponding author), Univ Chicago Hosp, Dept Pathol, 5841 S Maryland Ave,MC 6101, Chicago, IL 60637 USA.	patricia.adem@uchospitals.edu		Montgomery, Christopher/0000-0001-7247-0683	NIAID NIH HHS [R01 AI40481-01A1] Funding Source: Medline; ODCDC CDC HHS [R01 CCR523379] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ODCDC CDC HHS		Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Boyle-Vavra S, 2000, ANTIMICROB AGENTS CH, V44, P272, DOI 10.1128/AAC.44.2.272-277.2000; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; Dmochowski S, 1975, Gruzlica, V43, P291; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; FRIDERICHSEN C, 1955, ACTA ENDOCRINOL-COP, V18, P482, DOI 10.1530/acta.0.0180482; Friderichsen C, 1918, JB KINDERHEILKD, V87, P109; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Hamilton D, 2004, J CLIN PATHOL, V57, P208, DOI 10.1136/jcp.2003.9936; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Huemer GM, 2004, WIEN KLIN WOCHENSCHR, V116, P82, DOI 10.1007/BF03040700; JACOBS RF, 1983, PEDIATRICS, V72, P469; JACOBS RF, 1990, PEDIATR INFECT DIS J, V9, P196, DOI 10.1097/00006454-199003000-00010; Kondo N, 1997, Nihon Saikingaku Zasshi, V52, P417; Kravitz GR, 2005, CLIN INFECT DIS, V40, P941, DOI 10.1086/428573; KREISWIRTH B, 1993, SCIENCE, V259, P227, DOI 10.1126/science.8093647; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lindenmayer JM, 1998, ARCH INTERN MED, V158, P895, DOI 10.1001/archinte.158.8.895; Maslow Joel N., 1993, P563; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Mongkolrattanothai K, 2003, CLIN INFECT DIS, V37, P1050, DOI 10.1086/378277; MURRAY HW, 1977, ARCH INTERN MED, V137, P844, DOI 10.1001/archinte.137.7.844; SHULMAN ST, 1976, PEDIATRICS, V58, P59; SIVIT CM, 1993, PEDIATR RADIOL, V23, P519, DOI 10.1007/BF02012136; SPICER TE, 1976, AM J MED, V61, P566, DOI 10.1016/0002-9343(76)90339-9; SWIERCZEWSKI JA, 1970, AM J CLIN PATHOL, V54, P202; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Waterhouse R, 1911, LANCET, V1, P577; Wielders C, 2001, LANCET, V358, P424; 1999, MMWR MORB MORTAL WKL, V48, P707	33	192	201	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1245	1251		10.1056/NEJMoa044194	http://dx.doi.org/10.1056/NEJMoa044194			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	966DS	16177250	Bronze			2022-12-28	WOS:000232000400008
J	Sawano, F; Terasaki, I; Mori, H; Mori, T; Watanabe, M; Ikeda, N; Nogami, Y; Noda, Y				Sawano, F; Terasaki, I; Mori, H; Mori, T; Watanabe, M; Ikeda, N; Nogami, Y; Noda, Y			An organic thyristor	NATURE			English	Article							STATE; CONDUCTORS	Thyristors are a class of nonlinear electronic device that exhibit bistable resistance - that is, they can be switched between two different conductance states(1). Thyristors are widely used as inverters ( direct to alternating current converters) and for the smooth control of power in a variety of applications such as motors and refrigerators. Materials and structures that exhibit nonlinear resistance of this sort are not only useful for practical applications: they also provide systems for exploring fundamental aspects of solid- state and statistical physics. Here we report the discovery of a giant nonlinear resistance effect in the conducting organic salt(2) theta- ( BEDT- TTF) 2CsCo( SCN)(4), the voltage- current characteristics of which are essentially the same as those of a conventional thyristor. This intrinsic organic thyristor works as an inverter, generating an alternating current when a static direct- current voltage is applied. Whereas conventional thyristors consist of a series of diodes ( their nonlinearity comes from interface effects at the p- n junctions), the present salt exhibits giant nonlinear resistance as a bulk phenomenon. We attribute the origin of this effect to the current-induced melting of insulating charge- order domains, an intrinsically non- equilibrium phenomenon in the sense that ordered domains are melted by a steady flow.	Waseda Univ, Dept Appl Phys, Tokyo 1698555, Japan; Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan; Tokyo Inst Technol, Dept Organ & Polymer Mat, Tokyo 1528552, Japan; Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; Japan Synchrotron Radiat Res Inst, Mikazuki, Hyogo 6795198, Japan; Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Waseda University; Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Tohoku University; Japan Synchrotron Radiation Research Institute; Okayama University	Terasaki, I (corresponding author), Waseda Univ, Dept Appl Phys, Tokyo 1698555, Japan.	terra@waseda.jp	NOGAMI, Yoshio/B-1502-2011; TERASAKI, Ichiro/I-7083-2014; Noda, Yukio/K-8551-2014; IKEDA, Naoshi/B-2587-2011; Mori, Takehiko/C-4162-2015	TERASAKI, Ichiro/0000-0002-6073-2639; Watanabe, Masashi/0000-0002-8004-3208; Mori, Takehiko/0000-0002-0578-5885				Clay RT, 2002, J PHYS SOC JPN, V71, P1816, DOI 10.1143/JPSJ.71.1816; GRUNER G, 1994, DENSITY WAVES SOLIDS, P56; GUNN JB, 1963, SOLID STATE COMMUN, V1, P88, DOI 10.1016/0038-1098(63)90041-3; Inagaki K, 2004, J PHYS SOC JPN, V73, P3364, DOI 10.1143/JPSJ.73.3364; MAEDA A, 1987, PHYS REV B, V36, P7709, DOI 10.1103/PhysRevB.36.7709; Mori H, 1998, PHYS REV B, V57, P12023, DOI 10.1103/PhysRevB.57.12023; Mori T, 2003, J PHYS SOC JPN, V72, P1469, DOI 10.1143/JPSJ.72.1469; Nishio Y, 1999, SYNTHETIC MET, V103, P1907, DOI 10.1016/S0379-6779(98)00611-0; Nogami Y, 1999, SYNTHETIC MET, V103, P1911, DOI 10.1016/S0379-6779(98)00616-X; Seo H, 2000, J PHYS SOC JPN, V69, P805, DOI 10.1143/JPSJ.69.805; STREETMAN BG, 1980, SOLID STATE ELECT DE, pCH11; Takahashi T, 2002, J PHYS IV, V12, P201, DOI 10.1051/jp4:20020395; Watanabe M, 1999, J PHYS SOC JPN, V68, P2654, DOI 10.1143/JPSJ.68.2654	13	175	179	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					522	524		10.1038/nature04087	http://dx.doi.org/10.1038/nature04087			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177784				2022-12-28	WOS:000232004800043
J	Werner, SL; Barken, D; Hoffmann, A				Werner, SL; Barken, D; Hoffmann, A			Stimulus specificity of gene expression programs determined by temporal control of IKK activity	SCIENCE			English	Article							NF-KAPPA-B; PROTEINS; MICE	A small number of mammalian signaling pathways mediate a myriad of distinct physiological responses to diverse cellular stimuli. Temporal control of the signaling module that contains I kappa B kinase (IKK), its substrate inhibitor of NF-kappa B (I kappa B), and the key inflammatory transcription factor NF-kappa B can allow for selective gene activation. We have demonstrated that different inflammatory stimuli induce distinct IKK profiles, and we examined the underlying molecular mechanisms. Although tumor necrosis factor-alpha (TNF alpha)-induced IKK activity was rapidly attenuated by negative feedback, lipopolysaccharide (LPS) signaling and LPS-specific gene expression programs were dependent on a cytokine-mediated positive feedback mechanism. Thus, the distinct biological responses to LPS and TNF alpha depend on signaling pathway-specific mechanisms that regulate the temporal profile of IKK activity.	Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA		Hoffmann, A (corresponding author), Dept Chem & Biochem, Signaling Syst Lab, 9500 Gilman Dr,Mailcode 0375, La Jolla, CA 92093 USA.	ahoffmann@ucsd.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072024, R01GM071573] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM071573, GM72024] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Beutler B, 1995, J CARDIOVASC PHARM, V25, pS1, DOI 10.1097/00005344-199500252-00002; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; KEARNS JD, UNPUB; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; QUIAMBAO R, UNPUB; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914	18	395	405	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1857	1861		10.1126/science.1113319	http://dx.doi.org/10.1126/science.1113319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166517				2022-12-28	WOS:000231989500050
J	Skinner, MA; Moley, JA; Dilley, WG; Owzar, K; DeBenedetti, MK; Wells, SA				Skinner, MA; Moley, JA; Dilley, WG; Owzar, K; DeBenedetti, MK; Wells, SA			Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-CELL HYPERPLASIA; RET PROTOONCOGENE; MEDULLARY CARCINOMA; MEN 2A; MUTATIONS; CALCITONIN; FMTC; DISEASE; GLAND	BACKGROUND: Medullary thyroid carcinoma is the most common cause of death in patients with multiple endocrine neoplasia (MEN) type 2A (MEN-2A) or type 2B or familial medullary thyroid carcinoma. We sought to determine whether total thyroidectomy in asymptomatic young members of kindreds with MEN-2A who had a mutated allele of the RET proto-oncogene could prevent or cure medullary thyroid carcinoma. METHODS: A total of 50 patients 19 years of age or younger who were consecutively identified through a genetic screening program as carriers of a RET mutation characteristic of MEN-2A underwent total thyroidectomy. Five to 10 years after the surgery, each patient was evaluated by physical examination and by determination of plasma calcitonin levels after stimulation with provocative agents. RESULTS: In 44 of the 50 patients, basal and stimulated plasma calcitonin levels were at or below the limits of detection of the assay (proportion, 0.88; 95 percent confidence interval, 0.76 to 0.95). Two patients had basal and stimulated plasma calcitonin levels above the normal range. Stimulated plasma calcitonin levels had increased but remained within the normal range in four patients. The data suggest that there was a lower incidence of persistent or recurrent disease in children who underwent total thyroidectomy before eight years of age and in children in whom there were no metastases to cervical lymph nodes. CONCLUSIONS: In this study, young patients identified by direct DNA analysis as carriers of a RET mutation characteristic of MEN-2A had no evidence of persistent or recurrent medullary thyroid carcinoma five or more years after total thyroidectomy. A longer period of evaluation will be necessary to confirm that they are cured.	Duke Univ, Med Ctr, Sch Med, Dept Surg, Durham, NC 27710 USA; Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC 27710 USA; Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Duke University; Duke University; Washington University (WUSTL)	Wells, SA (corresponding author), Duke Univ, Med Ctr, Sch Med, Dept Surg, Box 3285, Durham, NC 27710 USA.	wells029@mc.duke.edu			NCI NIH HHS [P01CA53524] Funding Source: Medline; NCRR NIH HHS [M01RR00036] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA053524] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000036] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BOLINO A, 1995, ONCOGENE, V10, P2415; CARLSON KM, 1994, P NATL ACAD SCI USA, V91, P1579, DOI 10.1073/pnas.91.4.1579; CHI DD, 1994, SURGERY, V116, P124; CHONG GC, 1975, CANCER, V35, P695, DOI 10.1002/1097-0142(197503)35:3<695::AID-CNCR2820350323>3.0.CO;2-W; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; COX DR, 1989, ANAL BINARY DATA, P48; DISANTAGNESE PA, 1992, HUM PATHOL, V23, P287; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; FARNDON JR, 1986, BRIT J SURG, V73, P278, DOI 10.1002/bjs.1800730411; GRAHAM SM, 1987, J PEDIATR SURG, V22, P501, DOI 10.1016/S0022-3468(87)80205-1; HAJEK J, 1999, THEORY RANK TESTS, P96; *HUM GEN MUT DAT C, RET PROT; Machens A, 2003, NEW ENGL J MED, V349, P1517, DOI 10.1056/NEJMoa012915; MCCULLAGH P, 1989, GEN LINEAR MODELS, P248; MENDELSOHN G, 1978, AM J PATHOL, V92, P35; MILHAUD G, 1974, LANCET, V1, P462; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; MULLIGAN LM, 1994, NAT GENET, V6, P70, DOI 10.1038/ng0194-70; Pomares FJ, 2002, J AM COLL SURGEONS, V195, P630, DOI 10.1016/S1072-7515(02)01499-0; ROOS BA, 1998, J CLIN ENDOCR METAB, V83, P3296; STEINER AL, 1968, MEDICINE, V47, P371, DOI 10.1097/00005792-196809000-00001; WELLS SA, 1978, ANN SURG, V188, P139, DOI 10.1097/00000658-197808000-00002; WELLS SA, 1994, ANN SURG, V220, P237, DOI 10.1097/00000658-199409000-00002; WOLFE HJ, 1973, NEW ENGL J MED, V289, P437, DOI 10.1056/NEJM197308302890901	24	234	247	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1105	1113		10.1056/NEJMoa043999	http://dx.doi.org/10.1056/NEJMoa043999			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963YG	16162881	Bronze			2022-12-28	WOS:000231841900005
J	Allen, I				Allen, I			Women doctors and their careers: what now?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Westminster, Policy Studies Inst, London NW1 3SR, England	University of Westminster	Allen, I (corresponding author), Univ Westminster, Policy Studies Inst, London NW1 3SR, England.							AKBAR A, 2004, INDEPENDENT     0803; Allen, 1988, DOCTORS THEIR CAREER; ALLEN I, 1999, STRESS CONSULTANTS N; Allen I., 1994, DOCTORS THEIR CAREER; *BMA HLTH POL EC R, 2004, WOM AC MED CHALL ISS; *CHIEF MED OFF, 2004, STAT PUBL HLTH 2003, P36; *DEP HLTH, 1994, STAT B DOH; *DEP HLTH, 2004, STAT B DOH; Firth-Cozens J., 1999, STRESS HLTH PROFESSI; Goldacre MJ, 2004, BRIT MED J, V329, P597, DOI 10.1136/bmj.38202.364271.BE; *HIGH ED FUND COUN, 2004, MED RET M3 INT PRECL; LAURANCE J, 2004, INDEPENDENT     0802; Reichenbach L, 2004, BMJ-BRIT MED J, V329, P792, DOI 10.1136/bmj.329.7469.792; *UK HLTH DEP, 2004, MOD MED CAR NEXT STE	14	87	89	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 10	2005	331	7516					569	572		10.1136/bmj.331.7516.569	http://dx.doi.org/10.1136/bmj.331.7516.569			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965GX	16150771	Green Published, Green Accepted			2022-12-28	WOS:000231939700023
J	Keown, D				Keown, D			End of life: the Buddhist view	LANCET			English	Editorial Material									Univ London Goldsmiths Coll, London SE14 6NW, England	University of London; Goldsmiths University London	Keown, D (corresponding author), Univ London Goldsmiths Coll, London SE14 6NW, England.	d.keown@gold.ac.uk						FLORIDA RE, 1993, STUD RELIG-SCI RELIG, V22, P35, DOI 10.1177/000842989302200103; HARVEY P, 2001, BUDDHIST STUD REV, P183; HARVEY P, 2000, INTRO BUDDHIST ETHIC, P292; Hoffenberg R, 2001, BMJ-BRIT MED J, V323, P1478, DOI 10.1136/bmj.323.7327.1478; Keown D, 1998, J Law Relig, V13, P385, DOI 10.2307/1051472; KEOWN D, 2001, BUDDHISM BIOETHICS, P144; Keown Damien, 1999, BUDDHISM ABORTION, P199; LaFleur W. A., 2001, ETHICS WORLD RELIG, P271; OLDENBERG H, 1992, VINAYA PITAKAM; Potts Michael, 2000, BRAIN DEATH CASE BRA; RATANAKUL P, 2000, CONT BUDDHIST ETHICS, P169; TAKAKUSU J, 1975, SAMANTAPASADIKA; Youngner S., 1999, DEFINITION DEATH CON; Youngner SJ, 2001, J MED PHILOS, V26, P527, DOI 10.1076/jmep.26.5.527.3002	14	42	43	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					952	955		10.1016/S0140-6736(05)67323-0	http://dx.doi.org/10.1016/S0140-6736(05)67323-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	962YR	16154024				2022-12-28	WOS:000231770000035
J	Staessen, JA; Birkenhager, WH				Staessen, JA; Birkenhager, WH			Evidence that new anti hypertensives are superior to older drugs	LANCET			English	Editorial Material							BLOOD-PRESSURE REDUCTION; CARDIOVASCULAR PREVENTION; OUTCOMES; AMLODIPINE; CORONARY; EVENTS		Univ Louvain, Study Coordinating Ctr, Hypertens Unit, B-3000 Louvain, Belgium		Staessen, JA (corresponding author), Univ Louvain, Study Coordinating Ctr, Hypertens Unit, Campus Gasthuisberg, B-3000 Louvain, Belgium.	jan.staessen@med.kuleuven.be	Staessen, Jan A/A-1065-2011	Staessen, Jan A/0000-0002-3026-1637				Alderman MH, 2003, HYPERTENSION, V42, P239, DOI 10.1161/01.HYP.0000086521.95630.5A; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Sever PS, 2001, J HYPERTENS, V19, P1139, DOI 10.1097/00004872-200106000-00020; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Staessen JA, 2004, LANCET, V364, P931, DOI 10.1016/S0140-6736(04)17010-4; Staessen JA, 2004, J HYPERTENS, V22, P847, DOI 10.1097/00004872-200404000-00029; Staessen JA, 2005, HYPERTENS RES, V28, P385, DOI 10.1291/hypres.28.385; Staessen JA, 2003, J HYPERTENS, V21, P1055, DOI 10.1097/00004872-200306000-00002; Turnbull F, 2003, LANCET, V362, P1527; Verdecchia P, 2005, HYPERTENSION, V46, P386, DOI 10.1161/01.HYP.0000174591.42889.a2; Verdecchia P, 2004, HYPERTENSION, V43, P963, DOI 10.1161/01.HYP.0000125726.92964.ab	18	46	49	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					869	871		10.1016/S0140-6736(05)67147-4	http://dx.doi.org/10.1016/S0140-6736(05)67147-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16153995				2022-12-28	WOS:000231770000003
J	Rome, LC; Flynn, L; Goldman, EM; Yoo, TD				Rome, LC; Flynn, L; Goldman, EM; Yoo, TD			Generating electricity while walking with loads	SCIENCE			English	Article							MECHANICAL WORK; METABOLIC COST; ENERGY; MOTION; STEP; MASS	We have developed the suspended-load backpack, which converts mechanical energy from the vertical movement of carried loads (weighing 20 to 38 kilograms) to electricity during normal walking [generating up to 7.4 watts, or a 300-fold increase over previous shoe devices (20 milliwatts)]. Unexpectedly, little extra metabolic energy (as compared to that expended carrying a rigid backpack) is required during electricity generation. This is probably due to a compensatory change in gait or loading regime, which reduces the metabolic power required for walking. This electricity generation can help give field scientists, explorers, and disaster-relief workers freedom from the heavy weight of replacement batteries and thereby extend their ability to operate in remote areas.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	University of Pennsylvania; Marine Biological Laboratory - Woods Hole	Rome, LC (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	lrome@sas.upenn.edu		Flynn, Louis/0000-0003-2966-0355	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR038404, R01AR046125, R01AR038404] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR38404, AR46125] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALEXANDER RM, 1991, J EXP BIOL, V160, P55; [Anonymous], 2004, LOW POWER ELECT DESI; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; Cavagna GA, 2002, J EXP BIOL, V205, P3413; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; CAVAGNA GA, 1977, J PHYSIOL-LONDON, V268, P647, DOI DOI 10.1113/JPHYSI0L.1977.SP011866; Donelan JM, 2002, J EXP BIOL, V205, P3717; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; DRAKE J, 2001, WIRED, V9, P90; Ferguson RA, 2001, J PHYSIOL-LONDON, V536, P261, DOI 10.1111/j.1469-7793.2001.00261.x; Gard SA, 2004, HUM MOVEMENT SCI, V22, P597, DOI 10.1016/j.humov.2003.11.002; GonzuYlez JL., 2002, INT J SOC MAT ENG RE, V10, P34, DOI DOI 10.5188/IJSMER.10.34; Gottschall JS, 2003, J APPL PHYSIOL, V94, P1766, DOI 10.1152/japplphysiol.00670.2002; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; KRAM R, 1991, J APPL PHYSIOL, V71, P1119, DOI 10.1152/jappl.1991.71.3.1119; Kymissis J, 1998, SECOND INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS - DIGEST OF PAPERS, P132, DOI 10.1109/ISWC.1998.729539; Margaria R., 1976, BIOMECHANICS ENERGET; Minetti AE, 2004, J EXP BIOL, V207, P1265, DOI 10.1242/jeb.00886; Schmidt-Nielsen K., 1988, ANIMAL PHYSL ADAPTAT; STANFORD S, 2003, P 13 INT S UNM UNT S	21	446	467	13	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1725	1728		10.1126/science.1111063	http://dx.doi.org/10.1126/science.1111063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151012				2022-12-28	WOS:000231836700045
J	Zhang, YB; Yuan, FH; Presnell, SR; Tian, KL; Gao, Y; Tomkinson, AE; Gu, LY; Li, GM				Zhang, YB; Yuan, FH; Presnell, SR; Tian, KL; Gao, Y; Tomkinson, AE; Gu, LY; Li, GM			Reconstitution of 5 '-directed human mismatch repair in a purified system	CELL			English	Article						n	NUCLEOTIDE EXCISION-REPAIR; HUMAN EXONUCLEASE-I; REPLICATION PROTEIN-A; HOMEOLOGOUS RECOMBINATION; FUNCTIONAL INTERACTIONS; MUTL-ALPHA; DNA; INSTABILITY; DEFICIENCY; COMPONENTS	This paper reports reconstitution of 5'-nick-directed mismatch repair using purified human proteins. The reconstituted system includes MutS alpha or MutS beta, MutL alpha, RPA, EXO1, HMGB1, PCNA, RFC, polymerase delta, and ligase I. In this system, MutS beta plays a limited role in repair of base-base mismatches, but it processes insertion/deletion mispairs much more efficiently than MutSa, which efficiently corrects both types of heteroduplexes. MutL alpha reduces the processivity of EXO1 and terminates EXO1-catalyzed excision upon mismatch removal. In the absence of MutL alpha, mismatch-provoked excision by EXO1 occurs extensively. RPA and HMGB1 play similar but complementary roles in stimulating MutS alpha-activated, EXO1-catalyzed excision in the presence of a mismatch, but RPA has a distinct role in facilitating MutL alpha-mediated excision termination past mismatch. Evidence is provided that efficient repair of a single mismatch requires multiple molecules of MutS alpha-MutL alpha complex. These data suggest a model for human mismatch repair involving coordinated initiation and termination of mismatch-provoked excision.	Univ Kentucky, Med Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; Univ Kentucky, Dept Pathol, Med Ctr, Lexington, KY 40536 USA; Univ Kentucky, Dept Mol & Cellular Biochem, Med Ctr, Lexington, KY 40536 USA; Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Greenbaum Canc Ctr, Baltimore, MD 21201 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Li, GM (corresponding author), Univ Kentucky, Med Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA.	gmli@uky.edu	Yuan, Fenghua/F-8736-2011; Zhang, Yanbin/F-2998-2011; Li, Guo-Min/I-5016-2014	Zhang, Yanbin/0000-0002-7263-5510; Li, Guo-Min/0000-0002-9842-4578	NATIONAL CANCER INSTITUTE [R01CA104333, R01CA085377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER; NCI NIH HHS [CA85377, CA104333] Funding Source: Medline; NIEHS NIH HHS [ES013198] Funding Source: Medline; NIGMS NIH HHS [GM57479] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; Drummond JT, 1996, J BIOL CHEM, V271, P19645, DOI 10.1074/jbc.271.33.19645; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; ISACKSON PJ, 1979, J BIOL CHEM, V254, P5569; JAVAHERIAN K, 1979, NUCLEIC ACIDS RES, V6, P3569, DOI 10.1093/nar/6.11.3569; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Li GM, 1999, ONCOL RES, V11, P393; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Nicholson A, 2000, GENETICS, V154, P133; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Podust VN, 1998, J BIOL CHEM, V273, P12935, DOI 10.1074/jbc.273.21.12935; Ramilo C, 2002, MOL CELL BIOL, V22, P2037, DOI 10.1128/MCB.22.7.2037-2046.2002; Schmutte C, 1998, CANCER RES, V58, P4537; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran PT, 2001, P NATL ACAD SCI USA, V98, P9760, DOI 10.1073/pnas.161175998; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; Yuan FH, 2004, J BIOL CHEM, V279, P20935, DOI 10.1074/jbc.M401931200	45	281	290	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					693	705		10.1016/j.cell.2005.06.027	http://dx.doi.org/10.1016/j.cell.2005.06.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143102	Bronze			2022-12-28	WOS:000231844300010
J	Johnson, RT; Gonzalez, RG; Frosch, MP; Nguyen, T; Harris, NL; Ronan, LJ; Venna, N; Axelrod, L				Johnson, RT; Gonzalez, RG; Frosch, MP; Nguyen, T; Harris, NL; Ronan, LJ; Venna, N; Axelrod, L			An 80-year-old man with fatigue, unsteady gait, and confusion - Prion disease (sporadic Creutzfeldt-Jakob disease with MM1) PrPSc	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FATAL FAMILIAL INSOMNIA; DIFFUSION-WEIGHTED MRI; BLOOD-TRANSFUSION; VARIANT; PROTEIN; NEUROPATHOLOGY; CLASSIFICATION; PATIENT; SAMPLES		Johns Hopkins Univ, Sch Med, Dept Neurol Microbiol & Neurosci, Baltimore, MD 21218 USA; Bloomberg Sch Publ Hlth, Baltimore, MD USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Johnson, RT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol Microbiol & Neurosci, Baltimore, MD 21218 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861				BERNOULLI CC, 1979, SLOW TRANSMISSIBLE D, V1, P229; BROWN P, 1990, NEUROLOGY, V40, P887, DOI 10.1212/WNL.40.6.887; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Demaerel P, 1999, NEUROLOGY, V52, P205, DOI 10.1212/WNL.52.1.205; ERDTMANN R, 2004, ADV PRION SCI GUIDAN; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Ironside JW, 2004, CURR TOP MICROBIOL, V284, P133; Ironside JW, 2000, HISTOPATHOLOGY, V37, P1, DOI 10.1046/j.1365-2559.2000.00946.x; Johnson RT, 1998, NEW ENGL J MED, V339, P1994, DOI 10.1056/NEJM199812313392707; Kawasaki K, 1997, ACTA NEUROPATHOL, V93, P317, DOI 10.1007/s004010050621; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; LUGARESI E, 1986, NEW ENGL J MED, V315, P997, DOI 10.1056/NEJM198610163151605; *MASS GEN HOSP, 1961, NEW ENGL J MED, V264, P1359; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Mittal S, 2002, ARCH NEUROL-CHICAGO, V59, P128, DOI 10.1001/archneur.59.1.128; Montagna P, 2003, LANCET NEUROL, V2, P167, DOI 10.1016/S1474-4422(03)00323-5; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Scaravilli F, 2000, ANN NEUROL, V48, P665; Ukisu R, 2005, AM J ROENTGENOL, V184, P560, DOI 10.2214/ajr.184.2.01840560; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Will RG, 2004, CURR TOP MICROBIOL, V284, P121; Zeidler M, 2004, NEUROLOGY, V63, P410, DOI 10.1212/01.WNL.0000137379.68184.64	26	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					1042	1050		10.1056/NEJMcpc059024	http://dx.doi.org/10.1056/NEJMcpc059024			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148290				2022-12-28	WOS:000231698200011
J	Reichhardt, T				Reichhardt, T			Counting the dead	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2005	437	7056					176	176						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16158499				2022-12-28	WOS:000231696900017
J	Schwartzman, K; Oxlade, O; Barr, RG; Grimard, F; Acosta, I; Baez, J; Ferreira, E; Melgen, RE; Morose, W; Salgado, AC; Jacquet, V; Maloney, S; Laserson, K; Mendez, AP; Menzies, D				Schwartzman, K; Oxlade, O; Barr, RG; Grimard, F; Acosta, I; Baez, J; Ferreira, E; Melgen, RE; Morose, W; Salgado, AC; Jacquet, V; Maloney, S; Laserson, K; Mendez, AP; Menzies, D			Domestic returns from investment in the control of tuberculosis in other countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SOUTHEAST-ASIAN REFUGEES; UNITED-STATES; COST-EFFECTIVENESS; DRUG-RESISTANCE; IMMIGRANTS; HEALTH; ADULTS; SURVEILLANCE; PREVALENCE	BACKGROUND: We hypothesized that investments to improve the control of tuberculosis in selected high-incidence countries would prove to be cost saving for the United States by reducing the incidence of the disease among migrants. METHODS: Using decision analysis, we estimated tuberculosis-related morbidity, mortality, and costs among legal immigrants and refugees, undocumented migrants, and temporary visitors from Mexico after their entry into the United States. We assessed the current strategy of radiographic screening of legal immigrants plus current tuberculosis-control programs alone and with the addition of either U.S>funded expansion of the strategy of directly observed treatment, short course (DOTS), in Mexico or tuberculin skin testing to screen legal immigrants from Mexico. We also examined tuberculosis-related outcomes among migrants from Haiti and the Dominican Republic using the same three strategies. RESULTS: As compared with the current strategy, expanding the DOTS program in Mexico at a cost to the United States of $34.9 million would result in 2591 fewer cases of tuberculosis in the United States, with 349 fewer deaths from the disease and net discounted savings of $108 million over a 20-year period. Adding tuberculin skin testing to radiographic screening of legal immigrants from Mexico would result in 401 fewer cases of tuberculosis in the United States but would cost an additional $329 million. Expansion of the DOTS program would remain cost saving even if the initial investment were doubled, if the United States paid for all antituberculosis drugs in Mexico, or if the decline in the incidence of tuberculosis in Mexico was less than projected. A $9.4 million investment to expand the DOTS program in Haiti and the Dominican Republic would result in net U.S. savings of $20 million over a 20-year period. CONCLUSIONS: U.S-funded efforts to expand the DOTS program in Mexico, Haiti, and the Dominican Republic could reduce tuberculosis-related morbidity and mortality among migrants to the United States, producing net cost savings for the United States.	McGill Univ, Montreal Chest Inst, Resp Epidemiol Unit, Montreal, PQ H2X 2P4, Canada; McGill Univ, Dept Econ, Montreal, PQ H2X 2P4, Canada; Columbia Univ, Med Ctr, Dept Med, New York, NY USA; Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY USA; Natl TB Control Program, Santo Domingo, Dominican Rep; Ctr Nacl Invest Salud Materno Infantil, Santo Domingo, Dominican Rep; Natl TB Act Program, Mexico City, DF, Mexico; Natl TB Control Program, Port Au Prince, Haiti; Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; World Hlth Org, Geneva, Switzerland	McGill University; McGill University; Columbia University; Columbia University; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	Menzies, D (corresponding author), McGill Univ, Montreal Chest Inst, Resp Epidemiol Unit, 3650 St Urbain,Rm K1-24, Montreal, PQ H2X 2P4, Canada.	dick.menzies@mcgill.ca		Elias Melgen, Ricardo/0000-0001-7901-0532				[Anonymous], 1999, EPIDEMIOLOGIC BASIS; Binkin NJ, 1996, CLIN INFECT DIS, V23, P1226, DOI 10.1093/clinids/23.6.1226; BLUM RN, 1993, CHEST, V103, P1670, DOI 10.1378/chest.103.6.1670; Borjas G.J., 1999, HDB LABOR EC, P1697, DOI [10.1016/S1573-4463(99)03009-6, DOI 10.1016/S1573-4463(99)03009-6]; *BRIT COL CTR DIS, 2003, ANN REP TUB CONTR 20; BROWN RE, 1995, ARCH INTERN MED, V155, P1595, DOI 10.1001/archinte.155.15.1595; Catlos EK, 1998, AM J RESP CRIT CARE, V158, P1037, DOI 10.1164/ajrccm.158.4.9801024; *CDCP, 2001, REP TUB US 2001 TUB; *CDCP, 2000, REP TUB US 2000; *CDCP, 2003, REP TUB US 2002; Chen XY, 2004, LANCET, V364, P417; Coker RJ, 2004, INT J TUBERC LUNG D, V8, P1022; COMSTOCK GW, 1974, AM REV RESPIR DIS, V110, P572; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dasgupta K, 2000, AM J RESP CRIT CARE, V162, P2079, DOI 10.1164/ajrccm.162.6.2001111; *DEP LAB, CONS PRIC IND; Dye C, 2000, INT J EPIDEMIOL, V29, P558, DOI 10.1093/ije/29.3.558; ELLIS E, 2004, TUBERCULOSIS STAT 20; Elzinga G, 2004, LANCET, V363, P814, DOI 10.1016/S0140-6736(04)15698-5; Espinal MA, 1998, INT J TUBERC LUNG D, V2, P490; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Floyd K, 2002, SCIENCE, V295, P2040, DOI 10.1126/science.1069771; GEITER L, 2000, ENDING NEGLECT ELIMI; Granich RM, 2000, ARCH INTERN MED, V160, P639, DOI 10.1001/archinte.160.5.639; GREEN DA, 2003, IMMIGRANT EARNINGS P; GROTH-PETERSEN E., 1959, BULL WORLD HEALTH ORGAN, V21, P5; GRZYBOWSKI S, 1978, Bulletin of the International Union Against Tuberculosis, V53, P70; *ITA OFF TRAV TOUR, INF INB TRAV US; Jereb J, 2003, INT J TUBERC LUNG D, V7, pS384; *JOINT UN PROGR HI, UNAIDS HOM PAG; Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099; Khatri GR, 2002, NEW ENGL J MED, V347, P1420, DOI 10.1056/NEJMsa020098; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; LEE JW, 2002, REPORT SITE VISIT EV; LUBOTSKY D, 2001, EFFECT CHANGES US WA; MCCARTHY OR, 1984, BRIT J DIS CHEST, V78, P248, DOI 10.1016/S0007-0971(84)80118-7; MORANMENDOZA AO, 2004, VALUE TUBERCULIN SKI; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; NOLAN CM, 1986, AM REV RESPIR DIS, V133, P431; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; NOLAN CM, 1988, AM REV RESPIR DIS, V137, P805, DOI 10.1164/ajrccm/137.4.805; *OFF IMM STAT, 2003, 2002 YB IMM STAT OCT; PITCHENIK AE, 1982, NEW ENGL J MED, V307, P162, DOI 10.1056/NEJM198207153070306; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Sonnenberg P, 2002, LANCET, V359, P2120; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Styblo K., 1985, B INT UNION TUBERC, V60, P117; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Sutherland I., 1966, TUBERCLE, V47, P308; Torrance GW, 1987, METHODS EC EVALUATIO; Vaca J, 2005, INT J TUBERC LUNG D, V9, P521; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; *WHO, 2001, GLOB TUB CONTR SURV; *WHO, GLOB DRUG FAC 1 LIN; WHO, 1997, TREATM TUB GUID NAT, V2; *WHO, 1955, B WORLD HEALTH ORGAN, V22, P63; Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75; World Health Organization, 2003, GLOB TUB CONTR SURV; YUAN L, 1995, CAN MED ASSOC J, V153, P925; Zuber PLF, 1996, AM J RESP CRIT CARE, V154, P151, DOI 10.1164/ajrccm.154.1.8680671	63	123	125	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					1008	1020		10.1056/NEJMsa043194	http://dx.doi.org/10.1056/NEJMsa043194			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148286				2022-12-28	WOS:000231698200006
J	Arnedt, JT; Owens, J; Crouch, M; Stahl, J; Carskadon, MA				Arnedt, JT; Owens, J; Crouch, M; Stahl, J; Carskadon, MA			Neurobehavioral performance of residents after heavy night call vs after alcohol ingestion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SIMULATED DRIVING TASK; SLEEP-DEPRIVATION; NATIONAL-SURVEY; WORK HOURS; PROLONGED WAKEFULNESS; COGNITIVE PERFORMANCE; MARITIME CADETS; DOSE-RESPONSE; FATIGUE; INTERNS	Context Concern exists about the effect of extended resident work hours; however, no study has evaluated training-related performance impairments against an accepted standard of functional impairment. Objectives To compare post-call performance during a heavy call rotation (every fourth or fifth night) to performance with a blood alcohol concentration of 0.04 to 0.05 g% (per 100 mL of blood) during a light call rotation, and to evaluate the association between self-assessed and actual performance. Design, Setting, and Participants A prospective 2-session within-subject study of 34 pediatric residents (18 women and 16 men; mean age, 28.7 years) in an academic medical center conducted between October 2001 and August 2003, who were tested under 4 conditions: light call, light call with alcohol, heavy call, and heavy call with placebo. Interventions Residents attended a test session during the final week of alight call rotation (non-post-call) and during the final week of a heavy call rotation (post-call). At each session, they underwent a 60-minute test battery (light and heavy call conditions), ingested either alcohol (light call with alcohol condition) or placebo (heavy call with placebo condition), and repeated the test battery. Performance self-evaluations followed each test. Main Outcome Measures Sustained attention, vigilance, and simulated driving performance measures; and self-report sleepiness, performance, and effort measures. Results Participants achieved the target blood alcohol concentration. Compared with light call, heavy call reaction times were 7% slower (242.5 vs 225.9 milliseconds, P<001); commission errors were 40% higher (38.2 % vs 27.2 %, P<.001); and lane variability (7.0 vs 5.5 ft, P<.001) and speed variability (4.1 vs 2.4 mph, P<.001) on the driving simulator were 27% and 71 % greater, respectively. Speed variability was 29% greater in heavy call with placebo than light call with alcohol (4.2 vs 3.2 mph, P=.01), and reaction time, lapses, omission errors, and off-roads were not different. Correlation between self-assessed and actual performance under heavy call was significant for commission errors (r=-0.45, P=.01), lane variability (r=-0.76, P<.001), and speed variability (r=-0.71, P<001), but not for reaction time. Conclusions Post-call performance impairment during a heavy call rotation is comparable with impairment associated with a 0.04 to 0.05 g% blood alcohol concentration during a light call rotation, as measured by sustained attention, vigilance, and simulated driving tasks. Residents' ability to judge this impairment may be limited and task-specific.	Brown Med Sch, Dept Psychiat & Human Behav, Providence, RI USA; Rhode Isl Hosp, Div Ambulatory Pediat, Providence, RI USA; EP Bradley Hosp, Sleep & Chronobiol Res Lab, Providence, RI USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Arnedt, JT (corresponding author), Univ Michigan, Dept Psychiat, Sleep & Chronophysiol Lab, 2101 Commonwealth Blvd,Suite D, Ann Arbor, MI 48105 USA.	tarnedt@med.umich.edu	Arnedt, J. Todd/AAA-8939-2021	Arnedt, J. Todd/0000-0002-5084-9331				Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; Arnedt JT, 2001, ACCIDENT ANAL PREV, V33, P337, DOI 10.1016/S0001-4575(00)00047-6; Arnedt JT, 2001, SLEEP, V24, pA413; Arnedt JT, 2000, J SLEEP RES, V9, P233; Baldwin DC, 2004, SLEEP, V27, P217, DOI 10.1093/sleep/27.2.217; Baldwin DC, 2003, ACAD MED, V78, P1154, DOI 10.1097/00001888-200311000-00018; Baldwin PJ, 1997, SOC SCI MED, V45, P35, DOI 10.1016/S0277-9536(96)00306-1; BALLIN JC, 1986, JAMA-J AM MED ASSOC, V255, P522; Baranski JV, 1997, J SLEEP RES, V6, P84, DOI 10.1111/j.1365-2869.1997.00032.x; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Bartel P, 2004, OCCUP ENVIRON MED, V61, P167, DOI 10.1136/oem.2002.006197; BARTLE EJ, 1988, SURGERY, V104, P311; Cahalan D., 1969, AM DRINKING PRACTICE; Casbon TS, 2003, J ABNORM PSYCHOL, V112, P476, DOI 10.1037/0021-843X.112.3.476; Cavallo A, 2003, ERGONOMICS, V46, P653, DOI 10.1080/0014013031000085671; Daugherty SR, 1998, JAMA-J AM MED ASSOC, V279, P1194, DOI 10.1001/jama.279.15.1194; Daugherty SR, 1996, ACAD MED, V71, pS93, DOI 10.1097/00001888-199601000-00054; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; DEACONSON TF, 1988, JAMA-J AM MED ASSOC, V260, P1721, DOI 10.1001/jama.260.12.1721; Denisco R A, 1987, J Clin Monit, V3, P22, DOI 10.1007/BF00770879; Dinges DF, 1997, SLEEP, V20, P267; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Dorrian J, 2000, J SLEEP RES, V9, P137, DOI 10.1046/j.1365-2869.2000.00195.x; Fairclough SH, 1999, HUM FACTORS, V41, P118, DOI 10.1518/001872099779577336; Friel PN, 1999, J STUD ALCOHOL, V60, P555, DOI 10.15288/jsa.1999.60.555; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; HAYNES DF, 1995, SOUTHERN MED J, V88, P283, DOI 10.1097/00007611-199503000-00007; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Howland J, 2001, ACCIDENT ANAL PREV, V33, P257, DOI 10.1016/S0001-4575(00)00040-3; Howland J, 2000, ADDICTION, V95, P719, DOI 10.1046/j.1360-0443.2000.9557197.x; JACQUES CHM, 1990, J FAM PRACTICE, V30, P223; Kribbs N.B., 1994, SLEEP ONSET NORMAL A, P113, DOI [10.1037/10166-007, DOI 10.1037/10166-007]; Lamond N, 2004, ERGONOMICS, V47, P154, DOI 10.1080/00140130310001617930; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lee HC, 2003, ACCIDENT ANAL PREV, V35, P797, DOI 10.1016/S0001-4575(02)00083-0; Liguori A, 1999, ALCOHOL CLIN EXP RES, V23, P815, DOI 10.1111/j.1530-0277.1999.tb04188.x; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Marcus CL, 1996, SLEEP, V19, P763, DOI 10.1093/sleep/19.10.763; McCartt AT, 1996, ACCIDENT ANAL PREV, V28, P511, DOI 10.1016/0001-4575(96)00021-8; *MULT HLTH SYST IN, 1995, CONN CONT PERF TEST; Nelson C S, 1995, J Am Osteopath Assoc, V95, P600; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; Owens J A, 2001, Curr Opin Pulm Med, V7, P411, DOI 10.1097/00063198-200111000-00009; Papp KK, 2004, ACAD MED, V79, P394, DOI 10.1097/00001888-200405000-00007; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; REZNICK RK, 1987, AM J SURG, V154, P520, DOI 10.1016/0002-9610(87)90269-8; Risser MR, 2001, SLEEP, V24, pA125; ROBBINS J, 1990, WESTERN J MED, V152, P82; ROEHRS T, 1994, ALCOHOL CLIN EXP RES, V18, P154, DOI 10.1111/j.1530-0277.1994.tb00896.x; ROHSENOW DJ, 1981, ADDICT BEHAV, V6, P107, DOI 10.1016/0306-4603(81)90003-4; Rollinson DC, 2003, ANN EMERG MED, V41, P400, DOI 10.1067/mem.2003.77; Rosen IM, 2004, ACAD MED, V79, P407, DOI 10.1097/00001888-200405000-00009; RUBIN R, 1991, J OCCUP ENVIRON MED, V33, P13, DOI 10.1097/00043764-199101000-00007; SmithCoggins R, 1997, ACAD EMERG MED, V4, P951, DOI 10.1111/j.1553-2712.1997.tb03658.x; Steele MT, 1999, ACAD EMERG MED, V6, P1050, DOI 10.1111/j.1553-2712.1999.tb01191.x; STORER JS, 1989, ACAD MED, V64, P29, DOI 10.1097/00001888-198901000-00013; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Veasey S, 2002, JAMA-J AM MED ASSOC, V288, P1116, DOI 10.1001/jama.288.9.1116; Vermeeren A, 2002, SLEEP, V25, P224; Williamson AM, 2001, ACCIDENT ANAL PREV, V33, P313, DOI 10.1016/S0001-4575(00)00045-2; Williamson AM, 2000, OCCUP ENVIRON MED, V57, P649, DOI 10.1136/oem.57.10.649	64	275	282	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2005	294	9					1025	1033		10.1001/jama.294.9.1025	http://dx.doi.org/10.1001/jama.294.9.1025			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	960XU	16145022	Bronze			2022-12-28	WOS:000231627300002
J	Vaughn, MW; Martienssen, R				Vaughn, MW; Martienssen, R			It's a small RNA world, after all	SCIENCE			English	Article							IDENTIFICATION; MICRORNAS; TARGETS	Small RNAs (sRNAs) can regulate transcript and protein abundance. Previously, they have been identified using traditional cloning approaches, which has limited how many could be characterized. Now, the Meyers and Green laboratories have used massively parallel signature sequencing technology to find over 1.5 million sRNAs in Arabidopsis thaliana. These new sRNAs reveal a greater-than-expected potential role for sRNAs in gene regulation, preferential expression or usage of sRNAs in flowers, and the prospect of targeted sRNA-mediated regulation of pseudogenes. In addition, new plant microRNAs have been identified, some of which may be unique to Arabidopsis.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Vaughn, MW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Vaughn, Matthew/0000-0002-1384-4283				Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alonso CR, 2005, BIOESSAYS, V27, P463, DOI 10.1002/bies.20227; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Martienssen R, 2004, COLD SPRING HARB SYM, V69, P371, DOI 10.1101/sqb.2004.69.371; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Meins F, 2005, ANNU REV CELL DEV BI, V21, P297, DOI 10.1146/annurev.cellbio.21.122303.114706; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Stam M, 2002, GENETICS, V162, P917; Tang Guiliang, 2004, Methods Mol Biol, V257, P223, DOI 10.1385/1-59259-750-5:223; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Valencia-Sanchez MA, 2004, TRENDS CELL BIOL, V14, P594, DOI 10.1016/j.tcb.2004.09.010; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	21	22	39	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1525	1526		10.1126/science.1117805	http://dx.doi.org/10.1126/science.1117805			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141062				2022-12-28	WOS:000231715000037
J	Wheeler, C; Vogt, TM; Armstrong, GL; Vaughan, G; Weltman, A; Nainan, OV; Dato, V; Xia, GL; Waller, K; Amon, J; Lee, TM; Highbaugh-Battle, A; Hembree, C; Evenson, S; Ruta, MA; Williams, IT; Fiore, AE; Bell, BP				Wheeler, C; Vogt, TM; Armstrong, GL; Vaughan, G; Weltman, A; Nainan, OV; Dato, V; Xia, GL; Waller, K; Amon, J; Lee, TM; Highbaugh-Battle, A; Hembree, C; Evenson, S; Ruta, MA; Williams, IT; Fiore, AE; Bell, BP			An outbreak of hepatitis A associated with green onions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTISTATE OUTBREAK; UNITED-STATES; VIRUS; EPIDEMIOLOGY; INFECTION; SURVIVAL	Background: In November 2003, a large hepatitis A outbreak was identified among patrons of a single Pennsylvania restaurant. We investigated the cause of the outbreak and factors that contributed to its unprecedented size. Methods: Demographic and clinical outcome data were collected from patients with laboratory confirmation of hepatitis A, and restaurant workers were tested for hepatitis A. A case-control study was conducted among patrons who dined at the restaurant between October 3 and October 6, 2003. Sequence analysis was performed on a 315-nucleotide region of viral RNA extracted from serum specimens. Results: Of 601 patients identified, 3 died; at least 124 were hospitalized. Of 425 patients who recalled a single dining date at the restaurant, 356 (84 percent) had dined there between October 3 and October 6. Among 240 patients in the case-control study, 218 had eaten mild salsa (91 percent), as compared with 45 of 130 controls (35 percent) (odds ratio, 19.6; 95 percent confidence interval, 11.0 to 34.9) for whom data were available. A total of 98 percent of patients and 58 percent of controls reported having eaten a menu item containing green onions (odds ratio, 33.3; 95 percent confidence interval, 12.8 to 86.2). All restaurant workers were tested, but none were identified who could have been the source of the outbreak. Sequences of hepatitis A virus from all 170 patients who were tested were identical. Mild salsa, which contained green onions grown in Mexico, was prepared in large batches at the restaurant and provided to all patrons. Conclusions: Green onions that were apparently contaminated before arrival at the restaurant caused this unusually large foodborne outbreak of hepatitis A. The inclusion of contaminated green onions in large batches that were served to all customers contributed to the size of the outbreak.	Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Student Epidemiol Elect Program, Off Workforce & Career Dev, Atlanta, GA 30333 USA; Penn Dept Hlth, Harrisburg, PA 17108 USA; Ohio Dept Hlth, Columbus, OH 43266 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Fiore, AE (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Mailstop G37,1600 Clifton Rd, Atlanta, GA 30333 USA.	afiore@cdc.gov	Fiore, Anthony/AAO-8956-2020	Amon, Joseph/0000-0002-2455-6703				AMON J, 2004, 4 INT C EM INF DIS A; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; ARMSTRONG GA, 2003, 41 ANN M INF DIS SOC; Calvin L., EC FOOD SAFETY CASE; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1044; Croci L, 2002, INT J FOOD MICROBIOL, V73, P29, DOI 10.1016/S0168-1605(01)00689-4; Cummings K, 2001, EMERG INFECT DIS, V7, P1046, DOI 10.3201/eid0706.010625; DATTA SD, 2001, 39 ANN M INF DIS SOC; Dentinger CM, 2001, J INFECT DIS, V183, P1273, DOI 10.1086/319688; Fiore AE, 2004, CLIN INFECT DIS, V38, P705, DOI 10.1086/381671; *FOOD DRUG ADM, CONS ADV REC HEP OUT; *FOOD DRUG ADM, IMP AL 25 20 DET PHY; *FOOD DRUG ADM, GUID IND GUID MIN MI; HALLIDAY ML, 1991, J INFECT DIS, V164, P852, DOI 10.1093/infdis/164.5.852; Hutin YJF, 1999, NEW ENGL J MED, V340, P595, DOI 10.1056/NEJM199902253400802; Jean J, 2003, J FOOD PROTECT, V66, P115, DOI 10.4315/0362-028X-66.1.115; MCCAUSTLAND KA, 1982, J CLIN MICROBIOL, V16, P957, DOI 10.1128/JCM.16.5.957-958.1982; Nainan OV, 2005, J INFECT DIS, V191, P957, DOI 10.1086/427992; NIU MT, 1992, J INFECT DIS, V166, P518, DOI 10.1093/infdis/166.3.518; *PUBL HLTH SERV, 2001, FOOD COD; REID TMS, 1987, EPIDEMIOL INFECT, V98, P109, DOI 10.1017/S095026880006177X; ROSENBLUM LS, 1990, AM J PUBLIC HEALTH, V80, P1075, DOI 10.2105/AJPH.80.9.1075; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Sivapalasingam S, 2003, CLIN INFECT DIS, V37, P1585, DOI 10.1086/379710; Tanaka J, 2000, VACCINE, V18, pS57, DOI 10.1016/S0264-410X(99)00466-1; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425, DOI 10.3201/eid0304.970403; TICEHURST JR, 1987, J CLIN MICROBIOL, V25, P1822, DOI 10.1128/JCM.25.10.1822-1829.1987; Wasley A, 2005, JAMA-J AM MED ASSOC, V294, P194, DOI 10.1001/jama.294.2.194	28	248	260	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					890	897		10.1056/NEJMoa050855	http://dx.doi.org/10.1056/NEJMoa050855			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135833				2022-12-28	WOS:000231551100006
J	Schiermeier, Q				Schiermeier, Q			Bridging the gap in the German economy	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2005	436	7054					1087	1087		10.1038/4361087a	http://dx.doi.org/10.1038/4361087a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16127797	Bronze			2022-12-28	WOS:000231416600017
J	Keller, HU; Jorda, L; Kuppers, M; Gutierrez, PJ; Hviid, SF; Knollenberg, J; Lara, LM; Sierks, H; Barbieri, C; Lamy, P; Rickman, H; Rodrigo, R				Keller, HU; Jorda, L; Kuppers, M; Gutierrez, PJ; Hviid, SF; Knollenberg, J; Lara, LM; Sierks, H; Barbieri, C; Lamy, P; Rickman, H; Rodrigo, R			Deep impact observations by OSIRIS onboard the Rosetta spacecraft	SCIENCE			English	Article							FRAGMENTATION; NUCLEUS; RATES; DUST	The OSIRIS cameras (optical, spectroscopic, and infrared remote imaging system) onboard the European Space Agency's Rosetta spacecraft observed comet 9P/Tempel 1 for 17 days continuously around the time of NASA's Deep Impact mission. The cyanide-to-water production ratio was slightly enhanced in the impact cloud, compared with that of normal comet activity. Dust particles were flowing outward in the coma at >160 meters per second, accelerated by the gas. The slope of the brightness increase showed a dip about 200 seconds after the impact. Dust Af rho values before and long after the impact confirm the slight decrease of cometary activity. The dust-to-water mass ratio was much larger than 1.	Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Lab Astrophys Marseille, F-13376 Marseille, France; CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; Deutsch Zentrum Luft & Raumfahrt, Inst Planetenforsch, D-12489 Berlin, Germany; Univ Padua, Dipartimento Astron, I-35100 Padua, Italy; Univ Padua, Ctr Interdipartimentale Studi & Attivita Spaziali, I-35100 Padua, Italy; Uppsala Astron Observ, S-75120 Uppsala, Sweden	Max Planck Society; UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Helmholtz Association; German Aerospace Centre (DLR); University of Padua; University of Padua; Uppsala University	Keller, HU (corresponding author), Max Planck Inst Sonnensyst Forsch, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany.	keller@mps.mpg.de	Jorda, Laurent/AAA-1718-2021; Lara, Luisa M/F-5614-2012; Rickman, Hans/X-7631-2018; Gutiérrez, Pedro J/AAJ-6177-2020	Lara, Luisa M/0000-0002-7184-920X; Rickman, Hans/0000-0002-9603-6619; Gutiérrez, Pedro J/0000-0002-7332-6269				AHEARN MF, 1984, ASTRON J, V89, P579, DOI 10.1086/113552; Belton MJ, 2005, SPACE SCI REV, V117, P137, DOI 10.1007/s11214-005-3389-1; COMBI MR, 1994, ASTRON J, V108, P304, DOI 10.1086/117070; COMBI MR, 2004, COMETS, V2, P523; CROVISIER J, 1994, J GEOPHYS RES-PLANET, V99, P3777, DOI 10.1029/93JE02088; FAMHAM T, COMMUNICATION; FESTOU MC, 1984, ASTRON ASTROPHYS, V134, pL4; Haser L., 1957, B ACAD ROY SCI BELGI, V43, P740; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; HUEBNER WF, 1992, AP SS, V195, P7; KELLER HU, 1990, ASTRON ASTROPHYS, V227, pL1; KONNO I, 1993, ICARUS, V101, P84, DOI 10.1006/icar.1993.1008; KUPPERS M, IN PRESS NATURE; Lisse CM, 2005, SPACE SCI REV, V117, P161, DOI 10.1007/s11214-005-3384-6; Rauer H, 2003, ASTRON ASTROPHYS, V397, P1109, DOI 10.1051/0004-6361:20021550; Schultz PH, 2005, SPACE SCI REV, V117, P207, DOI 10.1007/s11214-005-3383-7; SWAMY KSK, 1997, WORLD SCI SERIES AST, V2	17	50	51	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					281	283		10.1126/science.1119020	http://dx.doi.org/10.1126/science.1119020			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16150976	Green Published			2022-12-28	WOS:000232670100042
J	Nash, JD; Moum, JN				Nash, JD; Moum, JN			River plumes as a source of large-amplitude internal waves in the coastal ocean	NATURE			English	Article							SOLITARY WAVES; GRAVITY CURRENT; TIDAL FLOW; GENERATION; SOLITONS; TURBULENCE; CURRENTS; TIDES	Satellite images have long revealed the surface expression of large amplitude internal waves that propagate along density interfaces beneath the sea surface(1-3). Internal waves are typically the most energetic high-frequency events in the coastal ocean(4-6), displacing water parcels by up to 100 m and generating strong currents and turbulence(7) that mix nutrients into near-surface waters for biological utilization. While internal waves are known to be generated by tidal currents over ocean-bottom topography(8-13), they have also been observed frequently in the absence of any apparent tide topography interactions(1,7,14). Here we present repeated measurements of velocity, density and acoustic backscatter across the Columbia River plume front. These show how internal waves can be generated from a river plume that flows as a gravity current into the coastal ocean. We find that the convergence of horizontal velocities at the plume front causes frontal growth and subsequent displacement downward of near-surface waters. Individual freely propagating waves are released from the river plume front when the front's propagation speed decreases below the wave speed in the water ahead of it. This mechanism generates internal waves of similar amplitude and steepness as internal waves from tide topography interactions observed elsewhere(11), and is therefore important to the understanding of coastal ocean mixing.	Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Nash, JD (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, 104 COAS Adm Bldg, Corvallis, OR 97331 USA.	nash@coas.oregonstate.edu	Moum, James N/N-1187-2019; Moum, James N/A-1880-2012; Nash, Jonathan/K-8101-2019	Nash, Jonathan/0000-0003-4005-9368				BRITTER RE, 1978, J FLUID MECH, V88, P223, DOI 10.1017/S0022112078002074; CHERESKIN TK, 1983, J GEOPHYS RES-OCEANS, V88, P2649, DOI 10.1029/JC088iC04p02649; CHRISTIE DR, 1981, NATURE, V293, P46, DOI 10.1038/293046a0; DOVIAK RJ, 1991, J ATMOS SCI, V48, P87, DOI 10.1175/1520-0469(1991)048<0087:ATGSWO>2.0.CO;2; Drazin P.G., 1982, HYDRODYNAMIC STABILI; Duda TF, 2004, IEEE J OCEANIC ENG, V29, P1105, DOI 10.1109/JOE.2004.836998; Farmer D, 1999, SCIENCE, V283, P188, DOI 10.1126/science.283.5399.188; FARMER DM, 1978, HYDRODYNAMICS ESTUAR, P465; FU LL, 1982, JPL PUBLICATION; HUTHNANCE JM, 1989, GEOPHYS ASTRO FLUID, V48, P81, DOI 10.1080/03091928908219527; Jackson C.R., ATLAS INTERNAL SOLIT; LAMB KG, 1994, J GEOPHYS RES-OCEANS, V99, P843, DOI 10.1029/93JC02514; LODER JW, 1992, J GEOPHYS RES-OCEANS, V97, P14331, DOI 10.1029/92JC01342; LUKETINA DA, 1987, J GEOPHYS RES-OCEANS, V92, P5435, DOI 10.1029/JC092iC05p05435; MAXWORTHY T, 1979, J GEOPHYS RES-OCEANS, V84, P338, DOI 10.1029/JC084iC01p00338; Maxworthy T, 2002, J FLUID MECH, V453, P371, DOI 10.1017/S0022112001007054; MOUM JN, 1995, J ATMOS OCEAN TECH, V12, P346, DOI 10.1175/1520-0426(1995)012<0346:COTKED>2.0.CO;2; Moum JN, 2003, J PHYS OCEANOGR, V33, P2093, DOI 10.1175/1520-0485(2003)033<2093:SAGOTA>2.0.CO;2; ODONNELL J, 1983, TELLUS A, V35, P73, DOI 10.1111/j.1600-0870.1983.tb00186.x; Orton PM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022372; OSBORNE AR, 1980, SCIENCE, V208, P451, DOI 10.1126/science.208.4443.451; OSTROVSKY LA, 1989, REV GEOPHYS, V27, P293, DOI 10.1029/RG027i003p00293; Rao MP, 2004, BOUND-LAY METEOROL, V111, P85, DOI 10.1023/B:BOUN.0000010998.10262.e2; Ray RD, 1996, GEOPHYS RES LETT, V23, P2101, DOI 10.1029/96GL02050; ROTTMAN JW, 1989, Q J ROY METEOR SOC, V115, P941, DOI 10.1256/smsqj.48808; Simpson J.E., 1987, GRAVITY CURRENTS ENV; SMITH RK, 1982, Q J ROY METEOR SOC, V108, P937, DOI 10.1002/qj.49710845813; Stanton TP, 1998, GEOPHYS RES LETT, V25, P2695, DOI 10.1029/98GL01772; Sutherland BR, 2002, PHYS FLUIDS, V14, P2244, DOI 10.1063/1.1483303	29	193	205	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					400	403		10.1038/nature03936	http://dx.doi.org/10.1038/nature03936			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163354				2022-12-28	WOS:000231849100051
J	Bucaneve, G; Micozzi, A; Menichetti, F; Martino, P; Dionisi, MS; Martinelli, G; Allione, B; D'Antonio, D; Buelli, M; Nosari, AM; Cilloni, D; Zuffa, E; Cantaffa, R; Specchia, G; Amadori, S; Fabbiano, F; Deliliers, GL; Lauria, F; Foa, R; Del Favero, A				Bucaneve, G; Micozzi, A; Menichetti, F; Martino, P; Dionisi, MS; Martinelli, G; Allione, B; D'Antonio, D; Buelli, M; Nosari, AM; Cilloni, D; Zuffa, E; Cantaffa, R; Specchia, G; Amadori, S; Fabbiano, F; Deliliers, GL; Lauria, F; Foa, R; Del Favero, A		GIMEMA Infection Program	Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANT ESCHERICHIA-COLI; PLACEBO-CONTROLLED TRIAL; HEMATOLOGIC MALIGNANCIES; DOUBLE-BLIND; ANTIMICROBIAL THERAPY; EMPIRIC THERAPY; PROPHYLAXIS; NORFLOXACIN; FEVER; GRANULOCYTOPENIA	BACKGROUND: The prophylactic use of fluoroquinolones in patients with cancer and neutropenia is controversial and is not a recommended intervention. METHODS: We randomly assigned 760 consecutive adult patients with cancer in whom chemotherapy-induced neutropenia (<1000 neutrophils per cubic millimeter) was expected to occur for more than seven days to receive either oral levofloxacin (500 mg daily) or placebo from the start of chemotherapy until the resolution of neutropenia. Patients were stratified according to their underlying disease (acute leukemia vs. solid tumor or lymphoma). RESULTS: An intention-to-treat analysis showed that fever was present for the duration of neutropenia in 65 percent of patients who received levofloxacin prophylaxis, as compared with 85 percent of those receiving placebo (243 of 375 vs. 308 of 363; relative risk, 0.76; absolute difference in risk, -20 percent; 95 percent confidence interval, -26 to -14 percent; P=0.001). The levofloxacin group had a lower rate of microbiologically documented infections (absolute difference in risk, -17 percent; 95 percent confidence interval, -24 to -10 percent; P<0.001), bacteremias (difference in risk, -16 percent; 95 percent confidence interval, -22 to -9 percent; P<0.001), and single-agent gram-negative bacteremias (difference in risk, -7 percent; 95 percent confidence interval, -10 to -2 percent; P<0.01) than did the placebo group. Mortality and tolerability were similar in the two groups. The effects of prophylaxis were also similar between patients with acute leukemia and those with solid tumors or lymphoma. CONCLUSIONS: Prophylactic treatment with levofloxacin is an effective and well-tolerated way of preventing febrile episodes and other relevant infection-related outcomes in patients with cancer and profound and protracted neutropenia. The long-term effect of this intervention on microbial resistance in the community is not known.	Univ Perugia, Monteluce Policlin, Ist Med Interna & Sci Oncol, I-06100 Perugia, Italy; Univ Roma La Sapienza, Rome, Italy; Osped Cisanello, Pisa, Italy; Ist Europeo Oncol, Milan, Italy; Osped Santi Antonio & Biagio, Alessandria, Italy; Osped Civile Santo Spirito, Pescara, Italy; Osped Riuniti Bergamo, I-24100 Bergamo, Italy; Osped Niguarda Ca Granda, Milan, Italy; Osped San Luigi, Orbassano, Italy; Osped Santa Maria delle Croci, Ravenna, Italy; Azienda Osped Pugliese Ciaccio, Catanzaro, Italy; Univ Bari, Bari, Italy; Osped SantEugenio, Rome, Italy; Azienda Osped Cervello, Palermo, Italy; Osped Maggiore, Ist Ricovero & Cura Carattere Sci, Milan, Italy; Policlin Scotte, Siena, Italy	University of Perugia; Sapienza University Rome; IRCCS European Institute of Oncology (IEO); Azienda Ospedaliera SS Antonio Biagio Cesare Arrigo; Ospedali Riuniti di Bergamo; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Universita degli Studi di Bari Aldo Moro; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Siena	Del Favero, A (corresponding author), Univ Perugia, Monteluce Policlin, Ist Med Interna & Sci Oncol, I-06100 Perugia, Italy.	delfa@unipg.it	; Specchia, Giorgina/K-3084-2016	Amadori, Sergio/0000-0002-2356-8681; Specchia, Giorgina/0000-0002-2479-9529				BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BODEY GP, 1978, CANCER, V41, P1610, DOI 10.1002/1097-0142(197804)41:4<1610::AID-CNCR2820410452>3.0.CO;2-B; CARRATALA J, 1995, CLIN INFECT DIS, V20, P557, DOI 10.1093/clinids/20.3.557; Cometta AF, 1996, ANTIMICROB AGENTS CH, V40, P1108, DOI 10.1128/AAC.40.5.1108; Cruciani M, 1996, CLIN INFECT DIS, V23, P795, DOI 10.1093/clinids/23.4.795; Del Favero A, 2001, CLIN INFECT DIS, V33, P1295, DOI 10.1086/322646; DELFAVERO A, 1991, ANN INTERN MED, V115, P7, DOI 10.7326/0003-4819-115-1-7; Engels EA, 1998, J CLIN ONCOL, V16, P1179, DOI 10.1200/JCO.1998.16.3.1179; Freifeld A, 1999, NEW ENGL J MED, V341, P305, DOI 10.1056/NEJM199907293410501; Gaya H, 1975, Eur J Cancer, V11suppl, P1; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; KARP JE, 1987, ANN INTERN MED, V106, P1, DOI 10.7326/0003-4819-106-1-1; KERN WV, 1994, ANTIMICROB AGENTS CH, V38, P681, DOI 10.1128/AAC.38.4.681; Kern WV, 1999, NEW ENGL J MED, V341, P312, DOI 10.1056/NEJM199907293410502; LEW MA, 1991, TRANSPLANTATION, V51, P630, DOI 10.1097/00007890-199103000-00017; Martino R, 1998, ACTA HAEMATOL-BASEL, V99, P206, DOI 10.1159/000040840; *PFN 2003, 2003, NUOV PRONT FARM NAZ; Reuter S, 2005, CLIN INFECT DIS, V40, P1087, DOI 10.1086/428732; SOMOLINOS N, 1992, J ANTIMICROB CHEMOTH, V30, P730, DOI 10.1093/jac/30.5.730; TALBOT GH, 1993, ANTIMICROB AGENTS CH, V37, P474, DOI 10.1128/AAC.37.3.474; Tascini Carlo, 1999, Clin Microbiol Infect, V5, P457, DOI 10.1111/j.1469-0691.1999.tb00175.x; Viscoli C, 2002, EUR J CANCER, V38, pS82, DOI 10.1016/S0959-8049(01)00461-0	22	414	436	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					977	987		10.1056/NEJMoa044097	http://dx.doi.org/10.1056/NEJMoa044097			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148283	Green Published, Bronze			2022-12-28	WOS:000231698200003
J	Nadir, E; Kaufshtein, M				Nadir, E; Kaufshtein, M			Candida albicans in a peripheral-blood smear	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hillel Yaffe Med Ctr, IL-38100 Hadera, Israel		Nadir, E (corresponding author), Hillel Yaffe Med Ctr, IL-38100 Hadera, Israel.		Nadir, Erez/J-5912-2013	Nadir, Erez/0000-0003-2694-8601					0	12	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					E9	E9		10.1056/NEJMicm041054	http://dx.doi.org/10.1056/NEJMicm041054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148280				2022-12-28	WOS:000231698200010
J	Werner, N; Kosiol, S; Schiegl, T; Ahlers, P; Walenta, K; Link, A; Bohm, M; Nickenig, G				Werner, N; Kosiol, S; Schiegl, T; Ahlers, P; Walenta, K; Link, A; Bohm, M; Nickenig, G			Circulating endothelial progenitor cells and cardiovascular outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; NEOINTIMA FORMATION; TRANSPLANTATION; MOBILIZATION; REENDOTHELIALIZATION; NEOVASCULARIZATION; ATHEROSCLEROSIS; ANGIOGENESIS; REGENERATION	BACKGROUND: Endothelial progenitor cells derived from bone marrow are believed to support the integrity of the vascular endothelium. The number and function of endothelial progenitor cells correlate inversely with cardiovascular risk factors, but the prognostic value associated with circulating endothelial progenitor cells has not been defined. METHODS: The number of endothelial progenitor cells positive for CD34 and kinase insert domain receptor (KDR) was determined with the use of flow cytometry in 519 patients with coronary artery disease as confirmed on angiography. After 12 months, we evaluated the association between baseline levels of endothelial progenitor cells and death from cardiovascular causes, the occurrence of a first major cardiovascular event (myocardial infarction, hospitalization, revascularization, or death from cardiovascular causes), revascularization, hospitalization, and death from all causes. RESULTS: A total of 43 participants died, 23 from cardiovascular causes. A first major cardiovascular event occurred in 214 patients. The cumulative event-free survival rate increased stepwise across three increasing baseline levels of endothelial progenitor cells in an analysis of death from cardiovascular causes, a first major cardiovascular event, revascularization, and hospitalization. After adjustment for age, sex, vascular risk factors, and other relevant variables, increased levels of endothelial progenitor cells were associated with a reduced risk of death from cardiovascular causes (hazard ratio, 0.31; 95 percent confidence interval, 0.16 to 0.63; P=0.001), a first major cardiovascular event (hazard ratio, 0.74; 95 percent confidence interval, 0.62 to 0.89; P=0.002), revascularization (hazard ratio, 0.77; 95 percent confidence interval, 0.62 to 0.95; P=0.02), and hospitalization (hazard ratio, 0.76; 95 percent confidence interval, 0.63 to 0.94; P=0.01). Endothelial progenitor-cell levels were not predictive of myocardial infarction or of death from all causes. CONCLUSIONS: The level of circulating CD34+KDR+ endothelial progenitor cells predicts the occurrence of cardiovascular events and death from cardiovascular causes and may help to identify patients at increased cardiovascular risk.	Univ Saarland, Dept Internal Med, Div Cardiol Angiol & Intens Care Med, D-6650 Homburg, Germany	Saarland University	Nickenig, G (corresponding author), Univ Klinikum Saarlandes, Innere Med Klin 3, D-66421 Homburg, Germany.	nickenig@med-in.uni-sb.de	Böhm, Michael/C-3638-2011					Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Gehling UM, 2000, BLOOD, V95, P3106; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Gill M, 2001, CIRC RES, V88, P167; Gunsilius E, 2001, CIRC RES, V88, pE1; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Nowak G, 2004, CIRCULATION, V110, P3699, DOI 10.1161/01.CIR.0000143626.16576.51; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Op den Buijs J, 2004, AM J PHYSIOL-HEART C, V287, pH2651, DOI 10.1152/ajpheart.00332.2004; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Rehman J, 2004, J AM COLL CARDIOL, V43, P2314, DOI 10.1016/j.jacc.2004.02.049; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; SCHWARTZ SM, 1976, P NATL ACAD SCI USA, V73, P651, DOI 10.1073/pnas.73.2.651; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9	36	1722	1847	1	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					999	1007		10.1056/NEJMoa043814	http://dx.doi.org/10.1056/NEJMoa043814			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148285	Bronze			2022-12-28	WOS:000231698200005
J	Sierles, FS; Brodkey, AC; Cleary, LM; McCurdy, FA; Mintz, M; Frank, J; Lynn, DJ; Chao, J; Morgenstern, BZ; Shore, W; Woodard, JL				Sierles, FS; Brodkey, AC; Cleary, LM; McCurdy, FA; Mintz, M; Frank, J; Lynn, DJ; Chao, J; Morgenstern, BZ; Shore, W; Woodard, JL			Medical students' exposure to and attitudes about drug company interactions - A national survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHARMACEUTICAL SALES REPRESENTATIVES; CONFLICTS-OF-INTEREST; PHYSICIANS BEHAVIOR; INDUSTRY; RESIDENTS; INFORMATION; EDUCATION; ACCURACY; QUALITY; FACULTY	Context While exposure to and attitudes about drug company interactions among residents have been studied extensively, relatively little is known about relationships between drug companies and medical students. Objective To measure third-year medical students' exposure to and attitudes about drug company interactions. Design, Setting, and Participants In 2003, we distributed a 64-item anonymous survey to 1143 third-year students at 8 US medical schools, exploring their exposure and response to drug company interactions. The schools' characteristics included a wide spectrum of ownership types, National Institutes of Health funding, and geographic locations. In 2005, we conducted a national survey of student affairs deans to measure the prevalence of school-wide policies on drug company-medical student interactions. Main Outcome Measures Monthly frequency of students' exposure to various activities and gifts during clerkships, and attitudes about receiving gifts. Results Overall response rate was 826/1143 (72.3%), with range among schools of 30.9%-90.7%. Mean exposure for each student was 1 gift or sponsored activity per week. Of respondents, 762/818 (93.2%) were asked or required by a physician to attend at least 1 sponsored lunch. Regarding attitudes, 556/808 (68.8%) believed gifts would not influence their practices and 464/804 (57.7%) believed gifts would not affect colleagues' practices. Of the students, 553/604 (80.3 %) believed that they were entitled to gifts. Of 183 students who thought a gift valued at less than $50 was inappropriate, 158 (86.3%) had accepted one. The number of students who simultaneously believed that sponsored grand rounds are educationally helpful and are likely to be biased was 452/758 (59.6%). Students at 1 school who had attended a seminar about drug company-physician relationships were no more likely than the nonattending classmates to show skepticism. Of the respondents, 704/822 (85.6%) did not know if their school had a policy on these relationships. In a national survey of student affairs deans, among the 99 who knew their policy status, only 10 (10.1 %) reported having school-wide policies about these interactions. Conclusions Student experiences and attitudes suggest that as a group they are at risk for unrecognized influence by marketing efforts. Research should focus on evaluating methods to limit these experiences and affect the development of students' attitudes to ensure that physicians' decisions are based solely on helping each patient achieve the greatest possible benefit.	Rosalind Franklin Univ Med & Sci Chicago Med Sch, Dept Psychiat & Behav Sci, N Chicago, IL 60064 USA; Rosalind Franklin Univ Med & Sci Chicago Med Sch, Dept Psychol, N Chicago, IL 60064 USA; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; SUNY Upstate Med Univ, Dept Internal Med, Syracuse, NY USA; Univ Nebraska, Sch Med, Dept Pediat, Omaha, NE 68198 USA; George Washington Univ, Dept Internal Med, Washington, DC USA; George Washington Univ, Dept Psychiat, Washington, DC USA; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; Case Western Reserve Univ, Dept Family Med, Cleveland, OH 44106 USA; Mayo Clin Coll Med, Dept Pediat, Rochester, MN USA; Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science; University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Nebraska System; George Washington University; George Washington University; University System of Ohio; Ohio State University; Case Western Reserve University; Mayo Clinic; University of California System; University of California San Francisco	Sierles, FS (corresponding author), Rosalind Franklin Univ Med & Sci Chicago Med Sch, Dept Psychiat & Behav Sci, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	frederick.sierles@rosalindfranklin.edu		Woodard, John/0000-0001-9196-3336; McCurdy, Fredrick/0000-0001-7879-8620				*ACCR COUNC CONT M, ACCME ANN REP DAT 20; *AM MED ASS, E8061 AM MED ASS; *AM MED STUD ASS, PRINC REG PHARM MED; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; BANKS JW, 1992, ACAD MED, V67, P610, DOI 10.1097/00001888-199209000-00017; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bellin M, 2004, ACAD MED, V79, P1041, DOI 10.1097/00001888-200411000-00005; Bero LA, 1996, INT J TECHNOL ASSESS, V12, P209, DOI 10.1017/S0266462300009582; Blumenthal D, 2004, NEW ENGL J MED, V351, P1885, DOI 10.1056/NEJMhpr042734; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; BOWER AD, 1987, J FAM PRACTICE, V24, P612; Bowman M A, 1988, J Contin Educ Health Prof, V8, P13, DOI 10.1002/chp.4750080104; BOWMAN MA, 1986, MOBIUS, V6, P66; Brodkey AC, 2005, ACAD PSYCHIATR, V29, P222, DOI 10.1176/appi.ap.29.2.222; BROTZMAN GL, 1993, J GEN INTERN MED, V8, P130, DOI 10.1007/BF02599757; Caudill TS, 1996, ARCH FAM MED, V5, P201, DOI 10.1001/archfami.5.4.201; Chew LD, 2000, J GEN INTERN MED, V15, P478, DOI 10.1046/j.1525-1497.2000.08014.x; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; HAAYER F, 1982, SOC SCI MED, V16, P2017, DOI 10.1016/0277-9536(82)90158-7; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; HODGES B, 1995, CAN MED ASSOC J, V153, P553; KEIM SM, 1993, ANN EMERG MED, V10, P1576; McCormick BB, 2001, JAMA-J AM MED ASSOC, V286, P1994, DOI 10.1001/jama.286.16.1994; MCKINNEY WP, 1990, JAMA-J AM MED ASSOC, V264, P1693, DOI 10.1001/jama.264.13.1693; *MED SCH US, 2003, JAMA-J AM MED ASSOC, V290, P1223; Mintzes B, 2003, CAN MED ASSOC J, V169, P405; Monaghan MS, 2003, TEACH LEARN MED, V15, P14, DOI 10.1207/S15328015TLM1501_04; *NIH, NIH AW MED SCH RANK; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; *PHARM RES MAN AM, 2001, PHARM IND PROF; Prosser H, 2003, FAM PRACT, V20, P61, DOI 10.1093/fampra/20.1.61; REEDER M, 1993, ANN EMERG MED, V22, P1593, DOI 10.1016/S0196-0644(05)81266-1; Relman AS, 2001, JAMA-J AM MED ASSOC, V285, P2009, DOI 10.1001/jama.285.15.2009; Sandberg WS, 1997, ACAD MED, V72, P916, DOI 10.1097/00001888-199710000-00018; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P98, DOI 10.1016/j.jclinepi.2004.06.002; Schulman KA, 2002, NEW ENGL J MED, V347, P1335, DOI 10.1056/NEJMsa020349; Siegel D, 1997, JAMA-J AM MED ASSOC, V278, P1745, DOI 10.1001/jama.278.21.1745; Spingarn RW, 1996, ACAD MED, V71, P86, DOI 10.1097/00001888-199601000-00022; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; Stryer D, 1996, J GEN INTERN MED, V11, P575, DOI 10.1007/BF02599024; Studdert DM, 2004, NEW ENGL J MED, V351, P1891, DOI 10.1056/NEJMlim042229; Villanueva P, 2003, LANCET, V361, P27, DOI 10.1016/S0140-6736(03)12118-6; Vinson D C, 1993, Fam Med, V25, P31; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Wilkes MS, 2001, ACAD MED, V76, P1271, DOI 10.1097/00001888-200112000-00026; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296	48	137	138	1	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2005	294	9					1034	1042		10.1001/jama.294.9.1034	http://dx.doi.org/10.1001/jama.294.9.1034			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XU	16145023				2022-12-28	WOS:000231627300003
J	Santer, M; Lewis-Jones, S; Fahey, T				Santer, M; Lewis-Jones, S; Fahey, T			10 minute consultation - Childhood eczema	BRITISH MEDICAL JOURNAL			English	Article									Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4AD, Scotland; Ninewells Hosp, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Santer, M (corresponding author), Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4AD, Scotland.	miriamsanter@aol.com	Fahey, Tom/C-9367-2012	Fahey, Tom/0000-0002-5896-5783; Santer, Miriam/0000-0001-7264-5260					0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 3	2005	331	7515					497	497		10.1136/bmj.331.7515.497	http://dx.doi.org/10.1136/bmj.331.7515.497			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963RA	16141156	Green Published, Bronze			2022-12-28	WOS:000231820400023
J	Guzman, MG				Guzman, MG			Deciphering dengue: The Cuban experience	SCIENCE			English	Article									Inst Med Trop Pedro Kouri, Dept Virol, PAHO WHO Collaborating Ctr Viral Dis, Havana, Cuba; Inst Med Trop Pedro Kouri, PAHO WHO Collaborating Ctr Study Dengue & Its Con, Havana, Cuba		Guzman, MG (corresponding author), Inst Med Trop Pedro Kouri, Dept Virol, PAHO WHO Collaborating Ctr Viral Dis, Autopista Novia del Mediodia,Km 6-1 2,POB Mariano, Havana, Cuba.	lupe@ipk.sld.cu						HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; Ligon B Lee, 2004, Semin Pediatr Infect Dis, V15, P199, DOI 10.1053/j.spid.2004.08.001; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; ROSEN L, 1989, REV INFECT DIS, V11, pS840	4	35	40	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1495	1497		10.1126/science.1115177	http://dx.doi.org/10.1126/science.1115177			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141052				2022-12-28	WOS:000231715000028
J	Macbeth, MR; Schubert, HL; VanDemark, AP; Lingam, AT; Hill, CP; Bass, BL				Macbeth, MR; Schubert, HL; VanDemark, AP; Lingam, AT; Hill, CP; Bass, BL			Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing	SCIENCE			English	Article							PRE-MESSENGER-RNA; ADENOSINE-DEAMINASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ENZYME; COMPLEX; BINDING; POLYPHOSPHATES; METHYLATION; MYSTERIES	We report the crystal structure of the catalytic domain of human ADAR2, an RNA editing enzyme, at 1.7 angstrom resolution. The structure reveals a zinc ion in the active site and suggests how the substrate adenosine is recognized. Unexpectedly, inositol hexakisphosphate (IP6) is buried within the enzyme core, contributing to the protein fold. Although there are no reports that adenosine deaminases that act on RNA (ADARs) require a cofactor, we show that IP6 is required for activity. Amino acids that coordinate IP6 in the crystal structure are conserved in some adenosine deaminases that act on transfer RNA (tRNA) (ADATs), related enzymes that edit tRNA. Indeed, IP6 is also essential for in vivo and in vitro deamination of adenosine 37 of tRNA(ala) by ADAT1.	Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Hill, CP (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA.	chris@biochem.utah.edu; bbass@howard.genetics.utah.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056775, R01GM044073] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044073, GM56775, R01 GM056775, GM44073] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNONE A, 1974, NATURE, V249, P34, DOI 10.1038/249034a0; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Carlow DC, 1999, BIOCHEMISTRY-US, V38, P12258, DOI 10.1021/bi990819t; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Gerber AP, 2001, TRENDS BIOCHEM SCI, V26, P376, DOI 10.1016/S0968-0004(01)01827-8; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; Grosjean H, 1996, BIOCHIMIE, V78, P488, DOI 10.1016/0300-9084(96)84755-9; Grosjean H., 1998, MODULATION ROLE MODI, P113; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoy M, 2002, P NATL ACAD SCI USA, V99, P6773, DOI 10.1073/pnas.102157499; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; KROGER M, 1979, BIOCHEMISTRY-US, V18, P3493, DOI 10.1021/bi00583a009; Kuratani M, 2005, J BIOL CHEM, V280, P16002, DOI 10.1074/jbc.M414541200; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas S, 2003, J BIOL CHEM, V278, P1391, DOI 10.1074/jbc.R200025200; Macbeth MR, 2004, RNA, V10, P1563, DOI 10.1261/rna.7920904; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; OConnell MA, 1997, J BIOL CHEM, V272, P473; Ongusaha PP, 1998, BIOCHEM J, V335, P671, DOI 10.1042/bj3350671; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Scadden ADJ, 2001, EMBO REP, V2, P1107, DOI 10.1093/embo-reports/kve244; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Stephens OM, 2000, BIOCHEMISTRY-US, V39, P12243, DOI 10.1021/bi0011577; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Valastro B, 2001, HIPPOCAMPUS, V11, P673, DOI 10.1002/hipo.1082; WEDEKIND JE, 1995, BIOCHEMISTRY-US, V34, P11049, DOI 10.1021/bi00035a010; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	41	301	318	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1534	1539		10.1126/science.1113150	http://dx.doi.org/10.1126/science.1113150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141067	Green Accepted			2022-12-28	WOS:000231715000042
J	Mattick, JS				Mattick, JS			The functional genomics of noncoding RNA	SCIENCE			English	Article							IDENTIFICATION; MOUSE; EXPRESSION	Large numbers of noncoding RNA transcripts (ncRNAS) are being revealed by complementary DNA cloning and genome tiling array studies in animals. The big and as yet largely unanswered question is whether these transcripts are relevant. A paper by Willingham et al. shows the way forward by developing a strategy for large-scale functional screening of ncRNAs, involving small interfering RNA knockdowns in cell-based screens, which identified a previously unidentified ncRNA repressor of the transcription factor NFAT. It appears likely that ncRNAs constitute a critical hidden layer of gene regulation in complex organisms, the understanding of which requires new approaches in functional genomics.	Univ Queensland, Inst Mol Biosci, Australian Res Council Special Res Ctr Funct & Ap, Brisbane, Qld 4072, Australia	University of Queensland	Mattick, JS (corresponding author), Univ Queensland, Inst Mol Biosci, Australian Res Council Special Res Ctr Funct & Ap, Brisbane, Qld 4072, Australia.	j.mattick@imb.uq.edu.au	Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012	Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527				Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Frith MC, 2005, EUR J HUM GENET, V13, P894, DOI 10.1038/sj.ejhg.5201459; HOGENESCH JB, COMMUNICATION; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; MATTICK JS, 1994, CURR OPIN GENET DEV, V4, P823, DOI 10.1016/0959-437X(94)90066-3; Numata K, 2003, GENOME RES, V13, P1301, DOI 10.1101/gr.1011603; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oudejans CBM, 2001, GENOMICS, V73, P331, DOI 10.1006/geno.2001.6522; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	22	231	250	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1527	1528		10.1126/science.1117806	http://dx.doi.org/10.1126/science.1117806			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141063				2022-12-28	WOS:000231715000038
J	Chaudhury, A				Chaudhury, A			Plant genetics - Hothead healer and extragenomic information	NATURE			English	Editorial Material							ARABIDOPSIS		CSIRO Plant Ind, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Chaudhury, A (corresponding author), CSIRO Plant Ind, GPO Box 1600, Canberra, ACT 2601, Australia.	abdul.chaudhury@csiro.au						DOWNS DM, 1987, GENETICS, V117, P367; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; Lolle SJ, 1998, GENETICS, V149, P607; MATZKE MA, 2005, NATURE, V455, P24; Mustajoki S, 1997, GENOME RES, V7, P1054, DOI 10.1101/gr.7.11.1054; RAY A, 2005, NATURE; Watson J.D., 2014, MOL BIOL GENE, V5, P657	7	12	12	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					E1	E1		10.1038/nature04062	http://dx.doi.org/10.1038/nature04062			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136082	Bronze			2022-12-28	WOS:000231560400035
J	Iglehart, JK				Iglehart, JK			Linking compensation to quality - Medicare payments to physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Iglehart JK, 2002, NEW ENGL J MED, V346, P1924, DOI 10.1056/NEJMhpr020324	2	25	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					870	872		10.1056/NEJMp058194	http://dx.doi.org/10.1056/NEJMp058194			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135830				2022-12-28	WOS:000231551100003
J	Mennel, S; Peter, S				Mennel, S; Peter, S			Air-pressure injury of the eye and intracranial structures	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Marburg, D-35037 Marburg, Germany; Acad Hosp Feldkirch, A-6807 Feldkirch, Austria	Philipps University Marburg	Mennel, S (corresponding author), Univ Marburg, D-35037 Marburg, Germany.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					E8	E8		10.1056/NEJMicm040866	http://dx.doi.org/10.1056/NEJMicm040866			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135827				2022-12-28	WOS:000231551100012
J	Oransky, I				Oransky, I			Zoltan Ovary - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 30	2005	366	9483					364	364		10.1016/S0140-6736(05)67013-4	http://dx.doi.org/10.1016/S0140-6736(05)67013-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16178121				2022-12-28	WOS:000230849700014
J	Burlaga, LF; Ness, NF; Acuna, IH; Acuna, MH; Lepping, RP; Connerney, JEP; Stone, EC; McDonald, FB				Burlaga, LF; Ness, NF; Acuna, IH; Acuna, MH; Lepping, RP; Connerney, JEP; Stone, EC; McDonald, FB			Crossing the termination shock into the hetiosheath: Magnetic fields	SCIENCE			English	Article							SOLAR-WIND; INTERSTELLAR-MEDIUM; VOYAGER-1; PICKUP; AU; HELIOSPHERE; MOTION; SPEED; MODEL	Magnetic fields measured by Voyager 1 show that the spacecraft crossed or was crossed by the termination shock on about 16 December 2004 at 94.0 astronomical units. An estimate of the compression ratio of the magnetic field strength B (+/- standard error of the mean) across the shock is B-2/B-1 = 3.05 +/- 0.04, but ratios in the range from 2 to 4 are admissible. The average B in the heliosheath from day 1 through day 110 of 2005 was 0.136 +/- 0.035 nanoteslas, similar to 4.2 times that predicted by Parker's model for B. The magnetic field in the heliosheath from day 361 of 2004 through day 110 of 2005 was pointing away from the Sun along the Parker spiral. The probability distribution of hourly averages of B in the heliosheath is a Gaussian distribution. The cosmic ray intensity increased when B was relatively large in the hetiosheath.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Catholic Univ Amer, Washington, DC 20064 USA; CALTECH, Pasadena, CA 91109 USA; Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Catholic University of America; California Institute of Technology; University System of Maryland; University of Maryland College Park	Burlaga, LF (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	Leonard.F.Burlaga@nasa.gov	connerney, john/I-5127-2013					BARNES A, 1993, J GEOPHYS RES-SPACE, V98, P15137, DOI 10.1029/92JA02895; BEHANNON KW, 1977, SPACE SCI REV, V21, P235, DOI 10.1007/BF00211541; Burlaga LF, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018291; Burlaga LF, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA009217; BURLAGA LF, 1985, J GEOPHYS RES-SPACE, V90, P2027, DOI 10.1029/JA090iA12p12027; Burlaga LF, 2001, J GEOPHYS RES-SPACE, V106, P15917, DOI 10.1029/2000JA000107; BURLAGA LF, 1995, INTERPLANETARY MAGNE; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; Gurnett DA, 2005, SCIENCE, V309, P2025, DOI 10.1126/science.1117425; HOLZER TE, 1989, ANNU REV ASTRON ASTR, V27, P199; JOKIPII R, IN PRESS ASTROPHYS J; KARMESIN SR, 1995, GEOPHYS RES LETT, V22, P1153, DOI 10.1029/95GL00603; Krimigis SM, 2003, NATURE, V426, P45, DOI 10.1038/nature02068; leRoux JA, 1997, J GEOPHYS RES-SPACE, V102, P17365, DOI 10.1029/97JA01301; LIEWER PC, 1993, J GEOPHYS RES-SPACE, V98, P15211, DOI 10.1029/93JA01172; McDonald FB, 2003, NATURE, V426, P48, DOI 10.1038/nature02066; NESS NF, IN PRESS AIP C P, V781; Parker E.N., 1963, ASTROPHYS J SUPPL S, DOI DOI 10.1086/190087; RICHARDSON JD, MIT SPACE PLASMA GRO; Scherer K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016073; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; STONE EC, 1977, SPACE SCI REV, V21, P355, DOI 10.1007/BF00211546; Stone EC, 2001, SCIENCE, V293, P55, DOI 10.1126/science.1060090; Wang C, 1999, J GEOPHYS RES-SPACE, V104, P549, DOI 10.1029/1998JA900052; WANG YM, 1990, ASTROPHYS J, V355, P726, DOI 10.1086/168805; WEYMANN R, 1960, ASTROPHYS J, V132, P380, DOI 10.1086/146937; Whang YC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018679; WHANG YC, 1993, J GEOPHYS RES-SPACE, V98, P15221, DOI 10.1029/93JA01472; Zank GP, 1999, SPACE SCI REV, V89, P413, DOI 10.1023/A:1005155601277; Zank GP, 1996, SPACE SCI REV, V78, P95, DOI 10.1007/BF00170796	30	223	224	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2027	2029		10.1126/science.1117542	http://dx.doi.org/10.1126/science.1117542			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179471				2022-12-28	WOS:000232181900041
J	Kaplan, MM; Gershwin, ME				Kaplan, MM; Gershwin, ME			Medical progress: Primary biliary cirrhosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							URSODEOXYCHOLIC-ACID THERAPY; RANDOMIZED CONTROLLED-TRIALS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; NATURAL-HISTORY; SUBOPTIMAL RESPONSE; SYMPTOM PROGRESSION; ORAL BUDESONIDE; BONE LOSS; METHOTREXATE		Tufts Univ, New England Med Ctr, Div Gastroenterol, Boston, MA 02111 USA; Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA	Tufts Medical Center; Tufts University; University of California System; University of California Davis	Kaplan, MM (corresponding author), Tufts Univ, New England Med Ctr, Div Gastroenterol, 750 Washington St, Boston, MA 02111 USA.	mkaplan@tufts-nemc.org						Almasio PL, 2000, ALIMENT PHARM THERAP, V14, P1645, DOI 10.1046/j.1365-2036.2000.00869.x; Amano K, 2004, J IMMUNOL, V172, P6444, DOI 10.4049/jimmunol.172.10.6444; Angulo P, 2000, HEPATOLOGY, V31, P318, DOI 10.1002/hep.510310209; Angulo P, 2000, HEPATOLOGY, V32, P897, DOI 10.1053/jhep.2000.18663; [Anonymous], 1993, J Hepatol, V17, P227; Bergasa Nora V, 2003, Clin Liver Dis, V7, P879, DOI 10.1016/S1089-3261(03)00105-3; Bittencourt PL, 2004, J GASTROEN HEPATOL, V19, P873, DOI 10.1111/j.1440-1746.2004.03396.x; Bonis PAL, 1999, GASTROENTEROLOGY, V117, P395, DOI 10.1053/gast.1999.0029900395; Boulton-Jones JR, 2004, ALIMENT PHARM THER, V20, P551, DOI 10.1111/j.1365-2036.2004.02089.x; BOYER TD, 1994, HEPATOLOGY, V20, P1482, DOI 10.1002/hep.1840200617; Bruggraber SFA, 2003, GASTROENTEROLOGY, V125, P1705, DOI 10.1053/j.gastro.2003.09.034; CHRISTENSEN E, 1985, GASTROENTEROLOGY, V89, P1084, DOI 10.1016/0016-5085(85)90213-6; COHEN LB, 1985, GUT, V26, P291, DOI 10.1136/gut.26.3.291; Combes B, 2003, HEPATOLOGY, V38, p210A; Corpechot C, 2005, GASTROENTEROLOGY, V128, P297, DOI 10.1053/j.gastro.2004.11.009; Corpechot C, 2003, HEPATOLOGY, V38, p519A; Corpechot C, 2000, HEPATOLOGY, V32, P1196, DOI 10.1053/jhep.2000.20240; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; Degott C, 1999, HEPATOLOGY, V29, P1007, DOI 10.1002/hep.510290444; Forton DM, 2004, GUT, V53, P587, DOI 10.1136/gut.2003.016766; Gershwin ME, 2000, IMMUNOL REV, V174, P210, DOI 10.1034/j.1600-0528.2002.017402.x; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; GHENT CN, 1988, GASTROENTEROLOGY, V94, P488, DOI 10.1016/0016-5085(88)90442-8; GLUUD C, 2002, COCHRANE DB SYST REV, V1; GonzalezKoch A, 1997, J HEPATOL, V27, P143, DOI 10.1016/S0168-8278(97)80294-2; Goulis J, 1999, LANCET, V354, P1053, DOI 10.1016/S0140-6736(98)11293-X; Guanabens N, 2003, AM J GASTROENTEROL, V98, P2268, DOI 10.1016/S0002-9270(03)00550-1; HEATHCOTE EJ, 1994, HEPATOLOGY, V19, P1149, DOI 10.1002/hep.1840190512; Hendrickse MT, 1999, GASTROENTEROLOGY, V117, P400, DOI 10.1053/gast.1999.0029900400; HOOFNAGLE JH, 1986, GASTROENTEROLOGY, V91, P1327, DOI 10.1016/0016-5085(86)90183-6; Howel D, 2000, HEPATOLOGY, V31, P1055, DOI 10.1053/he.2000.7050; Invernizzi P, 2004, LANCET, V363, P533, DOI 10.1016/S0140-6736(04)15541-4; Invernizzi P, 2003, J HEPATOL, V38, P401, DOI 10.1016/S0168-8278(02)00440-3; JAMES OFW, 1985, GUT, V26, P109, DOI 10.1136/gut.26.2.109; Jones David E J, 2003, Clin Liver Dis, V7, P841, DOI 10.1016/S1089-3261(03)00095-3; Kaplan MM, 1999, GASTROENTEROLOGY, V117, P1173, DOI 10.1016/S0016-5085(99)70403-8; Kaplan MM, 2004, HEPATOLOGY, V39, P915, DOI 10.1002/hep.20103; KAPLAN MM, 1986, NEW ENGL J MED, V315, P1448, DOI 10.1056/NEJM198612043152304; Kaplan MM, 1996, NEW ENGL J MED, V335, P1570, DOI 10.1056/NEJM199611213352107; Kaplan MM, 1997, ANN INTERN MED, V126, P682, DOI 10.7326/0003-4819-126-9-199705010-00002; Kita H, 2002, GASTROENTEROLOGY, V123, P1031, DOI 10.1053/gast.2002.36020; Kita H, 2002, J CLIN INVEST, V109, P1231, DOI 10.1172/JCI200214698; LAURIN JM, 1994, AM J GASTROENTEROL, V89, P1840; Lee YM, 2003, AM J GASTROENTEROL, V98, P205; Leung PSC, 2003, J IMMUNOL, V170, P5326, DOI 10.4049/jimmunol.170.10.5326; Leuschner M, 1999, GASTROENTEROLOGY, V117, P918, DOI 10.1016/S0016-5085(99)70351-3; Leuschner M, 2002, EUR J GASTROEN HEPAT, V14, P1369, DOI 10.1097/00042737-200212000-00014; Leuschner M, 2000, GUT, V46, P121, DOI 10.1136/gut.46.1.121; Levy Cynthia, 2003, Clin Liver Dis, V7, P901, DOI 10.1016/S1089-3261(03)00097-7; Lindor KD, 1997, MAYO CLIN PROC, V72, P1137, DOI 10.4065/72.12.1137; Locke GR, 1996, HEPATOLOGY, V23, P52, DOI 10.1002/hep.510230108; LOMBARD M, 1993, GASTROENTEROLOGY, V104, P519, DOI 10.1016/0016-5085(93)90422-9; Long SA, 2001, J IMMUNOL, V167, P2956, DOI 10.4049/jimmunol.167.5.2956; Longo M, 2002, GUT, V51, P265, DOI 10.1136/gut.51.2.265; MacQuillan Gerry C, 2003, Clin Liver Dis, V7, P941, DOI 10.1016/S1089-3261(03)00099-0; Matsumura S, 2002, HEPATOLOGY, V36, P1125, DOI 10.1053/jhep.2002.36161; MCCORMICK PA, 1994, J HEPATOL, V21, P496, DOI 10.1016/S0168-8278(94)80092-8; Menon KVN, 2003, AM J GASTROENTEROL, V98, P889, DOI 10.1016/S0002-9270(03)00005-4; Milkiewicz P, 2004, GUT, V53, P475, DOI 10.1136/gut.2003.025155; MITCHISON HC, 1992, J HEPATOL, V15, P336, DOI 10.1016/0168-8278(92)90065-W; Nakai S, 2000, AM J GASTROENTEROL, V95, P326; Nakanuma Y, 2003, J GASTROENTEROL, V38, P1110, DOI 10.1007/s00535-003-1211-y; Neuberger J, 2003, J HEPATOL, V39, P142, DOI 10.1016/S0168-8278(03)00283-6; Nijhawan PK, 1999, HEPATOLOGY, V29, P1396, DOI 10.1002/hep.510290511; Odin JA, 2001, J CLIN INVEST, V108, P223, DOI 10.1172/JCI200110716; Ormarsdottir S, 2002, J INTERN MED, V252, P537, DOI 10.1046/j.1365-2796.2002.01066.x; Pares A, 2000, J HEPATOL, V32, P561, DOI 10.1016/S0168-8278(00)80216-0; Pares Albert, 2003, Clin Liver Dis, V7, P779, DOI 10.1016/S1089-3261(03)00100-4; Parikh-Patel A, 2001, HEPATOLOGY, V33, P16, DOI 10.1053/jhep.2001.21165; Poupon R, 2004, HEPATOLOGY, V39, P900, DOI 10.1002/hep.20188; Poupon RE, 2004, HEPATOLOGY, V40, P489, DOI 10.1002/hep.20276; Poupon RE, 1999, HEPATOLOGY, V29, P1668, DOI 10.1002/hep.510290603; Poupon RE, 2003, J HEPATOL, V39, P12, DOI 10.1016/S0168-8278(03)00192-2; Poupon RE, 1997, GASTROENTEROLOGY, V113, P884, DOI 10.1016/S0016-5085(97)70183-5; Prince M, 2002, GASTROENTEROLOGY, V123, P1044, DOI 10.1053/gast.2002.36027; Prince Martin I, 2003, Clin Liver Dis, V7, P795, DOI 10.1016/S1089-3261(03)00102-8; Prince MI, 2004, GUT, V53, P865, DOI 10.1136/gut.2003.023937; Rautiainen H, 2005, HEPATOLOGY, V41, P747, DOI 10.1002/hep.20646; Reddy A, 2004, LIVER INT, V24, P194, DOI 10.1111/j.1478-3231.2004.00920.x; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Selmi C, 2004, GASTROENTEROLOGY, V127, P493, DOI 10.1053/j.gastro.2004.05.033; Selmi C, 2004, CURR OPIN RHEUMATOL, V16, P406, DOI 10.1097/01.bor.0000130538.76808.c2; Selmi C, 2003, HEPATOLOGY, V38, P1250, DOI 10.1053/jhep.2003.50446; Shimoda S, 1998, J CLIN INVEST, V102, P1831, DOI 10.1172/JCI4213; Sood S, 2004, GASTROENTEROLOGY, V127, P470, DOI 10.1053/j.gastro.2004.04.064; Springer J, 1999, AM J GASTROENTEROL, V94, P47; Springer JE, 2000, GASTROENTEROLOGY, V118, P145, DOI 10.1016/S0016-5085(00)70423-9; Talwalkar JA, 2005, J CLIN GASTROENTEROL, V39, P168; Talwalkar JA, 2003, CLIN GASTROENTEROL H, V1, P297, DOI 10.1016/S1542-3565(03)00134-4; Tanaka A, 1999, HEPATOLOGY, V30, P833, DOI 10.1002/hep.510300410; Therneau TM, 2000, MODELING SURVIVAL DA; THORNTON JR, 1989, Q J MED, V71, P467; VanNorstrand MD, 1997, HEPATOLOGY, V25, P6, DOI 10.1053/jhep.1997.v25.pm0008985257; Vela S, 2004, GASTROENTEROLOGY, V126, pA671; VUORISTO M, 1995, GASTROENTEROLOGY, V108, P1470, DOI 10.1016/0016-5085(95)90696-7; Watt FE, 2004, QJM-INT J MED, V97, P397, DOI 10.1093/qjmed/hch078; Worman HJ, 2003, AUTOIMMUN REV, V2, P211, DOI 10.1016/S1568-9972(03)00013-2; Xu LZ, 2003, P NATL ACAD SCI USA, V100, P8454, DOI 10.1073/pnas.1433063100	98	909	974	4	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1261	1273		10.1056/NEJMra043898	http://dx.doi.org/10.1056/NEJMra043898			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	966DS	16177252				2022-12-28	WOS:000232000400010
J	Singh, JA				Singh, JA			Zimbabwe: health and human rights versus African solidarity	LANCET			English	Editorial Material									Univ KwaZulu Natal, Howard Coll Sch Law, Ctr AIDS Programme Res S Africa, ZA-4001 Durban, South Africa; Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada	University of Kwazulu Natal; University of Toronto	Singh, JA (corresponding author), Univ KwaZulu Natal, Howard Coll Sch Law, Ctr AIDS Programme Res S Africa, ZA-4001 Durban, South Africa.	singhj9@ukzn.ac.za	Singh, Jerome Amir/ABG-1573-2021					*AMN INT, 2005, ZIMB UNPR CALL UN AU; *BBC, 2005, AFR REJ ACT ZIMB; EISENMAN J, 2005, RISING TIGERS ROAM H; HARTNACK M, 2005, IMF TEAM ARRIVES ZIM; Human Rights Watch, 2004, POL FOOD ASS ZIMB; MDE V, 2005, CRUNCH MUGABE 1BN LO; *SO AFR MIGR RES, 2004, ZIMB COV BRAIN DRAIN; Tibaijuka, 2005, REPORT FACT FINDING; *UN OFF COORD HUM, 2005, ZIMB FORC EV COULD A; *UN OFF COORD HUM, 2005, DOCT DEM BETT PAY IN; *UN POP FUND, 2004, STAT WORLD POP 2004; *ZIMB ASS DOCT HUM, 2005, OP MUR SWEEP RUBB	12	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 17	2005	366	9490					964	966		10.1016/S0140-6736(05)67351-5	http://dx.doi.org/10.1016/S0140-6736(05)67351-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965MZ	16168759				2022-12-28	WOS:000231955900007
J	Giovannoni, SJ; Stingl, U				Giovannoni, SJ; Stingl, U			Molecular diversity and ecology of microbial plankton	NATURE			English	Review							DISSOLVED ORGANIC-CARBON; MARINE BACTERIOPLANKTON; PHYLOGENETIC DIVERSITY; COMMUNITY STRUCTURE; SARGASSO SEA; ALGAL BLOOM; OPEN-OCEAN; ATLANTIC; PACIFIC; PROCHLOROCOCCUS	The history of microbial evolution in the oceans is probably as old as the history of life itself. In contrast to terrestrial ecosystems, microorganisms are the main form of biomass in the oceans, and form some of the largest populations on the planet. Theory predicts that selection should act more efficiently in large populations. But whether microbial plankton populations harbour organisms that are models of adaptive sophistication remains to be seen. Genome sequence data are piling up, but most of the key microbial plankton clades have no cultivated representatives, and information about their ecological activities is sparse.	Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	Oregon State University	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	Stingl, Uli/H-1191-2014	Stingl, Uli/0000-0002-0684-2597				Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BAUER JE, 1992, NATURE, V357, P667, DOI 10.1038/357667a0; Baumann P., 1984, BERGEYS MANUAL SYSTE, P518; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Benner R., 2002, BIOGEOCHEMISTRY MARI, P5990, DOI DOI 10.1016/B978-012323841-2/50005-1; BRITSCHGI TB, 1991, APPL ENVIRON MICROB, V57, P1707, DOI 10.1128/AEM.57.6.1707-1713.1991; Button DK, 2004, APPL ENVIRON MICROB, V70, P5511, DOI 10.1128/AEM.70.9.5511-5521.2004; BUTTON DK, 1993, APPL ENVIRON MICROB, V59, P881, DOI 10.1128/AEM.59.3.881-891.1993; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; Cavicchioli R, 2003, MICROB ECOL, V45, P203, DOI 10.1007/s00248-002-3008-6; Cho JC, 2004, APPL ENVIRON MICROB, V70, P432, DOI 10.1128/AEM.70.1.432-440.2004; Cho JC, 2004, ENVIRON MICROBIOL, V6, P611, DOI 10.1111/j.1462-2920.2004.00614.x; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Dethlefsen L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-3; Ducklow H., 2000, MICROBIAL ECOLOGY OC, P85, DOI DOI 10.1002/9780470281840; Eder W, 2002, ENVIRON MICROBIOL, V4, P758, DOI 10.1046/j.1462-2920.2002.00351.x; Egan S, 2000, ENVIRON MICROBIOL, V2, P343, DOI 10.1046/j.1462-2920.2000.00107.x; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Fuchs BM, 2000, ENVIRON MICROBIOL, V2, P191, DOI 10.1046/j.1462-2920.2000.00092.x; Fuhrman JA, 1997, MAR ECOL PROG SER, V150, P275, DOI 10.3354/meps150275; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Fuhrman JA, 1995, LIMNOL OCEANOGR, V40, P1236, DOI 10.4319/lo.1995.40.7.1236; FUHRMAN JA, 1993, APPL ENVIRON MICROB, V59, P1294, DOI 10.1128/AEM.59.5.1294-1302.1993; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Giovannoni SJ, 1996, P NATL ACAD SCI USA, V93, P7979, DOI 10.1073/pnas.93.15.7979; Giovannoni SJ., 2000, MICROBIAL ECOLOGY OC, P47; Gordon DA, 1996, APPL ENVIRON MICROB, V62, P1171, DOI 10.1128/AEM.62.4.1171-1177.1996; Hansell DA, 2001, DEEP-SEA RES PT II, V48, P1649, DOI 10.1016/S0967-0645(00)00153-3; Jenkins BD, 2004, APPL ENVIRON MICROB, V70, P1767, DOI 10.1128/AEM.70.3.1767-1776.2004; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; KIMURA M, 1962, GENETICS, V47, P713; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Lovejoy C, 1998, APPL ENVIRON MICROB, V64, P2806; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; MICHAELS AF, 1994, DEEP-SEA RES PT I, V41, P1013, DOI 10.1016/0967-0637(94)90016-7; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; Orcutt KM, 2002, APPL ENVIRON MICROB, V68, P2236, DOI 10.1128/AEM.68.5.2236-2245.2002; Rappe MS, 2000, FEMS MICROBIOL ECOL, V33, P219, DOI 10.1016/S0168-6496(00)00064-7; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Schwalbach MS, 2005, AQUAT MICROB ECOL, V39, P235, DOI 10.3354/ame039235; Simu K, 2004, APPL ENVIRON MICROB, V70, P2445, DOI 10.1128/AEM.70.4.2445-2451.2004; Stevenson BS, 2004, APPL ENVIRON MICROB, V70, P6670, DOI 10.1128/AEM.70.11.6670-6677.2004; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; Vancanneyt M, 2001, INT J SYST EVOL MICR, V51, P73, DOI 10.1099/00207713-51-1-73; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wright TD, 1997, APPL ENVIRON MICROB, V63, P1441, DOI 10.1128/AEM.63.4.1441-1448.1997; Wuchter C, 2003, FEMS MICROBIOL LETT, V219, P203, DOI 10.1016/S0378-1097(03)00060-0; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zubkov MV, 2003, APPL ENVIRON MICROB, V69, P1299, DOI 10.1128/AEM.69.2.1299-1304.2003; Zubkov MV, 2001, ENVIRON MICROBIOL, V3, P304, DOI 10.1046/j.1462-2920.2001.00196.x	72	304	323	6	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					343	348		10.1038/nature04158	http://dx.doi.org/10.1038/nature04158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163344				2022-12-28	WOS:000231849100040
J	Rouault, TA				Rouault, TA			The intestinal heme transporter revealed	CELL			English	Editorial Material							IRON; ABSORPTION; CLONING	The iron-containing porphyrin heme provides a rich source of dietary iron for mammals. The fact that animals can derive iron from heme implies the existence of a transporter that would transport heme from the gut lumen into intestinal epithelial cells. In this issue of Cell, Shayeghi, McKie, and coworkers (Shayeghi et al., 2005) now describe a heme transporter that is expressed in the apical region of epithelial cells in the mouse duodenum. Their identification of heme carrier protein 1 (HCP1) provides a major missing piece in our understanding of iron uptake and mammalian nutrition.	NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rouault, TA (corresponding author), NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001602] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001602] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Greenough M, 2004, AM J PHYSIOL-CELL PH, V287, pC1463, DOI 10.1152/ajpcell.00179.2004; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Kim Y, 2005, EMBO J, V24, P952, DOI 10.1038/sj.emboj.7600579; LASH RD, 2005, BIOORG MED CHEM LETT; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Ponka P, 2002, SEMIN HEMATOL, V39, P249, DOI 10.1053/shem.2002.35638; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; WHEBY MS, 1970, GASTROENTEROLOGY, V58, P647	15	19	20	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 9	2005	122	5					649	651		10.1016/j.cell.2005.08.027	http://dx.doi.org/10.1016/j.cell.2005.08.027			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143096	Bronze			2022-12-28	WOS:000231844300003
J	Weissman, JS; Betancourt, J; Campbell, EG; Park, ER; Kim, M; Clarridge, B; Blumenthal, D; Lee, KC; Maina, AW				Weissman, JS; Betancourt, J; Campbell, EG; Park, ER; Kim, M; Clarridge, B; Blumenthal, D; Lee, KC; Maina, AW			Resident physicians' preparedness to provide cross-cultural care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIDDEN CURRICULUM; INTERNAL-MEDICINE; COMPETENCE; SELF; VIEWS; PERSPECTIVES; EDUCATION; FACULTY; SKILLS	Context Two recent reports from the Institute of Medicine cited cross-cultural training as a mechanism to address racial and ethnic disparities in health care, but little is known about residents' educational experience in this area. Objective To assess residents' attitudes about cross-cultural care, perceptions of their preparedness to deliver quality care to diverse patient populations, and educational experiences and educational climate regarding cross-cultural training. Design, Setting, and Participants A survey was mailed in the winter of 2003 to a stratified random sample of 3435 resident physicians in their final year of training in emergency medicine, family practice, internal medicine, obstetrics/gynecology, pediatrics, psychiatry, or general surgery at US academic health centers. Results Responses were obtained from 2047 (60%) of the sample. Virtually all (96%) of the residents indicated that it was moderately or very important to address cultural issues when providing care. The number of respondents who indicated that they believed they were not prepared to care for diverse cultures in a general sense was only 8%. However, a larger percentage of respondents believed they were not prepared to provide specific components of cross-cultural care, including caring for patients with health beliefs at odds with Western medicine (25%), new immigrants (25%), and patients whose religious beliefs affect treatment (20%). In addition, 24% indicated that they lacked the skills to identify relevant cultural customs that impact medical care. In contrast, only a small percentage of respondents (1%-2%) indicated that they were not prepared to treat clinical conditions or perform procedures common in their specialty. Approximately one third to half of the respondents reported receiving little or no instruction in specific areas of cross-cultural care beyond what was learned in medical school. Forty-one percent (family medicine) to 83% (surgery and obstetrics/ gynecology) of respondents reported receiving little or no evaluation in cross-cultural care during their residencies. Barriers to delivering cross-cultural care included lack of time (58%) and lack of role models (31%). Conclusions Resident physicians' self-reported preparedness to deliver cross-cultural care lags well behind preparedness in other clinical and technical areas. Although cross-cultural care was perceived to be important, there was little clinical time allotted during residency to address cultural issues, and there was little training, formal evaluation, or role modeling. These mixed educational messages indicate the need for significant improvement in cross-cultural education to help eliminate racial and ethnic disparities in health care.	Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Child & Adolescent Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; Ewha Womans Univ, Seoul, South Korea; Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Ewha Womans University; University of Massachusetts System; University of Massachusetts Boston	Weissman, JS (corresponding author), Massachusetts Gen Hosp, Inst Hlth Policy, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	jweissman@partners.org		Walter, Angela/0000-0003-0098-6802				*ACGME OUTC PROJ, ADV ED MED PROF; *AM MED ASS, 2002, GRAD MED ED DIR 2002; *AM MED ASS, 2004, ETH HLTH DISP; *AM MED ASS, 2002, GRAD MED ED DAT; American Medical Association, FELL RES EL INT DAT; Berger JT, 1998, ARCH INTERN MED, V158, P2085, DOI 10.1001/archinte.158.19.2085; Betancourt JR, 2005, HEALTH AFFAIR, V24, P499, DOI 10.1377/hlthaff.24.2.499; Betancourt JR, 2004, NEW ENGL J MED, V351, P953, DOI 10.1056/NEJMp048033; Biernat K, 2003, ADV HEALTH SCI EDUC, V8, P105, DOI 10.1023/A:1024961618669; Block SD, 1996, JAMA-J AM MED ASSOC, V276, P677, DOI 10.1001/jama.276.9.677; Blumenthal D, 2001, JAMA-J AM MED ASSOC, V286, P1027, DOI 10.1001/jama.286.9.1027; Borowsky IW, 2002, PEDIATRICS, V110, P509, DOI 10.1542/peds.110.3.509; Brotherton SE, 2004, JAMA-J AM MED ASSOC, V292, P1032, DOI 10.1001/jama.292.9.1032; CANTOR JC, 1993, JAMA-J AM MED ASSOC, V270, P1035, DOI 10.1001/jama.270.9.1035; Collins KS, 2002, FINDINGS COMMONWEALT; Eisenberg L, 1977, Cult Med Psychiatry, V1, P9, DOI 10.1007/BF00114808; FINCHER RME, 1993, ACAD MED, V68, pS47, DOI 10.1097/00001888-199302000-00030; *GANN MARK SERV GR, TEL; Goroll AH, 2004, ANN INTERN MED, V140, P902, DOI 10.7326/0003-4819-140-11-200406010-00012; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; Hafferty FW, 1998, ACAD MED, V73, P403, DOI 10.1097/00001888-199804000-00013; Hawkins RE, 1999, AM J MED, V106, P206, DOI 10.1016/S0002-9343(98)00392-1; *I MED, 2002, UN TREATM CONFR RAC; Institute of Medicine, 2001, CROSSING QUALITY CHA; Johnson D, 1998, CRIT CARE MED, V26, P1811, DOI 10.1097/00003246-199811000-00020; Kenny NP, 2003, ACAD MED, V78, P1203, DOI 10.1097/00001888-200312000-00002; Lynch DC, 2003, FAM MED, V35, P324; Park ER, 2005, ACAD MED, V80, P874, DOI 10.1097/00001888-200509000-00019; Park ER, 2005, J GEN INTERN MED, V20, P386, DOI 10.1111/j.1525-1497.2005.0024.x; Roberts KB, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.4.e2; Schubert A, 1999, ANESTHESIOLOGY, V91, P288, DOI 10.1097/00000542-199907000-00037; Shapiro J, 2002, MED EDUC, V36, P749, DOI 10.1046/j.1365-2923.2002.01270.x; Stewart M, 1999, Cancer Prev Control, V3, P25; Swing SR, 2002, ACAD EMERG MED, V9, P1278, DOI 10.1111/j.1553-2712.2002.tb01588.x; Tucker CM, 2003, MED CARE, V41, P859, DOI 10.1097/00005650-200307000-00010; Turbes S, 2002, ACAD MED, V77, P209, DOI 10.1097/00001888-200203000-00007; Weissman JS, 2000, AM J MED, V109, P437, DOI 10.1016/S0002-9343(00)00581-7; Weissman JS, 2001, J URBAN HEALTH, V78, P535, DOI 10.1093/jurban/78.3.535; Wickstrom GC, 2000, J GEN INTERN MED, V15, P361, DOI 10.1046/j.1525-1497.2000.04118.x; Zonia SC, 2000, ACAD MED, V75, P742, DOI 10.1097/00001888-200007000-00020	40	214	215	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2005	294	9					1058	1067		10.1001/jama.294.9.1058	http://dx.doi.org/10.1001/jama.294.9.1058			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XU	16145026	Bronze			2022-12-28	WOS:000231627300006
J	Herbert, RD; Bo, K				Herbert, RD; Bo, K			Analysis of quality of interventions in systematic reviews	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCONTINENCE; PREGNANCY; TRIALS		Univ Sydney, Ctr Evidence Based Physiotherapy, Lidcombe, NSW 1825, Australia; Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway	University of Sydney; Norwegian School of Sport Sciences	Herbert, RD (corresponding author), Univ Sydney, Ctr Evidence Based Physiotherapy, POB 170, Lidcombe, NSW 1825, Australia.	R.Herbert@fhs.usyd.edu.au	Herbert, Rob/E-9442-2012	Herbert, Rob/0000-0003-4188-9195				Black NA, 1996, BRIT J UROL, V78, P497, DOI 10.1046/j.1464-410X.1996.01422.x; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Egger M, 2001, SYSTEMATIC REV HLTH; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; HEYMANS MW, 2004, COCHRANE DB SYST REV, V2; Hughes P., 2001, Neurourology and Urodynamics, V20, P447; Kettunen JA, 2004, SCAND J MED SCI SPOR, V14, P138, DOI 10.1111/j.1600-0838.2004.00396.x; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Morkved S, 2003, OBSTET GYNECOL, V101, P313, DOI 10.1016/S0029-7844(02)02711-4; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Reilly ETC, 2002, BJOG-INT J OBSTET GY, V109, P68, DOI 10.1016/S1470-0328(02)01116-3; Sampselle CM, 1998, OBSTET GYNECOL, V91, P406, DOI 10.1016/S0029-7844(97)00672-8; SCHONSTEIN E, 2002, COCHRANE DB SYST REV, V4; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; WELLS HM, 2003, COCHRANE DB SYST REV, V2; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	18	104	105	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2005	331	7515					507	509		10.1136/bmj.331.7515.507	http://dx.doi.org/10.1136/bmj.331.7515.507			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963RA	16141160	Green Published			2022-12-28	WOS:000231820400027
J	Schellekens, M; Hoppeler, R; Perrin, A; Gomes, JV; Boiron, D; Aspect, A; Westbrook, CI				Schellekens, M; Hoppeler, R; Perrin, A; Gomes, JV; Boiron, D; Aspect, A; Westbrook, CI			Hanbury Brown Twiss effect for ultracold quantum gases	SCIENCE			English	Article							INTERFEROMETRY; COLLISIONS; COHERENCE; ELECTRONS	We have studied two-body correlations of atoms in an expanding cloud above and below the Bose-Einstein condensation threshold. The observed correlation function for a thermal cloud shows a bunching behavior, whereas the correlation is flat for a coherent sample. These quantum correlations are the atomic analog of the Hanbury Brown Twiss effect. We observed the effect in three dimensions and studied its dependence on cloud size.	CNRS, Ctr Sci Orsay, UMR 8501, Lab Charles Fabry,Inst Opt, F-91403 Orsay, France; Univ Minho, Dept Fis, P-4710057 Braga, Portugal	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Universidade do Minho	Westbrook, CI (corresponding author), CNRS, Ctr Sci Orsay, UMR 8501, Lab Charles Fabry,Inst Opt, Batiment 503, F-91403 Orsay, France.	christoph.westbrook@iota.u-psud.fr	Perrin, Aurélien/C-2109-2008; Westbrook, Christoph I/B-6092-2009	Perrin, Aurélien/0000-0001-5195-438X; Westbrook, Christoph I/0000-0002-6490-0468				ARECCHI FT, 1966, PHYS LETT, V20, P27, DOI 10.1016/0031-9163(66)91034-1; Baym G, 1998, ACTA PHYS POL B, V29, P1839; Bell J.S., 2004, SPEAKABLE UNSPEAKABL, P14; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; BROWN RH, 1956, NATURE, V178, P1046; BROWN RH, 1956, NATURE, V177, P27, DOI 10.1038/177027a0; Burt EA, 1997, PHYS REV LETT, V79, P337, DOI 10.1103/PhysRevLett.79.337; Deng L, 1999, NATURE, V398, P218, DOI 10.1038/18395; FANO U, 1961, AM J PHYS, V29, P539, DOI 10.1119/1.1937827; Folling S, 2005, NATURE, V434, P481, DOI 10.1038/nature03500; GLAUBER RJ, 1963, PHYS REV LETT, V10, P84, DOI 10.1103/PhysRevLett.10.84; GLAUBER RJ, 1965, QUANTUM OPTICS ELECT, P63; Greiner M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.110401; Henny M, 1999, SCIENCE, V284, P296, DOI 10.1126/science.284.5412.296; Jagutzki O, 2002, NUCL INSTRUM METH A, V477, P244, DOI 10.1016/S0168-9002(01)01839-3; KAGAN Y, 1985, JETP LETT+, V42, P209; Kiesel H, 2002, NATURE, V418, P392, DOI 10.1038/nature00911; Naraschewski M, 1999, PHYS REV A, V59, P4595, DOI 10.1103/PhysRevA.59.4595; Oliver WD, 1999, SCIENCE, V284, P299, DOI 10.1126/science.284.5412.299; Ottl A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090404; Robert A, 2001, SCIENCE, V292, P461, DOI 10.1126/science.1060622; Stas RJW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.053001; Tolra BL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190401; Vogels JM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.020401; Yasuda M, 1996, PHYS REV LETT, V77, P3090, DOI 10.1103/PhysRevLett.77.3090	25	261	262	4	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					648	651		10.1126/science.1118024	http://dx.doi.org/10.1126/science.1118024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16166479	Green Submitted			2022-12-28	WOS:000232997700033
J	Dalziel, SR; Lim, VK; Lambert, A; McCarthy, D; Parag, V; Rodgers, A; Harding, JE				Dalziel, SR; Lim, VK; Lambert, A; McCarthy, D; Parag, V; Rodgers, A; Harding, JE			Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIRTH; CORTICOSTEROIDS; CHILDREN; OUTCOMES; AGE	Objectives To determine if antenatal exposure to betamethasone for the prevention of neonatal respiratory distress syndrome alters psychological functioning and health related quality of life in adulthood. Design Follow-up of the first and largest double blind, placebo controlled, randomised trial of a single course of antenatal betamethasone for the prevention of neonatal respiratory distress syndrome. Setting Tertiary obstetric hospital in Auckland, New Zealand. Participants 192 adult offspring, mean age 31 years, of mothers who took part in a randomised controlled trial of antenatal betamethasone for the prevention of neonatal respiratory distress syndrome (87 exposed to betamethasone and 105 exposed to placebo). Interventions Mothers received two doses of betamethasone or placebo 24 hours apart. Main outcome measures Cognitive functioning assessed with Wechsler abbreviated scale of intelligence; working memory and attention assessed with Benton visual retention test, paced auditory serial addition test, and Brown attention deficit disorder scale; psychiatric morbidity assessed with Beck depression inventory II, state-trait anxiety inventory, and schizotypy traits questionnaire; handedness assessed with Edinburgh handedness inventory; health related quality of life assessed with short form 36 health survey. Results No differences were found between groups exposed to betamethasone and placebo in cognitive functioning, working memory and attention, psychiatric morbidity, handedness, or health related quality of life. Conclusions Prenatal exposure to a single course of betamethasone does not alter cognitive functioning, working memory and attention, psychiatric morbidity, handedness, or health related quality of life in adulthood. Obstetricians should continue to use a single course of antenatal betamethasone for the prevention of neonatal respiratory distress syndrome.	Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand; Univ Auckland, Dept Psychol, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Harding, JE (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	j.harding@auckland.ac.nz	Lim, Vanessa/A-7158-2010; Harding, Jane E/J-5853-2015	Harding, Jane E/0000-0003-2697-1422; Lambert, Anthony/0000-0001-5715-8245; Rodgers, Anthony/0000-0003-1282-1896				[Anonymous], 1984, J PEDIATR-US, V104, P259; [Anonymous], 1994, NIH Consens Statement, V12, P1; Beck A. T., 1996, BECK DEPRESSION INVE; Beck AT, 1996, PSYCHOL ASSESS; Brown TE., 1996, BROWN ATTENTION DEFI; Castro L, 2004, PEDIATRICS, V114, P404, DOI 10.1542/peds.114.2.404; CLARIDGE G, 1984, PERS INDIV DIFFER, V5, P633, DOI 10.1016/0191-8869(84)90111-9; Crowley P, 2007, COCHRANE DB SYST REV, V18, DOI [10.1002/14651858.CD000065, DOI 10.1002/14651858.CD000065, 10.1002/14651858.CD000065.pub2, DOI 10.1002/14651858.CD000065.PUB2]; Dalziel SR, 2005, LANCET, V365, P1856, DOI 10.1016/S0140-6736(05)66617-2; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; Doyle LW, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e2; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Huang SJ, 2001, J VAC SCI TECHNOL B, V19, P115, DOI 10.1116/1.1335678; LIGGINS GC, 1972, PEDIATRICS, V50, P515; MACARTHUR BA, 1982, PEDIATRICS, V70, P99; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Scott KM, 1999, AUST NZ J PUBL HEAL, V23, P401, DOI 10.1111/j.1467-842X.1999.tb01282.x; Sivan A.B., 1992, BENTON VISUAL RETENT; Spielberger C. D., 1983, MIND GARDEN; Tin W, 1998, ARCH DIS CHILD-FETAL, V79, pF83, DOI 10.1136/fn.79.2.F83; Wechsler D., 2007, WASI 2 WECHSLER ABBR; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089	25	120	129	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2005	331	7518					665	668A		10.1136/bmj.38576.494363.E0	http://dx.doi.org/10.1136/bmj.38576.494363.E0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970HH	16143712	Green Published, Bronze			2022-12-28	WOS:000232295400017
J	Inoue, J; Ohno, H				Inoue, J; Ohno, H			Taking the Hall effect for a spin	SCIENCE			English	Editorial Material							SEMICONDUCTORS		Nagoya Univ, Grad Sch Engn, Dept Appl Phys, Chikusa Ku, Nagoya, Aichi 4648603, Japan; Tohoku Univ, Res Inst Elect Commun, Lab Nanoelect & Spintron, Aoba Ku, Sendai, Miyagi 9808577, Japan; Japan Sci & Technol Agcy, ERATO, Semicond Spintron Project, Aoba Ku, Sendai, Miyagi 9800023, Japan	Nagoya University; Tohoku University; Japan Science & Technology Agency (JST)	Inoue, J (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Appl Phys, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	ohno@riec.tohoku.ac.jp	Ohno, Hideo/E-6453-2010	Ohno, Hideo/0000-0001-9688-8259				Bauer GEW, 2004, SCIENCE, V306, P1898, DOI 10.1126/science.1106931; Berger L, 1970, PHYS REV B-SOLID ST, V2, P4559, DOI 10.1103/PhysRevB.2.4559; Bernevig BA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.016801; Dyakonov M I, 1971, PISMA ESKP TEOR FIZ, V13, P657; Hall E H, 1880, PHILOS MAG, V10, P301; Hall E.H., 1879, AM J MATH, V2, P287, DOI DOI 10.2307/2369245; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Inoue J, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.041303; Jungwirth T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207208; KARPLUS R, 1954, PHYS REV, V95, P1154, DOI 10.1103/PhysRev.95.1154; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; LAUGHLIN RB, 1998, COMMUNICATION; Mott N.F., 1936, P R SOC LONDON, V153, P699, DOI [10.1098/rspa.1936.0031, DOI 10.1098/RSPA.1936.0031]; Mott NF, 1936, P R SOC LONDON, V156, P368; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Murakami S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156804; Ohno H, 1999, J MAGN MAGN MATER, V200, P110, DOI 10.1016/S0304-8853(99)00444-8; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; SMIT J, 1958, PHYSICA, V24, P39, DOI 10.1016/S0031-8914(58)93541-9; VONKLITZING K, 1985, COMMUNICATION; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204	21	40	41	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2004	2005		10.1126/science.1113956	http://dx.doi.org/10.1126/science.1113956			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179462				2022-12-28	WOS:000232181900031
J	Rubin, KH; van der Zander, I; Smith, MC; Bergmanis, EC				Rubin, KH; van der Zander, I; Smith, MC; Bergmanis, EC			Minimum speed limit for ocean ridge magmatism from Pb-210-Ra-226-Th-230 disequilibria	NATURE			English	Article							U-SERIES; RADIOACTIVE DISEQUILIBRIA; AXIAL VOLCANO; LAVAS; CONSTRAINTS; BENEATH; EMPLACEMENT; SYSTEMATICS; GENERATION; INFERENCES	Although 70 per cent of global crustal magmatism occurs at mid-ocean ridges(1) - where the heat budget controls crustal structure, hydrothermal activity and a vibrant biosphere - the tempo of magmatic inputs in these regions remains poorly understood. Such timescales can be assessed, however, with natural radioactive-decay- chain nuclides, because chemical disruption to secular equilibrium systems initiates parent - daughter disequilibria, which re- equilibrate by the shorter half- life in a pair. Here we use (210) Pb - (226) Ra - (230) Th radioactive disequilibria and other geochemical attributes in oceanic basalts less than 20 years old to infer that melts of the Earth's mantle can be transported, accumulated and erupted in a few decades. This implies that magmatic conditions can fluctuate rapidly at ridge volcanoes. (210) Pb deficits of up to 15 per cent relative to (226) Ra occur in normal mid- ocean ridge basalts, with the largest deficits in the most magnesium- rich lavas. The 22- year half- life of (210) Pb requires very recent fractionation of these two uranium- series nuclides. Relationships between (210) Pb- deficits, ( (226) Ra/ (230) Th) activity ratios and compatible trace- element ratios preclude crustal- magma differentiation or daughter- isotope degassing as the main causes for the signal. A mantle- melting model(2) can simulate observed disequilibria but preservation requires a subsequent mechanism to transport melt rapidly. The likelihood of magmatic disequilibria occurring before melt enters shallow crustal magma bodies also limits differentiation and heat replenishment timescales to decades at the localities studied.	Univ Hawaii, Hawaii Ctr Volcanol, Dept Geol & Geophys, Honolulu, HI 96822 USA	University of Hawaii System	Rubin, KH (corresponding author), Univ Hawaii, Hawaii Ctr Volcanol, Dept Geol & Geophys, 1680 East West Rd, Honolulu, HI 96822 USA.	krubin@hawaii.edu	Rubin, Kenneth H/B-3685-2008	Rubin, Kenneth H/0000-0002-8554-1337				Blundy J, 2003, REV MINERAL GEOCHEM, V52, P59, DOI 10.2113/0520059; Chadwick J, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2003JB002767; Cherniak DJ, 1998, CHEM GEOL, V150, P105, DOI 10.1016/S0009-2541(98)00056-4; CONDOMINES M, 1981, EARTH PLANET SC LETT, V55, P247, DOI 10.1016/0012-821X(81)90104-7; CRISP JA, 1984, J VOLCANOL GEOTH RES, V20, P177, DOI 10.1016/0377-0273(84)90039-8; Embley RW, 1999, GEOPHYS RES LETT, V26, P3425, DOI 10.1029/1999GL002328; Garcia MO, 1998, B VOLCANOL, V59, P577, DOI 10.1007/s004450050211; Gauthier PJ, 1999, EARTH PLANET SC LETT, V172, P111, DOI 10.1016/S0012-821X(99)00195-8; GILL JB, 1990, GEOCHIM COSMOCHIM AC, V54, P1427, DOI 10.1016/0016-7037(90)90166-I; Jull M, 2002, GEOCHIM COSMOCHIM AC, V66, P4133, DOI 10.1016/S0016-7037(02)00984-5; McKenzie D, 2000, CHEM GEOL, V162, P81, DOI 10.1016/S0009-2541(99)00126-6; OVERSBY VM, 1968, EARTH PLANET SC LETT, V5, P199, DOI 10.1016/S0012-821X(68)80040-8; Perfit MR, 1998, GEOPH MONOG SERIES, V106, P59; Pietruszka AJ, 2001, EARTH PLANET SC LETT, V186, P15, DOI 10.1016/S0012-821X(01)00230-8; Rubin K, 1997, GEOCHIM COSMOCHIM AC, V61, P3525, DOI 10.1016/S0016-7037(97)00179-8; RUBIN KH, 1989, NATURE, V341, P50, DOI 10.1038/341050a0; RUBIN KH, 1988, NATURE, V335, P158, DOI 10.1038/335158a0; RUBIN KH, 1994, NATURE, V368, P841, DOI 10.1038/368841a0; Rubin KH, 2001, CHEM GEOL, V175, P723, DOI 10.1016/S0009-2541(00)00340-5; Rubin KH, 2001, EARTH PLANET SC LETT, V188, P349, DOI 10.1016/S0012-821X(01)00339-9; RUBIN KH, 1989, J VOLCANOL GEOTH RES, V38, P215, DOI 10.1016/0377-0273(89)90038-3; Saal AE, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000620; Sigmarsson O, 1996, NATURE, V382, P440, DOI 10.1038/382440a0; Sims KWW, 2002, GEOCHIM COSMOCHIM AC, V66, P3481, DOI 10.1016/S0016-7037(02)00909-2; Sims KWW, 1999, GEOCHIM COSMOCHIM AC, V63, P4119, DOI 10.1016/S0016-7037(99)00313-0; Sinton J, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000090; SMITH MC, 1994, J GEOPHYS RES-SOL EA, V99, P4787, DOI 10.1029/93JB02158; Turner S, 2004, EARTH PLANET SC LETT, V227, P1, DOI 10.1016/j.epsl.2004.08.017; West M, 2001, NATURE, V413, P833, DOI 10.1038/35101581; WILLIAMS RW, 1989, GEOCHIM COSMOCHIM AC, V53, P1607	30	96	97	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					534	538		10.1038/nature03993	http://dx.doi.org/10.1038/nature03993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177787				2022-12-28	WOS:000232004800046
J	Philipson, L				Philipson, L			Medical research activities, funding, and creativity in Europe - Comparison with research in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNION		Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Philipson, L (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	lennart.philipson@cmb.ki.se						*EUR COMM, 2002, B1049 EUR COMM; Evers K, 2002, NEW ENGL J MED, V346, P1579, DOI 10.1056/NEJMsb020527; Goffeau A, 1997, NATURE, V387, P5, DOI DOI 10.1038/387005B0.PUBMED:9169864; Moore A, 2004, EMBO REP, V5, P935, DOI 10.1038/sj.embor.7400268; Soteriades ES, 2005, BRIT MED J, V331, P192, DOI 10.1136/bmj.331.7510.192; van Dyck L, 2005, EMBO REP, V6, P194, DOI 10.1038/sj.embor.7400367	6	20	22	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1394	1398		10.1001/jama.294.11.1394	http://dx.doi.org/10.1001/jama.294.11.1394			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174700				2022-12-28	WOS:000231987800015
J	Menard, C; Hagege, AA; Agbulut, O; Barro, M; Morichetti, MC; Brasselet, C; Bel, A; Messas, E; Bissery, A; Bruneval, P; Desnos, M; Puceat, M; Menasche, P				Menard, C; Hagege, AA; Agbulut, O; Barro, M; Morichetti, MC; Brasselet, C; Bel, A; Messas, E; Bissery, A; Bruneval, P; Desnos, M; Puceat, M; Menasche, P			Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study	LANCET			English	Article							BONE-MARROW-CELLS; DIFFERENTIATION; CARDIOMYOCYTES; IDENTIFICATION; INTEGRATION; EXPRESSION; MYOCYTES; REQUIRES; PATHWAY; REGIONS	Background Heart failure develops after myocardial infarction and is a major cause of morbidity and mortality. The ability to direct differentiation of embryonic stem cells (ESC) towards a cardiomyogenic phenotype makes them an attractive therapeutic option for cardiac repair, but species-specific and individual-specific immunological imprinting remains a hurdle. Our aim was to ascertain whether the purported immune privilege of ESC allows for their cross-species engraftment in a clinically relevant large-animal model. Methods We studied engraftment and differentiation of cardiac-committed mouse ESC in 18 sheep in which a myocardial infarction had been induced; nine controls received medium and nine sheep (five of which were immunosuppressed) received ESC. The gain in myocardial function was measured by echocardiography 1 month after cell transplantation. Findings Cardiac-committed murine ESC engrafted in infarcted myocardium of immunosuppressed and immunocompetent sheep, and differentiated into mature cardiomyocytes that expressed connexins. Colonisation. of the scar area by ESC was accompanied by a functional benefit of the damaged myocardium. Left-ventricular ejection fraction deteriorated in the control group by a median of 9.9% (range -20 to 0.3) relative to baseline (p=0.011) whereas in the treated group it improved by 6.6% (-5.7 to 50.8; comparison between groups p=0.002). Interpretation These findings obtained in a clinically relevant large-animal model of heart failure strengthen the potential therapeutic use of ESC to regenerate the severely dysfunctional myocardium and bring additional evidence for an immune privilege of these cells.	CNRS, FRE 2593, Ctr Rech Biochim Macromol, F-34293 Montpellier, France; Univ Paris 05, Fac Med, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris,Dept Pathol, Paris, France; Univ Paris 05, Fac Med, Dept Cardiol, Paris, France; Univ Paris 05, Fac Med, Dept Cardiovasc Surg, Paris, France; Univ Paris 05, Fac Med, Clin Invest Ctr 92010, Paris, France; INSERM, U430, Paris, France; INSERM, U633, Lab Etud Greffes & Protheses Cardiaque, Paris, France; CHU Robert Debre, Assistance Publ Hop Paris, Ecole Chirurg, Reims, France; CHU Robert Debre, Dept Cardiol, Reims, France; Univ Paris 07, UFR Biochim, Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); CHU de Reims; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Reims; UDICE-French Research Universities; Universite Paris Cite	Puceat, M (corresponding author), CNRS, FRE 2593, Ctr Rech Biochim Macromol, F-34293 Montpellier, France.	michel.puceat@crbm.cnrs.fr	PUCEAT, michel/R-6140-2017	PUCEAT, michel/0000-0001-9055-7563; Agbulut, Onnik/0000-0003-1923-8871; HAGEGE, Albert/0000-0003-4685-6077				Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beghetti M, 1997, AM HEART J, V134, P1107; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Bel A, 2003, CIRCULATION, V108, P247, DOI 10.1161/01.cir.0000089040.11131.d4; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Braunwald E, 2000, CIRCULATION, V102, P14; Camelliti P, 2004, CARDIOVASC RES, V62, P415, DOI 10.1016/j.cardiores.2004.01.027; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Chiu RCJ, 2004, INT J CARDIOL, V95, pS43, DOI 10.1016/S0167-5273(04)90012-5; Deten A, 2005, CARDIOVASC RES, V65, P52, DOI 10.1016/j.cardiores.2004.11.009; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; ELDIN P, 1993, BIOCHEMISTRY-US, V32, P2542, DOI 10.1021/bi00061a011; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Fabricius D, 2005, TRANSPLANTATION, V79, P1040, DOI 10.1097/01.TP.0000159142.62535.37; FRANDRICH F, 2002, NAT MED, V8, P171; Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9; Ghostine S, 2002, CIRCULATION, V106, pI131, DOI 10.1161/01.cir.0000032889.55215.f1; Hodgson DM, 2004, AM J PHYSIOL-HEART C, V287, pH471, DOI 10.1152/ajpheart.01247.2003; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Mandon-Pepin B, 2003, BIOL REPROD, V68, P985, DOI 10.1095/biolreprod.102.008557; Meyer N, 2000, FEBS LETT, V478, P151, DOI 10.1016/S0014-5793(00)01839-1; Min JY, 2003, J THORAC CARDIOV SUR, V125, P361, DOI 10.1067/mtc.2003.101; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Ogata K, 2004, J HEART LUNG TRANSPL, V23, P515, DOI 10.1016/j.healun.2003.07.007; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajasinghe HA, 1996, TRANSPLANTATION, V62, P407, DOI 10.1097/00007890-199608150-00018; Reecy JM, 1999, DEVELOPMENT, V126, P839; Reinecke H, 2004, CIRC RES, V94, pE56, DOI 10.1161/01.RES.0000125294.04612.81; Rudy Y, 2004, CIRC RES, V94, P709, DOI 10.1161/01.RES.0000125647.56687.D3; Savatier P, 1996, ONCOGENE, V12, P309; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Tam P.P.L., 1999, HEART DEV, DOI [10.1016/b978-012329860-7/50003-9, DOI 10.1016/B978-012329860-7/50003-9]; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Xiao YF, 2004, ANN THORAC SURG, V77, P737, DOI 10.1016/j.athoracsur.2003.08.036; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326; Yoon YS, 2004, CIRCULATION, V109, P3154, DOI 10.1161/01.CIR.0000134696.08436.65	44	222	249	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					1005	1012		10.1016/S0140-6736(05)67380-1	http://dx.doi.org/10.1016/S0140-6736(05)67380-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168783				2022-12-28	WOS:000231955900036
J	Gandia-Herrero, F; Garcia-Carmona, F; Escribano, J				Gandia-Herrero, F; Garcia-Carmona, F; Escribano, J			Floral fluorescence effect	NATURE			English	Editorial Material									Univ Murcia, Dept Bioquim & Biol Mol A, Unidad Docente Biol, Fac Vet, E-30100 Murcia, Spain	University of Murcia	Gandia-Herrero, F (corresponding author), Univ Murcia, Dept Bioquim & Biol Mol A, Unidad Docente Biol, Fac Vet, E-30100 Murcia, Spain.	gcarmona@um.es	ESCRIBANO CEBRIAN, JOSEFA/K-9113-2017; Garcia-Carmona, Francisco/K-6520-2017; Gandia-Herrero, Fernando/L-9027-2014	ESCRIBANO CEBRIAN, JOSEFA/0000-0003-0529-1786; Gandia-Herrero, Fernando/0000-0003-4389-3454; Garcia-Carmona, Francisco/0000-0002-1318-7690				Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; De Ibarra NH, 2000, J EXP BIOL, V203, P3289; Gandia-Herrero F, 2005, J CHROMATOGR A, V1078, P83, DOI 10.1016/j.chroma.2005.05.013; Gandia-Herrero F, 2005, PLANT PHYSIOL, V138, P421, DOI 10.1104/pp.104.057992; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; Heiling AM, 2003, NATURE, V421, P334, DOI 10.1038/421334a; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; Vorobyev M, 2001, COLOR RES APPL, V26, pS214, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL45>3.0.CO;2-A; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971	10	76	79	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					334	334		10.1038/437334a	http://dx.doi.org/10.1038/437334a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163341				2022-12-28	WOS:000231849100035
J	Kaka, S; Pufall, MR; Rippard, WH; Silva, TJ; Russek, SE; Katine, JA				Kaka, S; Pufall, MR; Rippard, WH; Silva, TJ; Russek, SE; Katine, JA			Mutual phase-locking of microwave spin torque nano-oscillators	NATURE			English	Article							DRIVEN; RADIATION; EMISSION	The spin torque(1,2) effect that occurs in nanometre-scale magnetic multilayer devices can be used to generate steady-state microwave signals in response to a d.c. electrical current(3-8). This establishes a new functionality for magneto-electronic structures that are more commonly used as magnetic field sensors and magnetic memory elements(9). The microwave power emitted from a single spin torque nano-oscillator (STNO) is at present typically less than 1 nW. To achieve a more useful power level ( on the order of microwatts), a device could consist of an array of phase coherent STNOs, in a manner analogous to arrays of Josephson junctions and larger semiconductor oscillators(10-12). Here we show that two STNOs in close proximity mutually phase-lock - that is, they synchronize, which is a general tendency of interacting nonlinear oscillator systems(13-15). The phase-locked state is distinct, characterized by a sudden narrowing of signal linewidth and an increase in power due to the coherence of the individual oscillators. Arrays of phase-locked STNOs could be used as nanometre-scale reference oscillators. Furthermore, phase control of array elements ( phased array) could lead to nanometre-scale directional transmitters and receivers for wireless communications.	Natl Inst Stand & Technol, Div Electromagnet Technol, Boulder, CO 80305 USA; Hitachi San Jose Res Ctr, San Jose, CA 95120 USA	National Institute of Standards & Technology (NIST) - USA	Kaka, S (corresponding author), Natl Inst Stand & Technol, Div Electromagnet Technol, Boulder, CO 80305 USA.	shehzu21@gmail.com	Silva, Thomas J/C-7605-2013	Silva, Thomas J/0000-0001-8164-9642				BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; Bennett M, 2002, P ROY SOC A-MATH PHY, V458, P563, DOI 10.1098/rspa.2001.0888; BENZ SP, 1991, APPL PHYS LETT, V58, P2162, DOI 10.1063/1.104993; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Covington M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.184406; FINNEGAN TF, 1972, APPL PHYS LETT, V21, P541, DOI 10.1063/1.1654250; Katine JA, 2000, PHYS REV LETT, V84, P3149, DOI 10.1103/PhysRevLett.84.3149; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; Krivorotov IN, 2005, SCIENCE, V307, P228, DOI 10.1126/science.1105722; POPOVIC ZB, 1991, IEEE T MICROW THEORY, V39, P193, DOI 10.1109/22.102960; Razavi B, 2004, IEEE J SOLID-ST CIRC, V39, P1415, DOI 10.1109/JSSC.2004.831608; Rippard WH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067203; Rippard WH, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.100406; Russek SE, 2003, TOP APPL PHYS, V87, P93; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Slonczewski JC, 1999, J MAGN MAGN MATER, V195, pL261, DOI 10.1016/S0304-8853(99)00043-8; STROGATZ S, 2003, SYNC EMERGING SCI SP, V51, P116; SUHL H, 1956, P IRE, V44, P1270, DOI 10.1109/JRPROC.1956.274950; Tsoi M, 2000, NATURE, V406, P46, DOI 10.1038/35017512; WENGLER MJ, 1995, IEEE T MICROW THEORY, V43, P984, DOI 10.1109/22.375264; Wiesenfeld K, 1996, PHYS REV LETT, V76, P404, DOI 10.1103/PhysRevLett.76.404; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; YORK RA, 1993, IEEE T MICROW THEORY, V41, P1799, DOI 10.1109/22.247926	25	706	739	6	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					389	392		10.1038/nature04035	http://dx.doi.org/10.1038/nature04035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163351				2022-12-28	WOS:000231849100048
J	Lafon, M				Lafon, M			Bat rabies - the Achilles heel of a viral killer?	LANCET			English	Editorial Material							VIRUS GLYCOPROTEIN; VARIANTS		Inst Pasteur, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lafon, M (corresponding author), Inst Pasteur, F-75724 Paris, France.	mlafon@pasteur.fr		Lafon, Monique/0000-0002-4423-7996				Ceccaldi PE, 1998, J NEUROVIROL, V4, P115, DOI 10.3109/13550289809113489; Faber M, 2004, P NATL ACAD SCI USA, V101, P16328, DOI 10.1073/pnas.0407289101; Hemachudha T, 2003, J INFECT DIS, V188, P960, DOI 10.1086/378415; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lafon M, 2004, ARCH VIROL, P149; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Morimoto K, 2000, J NEUROVIROL, V6, P373, DOI 10.3109/13550280009018301; Prehaud C, 2003, J VIROL, V77, P10537, DOI 10.1128/JVI.77.19.10537-10547.2003; Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9	10	18	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					876	877		10.1016/S0140-6736(05)67297-2	http://dx.doi.org/10.1016/S0140-6736(05)67297-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16153999				2022-12-28	WOS:000231770000007
J	May, A				May, A			Cluster headache: pathogenesis, diagnosis, and management	LANCET			English	Review							BRAIN-STEM ACTIVATION; TRIGEMINAL AUTONOMIC CEPHALGIAS; SYMPATHETIC-NERVOUS-SYSTEM; PLACEBO-CONTROLLED TRIAL; GAMMA-KNIFE TREATMENT; HYPOTHALAMIC ACTIVATION; PROPHYLACTIC TREATMENT; PHARMACOLOGICAL-PROPERTIES; SUBCUTANEOUS SUMATRIPTAN; SODIUM VALPROATE	Cluster headache is a stereotyped primary pain syndrome characterised by strictly unilateral severe pain, localised in or around the eye and accompanied by ipsilateral autonomic features. The syndrome is characterised by the circadian rhythmicity of the short-lived attacks, and the regular recurrence of headache bouts, which are interspersed by periods of complete remission in most individuals. Headaches often start about 1-2 h after falling asleep or in the early morning, and show seasonal variation, suggesting that the hypothalamus has a role in the illness. Consequently, the vascular theory has been superseded by recognition that neurovascular factors are more important. The increased familial risk suggests that cluster headache has a genetic component in some families. Neuroimaging has broadened our pathophysiological view and has led to successful treatment by deep brain stimulation of the hypothalamus. Although most patients can be treated effectively, some do not respond to therapy. Fortunately, time to diagnosis of cluster headache has improved. This is probably the result of a better understanding of the pathophysiology in combination with efficient treatment strategies, leading to a broader acceptance of the syndrome by doctors.	Univ Hamburg, Hosp Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany	University of Hamburg	May, A (corresponding author), Univ Hamburg, Hosp Eppendorf, Dept Syst Neurosci, Martinistr 52, D-20246 Hamburg, Germany.	a.may@uke.uni-hamburg.de		May, Arne/0000-0002-3499-1506				Afridi SK, 2005, BRAIN, V128, P932, DOI 10.1093/brain/awh416; ANDERSSON PG, 1986, CEPHALALGIA, V6, P51, DOI 10.1046/j.1468-2982.1986.0601051.x; Anthony m, 1985, MIGRAINE CLIN RES AD, P169; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Bahra A, 2000, NEUROLOGY, V54, P1832, DOI 10.1212/WNL.54.9.1832; Bartsch T, 2004, PAIN, V109, P367, DOI 10.1016/j.pain.2004.02.005; Benjamin L, 2004, NEUROBIOL DIS, V16, P500, DOI 10.1016/j.nbd.2004.03.015; Black DF, 2002, CEPHALALGIA, V22, P201, DOI 10.1046/j.1468-2982.2002.00348.x; BOVIM G, 1992, HEADACHE, V32, P408; BRANDT T, 1991, NERVENARZT, V62, P329; BREDBERG U, 1986, EUR J CLIN PHARMACOL, V30, P75, DOI 10.1007/BF00614199; BUSSONE G, 1990, HEADACHE, V30, P411, DOI 10.1111/j.1526-4610.1990.hed3007411.x; Bussone G, 1999, ITAL J NEUROL SCI, V20, pS72, DOI 10.1007/PL00015008; CAMPBELL JK, 1993, J PAIN SYMPTOM MANAG, V8, P155, DOI 10.1016/0885-3924(93)90144-K; CHAZOT G, 1984, CEPHALALGIA, V4, P213, DOI 10.1046/j.1468-2982.1984.0404213.x; Cohen AS, 2004, CEPHALALGIA, V24, P1098; Costa A, 2000, CEPHALALGIA, V20, P85, DOI 10.1046/j.1468-2982.2000.00026.x; COUTURIER EGM, 1991, NEUROLOGY, V41, P761, DOI 10.1212/WNL.41.5.761; D'Amico D, 2002, CEPHALALGIA, V22, P818, DOI 10.1046/j.1468-2982.2002.00463.x; DALESSANDRO R, 1986, CEPHALALGIA, V6, P159, DOI 10.1046/j.1468-2982.1986.0603159.x; DECAROLIS P, 1987, HEADACHE, V27, P397; Dodick D W, 2001, Curr Pain Headache Rep, V5, P83, DOI 10.1007/s11916-001-0015-0; Dodick DW, 2000, CEPHALALGIA, V20, P787, DOI 10.1046/j.1468-2982.2000.00118.x; Dodick DW, 2004, HEADACHE, V44, pS20, DOI 10.1111/j.1526-4610.2004.04105.x; Donnet A, 2005, J NEUROL NEUROSUR PS, V76, P218, DOI 10.1136/jnnp.2004.041202; Drummond P D, 1994, Clin Auton Res, V4, P273, DOI 10.1007/BF01827433; DRUMMOND PD, 1988, CEPHALALGIA, V8, P181, DOI 10.1046/j.1468-2982.1988.0803181.x; DRUMMOND PD, 1988, BRAIN, V111, P1199, DOI 10.1093/brain/111.5.1199; EKBOM K, 1993, ACTA NEUROL SCAND, V88, P63; EKBOM K, 1968, ARCH NEUROL-CHICAGO, V19, P487, DOI 10.1001/archneur.1968.00480050057005; EKBOM K, 1991, NEW ENGL J MED, V325, P322, DOI 10.1056/nejm199108013250505; EKBOM K, 1990, CEPHALALGIA, V10, P195, DOI 10.1046/j.1468-2982.1990.1004195.x; EKBOM K, 1983, CEPHALALGIA, V3, P15, DOI 10.1046/j.1468-2982.1983.0301015.x; EKBOM K, 1987, CEPHALALGIA, V7, P21, DOI 10.1046/j.1468-2982.1987.0701021.x; Ekbom K, 1995, CEPHALALGIA, V15, P33; Ekbom K, 2002, DRUGS, V62, P61, DOI 10.2165/00003495-200262010-00003; EKBOM K, 1978, HEADACHE, V18, P9, DOI 10.1111/j.1526-4610.1978.hed1801009.x; Ekbom K, 2002, CEPHALALGIA, V22, P94, DOI 10.1046/j.1468-2982.2002.00318.x; EKBOM K, 1969, ACTA NEUROL SCAND, V45, P601; EKBOM K, 1981, HEADACHE, V21, P132, DOI 10.1111/j.1526-4610.1981.hed2104132.x; EKBOM K, 1970, ACTA NEUROL SCAND, V46, P225, DOI 10.1111/j.1600-0404.1970.tb05618.x; EKBOM K, 1995, CEPHALALGIA, V15, P230, DOI 10.1046/j.1468-2982.1995.015003230.x; Ekbom K, 1947, ACTA PSYCHIAT SCAND, V46, P106; El Amrani M, 2002, CEPHALALGIA, V22, P205, DOI 10.1046/j.1468-2982.2002.00349.x; El Amrani M, 2002, HEADACHE, V42, P974, DOI 10.1046/j.1526-4610.2002.02226.x; Evers S, 2002, CEPHALALGIA, V22, P699, DOI 10.1046/j.1468-2982.2002.00390.x; Evers S, 2002, CEPHALALGIA, V22, P160, DOI 10.1046/j.1468-2982.2002.00320.x; FANCIULLACCI M, 1982, CEPHALALGIA, V2, P135, DOI 10.1046/j.1468-2982.1982.0203135.x; FERRARI E, 1983, CEPHALALGIA, V3, P58, DOI 10.1177/03331024830030S107; FOGAN L, 1985, ARCH NEUROL-CHICAGO, V42, P362, DOI 10.1001/archneur.1985.04060040072015; Ford RG, 1998, HEADACHE, V38, P3, DOI 10.1046/j.1526-4610.1998.3801003.x; Forderreuther S, 2002, CEPHALALGIA, V22, P186, DOI 10.1046/j.1468-2982.2002.00339.x; Franzini A, 2003, NEUROSURGERY, V52, P1095, DOI 10.1227/01.NEU.0000057698.29634.D6; Frese A, 2003, CEPHALALGIA, V23, P67, DOI 10.1046/j.1468-2982.2003.00462.x; FUSCO BM, 1994, PAIN, V59, P321, DOI 10.1016/0304-3959(94)90017-5; GABAI IJ, 1989, HEADACHE, V29, P167, DOI 10.1111/j.1526-4610.1989.hed2903167.x; Gallagher R Michael, 2002, J Am Osteopath Assoc, V102, P92; Gallagher RM, 1996, HEADACHE, V36, P105, DOI 10.1046/j.1526-4610.1996.3602105.x; GARDNER WJ, 1947, J NEUROSURG, V4, P105, DOI 10.3171/jns.1947.4.2.0105; Geweke Lynne O, 2002, Curr Pain Headache Rep, V6, P76, DOI 10.1007/s11916-002-0028-3; Goadsby PJ, 1997, BRAIN, V120, P193, DOI 10.1093/brain/120.1.193; GOADSBY PJ, 1994, BRAIN, V117, P427, DOI 10.1093/brain/117.3.427; Goadsby PJ, 2002, LANCET NEUROL, V1, P251, DOI 10.1016/S1474-4422(02)00104-7; Goadsby PJ, 1999, CURR OPIN NEUROL, V12, P273, DOI 10.1097/00019052-199906000-00006; Gobel H, 1998, NEUROLOGY, V51, P908, DOI 10.1212/WNL.51.3.908; Graham J., 1966, NEW ENGL J MED, V270, P67; HANNERZ J, 1989, CEPHALALGIA, V9, P265, DOI 10.1046/j.1468-2982.1989.0904265.x; HARDEBO JE, 1994, HEADACHE, V34, P125, DOI 10.1111/j.1526-4610.1994.hed3403125.x; HARDEBO JE, 1991, HEADACHE, V31, P314, DOI 10.1111/j.1526-4610.1991.hed3105314.x; HERING R, 1989, CEPHALALGIA, V9, P195, DOI 10.1046/j.1468-2982.1989.0903195.x; Hering-Hanit R, 2001, Curr Pain Headache Rep, V5, P79, DOI 10.1007/s11916-001-0014-1; Hofman MA, 1996, ANAT RECORD, V244, P552, DOI 10.1002/(SICI)1097-0185(199604)244:4<552::AID-AR13>3.0.CO;2-O; ISLER H, 1993, CEPHALALGIA, V13, P172, DOI 10.1046/j.1468-2982.1993.1303172.x; Jarrar RG, 2003, NEUROLOGY, V60, P1360, DOI 10.1212/01.WNL.0000055902.23139.16; KUDROW L, 1987, CEPHALALGIA, V7, P197, DOI 10.1046/j.1468-2982.1987.0703197.x; KUDROW L, 1981, HEADACHE, V21, P1, DOI 10.1111/j.1526-4610.1981.hed2101001.x; Kudrow L., 1980, CLUSTER HEADACHE MEC; KUNKLE EC, 1952, T AM NEUROL ASSOC, P240; Lampl C, 2002, PEDIATR NEUROL, V27, P138, DOI 10.1016/S0887-8994(02)00406-X; Leone M, 1996, CEPHALALGIA, V16, P494, DOI 10.1046/j.1468-2982.1996.1607494.x; Leone M, 1999, ITAL J NEUROL SCI, V20, pS18, DOI 10.1007/PL00014991; Leone M, 2004, BRAIN, V127, P2259, DOI 10.1093/brain/awh245; Leone M, 2004, CEPHALALGIA, V24, P934, DOI 10.1111/j.1468-2982.2004.00742.x; Leone M, 1997, HEADACHE, V37, P559, DOI 10.1046/j.1526-4610.1997.3709559.x; Leone M, 2002, CEPHALALGIA, V22, P12, DOI 10.1046/j.1468-2982.2002.00312.x; Leone M, 2001, NEW ENGL J MED, V345, P1428, DOI 10.1056/NEJM200111083451915; Leone M, 2001, NEUROLOGY, V56, P1233, DOI 10.1212/WNL.56.9.1233; LEONE M, 1990, CEPHALALGIA, V10, P235, DOI 10.1046/j.1468-2982.1990.1005235.x; Leone M, 2000, NEUROLOGY, V54, P1382, DOI 10.1212/WNL.54.6.1382; Leone M, 2003, CEPHALALGIA, V23, P1001, DOI 10.1046/j.1468-2982.2003.00665.x; Leone Massimo, 2004, Curr Pain Headache Rep, V8, P347, DOI 10.1007/s11916-996-0007-1; Liano H, 1995, Rev Neurol, V23 Suppl 4, pS525; Lovely TJ, 1998, HEADACHE, V38, P590, DOI 10.1046/j.1526-4610.1998.3808590.x; Magnoux E, 2004, HEADACHE, V44, P249, DOI 10.1111/j.1526-4610.2004.04055.x; Malick A, 2000, J NEUROPHYSIOL, V84, P2078, DOI 10.1152/jn.2000.84.4.2078; Manzoni GC, 1999, CEPHALALGIA, V19, P88, DOI 10.1046/j.1468-2982.1999.019002088.x; MANZONI GC, 1983, CEPHALALGIA, V3, P109, DOI 10.1046/j.1468-2982.1983.0302109.x; MANZONI GC, 1983, CEPHALALGIA, V3, P21, DOI 10.1046/j.1468-2982.1983.0301021.x; Markley Herbert G, 2003, Curr Pain Headache Rep, V7, P139, DOI 10.1007/s11916-003-0024-2; MARKS DR, 1993, CEPHALALGIA, V13, P114, DOI 10.1046/j.1468-2982.1993.1302114.x; Martins IP, 2005, CEPHALALGIA, V25, P398, DOI 10.1111/j.1468-2982.2004.00870.x; Matharu MS, 2004, HEADACHE, V44, P747, DOI 10.1111/j.1526-4610.2004.04141.x; Matharu MS, 2003, DRUGS, V63, P1637, DOI 10.2165/00003495-200363160-00002; Matharu MS, 2003, EUR J NEUROL, V10, P53, DOI 10.1046/j.1468-1331.2003.00510.x; Matharu MS, 2002, BRAIN, V125, P976, DOI 10.1093/brain/awf118; May A, 1999, NEUROIMAGE, V9, P453, DOI 10.1006/nimg.1999.0427; May A, 1999, ANN NEUROL, V46, P791, DOI 10.1002/1531-8249(199911)46:5<791::AID-ANA18>3.0.CO;2-8; May A, 2003, CURR OPIN NEUROL, V16, P333, DOI 10.1097/00019052-200306000-00013; May A, 2004, NERVENHEILKUNDE, V23, P478; May A, 2003, J NEUROL, V250, P1273, DOI 10.1007/s00415-003-0241-y; May A, 1999, NAT MED, V5, P836, DOI 10.1038/10561; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; May A, 2000, NEUROLOGY, V55, P1328, DOI 10.1212/WNL.55.9.1328; May A, 1999, J CEREBR BLOOD F MET, V19, P115, DOI 10.1097/00004647-199902000-00001; McGeeney Brian E, 2003, Curr Pain Headache Rep, V7, P135, DOI 10.1007/s11916-003-0023-3; MEYER JS, 1985, HEADACHE, V25, P358, DOI 10.1111/j.1526-4610.1985.hed2507358.x; Mills TM, 1997, ANN PHARMACOTHER, V31, P914; Mir P, 2003, NEUROL SCI, V24, P318, DOI 10.1007/s10072-003-0182-3; Monstad I, 1995, HEADACHE, V35, P607, DOI 10.1111/j.1526-4610.1995.hed3510607.x; Mulder LJMM, 2002, CEPHALALGIA, V22, P815, DOI 10.1046/j.1468-2982.2002.00424.x; MULLER R, 1991, DEUT MED WOCHENSCHR, V116, P1433, DOI 10.1055/s-2008-1063769; NELSON RF, 1978, HEADACHE, V18, P265, DOI 10.1111/j.1526-4610.1978.hed1805265.x; Noll G, 1998, CARDIOLOGY, V89, P10, DOI 10.1159/000047274; Olesen J, 1999, HEADACHES, P731; ONOFRIO BM, 1986, MAYO CLIN PROC, V61, P537, DOI 10.1016/S0025-6196(12)62001-1; Peres MFP, 2002, CEPHALALGIA, V22, P520, DOI 10.1046/j.1468-2982.2002.00410.x; Pringsheim T, 2002, HEADACHE, V42, P787, DOI 10.1046/j.1526-4610.2002.02181.x; Purdy RA, 2004, NEUROL CLIN, V22, P39, DOI 10.1016/S0733-8619(03)00099-9; REIK L, 1987, HEADACHE, V27, P509, DOI 10.1111/j.1526-4610.1987.hed2709509.x; Remahl AIMN, 2003, CEPHALALGIA, V23, P504, DOI 10.1046/j.1468-2982.2003.00531.x; Remahl AIMN, 2002, CEPHALALGIA, V22, P730, DOI 10.1046/j.1468-2982.2002.00450.x; ROBBINS L, 1995, HEADACHE, V35, P83, DOI 10.1111/j.1526-4610.1995.hed3502083.x; Rozen TD, 2002, CEPHALALGIA, V22, P725, DOI 10.1046/j.1468-2982.2002.00432.x; Rozen TD, 2001, HEADACHE, V41, pS25; Russell M B, 1995, Eur J Neurol, V1, P253, DOI 10.1111/j.1468-1331.1995.tb00080.x; Russell MB, 2004, LANCET NEUROL, V3, P279, DOI 10.1016/S1474-4422(04)00735-5; RUSSELL MB, 1995, J NEUROL NEUROSUR PS, V58, P341, DOI 10.1136/jnnp.58.3.341; RUSSELL MB, 1995, J MED GENET, V32, P954, DOI 10.1136/jmg.32.12.954; Sanders M, 1997, J NEUROSURG, V87, P876, DOI 10.3171/jns.1997.87.6.0876; Sandrini G, 2004, EUR J NEUROL, V11, P217, DOI 10.1111/j.1468-1331.2003.00785.x; Saper JR, 2002, ARCH NEUROL-CHICAGO, V59, P990, DOI 10.1001/archneur.59.6.990; Schoenen J, 2005, BRAIN, V128, P940, DOI 10.1093/brain/awh411; Schuh-Hofer S, 2002, J NEUROL, V249, P94, DOI 10.1007/PL00007854; SICUTERI F, 1989, CLIN J PAIN, V5, P49, DOI 10.1097/00002508-198903000-00010; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2000, NEUROLOGY, V54, P219, DOI 10.1212/WNL.54.1.219; Siow HC, 2002, HEADACHE, V42, P136, DOI 10.1046/j.1526-4610.2002.02030.x; Sjaastad O, 2003, CEPHALALGIA, V23, P528, DOI 10.1046/j.1468-2982.2003.00585.x; SJAASTAD O, 1993, HEADACHE, V33, P214, DOI 10.1111/j.1526-4610.1993.hed33040214.x; Sjaastad O., 1992, CLUSTER HEADACHE SYN; Sorensen Sven Asger, 1993, P21; SPEIGHT TM, 1972, DRUGS, V3, P159, DOI 10.2165/00003495-197203030-00002; Sprenger T, 2005, PAIN, V113, P422, DOI 10.1016/j.pain.2004.09.021; Sprenger T, 2004, CEPHALALGIA, V24, P753, DOI 10.1111/j.1468-2982.2004.00753.x; Sprenger T, 2004, NEUROLOGY, V62, P516, DOI 10.1212/WNL.62.3.516; Steiner TJ, 1997, CEPHALALGIA, V17, P673, DOI 10.1046/j.1468-2982.1997.1706673.x; STOVNER LJ, 1995, CURR OPIN NEUROL, V8, P243, DOI 10.1097/00019052-199506000-00016; Strittmatter M, 1996, NEUROREPORT, V7, P1229, DOI 10.1097/00001756-199605170-00001; TAHA JM, 1995, HEADACHE, V35, P193, DOI 10.1111/j.1526-4610.1995.hed3504193.x; TFELTHANSEN P, 1999, CLUSTER HEADACHE REL, P257; TURKEWITZ LJ, 1992, HEADACHE, V32, P504, DOI 10.1111/j.1526-4610.1992.hed3210504.x; van Vliet JA, 2003, NEUROLOGY, V60, P630, DOI 10.1212/01.WNL.0000046589.45855.30; Vigl M, 2001, CEPHALALGIA, V21, P926, DOI 10.1046/j.1468-2982.2001.00282.x; WALDENLIND E, 1987, J NEUROL NEUROSUR PS, V50, P207, DOI 10.1136/jnnp.50.2.207; Waldenlind E, 1999, HEADACHES; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; WILKINSON M, 1995, CEPHALALGIA, V15, P337, DOI 10.1046/j.1468-2982.1995.1505337.x; Zebenholzer K, 2004, HEADACHE, V44, P361, DOI 10.1111/j.1526-4610.2004.04079.x	168	241	260	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2005	366	9488					843	855		10.1016/S0140-6736(05)67217-0	http://dx.doi.org/10.1016/S0140-6736(05)67217-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139660				2022-12-28	WOS:000231627000030
J	Rees, J				Rees, J			ABC of asthma - Methods of delivering drugs	BRITISH MEDICAL JOURNAL			English	Review									Guys Kings & St Thomass Sch Med, London SE1 9RT, England	University of London; King's College London	Rees, J (corresponding author), Guys Kings & St Thomass Sch Med, London SE1 9RT, England.	john.rees@kcl.ac.uk							0	11	11	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 3	2005	331	7515					504	506		10.1136/bmj.331.7515.504	http://dx.doi.org/10.1136/bmj.331.7515.504			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963RA	16141159	Green Published			2022-12-28	WOS:000231820400026
J	Claverie, JM				Claverie, JM			Fewer genes, more noncoding RNA	SCIENCE			English	Article							HUMAN GENOME; POLYMERASE; SEQUENCE; NUMBER	Recent studies showing that most "messenger" RNAs do not encode proteins finally explain the long-standing discrepancy between the small number of protein-coding genes found in vertebrate genomes and the much larger and ever-increasing number of polyadenylated transcripts identified by tag-sampling or microarray-based methods. Exploring the role and diversity of these numerous noncoding RNAs now constitutes a main challenge in transcription research.	Inst Biol Struct & Microbiol, Struct & Genom Informat Lab, CNRS, UPR 2589, F-13402 Marseille, France; Univ Mediterranee Sch Med, F-13385 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Claverie, JM (corresponding author), Inst Biol Struct & Microbiol, Struct & Genom Informat Lab, CNRS, UPR 2589, 31 Chemin Joseph Aiguier, F-13402 Marseille, France.	jean-michel.claverie@igs.cnrs-mrs.fr	Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019	Claverie, Jean-Michel/0000-0003-1424-0315; 				Boheler KR, 2003, TRENDS BIOTECHNOL, V21, P55, DOI 10.1016/S0167-7799(02)00031-8; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CHEN GJ, 2005, SCIENCE         0324, V308, P1149, DOI DOI 10.1126/SCIENCE.1108625; Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Davison DB, 2001, IBM J RES DEV, V45, P439, DOI 10.1147/rd.453.0439; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liang F, 2000, NUCLEIC ACIDS RES, V28, P3657, DOI 10.1093/nar/28.18.3657; Schadt EE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r73; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Shendure J, 2002, GENOME BIOL, V3; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wheeler DL, 2001, NUCLEIC ACIDS RES, V29, P11, DOI 10.1093/nar/29.1.11; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; 2000, NAT GENET, V25, P127	18	153	172	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1529	1530		10.1126/science.1116800	http://dx.doi.org/10.1126/science.1116800			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141064				2022-12-28	WOS:000231715000039
J	Hauser, MD				Hauser, MD			Beyond the chimpanzee genome: The threat of extinction	SCIENCE			English	Editorial Material									Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Biol Anthropol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Hauser, MD (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	mdh@wjh.harvard.edu						Cavalieri P., 1994, GREAT APE PROJECT EQ; DEWAAL F, 1982, CHIMPANZEE POLITICS; Goodall J., 1986, CHIMPANZEES GOMBE PA; HAUSER MD, 2000, WILD MINDS ANIMALS R; Huffman Michael A., 1994, P129; MATSUZAWA T, 2002, PRIMATE ORIGINS HUMA; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; PREMACK D, 2002, ORIGINAL INTELLIGENC; Tomasello M, 2003, TRENDS COGN SCI, V7, P153, DOI 10.1016/S1364-6613(03)00035-4; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Wrangham R., 1996, DEMONIC MALES	12	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1498	1499		10.1126/science.1111421	http://dx.doi.org/10.1126/science.1111421			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141053				2022-12-28	WOS:000231715000029
J	Zamore, PD; Haley, B				Zamore, PD; Haley, B			Ribo-gnome: The big world of small RNAs	SCIENCE			English	Review							DOUBLE-STRANDED-RNA; MESSENGER-RNA; GENE-REGULATION; POLYMERASE-II; MICRORNA; INTERFERENCE; HETEROCHROMATIN; DICER; DNA; METHYLATION	Small RNA guides-microRNAs, small interfering RNAs, and repeat-associated small interfering RNAs, 21 to 30 nucleotides in length-shape diverse cellular pathways, from chromosome architecture to stem cell maintenance. Fifteen years after the discovery of RNA silencing, we are only just beginning to understand the depth and complexity of how these RNAs regulate gene expression and to consider their role in shaping the evolutionary history of higher eukaryotes.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618	NIGMS NIH HHS [GM65236-01, GM62862-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862, R01GM065236] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Cox DN, 2000, DEVELOPMENT, V127, P503; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; HUTVAGNER G, 2005, SCIENCE, V309, P1518; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Schramke V, 2005, NATURE, V435, P1275, DOI 10.1038/nature03652; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	95	1062	1195	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1519	1524		10.1126/science.1111444	http://dx.doi.org/10.1126/science.1111444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141061				2022-12-28	WOS:000231715000036
J	Hughes, JF; Skaletsky, H; Pyntikova, T; Minx, PJ; Graves, T; Rozen, S; Wilson, RK; Page, DC				Hughes, JF; Skaletsky, H; Pyntikova, T; Minx, PJ; Graves, T; Rozen, S; Wilson, RK; Page, DC			Conservation of Y-linked genes during human evolution revealed by comparative sequencing in chimpanzee	NATURE			English	Article							MOLECULAR EVOLUTION; CHROMOSOME; SEX; CONVERSION; ALIGNMENT; MUTATION; GENOME	The human Y chromosome, transmitted clonally through males, contains far fewer genes than the sexually recombining autosome from which it evolved. The enormity of this evolutionary decline has led to predictions that the Y chromosome will be completely bereft of functional genes within ten million years(1,2). Although recent evidence of gene conversion within massive Y-linked palindromes runs counter to this hypothesis, most unique Y-linked genes are not situated in palindromes and have no gene conversion partners(3,4). The 'impending demise' hypothesis thus rests on understanding the degree of conservation of these genes. Here we find, by systematically comparing the DNA sequences of unique, Y-linked genes in chimpanzee and human, which diverged about six million years ago, evidence that in the human lineage, all such genes were conserved through purifying selection. In the chimpanzee lineage, by contrast, several genes have sustained inactivating mutations. Gene decay in the chimpanzee lineage might be a consequence of positive selection focused elsewhere on the Y chromosome and driven by sperm competition.	Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL)	Page, DC (corresponding author), Whitehead Inst, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	page_admin@wi.mit.edu	Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	Wilson, Richard K./0000-0002-1992-1358; Rozen, Steven G./0000-0002-4288-0056				Aitken RJ, 2002, NATURE, V415, P963, DOI 10.1038/415963a; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Casane D, 1997, J MOL EVOL, V45, P216, DOI 10.1007/PL00006223; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Filatov DA, 2000, NATURE, V404, P388, DOI 10.1038/35006057; Graves JAM, 2004, REPROD FERT DEVELOP, V16, P527, DOI 10.1071/RD03096; Hellmann I, 2003, GENOME RES, V13, P831, DOI 10.1101/gr.944903; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; RICE WR, 1987, GENETICS, V116, P161; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701	24	130	135	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					101	104		10.1038/nature04101	http://dx.doi.org/10.1038/nature04101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136134				2022-12-28	WOS:000231560400048
J	Im, YJ; Raychaudhuri, S; Prinz, WA; Hurley, JH				Im, YJ; Raychaudhuri, S; Prinz, WA; Hurley, JH			Structural mechanism for sterol sensing and transport by OSBP-related proteins	NATURE			English	Article							OXYSTEROL-BINDING-PROTEIN; PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; TOCOPHEROL TRANSFER PROTEIN; CRYSTAL-STRUCTURE; LIGAND-BINDING; LIPID-BINDING; DOMAIN; PHOSPHATIDYLCHOLINE; MEMBRANES; HOMOLOGS	The oxysterol-binding-protein (OSBP)-related proteins (ORPs) are conserved from yeast to humans(1,2), and are implicated in the regulation of sterol homeostasis(3,4) and in signal transduction pathways(5). Here we report the structure of the full-length yeast ORP Osh4 (also known as Kes1) at 1.5 - 1.9 angstrom resolution in complexes with ergosterol, cholesterol, and 7-, 20- and 25-hydroxycholesterol. We find that a single sterol molecule binds within a hydrophobic tunnel in a manner consistent with a transport function for ORPs. The entrance is blocked by a flexible amino-terminal lid and surrounded by basic residues that are critical for Osh4 function. The structure of the open state of a lid-truncated form of Osh4 was determined at 2.5 angstrom resolution. Structural analysis and limited proteolysis show that sterol binding closes the lid and stabilizes a conformation favouring transport across aqueous barriers and signal transmission. The structure of Osh4 in the absence of ligand exposes potential phospholipid-binding sites that are positioned for membrane docking and sterol exchange. On the basis of these observations, we propose a model in which sterol and membrane binding promote reciprocal conformational changes that facilitate a sterol transfer and signalling cycle.	NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; NIDDKD, Lab Cell Biochem & Biol, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Gwangju Inst Sci & Technol, Dept Life Sci, Gwangju City 500712, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Gwangju Institute of Science & Technology (GIST)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov		Raychaudhuri, Sumana/0000-0002-3164-0057	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118, Z01DK060004] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [Z01 DK036118-12] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Beh CT, 2001, GENETICS, V157, P1117; Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5; Choinowski T, 2000, BIOCHEMISTRY-US, V39, P1897, DOI 10.1021/bi992742e; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; KANDUTSCH AA, 1978, SCIENCE, V201, P498, DOI 10.1126/science.663671; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; LOPEZGARCIA F, 2000, J MOL BIOL, V0295; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; Olkkonen VM, 2004, BIOCHEM CELL BIOL, V82, P87, DOI 10.1139/o03-088; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Romanowski MJ, 2002, P NATL ACAD SCI USA, V99, P6949, DOI 10.1073/pnas.052140699; Schouten A, 2002, EMBO J, V21, P2117, DOI 10.1093/emboj/21.9.2117; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Williams S, 2003, J BIOL CHEM, V278, P27138, DOI 10.1074/jbc.M302260200; Wright CS, 2000, J MOL BIOL, V304, P411, DOI 10.1006/jmbi.2000.4225; Xu YQ, 2001, J BIOL CHEM, V276, P18407, DOI 10.1074/jbc.M101204200; Yoder MD, 2001, J BIOL CHEM, V276, P9246, DOI 10.1074/jbc.M010131200	30	318	328	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					154	158		10.1038/nature03923	http://dx.doi.org/10.1038/nature03923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136145	Green Accepted			2022-12-28	WOS:000231560400060
J	McBrearty, S; Jablonski, NG				McBrearty, S; Jablonski, NG			First fossil chimpanzee	NATURE			English	Article							KAPTHURIN FORMATION; PAN-TROGLODYTES; BARINGO; ORIGIN	There are thousands of fossils of hominins, but no fossil chimpanzee has yet been reported. The chimpanzee ( Pan) is the closest living relative to humans(1). Chimpanzee populations today are confined to wooded West and central Africa, whereas most hominin fossil sites occur in the semi-arid East African Rift Valley. This situation has fuelled speculation regarding causes for the divergence of the human and chimpanzee lineages five to eight million years ago. Some investigators have invoked a shift from wooded to savannah vegetation in East Africa, driven by climate change, to explain the apparent separation between chimpanzee and human ancestral populations and the origin of the unique hominin locomotor adaptation, bipedalism(2-5). The Rift Valley itself functions as an obstacle to chimpanzee occupation in some scenarios(6). Here we report the first fossil chimpanzee. These fossils, from the Kapthurin Formation, Kenya, show that representatives of Pan were present in the East African Rift Valley during the Middle Pleistocene, where they were contemporary with an extinct species of Homo. Habitats suitable for both hominins and chimpanzees were clearly present there during this period, and the Rift Valley did not present an impenetrable barrier to chimpanzee occupation.	Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA; Calif Acad Sci, Dept Anthropol, San Francisco, CA 94103 USA	University of Connecticut; California Academy of Sciences	McBrearty, S (corresponding author), Univ Connecticut, Dept Anthropol, Box U-2176, Storrs, CT 06269 USA.	mcbrearty@uconn.edu						ANEMONE RL, 1991, AM J PHYS ANTHROPOL, V86, P229, DOI 10.1002/ajpa.1330860211; Bishop Laura C., 1999, P99; COPPENS Y, 1994, SCI AM, V270, P88, DOI 10.1038/scientificamerican0594-88; Darwin C., 1871, P475; Dean MC, 2001, AM J PHYS ANTHROPOL, V116, P209, DOI 10.1002/ajpa.1116; Deino AL, 2002, J HUM EVOL, V42, P185, DOI 10.1006/jhev.2001.0517; JOHANSON DC, 1974, AM J PHYS ANTHROPOL, V41, P39, DOI 10.1002/ajpa.1330410106; JOHANSON DC, 1974, ODONTOLOGICAL STUDY; KINGSTON JD, 1994, SCIENCE, V264, P955, DOI 10.1126/science.264.5161.955; Kinzey W.G., 1984, P65; Kormos R., 2003, W AFRICAN CHIMPANZEE; KORTLANDT A, 1972, NEW PERSPECTIVES APE; KUYKENDALL KL, 1992, AM J PHYS ANTHROPOL, V89, P379, DOI 10.1002/ajpa.1330890310; Leakey M., 1969, P PREHIST SOC, V3, P48; Martyn J.E., 1969, THESIS U LONDON; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McBrearty S, 1996, J HUM EVOL, V30, P563, DOI 10.1006/jhev.1996.0043; McBrearty Sally, 1999, P143; MCGREW W, 1996, GREAT APE SOC; MCGREW WC, 1981, J HUM EVOL, V10, P227, DOI 10.1016/S0047-2484(81)80061-9; Pilbeam D, 2004, CR PALEVOL, V3, P305, DOI 10.1016/j.crpv.2004.01.006; RENAUT RW, 2000, LAKE BASINS SPACE TI, P561; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Skinner MF, 2004, AM J PHYS ANTHROPOL, V123, P216, DOI 10.1002/ajpa.10314; Smith B. Holly, 1994, Yearbook of Physical Anthropology, V37, P177; Swindler D.R., 2002, PRIMATE DENTITION; Tallon P.W.J., 1978, GEOLOGICAL BACKGROUN, P361; Uchida A., 1996, CRANIODENTAL VARIATI; WOOD BA, 1986, AM J PHYS ANTHROPOL, V69, P117, DOI 10.1002/ajpa.1330690113	29	101	108	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					105	108		10.1038/nature04008	http://dx.doi.org/10.1038/nature04008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	960AC	16136135				2022-12-28	WOS:000231560400049
J	Patel, NA; Curiel, S; Sridharan, TK; Zhang, QZ; Hunter, TR; Ho, PTP; Torrelles, JM; Moran, JM; Gomez, JF; Anglada, G				Patel, NA; Curiel, S; Sridharan, TK; Zhang, QZ; Hunter, TR; Ho, PTP; Torrelles, JM; Moran, JM; Gomez, JF; Anglada, G			A disk of dust and molecular gas around a high-mass protostar	NATURE			English	Article							STAR-FORMATION; ACCRETION; OUTFLOW; OBJECTS; SYSTEM; HW2	The processes leading to the birth of low-mass stars such as our Sun have been well studied(1), but the formation of high-mass ( over eight times the Sun's mass, M-.) stars remains poorly understood(2). Recent studies suggest that high-mass stars may form through accretion of material from a circumstellar disk(3), in essentially the same way as low-mass stars form, rather than through the merging of several low-mass stars(4). There is as yet, however, no conclusive evidence(5,6). Here we report the presence of a flattened disk-like structure around a massive 15M(.) protostar in the Cepheus A region, based on observations of continuum emission from the dust and line emission from the molecular gas. The disk has a radius of about 330 astronomical units (AU) and a mass of 1 to 8 M(: It is oriented perpendicular to, and spatially coincident with, the central embedded powerful bipolar radio jet, just as is the case with low-mass stars, from which we conclude that high-mass stars can form through accretion.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Nacl Autonoma Mexico, Inst Astron, Mexico City 04510, DF, Mexico; Acad Sinica, Inst Astron & Astrophys, Taipei 115, Taiwan; CSIC, IEEC, E-08034 Barcelona, Spain; INTA, Lab Astrofis Espacial & Fis Fundamental, E-28080 Madrid, Spain; CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Universidad Nacional Autonoma de Mexico; Academia Sinica - Taiwan; Consejo Superior de Investigaciones Cientificas (CSIC); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA)	Patel, NA (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St,MS78, Cambridge, MA 02138 USA.	npatel@cfa.harvard.edu	Torrelles, Jose Maria/ABD-8181-2020; Ho, Paul/AAZ-5108-2020; Torrelles, Jose Maria/ABF-5543-2020; Gomez, Jose Francisco/D-8392-2016	Ho, Paul/0000-0002-3412-4306; Curiel, Salvador/0000-0003-4576-0436; Gomez, Jose Francisco/0000-0002-7065-542X; Zhang, Qizhou/0000-0003-2384-6589; Tirupati Kumara, Sridharan/0000-0001-5921-5784; Moran, James/0000-0002-3882-4414; Anglada, Guillem/0000-0002-7506-5429; Torrelles, Jose Maria/0000-0002-6896-6085; Hunter, Todd/0000-0001-6492-0090				BLITZ L, 1979, ASTROPHYS J, V227, P152, DOI 10.1086/156714; Bonnell IA, 2002, MON NOT R ASTRON SOC, V336, P659, DOI 10.1046/j.1365-8711.2002.05794.x; Cesaroni R, 1999, ASTRON ASTROPHYS, V345, P949; Chini R, 2004, NATURE, V429, P155, DOI 10.1038/nature02507; CURIEL S, UNPUB ASTROPHYS J; DEBUIZER J, IN PRESS ASTROPHYS J; EVANS NJ, 1981, ASTROPHYS J, V244, P115, DOI 10.1086/158690; Furuya RS, 2003, ASTROPHYS J SUPPL S, V144, P71, DOI 10.1086/342749; Gomez JF, 1999, ASTROPHYS J, V514, P287, DOI 10.1086/306916; HILDEBRAND RH, 1983, Q J ROY ASTRON SOC, V24, P267; Ho PTP, 2004, ASTROPHYS J, V616, pL1, DOI 10.1086/423245; HUGHES VA, 1995, MON NOT R ASTRON SOC, V272, P469, DOI 10.1093/mnras/272.2.469; HUGHES VA, 1984, ASTROPHYS J, V276, P204, DOI 10.1086/161603; Hunter TR, 2000, ASTRON J, V119, P2711, DOI 10.1086/301391; LADA CJ, 1990, SCIENCE, V248, P564, DOI 10.1126/science.248.4955.564; McKee CF, 2003, ASTROPHYS J, V585, P850, DOI 10.1086/346149; Pankonin V, 2001, ASTROPHYS J, V558, P194, DOI 10.1086/322249; RODRIGUEZ LF, 1994, ASTROPHYS J, V430, pL65, DOI 10.1086/187439; Rodriguez LF, 2001, REV MEX ASTRON ASTR, V37, P95; RODRIGUEZ LF, 1980, ASTROPHYS J, V240, pL149, DOI 10.1086/183342; Sako S, 2005, NATURE, V434, P995, DOI 10.1038/nature03471; SARGENT AI, 1977, ASTROPHYS J, V218, P736, DOI 10.1086/155729; Shepherd DS, 2001, SCIENCE, V292, P1513, DOI 10.1126/science.1059475; SHU FH, 1995, ASTROPHYS J, V455, pL155, DOI 10.1086/309838; Stahler S. W., 2000, Protostars and planets 4, P327; Torrelles JM, 1998, ASTROPHYS J, V509, P262, DOI 10.1086/306485; Torrelles JM, 1996, ASTROPHYS J, V457, pL107, DOI 10.1086/309903; Williams SJ, 2004, ASTRON ASTROPHYS, V417, P115, DOI 10.1051/0004-6361:20031733; Zhang QZ, 1998, ASTROPHYS J, V505, pL151, DOI 10.1086/311609	30	151	153	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					109	111		10.1038/nature04011	http://dx.doi.org/10.1038/nature04011			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136136	Green Submitted			2022-12-28	WOS:000231560400050
J	Sabin, CA; Phillips, AN; Yee, TT; Griffioen, A; Lee, CA				Sabin, CA; Phillips, AN; Yee, TT; Griffioen, A; Lee, CA			Twenty five years of HIV infection in haemophilic men in Britain: an observational study	BRITISH MEDICAL JOURNAL			English	Article							PROGRESSION; COHORT		Royal Free & UC Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Royal Free NHS Trust, Haemophilia Ctr, London, England; Royal Free NHS Trust, Haemostasis Unit, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Sabin, CA (corresponding author), Royal Free & UC Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England.	c.sabin@pcps.ucl.ac.uk	Sabin, Caroline/C-2464-2008; Yee, Thynn Thynn/H-5862-2012; Phillips, Andrew N/B-4427-2008	Sabin, Caroline/0000-0001-5173-2760; Phillips, Andrew N/0000-0003-2384-4807				CHORBA TL, 1994, AM J HEMATOL, V45, P112, DOI 10.1002/ajh.2830450204; LEE CA, 1989, BRIT J HAEMATOL, V73, P228, DOI 10.1111/j.1365-2141.1989.tb00257.x; LEE CA, 1990, LANCET, V335, P426; PHILLIPS A, 1989, AIDS, V3, P737, DOI 10.1097/00002030-198911000-00008; Quintana M, 2003, HAEMOPHILIA, V9, P605, DOI 10.1046/j.1365-2516.2003.00804.x	5	4	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 29	2005	331	7523					997	998		10.1136/bmj.38604.468785.DE	http://dx.doi.org/10.1136/bmj.38604.468785.DE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981AU	16169870	Bronze, Green Published			2022-12-28	WOS:000233060200017
J	Ivanov, D; Nasmyth, K				Ivanov, D; Nasmyth, K			A topological interaction between cohesin rings and a circular minichromosome	CELL			English	Article							SISTER-CHROMATID COHESION; DNA-REPLICATION; ATP HYDROLYSIS; SLIDING CLAMP; PROTEINS; CHROMOSOMES; YEAST; SEPARATION; COMPLEXES; BINDING	Sister chromatid cohesion depends on a multiprotein cohesin complex containing two SMC subunits, Smc1 and Smc3, that dimerize to form V-shaped molecules with ABC-like ATPase heads at the tips of their two arms. Cohesin's Smc1 and Smc3 "heads" are connected by an alpha kleisin subunit called Scc1, forming a tripartite ring with a diameter around 40 nm. We show here that some cohesin remains tightly bound to circular minichromosomes after their purification from yeast cells and that cleavage either of cohesin's ring or of the minichromosome's DNA destroys their association. This suggests that the stable association between cohesin and chromatin detected here is topological rather than physical, which is consistent with the notion that DNA is trapped inside cohesin rings.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Nasmyth, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	knasmyth@imp.univie.ac.at		Nasmyth, Kim/0000-0001-7030-4403; Ivanov, Dmitri/0000-0002-4806-1369				Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; AULT JG, 1989, CHROMOSOMA, V98, P33, DOI 10.1007/BF00293332; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; DESHAIES RJ, 1995, P NATL ACAD SCI USA, V92, P1182, DOI 10.1073/pnas.92.4.1182; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; THOMA F, 1984, J MOL BIOL, V177, P715, DOI 10.1016/0022-2836(84)90046-9; TINKER RL, 1994, EMBO J, V13, P5330, DOI 10.1002/j.1460-2075.1994.tb06867.x; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030	33	156	159	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 23	2005	122	6					849	860		10.1016/j.cell.2005.07.018	http://dx.doi.org/10.1016/j.cell.2005.07.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179255	Bronze			2022-12-28	WOS:000232130200010
J	Telfer, EE; Gosden, RG; Byskov, AG; Spears, N; Albertini, D; Andersen, CY; Anderson, R; Braw-Tal, R; Clarke, H; Gougeon, A; McLaughlin, E; McLaren, A; McNatty, K; Schatten, G; Silber, S; Tsafriri, A				Telfer, EE; Gosden, RG; Byskov, AG; Spears, N; Albertini, D; Andersen, CY; Anderson, R; Braw-Tal, R; Clarke, H; Gougeon, A; McLaughlin, E; McLaren, A; McNatty, K; Schatten, G; Silber, S; Tsafriri, A			On regenerating the ovary and generating controversy	CELL			English	Letter							GERMLINE STEM-CELLS		Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland; Cornell Univ, Weill Med Coll, Ithaca, NY 14853 USA; Rigshosp, Lab Reprod Biol, DK-2100 Copenhagen, Denmark; Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; Univ Edinburgh, Ctr Reprod Biol, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; Volcani Ctr, Inst Anim Sci, Bet Dagan, Israel; McGill Univ, Royal Victoria Hosp, Dept Obstet & Gynecol, Montreal, PQ H3A 1A1, Canada; INSERM, Fac Med Lyon Sud, F-69008 Lyon, France; Univ Newcastle, Reprod Sci Grp, ARC Ctr Excellence Biotechnol & Dev, Newcastle, NSW 2308, Australia; Gurdon Inst Canc & Dev Biol, Wellcome Trust Canc Res UK, Cambridge, England; Univ Pittsburgh, Sch Med, Pittsburgh Dev Ctr, Pittsburgh, PA USA; St Lukes Hosp, St Louis, MO USA; Weizmann Inst Sci, Bernhard Zondek Hormone Res Lab, IL-76100 Rehovot, Israel	University of Edinburgh; Cornell University; Rigshospitalet; University of Copenhagen; University of Edinburgh; University of Kansas; University of Kansas Medical Center; University of Edinburgh; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; McGill University; Royal Victoria Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Newcastle; Cancer Research UK; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Saint Luke's Hospital - Missouri; Weizmann Institute of Science	Telfer, EE (corresponding author), Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	evelyn.telfer@ed.ac.uk	Schatten, Gerald/B-3253-2009; Albertini, David/AAD-3856-2021; McLaughlin, Eileen/AAF-5588-2021; TSAFRIRI, ALEX/K-1609-2012; McLaughlin, Eileen A/G-7620-2013	Schatten, Gerald/0000-0001-5206-7782; Albertini, David/0000-0001-6536-2828; Andersen, Claus Yding/0000-0001-7681-253X; Telfer, Evelyn/0000-0003-1468-4610; McLaughlin, Eileen/0000-0002-5837-3876				Albertini DF, 2004, REPRODUCTION, V127, P513, DOI 10.1530/rep.1.00247; GOLDBERG C, 2005, BOSTON GLOBE    0728; Gosden RG, 2004, HUM REPROD UPDATE, V10, P193, DOI 10.1093/humupd/dmh023; Greenfeld C, 2004, BIOESSAYS, V26, P829, DOI 10.1002/bies.20094; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Telfer Evelyn E, 2004, Reprod Biol Endocrinol, V2, P24, DOI 10.1186/1477-7827-2-24	8	129	133	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					821	822		10.1016/j.cell.2005.09.004	http://dx.doi.org/10.1016/j.cell.2005.09.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179247	Bronze			2022-12-28	WOS:000232130200002
J	O'Loughlin, AJ; Hayward, C				O'Loughlin, AJ; Hayward, C			Ebstein's anomaly	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Vincents Hosp, Sydney, NSW 2010, Australia	St Vincents Hospital Sydney	O'Loughlin, AJ (corresponding author), St Vincents Hosp, Sydney, NSW 2010, Australia.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					E11	E11		10.1056/NEJMicm031104	http://dx.doi.org/10.1056/NEJMicm031104			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	966DS	16177244				2022-12-28	WOS:000232000400012
J	Dahlof, B; Sever, PS; Poulter, NR; Wedel, H; Beevers, DG; Caulfield, M; Collins, R; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J				Dahlof, B; Sever, PS; Poulter, NR; Wedel, H; Beevers, DG; Caulfield, M; Collins, R; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J		ASCOT Investigators	Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial	LANCET			English	Article							DOUBLE-BLIND; CALCIUM-ANTAGONISTS; HYPERTENSION; MORTALITY; MORBIDITY; INTERVENTION; MANAGEMENT; BLOCKERS; CORONARY; DISEASE	Background The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics and beta blockers used. For a given reduction in blood pressure, some suggested that newer agents would confer advantages over diuretics and P blockers. Our aim, therefore, was to compare the effect on non-fatal myocardial infarction and fatal CHD of combinations of atenolol with a thiazide versus amlodipine with perindopril. Methods We did a multicentre, prospective, randomised controlled trial in 19 257 patients with hypertension who were aged 40-79 years and had at least three other cardiovascular risk factors. Patients were assigned either amlodipine 5-10 mg adding perindopril 4-8 mg as required (amlodipine-based regimen; n=9639) or atenolol 50-100 mg adding bendroflumethiazide 1.25-2.5 mg and potassium as required (atenolol-based regimen; n=9618). Our primary endpoint was non-fatal myocardial infarction (including silent myocardial infarction) and fatal CHD. Analysis was by intention to treat Findings The study was stopped prematurely after 5.5 years' median follow-up and accumulated in total 106 153 patient-years of observation. Though not significant, compared with the atenolol-based regimen, fewer individuals on the amlodipine-based regimen had a primary endpoint (429 vs 474; unadjusted HR 0.90, 95% CI 0.79-1.02, p=0.1052), fatal and non-fatal stroke (327 vs 422; 0.77, 0.66-0.89, p=0.0003), total cardiovascular events and procedures (1362 vs 1602; 0.84, 0.78-0.90, p<0.0001), and all-cause mortality (738 vs 820; 0.89, 0.81-0.99, p=0.025). The incidence of developing diabetes was less on the amlodipine-based regimen (567 vs 799; 0.70, 0.63-0.78, p<0.0001). Interpretation The amlodipine-based regimen prevented more major cardiovascular events and induced less diabetes than the atenolol-based regimen. On the basis of previous trial evidence, these effects might not be entirely explained by better control of blood pressure, and this issue is addressed in the accompanying article. Nevertheless, the results have implications with respect to optimum combinations of antihypertensive agents.	Sahlgrens Univ Hosp, Dept Med, SE-41685 Gothenburg, Sweden; Univ London Imperial Coll Sci Technol & Med, London, England; Nord Sch Publ Hlth, Gothenburg, Sweden; City Hosp, Birmingham, W Midlands, England; Barts & London Queen Marys Sch Med & Dent, London, England; Radcliffe Infirm, Oxford OX2 6HE, England; Ulleval Hosp, Oslo, Norway; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Hosp Reykjavik, Reykjavik, Iceland; Univ Glasgow, Glasgow, Lanark, Scotland; Frederiksberg Univ Hosp, Frederiksberg, Denmark; Univ Cent Hosp, Helsinki, Finland; Beaumont Hosp, Dublin 9, Ireland; Royal Coll Surgeons Ireland, Dublin 2, Ireland; Karolinska Hosp, S-10401 Stockholm, Sweden	Sahlgrenska University Hospital; Imperial College London; University of Birmingham; University of London; Queen Mary University London; Radcliffe Infirmary; University of Oslo; University of Michigan System; University of Michigan; Landspitali National University Hospital; University of Glasgow; University of Helsinki; Helsinki University Central Hospital; Royal College of Surgeons - Ireland; Karolinska Institutet; Karolinska University Hospital	Dahlof, B (corresponding author), Sahlgrens Univ Hosp, Dept Med, SE-41685 Gothenburg, Sweden.	bjorn.dahlof@scri.se	Mehlsen, Jesper/AAA-5848-2022; Stanton, Alice V/F-4697-2012	Caulfield, Mark/0000-0001-9295-3594				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Carlberg B, 2004, LANCET, V364, P1684, DOI 10.1016/S0140-6736(04)17355-8; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Colhoun HM, 1998, J HYPERTENS, V16, P747, DOI 10.1097/00004872-199816060-00005; COLLINS R, 1994, TXB HYPERTENSION, P1156; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Furberg CD, 1996, CARDIOVASC DRUG THER, V10, P463, DOI 10.1007/BF00051111; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HANSSON L, 1994, TXB HYPERTENSION, P1142; *HYP DET FOLL UP P, 1979, JAMA-J AM MED ASSOC, V242, P2562; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2002, J HYPERTENS, V20, P1461, DOI 10.1097/00004872-200208000-00001; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713; O'Brien, 1996, Blood Press Monit, V1, P55; Opie LH, 2004, J HYPERTENS, V22, P1453, DOI 10.1097/01.hjh.0000133732.24501.9e; Poulter NR, 2004, LANCET, V363, P1478, DOI 10.1016/S0140-6736(04)16120-5; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Sever PS, 2001, J HYPERTENS, V19, P1139, DOI 10.1097/00004872-200106000-00020; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Turnbull F, 2003, LANCET, V362, P1527; Verdecchia P, 2005, HYPERTENSION, V46, P386, DOI 10.1161/01.HYP.0000174591.42889.a2; Verdecchia P, 2004, HYPERTENSION, V43, P963, DOI 10.1161/01.HYP.0000125726.92964.ab; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Zanchetti A, 2002, CIRCULATION, V106, P2422, DOI 10.1161/01.CIR.0000039288.86470.DD	32	2133	2377	2	113	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					895	906		10.1016/S0140-6736(05)67185-1	http://dx.doi.org/10.1016/S0140-6736(05)67185-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154016				2022-12-28	WOS:000231770000027
J	Hammes, A; Andreassen, TK; Spoelgen, R; Raila, J; Hubner, N; Schulz, H; Metzger, J; Schweigert, FJ; Luppa, PB; Nykjaer, A; Willnow, TE				Hammes, A; Andreassen, TK; Spoelgen, R; Raila, J; Hubner, N; Schulz, H; Metzger, J; Schweigert, FJ; Luppa, PB; Nykjaer, A; Willnow, TE			Role of endocytosis in cellular uptake of sex steroids	CELL			English	Article							HORMONE-BINDING GLOBULIN; CRANIAL SUSPENSORY LIGAMENT; TESTICULAR DESCENT; RAT EPIDIDYMIS; RECEPTOR GENE; MICE; PROTEIN; CRYPTORCHIDISM; TRANSPORT; PLASMA	Androgens and estrogens are transported bound to the sex hormone binding globulin (SHBG). SHBG is believed to keep sex steroids inactive and to control the amount of free hormones that enter cells by passive diffusion. Contrary to the free hormone hypothesis, we demonstrate that megalin, an endocytic receptor in reproductive tissues, acts as a pathway for cellular uptake of biologically active androgens and estrogens bound to SHBG. In line with this function, lack of receptor expression in megalin knockout mice results in impaired descent of the testes into the scrotum in males and blockade of vagina opening in females. Both processes are critically dependent on sex-steroid signaling, and similar defects are seen in animals treated with androgen- or estrogen-receptor antagonists. Thus, our findings uncover the existence of endocytic pathways for protein bound androgens and estrogens and their crucial role in development of the reproductive organs.	Aarhus Univ, Dept Biochem Med, DK-8000 Aarhus, Denmark; Receptlcon ApS, DK-8000 Aarhus, Denmark; Tech Univ Munich, Klinikum Rechts Isar, Inst Clin Chem & Pathobiochem, D-81675 Munich, Germany; Univ Potsdam, Inst Nutr Sci, D-14558 Potsdam, Rehbrucke, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Aarhus University; Technical University of Munich; University of Potsdam; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Nykjaer, A (corresponding author), Aarhus Univ, Dept Biochem Med, DK-8000 Aarhus, Denmark.	an@biokemi.au.dk; wilinow@mdc-bedin.de		Nykjaer, Anders/0000-0001-6422-6736; Hammes-Lewin, Annette/0000-0003-1663-8378; Willnow, Thomas/0000-0001-9515-7921; Schweigert, Florian/0000-0001-7103-2438; Metzger, Jochen/0000-0003-4475-4499				Ashby J, 2002, REGUL TOXICOL PHARM, V35, P393, DOI 10.1006/rtph.2002.1557; CAIN MP, 1994, UROLOGY, V43, P375, DOI 10.1016/0090-4295(94)90083-3; CHADWICK RW, 1988, J BIOCHEM TOXICOL, V3, P147, DOI 10.1002/jbt.2570030303; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Couse JF, 1998, J MOL MED-JMM, V76, P497, DOI 10.1007/s001090050244; DAMASSA DA, 1991, ENDOCRINOLOGY, V129, P75, DOI 10.1210/endo-129-1-75; Diesing D, 2003, HORM RES, V60, P73, DOI 10.1159/000071874; DUNN JF, 1981, J CLIN ENDOCR METAB, V53, P58, DOI 10.1210/jcem-53-1-58; Emmen JMA, 1998, HUM REPROD, V13, P1272, DOI 10.1093/humrep/13.5.1272; FELDMAN M, 1981, J BIOL CHEM, V256, P5170; GIORGI EP, 1981, ENDOCRINOLOGY, V108, P688, DOI 10.1210/endo-108-2-688; HAMMOND GL, 1995, J STEROID BIOCHEM, V53, P543, DOI 10.1016/0960-0760(95)00110-L; HEYNS CF, 1995, J UROLOGY, V153, P754, DOI 10.1016/S0022-5347(01)67713-9; Hilpert J, 2001, BIOCHEM J, V360, P609, DOI 10.1042/0264-6021:3600609; HUSMANN DA, 1991, ENDOCRINOLOGY, V129, P1409, DOI 10.1210/endo-129-3-1409; HUTSON JM, 1994, REPROD FERT DEVELOP, V6, P151, DOI 10.1071/RD9940151; HUTSON JM, 1986, J PEDIATR SURG, V21, P195, DOI 10.1016/S0022-3468(86)80830-2; Krinke G.J., 2004, LAB MOUSE, V9, P133, DOI [10.1016/B978-012336425-8/50062-5, DOI 10.1016/B978-012336425-8/50062-5]; KRUPENKO SA, 1994, J STEROID BIOCHEM, V51, P115, DOI 10.1016/0960-0760(94)90122-8; Lee SMY, 1999, ANAT REC, V255, P306; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Metzger J, 2003, BIOCHEMISTRY-US, V42, P13735, DOI 10.1021/bi035269k; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; RIJLI FM, 1995, P NATL ACAD SCI USA, V92, P8185, DOI 10.1073/pnas.92.18.8185; Rodriguez I, 1997, DEV BIOL, V184, P115, DOI 10.1006/dbio.1997.8522; Rosner W, 1999, J STEROID BIOCHEM, V69, P481, DOI 10.1016/S0960-0760(99)00070-9; SCROCCHI LA, 1993, ENDOCRINOLOGY, V132, P903, DOI 10.1210/en.132.2.903; SPENCER JR, 1991, ENDOCRINOLOGY, V129, P741, DOI 10.1210/endo-129-2-741; SULLIVAN PM, 1991, J BIOL CHEM, V266, P143; Toppari J, 1999, HORM RES, V51, P261, DOI 10.1159/000023412; TURNER TT, 1984, ENDOCRINOLOGY, V115, P1925, DOI 10.1210/endo-115-5-1925; TURNER TT, 1990, BIOL REPROD, V43, P414, DOI 10.1095/biolreprod43.3.414; VANDERSCHOOT P, 1992, J ANDROL, V13, P534; VIANNEY MJ, 1965, FERTIL STERIL, V16, P401; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Wu SX, 2000, MOL ENDOCRINOL, V14, P1387, DOI 10.1210/me.14.9.1387; Yuan Y., 1987, MONOGRAPHS PATHOLOGY, P161; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	44	296	305	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					751	762		10.1016/j.cell.2005.06.032	http://dx.doi.org/10.1016/j.cell.2005.06.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143106	Bronze			2022-12-28	WOS:000231844300014
J	Hla, T				Hla, T			Dietary factors and immunological consequences	SCIENCE			English	Editorial Material							SPHINGOSINE 1-PHOSPHATE; RECEPTOR		Univ Connecticut, Ctr Hlth, Dept Cell Biol, Ctr Vasc Biol, Farmington, CT 06030 USA	University of Connecticut	Hla, T (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, Ctr Vasc Biol, Farmington, CT 06030 USA.	hla@nso2.uchc.edu	Hla, Timothy/G-5873-2012	Hla, Timothy/0000-0001-8355-4065	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067330, P01HL070694, R37HL067330] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL70694, HL67330] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Igarashi Y, 1998, ACTA BIOCHIM POL, V45, P299, DOI 10.18388/abp.1998_4226; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640	10	17	18	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2005	309	5741					1682	1683		10.1126/science.1118340	http://dx.doi.org/10.1126/science.1118340			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16150998				2022-12-28	WOS:000231836700029
J	Meersseman, W; Van Laethem, K; Lagrou, K; Wilms, G; Sciot, R; Van Ranst, M; Vandamme, A; Van Wijngaerden, E				Meersseman, W; Van Laethem, K; Lagrou, K; Wilms, G; Sciot, R; Van Ranst, M; Vandamme, A; Van Wijngaerden, E			Fatal brain necrosis in primary HIV infection	LANCET			English	Editorial Material							AIDS		Katholieke Univ Leuven, Rega Inst, Dept Internal Med, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Rega Inst, Dept Bacteriol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Rega Inst, Dept Pathol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Rega Inst, Dept Radiol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Rega Inst, Dept Clin & Epidemiol Virol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Rega Inst, AIDS Reference Lab, B-3000 Louvain, Belgium; Katholieke Univ Leuven Hosp, B-3000 Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Van Wijngaerden, E (corresponding author), Katholieke Univ Leuven, Rega Inst, Dept Internal Med, B-3000 Louvain, Belgium.	eric.vanwijngaerden@uz.kuleuven.ac.be	Van Laethem, Kristel/R-6282-2016; Vandamme, Anne-Mieke/I-4127-2012; Van Wijngaerden, Eric/AAB-9187-2021; Van Ranst, Marc/P-7522-2017	Van Laethem, Kristel/0000-0001-6036-2271; Vandamme, Anne-Mieke/0000-0002-6594-2766; Van Wijngaerden, Eric/0000-0001-8926-099X; Van Ranst, Marc/0000-0002-1674-4157; sciot, raf/0000-0003-2244-5839				COOPER DA, 1985, LANCET, V1, P537; JONES HR, 1988, ANN NEUROL, V23, P518; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001	5	9	10	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2005	366	9488					866	866		10.1016/S0140-6736(05)67220-0	http://dx.doi.org/10.1016/S0140-6736(05)67220-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139663				2022-12-28	WOS:000231627000033
J	Willingham, AT; Orth, AP; Batalov, S; Peters, EC; Wen, BG; Aza-Blanc, P; Hogenesch, JB; Schultz, PG				Willingham, AT; Orth, AP; Batalov, S; Peters, EC; Wen, BG; Aza-Blanc, P; Hogenesch, JB; Schultz, PG			A strategy for probing the function of noncoding RNAs finds a repressor of NFAT	SCIENCE			English	Article							PROTEIN PHOSPHATASE 2A; T-CELL-ACTIVATION; TRANSCRIPTION FACTORS; HUMAN GENOME; CHROMOSOME-22; CALCINEURIN; SEQUENCE	Noncoding RNA molecules (ncRNAs) have been implicated in numerous biological processes including transcriptional regulation and the modulation of protein function. Yet, in spite of the apparent abundance of ncRNA, little is known about the biological role of the projected thousands of ncRNA genes present in the human genome. To facilitate functional analysis of these RNAs, we have created an arrayed library of short hairpin RNAs (shRNAs) directed against 512 evolutionally conserved putative ncRNAs and, via cell-based assays, we have begun to determine their roles in cellular pathways. Using this system, we have identified an ncRNA repressor of the nuclear factor of activated T cells (NFAT), which interacts with multiple proteins including members of the importin-beta superfamily and likely functions as a specific regulator of NFAT nuclear trafficking.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Hogenesch, JB (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hogenesch@scripps.edu; schultz@scripps.edu	Peters, Eric/W-2739-2019	Batalov, Sergey/0000-0002-0925-0554				Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Lubert EJ, 2003, BIOCHEM BIOPH RES CO, V303, P908, DOI 10.1016/S0006-291X(03)00434-0; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Nakajima E, 2005, BIOCHEM BIOPH RES CO, V326, P249, DOI 10.1016/j.bbrc.2004.11.023; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Numata K, 2003, GENOME RES, V13, P1301, DOI 10.1101/gr.1011603; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Willingham AT, 2004, ONCOGENE, V23, P8392, DOI 10.1038/sj.onc.1208217; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	23	585	634	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1570	1573		10.1126/science.1115901	http://dx.doi.org/10.1126/science.1115901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141075				2022-12-28	WOS:000231715000052
J	Pitman, RJ; Cooper, BS; Trotter, CL; Gay, NJ; Edmunds, WJ				Pitman, RJ; Cooper, BS; Trotter, CL; Gay, NJ; Edmunds, WJ			Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation	BRITISH MEDICAL JOURNAL			English	Article									Hlth Protect Agcy, Ctr Infect, Modelling & Econ Unit, London NW9 5EQ, England	Health Protection Agency	Pitman, RJ (corresponding author), Hlth Protect Agcy, Ctr Infect, Modelling & Econ Unit, London NW9 5EQ, England.	richard.pitman@hpa.org.uk	Cooper, Ben/HGC-7082-2022; Trotter, Caroline L/H-5077-2013	Trotter, Caroline/0000-0003-4000-2708; Cooper, Ben/0000-0002-9445-7217				KUK AYC, 2005, IN PRESS STAT MED; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; World Health Organization, COMM DIS SURV RESP S	5	61	65	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 26	2005	331	7527					1242	1243		10.1136/bmj.38573.696100.3A	http://dx.doi.org/10.1136/bmj.38573.696100.3A			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16176938	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000233606800020
J	Brengues, M; Teixeira, D; Parker, R				Brengues, M; Teixeira, D; Parker, R			Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies	SCIENCE			English	Article							DECAY; PROTEINS; COMPLEX; EXPORT; SITES; YEAST; FOCI	Eukaryotic cells contain nontranslating messenger RNA concentrated in P-bodies, which are sites where the mRNA can be decapped and degraded. We present evidence that mRNA molecules within yeast P-bodies can also return to translation. First, inhibiting delivery of new mRNAs to P-bodies leads to their disassembly independent of mRNA decay. Second, P-bodies decline in a translation initiation-dependent manner during stress recovery. Third, reporter mRNAs concentrate in P-bodies when translation initiation is blocked and resume translation and exit P-bodies when translation is restored. Fourth, stationary phase yeast have large P-bodies containing mRNAs that reenter translation when growth resumes. The reciprocal movement of mRNAs between polysomes and P-bodies is likely to be important in the control of mRNA translation and degradation. Moreover, the presence of related proteins in P-bodies and maternal mRNA storage granules suggests this mechanism is widely adapted for mRNA storage.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443, R01GM045443] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45443, R37 GM045443] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Anderson P, 2002, J CELL SCI, V115, P3227; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; COLLER J, IN PRESS CELL; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Hilleren P, 2001, RNA, V7, P753, DOI 10.1017/S1355838201010147; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678	21	554	563	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					486	489		10.1126/science.1115791	http://dx.doi.org/10.1126/science.1115791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16141371	Green Accepted			2022-12-28	WOS:000232786000045
J	Dunn, M; Terrill, A; Reesink, G; Foley, RA; Levinson, SC				Dunn, M; Terrill, A; Reesink, G; Foley, RA; Levinson, SC			Structural phylogenetics and the reconstruction of ancient language history	SCIENCE			English	Article							CLASSIFICATION; AFRICA; SPREAD	The contribution of language history to the study of the early dispersals of modem humans throughout the Old World has been limited by the shallow time depth (about 8000 2000 years) of current linguistic methods. Here it is shown that the application of biological cladistic methods, not to vocabulary (as has been previously tried) but to language structure (sound systems and grammar), may extend the time depths at which language data can be used. The method was tested against well-understood families of Oceanic Austronesian languages, then applied to the Papuan languages of Island Melanesia, a group of hitherto unrelatable isolates. Papuan languages show an archipelago-based phylogenetic signal that is consistent with the current geographical distribution of languages. The most plausible hypothesis to explain this result is the divergence of the Papuan languages from a common ancestral stock, as part of late Pleistocene dispersals.	Max Planck Inst Psycholinguist, NL-6500 AH Nijmegen, Netherlands; Radford Univ, Ctr Language Studies, NL-6500 HC Nijmegen, Netherlands; Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 3DZ, England	Max Planck Society; Radboud University Nijmegen; University of Cambridge	Dunn, M (corresponding author), Max Planck Inst Psycholinguist, POB 310, NL-6500 AH Nijmegen, Netherlands.	michael.dunn@mpi.nl	Dunn, Michael/F-1077-2012	Dunn, Michael/0000-0001-5349-5252				Bolnick DA, 2004, AM J HUM GENET, V75, P519; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Dunn M, 2002, OCEAN LINGUIST, V41, P28, DOI 10.1353/ol.2002.0019; Forster P, 2003, P NATL ACAD SCI USA, V100, P9079, DOI 10.1073/pnas.1331158100; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Greenberg J. H., 1971, CURR TRENDS LINGUIST, V8, P807; Greenberg J. H, 1987, LANGUAGE AM; Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955; Holden CJ, 2003, P ROY SOC B-BIOL SCI, V270, P2425, DOI 10.1098/rspb.2003.2535; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; KIRCH PV, 1997, LAPITA PEOPLES; Lynch J., 2002, OCEANIC LANGUAGES; McMahon A, 2003, T PHILOL SOC, V101, P7, DOI 10.1111/1467-968X.00108; Merriwether DA, 1999, GENOMIC DIVERSITY, P153; Nichols J, 1995, AMST STUD THEORY HIS, V124, P337; Nichols J, 1998, MEM CALIF ACAD SCI, P127; Nichols Johanna, 2003, HDB HIST LINGUISTICS, P283, DOI DOI 10.1002/9780470756393.CH5; Nichols Johanna, 1992, LINGUISTIC DIVERSITY; Rexova K, 2003, CLADISTICS, V19, P120, DOI 10.1016/S0748-3007(02)00147-0; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; ROSS M, 2001, BOY BUNDABERG STUDIE, P301; Ross Malcolm, 1988, PACIFIC LINGUISTIC C, V98; Spriggs M., 1997, ISLAND MELANESIANS; TRYON DT, 1983, PACIFIC LINGUISTIC C, V72; Wurm Stephen A., 1982, PAPUAN LANGUAGES OCE	25	166	168	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2005	309	5743					2072	2075		10.1126/science.1114615	http://dx.doi.org/10.1126/science.1114615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179483	Green Published			2022-12-28	WOS:000232181900056
J	Jansen, VAA; Stumpf, MPH				Jansen, VAA; Stumpf, MPH			Making sense of evolution in an uncertain world	SCIENCE			English	Editorial Material							ADAPTIVE EVOLUTION		Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Univ London Imperial Coll Sci Technol & Med, Ctr Bioinformat, Div Mol Biosci, London SW7 2AZ, England	University of London; Royal Holloway University London; Imperial College London	Jansen, VAA (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	vincent.jansen@rhul.ac.uk	Jansen, Vincent A A/C-8353-2009	Jansen, Vincent A.A./0000-0002-6518-2090	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Avery J, 2003, INFORM THEORY EVOLUT; Johnson R.T., 1998, VIRAL INFECT NERVOUS; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; Stumpf MPH, 2002, P NATL ACAD SCI USA, V99, P15234, DOI 10.1073/pnas.232546899	7	14	14	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2005	309	5743					2005	2007		10.1126/science.1118711	http://dx.doi.org/10.1126/science.1118711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968SF	16179463				2022-12-28	WOS:000232181900032
J	Oberstrass, FC; Auweter, SD; Erat, M; Hargous, Y; Henning, A; Wenter, P; Reymond, L; Amir-Ahmady, B; Pitsch, S; Black, DL; Allain, FHT				Oberstrass, FC; Auweter, SD; Erat, M; Hargous, Y; Henning, A; Wenter, P; Reymond, L; Amir-Ahmady, B; Pitsch, S; Black, DL; Allain, FHT			Structure of PTB bound to RNA: Specific binding and implications for splicing regulation	SCIENCE			English	Article							POLYPYRIMIDINE TRACT; EXON DEFINITION; PROTEIN; RECOGNITION; REPRESSION; SITES; INHIBITION; SELECTION	The polypyrimidine tract binding protein (PTB) is a 58-kilodalton RNA binding protein involved in multiple aspects of messenger RNA metabolism, including the repression of alternative exons. We have determined the solution structures of the four RNA binding domains (RBDs) of PTB, each bound to a CUCUCU oligonucleotide. Each RBD binds RNA with a different binding specificity. RBD3 and RBD4 interact, resulting in an antiparallel orientation of their bound RNAs. Thus, PTB will induce RNA looping when bound to two separated pyrimidine tracts within the same RNA. This leads to structural models for how PTB functions as an alternative-splicing repressor.	ETH Honggerberg, Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; EPFL, Lab Nucl Acid Chem LCAN, CH-1015 Lausanne, Switzerland; Mol LIfe Sci PhD Program, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Allain, FHT (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	allain@mol.biol.ethz.ch		Henning, Anke/0000-0002-2267-4861; REYMOND, Luc/0000-0001-5282-9273				Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Ashiya M, 1997, RNA, V3, P996; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; CHAN RC, 1995, MOL CELL BIOL, V15, P6377; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Charlet-B N, 2002, MOL CELL, V9, P649, DOI 10.1016/S1097-2765(02)00479-3; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; Conte MR, 2000, EMBO J, V19, P3132, DOI 10.1093/emboj/19.12.3132; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; GOODING C, 1994, EMBO J, V13, P3861, DOI 10.1002/j.1460-2075.1994.tb06697.x; Gooding C, 1998, RNA, V4, P85; Gromak N, 2003, EMBO J, V22, P6356, DOI 10.1093/emboj/cdg609; Gromak N, 2003, RNA, V9, P443, DOI 10.1261/rna.2191903; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Liu HY, 2002, RNA, V8, P137, DOI 10.1017/S1355838202015029; Lou H, 1999, MOL CELL BIOL, V19, P78; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Perez I, 1997, RNA, V3, P764; Pilipenko EV, 2000, GENE DEV, V14, P2028; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Shen HH, 2004, RNA, V10, P787, DOI 10.1261/rna.5229704; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Southby J, 1999, MOL CELL BIOL, V19, P2699; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001	33	323	331	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2054	2057		10.1126/science.1114066	http://dx.doi.org/10.1126/science.1114066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179478				2022-12-28	WOS:000232181900050
J	Stone, EC; Cummings, AC; McDonald, FB; Heikkila, BC; Lal, N; Webber, WR				Stone, EC; Cummings, AC; McDonald, FB; Heikkila, BC; Lal, N; Webber, WR			Voyager 1 explores the termination shock region and the heliosheath beyond	SCIENCE			English	Article							ANOMALOUS COSMIC-RAYS; INTERSTELLAR MAGNETIC-FIELD; ENERGETIC PARTICLES; SOLAR-WIND; ACCELERATION; HELIOSPHERE; IONS	Voyager 1 crossed the termination shock of the supersonic flow of the solar wind on 16 December 2004 at a distance of 94.01 astronomical units from the Sun, becoming the first spacecraft to begin exploring the heliosheath, the outermost layer of the heliosphere. The shock is a steady source of low-energy protons with an energy spectrum similar to E-1.41 +/- 0.15 from 0.5 to similar to 3.5 megaelectron volts, consistent with a weak termination shock having a solar wind velocity jump ratio r = 2.6(-0.2)(+0.4). However, in contradiction to many predictions, the intensity of anomalous cosmic ray (ACR) helium did not peak at the shock, indicating that the ACR source is not in the shock region local to Voyager 1. The intensities of similar to 10-megaelectron volt electrons, ACRs, and galactic cosmic rays have steadily increased since late 2004 as the effects of solar modulation have decreased.	CALTECH, Pasadena, CA 91125 USA; Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; New Mexico State Univ, Dept Phys & Astron, Las Cruces, NM 88003 USA	California Institute of Technology; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; New Mexico State University	Stone, EC (corresponding author), CALTECH, Pasadena, CA 91125 USA.	ecs@srl.caltech.edu						Burlaga LF, 2005, SCIENCE, V309, P2027, DOI 10.1126/science.1117542; Cummings AC, 2002, ASTROPHYS J, V578, P194, DOI 10.1086/342427; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; Florinski V, 2004, ASTROPHYS J, V610, P1169, DOI 10.1086/421901; Florinski V, 2003, ASTROPHYS J, V591, P454, DOI 10.1086/375054; Giacalone J, 2004, AIP CONF PROC, V719, P266, DOI 10.1063/1.1809527; Gloeckler G, 2004, ADV SPACE RES-SERIES, V34, P53, DOI 10.1016/j.asr.2003.02.054; Jokipii JR, 2004, ASTROPHYS J, V611, pL141, DOI 10.1086/423993; JOKIPII JR, 2003, P 28 INT COSM RAY C, V7, P3753; Kota J, 2004, AIP CONF PROC, V719, P272; Krimigis SM, 2003, NATURE, V426, P45, DOI 10.1038/nature02068; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; McDonald FB, 2003, NATURE, V426, P48, DOI 10.1038/nature02066; MCDONALD FB, 2005, P 29 INT COSM RAY C; PESSES ME, 1981, ASTROPHYS J, V246, pL85, DOI 10.1086/183559; Pogorelov NV, 1998, J GEOPHYS RES-SPACE, V103, P237, DOI 10.1029/97JA02446; Ratkiewicz R, 1998, ASTRON ASTROPHYS, V335, P363; STONE EC, 1977, SPACE SCI REV, V21, P355, DOI 10.1007/BF00211546; Stone EC, 2001, SCIENCE, V293, P55, DOI 10.1126/science.1060090; WEBBER WR, IN PRESS J GEOPHYS R; Zank GP, 2001, ASTROPHYS J, V556, P494, DOI 10.1086/322238	21	491	493	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2005	309	5743					2017	2020		10.1126/science.1117684	http://dx.doi.org/10.1126/science.1117684			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179468				2022-12-28	WOS:000232181900038
J	Dodge-Kafka, KL; Soughayer, J; Pare, GC; Michel, JJC; Langeberg, LK; Kapiloff, MS; Scott, JD				Dodge-Kafka, KL; Soughayer, J; Pare, GC; Michel, JJC; Langeberg, LK; Kapiloff, MS; Scott, JD			The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways	NATURE			English	Article							CYCLIC-AMP; DEPENDENT REGULATION; CARDIAC-HYPERTROPHY; PHOSPHODIESTERASE; EPAC; PHOSPHORYLATION; ACTIVATION; MYOCYTES; BINDING; RAP1	Cyclic adenosine 3', 5'- monophosphate ( cAMP) is a ubiquitous mediator of intracellular signalling events. It acts principally through stimulation of cAMP- dependent protein kinases ( PKAs)(1,2) but also activates certain ion channels and guanine nucleotide exchange factors ( Epacs)(3). Metabolism of cAMP is catalysed by phosphodiesterases ( PDEs) (4,5). Here we identify a cAMP- responsive signalling complex maintained by the muscle-specific A- kinase anchoring protein ( mAKAP) that includes PKA, PDE4D3 and Epac1. These intermolecular interactions facilitate the dissemination of distinct cAMP signals through each effector protein. Anchored PKA stimulates PDE4D3 to reduce local cAMP concentrations, whereas an mAKAP- associated ERK5 kinase module suppresses PDE4D3. PDE4D3 also functions as an adaptor protein that recruits Epac1, an exchange factor for the small GTPase Rap1, to enable cAMP- dependent attenuation of ERK5. Pharmacological and molecular manipulations of the mAKAP complex show that anchored ERK5 can induce cardiomyocyte hypertrophy. Thus, two coupled cAMP- dependent feedback loops are coordinated within the context of the mAKAP complex, suggesting that local control of cAMP signalling by AKAP proteins is more intricate than previously appreciated.	Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA	Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University	Scott, JD (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97239 USA.	scott@ohsu.edu		Kapiloff, Michael/0000-0002-7005-6953	NHLBI NIH HHS [R01 HL088366, R01 HL075398-02, R01 HL075398] Funding Source: Medline; NIDDK NIH HHS [P01 DK054441] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088366, R01HL075398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beavo J A, 1974, Methods Enzymol, V38, P299; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kodama H, 2000, AM J PHYSIOL-HEART C, V279, pH1635, DOI 10.1152/ajpheart.2000.279.4.H1635; Laroche-Joubert N, 2002, J BIOL CHEM, V277, P18598, DOI 10.1074/jbc.M201868200; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Michel JJC, 2004, BIOCHEM J, V381, P587, DOI 10.1042/BJ20040846; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Pearson GW, 2002, J BIOL CHEM, V277, P48094, DOI 10.1074/jbc.M208535200; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; VAILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522, DOI 10.1128/MCB.14.10.6522; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	30	411	428	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					574	578		10.1038/nature03966	http://dx.doi.org/10.1038/nature03966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177794	Green Accepted			2022-12-28	WOS:000232004800055
J	Socolich, M; Lockless, SW; Russ, WP; Lee, H; Gardner, KH; Ranganathan, R				Socolich, M; Lockless, SW; Russ, WP; Lee, H; Gardner, KH; Ranganathan, R			Evolutionary information for specifying a protein fold	NATURE			English	Article							WW DOMAIN; MUTANT CYCLES; PDZ DOMAIN; BETA-SHEET; DETERMINANTS; DYNAMICS; CATALYSIS; PEPTIDE; PACKING; BINDING	Classical studies show that for many proteins, the information required for specifying the tertiary structure is contained in the amino acid sequence. Here, we attempt to define the sequence rules for specifying a protein fold by computationally creating artificial protein sequences using only statistical information encoded in a multiple sequence alignment and no tertiary structure information. Experimental testing of libraries of artificial WW domain sequences shows that a simple statistical energy function capturing coevolution between amino acid residues is necessary and sufficient to specify sequences that fold into native structures. The artificial proteins show thermodynamic stabilities similar to natural WW domains, and structure determination of one artificial protein shows excellent agreement with the WW fold at atomic resolution. The relative simplicity of the information used for creating sequences suggests a marked reduction to the potential complexity of the protein- folding problem.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu	Gardner, Kevin H./K-7802-2012; Gardner, Kevin/K-5493-2019	Gardner, Kevin H./0000-0002-8671-2556; Socolich, Michael/0000-0002-0702-1061				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen JM, 2001, BIOCHEMISTRY-US, V40, P14012, DOI 10.1021/bi011269d; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Gerstein M, 1996, P NATL ACAD SCI USA, V93, P10167, DOI 10.1073/pnas.93.19.10167; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Koepf EK, 1999, PROTEIN SCI, V8, P841, DOI 10.1110/ps.8.4.841; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liang J, 2001, BIOPHYS J, V81, P751, DOI 10.1016/S0006-3495(01)75739-6; LICATA VJ, 1995, BIOCHEMISTRY-US, V34, P3133, DOI 10.1021/bi00010a001; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Ota N, 2005, J MOL BIOL, V351, P345, DOI 10.1016/j.jmb.2005.05.043; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; RICHARDS FM, 1993, Q REV BIOPHYS, V26, P423, DOI 10.1017/S0033583500002845; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200	50	307	315	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					512	518		10.1038/nature03991	http://dx.doi.org/10.1038/nature03991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177782				2022-12-28	WOS:000232004800041
J	Wang, XJ; Yu, JJ; Sreekumar, A; Varambally, S; Shen, RL; Giacherio, D; Mehra, R; Montie, JE; Pienta, KJ; Sanda, MG; Kantoff, PW; Rubin, MA; Wei, JT; Ghosh, D; Chinnaiyan, AM				Wang, XJ; Yu, JJ; Sreekumar, A; Varambally, S; Shen, RL; Giacherio, D; Mehra, R; Montie, JE; Pienta, KJ; Sanda, MG; Kantoff, PW; Rubin, MA; Wei, JT; Ghosh, D; Chinnaiyan, AM			Autoantibody signatures in prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE-EXPRESSION ANALYSIS; HUMORAL IMMUNE-RESPONSE; METHYLACYL-COA RACEMASE; MOLECULAR-MARKER; ANTIBODIES; IDENTIFICATION; ANTIGENS; SERA	BACKGROUND: New biomarkers, such as autoantibody signatures, may improve the early detection of prostate cancer. METHODS: With a phage-display library derived from prostate-cancer tissue, we developed and used phage protein microarrays to analyze serum samples from 119 patients with prostate cancer and 138 controls, with the samples equally divided into training and validation sets. A phage-peptide detector that was constructed from the training set was evaluated on an independent validation set of 128 serum samples (60 from patients with prostate cancer and 68 from controls). RESULTS: A 22-phage-peptide detector had 88.2 percent specificity (95 percent confidence interval, 0.78 to 0.95) and 81.6 percent sensitivity (95 percent confidence interval, 0.70 to 0.90) in discriminating between the group with prostate cancer and the control group. This panel of peptides performed better than did prostate-specific antigen (PSA) in distinguishing between the group with prostate cancer and the control group (area under the curve for the autoantibody signature, 0.93; 95 percent confidence interval, 0.88 to 0.97; area under the curve for PSA, 0.80; 95 percent confidence interval, 0.71 to 0.88). Logistic-regression analysis revealed that the phage-peptide panel provided additional discriminative power over PSA (P<0.001). Among the 22 phage peptides used as a detector, 4 were derived from in-frame, named coding sequences. The remaining phage peptides were generated from untranslated sequences. CONCLUSIONS: Autoantibodies against peptides derived from prostate-cancer tissue could be used as the basis for a screening test for prostate cancer.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Dept Pathol & Urol, 1301 Catherine St,MSI 4237, Ann Arbor, MI 48109 USA.	arul@umich.edu	Sanda, Martin G/A-6202-2013; Sanda, Martin G/B-2023-2015; Wei, John T/E-8967-2012; DE COBELLI, OTTAVIO/O-2315-2017; Pienta, Kenneth/E-7679-2015	Rubin, Mark/0000-0002-8321-9950; DE COBELLI, OTTAVIO/0000-0002-0699-8620; Kantoff, Philip/0000-0001-7275-0597; Varambally, Sooryanarayana/0000-0002-2277-1127; Ghosh, Debashis/0000-0001-6618-1316; Pienta, Kenneth/0000-0002-4138-2186	NCI NIH HHS [R01 CA8241901-A1, UO1CA111275, 5P30CA46592, P50 CA69568] Funding Source: Medline; NIGMS NIH HHS [R01GM72007-01, R01 GM072007-03, R01 GM072007] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA111275, P30CA046592, R01CA082419, P50CA069568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072007] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598; CATALONA WJ, 1991, NEW ENGL J MED, V325, P1324; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Cohen Lorenzo, 2003, Cancer Epidemiology Biomarkers & Prevention, V12, P610; Dennis LK, 2000, PROSTATE, V42, P247; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Fernandez-Madrid F, 2004, CANCER RES, V64, P5089, DOI 10.1158/0008-5472.CAN-03-0932; Fu WJJ, 2005, BIOINFORMATICS, V21, P63, DOI 10.1093/bioinformatics/bth461; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jiang Z, 2001, AM J SURG PATHOL, V25, P1397, DOI 10.1097/00000478-200111000-00007; LaTulippe E, 2002, CANCER RES, V62, P4499; Luo J, 2001, CANCER RES, V61, P4683; Luo J, 2002, CANCER RES, V62, P2220; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Makinen T, 2004, CLIN CANCER RES, V10, P2231, DOI 10.1158/1078-0432.CCR-03-0338; Minenkova O, 2003, INT J CANCER, V106, P534, DOI 10.1002/ijc.11269; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Nilsson BO, 2001, UPSALA J MED SCI, V106, P43, DOI 10.3109/2000-1967-171; Old LJ, 1998, J EXP MED, V187, P1163, DOI 10.1084/jem.187.8.1163; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Schmid HP, 2003, RECENT RESULTS CANC, V163, P226; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Soussi T, 2000, CANCER RES, V60, P1777; Sreekumar, 2004, JNCI-J NATL CANCER I, V96, P1112, DOI 10.1093/jnci/djh222; Sreekumar A, 2004, JNCI-J NATL CANCER I, V96, P834, DOI 10.1093/jnci/djh145; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2004, NEW ENGL J MED, V351, P1470; Welsh JB, 2001, CANCER RES, V61, P5974; Zhong L, 2003, CANCER DETECT PREV, V27, P285, DOI 10.1016/S0361-090X(03)00097-7	33	476	542	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1224	1235		10.1056/NEJMoa051931	http://dx.doi.org/10.1056/NEJMoa051931			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	966DS	16177248				2022-12-28	WOS:000232000400006
J	Wood, AJJ; Drazen, JM; Greene, MF				Wood, AJJ; Drazen, JM; Greene, MF			A sad day for science at the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Vanderbilt University	Wood, AJJ (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.		Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890					0	24	24	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1197	1199		10.1056/NEJMp058222	http://dx.doi.org/10.1056/NEJMp058222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	966DS	16141387				2022-12-28	WOS:000232000400001
J	Strom, RG; Malhotra, R; Ito, T; Yoshida, F; Kring, DA				Strom, RG; Malhotra, R; Ito, T; Yoshida, F; Kring, DA			The origin of planetary impactors in the inner solar system	SCIENCE			English	Article							LATE HEAVY BOMBARDMENT; AGE SPECTRA; LUNAR; SIZE; DISTRIBUTIONS; BRECCIA; URANUS	Insights into the history of the inner solar system can be derived from the impact cratering record of the Moon, Mars, Venus, and Mercury and from the size distributions of asteroid populations. Old craters from a unique period of heavy bombardment that ended similar to 3.8 billion years ago were made by asteroids that were dynamically ejected from the main asteroid belt, possibly due to the orbital migration of the giant planets. The impactors of the past similar to 3.8 billion years have a size distribution quite different from that of the main belt asteroids but very similar to that of near-Earth asteroids.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Natl Astron Observ, Tokyo 1818588, Japan	University of Arizona; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Malhotra, R (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	renu@lpl.arizona.edu	Ito, Takashi/E-5270-2013; Yoshida, Fumi/I-6389-2016	Ito, Takashi/0000-0002-0549-9002; Yoshida, Fumi/0000-0002-3286-911X; Malhotra, Renu/0000-0002-1226-3305				[Anonymous], 1979, ICARUS, V37, P467, DOI 10.1016/0019-1035(79)90009-5; BOGARD DD, 1995, METEORITICS, V30, P244, DOI 10.1111/j.1945-5100.1995.tb01124.x; CHYBA CF, 1991, ICARUS, V92, P217, DOI 10.1016/0019-1035(91)90047-W; Cohen BA, 2000, SCIENCE, V290, P1754, DOI 10.1126/science.290.5497.1754; COHEN BA, IN PRESS METEORITICS; CROFT SK, 1985, J GEOPHYS RES, V90, pC828, DOI 10.1029/JB090iS02p0C828; DALRYMPLE GB, 1993, J GEOPHYS RES-PLANET, V98, P13085, DOI 10.1029/93JE01222; Dalrymple GB, 1996, J GEOPHYS RES-PLANET, V101, P26069, DOI 10.1029/96JE02806; Daubar IJ, 2002, METEORIT PLANET SCI, V37, P1797, DOI 10.1111/j.1945-5100.2002.tb01164.x; Farinella P, 1999, SCIENCE, V283, P1507, DOI 10.1126/science.283.5407.1507; FERNANDEZ JA, 1984, ICARUS, V58, P109, DOI 10.1016/0019-1035(84)90101-5; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Hahn JM, 1999, ASTRON J, V117, P3041, DOI 10.1086/300891; Hartmann W. K., 2000, ORIGIN EARTH MOON, P493; Ivezic Z, 2001, ASTRON J, V122, P2749, DOI 10.1086/323452; Jedicke R, 1998, ICARUS, V131, P245, DOI 10.1006/icar.1997.5876; Kring D. A., 2002, J GEOPHYS RES, V107; Levison HF, 2001, ICARUS, V151, P286, DOI 10.1006/icar.2001.6608; Liou JC, 1997, SCIENCE, V275, P375, DOI 10.1126/science.275.5298.375; MALHOTRA R, 1993, NATURE, V365, P819, DOI 10.1038/365819a0; MALHOTRA R, 1995, ASTRON J, V110, P420, DOI 10.1086/117532; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Morbidelli A, 2003, ICARUS, V163, P120, DOI 10.1016/S0019-1035(03)00047-2; Neukum G, 2001, SPACE SCI REV, V96, P55, DOI 10.1023/A:1011989004263; Ryder G., 1990, EOS T AM GEOPHYS UN, VAGU71, P313, DOI [10.1029/90EO00086, DOI 10.1029/90EO00086, 10.1029/ 90EO00086]; Schenk PM, 2004, CAMB PLANET, P427; Schmidt R.M., 1987, INT J IMPACT ENG, V5, P543, DOI [DOI 10.1016/0734-743X(87)90069-8, 10.1016/0734-743X(87)90069-8]; Strom R.G., 1992, MARS, P383, DOI DOI 10.1016/S0032-0633(99)00016-1; Strom R. G., 1988, MERCURY, P363; STROM RG, 1981, J GEOPHYS RES-SPACE, V86, P8659, DOI 10.1029/JA086iA10p08659; STROM RG, 1994, J GEOPHYS RES-PLANET, V99, P10899, DOI 10.1029/94JE00388; Stuart JS, 2004, ICARUS, V170, P295, DOI 10.1016/j.icarus.2004.03.018; Tera F., 1973, ABSTR LUN PLAN SCI C, V4, P723; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Turner G, 1997, GEOCHIM COSMOCHIM AC, V61, P3835, DOI 10.1016/S0016-7037(97)00285-8; Turner G., 1973, P LUNAR PLANET SCI C, P1889; Werner SC, 2002, ICARUS, V156, P287, DOI 10.1006/icar.2001.6789; WORONOW A, 1977, J GEOPHYS RES, V82, P2447, DOI 10.1029/JB082i017p02447; Yoshida F, 2003, PUBL ASTRON SOC JPN, V55, P701, DOI 10.1093/pasj/55.3.701; YOSHIDA F, UNPUB; ZAHNLE KJ, 1992, J GEOPHYS RES-PLANET, V97, P10243, DOI 10.1029/92JE00787	42	329	338	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1847	1850		10.1126/science.1113544	http://dx.doi.org/10.1126/science.1113544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166515	Green Submitted			2022-12-28	WOS:000231989500047
J	Cisternas, M; Atwater, BF; Torrejon, F; Sawai, Y; Machuca, G; Lagos, M; Eipert, A; Youlton, C; Salgado, I; Kamataki, T; Shishikura, M; Rajendran, CP; Malik, JK; Rizal, Y; Husni, M				Cisternas, M; Atwater, BF; Torrejon, F; Sawai, Y; Machuca, G; Lagos, M; Eipert, A; Youlton, C; Salgado, I; Kamataki, T; Shishikura, M; Rajendran, CP; Malik, JK; Rizal, Y; Husni, M			Predecessors of the giant 1960 Chile earthquake	NATURE			English	Article								It is commonly thought that the longer the time since last earthquake, the larger the next earthquake's slip will be. But this logical predictor of earthquake size(1), unsuccessful for large earthquakes on a strike-slip fault(2), fails also with the giant 1960 Chile earthquake of magnitude 9.5 (ref. 3). Although the time since the preceding earthquake spanned 123 years (refs 4, 5), the estimated slip in 1960, which occurred on a fault between the Nazca and South American tectonic plates, equalled 250 - 350 years' worth of the plate motion(3,6-10). Thus the average interval between such giant earthquakes on this fault should span several centuries(3,9,10). Here we present evidence that such long intervals were indeed typical of the last two millennia. We use buried soils and sand layers as records of tectonic subsidence and tsunami inundation at an estuary midway along the 1960 rupture. In these records, the 1960 earthquake ended a recurrence interval that had begun almost four centuries before, with an earthquake documented by Spanish conquistadors in 1575. Two later earthquakes, in 1737 and 1837, produced little if any subsidence or tsunami at the estuary and they therefore probably left the fault partly loaded with accumulated plate motion that the 1960 earthquake then expended.	Pontificia Univ Catolica Valparaiso, Fac Agron, Quillota, Chile; Univ Washington, US Geol Survey, Seattle, WA 98195 USA; Univ Concepcion, Ctr EULA Chile, Concepcion, Chile; Univ Concepcion, Dept Ciencias Hist & Sociales, Concepcion, Chile; Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Act Fault Res Ctr, Tsukuba, Ibaraki 3058567, Japan; Pontificia Univ Catolica Santiago, Inst Geog, Santiago, Chile; NOAA, Seattle, WA 98115 USA; Ctr Earth Sci Studies, Thiruvananthapuram 69603, Kerala, India; Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India; Inst Technol, Dept Geol, Bandung 40132, Indonesia; Meteorol & Geophys Agcy Indonesia, Potential Geophys Div, Jakarta 10720, Indonesia	Pontificia Universidad Catolica de Valparaiso; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; Universidad de Concepcion; Universidad de Concepcion; National Institute of Advanced Industrial Science & Technology (AIST); Pontificia Universidad Catolica de Chile; National Oceanic Atmospheric Admin (NOAA) - USA; Ministry of Earth Sciences (MoES) - India; National Centre for Earth Science Studies (NCESS); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Institute Technology of Bandung; Indonesian Agency for Meteorology, Climatology & Geophysics	Cisternas, M (corresponding author), Pontificia Univ Catolica Valparaiso, Fac Agron, Casilla 4-D, Quillota, Chile.	marco.cisternas@ucv.cl	Shishkura, Masanobu/N-2831-2018; Rajendran, CP/F-4424-2012; Sawai, Yuki/D-3216-2013	Rajendran, CP/0000-0002-1477-7705; Sawai, Yuki/0000-0001-7015-4361; Youlton, Cristian/0000-0002-2369-6990; Atwater, Brian/0000-0003-1155-2815				ABE K, 1979, J GEOPHYS RES, V84, P1561, DOI 10.1029/JB084iB04p01561; [Anonymous], COMPREHENSIVE LIST D; Atwater B.F., 1992, QUATERN INT, V15/16, P77, DOI [10.1016/1040-6182(92)90037-3, DOI 10.1016/1040-6182]; ATWATER BF, 1999, 1187 US GEOL SURV; BARRIENTOS SE, 1990, GEOPHYS J INT, V103, P589, DOI 10.1111/j.1365-246X.1990.tb05673.x; CIFUENTES IL, 1989, J GEOPHYS RES-SOLID, V94, P665, DOI 10.1029/JB094iB01p00665; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; GORMAZ FV, 1875, ESPLORACIONES HIDROG; JULIET C, 1875, ANUARIO HIDROGAFICO, P263; Kanamori H., 1974, Physics of the Earth and Planetary Interiors, V9, P128, DOI 10.1016/0031-9201(74)90029-6; LANDER JF, 1989, NATL EOPHYS DATA CTR, V412; Lay T, 2005, SCIENCE, V308, P1127, DOI 10.1126/science.1112250; LOCKRIDGE PA, 1985, SE39 WORLD DAT CTR A; Lomnitz C., 1970, SODERDRUCK GEOLOGISC, P938, DOI [10.1007/BF02042278, DOI 10.1007/BF02042278]; Ninomiya S., 1960, TOHOKU KENKYU, V10, P19; Ortiz M, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001941; PLAFKER G, 1970, GEOL SOC AM BULL, V81, P1001, DOI 10.1130/0016-7606(1970)81[1001:MOTCEO]2.0.CO;2; PLAFKER G, 1972, J GEOPHYS RES, V77, P901, DOI 10.1029/JB077i005p00901; *SERV HIDR OC ARM, 1961, EL MAR 22 MAYO 1960; SHIMAZAKI K, 1980, GEOPHYS RES LETT, V7, P279, DOI 10.1029/GL007i004p00279; URRUTIA R, 1993, CATASTRFES CHILE 154, P90; Weldon R., 2004, GSA TODAY, V14, P4, DOI [10.1130/1052-5173(2004)014%3C4:watecw%3E2.0.co;2, DOI 10.1130/1052-5173(2004)0142.0.CO;2,2004]	22	399	406	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2005	437	7057					404	407		10.1038/nature03943	http://dx.doi.org/10.1038/nature03943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163355				2022-12-28	WOS:000231849100052
J	Kemp, DB; Coe, AL; Cohen, AS; Schwark, L				Kemp, DB; Coe, AL; Cohen, AS; Schwark, L			Astronomical pacing of methane release in the Early Jurassic period	NATURE			English	Article							OCEANIC ANOXIC EVENT; SEA-LEVEL CHANGE; GAS-HYDRATE; ISOTOPE EVIDENCE; THERMAL MAXIMUM; TOARCIAN; DISSOCIATION; CARBON; SEDIMENTARY; END	A pronounced negative carbon-isotope (delta(13)C) excursion of similar to 5-7 parts per thousand (refs 1 - 7) indicates the occurrence of a significant perturbation to the global carbon cycle during the Early Jurassic period (early Toarcian age, similar to 183 million years ago). The rapid release of C-12-enriched biogenic methane as a result of continental-shelf methane hydrate dissociation has been put forward as a possible explanation for this observation(1,7,8). Here we report high-resolution organic carbon-isotope data from well-preserved mudrocks in Yorkshire, UK, which demonstrate that the carbon-isotope excursion occurred in three abrupt stages, each showing a shift of -2 parts per thousand to -3 parts per thousand. Spectral analysis of these carbon-isotope measurements and of high-resolution carbonate abundance data reveals a regular cyclicity. We interpret these results as providing strong evidence that methane release proceeded in three rapid pulses and that these pulses were controlled by astronomically forced changes in climate, superimposed upon longer-term global warming. We also find that the first two pulses of methane release each coincided with the extinction of a large proportion of marine species(9).	Open Univ, Ctr Earth Planetary Space & Astron Res, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; Univ Cologne, Inst Geol, D-50674 Cologne, Germany	Open University - UK; University of Cologne	Kemp, DB (corresponding author), Open Univ, Ctr Earth Planetary Space & Astron Res, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England.	d.kemp@open.ac.uk	Kemp, David/D-7288-2012; Schwark, Lorenz/AAF-1902-2021; Coe, Angela/AAA-2913-2021	Coe, Angela/0000-0003-1416-5052; Kemp, David/0000-0002-5116-5046; Schwark, Lorenz/0000-0003-0683-0817				Bailey TR, 2003, EARTH PLANET SC LETT, V212, P307, DOI 10.1016/S0012-821X(03)00278-4; Bains S, 1999, SCIENCE, V285, P724, DOI 10.1126/science.285.5428.724; Beerling DJ, 2002, AM J SCI, V302, P28, DOI 10.2475/ajs.302.1.28; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Cohen AS, 2004, GEOLOGY, V32, P157, DOI 10.1130/G20158.1; Cope JCW, 1998, J GEOL SOC LONDON, V155, P421; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Duncan RA, 1997, J GEOPHYS RES-SOL EA, V102, P18127, DOI 10.1029/97JB00972; Hallam A, 1997, J GEOL SOC LONDON, V154, P773, DOI 10.1144/gsjgs.154.5.0773; Harries PJ, 1999, PALAEOGEOGR PALAEOCL, V154, P39, DOI 10.1016/S0031-0182(99)00086-3; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Hinnov LA, 1999, PHILOS T R SOC A, V357, P1831, DOI 10.1098/rsta.1999.0403; Howarth M. K., 1992, MONOGRAPH PALAEONT S, V145, P1; JENKYNS HC, 1988, AM J SCI, V288, P101, DOI 10.2475/ajs.288.2.101; Jenkyns HC, 2001, PALEOCEANOGRAPHY, V16, P593, DOI 10.1029/2000PA000558; Jenkyns HC, 2002, J GEOL SOC LONDON, V159, P351, DOI 10.1144/0016-764901-130; Jenkyns HC, 2003, PHILOS T R SOC A, V361, P1885, DOI 10.1098/rsta.2003.1240; Kent DV, 2003, EARTH PLANET SC LETT, V211, P13, DOI 10.1016/S0012-821X(03)00188-2; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; Kuspert W., 1982, CYCLIC EVENT STRATIF, P482, DOI DOI 10.1007/978-3-642-75829-4_36; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Palfy J, 2002, GEOL SOC AM SPEC PAP, V356, P523; Palliani RB, 2002, MAR MICROPALEONTOL, V46, P223; Paull CK, 1996, GEOLOGY, V24, P143, DOI 10.1130/0091-7613(1996)024<0143:ICMSFD>2.3.CO;2; Rohl HJ, 2001, PALAEOGEOGR PALAEOCL, V169, P271, DOI 10.1016/S0031-0182(01)00224-3; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Saelen G, 2000, PALAEOGEOGR PALAEOCL, V163, P163, DOI 10.1016/S0031-0182(00)00150-4; Schouten S, 2000, AM J SCI, V300, P1, DOI 10.2475/ajs.300.1.1; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566	29	341	354	4	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					396	399		10.1038/nature04037	http://dx.doi.org/10.1038/nature04037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163353				2022-12-28	WOS:000231849100050
J	Chemla, YR; Aathavan, K; Michaelis, J; Grimes, S; Jardine, PJ; Anderson, DL; Bustamante, C				Chemla, YR; Aathavan, K; Michaelis, J; Grimes, S; Jardine, PJ; Anderson, DL; Bustamante, C			Mechanism of force generation of a viral DNA packaging motor	CELL			English	Article							BACTERIOPHAGE-PHI-29 DNA; SINGLE-MOLECULE; PROTEIN GP16; GENOMIC DNA; RNA; TRANSLOCATION; PHAGE; FTSK; ATP; MECHANOCHEMISTRY	A large family of multimeric ATPases are involved in such diverse tasks as cell division, chromosome segregation, DNA recombination, strand separation, conjugation, and viral genome packaging. One such system is the Bacillus subtilis phage phi 29 DNA packaging motor, which generates large forces to compact its genome into a small protein capsid. Here we use optical tweezers to study, at the single-molecule level, the mechanism of force generation in this motor. We determine the kinetic parameters of the packaging motor and their dependence on external load to show that DNA translocation does not occur during ATP binding but is likely triggered by phosphate release. We also show that the motor subunits act in a coordinated, successive fashion with high processivity. Finally, we propose a minimal mechanochemical cycle of this DNA-translocating ATPase that rationalizes all of our findings. A large family of multimeric ATPases are involved in such diverse tasks as cell division, chromosome segregation, DNA recombination, strand separation, conjugation, and viral genome packaging. One such system is the Bacillus subtilis phage phi 29 DNA packaging motor, which generates large forces to compact its genome into a small protein capsid. Here we use optical tweezers to study, at the single-molecule level, the mechanism of force generation in this motor. We determine the kinetic parameters of the packaging motor and their dependence on external load to show that DNA translocation does not occur during ATP binding but is likely triggered by phosphate release. We also show that the motor subunits act in a coordinated, successive fashion with high processivity. Finally, we propose a minimal mechanochemical cycle of this DNA-translocating ATPase that rationalizes all of our findings.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Minnesota, Dept Oral Sci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Michaelis, Jens/P-2873-2016	Chemla, Yann/0000-0001-9167-0234; Jardine, Paul/0000-0002-1090-0550; Bustamante, Carlos/0000-0002-2970-0073; Michaelis, Jens/0000-0002-2739-4172	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059604, R01GM071552] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE-GM-65786] Funding Source: Medline; NIGMS NIH HHS [R01 GM059604, GM-071552] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BJORNSTI MA, 1983, J VIROL, V45, P383, DOI 10.1128/JVI.45.1.383-396.1983; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Chen CP, 1997, J VIROL, V71, P3864, DOI 10.1128/JVI.71.5.3864-3871.1997; Dawid A, 2004, P NATL ACAD SCI USA, V101, P11611, DOI 10.1073/pnas.0404369101; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Gonzalez-Huici V, 2004, MOL MICROBIOL, V52, P529, DOI 10.1111/j.1365-2958.2004.03993.x; GRIMES S, 1990, J MOL BIOL, V215, P559, DOI 10.1016/S0022-2836(05)80168-8; Grimes S, 2002, ADV VIRUS RES, V58, P255, DOI 10.1016/S0065-3527(02)58007-6; Grimes S, 1997, J MOL BIOL, V266, P901, DOI 10.1006/jmbi.1996.0843; Guasch A, 2002, J MOL BIOL, V315, P663, DOI 10.1006/jmbi.2001.5278; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1987, SCIENCE, V236, P690, DOI 10.1126/science.3107124; Guo PX, 1998, MOL CELL, V2, P149, DOI 10.1016/S1097-2765(00)80124-0; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; JARDINE PJ, 2006, IN PRESS BACTERIOPHA; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Morais MC, 2001, J STRUCT BIOL, V135, P38, DOI 10.1006/jsbi.2001.4379; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Pease PJ, 2005, SCIENCE, V307, P586, DOI 10.1126/science.1104885; Saleh OA, 2004, EMBO J, V23, P2430, DOI 10.1038/sj.emboj.7600242; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; Shu D, 2003, VIROLOGY, V309, P108, DOI 10.1016/S0042-6822(03)00011-4; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Trottier M, 1996, J VIROL, V70, P55, DOI 10.1128/JVI.70.1.55-61.1996; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Zhang F, 1998, MOL CELL, V2, P141, DOI 10.1016/S1097-2765(00)80123-9	31	222	226	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					683	692		10.1016/j.cell.2005.06.024	http://dx.doi.org/10.1016/j.cell.2005.06.024			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143101	Bronze			2022-12-28	WOS:000231844300009
J	Nahlen, BL; Korenromp, EL; Miller, JM; Shibuya, K				Nahlen, BL; Korenromp, EL; Miller, JM; Shibuya, K			Malaria risk - Estimating clinical episodes of malaria	NATURE			English	Letter									WHO, Roll Back Malaria Dept, CH-1211 Geneva, Switzerland; WHO, Evidence Informat & Policy Dept, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization	Nahlen, BL (corresponding author), WHO, Roll Back Malaria Dept, CH-1211 Geneva, Switzerland.	korenrompe@who.int	Nahlen, Bernard/AAH-2051-2021	Shibuya, Kenji/0000-0003-2528-7530				KORENROMP E, 2005, MALARIA INCIDENCE ES; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; *WHO, 2004, 1 MERG TASK FORC M M; *WHO EXP COMM, 2000, 20 WHO EXP COMM	4	14	14	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					E3	E3		10.1038/nature04178	http://dx.doi.org/10.1038/nature04178			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148888	Bronze			2022-12-28	WOS:000231696900043
J	Stossel, TP				Stossel, TP			Regulating academic-industrial research relationships - Solving problems or stifling progress?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONFLICTS-OF-INTEREST; POLICIES; INVESTIGATORS; DISCLOSURE; THERAPY; SAFETY		Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Stossel, TP (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Amer Soc Clin Oncology, 2003, J CLIN ONCOL, V21, P2394, DOI 10.1200/JCO.2003.04.524; Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; Angell M., 2004, TRUTH DRUG CO THEY D; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Bok D., 2003, U MARKETPLACE COMMER; BOK D, 2003, CHRONICLE HIGHE 0404, pB7; Boyd EA, 2004, HEALTH AFFAIR, V23, P206, DOI 10.1377/hlthaff.23.2.206; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; Cohen AR, 2003, BLOOD, V102, P1583, DOI 10.1182/blood-2002-10-3280; CREMERS KJM, DOES SKIN GAME MATTE; DASSIRER JP, 2004, TAKE AM COMPLICITY B; DeAngelis CD, 2000, JAMA-J AM MED ASSOC, V284, P2237, DOI 10.1001/jama.284.17.2237; DEMBNER A, 1998, BOSTON GLOBE    0405; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; EPSTEIN RA, 2005, LEGAL AFFAIRS    JAN, P60; Fleck Ludwik, 1979, GENESIS DEV SCI FACT; Hayek FriedrichA., 1960, CONSTITUTION LIBERTY; Healy D, 2003, SCI ENG ETHICS, V9, P59, DOI 10.1007/s11948-003-0020-2; Hoffbrand AV, 2005, BEST PRACT RES CL HA, V18, P299, DOI 10.1016/j.beha.2004.08.026; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; HOSCHNEIDER P, 2001, RECOMBINANT PROTEIN, P43; Johns MME, 2003, JAMA-J AM MED ASSOC, V289, P741, DOI 10.1001/jama.289.6.741; Kaiser J, 2005, SCIENCE, V307, P1703, DOI 10.1126/science.307.5716.1703; Kassirer JP, 2001, AM J LAW MED, V27, P149; Kelch RP, 2002, NEW ENGL J MED, V346, P285, DOI 10.1056/NEJM200201243460413; Kenney Martin, 1986, BIOTECHNOLOGY U IND; Krimsky S., 2004, SCI PRIVATE INTEREST; Kuhn T.S., 1970, STRUCTURE SCI REVOLU, P174; Lo B, 2000, NEW ENGL J MED, V343, P1616, DOI 10.1056/NEJM200011303432206; McCrary SV, 2000, NEW ENGL J MED, V343, P1621, DOI 10.1056/NEJM200011303432207; Mello MM, 2005, NEW ENGL J MED, V352, P2202, DOI 10.1056/NEJMsa044115; MERTON RK, 1957, AM SOCIOL REV, V22, P635, DOI 10.2307/2089193; MILL JS, 1989, LIB OTHER WRITINGS; NAIK G, 2003, WALL STREET J   1013, pB6; NAIK G, 2003, WALL STREET J   1013, pB1; Nathan DG, 2002, NEW ENGL J MED, V347, P1368, DOI 10.1056/NEJMsb020394; *PRES FELL HARV CO, POL CONFL INT COMM; PROCTOR J, 2001, AAMC REPORTER    APR, P1; RELMAN AS, 2005, NEW REPUBLIC    0307, P23; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P1238, DOI 10.1001/jama.277.15.1238; *RES AM, POLL DAT PUBL OP POL; Steinbrook R, 2004, NEW ENGL J MED, V350, P327, DOI 10.1056/NEJMp038247; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; STEVENS AJ, 2003, AUTM LICENSING SURVE; TAYLOR H, 2003, SCI FIREMEN DOCTORS; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Warner R, 1954, THUCYDIDES HIST PELO; 2004, MED LETT DRUGS THER, V46, P53	50	105	108	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					1060	1065		10.1056/NEJMsb051758	http://dx.doi.org/10.1056/NEJMsb051758			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148294				2022-12-28	WOS:000231698200015
J	Chester, JS; Chester, FM; Kronenberg, AK				Chester, JS; Chester, FM; Kronenberg, AK			Fracture surface energy of the Punchbowl fault, San Andreas system	NATURE			English	Article							EARTHQUAKE RUPTURE; STRESS DROP; SLIP; EFFICIENCY; GOUGE; ZONE; CALIFORNIA; GROWTH	Fracture energy is a form of latent heat required to create an earthquake rupture surface and is related to parameters governing rupture propagation and processes of slip weakening(1-3). Fracture energy has been estimated from seismological and experimental rock deformation data(4-8), yet itsmagnitude, mechanisms of rupture surface formation and processes leading to slip weakening are not well defined(8-10). Here we quantify structural observations of the Punchbowl fault, a large-displacement exhumed fault(11,12) in the San Andreas fault system, and show that the energy required to create the fracture surface area in the fault is about 300 times greater than seismological estimates would predict for a single large earthquake. If fracture energy is attributed entirely to the production of fracture surfaces, then all of the fracture surface area in the Punchbowl fault could have been produced by earthquake displacements totalling <1 km. But this would only account for a small fraction of the total energy budget, and therefore additional processes probably contributed to slip weakening during earthquake rupture.	Texas A&M Univ, Dept Geol & Geophys, Ctr Tectonophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Chester, JS (corresponding author), Texas A&M Univ, Dept Geol & Geophys, Ctr Tectonophys, College Stn, TX 77843 USA.	chesterj@geo.tamu.edu	Chester, Frederick M/U-6789-2017; Chester, Frederick/X-4706-2019	Chester, Frederick M/0000-0001-7665-3647; 				Abercrombie RE, 2005, GEOPHYS J INT, V162, P406, DOI 10.1111/j.1365-246X.2005.02579.x; Andrews DJ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003191; Andrews DJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2002JB001942; Beeler NM, 2003, B SEISMOL SOC AM, V93, P1381, DOI 10.1785/0120020162; Bonnet E, 2001, REV GEOPHYS, V39, P347, DOI 10.1029/1999RG000074; BRACE WF, 1962, AM MINERAL, V47, P1111; Chester FM, 2004, MARG THEOR EXP EARTH, P223; CHESTER FM, 1987, J STRUCT GEOL, V9, P621, DOI 10.1016/0191-8141(87)90147-7; CHESTER JS, 2003, EOS, V84; Evans J.P., 2000, P 3 C TECT PROBL SAN, V21, P67; FRIEDMAN M, 1972, INT J ROCK MECH MIN, V9, P757, DOI 10.1016/0148-9062(72)90034-4; Guatteri M, 2001, J GEOPHYS RES-SOL EA, V106, P26511, DOI 10.1029/2001JB000294; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; HUSSEINI MI, 1976, B SEISMOL SOC AM, V66, P1173; IDA Y, 1972, J GEOPHYS RES, V77, P3796, DOI 10.1029/JB077i020p03796; KANAMORI H, 1994, ANNU REV EARTH PL SC, V22, P207, DOI 10.1146/annurev.ea.22.050194.001231; Kanamori H, 2000, GEOCOMPLEXITY PHYS E; MCGARR A, 1979, J GEOPHYS RES, V84, P2251, DOI 10.1029/JB084iB05p02251; OKUBO PG, 1984, J GEOPHYS RES, V89, P5817, DOI 10.1029/JB089iB07p05817; OLGAARD DL, 1983, INT J ROCK MECH MIN, V20, P11, DOI 10.1016/0148-9062(83)91610-8; Rice JR, 2005, B SEISMOL SOC AM, V95, P109, DOI 10.1785/0120030166; SCHOLZ CH, 1993, J GEOPHYS RES-SOL EA, V98, P21951, DOI 10.1029/93JB01008; Sibson RH, 2003, B SEISMOL SOC AM, V93, P1169, DOI 10.1785/0120020061; Underwood E.E., 1970, QUANTITATIVE STEREOL; Venkataraman A, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002548; Wilson B, 2005, NATURE, V434, P749, DOI 10.1038/nature03433; Wilson JE, 2003, J STRUCT GEOL, V25, P1855, DOI 10.1016/S0191-8141(03)00036-1; Wong T., 1986, EARTHQ SOURCE MEC, V37, P1; WONG TF, 1982, J GEOPHYS RES, V87, P990, DOI 10.1029/JB087iB02p00990; YUNG RA, 1990, J GEOPHYS RES-SOLID, V95, P15589, DOI 10.1029/JB095iB10p15589	30	236	242	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					133	136		10.1038/nature03942	http://dx.doi.org/10.1038/nature03942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136142				2022-12-28	WOS:000231560400056
J	Wills, BA; Dung, NM; Loan, HT; Tam, DTH; Thuy, TTN; Minh, LTT; Diet, TV; Hao, NT; Chau, NV; Stepniewska, K; White, NJ; Farrar, JJ				Wills, BA; Dung, NM; Loan, HT; Tam, DTH; Thuy, TTN; Minh, LTT; Diet, TV; Hao, NT; Chau, NV; Stepniewska, K; White, NJ; Farrar, JJ			Comparison of three fluid solutions for resuscitation in dengue shock syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLLOIDS; ALBUMIN; PLASMA	Background: Dengue shock syndrome is characterized by severe vascular leakage and disordered hemostasis and progresses to death in 1 to 5 percent of cases. Although volume replacement is recognized as the critical therapeutic intervention, World Health Organization management guidelines remain empirical rather than evidence-based. Methods: We performed a double-blind, randomized comparison of three fluids for initial resuscitation of Vietnamese children with dengue shock syndrome. We randomly assigned 383 children with moderately severe shock to receive Ringer's lactate, 6 percent dextran 70 (a colloid), or 6 percent hydroxyethyl starch (a colloid) and 129 children with severe shock to receive one of the colloids. The primary outcome measure was requirement for rescue colloid at any time after administration of the study fluid. Results: Only one patient died (< 0.2 percent mortality). The primary outcome measure - requirement for rescue colloid -- was similar for the different fluids in the two severity groups. The relative risk of requirement for rescue colloid was 1.08 (95 percent confidence interval, 0.78 to 1.47; P=0.65) among children with moderate shock who received Ringer's lactate as compared with either of the colloid solutions, 1.13 (95 percent confidence interval, 0.74 to 1.74; P=0.59) among children who received dextran as compared with starch in the group with severe shock, and 0.88 (95 percent confidence interval, 0.66 to 1.17; P=0.38) among children who received dextran as compared with starch in the combined analysis. Although treatment with Ringer's lactate resulted in less rapid improvement in the hematocrit and a marginally longer time to initial recovery than did treatment with either of the colloid solutions, there were no differences in all other measures of treatment response. Only minor differences in efficacy were detected between the two colloids, but significantly more recipients of dextran than of starch had adverse reactions. Bleeding manifestations, coagulation derangements, and severity of fluid overload were similar for all fluid-treatment groups. Conclusions: Initial resuscitation with Ringer's lactate is indicated for children with moderately severe dengue shock syndrome. Dextran 70 and 6 percent hydroxyethyl starch perform similarly in children with severe shock, but given the adverse reactions associated with the use of dextran, starch may be preferable for this group.	Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England	University of Oxford; University of Oxford	Wills, BA (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, 190 Ben Ham Tu, Ho Chi Minh City, Vietnam.	bridgetw@hcm.vnn.vn	Farrar, Jeremy J./HGA-7610-2022; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978; Wills, Bridget/0000-0001-9086-8804; Farrar, Jeremy/0000-0002-2700-623X; Stepniewska, Kasia/0000-0002-1713-6209	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALDERSON P, 2000, COCHRANE DB SYST REV, V2; Choi PTL, 1999, CRIT CARE MED, V27, P200, DOI 10.1097/00003246-199901000-00053; COHEN SN, 1966, J PEDIATR-US, V68, P448, DOI 10.1016/S0022-3476(66)80249-4; Dung NM, 1999, CLIN INFECT DIS, V29, P787, DOI 10.1086/520435; Finfer S, 2004, NEW ENGL J MED, V350, P2247; GRIFFEL MI, 1992, CRIT CARE CLIN, V8, P235, DOI 10.1016/S0749-0704(18)30249-5; Halstead Scott B., 1997, P23; HARALDSSON B, 1987, ACTA PHYSIOL SCAND, V129, P127, DOI 10.1111/j.1748-1716.1987.tb08047.x; HAUPT MT, 1992, CRIT CARE CLIN, V8, P341, DOI 10.1016/S0749-0704(18)30254-9; HUXLEY VH, 1991, AM J PHYSIOL, V260, pH1645, DOI 10.1152/ajpheart.1991.260.5.H1645; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Nhan NT, 2001, CLIN INFECT DIS, V32, P204, DOI 10.1086/318479; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Schierhout G, 1998, BMJ-BRIT MED J, V316, P961, DOI 10.1136/bmj.316.7136.961; SCHNEEBERGER EE, 1990, AM J PHYSIOL, V258, pL89, DOI 10.1152/ajplung.1990.258.2.L89; Starling E H, 1896, J Physiol, V19, P312; Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285; WHO, 1997, DENG HAEM FEV DIAGN; Wills BA, 2004, J INFECT DIS, V190, P810, DOI 10.1086/422754; World Health Organization, 1975, TECHN GUID DIAGN TRE	21	283	302	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					877	889		10.1056/NEJMoa044057	http://dx.doi.org/10.1056/NEJMoa044057			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135832	Bronze			2022-12-28	WOS:000231551100005
J	Ciais, P; Reichstein, M; Viovy, N; Granier, A; Ogee, J; Allard, V; Aubinet, M; Buchmann, N; Bernhofer, C; Carrara, A; Chevallier, F; De Noblet, N; Friend, AD; Friedlingstein, P; Grunwald, T; Heinesch, B; Keronen, P; Knohl, A; Krinner, G; Loustau, D; Manca, G; Matteucci, G; Miglietta, F; Ourcival, JM; Papale, D; Pilegaard, K; Rambal, S; Seufert, G; Soussana, JF; Sanz, MJ; Schulze, ED; Vesala, T; Valentini, R				Ciais, P; Reichstein, M; Viovy, N; Granier, A; Ogee, J; Allard, V; Aubinet, M; Buchmann, N; Bernhofer, C; Carrara, A; Chevallier, F; De Noblet, N; Friend, AD; Friedlingstein, P; Grunwald, T; Heinesch, B; Keronen, P; Knohl, A; Krinner, G; Loustau, D; Manca, G; Matteucci, G; Miglietta, F; Ourcival, JM; Papale, D; Pilegaard, K; Rambal, S; Seufert, G; Soussana, JF; Sanz, MJ; Schulze, ED; Vesala, T; Valentini, R			Europe-wide reduction in primary productivity caused by the heat and drought in 2003	NATURE			English	Article							CARBON; BALANCE; GROWTH; CO2	Future climate warming is expected to enhance plant growth in temperate ecosystems and to increase carbon sequestration(1,2). But although severe regional heatwaves may become more frequent in a changing climate(3,4), their impact on terrestrial carbon cycling is unclear. Here we report measurements of ecosystem carbon dioxide fluxes, remotely sensed radiation absorbed by plants, and country- level crop yields taken during the European heatwave in 2003. We use a terrestrial biosphere simulation model(5) to assess continental- scale changes in primary productivity during 2003, and their consequences for the net carbon balance. We estimate a 30 per cent reduction in gross primary productivity over Europe, which resulted in a strong anomalous net source of carbon dioxide ( 0.5 Pg Cyr(-1)) to the atmosphere and reversed the effect of four years of net ecosystem carbon sequestration(6). Our results suggest that productivity reduction in eastern and western Europe can be explained by rainfall deficit and extreme summer heat, respectively. We also find that ecosystem respiration decreased together with gross primary productivity, rather than accelerating with the temperature rise. Model results, corroborated by historical records of crop yields, suggest that such a reduction in Europe's primary productivity is unprecedented during the last century. An increase in future drought events could turn temperate ecosystems into carbon sources, contributing to positive carbon- climate feedbacks already anticipated in the tropics and at high latitudes(1,2).	Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Univ Tuscia, DISAFRI, Dept Forest Environm & Resources, I-01100 Viterbo, Italy; Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; Ctr Nancy, F-54280 Champenoux, France; INRA, Ephyse, Funct Ecol & Environm Phys, F-33612 Villenave Dornon, France; INRA, Grassland Ecosyst Res, F-63039 Clermont Ferrand, France; ETH Zentrum, Inst Plant Sci, CH-8092 Zurich, Switzerland; Fac Sci Agron Etat Gembloux, B-5030 Gembloux, Belgium; Tech Univ Dresden, Dept Meteorol, Inst Hydrol & Meteorol, D-01062 Dresden, Germany; Fdn CEAM, E-46980 Valencia, Spain; Univ Helsinki, Dept Phys Sci, FIN-00014 Helsinki, Finland; Max Planck Inst Biogeochem, D-07701 Jena, Germany; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Ecosyst Sci Div, Berkeley, CA 94720 USA; Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy; CNR, IBIMET, I-50144 Florence, Italy; CNRS, DREAM CEFE, F-34293 Montpellier, France; Riso Natl Lab, Biosyst Dept, DK-4000 Roskilde, Denmark	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Tuscia University; Potsdam Institut fur Klimafolgenforschung; INRAE; INRAE; VetAgro Sup; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Liege; Technische Universitat Dresden; University of Helsinki; Max Planck Society; University of California System; University of California Berkeley; European Commission Joint Research Centre; EC JRC ISPRA Site; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Technical University of Denmark	Ciais, P (corresponding author), Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France.	philippe.ciais@cea.fr	Pilegaard, Kim/I-7137-2013; Ciais, Philippe/A-6840-2011; Keronen, Petri I.K./B-6222-2008; Valentini, Riccardo/D-1226-2010; Vesala, Timo/C-3795-2017; Miglietta, Franco/B-6137-2008; Soussana, Jean-Francois/P-2094-2016; Papale, Dario/W-7302-2019; Knohl, Alexander/F-9453-2014; de NOBLET, Nathalie I/O-8613-2015; Ogée, Jérôme/C-7185-2013; Viovy, Nicolas/S-2631-2018; Allard, Vincent/B-8806-2009; Seufert, Günther/J-9918-2013; Matteucci, Giorgio/N-3526-2015; Schulze, Ernst-Detlef/K-9627-2014; Buchmann, Nina/E-6095-2011; Krinner, Gerhard/AAB-8837-2022; Pilegaard, Kim/H-9026-2019; Chevallier, Frederic JM/E-9608-2016; Krinner, Gerhard/A-6450-2011; Zhong, Hong Lin/C-2633-2012; Sanz, Maria Jose/A-6099-2016; Carrara, Arnaud/L-8144-2014; Carrara, Arnaud/ABH-5319-2020; Rambal, Serge/H-5705-2019; Reichstein, Markus/A-7494-2011; Matteucci, Giorgio/AAB-7022-2021; Soussana, Jean-Francois/M-2814-2017; Friedlingstein, Pierre/H-2700-2014	Pilegaard, Kim/0000-0002-5169-5717; Ciais, Philippe/0000-0001-8560-4943; Valentini, Riccardo/0000-0002-6756-5634; Vesala, Timo/0000-0002-4852-7464; Miglietta, Franco/0000-0003-1474-8143; Soussana, Jean-Francois/0000-0002-1932-6583; Papale, Dario/0000-0001-5170-8648; Knohl, Alexander/0000-0002-7615-8870; Ogée, Jérôme/0000-0002-3365-8584; Viovy, Nicolas/0000-0002-9197-6417; Allard, Vincent/0000-0003-1949-9158; Seufert, Günther/0000-0002-6019-6688; Matteucci, Giorgio/0000-0002-4790-9540; Buchmann, Nina/0000-0003-0826-2980; Krinner, Gerhard/0000-0002-2959-5920; Pilegaard, Kim/0000-0002-5169-5717; Chevallier, Frederic JM/0000-0002-4327-3813; Krinner, Gerhard/0000-0002-2959-5920; Sanz, Maria Jose/0000-0003-0471-3094; Carrara, Arnaud/0000-0002-9095-8807; Rambal, Serge/0000-0001-5869-8382; Reichstein, Markus/0000-0001-5736-1112; Friedlingstein, Pierre/0000-0003-3309-4739; Keronen, Petri/0000-0001-5019-0904; Loustau, Denis/0000-0003-3990-400X				[Anonymous], 2004, 55 TYND CTR CLIM CHA; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; BOYER JS, 1995, ANNU REV PHYTOPATHOL, V33, P251, DOI 10.1146/annurev.py.33.090195.001343; BUTTNER G, 2000, 89 EUR ENV AG; Cherbuy B, 2001, TREE PHYSIOL, V21, P9, DOI 10.1093/treephys/21.1.9; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Dufresne JL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013777; ELLIOTT KJ, 1994, J VEG SCI, V5, P229, DOI 10.2307/3236155; *FOOD AGR ORG, 2004, FOOD AGR ORG DAT; Goudriaan J, 2001, TERRESTRIAL GLOBAL P; Granier A, 1999, ECOL MODEL, V116, P269, DOI 10.1016/S0304-3800(98)00205-1; Irvine J, 1998, TREE PHYSIOL, V18, P393; Janssens IA, 2003, SCIENCE, V300, P1538, DOI 10.1126/science.1083592; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Monsi TM, 1953, JAP J BOT, V14, P22; Mucher CA, 2000, INT J REMOTE SENS, V21, P1159, DOI 10.1080/014311600210128; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003430; Reichstein M, 2002, GLOBAL CHANGE BIOL, V8, P999, DOI 10.1046/j.1365-2486.2002.00530.x; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Schimel JP, 1999, SOIL BIOL BIOCHEM, V31, P831, DOI 10.1016/S0038-0717(98)00182-5; Simmons A. J., 2000, ERA 40 PROJECT PLAN, P1; TYREE MT, 1988, PLANT PHYSIOL, V88, P574, DOI 10.1104/pp.88.3.574; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084	28	2590	2720	132	1589	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					529	533		10.1038/nature03972	http://dx.doi.org/10.1038/nature03972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177786				2022-12-28	WOS:000232004800045
J	Hsiung, F; Ramirez-Weber, FA; Iwaki, DD; Kornberg, TB				Hsiung, F; Ramirez-Weber, FA; Iwaki, DD; Kornberg, TB			Dependence of Drosophila wing imaginal disc cytonemes on decapentaplegic	NATURE			English	Article							LONG-RANGE ACTION; GRADIENT FORMATION; MORPHOGEN GRADIENT; TRACHEAL SYSTEM; DPP; HEDGEHOG; CELLS; FGF; EXPRESSION; FILOPODIA	The anterior/ posterior ( A/ P) and dorsal/ ventral ( D/ V) compartment borders that subdivide the wing imaginal discs of Drosophila third instar larvae are each associated with a developmental organizer. Decapentaplegic ( Dpp), a member of the transforming growth factor-beta ( TGF-beta) superfamily, embodies the activity of the A/ P organizer. It is produced at the A/ P organizer and distributes in a gradient of decreasing concentration to regulate target genes, functioning non- autonomously to regulate growth and patterning of both the anterior and posterior compartments(1 - 3). Wingless ( Wg) is produced at the D/ V organizer and embodies its activity(4,5). The mechanisms that distribute Dpp and Wg are not known, but proposed mechanisms include extracellular diffusion(6), successive transfers between neighbouring cells(7,8), vesicle- mediated movement(9), and direct transfer via cytonemes(10). Cytonemes are actin-based filopodial extensions that have been found to orient towards the A/ P organizer from outlying cells. Here we show that in the wing disc, cytonemes orient towards both the A/ P and D/ V organizers, and that their presence and orientation correlates with Dpp signalling. We also show that the Dpp receptor, Thickveins ( Tkv), is present in punctae that move along cytonemes. These observations are consistent with a role for cytonemes in signal transduction.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kornberg, TB (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	tkornberg@biochem.ucsf.edu						Akiyama-Oda Y, 2003, DEVELOPMENT, V130, P1735, DOI 10.1242/dev.00390; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chou YH, 2002, DEV CELL, V3, P839, DOI 10.1016/S1534-5807(02)00362-3; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Kranewitter WJ, 2001, CELL MOTIL CYTOSKEL, V49, P154, DOI 10.1002/cm.1029; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; Sato M, 2000, MECH DEVELOP, V93, P127, DOI 10.1016/S0925-4773(00)00282-3; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Wolf C, 2002, EMBO REP, V3, P563, DOI 10.1093/embo-reports/kvf115; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; ZIGMOND SH, 1993, CELL MOTIL CYTOSKEL, V25, P309, DOI 10.1002/cm.970250402	24	155	157	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					560	563		10.1038/nature03951	http://dx.doi.org/10.1038/nature03951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177792				2022-12-28	WOS:000232004800052
J	Arpino, G; Laucirica, R; Elledge, RM				Arpino, G; Laucirica, R; Elledge, RM			Premalignant and in situ breast disease: Biology and clinical implications	ANNALS OF INTERNAL MEDICINE			English	Review							SURGICAL ADJUVANT BREAST; ATYPICAL DUCTAL HYPERPLASIA; TERM-FOLLOW-UP; COMPARATIVE GENOMIC HYBRIDIZATION; HEALTHY POSTMENOPAUSAL WOMEN; STEREOTAXIC CORE BIOPSY; ESTROGEN-RECEPTOR-ALPHA; CELL PROLIFERATION RATE; P53 PROTEIN EXPRESSION; NSABP PROTOCOL B-17	Most types of invasive breast cancer are thought to evolve over long periods from specific preexisting benign lesions. Of the many types of benign entities found in the human breast, only a few have clinically significant premalignant potential. Currently, the best-characterized premalignant lesions are atypical ductal hyperplasia, atypical lobular hyperplasia, and lobular carcinoma in situ. Ductal carcinoma in situ is considered to be a preinvasive malignant lesion. Two additional lesions, unfolded lobules and usual ductal hyperplasia, are sometimes considered to be very early premalignant epithelial abnormalities. Premalignant lesions are currently defined by their histologic features, and not all necessarily progress to invasive cancer. This suggests that although lesions within specific categories look alike, they must possess underlying genetic differences that cause some to remain stable and others to advance. The development of modern molecular genetic techniques has allowed breast cancer researchers to clarify the multistep model of breast carcinogenesis. Recent studies indicate that cancer evolves by highly diverse genetic mechanisms, and research into these altered pathways may identify specific early defects that might be targeted to prevent progression of premalignant lesions to invasive cancer. Current clinical management is heterogeneous and depends on histologic examination and individual patient factors. Options for breast cancer risk reduction and prevention are available.	Baylor Coll Med, Methodist Hosp, Houston, TX 77030 USA; Ben Taub Gen Hosp, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston	Elledge, RM (corresponding author), 6550 Fannin St,Suite 701, Houston, TX 77030 USA.	relledge@breastcenter.tmc.edu			NATIONAL CANCER INSTITUTE [P50CA058183, P01CA030195, U19CA086809] Funding Source: NIH RePORTER; NCI NIH HHS [U-19 CA86809, P01 CA30195, P50 CA58183] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allred DC, 2001, ENDOCR-RELAT CANCER, V8, P47, DOI 10.1677/erc.0.0080047; Allred DC, 2002, BREAST CANCER RES TR, V76, pS36; Allred DC, 2000, J MAMMARY GLAND BIOL, V5, P351, DOI 10.1023/A:1009573710675; ALLRED DC, 1994, BREAST CANCER RES TR, V32, P13, DOI 10.1007/BF00666202; ALLRED DC, 1992, HUM PATHOL, V23, P974, DOI 10.1016/0046-8177(92)90257-4; ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; ALLRED DC, 1997, DUCTAL CARCINOMA IN, P37; ALPERS CE, 1985, HUM PATHOL, V16, P796, DOI 10.1016/S0046-8177(85)80251-3; ANDERSEN JA, 1974, ACTA PATH MICRO IM A, VA 82, P735; Arpino G, 2004, CANCER-AM CANCER SOC, V101, P242, DOI 10.1002/cncr.20318; BARNES R, 1990, AM J CLIN PATHOL, V94, P533, DOI 10.1093/ajcp/94.5.533; BARTEK J, 1990, INT J CANCER, V46, P839, DOI 10.1002/ijc.2910460515; Baxter NN, 2004, JNCI-J NATL CANCER I, V96, P443, DOI 10.1093/jnci/djh069; BERARDO M, 1996, LAB INVEST, V74, pA15; Berg WA, 2001, RADIOLOGY, V218, P503, DOI 10.1148/radiology.218.2.r01fe32503; BETSILL WL, 1978, JAMA-J AM MED ASSOC, V239, P1863, DOI 10.1001/jama.239.18.1863; BLACK WC, 1995, J NATL CANCER I, V87, P720, DOI 10.1093/jnci/87.10.720; BOBROW LG, 1994, SEMIN DIAGN PATHOL, V11, P199; BODIAN CA, 1993, CANCER, V71, P3908, DOI 10.1002/1097-0142(19930615)71:12<3908::AID-CNCR2820711218>3.0.CO;2-F; BODIAN CA, 1993, EPIDEMIOL REV, V15, P177, DOI 10.1093/oxfordjournals.epirev.a036103; Boecker W, 2001, J PATHOL, V195, P415, DOI 10.1002/path.982; Boyages J, 1999, CANCER, V85, P616, DOI 10.1002/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.0.CO;2-7; Bratthauer GL, 2004, VIRCHOWS ARCH, V444, P340, DOI 10.1007/s00428-004-0976-6; Buerger H, 2000, J CLIN PATHOL-MOL PA, V53, P118, DOI 10.1136/mp.53.3.118; Burak WE, 2000, ARCH SURG-CHICAGO, V135, P700, DOI 10.1001/archsurg.135.6.700; CARTER CL, 1988, AM J EPIDEMIOL, V128, P467, DOI 10.1093/oxfordjournals.aje.a114995; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Chuaqui RF, 1997, AM J PATHOL, V150, P297; Copeland EM, 1997, ANN SURG, V225, P731; DEPOTTER CR, 1989, HISTOPATHOLOGY, V15, P351; DEPOTTER CR, 1987, HISTOPATHOLOGY, V11, P1307; Dillon EK, 1997, BRIT J CANCER, V76, P156, DOI 10.1038/bjc.1997.357; DOMAGALA W, 1993, VIRCHOWS ARCH A, V423, P497, DOI 10.1007/BF01606541; Domagala W, 1996, CLIN CANCER RES, V2, P147; DUPONT WD, 1993, CANCER, V71, P1258, DOI 10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Ernster V L, 1997, J Natl Cancer Inst Monogr, P151; Ernster VL, 2002, J NATL CANCER I, V94, P1546; EUSEBI V, 1994, SEMIN DIAGN PATHOL, V11, P223; Farrow J H, 1970, Cancer, V25, P468, DOI 10.1002/1097-0142(197002)25:2<468::AID-CNCR2820250226>3.0.CO;2-0; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Fisher B, 2001, SEMIN ONCOL, V28, P400, DOI 10.1053/sonc.2001.26151; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1993, NEW ENGL J MED, V328, P1581, DOI 10.1056/NEJM199306033282201; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Fisher ER, 2004, CANCER-AM CANCER SOC, V100, P238, DOI 10.1002/cncr.11883; Fisher ER, 1996, CANCER-AM CANCER SOC, V78, P1403, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1403::AID-CNCR6>3.0.CO;2-L; FISHER ER, 1995, CANCER-AM CANCER SOC, V75, P1310, DOI 10.1002/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO;2-G; Fujii H, 1996, CANCER RES, V56, P1493; Fuqua SAW, 2000, CANCER RES, V60, P4026; George WD, 2003, LANCET, V362, P95, DOI 10.1016/S0140-6736(03)13859-7; GIRI DD, 1989, HISTOPATHOLOGY, V15, P575, DOI 10.1111/j.1365-2559.1989.tb01623.x; GUSTERSON BA, 1988, BRIT J CANCER, V58, P453, DOI 10.1038/bjc.1988.239; HAAGENSEN CD, 1972, SURG CLIN N AM, V52, P497; HAAGENSEN CD, 1986, LOBULAR NEOPLASIA LO, V192; HOSHI K, 1995, JPN J CANC CHEMOT S1, V22, P36; Hwang ES, 2004, CLIN CANCER RES, V10, P5160, DOI 10.1158/1078-0432.CCR-04-0165; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Julien JP, 2000, LANCET, V355, P528, DOI 10.1016/S0140-6736(99)06341-2; KRAUS FT, 1962, CANCER, V15, P444, DOI 10.1002/1097-0142(196205/06)15:3<444::AID-CNCR2820150303>3.0.CO;2-0; LAKHANI SR, 1995, J CLIN PATHOL, V48, P611, DOI 10.1136/jcp.48.7.611; Lakhani SR, 2003, LANCET, V361, P96, DOI 10.1016/S0140-6736(03)12240-4; Lakhani SR, 1996, LAB INVEST, V74, P129; LAMBIRD PA, 1969, J AMER MED ASSOC, V210, P689; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; Li CI, 2002, BREAST CANCER RES TR, V75, P259, DOI 10.1023/A:1019950918046; Li CI, 2000, CANCER, V88, P2570, DOI 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O; LIBERMAN L, 1995, RADIOLOGY, V194, P379, DOI 10.1148/radiology.194.2.7824713; LIBERMAN L, 1995, AM J ROENTGENOL, V164, P1111, DOI 10.2214/ajr.164.5.7717215; LODATO RF, 1990, MODERN PATHOL, V3, P449; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; Lu YJ, 1998, CANCER RES, V58, P4721; MALAFA M, 1990, AM SURGEON, V56, P436; MCDIVITT RW, 1992, CANCER-AM CANCER SOC, V69, P1408, DOI 10.1002/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C; MIDULLA C, 1995, ANAL QUANT CYTOL, V17, P157; MILLIS RR, 1975, BRIT J SURG, V62, P957, DOI 10.1002/bjs.1800621209; MOHSIN SK, 2000, MODERN PATHOL, V13, pA28; MOLL R, 1993, AM J PATHOL, V143, P1731; Mommers ECM, 1999, BREAST CANCER RES TR, V58, P163, DOI 10.1023/A:1006396103777; Mommers ECM, 2001, J PATHOL, V193, P33, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH744>3.0.CO;2-Q; Mommers ECM, 1998, HUM PATHOL, V29, P1539, DOI 10.1016/S0046-8177(98)90028-4; Moore MM, 1997, ANN SURG, V225, P726, DOI 10.1097/00000658-199706000-00010; Nyante SJ, 2004, HUM PATHOL, V35, P759, DOI 10.1016/j.humpath.2003.11.009; O'Connell P, 1998, JNCI-J NATL CANCER I, V90, P697, DOI 10.1093/jnci/90.9.697; Orel SG, 1997, RADIOLOGY, V202, P413, DOI 10.1148/radiology.202.2.9015067; OSTEEN RT, 1994, J AM COLL SURGEONS, V178, P213; OTTESEN GL, 1993, AM J SURG PATHOL, V17, P14, DOI 10.1097/00000478-199301000-00002; PAGE DL, 1982, CANCER, V49, P751, DOI 10.1002/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y; Page DL, 2003, LANCET, V361, P125, DOI 10.1016/S0140-6736(03)12230-1; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; PAGE DL, 1986, CANCER DETECT PREV, V9, P441; PAGE DL, 1991, HUM PATHOL, V22, P1232, DOI 10.1016/0046-8177(91)90105-X; PAGE DL, 1992, HUM PATHOL, V23, P1095, DOI 10.1016/0046-8177(92)90026-Y; PAGE DL, 1990, CANCER, V66, P1326, DOI 10.1002/1097-0142(19900915)66:14+<1326::AID-CNCR2820661405>3.0.CO;2-P; PAGE DL, 1993, BREAST CANCER RES TR, V28, P157, DOI 10.1007/BF00666428; Page DL, 1987, DIAGNOSTIC HISTOPATH, P120; PALLIS L, 1992, ANTICANCER RES, V12, P2113; PERTSCHUK LP, 1990, CANCER, V66, P1663, DOI 10.1002/1097-0142(19901015)66:8<1663::AID-CNCR2820660802>3.0.CO;2-C; POLLER DN, 1991, BREAST CANCER RES TR, V20, P3, DOI 10.1007/BF01833351; PORTER PL, 1991, CANCER, V68, P331, DOI 10.1002/1097-0142(19910715)68:2<331::AID-CNCR2820680221>3.0.CO;2-X; Querzoli P, 1998, CANCER-AM CANCER SOC, V83, P89, DOI 10.1002/(SICI)1097-0142(19980701)83:1<89::AID-CNCR12>3.0.CO;2-8; RADFORD DM, 1995, CANCER RES, V55, P5180; RAMACHANDRA S, 1990, J PATHOL, V161, P7, DOI 10.1002/path.1711610104; RASBRIDGE SA, 1993, J PATHOL, V169, P245, DOI 10.1002/path.1711690211; ROSEN P P, 1984, P59; ROSEN PP, 1980, CANCER, V46, P919, DOI 10.1002/1097-0142(19800815)46:4+<919::AID-CNCR2820461311>3.0.CO;2-Z; ROSEN PP, 1999, BREAST PATHOLOGY DIA, P197; Rosenberg CL, 1997, HUM PATHOL, V28, P214, DOI 10.1016/S0046-8177(97)90109-X; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rudas M, 1997, EUR J CANCER, V33, P39, DOI 10.1016/S0959-8049(96)00368-1; SCHILDKRAUT JM, 1995, AM J OBSTET GYNECOL, V172, P908, DOI 10.1016/0002-9378(95)90020-9; Schmitt FC, 1995, EUR J CANCER, V31A, P2049, DOI 10.1016/0959-8049(95)00430-0; Schwartz GF, 1997, HUM PATHOL, V28, P1221; Shaaban AM, 2002, AM J SURG PATHOL, V26, P421, DOI 10.1097/00000478-200204000-00003; Shaaban AM, 2002, AM J PATHOL, V160, P597, DOI 10.1016/S0002-9440(10)64879-1; Silverstein MJ, 1998, J CLIN ONCOL, V16, P1367, DOI 10.1200/JCO.1998.16.4.1367; SILVERSTEIN MJ, 1995, EUR J CANCER, V31A, P1425, DOI 10.1016/0959-8049(95)00283-O; Silverstein MJ, 1999, NEW ENGL J MED, V340, P1455, DOI 10.1056/NEJM199905133401902; Simpson PT, 2005, J PATHOL, V205, P248, DOI 10.1002/path.1691; Soderstrom CE, 1996, RADIOLOGY, V201, P427, DOI 10.1148/radiology.201.2.8888235; SOMERVILLE JE, 1992, J CLIN PATHOL, V45, P16, DOI 10.1136/jcp.45.1.16; TAVASSOLI FA, 1990, CANCER, V65, P518, DOI 10.1002/1097-0142(19900201)65:3<518::AID-CNCR2820650324>3.0.CO;2-O; TAVASSOLI FA, 1999, PATHOLOGY BREAST, P373; VISSCHER DW, 1991, ANAL QUANT CYTOL, V13, P418; Vos CBJ, 1997, BRIT J CANCER, V76, P1131, DOI 10.1038/bjc.1997.523; Wang JP, 2004, J NATL CANCER I, V96, P616, DOI 10.1093/jnci/djhs105; WELLINGS SR, 1973, J NATL CANCER I, V50, P1111, DOI 10.1093/jnci/50.5.1111; WELLINGS SR, 1975, J NATL CANCER I, V55, P231; YOUNES M, 1995, HUM PATHOL, V26, P155, DOI 10.1016/0046-8177(95)90031-4; ZHUANG ZP, 1995, CANCER RES, V55, P467	131	137	138	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2005	143	6					446	457		10.7326/0003-4819-143-6-200509200-00009	http://dx.doi.org/10.7326/0003-4819-143-6-200509200-00009			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967OG	16172443				2022-12-28	WOS:000232099900006
J	Rowe, AK; de Savigny, D; Lanata, CF; Victora, CG				Rowe, AK; de Savigny, D; Lanata, CF; Victora, CG			How can we achieve and maintain high-quality performance of health workers in low-resource settings?	LANCET			English	Review							CHILDHOOD ILLNESS; PUBLIC-HEALTH; INTEGRATED MANAGEMENT; CLINICAL-PRACTICE; DRUG-USE; CARE; FACILITIES; CHILDREN; KNOWLEDGE; SERVICES	In low and middle income countries, health workers are essential for the delivery of health interventions. However, inadequate health-worker performance is a very widespread problem. We present an overview of issues and evidence about the determinants of performance and strategies for improving it. Health-worker practices are complex behaviours that have many potential influences. Reviews of intervention studies in low and middle income countries suggest that the simple dissemination of written guidelines is often ineffective, that supervision and audit with feedback is generally effective, and that multifaceted interventions might be more effective than single interventions. Few interventions have been evaluated with rigorous cost-effectiveness trials, and such studies are urgently needed to guide policy. We propose an international collaborative research agenda to generate knowledge about the true determinants of performance and about the effectiveness of strategies to improve performance. Furthermore, we recommend that ministries of health and international organisations should actively help translate research findings into action to improve health-worker performance, and thereby improve health.	Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30341 USA; Swiss Trop Inst, CH-4002 Basel, Switzerland; Tanzania Minist Hlth, Tanzania Essential Hlth Intervent Project, Dar Es Salaam, Tanzania; Inst Invest Nutr, Lima, Peru; Univ Fed Pelotas, Pelotas, Brazil	Centers for Disease Control & Prevention - USA; University of Basel; Swiss Tropical & Public Health Institute; Universidade Federal de Pelotas	Rowe, AK (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis, Natl Ctr Infect Dis, Mailstop F22,4770 Buford Highway, Atlanta, GA 30341 USA.	axr9@cdc.gov	Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013; Lanata, Claudio F./N-7997-2018	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Lanata, Claudio F./0000-0002-6994-7425				Abas M, 2003, HARVARD REV PSYCHIAT, V11, P166, DOI 10.1080/10673220303954; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Alliance for Health Policy and Systems Research, 2004, STRENGTH HLTH SYST R; ANGUNAWELA II, 1991, INT J EPIDEMIOL, V20, P558, DOI 10.1093/ije/20.2.558; Bazin D., 2009, EC ANAL, V42, P7; Beaglehole R., 2003, WORLD HLTH REPORT 20; Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; Bickler SW, 2002, B WORLD HEALTH ORGAN, V80, P829; Bitera Raphael, 2002, Sante, V12, P233; Black N, 1996, BRIT MED J, V312, P1215; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BOSE S, 2001, 24 JHPIEGO CORP QUAL; Briggs CJ, 2001, COCHRANE DB SYST REV, V4; Brugha R, 1998, HEALTH POLICY PLANN, V13, P107, DOI 10.1093/heapol/13.2.107; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Chalker J, 2005, SOC SCI MED, V60, P131, DOI 10.1016/j.socscimed.2004.04.019; CHALKER J, COMMUNICATION; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; DESAVIGNY D, 2004, FIXING HLTH SYSTEMS; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Goldman N, 2003, SOC SCI MED, V56, P685, DOI 10.1016/S0277-9536(02)00065-5; Gouws E, 2004, B WORLD HEALTH ORGAN, V82, P509; Graham LE, 2003, TROP DOCT, V33, P36, DOI 10.1177/004947550303300118; Green LW., 1980, HLTH ED PLANNING DIA, V1; Grimshaw JM, 2004, HLTH TECHNOL ASSESS, V8; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; HOGERZEIL HV, 1993, LANCET, V342, P1408, DOI 10.1016/0140-6736(93)92760-Q; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KNEBEL E, 2000, 11 U RES CO LLC QUAL; KNEBEL E, 2001, 22 U RES CO LLC QUAL; KNEBEL E, 2000, 12 U RES CO LLC QUAL; Laing RO, 2001, HEALTH POLICY PLANN, V16, P13, DOI 10.1093/heapol/16.1.13; LANATA CF, 2002, MEJORANDO CALIDAD AT; LOMAS J, 1988, American Journal of Preventive Medicine, V4, P77; MARQUEZ L, 2002, POPULATION REPORTS S, V30; MARQUEZ L, 2001, 23 U RES CO LLC QUAL; Massoud R., 2001, QA MONOGRAPH SERIES, V1; Mills A, 2002, B WORLD HEALTH ORGAN, V80, P325; Montagu D, 2002, HEALTH POLICY PLANN, V17, P121, DOI 10.1093/heapol/17.2.121; NAIMOLI J, 2001, THESIS HARVARD SCH P; OforiAdjei D, 1996, SOC SCI MED, V42, P1169, DOI 10.1016/0277-9536(95)00389-4; Paredes P, 1996, SOC SCI MED, V42, P1141, DOI 10.1016/0277-9536(95)00387-8; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Ratanawijitrasin S, 2001, SOC SCI MED, V53, P831, DOI 10.1016/S0277-9536(00)00390-7; Roethlisberger F.J., 1939, MANAGEMENT WORKER AC; Ross-Degnan D, 1997, INT C IMPR US MED CH; Rowe AK, 2000, AM J EPIDEMIOL, V151, P1029, DOI 10.1093/oxfordjournals.aje.a010131; Rowe AK, 2003, INT J EPIDEMIOL, V32, P296, DOI 10.1093/ije/dyg063; Rowe AK, 2001, AM J PUBLIC HEALTH, V91, P1625, DOI 10.2105/AJPH.91.10.1625; SALMON JW, OPERATIONS RES RESUL, V2; Santoso B, 1996, SOC SCI MED, V42, P1163, DOI 10.1016/0277-9536(95)00390-8; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Shortell SM, 1998, MILBANK Q, V76, P593, DOI 10.1111/1468-0009.00107; Silimperi DR, 2002, INT J QUAL HEALTH C, V14, P67, DOI 10.1093/intqhc/14.suppl_1.67; Tanser F, 2001, TROP MED INT HEALTH, V6, P826, DOI 10.1046/j.1365-3156.2001.00794.x; Tavrow P, 2002, INT J QUAL HEALTH C, V14, P57, DOI 10.1093/intqhc/14.suppl_1.57; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Weinberg M, 2001, ARCH INTERN MED, V161, P2357, DOI 10.1001/archinte.161.19.2357; Whiting DR, 2003, J CARDIOVASC RISK, V10, P103, DOI 10.1097/00043798-200304000-00005; Whittaker S, 2000, INT J QUAL HEALTH C, V12, P247, DOI 10.1093/intqhc/12.3.247; *WHO, IMPR QUAL PAED CAR S; WHO, 2003, HLTH FAC SURV TOOL E; *WHO ROLL BACK MAL, 2000, FRAM MON PROGR EV OU; WHO. World Health Organization, 1993, INVESTIGATE DRUG USE; WOODWARD CA, 2000, 1 WHO DEP ORG HLTH S; Wootton R, 2001, J TELEMED TELECARE, V7, P3, DOI [10.1258/1357633011937245, 10.1258/1357633011936589]; World Bank, 2004, WORLD DEV REP 2004 M; World Health Organization, 1994, 9 WHO PROGR CONTR DI; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253; 2 INT C IMPR US MED; 1993, FAM PLAN MANAGER, V2, P1	79	696	700	0	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					1026	1035		10.1016/S0140-6736(05)67028-6	http://dx.doi.org/10.1016/S0140-6736(05)67028-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965MZ	16168785				2022-12-28	WOS:000231955900038
J	Ferretti, DF; Miller, JB; White, JWC; Etheridge, DM; Lassey, KR; Lowe, DC; Meure, CMM; Dreier, MF; Trudinger, CM; van Ommen, TD; Langenfelds, RL				Ferretti, DF; Miller, JB; White, JWC; Etheridge, DM; Lassey, KR; Lowe, DC; Meure, CMM; Dreier, MF; Trudinger, CM; van Ommen, TD; Langenfelds, RL			Unexpected changes to the global methane budget over the past 2000 years	SCIENCE			English	Article							ANTARCTIC FIRN AIR; ATMOSPHERIC METHANE; ANTHROPOGENIC EMISSIONS; ICE CORE; HISTORY; DELTA-C-13; RESOLUTION; RAINFALL; DROUGHT; CLIMATE	We report a 2000-year Antarctic ice-core record of stable carbon isotope measurements in atmospheric methane (delta(CH4)-C-13). Large delta(CH4)-C-13 variations indicate that the methane budget varied unexpectedly during the late preindustrial Holocene (circa 0 to 1700 A.D.). During the first thousand years (0 to 1000 A.D.), delta(CH4)-C-13 was at least 2 per mil enriched compared to expected values, and during the following 700 years, an about 2 per mil depletion occurred. Our modeled methane source partitioning implies that biomass burning emissions were high from 0 to 1000 A.D. but reduced by almost similar to 40% over the next 700 years. We suggest that both human activities and natural climate change influenced preindustrial biomass burning emissions and that these emissions have been previously understated in late preindustrial Holocene methane budget research.	Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; NOAA, RCMDL1, Boulder, CO 80305 USA; CSIRO, Aspendale, Vic 3195, Australia; Australian Antarctic Div, Dept Environm & Heritage, Hobart, Tas 7001, Australia; Antarctic Climate & Ecosyst CRC, Hobart, Tas 7001, Australia	University of Colorado System; University of Colorado Boulder; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Antarctic Division; University of Tasmania	Ferretti, DF (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA.	d.ferretti@niwa.co.nz	White, James W.C./A-7845-2009; van Ommen, Tas D/B-5020-2012; Etheridge, David M/B-7334-2013; Langenfelds, Raymond L/B-5381-2012; Miller, John B./AAE-7714-2019; Trudinger, Cathy/A-2532-2008	White, James W.C./0000-0001-6041-4684; van Ommen, Tas D/0000-0002-2463-1718; Langenfelds, Raymond L/0000-0003-4890-2049; Miller, John B./0000-0001-8630-1610; Trudinger, Cathy/0000-0002-4844-2153; Lassey, Keith/0000-0003-0350-4215; Etheridge, David/0000-0001-7970-2002				ANDERSON MK, 1994, CHEMOSPHERE, V29, P913, DOI 10.1016/0045-6535(94)90160-0; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Braunlich M, 2001, J GEOPHYS RES-ATMOS, V106, P20465, DOI 10.1029/2001JD900190; Carcaillet C, 2002, CHEMOSPHERE, V49, P845, DOI 10.1016/S0045-6535(02)00385-5; CRAIG H, 1988, SCIENCE, V242, P1535, DOI 10.1126/science.242.4885.1535; DENEVAN W, 1992, NATIVE POPULATION AM, P386; Etheridge DM, 1998, J GEOPHYS RES-ATMOS, V103, P15979, DOI 10.1029/98JD00923; Etiope G, 2004, ATMOS ENVIRON, V38, P3099, DOI 10.1016/j.atmosenv.2004.04.002; FERRETTI D, UNPUB; Francey RJ, 1999, J GEOPHYS RES-ATMOS, V104, P23631, DOI 10.1029/1999JD900357; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Hallett DJ, 2003, HOLOCENE, V13, P751, DOI 10.1191/0959683603hl660rp; Houweling S, 2000, J GEOPHYS RES-ATMOS, V105, P17243, DOI 10.1029/2000JD900193; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Lassey KR, 2000, GLOBAL BIOGEOCHEM CY, V14, P41, DOI 10.1029/1999GB900094; Lowe DC, 1997, GEOPHYS RES LETT, V24, P857, DOI 10.1029/97GL00830; McEvEDY C., 1978, Atlas of world population history.; MEURE CM, 2004, THESIS U MELBOURNE; MILLER JB, 1999, THESIS U COLORADO BO; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; RASMUSSEN RA, 1984, J GEOPHYS RES-ATMOS, V89, P1599, DOI 10.1029/JD089iD07p11599; Ren GY, 1998, GEOPHYS RES LETT, V25, P1931, DOI 10.1029/98GL01508; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Savarino J, 1998, J GEOPHYS RES-ATMOS, V103, P8267, DOI 10.1029/97JD03748; Sowers T, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002408; SUBAK S, 1994, CHEMOSPHERE, V29, P843, DOI 10.1016/0045-6535(94)90157-0; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; van Aardenne JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P909, DOI 10.1029/2000GB001265; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Wang YH, 1998, J GEOPHYS RES-ATMOS, V103, P31123, DOI 10.1029/1998JD100004; WOODCOCK DW, 1994, CHEMOSPHERE, V29, P935, DOI 10.1016/0045-6535(94)90161-9	32	200	209	5	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1714	1717		10.1126/science.1115193	http://dx.doi.org/10.1126/science.1115193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151008				2022-12-28	WOS:000231836700041
J	Hohlfeld, J; Roessingh, AD; Hirt-Burri, N; Chaubert, P; Gerber, S; Scaletta, C; Hohlfeld, P; Applegate, LA				Hohlfeld, J; Roessingh, AD; Hirt-Burri, N; Chaubert, P; Gerber, S; Scaletta, C; Hohlfeld, P; Applegate, LA			Tissue engineered fetal skin constructs for paediatric burns	LANCET			English	Article							REPAIR; CELL	Autologous skin-grafting is the gold standard for treatment of deep second and third degree bums. Available bioengineered skin products also necessitate this two-step surgical procedure. Therefore, we developed fetal skin constructs to improve healing of such degree bums. A bank of fetal skin cells was developed from one organ donation (4 cm(2) of skin allowing the preparation of several million three-dimensional skin constructs, 9 X 12 cm, on native horse Collagen). Successive fetal constructs were applied to eight patients at every change of dressing during 1-3 weeks in an outpatient setting. Complete closure was rapid (mean 15.3 days [SD 5.5]) with little hypertrophy of new skin and no retraction seen. This simple technique provided complete treatment without auto-grafting, showing that fetal skin cells might have great potential to treat bums and eventually acute and chronic wounds of other types.	Univ Lausanne Hosp, CHU Vaudois, Dept Obstet, Div Fetal Med, CH-1011 Lausanne, Switzerland; Univ Lausanne Hosp, CHU Vaudois, Dept Paediat Surg, CH-1011 Lausanne, Switzerland; Univ Lausanne Hosp, CHU Vaudois, Inst Pathol, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Applegate, LA (corresponding author), Univ Lausanne Hosp, CHU Vaudois, Dept Obstet, Div Fetal Med, MAT 07, CH-1011 Lausanne, Switzerland.	Lee.Laurent-Applegate@chuv.hospvd.ch						ADZICK NS, 1994, ANN SURG, V220, P10, DOI 10.1097/00000658-199407000-00003; Cass DL, 1997, PEDIATR SURG INT, V12, P484, DOI 10.1007/s003830050189; FOGLIA RP, 1986, ANN SURG, V204, P402, DOI 10.1097/00000658-198610000-00008; LORENZ HP, 1995, PLAST RECONSTR SURG, V96, P1251, DOI 10.1097/00006534-199511000-00001; Stelnicki EJ, 2000, PLAST RECONSTR SURG, V105, P140, DOI 10.1097/00006534-200001000-00024; Still J, 2003, BURNS, V29, P837, DOI 10.1016/S0305-4179(03)00164-5; Wisser D, 2004, BURNS, V30, P399, DOI 10.1016/j.burns.2003.11.012	7	108	121	2	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2005	366	9488					840	842		10.1016/S0140-6736(05)67107-3	http://dx.doi.org/10.1016/S0140-6736(05)67107-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139659				2022-12-28	WOS:000231627000029
J	Parkhurst, JO; Danischevski, K; Balabanova, D				Parkhurst, JO; Danischevski, K; Balabanova, D			International maternal health indicators and middle-income countries: Russia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COVERAGE; CARE		Univ London London Sch Hyg & Trop Med, Hlth Syst Dev Programme, London WC1E 7HT, England; Moscow Med Acad, Moscow 109507, Russia	University of London; London School of Hygiene & Tropical Medicine; Sechenov First Moscow State Medical University	Parkhurst, JO (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Syst Dev Programme, Keppel St, London WC1E 7HT, England.	justin.parkhurst@lshtm.ac.uk	Parkhurst, Justin/AAP-3615-2021					Balabanova DC, 2003, AM J PUBLIC HEALTH, V93, P2124, DOI 10.2105/AJPH.93.12.2124; BATENEVA T, 2000, IZVESTIA; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; *CDCP, 1998, RUSS WOM REPR HLTH S; DANISHEVSKI K, 2002, RUSSIA REPROD HLTH S; DAVANZO J, 2001, DIRE DEMOGRAPHICS PO; DAVID P, 2000, WOMEN INFANT HLTH PR; DAVID PH, 2001, WOMEN INFANT HLTH PR; FROLOVA O, 2001, MATERNAL MORTALITY A; Koblinsky M., 1999, MOTHERCARE MATTERS, V8, P1; Mathews Z., 2001, ASSESSING HLTH POOR; Pittrof R, 1997, TROP DOCT, V27, P25, DOI 10.1177/004947559702700110; Ronsmans C, 2002, B WORLD HEALTH ORGAN, V80, P317; Ronsmans C, 2001, SAFE MOTHERHOOD STRA; Starrs's Ann, 1997, SAFE MOTHERHOOD ACTI; Tinker A, 1993, MAKING MOTHERHOOD SA; Tkatchenko E, 2000, HEALTH POLICY PLANN, V15, P164, DOI 10.1093/heapol/15.2.164; *UNICEF WHO UN POP, 1997, GUID MON AV US OBST; VANLERBERGHE W, 2001, SAFE MOTHERHOOD STRA; VANNAPPAGARI V, 2004, MONITORING SEXUAL BE; Vlassov V, 2000, J EPIDEMIOL COMMUN H, V54, P740, DOI 10.1136/jech.54.10.740; WARDLAW T, 1999, SAFE MOTHERHOOD INIT; *WHO UN POP FUND U, 1999, RED MAT MORT; WORLD HEALTH ORGANIZATION (WHO) REGIONAL OFFICE FOR EUROPE, 2003, EUR HLTH ALL DAT; Zhirova IA, 2004, STUD FAMILY PLANN, V35, P178, DOI 10.1111/j.1728-4465.2004.00021.x	25	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2005	331	7515					510	513		10.1136/bmj.331.7515.510	http://dx.doi.org/10.1136/bmj.331.7515.510			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	963RA	16141161	Green Published, Green Accepted			2022-12-28	WOS:000231820400028
J	Smith, LK; Pope, C; Botha, JL				Smith, LK; Pope, C; Botha, JL			Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis	LANCET			English	Article							BREAST-CANCER; TESTICULAR CANCER; COLORECTAL-CANCER; PROSTATE-CANCER; SYMPTOMS; CARE; DIAGNOSIS; PERCEPTIONS; MEN; OBSTACLES	Background The reduction of delay in cancer diagnosis has been targeted as a way to improve survival. We undertook a qualitative synthesis of international research evidence to provide insight into patients' experiences of recognising symptoms of cancer and seeking help. Methods We searched international publications (1985-2004) for delay in cancer diagnosis to identify the relevant qualitative research, and used meta-ethnography to identify the common themes across the studies. Our synthesis interpreted individual studies by identification of second-order constructs (interpretations offered by the original researchers) and third-order constructs (development of new interpretations beyond those offered in individual studies). Findings We identified 32 papers (>775 patients and carers) reporting help-seeking experiences for at least 20 different types of cancer. The analysis showed strong similarities in patients with different cancer types. Key concepts were recognition and interpretation of symptoms, and fear of consultation. Fear manifested as a fear of embarrassment (the feeling that symptoms were trivial or that symptoms affected a sensitive body area), or a fear of cancer (pain, suffering, and death), or both. Such analyses allowed exploration of third-order constructs. The patient's gender and the sanctioning of help-seeking were important factors in prompt consultation. Interpretation Strategies to understand and reduce patients' delay in cancer presentation can help symptom recognition but need to address patients' anxieties. The effect of the patient's sex in help-seeking also needs to be recognised, as does the important role of friends, family, and health-care professionals in the sanctioning of consultation. This meta-ethnography provides an international overview through the systematic synthesis of a diverse group of small-scale qualitative studies.	Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; Univ Southampton, Sch Nursing & Midwifery, Southampton, Hants, England; Univ Leicester, Dept Med & Social Care Educ, Leicester, Leics, England	University of Leicester; University of Southampton; University of Leicester	Smith, LK (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England.	lks1@le.ac.uk	Smith, Lucy K/S-6593-2019; Smith, Lucy K/I-6300-2018	Smith, Lucy K/0000-0001-9470-0793; Smith, Lucy K/0000-0001-9470-0793; Pope, Catherine/0000-0002-8935-6702				Bain NS, 2002, FAM PRACT, V19, P369, DOI 10.1093/fampra/19.4.369; Bain NSC, 2000, FAM PRACT, V17, P475, DOI 10.1093/fampra/17.6.475; Boehmer UE, 2001, PSYCHO-ONCOL, V10, P147, DOI 10.1002/pon.504; Bottomley A, 1997, Eur J Cancer Care (Engl), V6, P124, DOI 10.1046/j.1365-2354.1997.00021.x; Braun KL, 2002, CANCER PRACT, V10, P192, DOI 10.1046/j.1523-5394.2002.104001.x; Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732; Broughton M, 2004, EUR J CANCER CARE, V13, P318, DOI 10.1111/j.1365-2354.2004.00477.x; Burgess C, 2001, BRIT J GEN PRACT, V51, P967; Burgess CC, 1998, BRIT J CANCER, V77, P1343, DOI 10.1038/bjc.1998.224; Cameron S, 1998, Can Oncol Nurs J, V8, P40; Campbell R, 2003, SOC SCI MED, V56, P671, DOI 10.1016/S0277-9536(02)00064-3; Caplan LS, 1996, PREV MED, V25, P218, DOI 10.1006/pmed.1996.0049; Chapple A, 2004, BMJ-BRIT MED J, V328, P1470, DOI 10.1136/bmj.38111.639734.7C; Chapple A, 2004, BRIT J GEN PRACT, V54, P25; Chapple A, 2002, SOCIOL HEALTH ILL, V24, P820, DOI 10.1111/1467-9566.00320; de Nooijer J, 2001, PATIENT EDUC COUNS, V42, P145, DOI 10.1016/S0738-3991(00)00104-X; De Nooijer J, 2001, PSYCHO-ONCOL, V10, P469, DOI 10.1002/pon.535; *DEP HLTH, 2000, NHS PLAN; Dixon-Woods M, 2001, J EVAL CLIN PRACT, V7, P125, DOI 10.1046/j.1365-2753.2001.00257.x; Entwistle V, 2002, EUR J CANCER CARE, V11, P232, DOI 10.1046/j.1365-2354.2002.00344.x; Evans D, 2002, J MED LIBR ASSOC, V90, P290; Facione N C, 1995, Cancer Pract, V3, P219; FACIONE NC, 1993, SOC SCI MED, V36, P1521, DOI 10.1016/0277-9536(93)90340-A; Fitch Margaret, 2002, Can Oncol Nurs J, V12, P152; France L, 2000, BREAST, V9, P343, DOI 10.1054/brst.2000.0173; Gascoigne P, 1999, PSYCHO-ONCOL, V8, P144, DOI 10.1002/(SICI)1099-1611(199903/04)8:2<144::AID-PON349>3.3.CO;2-G; GASCOIGNE P, 1999, EUROPEAN J ONCOLOGY, V3, P62, DOI DOI 10.1016/S1462-3889(99)81296-4; Gates M F, 2001, Oncol Nurs Forum, V28, P529; Green J, 1998, BMJ-BRIT MED J, V316, P1230, DOI 10.1136/bmj.316.7139.1230; Lackey N R, 2001, Oncol Nurs Forum, V28, P519; Lam WWT, 2003, PSYCHO-ONCOL, V12, P127, DOI 10.1002/pon.621; Leydon GM, 2003, EUR J CANCER CARE, V12, P317, DOI 10.1046/j.1365-2354.2003.00418.x; LITTLEWOOD J, 2000, RISK DEC POLICY, V5, P215; MACDONALD S, IN PRESS FACTORS INF; MATHEWS HF, 1994, SOC SCI MED, V38, P789, DOI 10.1016/0277-9536(94)90151-1; *NHS EX, 2000, 2000013 NHS EX HSC; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Nosarti C, 2000, BRIT J CANCER, V82, P742; Papadopoulos I, 2004, EUR J CANCER CARE, V13, P154, DOI 10.1111/j.1365-2354.2004.00448.x; Popay J, 1998, J ROY SOC MED, V91, P32, DOI 10.1177/014107689809135S08; Ramirez AJ, 1999, LANCET, V353, P1127, DOI 10.1016/S0140-6736(99)02142-X; Salander P, 1999, FAM PRACT, V16, P143, DOI 10.1093/fampra/16.2.143; Sanden I, 2000, CANCER NURS, V23, P304, DOI 10.1097/00002820-200008000-00008; Shaw Rachel L, 2004, BMC Med Res Methodol, V4, P5, DOI 10.1186/1471-2288-4-5; TEMOSHOK L, 1984, CANCER, V54, P3048, DOI 10.1002/1097-0142(19841215)54:12<3048::AID-CNCR2820541239>3.0.CO;2-M; Tishelman C, 1998, QUAL HEALTH RES, V8, P48, DOI 10.1177/104973239800800104; Underwood S M, 1994, Oncol Nurs Forum, V21, P47; Vaartio Heli, 2003, Eur J Oncol Nurs, V7, P182, DOI 10.1016/S1462-3889(03)00006-1; Van der Molen B, 2000, EUR J CANCER CARE, V9, P41; Williams BG, 2003, BRIT J CANCER, V89, P1834, DOI 10.1038/sj.bjc.6601305; ZOLA IK, 1973, SOC SCI MED, V7, P677, DOI 10.1016/0037-7856(73)90002-4	51	371	375	0	37	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 3	2005	366	9488					825	831		10.1016/S0140-6736(05)67030-4	http://dx.doi.org/10.1016/S0140-6736(05)67030-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	960XR	16139657				2022-12-28	WOS:000231627000027
J	Jopling, CL; Yi, MK; Lancaster, AM; Lemon, SM; Sarnow, P				Jopling, CL; Yi, MK; Lancaster, AM; Lemon, SM; Sarnow, P			Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA	SCIENCE			English	Article							5' NONTRANSLATED REGION; TRANSLATION INITIATION; MESSENGER-RNA; EFFICIENT REPLICATION; HUH7 CELLS; EXPRESSION; IDENTIFICATION; ARABIDOPSIS; REPLICONS; SEQUENCES	MicroRNAs are small RNA molecules that regulate messenger RNA (mRNA) expression. MicroRNA 122 (miR-122) is specifically expressed and highly abundant in the human liver. We show that the sequestration of miR-122 in liver cells results in marked loss of autonomously replicating hepatitis C viral RNAs. A genetic interaction between miR-122 and the 5' noncoding region of the viral genome was revealed by mutational analyses of the predicted microRNA binding site and ectopic expression of miR-122 molecules containing compensatory mutations. Studies with replication-defective RNAs suggested that miR-122 did not detectably affect mRNA translation or RNA stability. Therefore, miR-122 is likely to facilitate replication of the viral RNA, suggesting that miR-122 may present a target for antiviral intervention.	Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Univ Texas, Med Branch, Dept Microbiol & Immunol, Ctr Hepatitis Res, Galveston, TX 77555 USA	Stanford University; University of Texas System; University of Texas Medical Branch Galveston	Sarnow, P (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	psarnow@stanford.edu		Sarnow, Peter/0000-0002-2043-2770; Jopling, Catherine/0000-0001-6046-1456	NIAID NIH HHS [AI47365, AI40035, AI63451] Funding Source: Medline; NIGMS NIH HHS [GM069007] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI040035, R21AI063451, R01AI047365, R37AI047365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069007] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali S, 2004, J VIROL, V78, P491, DOI 10.1128/JVI.78.1.491-501.2004; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Ji H, 2004, P NATL ACAD SCI USA, V101, P16990, DOI 10.1073/pnas.0407402101; Kato T, 2005, J VIROL, V79, P592, DOI 10.1128/JVI.79.1.592-596.2005; Kim YK, 2003, RNA, V9, P599, DOI 10.1261/rna.2185603; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004; Yi MK, 2002, VIROLOGY, V304, P197, DOI 10.1006/viro.2002.1652; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	34	1989	2193	5	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1577	1581		10.1126/science.1113329	http://dx.doi.org/10.1126/science.1113329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141076	Green Submitted			2022-12-28	WOS:000231715000054
J	Meech, KJ; Ageorges, N; A'Hearn, MF; Arpigny, C; Ates, A; Aycock, J; Bagnulo, S; Bailey, J; Barber, R; Barrera, L; Barrena, R; Bauer, JM; Belton, MJS; Bensch, F; Bhattacharya, B; Biver, N; Blake, G; Bocklee-Morvan, D; Boehnhardt, H; Bonev, BP; Bonev, T; Buie, MW; Burton, MG; Butner, HM; Cabanac, R; Campbell, R; Campins, H; Capria, MT; Carroll, T; Chaffee, F; Charnley, SB; Cleis, R; Coates, A; Cochran, A; Colom, P; Conrad, A; Coulson, IM; Crovisier, J; deBuizer, J; Dekany, R; de Leon, J; Dello Russo, N; Delsanti, A; DiSanti, M; Drummond, J; Dundon, L; Etzel, PB; Farnham, TL; Feldman, P; Fernandez, YR; Filipovic, MD; Fisher, S; Fitzsimmons, A; Fong, D; Fugate, R; Fujiwara, H; Fujiyoshi, T; Furusho, R; Fuse, T; Gibb, E; Groussin, O; Gulkis, S; Gurwell, M; Hadamcik, H; Hainaut, O; Harker, D; Harrington, D; Harwit, M; Hasegawa, S; Hergenrother, CW; Hirst, P; Hodapp, K; Honda, M; Howell, ES; Hutsemekers, D; Iono, D; Ip, WH; Jackson, W; Jehin, E; Jiang, ZJ; Jones, GH; Jones, PA; Kadono, T; Kamath, UW; Kaufl, HU; Kasuga, T; Kawakita, H; Kelley, MS; Kerber, F; Kidger, M; Kinoshita, D; Knight, M; Lara, L; Larson, SM; Lederer, S; Lee, CF; Levasseur-Regourd, AC; Li, JY; Li, QS; Licandro, J; Lin, ZY; Lisse, CM; LoCurto, G; Lovell, AJ; Lowry, SC; Lyke, J; Lynch, D; Ma, J; Magee-Sauer, K; Maheswar, G; Manfroid, J; Marco, O; Martin, P; Melnick, G; Miller, S; Miyata, T; Moriarty-Schieven, GH; Moskovitz, N; Mueller, BEA; Mumma, MJ; Muneer, S; Neufeld, DA; Ootsubo, T; Osip, D; Pandea, SK; Pantin, E; Paterno-Mahler, R; Patten, B; Penprase, BE; Peck, A; Petitas, G; Pinilla-Alonso, N; Pittichova, J; Pompei, E; Prabhu, TP; Qi, C; Rao, R; Rauer, H; Reitsema, H; Rodgers, SD; Rodriguez, P; Ruane, R; Ruch, G; Rujopakarn, W; Sahu, DK; Sako, S; Sakon, I; Samarasinha, N; Sarkissian, JM; Saviane, I; Schirmer, M; Schultz, P; Schulz, R; Seitzer, P; Sekiguchi, T; Selman, F; Serra-Ricart, M; Sharp, R; Snell, RL; Snodgrass, C; Stallard, T; Stecklein, G; Sterken, C; Stuwe, JA; Sugita, S; Sumner, M; Suntzeff, N; Swaters, R; Takakuwa, S; Takata, N; Thomas-Osip, J; Thompson, E; Tokunaga, AT; Tozzi, GP; Tran, H; Troy, M; Trujillo, C; Van Cleve, J; Vasundhara, R; Vazquez, R; Vilas, F; Villanueva, G; von Braun, K; Vora, P; Wainscoat, RJ; Walsh, K; Watanabe, J; Weaver, HA; Weaver, W; Weiler, M; Weissman, PR; Welsh, WF; Wilner, D; Wolk, S; Womack, M; Wooden, D; Woodney, LM; Woodward, C; Wu, ZY; Wu, JH; Yamashita, T; Yang, B; Yang, YB; Yokogawa, S; Zook, AC; Zauderer, A; Zhao, X; Zhou, X; Zucconi, JM				Meech, KJ; Ageorges, N; A'Hearn, MF; Arpigny, C; Ates, A; Aycock, J; Bagnulo, S; Bailey, J; Barber, R; Barrera, L; Barrena, R; Bauer, JM; Belton, MJS; Bensch, F; Bhattacharya, B; Biver, N; Blake, G; Bocklee-Morvan, D; Boehnhardt, H; Bonev, BP; Bonev, T; Buie, MW; Burton, MG; Butner, HM; Cabanac, R; Campbell, R; Campins, H; Capria, MT; Carroll, T; Chaffee, F; Charnley, SB; Cleis, R; Coates, A; Cochran, A; Colom, P; Conrad, A; Coulson, IM; Crovisier, J; deBuizer, J; Dekany, R; de Leon, J; Dello Russo, N; Delsanti, A; DiSanti, M; Drummond, J; Dundon, L; Etzel, PB; Farnham, TL; Feldman, P; Fernandez, YR; Filipovic, MD; Fisher, S; Fitzsimmons, A; Fong, D; Fugate, R; Fujiwara, H; Fujiyoshi, T; Furusho, R; Fuse, T; Gibb, E; Groussin, O; Gulkis, S; Gurwell, M; Hadamcik, H; Hainaut, O; Harker, D; Harrington, D; Harwit, M; Hasegawa, S; Hergenrother, CW; Hirst, P; Hodapp, K; Honda, M; Howell, ES; Hutsemekers, D; Iono, D; Ip, WH; Jackson, W; Jehin, E; Jiang, ZJ; Jones, GH; Jones, PA; Kadono, T; Kamath, UW; Kaufl, HU; Kasuga, T; Kawakita, H; Kelley, MS; Kerber, F; Kidger, M; Kinoshita, D; Knight, M; Lara, L; Larson, SM; Lederer, S; Lee, CF; Levasseur-Regourd, AC; Li, JY; Li, QS; Licandro, J; Lin, ZY; Lisse, CM; LoCurto, G; Lovell, AJ; Lowry, SC; Lyke, J; Lynch, D; Ma, J; Magee-Sauer, K; Maheswar, G; Manfroid, J; Marco, O; Martin, P; Melnick, G; Miller, S; Miyata, T; Moriarty-Schieven, GH; Moskovitz, N; Mueller, BEA; Mumma, MJ; Muneer, S; Neufeld, DA; Ootsubo, T; Osip, D; Pandea, SK; Pantin, E; Paterno-Mahler, R; Patten, B; Penprase, BE; Peck, A; Petitas, G; Pinilla-Alonso, N; Pittichova, J; Pompei, E; Prabhu, TP; Qi, C; Rao, R; Rauer, H; Reitsema, H; Rodgers, SD; Rodriguez, P; Ruane, R; Ruch, G; Rujopakarn, W; Sahu, DK; Sako, S; Sakon, I; Samarasinha, N; Sarkissian, JM; Saviane, I; Schirmer, M; Schultz, P; Schulz, R; Seitzer, P; Sekiguchi, T; Selman, F; Serra-Ricart, M; Sharp, R; Snell, RL; Snodgrass, C; Stallard, T; Stecklein, G; Sterken, C; Stuwe, JA; Sugita, S; Sumner, M; Suntzeff, N; Swaters, R; Takakuwa, S; Takata, N; Thomas-Osip, J; Thompson, E; Tokunaga, AT; Tozzi, GP; Tran, H; Troy, M; Trujillo, C; Van Cleve, J; Vasundhara, R; Vazquez, R; Vilas, F; Villanueva, G; von Braun, K; Vora, P; Wainscoat, RJ; Walsh, K; Watanabe, J; Weaver, HA; Weaver, W; Weiler, M; Weissman, PR; Welsh, WF; Wilner, D; Wolk, S; Womack, M; Wooden, D; Woodney, LM; Woodward, C; Wu, ZY; Wu, JH; Yamashita, T; Yang, B; Yang, YB; Yokogawa, S; Zook, AC; Zauderer, A; Zhao, X; Zhou, X; Zucconi, JM			Deep Impact: Observations from a worldwide Earth-based campaign	SCIENCE			English	Article							9P/TEMPEL-1	On 4 July 2005, many observatories around the world and in space observed the collision of Deep Impact with comet 9P/Tempet 1 or its aftermath. This was an unprecedented coordinated observational campaign. These data show that (i) there was new material after impact that was compositionally different from that seen before impact; (ii) the ratio of dust mass to gas mass in the ejecta was much larger than before impact; (iii) the new activity did not last more than a few days, and by 9 July the comet's behavior was indistinguishable from its pre-impact behavior; and (iv) there were interesting transient phenomena that may be correlated with cratering physics.	Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA; European So Observ, Santiago 19, Chile; Univ Maryland, College Pk, MD 20742 USA; Univ Liege, B-4000 Liege, Belgium; Pomona Coll, Claremont, CA 91711 USA; Keck Observ, Kamuela, HI 96743 USA; Macquarie Univ, Australian Ctr Astrobiol, Sydney, NSW 2109, Australia; UCL, London WC1E 6BT, England; Univ Metropolitana Ciencias Educ, Santiago, Chile; Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain; NASA, Jet Prop Lab, Pasadena, CA 91109 USA; Belton Space Initiat, Tucson, AZ 85716 USA; Univ Bonn, Inst Radioastron, D-53121 Bonn, Germany; CALTECH, Pasadena, CA 91125 USA; Observ Paris, F-92195 Meudon, France; Max Planck Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Univ Toledo, Toledo, OH 43606 USA; Inst Astron, Sofia 1784, Bulgaria; Lowell Observ, Flagstaff, AZ 86001 USA; Univ New S Wales, Sydney, NSW 2052, Australia; Joint Astron Ctr, Hilo, HI 96720 USA; Canada France Hawaii Telescope Corp, Kamuela, HI 96743 USA; Univ Cent Florida, Orlando, FL 32816 USA; Inst Astrofis Spaziale & Fis Cosm, I-00133 Rome, Italy; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; USAF, Res Lab, Kirtland AFB, NM 87117 USA; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Univ Texas, Austin, TX 78712 USA; Gemini Observ, Serena, Chile; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20770 USA; San Diego State Univ, San Diego, CA 92182 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA; Univ Western Sydney, Sydney, NSW 1797, Australia; Gemini Observ N, Hilo, HI 96720 USA; Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Tokyo, Tokyo 1138654, Japan; Subaru Telescope, Hilo, HI 96720 USA; Waseda Univ, Tokyo 1698050, Japan; Univ Notre Dame, Notre Dame, IN 46556 USA; CNRS, Serv Aeron, F-91371 Verrieres Le Buisson, France; Univ Calif San Diego, La Jolla, CA 92093 USA; Cornell Univ, Ithaca, NY 14853 USA; Inst Space & Astronaut Sci, Kanagawa 2298510, Japan; Univ Arizona, Tucson, AZ 85721 USA; Arecibo Observ, Arecibo, PR 00612 USA; Natl Cent Univ, Taoyuan 32001, Taiwan; Univ Calif Davis, Davis, CA 95616 USA; Natl Astron Observ, Beijing 100012, Peoples R China; Australian Telescope, Natl Facil, Epping, NSW 1710, Australia; Japan Agcy Marine Earth Sci & Technol, Kanagawa 2370061, Japan; Indian Inst Astrophys, Bangalore 560034, Karnataka, India; Natl Astron Observ Japan, Tokyo 1818588, Japan; Kyoto Sangyo Univ, Kyoto 6038555, Japan; Univ Minnesota, Minneapolis, MN 55455 USA; CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; Calif State Univ San Bernardino, San Bernardino, CA 92407 USA; Isaac Newton Grp Telescopes, E-38700 La Palma, Spain; Agnes Scott Coll, Decatur, GA 30030 USA; Aerosp Corp, Los Angeles, CA 90009 USA; Rowan Univ, Glassboro, NJ 08028 USA; Natl Opt Astron Observ, Tucson, AZ 85719 USA; Nagoya Univ, Nagoya, Aichi 4648601, Japan; Las Campanas Observ, Pasadena, CA 91101 USA; CEA, Serv Astron, F-91191 Gif Sur Yvette, France; Fdn Galileo Galilei & Telescopio Nazl Galileo, La Palma 38700, Spain; Deutsch Zentrum Luft & Raumfahrt, D-12489 Berlin, Germany; Ball Aerosp, Boulder, CO 80306 USA; European Space Agcy, Madrid 28080, Spain; Univ Michigan, Ann Arbor, MI 48109 USA; Brown Univ, Providence, RI 02912 USA; European Space Agcy, NL-2200 AG Noordwijk, Netherlands; Anglo Australian Observ, Epping, NSW 1710, Australia; Univ Massachusetts, Amherst, MA 01003 USA; Univ Brussels, B-1050 Brussels, Belgium; Leiden Observ, NL-2300 RA Leiden, Netherlands; Osserv Astrofis Arcetri, I-50125 Florence, Italy; Univ Nacl Autonoma Mexico, Ensenada 22800, Baja California, Mexico; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Carnegie Inst Sci, Washington, DC 20015 USA; Coll William & Mary, Williamsburg, VA 23187 USA; St Cloud State Univ, St Cloud, MN 56301 USA; Observ Besancon, F-25010 Besancon, France	University of Hawaii System; University of Hawaii Manoa; European Southern Observatory; University System of Maryland; University of Maryland College Park; University of Liege; Claremont Colleges; Pomona College; Macquarie University; University of London; University College London; Universidad Metropolitana de Ciencias de la Educacion (UMCE); Instituto de Astrofisica de Canarias; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Bonn; California Institute of Technology; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Max Planck Society; University System of Ohio; University of Toledo; Bulgarian Academy of Sciences; University of New South Wales Sydney; Canada France Hawaii Telescope; State University System of Florida; University of Central Florida; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Defense; United States Air Force; University of London; University College London; University of Texas System; University of Texas Austin; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California State University System; San Diego State University; Johns Hopkins University; Western Sydney University; Queens University Belfast; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Waseda University; University of Notre Dame; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California San Diego; Cornell University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Arizona; National Aeronautics & Space Administration (NASA); National Central University; University of California System; University of California Davis; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Department of Science & Technology (India); Indian Institute of Astrophysics (IIA); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kyoto Sangyo University; University of Minnesota System; University of Minnesota Twin Cities; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); California State University System; California State University San Bernardino; Isaac Newton Group of Telescopes; Aerospace Corporation - USA; Rowan University; National Optical Astronomy Observatory; Nagoya University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; German Aerospace Centre (DLR); European Space Agency; University of Michigan System; University of Michigan; Brown University; European Space Agency; University of Massachusetts System; University of Massachusetts Amherst; Leiden University; Leiden University - Excl LUMC; Istituto Nazionale Astrofisica (INAF); Universidad Nacional Autonoma de Mexico; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Carnegie Institution for Science; William & Mary; Minnesota State Colleges & Universities; Saint Cloud State University	Meech, KJ (corresponding author), Univ Hawaii Manoa, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	meech@ifa.hawaii.edu	Sugita, Seiji/GQI-1142-2022; Meech, Karen/CAH-1412-2022; Lara, Luisa M/F-5614-2012; Charnley, Steven B/C-9538-2012; Curto, Gaspare Lo/AAB-2630-2021; de León, Julia/H-7569-2015; Licandro, Javier/L-7667-2014; Welsh, William/AAS-3445-2021; Weaver, Harold A/D-9188-2016; Muneer, Sowbiya/S-5382-2019; mumma, michael j/I-2764-2013; Filipovic, Miroslav/AAN-9577-2020; Jones, Geraint H./C-1682-2008; Russo, Neil Dello/G-2727-2015; Jackson, William/G-6983-2017; Weiler, Michael/G-2028-2016; Magee-Sauer, Karen/K-6061-2015; Lee, Chin-Fei/AAZ-3391-2020; Lisse, Carey M/B-7772-2016; Pittichova, Jana/AAG-6364-2020; Coates, Andrew/C-2396-2008; Pinilla-Alonso, Noemi/K-4361-2017; Rujopakarn, Wiphu/E-7849-2012; Womack, Maria/AAE-8510-2019; Prabhu, Tushar/AAD-7280-2021; Stallard, Tom/W-8743-2019; Stecklein, Gordon/Q-4099-2019; Pinilla-Alonso, Noemi/B-8583-2008; Hainaut, Olivier R./AAY-7006-2021; Rujopakarn, Wiphu/AAV-2176-2021; Vázquez, Roberto/L-3613-2016; Cochran, Alyssa/GPX-7835-2022; Serra-Ricart, Miguel/AAB-2812-2019; Hasegawa, Sunao/R-4768-2017; Rao, Ramprasad/L-2115-2017	Sugita, Seiji/0000-0001-6076-3614; Lara, Luisa M/0000-0002-7184-920X; de León, Julia/0000-0002-0696-0411; Licandro, Javier/0000-0002-9214-337X; Weaver, Harold A/0000-0003-0951-7762; mumma, michael j/0000-0003-4627-750X; Filipovic, Miroslav/0000-0002-4990-9288; Jones, Geraint H./0000-0002-5859-1136; Russo, Neil Dello/0000-0002-8379-7304; Magee-Sauer, Karen/0000-0002-4979-9875; Lee, Chin-Fei/0000-0002-3024-5864; Lisse, Carey M/0000-0002-9548-1526; Coates, Andrew/0000-0002-6185-3125; Pinilla-Alonso, Noemi/0000-0002-2770-7896; Womack, Maria/0000-0003-4659-8653; Stallard, Tom/0000-0003-3990-670X; Vázquez, Roberto/0000-0002-3279-9764; Knight, Matthew/0000-0003-2781-6897; Snodgrass, Colin/0000-0001-9328-2905; Burton, Michael/0000-0001-7289-1998; Sharp, Rob/0000-0003-4877-7866; Gurwell, Mark/0000-0003-0685-3621; Wolk, Scott/0000-0002-0826-9261; Meech, Karen/0000-0002-2058-5670; Paterno-Mahler, Rachel/0000-0003-3653-3741; Harker, David/0000-0001-6397-9082; Schirmer, Mischa/0000-0003-2568-9994; Mueller, Beatrice/0000-0001-6194-3174; Jackson, William M./0000-0002-1961-9466; Jones, Paul/0000-0001-9429-9135; Suntzeff, Nicholas/0000-0002-8102-181X; Kelley, Michael/0000-0002-6702-7676; Sahu, Devendra Kumar/0000-0002-6688-0800; Prabhu, Tushar/0000-0003-0797-5057; Hodapp, Klaus/0000-0003-0786-2140; Hasegawa, Sunao/0000-0001-6366-2608; Troy, Mitchell/0000-0002-0040-5409; Tozzi, Gian Paolo/0000-0003-4775-5788; Lowry, Stephen/0000-0002-5605-4329; Samarasinha, Nalin/0000-0001-8925-7010; Vilas, Faith/0000-0003-4723-5870; Rao, Ramprasad/0000-0002-1407-7944; DELSANTI, Audrey/0000-0002-1413-2288; Drummond, Jack/0000-0001-5289-3734; Marco, Olivier/0000-0002-2967-6368; Rodriguez Pascual, Pedro/0000-0002-6505-1349; Weiler, Michael/0000-0002-3007-3927; Miller, Steven/0000-0002-7159-6871; Tokunaga, Alan/0000-0001-8136-9704; Wilner, David/0000-0003-1526-7587; Reitsema, Harold/0000-0002-4119-5700; Saviane, Ivo/0000-0002-5878-5299; Trujillo, Chadwick/0000-0001-9859-0894; Fernandez, Yanga/0000-0003-1156-9721; Butner, Harold/0000-0003-4899-2064				A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; Belton MJ, 2005, SPACE SCI REV, V117, P137, DOI 10.1007/s11214-005-3389-1; Harker DE, 2005, SCIENCE, V310, P278, DOI 10.1126/science.1119143; HUTSEMEKERS D, IN PRESS ASTRON ASTR; KAUFL HU, 2005, 8593 INT ASTR UN; Lara L.S., UNPUB; LISSE C, 2005, 8571 INT ASTR UN; Lisse CM, 2005, SPACE SCI REV, V117, P161, DOI 10.1007/s11214-005-3384-6; LISSE CM, 2005, COMETS, V2, P631; Meech KJ, 2005, SPACE SCI REV, V117, P297, DOI 10.1007/s11214-005-3382-8; Mumma MJ, 2005, SCIENCE, V310, P270, DOI 10.1126/science.1119337; SCHLEICHER DG, UNPUB; Sekanina Z, 1997, EARTH MOON PLANETS, V78, P313, DOI 10.1023/A:1006286024437; Sugita S, 2005, SCIENCE, V310, P274, DOI 10.1126/science.1119091	15	139	140	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					265	269		10.1126/science.1118978	http://dx.doi.org/10.1126/science.1118978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16150977				2022-12-28	WOS:000232670100038
J	Decker, RB; Krimigis, SM; Roelof, EC; Hill, ME; Armstrong, TP; Gloeckler, G; Hamilton, DC; Lanzerotti, LJ				Decker, RB; Krimigis, SM; Roelof, EC; Hill, ME; Armstrong, TP; Gloeckler, G; Hamilton, DC; Lanzerotti, LJ			Voyager 1 in the foreshock, termination shock, and heliosheath	SCIENCE			English	Article							ANOMALOUS COSMIC-RAYS; SOLAR-WIND; ENERGETIC PARTICLES; SIMILAR-TO-85 AU; IONS; ACCELERATION; PICKUP	Voyager 1 (V1) began measuring precursor energetic ions and electrons from the heliospheric termination shock (TS) in July 2002. During the ensuing 2.5 years, average particle intensities rose as V1 penetrated deeper into the energetic particle foreshock of the TS. Throughout 2004, V1 observed even larger, fluctuating intensities of ions from 40 kiloetectron volts (keV) to >= 50 megaelectron volts per nucleon and of electrons from >26 keV to >= 350 keV. On day 350 of 2004 (2004/350), V1 observed an intensity spike of ions and electrons that was followed by a sustained factor of 10 increase at the lowest energies and lesser increases at higher energies, larger than any intensities since V1 was at 15 astronomical units in 1982. The estimated solar wind radial flow speed was positive.(outward) at similar to +100 kilometers per second (km s(-1)) from 2004/352 until 2005/018, when the radial flows became predominantly negative (sunward) and fluctuated between similar to -50 and 0 km s(-1) until about 005/110; they then became more positive, with recent values (2005/179) of similar to +50 km s(-1). The energetic proton spectrum averaged over the postshock period is apparently dominated by strongly heated interstellar pickup ions. We interpret these observations as evidence that V1 was crossed by the TS on 2004/351 (during a tracking gap) at 94.0 astronomical units, evidently as the shock was moving radially inward in response to decreasing solar wind ram pressure, and that V1 has remained in the heliosheath until at least mid-2005.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Fundamental Technol, Lawrence, KS 66046 USA; Bell Labs, Murray Hill, NJ 07974 USA; New Jersey Inst Technol, Ctr Solar Terr Res, Newark, NJ 07102 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University System of Maryland; University of Maryland College Park; AT&T; New Jersey Institute of Technology	Decker, RB (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	robert.decker@jhuapl.edu	Hill, Matthew/H-4312-2016; Krimigis, Stamatios/G-4591-2019; Roelof, Edmond/G-6654-2019	Hill, Matthew/0000-0002-5674-4936; Krimigis, Stamatios/0000-0003-2781-2386; Roelof, Edmond/0000-0002-2270-0652; Hamilton, Douglas/0000-0001-6103-8019				Burlaga LF, 2005, SCIENCE, V309, P2027, DOI 10.1126/science.1117542; BURLAGA LF, 2005, COMMUNICATION    MAY; Cummings AC, 1998, SPACE SCI REV, V83, P51, DOI 10.1023/A:1005057010311; Cummings AC, 2002, ASTROPHYS J, V578, P194, DOI 10.1086/342427; Decker RB, 2004, AIP CONF PROC, V719, P150, DOI 10.1063/1.1809512; DECKER RB, 2005, EOS, V86; DECKER RB, 2004, EOS, V85; Fichtner H, 2001, SPACE SCI REV, V95, P639, DOI 10.1023/A:1010376901322; Florinski V, 2003, ASTROPHYS J, V591, P454, DOI 10.1086/375054; Gloeckler G, 2004, AIP CONF PROC, V719, P201, DOI 10.1063/1.1809518; GLOECKLER G, 2005, P SOL WIND 11 SOHO 1; Gurnett DA, 2005, SCIENCE, V309, P2025, DOI 10.1126/science.1117425; GURNETT DA, 2005, EOS, V86; Jokipii JR, 2004, ASTROPHYS J, V611, pL141, DOI 10.1086/423993; Jokipii JR, 2000, AIP CONF PROC, V528, P309; Jokipii JR, 1998, SPACE SCI REV, V83, P123, DOI 10.1023/A:1005077629875; JOKIPII JR, IN PRESS ASTROPHYS J; Krimigis SM, 2004, AIP CONF PROC, V719, P133, DOI 10.1063/1.1809510; Krimigis SM, 2003, NATURE, V426, P45, DOI 10.1038/nature02068; KRIMIGIS SM, 1977, SPACE SCI REV, V21, P329, DOI 10.1007/BF00211545; KRIMIGIS SM, 2005, P SOL WIND 11 SOHO 1; le Roux JA, 2000, GEOPHYS RES LETT, V27, P2873, DOI 10.1029/2000GL000096; McDonald FB, 2003, NATURE, V426, P48, DOI 10.1038/nature02066; NESS NF, 2004, EOS, V85; RICHARDSON JD, 2005, P SOL WIND 11 SOHO 1; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; Stone EC, 2001, SCIENCE, V293, P55, DOI 10.1126/science.1060090; STONE EC, 2004, EOS, V85; STONE EC, 2005, EOS, V86; Zank GP, 1999, SPACE SCI REV, V89, P413, DOI 10.1023/A:1005155601277; Zhang M, 2005, ASTROPHYS J, V624, P1038, DOI 10.1086/429364	31	408	410	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2005	309	5743					2020	2024		10.1126/science.1117569	http://dx.doi.org/10.1126/science.1117569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179469				2022-12-28	WOS:000232181900039
J	Russ, WP; Lowery, DM; Mishra, P; Yaffe, MB; Ranganathan, R				Russ, WP; Lowery, DM; Mishra, P; Yaffe, MB; Ranganathan, R			Natural-like function in artificial WW domains	NATURE			English	Article							YES-ASSOCIATED PROTEIN; LIGAND RECOGNITION; PROLINE; DESIGN; SPECIFICITY; MECHANISM; REDESIGN	Protein sequences evolve through random mutagenesis with selection for optimal fitness(1). Cooperative folding into a stable tertiary structure is one aspect of fitness, but evolutionary selection ultimately operates on function, not on structure. In the accompanying paper(2), we proposed a model for the evolutionary constraint on a small protein interaction module ( the WW domain) through application of the SCA, a statistical analysis of multiple sequence alignments(3,4). Construction of artificial protein sequences directed only by the SCA showed that the information extracted by this analysis is sufficient to engineer the WW fold at atomic resolution. Here, we demonstrate that these artificial WW sequences function like their natural counterparts, showing class-specific recognition of proline- containing target peptides(5 - 8). Consistent with SCA predictions, a distributed network of residues mediates functional specificity in WW domains. The ability to recapitulate natural- like function in designed sequences shows that a relatively small quantity of sequence information is sufficient to specify the global energetics of amino acid interactions.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; MIT, Dept Biol, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Div Biol Engn, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ranganathan, R (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu						Bedford MT, 2000, J BIOL CHEM, V275, P10359, DOI 10.1074/jbc.275.14.10359; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DeLano W.L, PYMOL MOL GRAPHICS S; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Espanel X, 1999, J BIOL CHEM, V274, P17284, DOI 10.1074/jbc.274.24.17284; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13002, DOI 10.1073/pnas.221467198; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kato Y, 2004, J BIOL CHEM, V279, P31833, DOI 10.1074/jbc.M404719200; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kraemer-Pecore CM, 2003, PROTEIN SCI, V12, P2194, DOI 10.1110/ps.03190903; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toepert F, 2001, ANGEW CHEM INT EDIT, V40, P897, DOI 10.1002/1521-3773(20010302)40:5<897::AID-ANIE897>3.0.CO;2-X; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891	29	189	193	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					579	583		10.1038/nature03990	http://dx.doi.org/10.1038/nature03990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177795				2022-12-28	WOS:000232004800056
J	Zhang, J; Hupfeld, CJ; Taylor, SS; Olefsky, JM; Tsien, RY				Zhang, J; Hupfeld, CJ; Taylor, SS; Olefsky, JM; Tsien, RY			Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes	NATURE			English	Article							3T3-L1 ADIPOCYTES; BETA(2)-ADRENERGIC RECEPTOR; GENE-EXPRESSION; GRANULOSA-CELLS; CAMP; PHOSPHORYLATION; BETA-ARRESTIN-1; DESENSITIZATION; STIMULATION; ACTIVATION	Hormones mobilize intracellular second messengers and initiate signalling cascades involving protein kinases and phosphatases, which are often spatially compartmentalized by anchoring proteins to increase signalling specificity(1). These scaffold proteins may themselves be modulated by hormones(2 - 4). In adipocytes, stimulation of beta- adrenergic receptors increases cyclic AMP levels and activates protein kinase A ( PKA)(5), which stimulates lipolysis by phosphorylating hormone- sensitive lipase and perilipin(6 - 8). Acute insulin treatment activates phosphodiesterase 3B, reduces cAMP levels and quenches beta- adrenergic receptor signalling(9). In contrast, chronic hyperinsulinaemic conditions ( typical of type 2 diabetes) enhance beta- adrenergic receptor- mediated cAMP production(10). This amplification of cAMP signalling is paradoxical because it should enhance lipolysis, the opposite of the known short- term effect of hyperinsulinaemia. Here we show that in adipocytes, chronically high insulin levels inhibit beta- adrenergic receptors ( but not other cAMP- elevating stimuli) from activating PKA. We measured this using an improved fluorescent reporter and by phosphorylation of endogenous cAMP- response- element binding protein ( CREB). Disruption of PKA scaffolding mimics the interference of insulin with beta- adrenergic receptor signalling. Chronically high insulin levels may disrupt the close apposition of beta- adrenergic receptors and PKA, identifying a new mechanism for crosstalk between heterologous signal transduction pathways.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Tsien, RY (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	rtsien@ucsd.edu						CARR DW, 1993, J BIOL CHEM, V268, P20729; Dalle S, 2002, MOL CELL BIOL, V22, P6272, DOI 10.1128/MCB.22.17.6272-6285.2002; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; ELKS ML, 1985, ENDOCRINOLOGY, V116, P2119, DOI 10.1210/endo-116-5-2119; Fasshauer M, 2001, FEBS LETT, V507, P142, DOI 10.1016/S0014-5793(01)02960-X; Fasshauer M, 2001, FEBS LETT, V500, P60, DOI 10.1016/S0014-5793(01)02588-1; Feliciello A, 1998, J BIOL CHEM, V273, P23361, DOI 10.1074/jbc.273.36.23361; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hupfeld CJ, 2003, P NATL ACAD SCI USA, V100, P161, DOI 10.1073/pnas.0235674100; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; Kosaki A, 1996, DIABETES, V45, P1744, DOI 10.2337/diabetes.45.12.1744; Lin FB, 2000, J BIOL CHEM, V275, P19025, DOI 10.1074/jbc.275.25.19025; LONDOS C, 1985, J BIOL CHEM, V260, P5139; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NERBONNE JM, 1984, NATURE, V310, P74, DOI 10.1038/310074a0; Salvador LM, 2004, J BIOL CHEM, V279, P27621, DOI 10.1074/jbc.M402980200; Scott JD, 1998, METH MOL B, V88, P161; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; WON W, 2004, NATURE REV MOL CELL, V5, P959; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	26	238	254	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					569	573		10.1038/nature04140	http://dx.doi.org/10.1038/nature04140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177793				2022-12-28	WOS:000232004800054
J	Cohen, JJ; Siegel, EK				Cohen, JJ; Siegel, EK			Academic medical centers and medical research - The challenges ahead	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNATIONAL COMMITTEE; JOURNAL EDITORS; STATEMENT	Although the present era offers more promise for medical research progress than ever before, academic medical centers also face more daunting challenges for the conduct of medical research: high expectations by the public for a steady stream of lifesaving discoveries, news about financial conflicts of interest and scientific misconduct by researchers that threatens to erode public trust in academic institutions, tensions between the cultural norms of academe and industry that cloud their growing partnerships, obstacles to recruiting and retaining physician-scientists, constrained funding sources and increasing costs of research, and the need to transform the academic reward structure and culture to encourage collaboration and adapt to the new "team science." The interconnectedness of these challenges magnifies their difficulties and importance. Maintaining academic medicine's integrity and effectiveness in pursuing its vital research mission will be a crucial challenge for medical schools and teaching hospitals in the years ahead.	Assoc Amer Med Coll, Washington, DC 20037 USA	Association of American Medical Colleges	Siegel, EK (corresponding author), Assoc Amer Med Coll, 2450 N St NW, Washington, DC 20037 USA.	esiegel@aamc.org						*AM MED ASS, E80315 AM MED ASS; *AM SOC GEN THER P, 2000, FIN CONFL INT CLIN R; Angell M., 2004, TRUTH DRUG CO THEY D; *ASS AM MED COLL, PROT SUBJ PRES TRUST; *ASS AM MED COLL, 2004, WHAT AM SAY NAT MED; *ASS U TECHN MAN, 2005, AUTM LIC SURV FY 200; BALTIMORE D, 2004, SPRING M COUNC AC SO; BYERS T, 2005, DENVER POST     0522; Davidoff F, 2001, JAMA-J AM MED ASSOC, V286, P1232, DOI 10.1001/jama.286.10.1232; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; De Angelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2927, DOI 10.1001/jama.293.23.jed50037; EHRINGHAUS S, US MED SCH POLICIES; *EX OFF PRES OFF M, A21 EX OFF PRES OFF; FISHBURN J, 2005, NIH FY 2006 BUDGET A, P83; GOLDMAN CA, PAYING U RES FACILIT; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; JDAM, 10640 NAT BUR EC RES; Kassirer J, 2005, TAKE AM COMPLICITY B; Lander ES, 2000, SCIENCE, V287, P1777, DOI 10.1126/science.287.5459.1777; MALLON WT, IN PRESS ACAD MED; MANNING F, 2004, NIH EXTRAMURAL CTR P; MARBURGER J, 2005, POLICY TREATMENT PRI; Nathan DG, 1998, JAMA-J AM MED ASSOC, V280, P1427, DOI 10.1001/jama.280.16.1427; National Academy of Sciences, 2004, FAC INT RES; *OFF RES INT, ANN REP 2004; Task Force on Research Accountability, 2001, REP IND I FIN CONFL; *US ATT OFF, US SETTL GEN THER ST; *US PHS, 1995, RESP APPL PROM OBJ R; WASHBURN J, 2004, U INC CORPORATE CORR; WILLMAN D, 2004, LOS ANGELES TIM 1222, pA1; *WORK GROUP COST D, COUNC GOV REL WEB SI; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867; ZERHOUNI E, STRONG FDN BUILDING; 2005, FED REG         0128, V70, P4159; 2004, FED REG         0512, V69, P26393; 2005, FED REG         0209, V70, P6891; 1999, FED REG         1223, V64, P72090	37	27	27	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1367	1372		10.1001/jama.294.11.1367	http://dx.doi.org/10.1001/jama.294.11.1367			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174695				2022-12-28	WOS:000231987800010
J	Weissman, I				Weissman, I			Stem cell research - Paths to cancer therapies and regenerative medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MARROW-CELLS; COMMON LYMPHOID PROGENITORS; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM; SPLEEN COLONIES; BREAST-CANCER; MOUSE EMBRYOS; T-CELLS; IN-VIVO; TRANSPLANTATION	Most tissues in complex metazoans contain a rare subset of cells that, at the single-cell level, can self-renew and also give rise to mature daughter cells. Such stem cells likely in development build tissues and are retained in adult life to regenerate them. Cancers and leukemias are apparently not an exception: rare leukemia stem cells and cancer stem cells have been isolated that contain all of the tumorigenicity of the whole tumor, and it is their properties that will guide future therapies. None of this was apparent just 20 years ago, yet this kind of stem cell thinking already provides new perspectives in medical science and could usher in new therapies. Today, political, religious, and ethical issues surround embryonic stem cell and patient-specific pluripotent stem cell research and are center stage in the attempts by governments to ban these fields for discovery and potential therapies. These interventions require physicians and physician-scientists to determine for themselves whether patient welfare or personal ethics will dominate in their practices, and whether all aspects of stem cell research can be pursued in a safe and regulated fashion.	Stanford Comprehens Canc Ctr, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Weissman, I (corresponding author), Stanford Comprehens Canc Ctr, Inst Stem Cell Biol & Regenerat Med, B257 Beckman Ctr,MC 5329, Stanford, CA 94305 USA.	irv@stanford.edu						ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ALSAM LB, 2004, NATURE, V4428, P668; Arber C, 2003, BLOOD, V102, P421, DOI 10.1182/blood-2002-12-3834; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Beilhack GF, 2003, DIABETES, V52, P59, DOI 10.2337/diabetes.52.1.59; BitMansour A, 2002, BLOOD, V100, P4660, DOI 10.1182/blood-2002-05-1552; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; *COMMM BIOL BIOM A, 2002, STEM CELLS FUT REG M; CUMMINGS BJ, IN PRESS P NATL ACAD; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; EZINE S, 1984, NATURE, V309, P629, DOI 10.1038/309629a0; EZINE S, 1987, J IMMUNOL, V139, P2195; Fathman CG, 2005, NATURE, V435, P605, DOI 10.1038/nature03726; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fossati L, 1995, EUR J IMMUNOL, V25, P3412, DOI 10.1002/eji.1830251231; Gandy KL, 1998, TRANSPLANTATION, V65, P295, DOI 10.1097/00007890-199802150-00001; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; HULETT HR, 1969, SCIENCE, V166, P747, DOI 10.1126/science.166.3906.747; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; Ikehara S, 2001, EXP HEMATOL, V29, P661, DOI 10.1016/S0301-472X(01)00645-2; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jaenisch Rudolf, 2005, V265, P107; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kogan SC, 2001, J EXP MED, V193, P531, DOI 10.1084/jem.193.4.531; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; MANZ MG, 2004, THOMAS HEMATOPOIETIC, P69; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Michallet M, 2000, EXP HEMATOL, V28, P858, DOI 10.1016/S0301-472X(00)00169-7; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; MORTON JI, 1979, TRANSPLANTATION, V27, P133; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; *NAT AC SCI PAN SC, 2002, SCI MED ASP HUM REPR; *NAT RES COUNC I M, 2005, GUID HUM EMB STEM CE; Negrin RS, 2000, BIOL BLOOD MARROW TR, V6, P262, DOI 10.1016/S1083-8791(00)70008-5; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rioux JD, 2005, NATURE, V435, P584, DOI 10.1038/nature03723; Sherwood RI, 2004, STEM CELLS, V22, P1292, DOI 10.1634/stemcells.2004-0090; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; Shizuru JA, 2000, P NATL ACAD SCI USA, V97, P9555, DOI 10.1073/pnas.170279297; SHIZURU JA, 2004, THOMAS HEMATOPOIETIC, P324; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1988, J IMMUNOL, V141, P1877; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; TSUKAMOTO A, 1995, HEMATOPOIETIC STEM C, P85; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; UCHIDA N, 2005, 10 INT C NEUR CER LI; Vose JM, 2001, BIOL BLOOD MARROW TR, V7, P680, DOI 10.1053/bbmt.2001.v7.pm11787531; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; WEISSMAN I, 1978, IMMUNOLOGY, pCH5; Weissman IL, 2002, NEW ENGL J MED, V346, P1576, DOI 10.1056/NEJMsb020693; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	89	102	108	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1359	1366		10.1001/jama.294.11.1359	http://dx.doi.org/10.1001/jama.294.11.1359			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174694				2022-12-28	WOS:000231987800009
J	de Winter, RJ; Windhausen, F; Cornel, JH; Dunselman, PHJM; Janus, CL; Bendermacher, PEF; Michels, HR; Sanders, GT; Tijssen, JGP; Verheugt, FWA				de Winter, RJ; Windhausen, F; Cornel, JH; Dunselman, PHJM; Janus, CL; Bendermacher, PEF; Michels, HR; Sanders, GT; Tijssen, JGP; Verheugt, FWA		ICTUS Investigators	Early invasive versus selectively invasive management for acute coronary syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; ENOXAPARIN; COMMITTEE; STRATEGY; OUTCOMES; COLLEGE; EVENTS	BACKGROUND: Current guidelines recommend an early invasive strategy for patients who have acute coronary syndromes without ST-segment elevation and with an elevated cardiac troponin T level. However, randomized trials have not shown an overall reduction in mortality, and the reduction in the rate of myocardial infarction in previous trials has varied depending on the definition of myocardial infarction. METHODS: We randomly assigned 1200 patients with acute coronary syndrome without ST-segment elevation who had chest pain, an elevated cardiac troponin T level (greater/equal 0.03 microg per liter), and either electrocardiographic evidence of ischemia at admission or a documented history of coronary disease to an early invasive strategy or to a more conservative (selectively invasive) strategy. Patients received aspirin daily, enoxaparin for 48 hours, and abciximab at the time of percutaneous coronary intervention. The use of clopidogrel and intensive lipid-lowering therapy was recommended. The primary end point was a composite of death, nonfatal myocardial infarction, or rehospitalization for anginal symptoms within one year after randomization. RESULTS: The estimated cumulative rate of the primary end point was 22.7 percent in the group assigned to early invasive management and 21.2 percent in the group assigned to selectively invasive management (relative risk, 1.07; 95 percent confidence interval, 0.87 to 1.33; P=0.33). The mortality rate was the same in the two groups (2.5 percent). Myocardial infarction was significantly more frequent in the group assigned to early invasive management (15.0 percent vs. 10.0 percent, P=0.005), but rehospitalization was less frequent in that group (7.4 percent vs. 10.9 percent, P=0.04). CONCLUSIONS: We could not demonstrate that, given optimized medical therapy, an early invasive strategy was superior to a selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation and with an elevated cardiac troponin T level.	Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands; Med Ctr Alkmaar, Alkmaar, Netherlands; Amphia Ziekenhuizen, Breda, Netherlands; WestFriesGasthuis, Hoorn, Netherlands; Elkerliek Ziekenhuis, Helmond, Netherlands; Catharina Hosp, Eindhoven, Netherlands; Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Medical Center Of Alkmaar; Amphia Hospital; Catharina Hospital; Radboud University Nijmegen	de Winter, RJ (corresponding author), Acad Med Ctr, Dept Cardiol, B2-137,Meibergdreef 9,POB 22660, NL-1100 DD Amsterdam, Netherlands.	r.j.dewinter@amc.uva.nl	Verheugt, F.W.A./H-8105-2014; cornel, jan hein/Y-7065-2019	cornel, jan hein/0000-0002-1006-2112				Akkerhuis KM, 2002, CIRCULATION, V105, P554, DOI 10.1161/hc0502.104278; Alpert JS, 2001, J AM COLL CARDIOL, V37, P973; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; [Anonymous], 1994, Circulation, V89, P1545; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Bertrand ME, 2003, EUR HEART J, V24, P1174, DOI 10.1016/S0195-668X(03)00231-8; Bertrand ME, 2003, EUR HEART J, V24, P485, DOI 10.1016/S0195-668X(03)00080-0; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Boden WE, 2003, J AM COLL CARDIOL, V41, p113S, DOI 10.1016/S0735-1097(02)02963-7; Boden WE, 1998, NEW ENGL J MED, V339, P1397; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Ferguson JJ, 2003, AM HEART J, V146, P628, DOI 10.1016/S0002-8703(03)00165-0; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Hamm CW, 2000, CIRCULATION, V102, P118, DOI 10.1161/01.CIR.102.1.118; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; Roe MT, 2004, EUR HEART J, V25, P313, DOI 10.1016/j.ehj.2003.12.009; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; Van de Werf F, 2005, BRIT MED J, V330, P441, DOI 10.1136/bmj.38335.390718.82; Wallentin L, 1999, LANCET, V354, P708; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; [No title captured]	26	377	390	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1095	1104		10.1056/NEJMoa044259	http://dx.doi.org/10.1056/NEJMoa044259			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963YG	16162880	Green Published			2022-12-28	WOS:000231841900004
J	Farmelo, G				Farmelo, G			Dirac's hidden geometry	NATURE			English	Editorial Material									Northeastern Univ, Boston, MA 02115 USA	Northeastern University	Farmelo, G (corresponding author), Northeastern Univ, Boston, MA 02115 USA.							DARRIGOL O, 1992, C NUMBERS Q NUMBERS, pCH6; GALISON P, 2000, SUPPRESSED DRAWING P, P145	2	0	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2005	437	7057					323	323		10.1038/437323a	http://dx.doi.org/10.1038/437323a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163331	Bronze			2022-12-28	WOS:000231849100026
J	Steinbrook, R				Steinbrook, R			Wall Street and clinical trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Ferguson JR, 1997, NEW ENGL J MED, V337, P631, DOI 10.1056/NEJM199708283370910; SAUL S, 2005, NY TIMES        0613, pA1; Steinbrook R, 2005, NEW ENGL J MED, V352, P2160, DOI 10.1056/NEJMp048353; Timmerman Luke, 2005, SEATTLE TIMES   0807; Topol EJ, 2005, JAMA-J AM MED ASSOC, V293, P2654, DOI 10.1001/jama.293.21.2654	5	18	19	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1091	1093		10.1056/NEJMp058216	http://dx.doi.org/10.1056/NEJMp058216			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	963YG	16162879				2022-12-28	WOS:000231841900003
J	Wang, JM				Wang, JM			Hoogsteen base-pairing in DNA replication?	NATURE			English	Editorial Material							POLYMERASE; IOTA; INHIBITORS; PROTEASE		Yale Univ, Ctr Struct Biol, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Wang, JM (corresponding author), Yale Univ, Ctr Struct Biol, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	wang@csb.yale.edu						DREYER GB, 1992, BIOCHEMISTRY-US, V31, P6646, DOI 10.1021/bi00144a004; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; MURTHY KHM, 1992, J BIOL CHEM, V267, P22770; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Tissier A, 2000, GENE DEV, V14, P1642	6	24	25	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2005	437	7057					E6	E7		10.1038/nature04199	http://dx.doi.org/10.1038/nature04199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163299				2022-12-28	WOS:000231849100036
J	Godfrey, C				Godfrey, C		UKATT Res Team	Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT)	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To compare the cost effectiveness of social behaviour and network therapy (a new social treatment for alcohol problems) with that of the proved motivational enhancement therapy. Design Cost effectiveness analysis alongside a pragmatic randomised trial. Setting Seven treatment sites around Birmingham, Cardiff, and Leeds. Participants 742 clients with alcohol problems; 617 (83.2%) were interviewed at 12 months and hill economic data were obtained on 608 (98.5% of 617). Main economic measures Quality adjusted life years (QALYs), costs of trial treatments, and consequences for public sector resources (health care, other alcohol treatment, social services, and criminal justice services). Results Both therapies saved about five times as much in expenditure on health, social, and criminal justice services as they cost. Neither net savings nor cost effectiveness differed significantly between the therapies, despite the average cost of social behaviour and network therapy (221; pound $385; E320) being significantly more than that of motivational enhancement therapy (129) pound. If a QALY were worth 30 pound 000, then the motivational therapy would have 58% chance of being more cost effective than the social network therapy, and social network therapy would have 42% chance of being more cost effective than the motivational therapy. Conclusion Trial participants reported highly significant reductions in drinking and associated problems and costs. The novel social behaviour and network therapy did not differ significantly in cost effectiveness from the proved motivational enhancement therapy.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of York - UK	Godfrey, C (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	cg2@york.ac.uk	Russell, Ian T/H-1181-2012					Briggs A.H., 1999, HEALTH TECHNOL ASSES, V3, P2; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cisler R, 1998, J STUD ALCOHOL, V59, P503, DOI 10.15288/jsa.1998.59.503; Copello A, 2001, ALCOHOL ALCOHOLISM, V36, P11; Gerstein DR, 1994, EVALUATING RECOVERY; Gold MR, 1996, COST EFFECTIVENESS H; Gray AM, 1999, HLTH TECHNOL ASSESS, V3; HARRIES R, 1999, HOME OFFICE RES FIND, V103; *HM TREAS, 2000, CM4601; HOLDER H, 1991, J STUD ALCOHOL, V52, P517, DOI 10.15288/jsa.1991.52.517; Holder HD, 2000, ADDICTION, V95, P999, DOI 10.1046/j.1360-0443.2000.9579993.x; *HOM OFF, 1998, STAT RAC CRIM JUST S; KIND P, 1999, 172 U YORK CTR HLTH; Leontaridi R., 2003, ALCOHOL MISUSE MUCH; LUDBROOK A, 2001, EFFECTIVE COST AFFEC; LUDBROOK A, 2001, EFFECTIVE COST EFFEC; McCollister KE, 2003, ADDICTION, V98, P1647, DOI 10.1111/j.1360-0443.2003.00541.x; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; NETTEN A, 2002, UNIT COSTS HLTH SOCI; Orford J, 2005, BMJ-BRIT MED J, V331, P541; Parthasarathy S, 2001, J STUD ALCOHOL, V62, P89, DOI 10.15288/jsa.2001.62.89; POTAMIANOS G, 1986, LANCET, V2, P797; Raftery J, 2001, BRIT MED J, V323, P1300, DOI 10.1136/bmj.323.7324.1300; Richardson G, 2004, HEALTH ECON, V13, P1203, DOI 10.1002/hec.901; SLATTERY J, 2003, PREVENTION RELAPSE A; Vickers A J, 2001, BMC Complement Altern Med, V1, P1, DOI 10.1186/1472-6882-1-1; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123	28	121	121	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2005	331	7516					544	548						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965GX	16150765				2022-12-28	WOS:000231939700016
J	Griffiths, PD; Paley, MNJ; Widjaja, E; Taylor, C; Whitby, EH				Griffiths, PD; Paley, MNJ; Widjaja, E; Taylor, C; Whitby, EH			Science, medicine, and the future - In utero magnetic resonance imaging for brain and spinal abnormalities in fetuses	BRITISH MEDICAL JOURNAL			English	Review							CENTRAL-NERVOUS-SYSTEM; FETAL-BRAIN; DIAGNOSIS; 2ND-TRIMESTER; MATURATION; ULTRASOUND; PREGNANCY; EXPOSURE		Univ Sheffield, Royal Hallamshire Hosp, Acad Unit Radiol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Griffiths, PD (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Acad Unit Radiol, Sheffield S10 2JF, S Yorkshire, England.	p.griffiths@sheffield.ac.uk		Whitby, Elspeth/0000-0002-8912-8013				Girard N, 2003, CHILD NERV SYST, V19, P490, DOI 10.1007/s00381-003-0761-x; Griffiths PD, 2003, AM J NEURORADIOL, V24, P22; Hubbard AM, 1999, RADIOLOGY, V212, P43, DOI 10.1148/radiology.212.1.r99jl3143; Kok RD, 2004, MAGN RESON IMAGING, V22, P851, DOI 10.1016/j.mri.2004.01.047; Kok RD, 2002, MAGNET RESON MED, V48, P611, DOI 10.1002/mrm.10264; Kurihara N, 2001, PEDIATR RADIOL, V31, P160, DOI 10.1007/s002470000389; Levine D, 2000, AM J ROENTGENOL, V175, P1067, DOI 10.2214/ajr.175.4.1751067; Levine D, 1999, RADIOLOGY, V210, P751, DOI 10.1148/radiology.210.3.r99mr47751; Levine D, 1997, RADIOLOGY, V204, P635, DOI 10.1148/radiology.204.3.9280237; Malinger G, 2004, RADIOLOGY, V232, P306, DOI 10.1148/radiol.2321032051; Malinger G, 2004, ULTRASOUND OBST GYN, V23, P333, DOI 10.1002/uog.1016; Myers C, 1998, BRIT J RADIOL, V71, P549, DOI 10.1259/bjr.71.845.9691901; Prayer D, 2003, EUR J RADIOL, V45, P235, DOI 10.1016/S0720-048X(02)00312-1; WEINREB JC, 1985, RADIOLOGY, V154, P157, DOI 10.1148/radiology.154.1.3880601; Whitby E, 2001, BRIT J OBSTET GYNAEC, V108, P519, DOI 10.1016/S0306-5456(00)00115-7; Whitby EH, 2004, BJOG-INT J OBSTET GY, V111, P784, DOI 10.1111/j.1471-0528.2004.00149.x; WILLIAMSON RA, 1989, OBSTET GYNECOL, V73, P952	17	15	16	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 10	2005	331	7516					562	565		10.1136/bmj.331.7516.562	http://dx.doi.org/10.1136/bmj.331.7516.562			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965GX	16150769	Green Published			2022-12-28	WOS:000231939700021
J	Avorn, J				Avorn, J			FDA standards - Good enough for government work?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Avorn J, 2004, POWERFUL MED BENEFIT; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; *CTR MED MED SERV, 2003, HLTH CAR IND MARK UP; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X	4	23	23	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					969	972		10.1056/NEJMp058174	http://dx.doi.org/10.1056/NEJMp058174			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148281				2022-12-28	WOS:000231698200001
J	Couder, Y; Protiere, S; Fort, E; Boudaoud, A				Couder, Y; Protiere, S; Fort, E; Boudaoud, A			Dynamical phenomena - Walking and orbiting droplets	NATURE			English	Article							SOLITONS; SYSTEMS; STATES; WAVES		Univ Paris 07, F-75005 Paris, France; Lab Phys Stat, F-75231 Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Couder, Y (corresponding author), Univ Paris 07, F-75005 Paris, France.	boudaoud@lps.ens.fr	Fort, Emmanuel/C-4981-2012; Boudaoud, Arezki/Q-7436-2016	Boudaoud, Arezki/0000-0002-2780-4717				ARANSON IS, 1990, PHYSICA D, V43, P435, DOI 10.1016/0167-2789(90)90146-G; Boudaoud A, 1999, EUR PHYS J B, V9, P159, DOI 10.1007/s100510050751; Boudaoud A, 1999, PHYS REV LETT, V82, P3847, DOI 10.1103/PhysRevLett.82.3847; Couder Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.177801; FAUVE S, 1990, PHYS REV LETT, V64, P282, DOI 10.1103/PhysRevLett.64.282; Liehr AW, 2004, EUR PHYS J B, V37, P199, DOI 10.1140/epjb/e2004-00047-7; Lioubashevski O, 1996, PHYS REV LETT, V76, P3959, DOI 10.1103/PhysRevLett.76.3959; Moskalenko AS, 2003, EUROPHYS LETT, V63, P361, DOI 10.1209/epl/i2003-00532-1; Stegeman GI, 1999, SCIENCE, V286, P1518, DOI 10.1126/science.286.5444.1518; Umbanhowar PB, 1996, NATURE, V382, P793, DOI 10.1038/382793a0	10	263	266	4	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					208	208		10.1038/437208a	http://dx.doi.org/10.1038/437208a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148925	Bronze			2022-12-28	WOS:000231696900042
J	Di Nisio, M; Middeldorp, S; Buller, HR				Di Nisio, M; Middeldorp, S; Buller, HR			Drug therapy - Direct thrombin inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEPARIN-INDUCED THROMBOCYTOPENIA; MOLECULAR-WEIGHT HEPARIN; ECARIN CLOTTING TIME; TOTAL HIP-REPLACEMENT; PERCUTANEOUS CORONARY INTERVENTION; GLYCOPROTEIN IIB/IIIA INHIBITION; NONVALVULAR ATRIAL-FIBRILLATION; RANDOMIZED CONTROLLED-TRIAL; ACUTE MYOCARDIAL-INFARCTION; DEEP-VEIN THROMBOSIS		Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Gabriele DAnnunzio Univ Fdn, Sch Med, Dept Med & Aging, Chieti, Italy; Gabriele DAnnunzio Univ Fdn, Aging Res Ctr, Chieti, Italy	University of Amsterdam; Academic Medical Center Amsterdam; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Di Nisio, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med F4 138, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.dinisio@amc.uva.nl	Middeldorp, Saskia/ABI-8197-2020	Middeldorp, Saskia/0000-0002-1006-6420				Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; Antman EM, 1999, CIRCULATION, V100, P1602, DOI 10.1161/01.CIR.100.15.1602; BANNER DW, 1993, ADV EXP MED BIOL, V340, P27; Bates S M, 2000, J Invasive Cardiol, V12 Suppl F, p27F; Bergqvist D, 2004, CLIN DRUG INVEST, V24, P127, DOI 10.2165/00044011-200424030-00001; BERRY CN, 1994, THROMB HAEMOSTASIS, V72, P381; BITTL JA, 1995, NEW ENGL J MED, V333, P764, DOI 10.1056/NEJM199509213331204; Bittl JA, 2001, AM HEART J, V142, P952, DOI 10.1067/mhj.2001.119374; BOSHKOV LK, 1993, BRIT J HAEMATOL, V84, P322, DOI 10.1111/j.1365-2141.1993.tb03072.x; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Callas DD, 1996, THROMB RES, V83, P463, DOI 10.1016/0049-3848(96)00155-7; CALLAS DD, 1996, ANN HEMATOL, V1, pA58; Casserly IP, 2004, THROMB RES, V113, P115, DOI 10.1016/j.thromres.2004.02.012; Chew DP, 2005, AM J CARDIOL, V95, P581, DOI 10.1016/j.amjcard.2004.11.003; Chew DP, 2003, AM J CARDIOL, V92, P919, DOI 10.1016/S0002-9149(03)00970-6; Cho L, 2003, AM J CARDIOL, V91, P1110, DOI 10.1016/S0002-9149(03)00159-0; CLARKE RJ, 1991, CIRCULATION, V83, P1510, DOI 10.1161/01.CIR.83.5.1510; Cohen DJ, 2004, J AM COLL CARDIOL, V44, P1792, DOI 10.1016/j.jacc.2004.05.085; Colwell CW, 2003, J THROMB HAEMOST, V1, P2119, DOI 10.1046/j.1538-7836.2003.00368.x; Eichler P, 2000, BLOOD, V96, P2373; Eikelboom JW, 2000, LANCET, V355, P1936, DOI 10.1016/S0140-6736(00)02324-2; Eikelboom JW, 2000, LANCET, V356, P600; Eriksson BI, 1997, J BONE JOINT SURG AM, V79A, P326, DOI 10.2106/00004623-199703000-00002; Eriksson BI, 1997, NEW ENGL J MED, V337, P1329, DOI 10.1056/NEJM199711063371901; Eriksson BI, 2005, J THROMB HAEMOST, V3, P103, DOI 10.1111/j.1538-7836.2004.01100.x; Eriksson BI, 2003, J THROMB HAEMOST, V1, P2490, DOI 10.1111/j.1538-7836.2003.00494.x; Eriksson BI, 2003, THROMB HAEMOSTASIS, V89, P288; Eriksson H, 1999, THROMB HAEMOSTASIS, V81, P358; Faaij RA, 2001, EUR J CLIN PHARMACOL, V57, P25, DOI 10.1007/s002280100270; Fager G, 2003, EUR J CLIN PHARMACOL, V59, P283, DOI 10.1007/s00228-003-0619-x; Fenyvesi T, 2002, SEMIN THROMB HEMOST, V28, P361, DOI 10.1055/s-2002-34305; Fiessinger JN, 2005, JAMA-J AM MED ASSOC, V293, P681, DOI 10.1001/jama.293.6.681; Fischer KG, 2002, SEMIN THROMB HEMOST, V28, P467, DOI 10.1055/s-2002-35288; *FOOD DRUG ADM CAR, 2004, INT EX SUMM FDA REV; Francis CW, 2003, NEW ENGL J MED, V349, P1703, DOI 10.1056/NEJMoa035162; Francis CW, 2002, ANN INTERN MED, V137, P648, DOI 10.7326/0003-4819-137-8-200210150-00008; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Greinacher A, 2000, BLOOD, V96, P846, DOI 10.1182/blood.V96.3.846.015k09_846_851; Greinacher A, 2003, CIRCULATION, V108, P2062, DOI 10.1161/01.CIR.0000096056.37269.14; Greinacher A, 2005, CHEST, V127, P416; Gustafsson D, 2003, THROMB RES, V109, pS9, DOI 10.1016/S0049-3848(03)00249-4; Harrington RA, 2004, CHEST, V126, p513S, DOI 10.1378/chest.126.3_suppl.513S; Hauptmann J, 1999, THROMB RES, V93, P203, DOI 10.1016/S0049-3848(98)00192-3; Huhle G, 1999, BRIT J HAEMATOL, V106, P195; LaMonte MP, 2004, STROKE, V35, P1677, DOI 10.1161/01.STR.0000131549.20581.ba; Lewis BE, 2003, ARCH INTERN MED, V163, P1849, DOI 10.1001/archinte.163.15.1849; Lewis BE, 2001, CIRCULATION, V103, P1838; Liaw PCY, 2001, J BIOL CHEM, V276, P20959, DOI 10.1074/jbc.M010584200; Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696; LINCOFF AM, 2003, JAMA-J AM MED ASSOC, V289, P1638; Lubenow N, 2004, BLOOD, V104, P3072, DOI 10.1182/blood-2004-02-0621; MARAGANORE JM, 1990, BIOCHEMISTRY-US, V29, P7095, DOI 10.1021/bi00482a021; MARBET GA, 1993, J CARDIOVASC PHARM, V22, P364, DOI 10.1097/00005344-199309000-00004; Menon V, 2004, CHEST, V126, p549S, DOI 10.1378/chest.126.3_suppl.549S; Merry AF, 2004, ANN THORAC SURG, V77, P925, DOI 10.1016/j.athoracsur.2003.09.061; Moser M, 2001, J THROMB THROMBOLYS, V12, P165, DOI 10.1023/A:1012975522037; NURMOHAMED MT, 1994, THROMB HAEMOSTASIS, V72, P685; PARRY MAA, 1994, BIOCHEMISTRY-US, V33, P14807, DOI 10.1021/bi00253a020; Petersen JL, 2004, JAMA-J AM MED ASSOC, V292, P89, DOI 10.1001/jama.292.1.89; RADZIWON P, 1996, ANN HEMATOL, V1, pA57; Robson R, 2002, CLIN PHARMACOL THER, V71, P433, DOI 10.1067/mcp.2002.124522; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Sarich TC, 2003, J AM COLL CARDIOL, V41, P557, DOI 10.1016/S0735-1097(02)02868-1; Saw J, 2004, J AM COLL CARDIOL, V44, P1194, DOI 10.1016/j.jacc.2004.06.049; Schenk JF, 1996, HAEMOSTASIS, V26, P140; Schiele F, 1997, THROMB HAEMOSTASIS, V77, P834; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Singer DE, 2004, CHEST, V126, p429S, DOI 10.1378/chest.126.3_suppl.429S; Swan SK, 2000, PHARMACOTHERAPY, V20, P318, DOI 10.1592/phco.20.4.318.34881; Tulinsky A, 1996, SEMIN THROMB HEMOST, V22, P117, DOI 10.1055/s-2007-998998; Van de Werf F, 2001, LANCET, V358, P605; Wahlander K, 2003, CLIN PHARMACOKINET, V42, P755; WALENGA JM, 1991, SEMIN THROMB HEMOST, V17, P103, DOI 10.1055/s-2007-1002597; Walenga JM, 2002, THROMB RES, V105, P401, DOI 10.1016/S0049-3848(02)00049-X; Wallentin L, 2003, LANCET, V362, P789, DOI 10.1016/S0140-6736(03)14287-0; Warkentin TE, 2004, CHEST, V126, p311S, DOI 10.1378/chest.126.3_suppl.311S; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; Weitz JI, 1998, CIRCULATION, V97, P544; White HD, 2001, LANCET, V358, P1855; Wolzt M, 2004, THROMB HAEMOSTASIS, V91, P1090, DOI 10.1160/TH03-09-0605; Xiao ZH, 1998, CIRCULATION, V97, P251, DOI 10.1161/01.CIR.97.3.251; Yusuf S, 2002, LANCET, V359, P294	83	442	460	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					1028	1040		10.1056/NEJMra044440	http://dx.doi.org/10.1056/NEJMra044440			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148288	Green Published			2022-12-28	WOS:000231698200008
J	Silveira, JR; Raymond, GJ; Hughson, AG; Race, RE; Sim, VL; Hayes, SF; Caughey, B				Silveira, JR; Raymond, GJ; Hughson, AG; Race, RE; Sim, VL; Hayes, SF; Caughey, B			The most infectious prion protein particles	NATURE			English	Article							SCRAPIE INFECTIVITY; AGENT; REPLICATION; RESISTANCE; LIPOSOMES; DISEASES; SIZES; ASSAY	Neurodegenerative diseases such as Alzheimer's, Parkinson's and the transmissible spongiform encephalopathies (TSEs) are characterized by abnormal protein deposits, often with large amyloid fibrils. However, questions have arisen as to whether such fibrils or smaller subfibrillar oligomers are the prime causes of disease(1,2). Abnormal deposits in TSEs are rich in PrPres, a protease-resistant form of the PrP protein with the ability to convert the normal, protease-sensitive form of the protein (PrPsen) into PrPres (ref. 3). TSEs can be transmitted between organisms by an enigmatic agent (prion) that contains PrPres (refs 4 and 5). To evaluate systematically the relationship between infectivity, converting activity and the size of various PrPres-containing aggregates, PrPres was partially disaggregated, fractionated by size and analysed by light scattering and non-denaturing gel electrophoresis. Our analyses revealed that with respect to PrP content, infectivity and converting activity peaked markedly in 17 - 27- nm (300 - 600 kDa) particles, whereas these activities were substantially lower in large fibrils and virtually absent in oligomers of <= 5 PrP molecules. These results suggest that non-fibrillar particles, with masses equivalent to 14 - 28 PrP molecules, are the most efficient initiators of TSE disease.	NIAID, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA; NIAID, Electron Microscopy Core Facil, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Caughey, B (corresponding author), NIAID, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA.	bcaughey@nih.gov	Sim, Valerie/C-4137-2013	Sim, Valerie/0000-0002-0088-8666	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000265, Z01AI000580] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [Z01 AI000580-16] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALPER T, 1966, BIOCHEM BIOPH RES CO, V22, P278, DOI 10.1016/0006-291X(66)90478-5; BELLINGERKAWAHARA CG, 1988, VIROLOGY, V164, P537, DOI 10.1016/0042-6822(88)90569-7; BROWN P, 1990, P NATL ACAD SCI USA, V87, P7240, DOI 10.1073/pnas.87.18.7240; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Caughey B, 1997, J VIROL, V71, P4107, DOI 10.1128/JVI.71.5.4107-4110.1997; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; GAST K, 1992, LASER LIGHT SCATTERI, P209; GIBBS CJ, 1978, P NATL ACAD SCI USA, V75, P6268, DOI 10.1073/pnas.75.12.6268; HOPE J, 1994, ANN NY ACAD SCI, V724, P282, DOI 10.1111/j.1749-6632.1994.tb38917.x; JEFFREY M, 1994, BRAIN RES, V656, P329, DOI 10.1016/0006-8993(94)91477-X; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Masel J, 2005, J MOL BIOL, V345, P1243, DOI 10.1016/j.jmb.2004.10.088; Masel J, 1999, BIOPHYS CHEM, V77, P139, DOI 10.1016/S0301-4622(99)00016-2; Maxson L, 2003, ANAL BIOCHEM, V323, P54, DOI 10.1016/j.ab.2003.07.028; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1980, BIOCHEMISTRY-US, V19, P4883, DOI 10.1021/bi00562a028; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raymond G. J., 2004, TECHNIQUES PRION RES, P16; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Riesner D, 1996, J VIROL, V70, P1714, DOI 10.1128/JVI.70.3.1714-1722.1996; SAFAR J, 1990, P NATL ACAD SCI USA, V87, P6373, DOI 10.1073/pnas.87.16.6373; Silveira JR, 2004, CURR TOP MICROBIOL, V284, P1; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Wahlund K-G, 2000, FIELD FLOW FRACTIONA, P279	27	709	733	0	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					257	261		10.1038/nature03989	http://dx.doi.org/10.1038/nature03989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148934	Green Accepted			2022-12-28	WOS:000231696900056
J	Wyllie, DH; Peto, TEA; Crook, D				Wyllie, DH; Peto, TEA; Crook, D			MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN; COMMUNITY; INFECTIONS; PREVALENCE; ADMISSION; RISK; PROCALCITONIN; SURVEILLANCE; POPULATION	Objective To describe the incidence and determinants of methicillin resistant and methicillin sensitive Staphylococcus aureus (NMSA and MSSA) bacteraemia in patients presenting to acute hospitals. Design Anonymised record linkage study with information from hospital information systems and microbiology databases. Setting One teaching hospital and one district general hospital in Oxfordshire. Participants All patients admitted to a teaching hospital I April 1997 to 31 March 2003 and to a district general hospital I April 1999 to 31 March 2003. Main outcome measures Detection of MRSA and MSSA from blood cultures taken during the first two days of admission to hospital. Results In the teaching hospital, there were 479 patients with MSSA and 116 with MRSA bacteraemia admitted from the community. Among this group, which comprised 24% of all hospital MRSA cases, 31% (36 cases) of patients had been admitted to renal, oncology, or haematology services for intensive day case therapy. The 69% remaining were most commonly patients admitted as medical or surgical emergencies. At least 91% had been in hospital previously; the median time since discharge was 46 days. About half of cases were in patients in whom MRSA had not been isolated before. Similar epidemiology was observed in the district general hospital. Conclusion Diagnostic algorithms and policies on use of antibiotics need to reflect the fact that a quarter of hospital MRSA cases occur in patients who have previously been in hospital and are subsequently readmitted.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Wyllie, DH (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England.	david.wyllie@ndcls.ox.ac.uk		peto, tim/0000-0003-3477-8307				Ayliffe GAJ, 1998, J HOSP INFECT, V39, P253, DOI 10.1016/S0195-6701(98)90293-6; Brown DFJ, 2001, J ANTIMICROB CHEMOTH, V48, P65, DOI 10.1093/jac/48.suppl_1.65; Caterino JM, 2004, ACAD EMERG MED, V11, P393, DOI 10.1197/j.aem.2003.10.027; Chassagne P, 1996, AM J MED, V100, P65, DOI 10.1016/S0002-9343(96)90013-3; Chirouze C, 2002, CLIN INFECT DIS, V35, P156, DOI 10.1086/341023; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; *DEP HTH HLTH PROT, MRSA SURV SYST RES; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goetz A, 1999, INFECT CONT HOSP EP, V20, P689, DOI 10.1086/501567; *HLTH PROT AG COM, MRSA SURV SYST RES; Hori S, 2002, J HOSP INFECT, V50, P25, DOI 10.1053/jhin.2001.1130; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Lodise TR, 2003, INFECT CONT HOSP EP, V24, P655, DOI 10.1086/502269; Lucet JC, 2005, INFECT CONT HOSP EP, V26, P121, DOI 10.1086/502514; Maudsley J, 2004, J HOSP INFECT, V57, P258, DOI 10.1016/j.jhin.2004.03.023; Morgan M, 1999, J HOSP INFECT, V41, P173, DOI 10.1016/S0195-6701(99)90014-2; Morin CA, 2001, J INFECT DIS, V184, P1029, DOI 10.1086/323459; REID J, BLOODBORNE MRSA INFE; Rezende NA, 2002, AM J MED SCI, V323, P117, DOI 10.1097/00000441-200203000-00001; Speller DCE, 1997, LANCET, V350, P323, DOI 10.1016/S0140-6736(97)12148-1; Tacconelli E, 2004, J ANTIMICROB CHEMOTH, V53, P474, DOI 10.1093/jac/dkh107; WANG RKK, 2000, P SOC PHOTO-OPT INS, V1, P36; Wyllie DH, 2005, J CLIN PATHOL, V58, P352, DOI 10.1136/jcp.2004.022293	26	43	44	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2005	331	7523					992	995		10.1136/bmj.38558.453310.8F	http://dx.doi.org/10.1136/bmj.38558.453310.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981AU	16155048	Green Published, Bronze			2022-12-28	WOS:000233060200015
J	Colombani, J; Bianchini, L; Layalle, S; Pondeville, E; Dauphin-Villemant, C; Antoniewski, C; Carre, C; Noselli, S; Leopold, P				Colombani, J; Bianchini, L; Layalle, S; Pondeville, E; Dauphin-Villemant, C; Antoniewski, C; Carre, C; Noselli, S; Leopold, P			Antagonistic actions of ecdysone and insulins determine final size in Drosophila	SCIENCE			English	Article							CELLULAR GROWTH; BODY-SIZE; ENZYME	All animals coordinate growth and maturation to reach their final size and shape. In insects, insulin family molecules control growth and metabolism, whereas pulses of the steroid 20-hydroxyecdysone (20E) initiate major developmental transitions. We show that 20E signaling also negatively controls animal growth rates by impeding general insulin signaling involving localization of the transcription factor dFOXO and transcription of the translation inhibitor 4E-BP. We also demonstrate that the larval fat body, equivalent to the vertebrate liver, is a key relay element for ecdysone-dependent growth inhibition. Hence, ecdysone counteracts the growth-promoting action of insulins, thus forming a humoral. regulatory loop that determines organismal size.	Univ Nice, CNRS, UMR6543, F-06108 Nice, France; Univ Paris 06, CNRS, FRE2852, F-75252 Paris, France; Inst Pasteur, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Leopold, P (corresponding author), Univ Nice, CNRS, UMR6543, Parc Valrose, F-06108 Nice, France.	leopolid@unice.fr	Antoniewski, Christophe/G-4519-2011; Layalle, Sophie/N-3815-2017	Antoniewski, Christophe/0000-0001-7709-2116; Layalle, Sophie/0000-0002-3650-0598; Colombani, Julien/0000-0002-8250-4899; Noselli, stephane/0000-0002-7296-324X; Pondeville, Emilie/0000-0001-8545-8472				Adam G, 2003, DEVELOPMENT, V130, P2397, DOI 10.1242/dev.00460; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; COLOMBANI J, UNPUB; Hafen E, 2003, CURR TOP MICROBIOL, V279, P153; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Janning W, 1997, SEMIN CELL DEV BIOL, V8, P469, DOI 10.1006/scdb.1997.0172; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RIDDIFORD LM, 1993, RECEPTOR, V3, P203; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Stern D, 2003, CURR BIOL, V13, pR267, DOI 10.1016/S0960-9822(03)00197-0; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009	21	447	464	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					667	670		10.1126/science.1119432	http://dx.doi.org/10.1126/science.1119432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16179433				2022-12-28	WOS:000232997700039
J	Koo, SH; Flechner, L; Qi, L; Zhang, XM; Screaton, RA; Jeffries, S; Hedrick, S; Xu, W; Boussouar, F; Brindle, P; Takemori, H; Montminy, M				Koo, SH; Flechner, L; Qi, L; Zhang, XM; Screaton, RA; Jeffries, S; Hedrick, S; Xu, W; Boussouar, F; Brindle, P; Takemori, H; Montminy, M			The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; HEPATIC GLUCONEOGENESIS; LIPID-METABOLISM; BINDING PROTEIN; GENE-EXPRESSION; INSULIN; CAMP; TRANSCRIPTION; PGC-1; LIVER	Glucose homeostasis is regulated systemically by hormones such as insulin and glucagon, and at the cellular level by energy status. Glucagon enhances glucose output from the liver during fasting by stimulating the transcription of gluconeogenic genes via the cyclic AMP-inducible factor CREB (CRE binding protein). When cellular ATP levels are low, however, the energy-sensing kinase AMPK inhibits hepatic gluconeogenesis through an unknown mechanism. Here we show that hormonal and energy-sensing pathways converge on the coactivator TORC2 (transducer of regulated CREB activity 2) to modulate glucose output. Sequestered in the cytoplasm under feeding conditions, TORC2 is dephosphorylated and transported to the nucleus where it enhances CREB-dependent transcription in response to fasting stimuli. Conversely, signals that activate AMPK attenuate the gluconeogenic programme by promoting TORC2 phosphorylation and blocking its nuclear accumulation. Individuals with type 2 diabetes often exhibit fasting hyperglycaemia due to elevated gluconeogenesis; compounds that enhance TORC2 phosphorylation may offer therapeutic benefits in this setting.	Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; Osaka Univ, Grad Sch Med H1, Dept Biochem & Mol Biol, Suita, Osaka 5650871, Japan	Salk Institute; St Jude Children's Research Hospital; Osaka University	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Boussouar, Fayçal/E-7542-2019; Koo, Seung-Hoi/E-2763-2015; Boussouar, Fayçal/N-2511-2013	Boussouar, Fayçal/0000-0003-4529-4893; Koo, Seung-Hoi/0000-0001-8769-2879; Xu, Wu/0000-0002-2982-3276; Qi, Ling/0000-0001-8229-0184; Brindle, Paul/0000-0001-7172-8478; Screaton, Robert/0000-0002-4917-9473				Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Hall Robert K., 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P119; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kasper LH, 2002, NATURE, V419, P738, DOI 10.1038/nature01062; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lochhead PA, 2001, DIABETES, V50, P937, DOI 10.2337/diabetes.50.5.937; Phillips Carrie A, 2002, Curr Diab Rep, V2, P523, DOI 10.1007/s11892-002-0123-1; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Radziuk Jerry, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P151; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SASAKI K, 1984, J BIOL CHEM, V259, P5242; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	32	746	798	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2005	437	7062					1109	1114		10.1038/nature03967	http://dx.doi.org/10.1038/nature03967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16148943				2022-12-28	WOS:000232660500034
J	Stelzl, U; Worm, U; Lalowski, M; Haenig, C; Brembeck, FH; Goehler, H; Stroedicke, M; Zenkner, M; Schoenherr, A; Koeppen, S; Timm, J; Mintzlaff, S; Abraham, C; Bock, N; Kietzmann, S; Goedde, A; Toksoz, E; Droege, A; Krobitsch, S; Korn, B; Birchmeier, W; Lehrach, H; Wanker, EE				Stelzl, U; Worm, U; Lalowski, M; Haenig, C; Brembeck, FH; Goehler, H; Stroedicke, M; Zenkner, M; Schoenherr, A; Koeppen, S; Timm, J; Mintzlaff, S; Abraham, C; Bock, N; Kietzmann, S; Goedde, A; Toksoz, E; Droege, A; Krobitsch, S; Korn, B; Birchmeier, W; Lehrach, H; Wanker, EE			A human protein-protein interaction network: A resource for annotating the proteome	CELL			English	Article							INTERACTION MAP; BETA-CATENIN; YEAST; TRANSCRIPTION; MODULARITY; BIOLOGY; MOTIFS; PP32; TOOL	Protein-protein interaction maps provide a valuable framework for a better understanding of the functional organization of the proteome. To detect interacting pairs of human proteins systematically, a protein matrix of 4456 baits and 5632 preys was screened by automated yeast two-hybrid (Y2H) interaction mating. We identified 3186 mostly novel interactions among 1705 proteins, resulting in a large, highly connected network. Independent pull-down and coimmunoprecipitation assays validated the overall quality of the Y2H interactions. Using topological and GO criteria, a scoring system was developed to define 911 high-confidence interactions among 401 proteins. Furthermore, the network was searched for interactions linking uncharacterized gene products and human disease proteins to regulatory cellular pathways. Two novel Axin-1 interactions were validated experimentally, characterizing ANP32A and CRMP1 as modulators of Writ signaling. Systematic human protein interaction screens can lead to a more comprehensive understanding of protein function and cellular processes.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; German Genome Resource Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society	Wanker, EE (corresponding author), Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.	erich.w@mdc-berlin.de	Lalowski, Maciej/AAB-4151-2019; Stelzl, Ulrich/J-9506-2015	Lalowski, Maciej/0000-0002-3683-4096; Stelzl, Ulrich/0000-0003-2500-3585; Wanker, Erich/0000-0001-8072-1630				Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Shih JY, 2003, CLIN EXP METASTAS, V20, P69, DOI 10.1023/A:1022598604565; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ulitzur N, 1997, J BIOL CHEM, V272, P30577, DOI 10.1074/jbc.272.48.30577; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yu HY, 2004, NUCLEIC ACIDS RES, V32, P328, DOI 10.1093/nar/gkh164	45	1739	1814	4	225	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					957	968		10.1016/j.cell.2005.08.029	http://dx.doi.org/10.1016/j.cell.2005.08.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16169070	Green Published, Bronze			2022-12-28	WOS:000232130200019
J	Konneke, M; Bernhard, AE; de la Torre, JR; Walker, CB; Waterbury, JB; Stahl, DA				Konneke, M; Bernhard, AE; de la Torre, JR; Walker, CB; Waterbury, JB; Stahl, DA			Isolation of an autotrophic ammonia-oxidizing marine archaeon	NATURE			English	Article							PLANKTONIC ARCHAEA; BACTERIA	For years, microbiologists characterized the Archaea as obligate extremophiles that thrive in environments too harsh for other organisms. The limited physiological diversity among cultivated Archaea suggested that these organisms were metabolically constrained to a few environmental niches. For instance, all Crenarchaeota that are currently cultivated are sulphur-metabolizing thermophiles(1). However, landmark studies using cultivation- independent methods uncovered vast numbers of Crenarchaeota in cold oxic ocean waters(2,3). Subsequent molecular surveys demonstrated the ubiquity of these low- temperature Crenarchaeota in aquatic and terrestrial environments(4). The numerical dominance of marine Crenarchaeota - estimated at 10(28) cells in the world's oceans(5) - suggests that they have a major role in global biogeochemical cycles. Indeed, isotopic analyses of marine crenarchaeal lipids suggest that these planktonic Archaea fix inorganic carbon(6). Here we report the isolation of a marine crenarchaeote that grows chemolithoautotrophically by aerobically oxidizing ammonia to nitrite - the first observation of nitrification in the Archaea. The autotrophic metabolism of this isolate, and its close phylogenetic relationship to environmental marine crenarchaeal sequences, suggests that nitrifying marine Crenarchaeota may be important to global carbon and nitrogen cycles.	Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	University of Washington; University of Washington Seattle; Woods Hole Oceanographic Institution	Stahl, DA (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.	dastahl@u.washington.edu	Koenneke, Martin/E-6893-2013; de la Torre, Jose R/H-2081-2012	Koenneke, Martin/0000-0001-6770-414X; de la Torre, Jose R/0000-0002-9553-6048; Bernhard, Anne/0000-0002-8639-9555				Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Beja O, 2002, APPL ENVIRON MICROB, V68, P335, DOI 10.1128/AEM.68.1.335-345.2002; BOCK E, 2001, PROKARYOTES EVOLVING; Burggraf S, 1997, INT J SYST BACTERIOL, V47, P657, DOI 10.1099/00207713-47-3-657; Capone D. G., 2000, MICROBIAL ECOLOGY OC, P455; Dawson S. C., 2000, PROKARYOTES EVOLVING; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Ducklow H., 2000, MICROBIAL ECOLOGY OC, P85, DOI DOI 10.1002/9780470281840; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Hovanec TA, 1996, APPL ENVIRON MICROB, V62, P2888, DOI 10.1128/AEM.62.8.2888-2896.1996; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Menendez C, 1999, J BACTERIOL, V181, P1088, DOI 10.1128/JB.181.4.1088-1098.1999; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Pearson A, 2004, APPL ENVIRON MICROB, V70, P5229, DOI 10.1128/AEM.70.9.5229-5237.2004; Pearson A, 2001, GEOCHIM COSMOCHIM AC, V65, P3123, DOI 10.1016/S0016-7037(01)00657-3; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Stickland JDH, 1972, PRACTICAL HDB SEAWAT; Swofford D.L., 2003, PAUP VERSION 40 B10; Treusch AH, 2004, ENVIRON MICROBIOL, V6, P970, DOI 10.1111/j.1462-2920.2004.00663.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WADA E, 1971, LIMNOL OCEANOGR, V16, P766, DOI 10.4319/lo.1971.16.5.0766; Widdel F., 1992, PROKARYOTES, DOI 10.1007/978-1-4757-2191-1_2; Wuchter C, 2003, FEMS MICROBIOL LETT, V219, P203, DOI 10.1016/S0378-1097(03)00060-0	27	1977	2164	45	984	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					543	546		10.1038/nature03911	http://dx.doi.org/10.1038/nature03911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177789				2022-12-28	WOS:000232004800048
J	Zerhouni, EA				Zerhouni, EA			US biomedical research - Basic, translational, and clinical sciences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EBOLA-VIRUS GLYCOPROTEIN; SMALLPOX VACCINE; MICE	The National Institutes of Health (NIH) is the world's largest biomedical research agency, with a 75-year record of responding to the nation's key medical challenges. Today, medical science is entering a revolutionary period marked by a shift in focus from acute to chronic diseases, rapidly escalating health care costs, a torrent of biological data generated by the sequencing of the human genome, and the development of advanced high-throughput technologies that allow for the study of vast molecular networks in health and disease. This unique period offers the unprecedented opportunity to identify individuals at risk of disease based on precise molecular knowledge, and the chance to intervene to preempt disease before it strikes. Conceptually, this represents the core scientific challenge of the coming century. The NIH is committed to the discoveries that will change the practice of medicine as we know it in order to meet this challenge. The NIH Roadmap constitutes an important vehicle for generating change-a most critical element of this plan is the reengineering of the national clinical research enterprise. This reinvention will call for the transformation of translational clinical science and for novel interdisciplinary approaches that will advance science and enhance the health of the nation.	NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Zerhouni, EA (corresponding author), NIH, 1 Ctr Dr,Bldg 1,Room 126, Bethesda, MD 20892 USA.	zerhoune@od.nih.gov						[Anonymous], 2003, SCIENCE, V302, P2039; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; CUTLER DM, 2004, YOUR MONEY YOUR LIFE, P51; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; *GEMCRIS, GEN MOD CLIN RES INF; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Health, 2005, MED BENEFITS, V22, P12; Higginbotham EJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P813, DOI 10.1001/archopht.122.6.813; Lethbridge-Cejku M, 2004, VITAL HLTH STAT, V10, P1; *NAT HEART LUNG BL, MORB MORT 2004 CHART; *NAT LIB MED, KEY MEDLINE IND; *NIH, NEW PATHW DISC; *NIH, CTR EXC TRANSL HUM S; *NIH, NIH STRAT PLAN RED H; *NIH, NIH BLUEPR; *NIH, NIH ROADM MED RES; *NIH, RES TEAMS FUT; *NIH, REEN CLIN RES ENT; *NIH, MARK O HATF CLIN RES; *NIH, STRAT PLAN NIH OB RE; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; *PHARM MAN AM, 2005, PHARMM IND PROF 2005; Ries LAG, SEER CANC STAT REV 1; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Sullivan NJ, 2005, J VIROL, V79, P547, DOI 10.1128/JVI.79.1.547-553.2005; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; United States Census Bureau, US INT PROJ AG SEX R; Wright JT, 2005, JAMA-J AM MED ASSOC, V293, P1595, DOI 10.1001/jama.293.13.1595; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; ZACHARY CP, 1997, ENDLESS FRONTIER VAN, P218; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	39	190	195	2	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1352	1358		10.1001/jama.294.11.1352	http://dx.doi.org/10.1001/jama.294.11.1352			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174693				2022-12-28	WOS:000231987800008
J	Victor, DG; House, JC; Joy, S				Victor, DG; House, JC; Joy, S			A Madisonian approach to climate policy	SCIENCE			English	Editorial Material									PESD, Stanford, CA 94305 USA		Victor, DG (corresponding author), PESD, Stanford, CA 94305 USA.	david.victor@stanford.edu						BAILYN B, 1993, DEBATE CONSTITUTION; BOLDSMITH JL, 2005, LIMITS INT LAW; Browne J, 2004, FOREIGN AFF, V83, P20, DOI 10.2307/20034044; Ellerman A. Denny, 2003, EMISSIONS TRADING US; HAHN RW, 1989, YALE J REGUL, V6, P109; Heller T., 2003, KYOTO ADV INT EFFORT; International Energy Agency, 2004, WORLD EN OUTL 2004; Martin P, 2005, FOREIGN AFF, V84, P2, DOI 10.2307/20034343; Morgan MG, 2000, SCIENCE, V289, P2285, DOI 10.1126/science.289.5488.2285; Stavins RN, 1998, J ECON PERSPECT, V12, P69, DOI 10.1257/jep.12.3.69; STEWART RICHARD B., 2003, RECONSTRUCTING CLIMA; UNDERDAL A, 1987, J PEACE RES, V24, P167, DOI 10.1177/002234338702400206; VICTOR DG, 2004, CLIMATE CHANGE DEBAT; VICTOR DG, 1998, IMPLEMENTATION EFFEC, P659	14	97	100	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2005	309	5742					1820	1821		10.1126/science.1113180	http://dx.doi.org/10.1126/science.1113180			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	965ZN	16166505				2022-12-28	WOS:000231989500035
J	Macedo, TA				Macedo, TA			Atherosclerotic aortic occlusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Macedo, TA (corresponding author), Mayo Clin, Rochester, MN 55905 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					E10	E10		10.1056/NEJMicm040599	http://dx.doi.org/10.1056/NEJMicm040599			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963YG	16162876				2022-12-28	WOS:000231841900010
J	Wolf, M; Harris, NL; Smith, RN; Rose, H; McCluskey, RT				Wolf, M; Harris, NL; Smith, RN; Rose, H; McCluskey, RT			A 42-year-old man with weight loss, weakness, and a rash - Necrotizing glomerulonephritis and tubulointerstitial nephritis with antibodies to myeloperoxidase; renal involvement by the Churg-Strauss syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VASCULITIS; HEMORRHAGE; TESTS		Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Berkshire Med Ctr, Dept Med, Div Nephrol, Pittsfield, MA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wolf, M (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA.							Choi HK, 2001, J RHEUMATOL, V28, P1584; CHURG J, 1951, AM J PATHOL, V27, P277; CLUTTERBUCK EJ, 1990, NEPHROL DIAL TRANSPL, V5, P161, DOI 10.1093/ndt/5.3.161; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; DAGATI V, 1986, AM J KIDNEY DIS, V7, P95, DOI 10.1016/S0272-6386(86)80062-2; Han WK, 2003, KIDNEY INT, V63, P1079, DOI 10.1046/j.1523-1755.2003.00821.x; Hricik DE, 1998, NEW ENGL J MED, V339, P888, DOI 10.1056/NEJM199809243391306; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; JENNETTE JC, 1989, AM J PATHOL, V135, P921; KOSS MN, 1981, AM J SURG PATHOL, V5, P21, DOI 10.1097/00000478-198101000-00005; Niles JL, 1996, ARCH INTERN MED, V156, P440, DOI 10.1001/archinte.156.4.440; Niles JL, 1996, ANNU REV MED, V47, P303; Noth I, 2003, LANCET, V361, P587, DOI 10.1016/S0140-6736(03)12518-4; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Seo P, 2004, AM J MED, V117, P39, DOI 10.1016/j.amjmed.2004.02.030; Specks U, 2001, CURR OPIN RHEUMATOL, V13, P12, DOI 10.1097/00002281-200101000-00003; Stone JH, 2000, ARTHRIT CARE RES, V13, P424, DOI 10.1002/1529-0131(200012)13:6<424::AID-ART14>3.0.CO;2-Q; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Trojaborg W, 1998, ELECTROEN CLIN NEURO, V107, P303, DOI 10.1016/S0013-4694(98)00096-0; Wechsler ME, 1999, DRUG SAFETY, V21, P241, DOI 10.2165/00002018-199921040-00001; Wechsler ME, 2000, CHEST, V117, P708, DOI 10.1378/chest.117.3.708	21	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1148	1157		10.1056/NEJMcpc059022	http://dx.doi.org/10.1056/NEJMcpc059022			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963YG	16162886				2022-12-28	WOS:000231841900011
J	Reed, DA; Kern, DE; Levine, RB; Wright, SM				Reed, DA; Kern, DE; Levine, RB; Wright, SM			Costs and funding for published medical education research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCHOOL-OF-MEDICINE; OUTCOMES RESEARCH; OPPORTUNITIES; INNOVATIONS; PERSPECTIVE; PROMOTION; TRENDS; CALL	Context The Institute of Medicine has called for increased rigor of education research and funding to support educational innovation. However, funding for medical education research is scarce. The costs of conducting studies in medical education and how such research is currently funded have not been systematically evaluated. Objectives To determine how medical education research studies that were recently published were funded and to approximate the costs of conducting these studies. Design, Setting, and Participants We conducted a cross-sectional survey of first authors of medical education studies published from September 1, 2002, to December 31, 2003. Original medical education research studies conducted at US institutions and published in 13 prominent peer-reviewed journals were included. Main Outcome Measures For each study we measured duration, percentage of the authors' total work commitment ("percentage effort") devoted to the study, resources used and their costs, attainment of funding, and the first author's estimated cost of conducting the study. The cost of each study was calculated by multiplying the percentage effort of each author for the duration of the study by the national median salary for each author, according to specialty and academic rank, and then adding the costs of resources used. Results Responses were received from authors of 243 (84%) of 290 identified medical education studies. The median calculated cost of conducting the 243 studies was $24471 (interquartile range [IQR], $11531-$63 808). The median authors' estimate of study cost was $10 000 (IQR, $4000-$25 000). Some funding was obtained for 72 (29.6%) of the studies. Of studies that were funded, the median amount of funding was $15 000 (IQR, $5000-$66 500). The median calculated cost of funded studies was $37 315 (IQR, $18 731 - $82 393). Private foundation grants were the most common funding source (n =30 [41.7%]). Factors independently associated with attaining funding were training in grant writing (odds ratio, 2.05; 95% confidence interval, 1.11-3.79) and number of medical education studies published by the first author (odds ratio, 2.4; 95% confidence interval, 1.24-4.63). Conclusions The majority of published medical education research is not formally funded, and the studies that do receive support are substantially underfunded. To realize the Institute of Medicine's directive and to improve the quality of medical research, policy reform that increases funding for medical education scholarship will likely be required.	Mayo Clin Coll Med, Div Primary Care Internal Med, Rochester, MN 55905 USA; Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Div Gen Internal Med, Baltimore, MD USA	Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine	Reed, DA (corresponding author), Mayo Clin Coll Med, Div Primary Care Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	reed.darcy@mayo.edu		Levine, Rachel/0000-0002-1138-1289	PHS HHS [5 T32 HP10025] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Albanese M, 1998, ACAD MED, V73, P756, DOI 10.1097/00001888-199807000-00011; *ASS AM MED COLL, AAMC FAC SAL SURV RE; Beasley BW, 2003, J GEN INTERN MED, V18, P705, DOI 10.1046/j.1525-1497.2003.20639.x; Bligh J, 1999, MED EDUC, V33, P162, DOI 10.1046/j.1365-2923.1999.0389a.x; Branch MT, 2004, J GEN INTERN MED, V19, P606, DOI 10.1111/j.1525-1497.2004.45001.x; Carline JD, 2004, ACAD MED, V79, P918, DOI 10.1097/00001888-200410000-00004; Carney PA, 2004, JAMA-J AM MED ASSOC, V292, P1044, DOI 10.1001/jama.292.9.1044; Chen FM, 2004, ACAD MED, V79, P955, DOI 10.1097/00001888-200410000-00010; Dauphinee WD, 2004, ACAD MED, V79, P925, DOI 10.1097/00001888-200410000-00005; GOLDSTEIN BP, 1994, ACAD MED, V69, P625; Golub RM, 2005, JAMA-J AM MED ASSOC, V293, P742, DOI 10.1001/jama.293.6.742; Harden RM, 2000, ADV HEALTH SCI EDUC, V5, P71, DOI 10.1023/A:1009896431203; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; *I MED, 2003, AC HLTH CTR LEAD CHA; Irby DM, 2003, J GEN INTERN MED, V18, P370, DOI 10.1046/j.1525-1497.2003.21049.x; *MGMA, 2004, AC PRACT COMP PROD S; Prideaux D, 2002, MED EDUC, V36, P1114, DOI 10.1046/j.1365-2923.2002.01411.x; Prystowsky JB, 2001, MED EDUC, V35, P331, DOI 10.1046/j.1365-2923.2001.00910.x; Regehr G, 2004, ACAD MED, V79, P939, DOI 10.1097/00001888-200410000-00008; Retchin SM, 2005, J HEALTHC MANAG, V50, P121, DOI 10.1097/00115514-200503000-00010; Shea JA, 2004, ACAD MED, V79, P931, DOI 10.1097/00001888-200410000-00006; Sheffield JVL, 1998, J GEN INTERN MED, V13, P406, DOI 10.1046/j.1525-1497.1998.00120.x; *TASK FORC AC HLTH, 2004, ENV FUT AC HLTH CTR; Thomas PA, 2004, ACAD MED, V79, P975, DOI 10.1097/00001888-200410000-00017; Thomas PA, 2004, ACAD MED, V79, P258, DOI 10.1097/00001888-200403000-00013; Torgerson CJ, 2002, MED EDUC, V36, P1002, DOI 10.1046/j.1365-2923.2002.01335.x; Wartman SA, 2004, ACAD MED, V79, P910, DOI 10.1097/00001888-200410000-00003; WARTMAN SA, 1994, ACAD MED, V69, P608, DOI 10.1097/00001888-199408000-00003; Whitcomb ME, 2002, ACAD MED, V77, P1067, DOI 10.1097/00001888-200211000-00001; Whitcomb ME, 2005, ACAD MED, V80, P117, DOI 10.1097/00001888-200502000-00001; Wright SM, 1999, J GEN INTERN MED, V14, P775, DOI 10.1046/j.1525-1497.1999.14121.x	32	77	79	1	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2005	294	9					1052	1057		10.1001/jama.294.9.1052	http://dx.doi.org/10.1001/jama.294.9.1052			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XU	16145025	Bronze			2022-12-28	WOS:000231627300005
J	Salama, P; McFarland, J; Mulholland, K				Salama, P; McFarland, J; Mulholland, K			Reaching the unreached with measles vaccination	LANCET			English	Editorial Material							IMMUNIZATION; MORTALITY; CHILDREN		UNICEF, New York, NY 10017 USA; London Sch Hyg & Trop Med, London WC1, England	UNICEF; University of London; London School of Hygiene & Tropical Medicine	Salama, P (corresponding author), UNICEF, New York, NY 10017 USA.	psalama@unicef.org						Aaby P, 2005, B WORLD HEALTH ORGAN, V83, P238; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Dayan GH, 2004, VACCINE, V22, P475, DOI 10.1016/j.vaccine.2003.07.007; Jamison D.T., 1993, DIS CONTROL PRIORITI; Otten M, 2005, LANCET, V366, P832, DOI 10.1016/S0140-6736(05)67216-9; Uzicanin A, 2004, VACCINE, V22, P3419, DOI 10.1016/j.vaccine.2004.02.042; VIJAYARAGHAVIAN.M, 2002, IN PRESS DISASTERS; *WHO UNICEF, 2001, MEASL MORT RED REG E; *WHO UNICEF, 2005, GLOB IMM VIS STRAT	10	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 3	2005	366	9488					787	788		10.1016/S0140-6736(05)67191-7	http://dx.doi.org/10.1016/S0140-6736(05)67191-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139639				2022-12-28	WOS:000231627000006
J	Nielsen, H; Westhof, E; Johansen, S				Nielsen, H; Westhof, E; Johansen, S			An mRNA is capped by a 2 ',5 ' lariat catalyzed by a group I-like ribozyme	SCIENCE			English	Article							CORE ORGANIZATION; INTRON; ENDONUCLEASE; EXPRESSION	Twin-ribozyme introns are formed by two ribozymes belonging to the group I family and occur in some ribosomal RNA transcripts. The group l-like ribozyme, GIR1, liberates the S' end of a homing endonuclease messenger RNA in the slime mold Didymium iridis. We demonstrate that this cleavage occurs by a transesterification reaction with the joining of the first and the third nucleotide of the messenger by a 2',5'-phosphodiester linkage, Thus, a group l-like ribozyme catalyzes an RNA branching reaction similar to the first step of splicing in group II introns and spliceosomal introns. The resulting short lariat, by forming a protective 5' cap, might have been useful in a primitive RNA world.	Univ Copenhagen, Panum Inst, Dept Med Biochem & Genet, DK-2200 Copenhagen, Denmark; Univ Tromso, Inst Med Biol, Dept Mol Biotechnol, RNA Res Grp, N-9037 Tromso, Norway; Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France	University of Copenhagen; UiT The Arctic University of Tromso; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Nielsen, H (corresponding author), Univ Copenhagen, Panum Inst, Dept Med Biochem & Genet, DK-2200 Copenhagen, Denmark.	hamra@imbg.ku.dk						AGBACK P, 1993, J BIOCHEM BIOPH METH, V27, P229, DOI 10.1016/0165-022X(93)90006-A; Birgisdottir AB, 2005, NUCLEIC ACIDS RES, V33, P2042, DOI 10.1093/nar/gki341; Burge CB, 1999, RNA WORLD, P525; Cougot N, 2004, TRENDS BIOCHEM SCI, V29, P436, DOI 10.1016/j.tibs.2004.06.008; DECATUR WA, 1995, EMBO J, V14, P4558, DOI 10.1002/j.1460-2075.1995.tb00135.x; Decatur WA, 2000, RNA, V6, P616, DOI 10.1017/S1355838200992203; Einvik C, 1997, RNA, V3, P710; Einvik C, 1998, RNA, V4, P530, DOI 10.1017/S1355838298971758; GOLDEN BL, 1999, RNA WORLD, P321; Jabri E, 1997, BIOCHEMISTRY-US, V36, P16345, DOI 10.1021/bi9718595; JOHANSEN S, 1994, CELL, V76, P725, DOI 10.1016/0092-8674(94)90511-8; Johansen S, 2002, BIOCHIMIE, V84, P905, DOI 10.1016/S0300-9084(02)01443-8; REILLY JD, 1989, METHOD ENZYMOL, V180, P177; Trotta CR, 1999, RNA WORLD, P561; Vader A, 1999, EMBO J, V18, P1003, DOI 10.1093/emboj/18.4.1003	15	53	64	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1584	1587		10.1126/science.1113645	http://dx.doi.org/10.1126/science.1113645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141078				2022-12-28	WOS:000231715000056
J	Brody, LC				Brody, LC			Treating cancer by targeting a weakness	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Brody, LC (corresponding author), NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000120, Z01HG000120] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445	3	34	39	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					949	950		10.1056/NEJMcibr052331	http://dx.doi.org/10.1056/NEJMcibr052331			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135843				2022-12-28	WOS:000231551100017
J	Gagneux, P; Moore, JJ; Varki, A				Gagneux, P; Moore, JJ; Varki, A			The ethics of research on great apes	NATURE			English	Editorial Material									Zool Soc San Diego, Conservat & Res Endangered Species, San Diego, CA 92112 USA; Univ Calif San Diego, Dept Med & Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA	Zoological Society of San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Gagneux, P (corresponding author), Zool Soc San Diego, Conservat & Res Endangered Species, San Diego, CA 92112 USA.							Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981	1	34	34	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					27	29		10.1038/437027a	http://dx.doi.org/10.1038/437027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	960AC	16136111				2022-12-28	WOS:000231560400023
J	Pinto, DS; Blair, BM; Schwartzstein, RM; Smith, CC				Pinto, DS; Blair, BM; Schwartzstein, RM; Smith, CC			Clinical problem-solving: A sailor's heartbreak	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC ANGIOSARCOMA; TUMORS; ECHOCARDIOGRAPHY; TRANSESOPHAGEAL		Beth Israel Deaconess Med Ctr, Intervent Cardiol Sect, Div Cardiol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Pulm & Crit Care Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Pinto, DS (corresponding author), Beth Israel Deaconess Med Ctr, Intervent Cardiol Sect, Div Cardiol, 185 Pilgrim Rd, Boston, MA 02215 USA.	dpinto@bidmc.harvard.edu	Schwartzstein, Richard/AGO-8549-2022; Schwartzstein, Richard/L-4420-2019	Pinto, Duane/0000-0002-2309-8480	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007061] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAAY P, 1994, J HEART LUNG TRANSPL, V13, P923; BURKE AP, 1992, CANCER, V69, P387, DOI 10.1002/1097-0142(19920115)69:2<387::AID-CNCR2820690219>3.0.CO;2-N; Corso Ricardo Barros, 2003, Arq. Bras. Cardiol., V81, P611, DOI 10.1590/S0066-782X2003001400008; Geibel A, 1996, ACTA CARDIOL, V51, P395; LAM KY, 1993, ARCH PATHOL LAB MED, V117, P1027; LEIBOWITZ G, 1995, AM HEART J, V130, P1224, DOI 10.1016/0002-8703(95)90146-9; Oshima K, 1999, JPN CIRC J, V63, P822, DOI 10.1253/jcj.63.822; Rodriguez-Vera F J, 2000, Rev Port Cardiol, V19, P361; Serra Viviana, 2004, Rev Port Cardiol, V23, P731	9	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					934	939		10.1056/NEJMcps044239	http://dx.doi.org/10.1056/NEJMcps044239			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135839				2022-12-28	WOS:000231551100013
J	Willimsky, G; Blankenstein, T				Willimsky, G; Blankenstein, T			Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance	NATURE			English	Article							IMMUNE SURVEILLANCE; INTERFERON-GAMMA; CANCER; ANTIGEN; BETA; MICE; IMMUNOSURVEILLANCE; CARCINOGENESIS; ACTIVATION; EXPRESSION	The recognition and elimination of tumours by T cells, a process termed cancer immunosurveillance(1), is effective against certain virus-associated cancers(2). Spontaneous tumours often induce a specific immune response and are therefore also immunogenic. However, it is not clear whether they can be controlled by T cells(3-10). The immunosurveillance hypothesis postulates that tumours, if they eventually grow, escaped T-cell recognition by losing immunogenicity(6-8). Here we show, by generating a mouse model of sporadic cancer based on rare spontaneous activation of a dormant oncogene, that immunogenic tumours do not escape their recognition but induce tolerance. In this model, tumours derive from single cells and express a tumour-specific transplantation rejection antigen. Whereas vaccinated mice remain tumour-free throughout their lifetime, naive mice always develop a progressively growing tumour. We also show that despite specific recognition by T cells, the tumours do not lose their intrinsic immunogenicity and are rejected after transplantation in T-cell-competent recipients. Furthermore, in the primary host tumour-induced tolerance is associated with the expansion of non-functional T cells. Together, our data argue against immunosurveillance of spontaneous cancer.	Inst Immunol, D-12200 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Blankenstein, T (corresponding author), Inst Immunol, Charite Campus Benjamin Franklin,Hindenburgdamm 3, D-12200 Berlin, Germany.	tblanke@mdc-berlin.de	Willimsky, Gerald/AAA-2445-2021	Willimsky, Gerald/0000-0002-9693-948X				ADAMS TE, 1987, NATURE, V325, P223, DOI 10.1038/325223a0; Beck C, 2001, MICROSC RES TECHNIQ, V52, P387, DOI 10.1002/1097-0029(20010215)52:4<387::AID-JEMT1023>3.0.CO;2-W; Blankenstein T, 2005, CURR OPIN IMMUNOL, V17, P180, DOI 10.1016/j.coi.2005.01.008; Blankenstein T, 2003, ADV CANCER RES, V90, P179, DOI 10.1016/S0065-230X(03)90006-6; BURNET M, 1964, BRIT MED BULL, V20, P154, DOI 10.1093/oxfordjournals.bmb.a070310; Cayeux S, 1997, J IMMUNOL, V158, P2834; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; KLEIN G, 1960, CANCER RES, V20, P1561; KLEIN G, 1977, P NATL ACAD SCI USA, V74, P2121, DOI 10.1073/pnas.74.5.2121; KRIPKE ML, 1976, J NATL CANCER I, V57, P211, DOI 10.1093/jnci/57.1.211; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Li LP, 1997, HUM GENE THER, V8, P1695, DOI 10.1089/hum.1997.8.14-1695; Meuwissen R, 2001, EXP CELL RES, V264, P100, DOI 10.1006/excr.2000.5146; MULLEN CA, 1985, J EXP MED, V162, P1665, DOI 10.1084/jem.162.5.1665; OLD LJ, 1962, ANN NY ACAD SCI, V101, P80, DOI 10.1111/j.1749-6632.1962.tb26446.x; PREHN RT, 1994, CANCER RES, V54, P908; Qin ZH, 2004, NAT IMMUNOL, V5, P3, DOI 10.1038/ni0104-3; Sakai K, 1995, BIOCHEM BIOPH RES CO, V217, P393, DOI 10.1006/bbrc.1995.2789; Schell TD, 2000, CANCER RES, V60, P3002; Schreiber H., 2003, FUNDAMENTAL IMMUNOLO, P1557; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; STUTMAN O, 1974, SCIENCE, V183, P534, DOI 10.1126/science.183.4124.534; van Mierlo GJD, 2004, J IMMUNOL, V173, P6753, DOI 10.4049/jimmunol.173.11.6753	29	320	341	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					141	146		10.1038/nature03954	http://dx.doi.org/10.1038/nature03954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136144				2022-12-28	WOS:000231560400058
J	Petta, JR; Johnson, AC; Taylor, JM; Laird, EA; Yacoby, A; Lukin, MD; Marcus, CM; Hanson, MP; Gossard, AC				Petta, JR; Johnson, AC; Taylor, JM; Laird, EA; Yacoby, A; Lukin, MD; Marcus, CM; Hanson, MP; Gossard, AC			Coherent manipulation of coupled electron spins in semiconductor quantum dots	SCIENCE			English	Article							BLOCKADE; COULOMB	We demonstrated coherent control of a quantum two-level system based on two-electron spin states in a double quantum dot, allowing state preparation, coherent manipulation, and projective readout. These techniques are based on rapid electrical control of the exchange interaction. Separating and later recombining a singlet spin state provided a measurement of the spin dephasing time, T-2*, of similar to 10 nanoseconds, limited by hyperfine interactions with the gallium arsenide host nuclei. Rabi oscillations of two-electron spin states were demonstrated, and spin-echo pulse sequences were used to suppress hyperfine-induced dephasing. Using these quantum control techniques, a coherence time for two-electron spin states exceeding 1 microsecond was observed.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel; Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	Harvard University; Weizmann Institute of Science; University of California System; University of California Santa Barbara	Petta, JR (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.		Marcus, Charles M./M-4526-2014; Laird, Edward/N-6411-2016; Taylor, Jacob/O-1670-2019; Petta, Jason R/J-6663-2013; Taylor, Jacob M/B-7826-2011	Marcus, Charles M./0000-0003-2420-4692; Laird, Edward/0000-0001-9589-127X; Taylor, Jacob/0000-0003-0493-5594; Petta, Jason R/0000-0002-6416-0789; Taylor, Jacob M/0000-0003-0493-5594; Johnson, Alex/0000-0003-4623-4147				Bracker AS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047402; Burkard G, 1999, PHYS REV B, V59, P2070, DOI 10.1103/PhysRevB.59.2070; CALDEIRA AO, 1981, PHYS REV LETT, V46, P211, DOI 10.1103/PhysRevLett.46.211; Chiaverini J, 2005, SCIENCE, V308, P997, DOI 10.1126/science.1110335; Ciorga M, 2000, PHYS REV B, V61, P16315, DOI 10.1103/PhysRevB.61.R16315; Coish WA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195340; COISH WA, 2005, CONDMAT0506090; de Sousa R, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.115322; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Elzerman JM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.161308; Engel HA, 2005, SCIENCE, V309, P586, DOI 10.1126/science.1113203; FIELD M, 1993, PHYS REV LETT, V70, P1311, DOI 10.1103/PhysRevLett.70.1311; Fujisawa T, 2002, NATURE, V419, P278, DOI 10.1038/nature00976; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Johnson AC, 2005, NATURE, V435, P925, DOI 10.1038/nature03815; JOHNSON AC, 2004, CONDMAT0410679; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; KOPPENS FHL, 2005, SCIENCE         0727, DOI DOI 10.1126/SCIENCE.1113719; Levy J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.147902; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Ono K, 2002, SCIENCE, V297, P1313, DOI 10.1126/science.1070958; PAGET D, 1977, PHYS REV B, V15, P5780, DOI 10.1103/PhysRevB.15.5780; Petta JR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.186802; PETTA JR, 2004, CONDMAT0412048; SCHULTEN K, 1978, J CHEM PHYS, V68, P3292, DOI 10.1063/1.436135; Shor P. W., 1994, P 35 ANN S FDN COMP; Slichter C. P., 1996, PRINCIPLES MAGNETIC; Taylor JM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.236803; Vandersypen LMK, 2004, REV MOD PHYS, V76, P1037, DOI 10.1103/RevModPhys.76.1037; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wu LA, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207902	32	2491	2522	13	519	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2180	2184		10.1126/science.1116955	http://dx.doi.org/10.1126/science.1116955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16141370	Green Submitted			2022-12-28	WOS:000232318000033
J	Colman-Lerner, A; Gordon, A; Serra, E; Chin, T; Resnekov, O; Endy, D; Pesce, CG; Brent, R				Colman-Lerner, A; Gordon, A; Serra, E; Chin, T; Resnekov, O; Endy, D; Pesce, CG; Brent, R			Regulated cell-to-cell variation in a cell-fate decision system	NATURE			English	Article							KINASE SIGNALING SPECIFICITY; EUKARYOTIC GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; C-ELEGANS; CAENORHABDITIS-ELEGANS; PHEROMONE RESPONSE; PROTEIN-KINASE; SINGLE-CELL; YEAST; NOISE	Here we studied the quantitative behaviour and cell-to-cell variability of a prototypical eukaryotic cell-fate decision system, the mating pheromone response pathway in yeast. We dissected and measured sources of variation in system output, analysing thousands of individual, genetically identical cells. Only a small proportion of total cell-to-cell variation is caused by random fluctuations in gene transcription and translation during the response ('expression noise'). Instead, variation is dominated by differences in the capacity of individual cells to transmit signals through the pathway ('pathway capacity') and to express proteins from genes ('expression capacity'). Cells with high expression capacity express proteins at a higher rate and increase in volume more rapidly. Our results identify two mechanisms that regulate cell-to-cell variation in pathway capacity. First, the MAP kinase Fus3 suppresses variation at high pheromone levels, while the MAP kinase Kss1 enhances variation at low pheromone levels. Second, pathway capacity and expression capacity are negatively correlated, suggesting a compensatory mechanism that allows cells to respond more precisely to pheromone in the presence of a large variation in expression capacity.	Inst Mol Sci, Berkeley, CA 94704 USA; MIT, Div Biol Engn, Cambridge, MA 02139 USA	The Molecular Sciences Institute; Massachusetts Institute of Technology (MIT)	Gordon, A (corresponding author), Inst Mol Sci, 2168 Shattuck Ave, Berkeley, CA 94704 USA.	gordon@molsci.org; brent@molsci.org	Colman-Lerner, Alejandro/ABC-3808-2020; Serra, Eduard/K-1332-2013	Colman-Lerner, Alejandro/0000-0002-2557-8883; Serra, Eduard/0000-0003-2895-9857; Endy, Drew/0000-0001-6952-8098				Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; [Anonymous], 2004, CURRENT PROTOCOLS MO; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; DELBRUCK M, 1945, J BACTERIOL, V50, P131; DOE CQ, 1985, DEV BIOL, V111, P206, DOI 10.1016/0012-1606(85)90446-4; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Guthrie C., 1991, METHODS ENZYMOLOGY G; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Hoang T, 2004, ONCOGENE, V23, P7188, DOI 10.1038/sj.onc.1207937; JAN YN, 1995, NEURON, V14, P1; JENNESS DD, 1986, MOL CELL BIOL, V6, P318, DOI 10.1128/MCB.6.1.318; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Karp X, 2003, GENE DEV, V17, P3100, DOI 10.1101/gad.1160803; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Lee BN, 1999, P NATL ACAD SCI USA, V96, P12679, DOI 10.1073/pnas.96.22.12679; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; OEHLEN LJWM, 1994, GENE DEV, V8, P1058, DOI 10.1101/gad.8.9.1058; Oehlen LJWM, 1998, J BIOL CHEM, V273, P25089, DOI 10.1074/jbc.273.39.25089; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; PRIESS JR, 1987, CELL, V48, P241, DOI 10.1016/0092-8674(87)90427-2; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; Wassmann K, 1997, J BIOL CHEM, V272, P13180, DOI 10.1074/jbc.272.20.13180	38	321	327	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					699	706		10.1038/nature03998	http://dx.doi.org/10.1038/nature03998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16170311				2022-12-28	WOS:000232157900045
J	Kassai, Y; Munne, P; Hotta, YH; Penttila, E; Kavanagh, K; Ohbayashi, N; Takada, S; Thesleff, I; Jernvall, J; Itoh, N				Kassai, Y; Munne, P; Hotta, YH; Penttila, E; Kavanagh, K; Ohbayashi, N; Takada, S; Thesleff, I; Jernvall, J; Itoh, N			Regulation of mammalian tooth cusp patterning by ectodin	SCIENCE			English	Article							ENAMEL KNOT; EXPRESSION PATTERNS; BMP ANTAGONIST; MORPHOGENESIS; MOUSE; GENE; DIFFERENTIATION; CHARACTERS; EVOLUTION; TEETH	Mammalian tooth crowns have precise functional requirements but cannot be substantially remodeled after eruption. In developing teeth, epithelial, signaling centers, the enamel knots, form at future cusp positions and are the first signs of cusp patterns that distinguish species. We report that ectodin, a secreted bone morphogenetic protein (BMP) inhibitor, is expressed as a "negative'! image of mouse enamel knots. Furthermore, we show that ectodin-deficient mice have enlarged enamel knots, highly altered cusp patterns, and extra teeth. Unlike in normal teeth, excess BMP accelerates patterning in ectodin-deficient teeth. We propose that ectodin is critical for robust spatial delineation of enamel knots and cusps.	Univ Helsinki, Viikki Bioctr, Inst Biotechnol, Dev Biol Program, FIN-00014 Helsinki, Finland; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Kyoto 6068501, Japan; Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	University of Helsinki; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Jernvall, J (corresponding author), Univ Helsinki, Viikki Bioctr, Inst Biotechnol, Dev Biol Program, POB 56, FIN-00014 Helsinki, Finland.	jernvall@fastmail.fm; itohnobu@pharm.kyoto-u.ac.jp	Munne, Pauliina/M-8629-2015	Munne, Pauliina/0000-0002-9720-9964; Takada, Shinji/0000-0003-4125-6056				Aberg T, 1997, DEV DYNAM, V210, P383, DOI 10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO;2-C; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; BUTLER PM, 1956, BIOL REV, V31, P30, DOI 10.1111/j.1469-185X.1956.tb01551.x; Chen YP, 1996, DEVELOPMENT, V122, P3035; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; FISHER AR, 1971, ARCH ORAL BIOL, V16, P1481, DOI 10.1016/0003-9969(71)90084-7; GLASSTONE S, 1963, J DENT RES, V42, P1364, DOI 10.1177/00220345630420061101; GLASSTONE S, 1939, P ROY SOC LOND B BIO, V126, P315; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; JERNVALL J, 1994, INT J DEV BIOL, V38, P463; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Jernvall J, 2000, YEARB PHYS ANTHROPOL, V43, P171; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; MARSHALL PM, 1966, ARCH ORAL BIOL, V11, P949, DOI 10.1016/0003-9969(66)90197-X; Merino R, 1999, DEVELOPMENT, V126, P5515; Noramly S, 1998, DEVELOPMENT, V125, P3775; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024	26	224	232	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2067	2070		10.1126/science.1116848	http://dx.doi.org/10.1126/science.1116848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179481				2022-12-28	WOS:000232181900054
J	Mark, DF; Parnell, J; Kelly, SP; Lee, M; Sherlock, SC; Carr, A				Mark, DF; Parnell, J; Kelly, SP; Lee, M; Sherlock, SC; Carr, A			Dating of multistage fluid flow in sandstones	SCIENCE			English	Article							K-AR; INCLUSIONS; RESERVOIR	Through ultraviolet laser argon-argon dating of potassium feldspar cements containing fluid inclusions, we determined temperature-composition-time data for paleofluids in a sedimentary basin, including data for an evolving episode of fluid flow recorded in distinct phases of cement. The fluid evolved from mixed aqueous oil 83 million years ago to purely aqueous by 76 million years ago, thus dating the time of oil charge in this reservoir.	Univ Aberdeen, Dept Geol & Petr Geol, Aberdeen AB24 3UE, Scotland; Open Univ, Dept Earth Sci, CEPSAR, Milton Keynes MK7 6AA, Bucks, England; Univ Glasgow, Ctr GEosci, Div Earth Sci, Glasgow G12 8QQ, Lanark, Scotland; Adv Geochem Syst Ltd, Loughborough LE12 5TD, Leics, England	University of Aberdeen; Open University - UK; University of Glasgow	Mark, DF (corresponding author), Univ Aberdeen, Dept Geol & Petr Geol, Meston Bldg,Meston Walk, Aberdeen AB24 3UE, Scotland.	d.mark@abdn.ac.uk	Lee, Martin R/D-9169-2011; Kelley, Simon/AAR-7075-2020; Mark, Darren/A-5121-2009; Lee, Martin/Q-1040-2019	Lee, Martin R/0000-0002-6004-3622; Kelley, Simon/0000-0002-1756-0480; Lee, Martin/0000-0002-6004-3622; Sherlock, Sarah/0000-0003-0494-6760	Natural Environment Research Council [NER/T/S/2003/00113, NER/A/S/2003/00346, NER/I/S/2002/00692] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		BAILEY NJL, 1987, PETROLEUM GEOLOGY N, P711; Carr AD, 2003, PETROL GEOSCI, V9, P333, DOI 10.1144/1354-079302-494; Goldstein RH, 2001, LITHOS, V55, P159, DOI 10.1016/S0024-4937(00)00044-X; Goodchild M.W., 1999, PETROLEUM GEOLOGY NW, P713, DOI [10.1144/0050713, DOI 10.1144/0050713]; Hagen E, 2001, J GEOL SOC LONDON, V158, P801, DOI 10.1144/jgs.158.5.801; HAMILTON PJ, 1989, CLAY MINER, V24, P215, DOI 10.1180/claymin.1989.024.2.08; HEARN PP, 1987, GEOCHIM COSMOCHIM AC, V51, P1323, DOI 10.1016/0016-7037(87)90222-5; KARLSEN DA, 1993, GEOCHIM COSMOCHIM AC, V57, P3641, DOI 10.1016/0016-7037(93)90146-N; Kelley S, 2002, CHEM GEOL, V188, P1, DOI 10.1016/S0009-2541(02)00064-5; Kendrick MA, 2002, ECON GEOL BULL SOC, V97, P435, DOI 10.2113/97.3.435; LEE MC, 1985, AAPG BULL, V69, P1381; Lee MR, 2003, SEDIMENTOLOGY, V50, P597, DOI 10.1046/j.1365-3091.2003.00567.x; LIEWIG N, 1987, AAPG BULL, V71, P1467; ONSTOTT TC, 1995, GEOCHIM COSMOCHIM AC, V59, P1821, DOI 10.1016/0016-7037(95)00085-E; Parnell J, 1999, PETROLEUM GEOLOGY NW, P613, DOI [10.1144/0050613, DOI 10.1144/0050613]; SHERLOCK SC, IN PRESS EARTH PLANE; Villa IM, 1997, GEOCHIM COSMOCHIM AC, V61, P689, DOI 10.1016/S0016-7037(97)00002-1; WORDEN RH, 1992, J SEDIMENT PETROL, V62, P779	18	45	67	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2048	2051		10.1126/science.1116034	http://dx.doi.org/10.1126/science.1116034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179477				2022-12-28	WOS:000232181900048
J	Nusbaum, C; Zody, MC; Borowsky, ML; Kamal, M; Kodira, CD; Taylor, TD; Whittaker, CA; Chang, JL; Cuomo, CA; Dewar, K; FitzGerald, MG; Yang, XP; Abouelleil, A; Allen, NR; Anderson, S; Bloom, T; Bugalter, B; Butler, J; Cook, A; DeCaprio, D; Engels, R; Garber, M; Gnirke, A; Hafez, N; Hall, JL; Norman, CH; Itoh, T; Jaffe, DB; Kuroki, Y; Lehoczky, J; Lui, A; Macdonald, P; Mauceli, E; Mikkelsen, TS; Naylor, JW; Nicol, R; Nguyen, C; Noguchi, H; O'Leary, SB; Piqani, B; Smith, CL; Talamas, JA; Topham, K; Totoki, Y; Toyoda, A; Wain, HM; Young, SK; Zeng, QD; Zimmer, AR; Fujiyama, A; Hattori, M; Birren, BW; Sakaki, Y; Lander, ES				Nusbaum, C; Zody, MC; Borowsky, ML; Kamal, M; Kodira, CD; Taylor, TD; Whittaker, CA; Chang, JL; Cuomo, CA; Dewar, K; FitzGerald, MG; Yang, XP; Abouelleil, A; Allen, NR; Anderson, S; Bloom, T; Bugalter, B; Butler, J; Cook, A; DeCaprio, D; Engels, R; Garber, M; Gnirke, A; Hafez, N; Hall, JL; Norman, CH; Itoh, T; Jaffe, DB; Kuroki, Y; Lehoczky, J; Lui, A; Macdonald, P; Mauceli, E; Mikkelsen, TS; Naylor, JW; Nicol, R; Nguyen, C; Noguchi, H; O'Leary, SB; Piqani, B; Smith, CL; Talamas, JA; Topham, K; Totoki, Y; Toyoda, A; Wain, HM; Young, SK; Zeng, QD; Zimmer, AR; Fujiyama, A; Hattori, M; Birren, BW; Sakaki, Y; Lander, ES			DNA sequence and analysis of human chromosome 18	NATURE			English	Article							HUMAN GENOME; GENE DESERTS; EVOLUTION; MOUSE; DUPLICATION; DATABASE; INVERSION; SEARCH; BLAST; MAP	Chromosome 18 appears to have the lowest gene density of any human chromosome and is one of only three chromosomes for which trisomic individuals survive to term(1). There are also a number of genetic disorders stemming from chromosome 18 trisomy and aneuploidy. Here we report the finished sequence and gene annotation of human chromosome 18, which will allow a better understanding of the normal and disease biology of this chromosome. Despite the low density of protein- coding genes on chromosome 18, we find that the proportion of non- protein-coding sequences evolutionarily conserved among mammals is close to the genome- wide average. Extending this analysis to the entire human genome, we find that the density of conserved non- protein- coding sequences is largely uncorrelated with gene density. This has important implications for the nature and roles of non- protein- coding sequence elements.	MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Cambridge, MA 02141 USA; RIKEN, Genom Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; Mitsubishi Res Inst Inc, Chiyoda Ku, Tokyo 1008141, Japan; Univ Tokyo, Kashiwa, Chiba 2770882, Japan; UCL, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England; Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; Kitasato Univ, Kitsato Inst Life Sci, Kanagawa 2288555, Japan	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; RIKEN; Mitsubishi Research Institute; University of Tokyo; University of London; University College London; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Kitasato University	Nusbaum, C (corresponding author), MIT, Broad Inst, 320 Charles St, Cambridge, MA 02141 USA.	chad@broad.mit.edu	Taylor, Todd/A-7121-2009; Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019; Mikkelsen, Tarjei S/A-1306-2007; Itoh, Takehiko/E-8873-2014; Zeng, Qiandong/AAF-3305-2019; Cuomo, Christina/L-2222-2019	Taylor, Todd/0000-0003-4247-6253; Hattori, Masahira/0000-0001-9467-0344; Mikkelsen, Tarjei S/0000-0002-8133-3135; Itoh, Takehiko/0000-0002-6113-557X; Cuomo, Christina/0000-0002-5778-960X; Whittaker, Charles/0000-0002-2400-0094; Engels, Reinhard/0000-0003-0921-0736; Nicol, Robert/0000-0003-1932-1392; DeCaprio, Dave/0000-0001-8931-9461				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Chiaromonte F, 2003, COLD SPRING HARB SYM, V68, P245, DOI 10.1101/sqb.2003.68.245; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Dennehey BK, 2004, GENOMICS, V83, P493, DOI 10.1016/j.ygeno.2003.08.017; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goidts V, 2004, HUM GENET, V115, P116, DOI 10.1007/s00439-004-1120-z; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hernandez D, 1999, TRENDS GENET, V15, P241, DOI 10.1016/S0168-9525(99)01743-6; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; King M., 1993, SPECIES EVOLUTION RO, P72; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MOUCHIROUD D, 1991, GENE, V100, P181, DOI 10.1016/0378-1119(91)90364-H; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Rebhan M., 1997, GENECARDS ENCY GENES; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Veeramachaneni V, 2004, GENOME RES, V14, P280, DOI 10.1101/gr.1590904; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	34	39	219	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					551	555		10.1038/nature03983	http://dx.doi.org/10.1038/nature03983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177791	Bronze			2022-12-28	WOS:000232004800050
J	Polaszek, A				Polaszek, A			A universal register for animal names	NATURE			English	Editorial Material									Nat Hist Museum, Int Commiss Zool Nomenclature, London SW7 5BD, England	Natural History Museum London	Polaszek, A (corresponding author), Nat Hist Museum, Int Commiss Zool Nomenclature, Cromwell Rd, London SW7 5BD, England.		Brothers, Denis J/A-8692-2010; Beccaloni, George/AAL-1655-2021; Mace, Georgina M/I-3072-2016	Brothers, Denis J/0000-0001-8850-514X; Beccaloni, George/0000-0003-0323-8535; Mace, Georgina M/0000-0001-8965-5211; Miller, Scott/0000-0002-4138-1378					0	92	102	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2005	437	7058					477	477		10.1038/437477a	http://dx.doi.org/10.1038/437477a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966FF	16177765	Bronze, Green Submitted			2022-12-28	WOS:000232004800024
J	Marshall, BJ				Marshall, BJ			The Lasker Awards: Celebrating scientific discovery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HELICOBACTER-PYLORI INFECTION; CAGA; RISK		Univ Western Australia, Dept Med, Crawley, WA 6009, Australia; Univ Western Australia, Dept Pharmacol, Crawley, WA 6009, Australia	University of Western Australia; University of Western Australia	Marshall, BJ (corresponding author), Univ Western Australia, Dept Med, 35 Stirling Hwy,M502, Crawley, WA 6009, Australia.	bmarshall@hpylori.com.au		Marshall, Barry/0000-0003-4853-5015				BLASER MJ, 1995, CANCER RES, V55, P2111; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Kirk R L, 1982, Prog Clin Biol Res, V103 Pt A, P215; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Suerbaum S, 2004, INT J MED MICROBIOL, V294, P133, DOI 10.1016/j.ijmm.2004.06.014; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999	8	4	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1420	1421		10.1001/jama.294.11.1420	http://dx.doi.org/10.1001/jama.294.11.1420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174708				2022-12-28	WOS:000231987800023
J	Clifford, GM; Gallus, S; Herrero, R; Munoz, N; Snijders, PJF; Vaccarella, S; Anh, PTH; Ferreccio, C; Hieu, NT; Matos, E; Molano, M; Rajkumar, R; Ronco, G; de Sanjose, S; Shin, HR; Sukvirach, S; Thomas, JO; Tunsakul, S; Meijer, CJLM; Franceschi, S				Clifford, GM; Gallus, S; Herrero, R; Munoz, N; Snijders, PJF; Vaccarella, S; Anh, PTH; Ferreccio, C; Hieu, NT; Matos, E; Molano, M; Rajkumar, R; Ronco, G; de Sanjose, S; Shin, HR; Sukvirach, S; Thomas, JO; Tunsakul, S; Meijer, CJLM; Franceschi, S		IARC HPV Prevalence Surveys Study	Worldwide distribution of human papillomavirus types in cytologically normal women in the international Agency for Research on Cancer HPV prevalence surveys: a pooled analysis	LANCET			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; GRADE CERVICAL LESIONS; FLOATING ABSOLUTE RISK; UNIVERSITY-STUDENTS; SOUTH-KOREA; YOUNG-WOMEN; INFECTION; POPULATION; NEOPLASIA; FEMALE	Background The proportion of women infected with human papillomavirus (HPV) varies greatly across populations, as might the distribution of HPV types. We aimed to compare HPV-type distribution in representative samples of women from different world regions. Methods Women were randomly selected from the general population of 13 areas from 11 countries (Nigeria, India, Vietnam, Thailand, Korea, Colombia, Argentina, Chile, the Netherlands, Italy, and Spain). A standardised protocol was used for cervical specimen collection. All HPV testing was by GP5+/6+ PCR-based EIA. The proportion of HPV-positive women infected with different HPV types was compared by study area and between pooled regions with age-adjusted odds ratios (ORs) with corresponding 95% floating CIS. Findings 15 613 women aged 15-74 years without cytological abnormalities were included in a pooled analysis. Age-standardised HPV prevalence varied nearly 20 times between populations, from 1.4% (95% CI 0.5-2.2) in Spain to 25.6% (22.4-28.8) in Nigeria. Although both overall HPV prevalence and HPV16 prevalence were highest in sub-Saharan Africa, HPV-positive women in Europe were significantly more likely to be infected with HPV16 than were those in sub-Saharan Africa (OR 2.64, p=0.0002), and were significantly less likely to be infected with high-risk HPV types other than HPV16 (OR 0.57, p=0.004) and/or low-risk HPV types (OR 0.44. p=0.0002). Women from South America had HPV-type distribution in between those from sub-Saharan Africa and Europe. Heterogeneity between areas of Asia was significant. Interpretation Heterogeneity in HPV type distribution among women from different populations should be taken into account when developing screening tests for the virus and predicting the effect of vaccines on the incidence of infection.	Int Agcy Res Canc, F-69372 Lyon, France; Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; Fdn Inst Costarricense Invest & Ensenanza Nutr &, Proyecto Epidemiol Guanacaste, San Jose, Costa Rica; Inst Nacl Cancerol, Bogota, Colombia; Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; Natl Canc Inst, Hanoi, Vietnam; Pontificia Univ Catolica Chile, Escuela Med, Santiago, Chile; Hung Vuong Hosp, Dept Neonatol, Ho Chi Minh City, Vietnam; Univ Buenos Aires, Inst Oncol, Buenos Aires, DF, Argentina; Christian Fellowship Community Hlth Area, Ambilikai, Tamil Nadu, India; Ctr Epidemiol & Prevenz Oncol, Turin, Italy; Inst Catala Oncol, Barcelona, Spain; Natl Canc Ctr, Res Inst, Goyang, South Korea; Natl Canc Inst, Div Res, Bangkok, Thailand; Univ Ibadan, Coll Med, Ibadan, Nigeria	World Health Organization; International Agency for Research on Cancer (IARC); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Vrije Universiteit Amsterdam; Pontificia Universidad Catolica de Chile; University of Buenos Aires; Catalan Institute of Oncology; National Cancer Center - Korea (NCC); National Cancer Institute - Thailand; University of Ibadan	Clifford, GM (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	clifford@iarc.fr	Gallus, Silvano/AAB-4127-2019; franceschi, silvia/M-2452-2014; de Sanjosé Llongueras, Silvia/H-6339-2014; Rajkumar, Rajamanickam/D-7350-2016; JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012	Gallus, Silvano/0000-0002-8967-0400; franceschi, silvia/0000-0003-4181-8071; Rajkumar, Rajamanickam/0000-0003-4904-8884; JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; ferreccio, catterina/0000-0001-6331-5534; Vaccarella, Salvatore/0000-0002-2516-2167				Anh PTH, 2003, INT J CANCER, V104, P213, DOI 10.1002/ijc.10936; [Anonymous], 1966, CANC INCIDENCE 5 CON, DOI DOI 10.1001/jamaoncol.2019.2996; Brown DR, 2002, SEX TRANSM DIS, V29, P763, DOI 10.1097/00007435-200212000-00005; Castellsague X, 2001, LANCET, V358, P1429, DOI 10.1016/S0140-6736(01)06523-0; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; De Sanjose S, 2003, SEX TRANSM DIS, V30, P788, DOI 10.1097/01.OLQ.0000080177.82204.E0; De Vuyst H, 2003, SEX TRANSM DIS, V30, P137, DOI 10.1097/00007435-200302000-00009; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Ferreccio C, 2004, CANCER EPIDEM BIOMAR, V13, P2271; Franceschi S, 2005, J NATL CANCER I, V97, P938, DOI 10.1093/jnci/dji159; Franceschi S, 2005, BRIT J CANCER, V92, P601, DOI 10.1038/sj.bjc.6602348; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]; Lazcano-Ponce E, 2001, INT J CANCER, V91, P412, DOI 10.1002/1097-0215(20010201)91:3&lt;412::AID-IJC1071&gt;3.0.CO;2-M; Liaw KL, 1997, INT J CANCER, V73, P775, DOI 10.1002/(SICI)1097-0215(19971127)73:5<775::AID-IJC27>3.0.CO;2-3; Matos E, 2003, SEX TRANSM DIS, V30, P593, DOI 10.1097/01.OLQ.0000085181.25063.6C; Molano M, 2002, BRIT J CANCER, V87, P324, DOI 10.1038/sj.bjc.6600442; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Peto J, 2004, BRIT J CANCER, V91, P942, DOI 10.1038/sj.bjc.6602049; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Ronco G, 2005, EUR J CANCER, V41, P297, DOI 10.1016/j.ejca.2004.07.005; Shin HR, 2004, J INFECT DIS, V190, P468, DOI 10.1086/421279; Shin HR, 2003, INT J CANCER, V103, P413, DOI 10.1002/ijc.10825; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Sukvirach S, 2003, J INFECT DIS, V187, P1246, DOI 10.1086/373901; Thomas JO, 2004, BRIT J CANCER, V90, P638, DOI 10.1038/sj.bjc.6601515; Xi LF, 2003, INT J CANCER, V103, P803, DOI 10.1002/ijc.10876	36	772	832	1	63	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					991	998		10.1016/S0140-6736(05)67069-9	http://dx.doi.org/10.1016/S0140-6736(05)67069-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168781				2022-12-28	WOS:000231955900034
J	Gray, N				Gray, N			Mixed feelings on snus	LANCET			English	Editorial Material							SMOKELESS TOBACCO; PUBLIC-HEALTH		Int Agcy Res Canc, Tobacco Unit, F-69008 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Gray, N (corresponding author), Int Agcy Res Canc, Tobacco Unit, F-69008 Lyon, France.	nigel@uicc.org						Bates C, 2003, TOB CONTROL, V12, P360, DOI 10.1136/tc.12.4.360; Boffetta P, 2005, INT J CANCER, V114, P992, DOI 10.1002/ijc.20811; *BRIT AM TOB, 2005, SMOK SNUS BRIT AM TO; Cogliano V, 2004, LANCET ONCOL, V5, P708, DOI 10.1016/S1470-2045(04)01633-X; EKMAN I, 2005, INT HERALD TRIB 0527, P1; EKMAN I, 2005, INT HERALD TRIB 0527, P7; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Gray N, 2003, LANCET, V362, P845, DOI 10.1016/S0140-6736(03)14348-6; Hughes JR, 2005, TOB CONTROL, V14, P49, DOI 10.1136/tc.2004.008367; International Agency for Research on Cancer, 2004, TOB SMOK INV SMOK; WEINSTEIN ND, 2001, PUBL UND RISK REAS S, P193	11	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					966	967		10.1016/S0140-6736(05)67352-7	http://dx.doi.org/10.1016/S0140-6736(05)67352-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168760				2022-12-28	WOS:000231955900008
J	van den Bent, MJ; Afra, D; de Witte, O; Ben Hassel, M; Schraub, S; Hoang-Xuan, K; Malmstrom, PO; Collette, L; Pierart, M; Mirimanoff, R; Karim, ABMF				van den Bent, MJ; Afra, D; de Witte, O; Ben Hassel, M; Schraub, S; Hoang-Xuan, K; Malmstrom, PO; Collette, L; Pierart, M; Mirimanoff, R; Karim, ABMF		EORTC Radiotherapy Grp; EORTC Brain Tumor Grp; UK Med Res Council	Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial	LANCET			English	Article							QUALITY-OF-LIFE; RADIATION-THERAPY; EUROPEAN ORGANIZATION; PROGNOSTIC FACTORS; MALIGNANT GLIOMA; TEMOZOLOMIDE; CHEMOTHERAPY; PROCARBAZINE	Background Postoperative policies of "wait-and-see" and radiotherapy for low-grade glioma are poorly defined. A trial in the mid 1980s established the radiation dose. In 1986 the EORTC Radiotherapy and Brain Tumor Groups initiated a prospective trial to compare early radiotherapy with delayed radiotherapy. An interim analysis has been reported. We now present the long-term results. Methods After surgery, patients from 24 centres across Europe were randomly assigned to either early radiotherapy of 54 Gy in fractions of 1.8 Gy or deferred radiotherapy until the time of progression (control group). Patients with low-grade astrocytoma, oligodendroglioma, mixed oligoastrocytoma, and incompletely resected pilocytic astrocytoma, with a WHO performance status 0-2 were eligible. Analysis was by intention to treat, and primary endpoints were overall and progression-free survival. Findings 157 patients were assigned early radiotherapy, and 157 control. Median progression-free survival was 5.3 years in the early radiotherapy group and 3.4 years in the control group (hazard ratio 0.59, 95% CI 0.45-0.77; p<0.0001). However, overall survival was similar between groups: median survival in the radiotherapy group was 7.4 years compared with 7.2 years in the control group (hazard ratio 0.97, 95% CI 0.71-1.34; p=0.872). In the control group, 65% of patients received radiotherapy at progression. At 1 year, seizures were better controlled in the early radiotherapy group. Interpretation Early radiotherapy after surgery lengthens the period without progression but does not affect overall survival. Because quality of life was not studied, it is not known whether time to progression reflects clinical deterioration. Radiotherapy could be deferred for patients with low-grade glioma who are in a good condition, provided they are carefully monitored.	Erasmus Univ Hosp Rotterdam, Daniel den Hoed Oncol Ctr, Erasmus Med Ctr, Neurooncol Unit, NL-3008 AE Rotterdam, Netherlands; Natl Inst Neurosurg, Budapest, Hungary; Hop Univ Erasme, Brussels, Belgium; EORTC Data Ctr, Brussels, Belgium; Ctr Eugene Marquis, Rennes, France; Hop Jean Minjoz, F-25030 Besancon, France; Ctr Univ Pitie Salpetriere, Paris, France; Univ Lund Hosp, S-22185 Lund, Sweden; CHU Vaudois, Lausanne, Switzerland; Vrije Univ Amsterdam, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Universite Libre de Bruxelles; European Organisation for Research & Treatment of Cancer; UNICANCER; Centre Eugene Marquis; Universite de Franche-Comte; CHU Besancon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Lund University; Skane University Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Vrije Universiteit Amsterdam	van den Bent, MJ (corresponding author), Erasmus Univ Hosp Rotterdam, Daniel den Hoed Oncol Ctr, Erasmus Med Ctr, Neurooncol Unit, POB 5201, NL-3008 AE Rotterdam, Netherlands.	m.vandenbent@erasmusmc.nl	Hoang-Xuan, Khe/O-7527-2017	de witte, olivier/0000-0002-7700-8006; van den Bent, Martin/0000-0001-5710-5127; Collette, Laurence/0000-0003-2518-7281	NATIONAL CANCER INSTITUTE [U10CA011488] Funding Source: NIH RePORTER; NCI NIH HHS [5U10 CA11488-16, 5U10 CA11488-] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERT FK, 1994, NEUROSURGERY, V34, P45, DOI 10.1097/00006123-199401000-00008; Biemond-ter Stege EM, 2005, CANCER-AM CANCER SOC, V103, P802, DOI 10.1002/cncr.20828; Brada M, 2003, ANN ONCOL, V14, P1715, DOI 10.1093/annonc/mdg371; Brown PD, 2003, J CLIN ONCOL, V21, P2519, DOI 10.1200/JCO.2003.04.172; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Cox DR., 1984, ANAL SURVIVAL DATA; DEANGELIS LM, 1989, NEUROLOGY, V39, P789, DOI 10.1212/WNL.39.6.789; EMERSON JD, 1982, BIOMETRICS, V38, P17, DOI 10.2307/2530285; Hoang-Xuan K, 2004, J CLIN ONCOL, V22, P3133, DOI 10.1200/JCO.2004.10.169; *INT COMM, 1978, 29 ICRU; Karim ABMF, 1996, INT J RADIAT ONCOL, V36, P549, DOI 10.1016/S0360-3016(96)00352-5; Karim ABMF, 2002, INT J RADIAT ONCOL, V52, P316, DOI 10.1016/S0360-3016(01)02692-X; Klein M, 2002, LANCET, V360, P1361, DOI 10.1016/S0140-6736(02)11398-5; LAACK N, 2003, INT J RAD ONCOL B S1, V57, P134; Olson JD, 2000, NEUROLOGY, V54, P1442, DOI 10.1212/WNL.54.7.1442; Osoba D, 2000, J CLIN ONCOL, V18, P1481, DOI 10.1200/JCO.2000.18.7.1481; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; SCOTT CB, 1995, CANCER, V76, P307, DOI 10.1002/1097-0142(19950715)76:2<307::AID-CNCR2820760222>3.0.CO;2-L; Shaw E, 2002, J CLIN ONCOL, V20, P2267, DOI 10.1200/JCO.2002.09.126; TAPHOORN MJB, 1994, ANN NEUROL, V36, P48, DOI 10.1002/ana.410360111; Zulch KJ, 1979, HISTOLOGICAL TYPING	22	643	651	0	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 17	2005	366	9490					985	990		10.1016/S0140-6736(05)67070-5	http://dx.doi.org/10.1016/S0140-6736(05)67070-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168780				2022-12-28	WOS:000231955900033
J	Burns, CJ				Burns, CJ			Bridging a gap in actinide chemistry	SCIENCE			English	Editorial Material							URANIUM		Los Alamos Natl Lab, Div Chem, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Burns, CJ (corresponding author), Los Alamos Natl Lab, Div Chem, MS J514, Los Alamos, NM 87545 USA.	cjb@lanl.gov		Burns, Carol/0000-0003-0388-5249				Arney DSJ, 1996, J AM CHEM SOC, V118, P6780, DOI 10.1021/ja960221y; BRENNAN JG, 1985, J AM CHEM SOC, V107, P514, DOI 10.1021/ja00288a047; Castro-Rodriguez I, 2004, SCIENCE, V305, P1757, DOI 10.1126/science.1102602; Conradson SD, 2004, J AM CHEM SOC, V126, P13443, DOI 10.1021/ja049192e; Curro NJ, 2005, NATURE, V434, P622, DOI 10.1038/nature03428; Duval PB, 2001, ANGEW CHEM INT EDIT, V40, P3358; Evans WJ, 2005, SCIENCE, V309, P1835, DOI 10.1126/science.1116452; Korobkov I, 2002, ANGEW CHEM INT EDIT, V41, P3433, DOI 10.1002/1521-3773(20020916)41:18<3433::AID-ANIE3433>3.0.CO;2-V; Ventelon L, 1999, CHEM COMMUN, P659, DOI 10.1039/a900466a; Wilkerson MP, 2000, INORG CHEM, V39, P5277, DOI 10.1021/ic000142u	10	32	32	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1823	1824		10.1126/science.1118701	http://dx.doi.org/10.1126/science.1118701			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166507				2022-12-28	WOS:000231989500037
J	Hesketh, T; Lu, L; Xing, ZW				Hesketh, T; Lu, L; Xing, ZW			The effect of China's one-child family policy after 25 years	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEX-RATIOS; RURAL CHINA; SURPLUS; HEALTH; BIRTHS; MEN		UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1E 6BT, England; Zhejiang Univ, Inst Social & Family Med, Hangzhou 310027, Peoples R China; Zhejiang Normal Univ, Inst Publ Hlth, Jinhua, Peoples R China	University of London; University College London; Zhejiang University; Zhejiang Normal University	Hesketh, T (corresponding author), UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1E 6BT, England.			Hesketh, Therese/0000-0002-7564-9221				Bogg L, 1998, AM J PUBLIC HEALTH, V88, P649, DOI 10.2105/AJPH.88.4.649; Chen H, 1997, China Popul Today, V14, P24; *CHIN POP INF RES, BAS POP DAT CHIN 194; COALE AJ, 1994, DEMOGRAPHY, V31, P459, DOI 10.2307/2061752; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; Doherty JP, 2001, SOC SCI MED, V52, P745, DOI 10.1016/S0277-9536(00)00175-1; GREENHALGH S, 1987, SCIENCE, V235, P1167, DOI 10.1126/science.3823877; Gu B, 1995, Asia Pac Popul J, V10, P17; Hardee K, 2004, INT FAM PLAN PERSPEC, V30, P68, DOI 10.1363/3006804; Hesketh T, 1997, BRIT MED J, V314, P1685, DOI 10.1136/bmj.314.7095.1685; Hudson VM, 2002, INT SECURITY, V26, P5, DOI 10.1162/016228802753696753; KANG C, 2003, THESES COLLECTION 20, P88; Li JH, 2004, SOC SCI MED, V59, P695, DOI 10.1016/j.socscimed.2003.11.041; LIN B, 2003, THESES COLLECTION 20, P57; Lofstedt P, 2004, REPROD HEALTH MATTER, V12, P86, DOI 10.1016/S0968-8080(04)24147-7; Merli MG, 2000, DEMOGRAPHY, V37, P109, DOI 10.2307/2648100; NI HY, 1994, EPIDEMIOLOGY, V5, P490; PAN JH, 2003, THESES COLLECTION 20, P16; Peng P, 1998, China Popul Today, V15, P5; Peng P, 1998, CHINA POPUL TODAY, V15, P10; Short SE, 1998, STUD FAMILY PLANN, V29, P373, DOI 10.2307/172250; Sun F, 1998, Asia Pac Popul J, V13, P75; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; TULJAPURKAR S, 1995, SCIENCE, V267, P874, DOI 10.1126/science.7846529; *UN DEV PROGR, 2003, TOT FERT RAT; *UN POP FUND, FAM PLANN HUM RIGHT; Wang J. Y., 2003, THESES COLLECTION 20, P1; Winckler EA, 2002, POPUL DEV REV, V28, P379, DOI 10.1111/j.1728-4457.2002.00379.x; *WORLD BANK HLTH N, DEV DAT; Wu ZC, 2003, BRIT MED J, V327, P1319, DOI 10.1136/bmj.327.7427.1319; Yang Q, 1994, Asia Pac Popul J, V9, P23; YIN Q, 2003, THESES COLLECTION 20, P116; Zhu WX, 2003, ARCH DIS CHILD, V88, P463, DOI 10.1136/adc.88.6.463; 2002, PEOPLES DAILY B 0902	34	315	318	10	215	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1171	1176		10.1056/NEJMhpr051833	http://dx.doi.org/10.1056/NEJMhpr051833			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	963YG	16162890	Green Published			2022-12-28	WOS:000231841900015
J	Suttle, CA				Suttle, CA			Viruses in the sea	NATURE			English	Review							COMPLETE GENOME SEQUENCE; HETEROSIGMA-AKASHIWO; VIRAL ABUNDANCE; MARINE VIRUSES; PHOTOSYNTHESIS GENES; COUNTING VIRUSES; BRITISH-COLUMBIA; DNA; DIVERSITY; BACTERIA	Viruses exist wherever life is found. They are a major cause of mortality, a driver of global geochemical cycles and a reservoir of the greatest genetic diversity on Earth. In the oceans, viruses probably infect all living things, from bacteria to whales. They affect the form of available nutrients and the termination of algal blooms. Viruses can move between marine and terrestrial reservoirs, raising the spectre of emerging pathogens. Our understanding of the effect of viruses on global systems and processes continues to unfold, overthrowing the idea that viruses and virus-mediated processes are sidebars to global processes.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Suttle, CA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	csuttle@eos.ubc.ca	suttle, c/N-1144-2019; Suttle, Curtis A/C-3150-2008	suttle, c/0000-0002-0372-0033; Suttle, Curtis A/0000-0002-0372-0033				BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Bettarel Y, 2000, APPL ENVIRON MICROB, V66, P2283, DOI 10.1128/AEM.66.6.2283-2289.2000; BETTAREL Y, IN PRESS AQUAT MICRO; Bird DF, 2001, MAR GEOL, V174, P227, DOI 10.1016/S0025-3227(00)00152-3; BOEHME J, 1993, MAR ECOL PROG SER, V97, P1, DOI 10.3354/meps097001; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brussaard CPD, 2004, VIROLOGY, V319, P280, DOI 10.1016/j.virol.2003.10.033; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Chen F, 2002, APPL ENVIRON MICROB, V68, P2589, DOI 10.1128/AEM.68.5.2589-2594.2002; Chen F, 1996, APPL ENVIRON MICROB, V62, P2869, DOI 10.1128/AEM.62.8.2869-2874.1996; COCHLAN WP, 1993, MAR ECOL PROG SER, V92, P77, DOI 10.3354/meps092077; COTTRELL MT, 1995, LIMNOL OCEANOGR, V40, P730, DOI 10.4319/lo.1995.40.4.0730; Culley AI, 2003, NATURE, V424, P1054, DOI 10.1038/nature01886; Danovaro R, 2005, ENVIRON MICROBIOL, V7, P586, DOI 10.1111/j.1462-2920.2005.00727.x; Daughney CJ, 2004, MAR CHEM, V91, P101, DOI 10.1016/j.marchem.2004.06.003; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Evans C, 2003, AQUAT MICROB ECOL, V30, P207, DOI 10.3354/ame030207; FRANK H, 1987, HELGOLANDER MEERESUN, V41, P385, DOI 10.1007/BF02365400; Frederickson CM, 2003, MICROB ECOL, V46, P348, DOI 10.1007/s00248-003-1010-2; Fuhrman JA, 1995, LIMNOL OCEANOGR, V40, P1236, DOI 10.4319/lo.1995.40.7.1236; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Garza DR, 1995, AQUAT MICROB ECOL, V9, P203, DOI 10.3354/ame009203; Gobler CJ, 1997, LIMNOL OCEANOGR, V42, P1492, DOI 10.4319/lo.1997.42.7.1492; Guixa-Boixereu N, 2002, DEEP-SEA RES PT II, V49, P827, DOI 10.1016/S0967-0645(01)00126-6; Hambly E, 2005, CURR OPIN MICROBIOL, V8, P444, DOI 10.1016/j.mib.2005.06.005; Hardies SC, 2003, VIROLOGY, V310, P359, DOI 10.1016/S0042-6822(03)00172-7; HELDAL M, 1991, MAR ECOL PROG SER, V72, P205, DOI 10.3354/meps072205; HENNES KP, 1995, LIMNOL OCEANOGR, V40, P1050, DOI 10.4319/lo.1995.40.6.1050; Hewson I, 2001, LIMNOL OCEANOGR, V46, P1734, DOI 10.4319/lo.2001.46.7.1734; Jelmert A, 1996, CONSERV BIOL, V10, P653, DOI 10.1046/j.1523-1739.1996.10020653.x; KELLOGG CA, 1995, MAR ECOL PROG SER, V120, P89, DOI 10.3354/meps120089; Lang AS, 2004, VIROLOGY, V320, P206, DOI 10.1016/j.virol.2003.10.015; Lawrence JE, 2001, J PHYCOL, V37, P216, DOI 10.1046/j.1529-8817.2001.037002216.x; Lawrence JE, 2004, AQUAT MICROB ECOL, V37, P1, DOI 10.3354/ame037001; Lawrence JE, 2002, LIMNOL OCEANOGR, V47, P545, DOI 10.4319/lo.2002.47.2.0545; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; MARANGER R, 1995, MAR ECOL PROG SER, V121, P217, DOI 10.3354/meps121217; MIddelboe M, 2003, AQUAT MICROB ECOL, V33, P1, DOI 10.3354/ame033001; Middelboe M, 2003, LIMNOL OCEANOGR, V48, P1447, DOI 10.4319/lo.2003.48.4.1447; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; MOEBUS K, 1981, HELGOLANDER MEERESUN, V34, P375, DOI 10.1007/BF02074130; Nagasaki K, 2005, APPL ENVIRON MICROB, V71, P3528, DOI 10.1128/AEM.71.7.3528-3535.2005; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Noble RT, 2000, APPL ENVIRON MICROB, V66, P3790, DOI 10.1128/AEM.66.9.3790-3797.2000; Ortmann AC, 2005, DEEP-SEA RES PT I, V52, P1515, DOI 10.1016/j.dsr.2005.04.002; Paul JH, 2005, APPL ENVIRON MICROB, V71, P3311, DOI 10.1128/AEM.71.6.3311-3320.2005; PAUL JH, 1993, APPL ENVIRON MICROB, V59, P718, DOI 10.1128/AEM.59.3.718-724.1993; Philippa JDW, 2004, VET REC, V155, P135, DOI 10.1136/vr.155.5.135; Poorvin L, 2004, LIMNOL OCEANOGR, V49, P1734, DOI 10.4319/lo.2004.49.5.1734; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; Short SM, 2002, APPL ENVIRON MICROB, V68, P1290, DOI 10.1128/AEM.68.3.1290-1296.2002; Smith AW, 2002, CURR OPIN MOL THER, V4, P177; Steward Grieg F., 1992, Marine Microbial Food Webs, V6, P79; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1994, MICROBIAL ECOL, V28, P237, DOI 10.1007/BF00166813; SUTTLE CA, 1990, NATURE, V347, P467, DOI 10.1038/347467a0; SUTTLE CA, 1994, APPL ENVIRON MICROB, V60, P3167, DOI 10.1128/AEM.60.9.3167-3174.1994; Suttle CA, 2000, VIRAL ECOLOGY, P247, DOI 10.1016/B978-012362675-2/50007-0; SUTTLE CA, 1992, APPL ENVIRON MICROB, V58, P3721, DOI 10.1128/AEM.58.11.3721-3729.1992; Takao Y, 2005, APPL ENVIRON MICROB, V71, P4516, DOI 10.1128/AEM.71.8.4516-4522.2005; Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Wen K, 2004, APPL ENVIRON MICROB, V70, P3862, DOI 10.1128/AEM.70.7.3862-3867.2004; Wichels A, 1998, APPL ENVIRON MICROB, V64, P4128; Wilhelm SW, 1998, AQUAT MICROB ECOL, V14, P215, DOI 10.3354/ame014215; Wilhelm SW, 2002, MICROBIAL ECOL, V43, P168, DOI 10.1007/s00248-001-1021-9; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Wilson W. H., 1999, B I OCEANOGR MONACO, V19, P209; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Zeidner G, 2005, ENVIRON MICROBIOL, V7, P1505, DOI 10.1111/j.1462-2920.2005.00833.x; Zhang S, 2004, J FISH DIS, V27, P687, DOI 10.1111/j.1365-2761.2004.00587.x; Zhong Y, 2002, APPL ENVIRON MICROB, V68, P1576, DOI 10.1128/AEM.68.4.1576-1584.2002	85	1352	1434	14	431	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					356	361		10.1038/nature04160	http://dx.doi.org/10.1038/nature04160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163346				2022-12-28	WOS:000231849100042
J	Allwood, DA; Xiong, G; Faulkner, CC; Atkinson, D; Petit, D; Cowburn, RP				Allwood, DA; Xiong, G; Faulkner, CC; Atkinson, D; Petit, D; Cowburn, RP			Magnetic domain-wall logic	SCIENCE			English	Review							SPIN-POLARIZED CURRENT; RANDOM-ACCESS MEMORY; FERROMAGNETIC SEMICONDUCTOR; GIANT-MAGNETORESISTANCE; CELLULAR-AUTOMATA; TUNNEL-JUNCTIONS; INJECTION; FIELD; PROPAGATION; NANOWIRES	"Spintronics," in which both the spin and charge of electrons are used for logic and memory operations, promises an alternate route to traditional semiconductor electronics. A complete logic architecture can be constructed, which uses planar magnetic wires that are less than a micrometer in width. Logical NOT, logical AND, signal fan-out, and signal cross-over elements each have a simple geometric design, and they can be integrated together into one circuit. An additional element for data input allows information to be written to domain-wall logic circuits.	Univ London Imperial Coll Sci Technol & Med, Blackett Phys Lab, London SW7 2BW, England; Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England; Univ Durham, Dept Phys, Durham DH1 3LE, England; Univ Durham, Durham Magneto Opt Ltd, Durham DH1 3HP, England	Imperial College London; University of Sheffield; Durham University; Durham University	Cowburn, RP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Phys Lab, Prince Consort Rd, London SW7 2BW, England.	r.cowburn@irnperial.ac.uk	intern, pss/U-3221-2017; Cowburn, Russell/D-5820-2015	Cowburn, Russell/0000-0003-0867-8900; Atkinson, Del/0000-0002-9438-7407				Allwood DA, 2004, J APPL PHYS, V95, P8264, DOI 10.1063/1.1751236; Allwood DA, 2003, J PHYS D APPL PHYS, V36, P2175, DOI 10.1088/0022-3727/36/18/001; Allwood DA, 2002, SCIENCE, V296, P2003, DOI 10.1126/science.1070595; Allwood DA, 2002, APPL PHYS LETT, V81, P4005, DOI 10.1063/1.1523634; Amlani I, 1999, SCIENCE, V284, P289, DOI 10.1126/science.284.5412.289; Atkinson D, 2005, J MAGN MAGN MATER, V290, P165, DOI 10.1016/j.jmmm.2004.11.173; Atkinson D, 2003, NAT MATER, V2, P85, DOI 10.1038/nmat803; BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Black WC, 2000, J APPL PHYS, V87, P6674, DOI 10.1063/1.372806; Chiba D, 2003, SCIENCE, V301, P943, DOI 10.1126/science.1086608; Cowburn RP, 2000, SCIENCE, V287, P1466, DOI 10.1126/science.287.5457.1466; Cowburn RP, 2003, J APPL PHYS, V93, P9310, DOI 10.1063/1.1574596; Csaba G, 2003, INT J CIRC THEOR APP, V31, P67, DOI 10.1002/cta.226; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; Faulkner CC, 2003, IEEE T MAGN, V39, P2860, DOI 10.1109/TMAG.2003.816247; Grynkewich G, 2004, MRS BULL, V29, P818, DOI 10.1557/mrs2004.234; Himeno A, 2003, J APPL PHYS, V93, P8430, DOI 10.1063/1.1556980; Imre A, 2003, PHYSICA E, V19, P240, DOI 10.1016/S1386-9477(03)00323-0; Katine JA, 2000, PHYS REV LETT, V84, P3149, DOI 10.1103/PhysRevLett.84.3149; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; Lim CK, 2004, APPL PHYS LETT, V84, P2820, DOI 10.1063/1.1711168; McMichael RD, 1997, IEEE T MAGN, V33, P4167, DOI 10.1109/20.619698; Nakatani Y, 2003, NAT MATER, V2, P521, DOI 10.1038/nmat931; Navabi Zainalabedin, 2005, DIGITAL DESIGN IMPLE; Ney A, 2003, NATURE, V425, P485, DOI 10.1038/nature02014; Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509; Ono T, 1999, SCIENCE, V284, P468, DOI 10.1126/science.284.5413.468; Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660; Reiss G, 2004, PHYS STATUS SOLIDI A, V201, P1628, DOI 10.1002/pssa.200304683; Richter R, 2002, SOLID STATE ELECTRON, V46, P639, DOI 10.1016/S0038-1101(01)00330-6; SLONCZEWSKI JC, 1996, J MAGN MAGN MATER, V159, P1; Tsoi M, 2003, APPL PHYS LETT, V83, P2617, DOI 10.1063/1.1578165; Vernier N, 2004, EUROPHYS LETT, V65, P526, DOI 10.1209/epl/i2003-10112-5; WASER R, 2003, NANOELECTRONICS INFO, P330; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389	37	1725	1755	17	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1688	1692		10.1126/science.1108813	http://dx.doi.org/10.1126/science.1108813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151002				2022-12-28	WOS:000231836700033
J	Aspuru-Guzik, A; Dutoi, AD; Love, PJ; Head-Gordon, M				Aspuru-Guzik, A; Dutoi, AD; Love, PJ; Head-Gordon, M			Simulated quantum computation of molecular energies	SCIENCE			English	Article								The calculation time for the energy of atoms and molecules scales exponentially with system size on a classical computer but polynomially using quantum algorithms. We demonstrate that such algorithms can be applied to problems of chemical interest using modest numbers of quantum bits. Calculations of the water and lithium hydride molecular ground-state energies have been carried out on a quantum computer simulator using a recursive phase-estimation algorithm. The recursive algorithm reduces the number of quantum bits required for the readout register from about 20 to 4. Mappings of the molecular wave function to the quantum bits are described. An adiabatic method for the preparation of a good approximate ground-state wave function is described and demonstrated for a stretched hydrogen molecule. The number of quantum bits required scales linearly with the number of basis functions, and the number of gates required grows polynomially with the number of quantum bits.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; D Wave Syst Inc, Burnaby, BC V5C 6G9, Canada; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Aspuru-Guzik, A (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	alan@aspuru.com	Aspuru-Guzik, Alan/A-4984-2008; Head-Gordon, Martin/AAR-4028-2020	Aspuru-Guzik, Alan/0000-0002-8277-4434; 				Abrams DS, 1997, PHYS REV LETT, V79, P2586, DOI 10.1103/PhysRevLett.79.2586; Abrams DS, 1999, PHYS REV LETT, V83, P5162, DOI 10.1103/PhysRevLett.83.5162; Bergholm V, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.052330; Born M, 1928, Z PHYS, V51, P165, DOI 10.1007/BF01343193; CLEVE R, 1998, P ROY SOC LOND A MAT, V454, P313; Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; FARHI E, 2000, ARXIV E PRINT; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Helgaker T., 2002, MOL ELECT STRUCTURE; KITAEV AY, 1995, ARXIV E PRINT; Kohn W, 1999, REV MOD PHYS, V71, P1253, DOI 10.1103/RevModPhys.71.1253; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Ortiz G, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.022319; Thogersen L, 2004, CHEM PHYS LETT, V393, P36, DOI 10.1016/j.cplett.2004.06.001	14	606	630	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1704	1707		10.1126/science.1113479	http://dx.doi.org/10.1126/science.1113479			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151006	Green Submitted			2022-12-28	WOS:000231836700038
J	Kuo, AD				Kuo, AD			Harvesting energy by improving the economy of human walking	SCIENCE			English	Editorial Material									Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kuo, AD (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	artkuo@umich.edu	Kuo, Arthur/L-3359-2013	Kuo, Arthur/0000-0001-5233-9709				ALEXANDER R. M., 1995, APPL MECH REV, V48, P461, DOI [10.1115/1.3005107, DOI 10.1115/1.3005107]; Alexander RM, 2005, SCIENCE, V308, P58, DOI 10.1126/science.1111110; Chatterjee A, 2002, INT J ROBOT RES, V21, P621, DOI 10.1177/027836402322023213; Donelan JM, 2002, J EXP BIOL, V205, P3717; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063	7	118	124	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1686	1687		10.1126/science.1118058	http://dx.doi.org/10.1126/science.1118058			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963WK	16151001				2022-12-28	WOS:000231836700032
J	Check, E				Check, E			Threat of disease	NATURE			English	News Item								Most of the deaths from Hurricane Katrina have been caused by drowning, however people still living in the area may be at risk from diarrheal diseases, respiratory tract infections and mosquito-borne illnesses, especially the West Nile virus.											0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2005	437	7056					175	175						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16158498				2022-12-28	WOS:000231696900016
J	Evans, RL; Hirth, G; Baba, K; Forsyth, D; Chave, A; Mackie, R				Evans, RL; Hirth, G; Baba, K; Forsyth, D; Chave, A; Mackie, R			Geophysical evidence from the MELT area for compositional controls on oceanic plates	NATURE			English	Article							EAST PACIFIC RISE; UPPER-MANTLE; ELECTRICAL-CONDUCTIVITY; WATER; FLOW; VELOCITIES; TRANSITION; HYDROGEN; BENEATH; REGION	Magnetotelluric and seismic data, collected during the MELT experiment at the southern East Pacific Rise(1,2), constrain the distribution of melt beneath this mid-ocean-ridge spreading centre and also the evolution of the oceanic lithosphere during its early cooling history. Here we focus on structures imaged at distances similar to 100 to 350 km east of the ridge crest, corresponding to seafloor ages of similar to 1.3 to 4.5 million years (Myr), where the seismic and electrical conductivity structure is nearly constant and independent of age. Beginning at a depth of about 60 km, we image a large increase in electrical conductivity and a change from isotropic to transversely anisotropic electrical structure, with higher conductivity in the direction of fast propagation for seismic waves. Conductive cooling models predict structure that increases in depth with age, extending to about 30 km at 4.5 Myr ago. We infer, however, that the structure of young oceanic plates is instead controlled by a decrease in water content above a depth of 60 km induced by the melting process beneath the spreading centre(3).	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA; Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Kanagawa 2370061, Japan; Brown Univ, Dept Geol, Providence, RI 02912 USA; GSY USA Inc, San Francisco, CA 94114 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Brown University	Evans, RL (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	revans@whoi.edu	Baba, Kiyoshi/AAH-9047-2019; evans, rob/C-6887-2011	Baba, Kiyoshi/0000-0002-2963-2429; Chave, Alan/0000-0002-2460-1172; Evans, Robert/0000-0001-5585-0684				AUBAUD C, IN PRESS GEOPHYS RES; BABA K, UNPUB J GEOPHYS RES; Conder JA, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000807; Dunn RA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002217; Evans RL, 1999, SCIENCE, V286, P752, DOI 10.1126/science.286.5440.752; Faul UH, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002407; Forsyth DW, 1998, SCIENCE, V280, P1235, DOI 10.1126/science.280.5367.1235; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; FORSYTH DW, IN PRESS AGU GEOPHYS; Gaherty JB, 1996, J GEOPHYS RES-SOL EA, V101, P22291, DOI 10.1029/96JB01882; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10987, DOI 10.1029/2000JB900042; Hier-Majumder S, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003292; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Huang XG, 2005, NATURE, V434, P746, DOI 10.1038/nature03426; KARATO S, 1995, P JPN ACAD B-PHYS, V71, P61, DOI 10.2183/pjab.71.61; KARATO S, 1990, NATURE, V347, P272, DOI 10.1038/347272a0; Karato S.-i, 2003, GEOPHYS MONOGR AM GE, V138, P135; Kohlstedt DL, 1998, Z PHYS CHEM, V207, P147, DOI 10.1524/zpch.1998.207.Part_1_2.147; Kohlstedt DL, 1999, NATO ADV SCI I C-MAT, V543, P539; LIZARRALDE D, 1995, J GEOPHYS RES-SOL EA, V100, P17837, DOI 10.1029/95JB01244; NISHIMURA CE, 1989, GEOPHYS J INT, V96, P203, DOI 10.1111/j.1365-246X.1989.tb04446.x; PARSONS B, 1977, J GEOPHYS RES, V82, P803, DOI 10.1029/JB082i005p00803; Rodi W, 2001, GEOPHYSICS, V66, P174, DOI 10.1190/1.1444893; Simpson F, 2002, EARTH PLANET SC LETT, V203, P535, DOI 10.1016/S0012-821X(02)00862-2; Wolfe CJ, 1998, SCIENCE, V280, P1230, DOI 10.1126/science.280.5367.1230; Xu YS, 2000, J GEOPHYS RES-SOL EA, V105, P27865, DOI 10.1029/2000JB900299; Xu YS, 2000, PHYS EARTH PLANET IN, V118, P149, DOI 10.1016/S0031-9201(99)00135-1	27	193	214	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					249	252		10.1038/nature04014	http://dx.doi.org/10.1038/nature04014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148932	Green Submitted			2022-12-28	WOS:000231696900054
J	Fiore, MC; Keller, PA; Baker, TB				Fiore, MC; Keller, PA; Baker, TB			The Justice Department's case against the tobacco companies.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Wisconsin, Sch Med, Ctr Tobacco Res & Inervent, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fiore, MC (corresponding author), Univ Wisconsin, Sch Med, Ctr Tobacco Res & Inervent, Madison, WI 53706 USA.							Fiore MC, 2004, AM J PUBLIC HEALTH, V94, P205, DOI 10.2105/AJPH.94.2.205; RISEN J, 2005, NY TIMES        1216, pA1; WAXMAN HA, 2005, COMMUNICATION   0620; 2005, NY TIMES        0608; 2005, WASHINGTON POST 0615, pA24	5	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					972	975		10.1056/NEJMp058164	http://dx.doi.org/10.1056/NEJMp058164			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961YQ	16148282				2022-12-28	WOS:000231698200002
J	Arroll, B; Goodyear-Smith, F; Kerse, N; Fishman, T; Gunn, J				Arroll, B; Goodyear-Smith, F; Kerse, N; Fishman, T; Gunn, J			Effect of the addition of a "help" question to two screening questions on specificity for diagnosis of depression in general practice: diagnostic validity study	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; RECOGNITION; DISORDERS; EPIDEMIOLOGY; VALIDATION; DISABILITY; UTILITY	Objective To determine the validity of two written screening questions for depression with the addition of a question inquiring if help is needed. Design Cross sectional validation study. Setting 19 general practitioners in six clinics in New Zealand. Participants 1025 consecutive patients receiving no psychotropic drugs. Main outcome measures Sensitivity, specificity, and likelihood ratios of the two screening questions, the help question, combinations of the screening and help questions, and diagnosis by general practitioners. Results The help question alone had a sensitivity of 75% (95% confidence interval 60% to 85%) and a specificity of 94% (93% to 96%). The positive likelihood ratio for the help question was 13.0 (9.5 to 17.8) and the negative likelihood ratio was 0.27 (0.17 to 0.44). The likelihood ratio for patients wanting help today was 17.5 (11.1. to 27.7). The general practitioner diagnosis had a sensitivity of 79% (65% to 88%) and a specificity of 94% (92% to 95%). Conclusion Adding a question inquiring if help is needed to the two screening questions for depression improves the specificity of a general practitioner diagnosis of depression.	Univ Auckland, Sch Populat Hlth, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand; Univ Melbourne, Dept Gen Practice, Parkville, Vic 3052, Australia	University of Auckland; University of Melbourne	Arroll, B (corresponding author), Univ Auckland, Sch Populat Hlth, Dept Gen Practice & Primary Hlth Care, Bag 92019, Auckland 1, New Zealand.	b.arroll@auckland.ac.nz	Goodyear-Smith, Felicity/K-2538-2017; Kerse, Ngaire/AFF-8119-2022	Goodyear-Smith, Felicity/0000-0002-6657-9401; Gunn, Jane/0000-0001-8836-7525				Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; BROADHEAD WE, 1990, JAMA-J AM MED ASSOC, V264, P2524, DOI 10.1001/jama.264.19.2524; *COUNS VERS ANT PR, 1999, BR J GEN PRACT, V49, P95; Gilbody SM, 2001, BRIT MED J, V322, P406, DOI 10.1136/bmj.322.7283.406; GOOD MJD, 1987, J FAM PRACTICE, V25, P53; GUYATT GH, 2002, USERS GUIDE MED LIT; Jordanova V, 2004, PSYCHOL MED, V34, P1013, DOI 10.1017/S0033291703001727; KATON W, 1992, GEN HOSP PSYCHIAT, V14, P237, DOI 10.1016/0163-8343(92)90094-Q; McLeod D, 2004, AUST NZ J PSYCHIAT, V38, P789; MILLAR T, 1991, BRIT J GEN PRACT, V41, P357; MONK M, 1987, EPIDEMIOL REV, V9, P51, DOI 10.1093/oxfordjournals.epirev.a036308; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nease DE, 2003, J FAM PRACTICE, V52, P118; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X; The Macarthur foundation, MAC IN DEPR PRIM CAR; WAXMAN HM, 1985, GERONTOLOGIST, V25, P501, DOI 10.1093/geront/25.5.501; WHEWELL PJ, 1988, J ROY COLL GEN PRACT, V38, P259; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x	20	152	154	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 15	2005	331	7521					884	886A		10.1136/bmj.38607.464537.7C	http://dx.doi.org/10.1136/bmj.38607.464537.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975SX	16166106	Bronze, Green Published			2022-12-28	WOS:000232683300024
J	Balashov, SP; Imasheva, ES; Boichenko, VA; Anton, J; Wang, JM; Lanyi, JK				Balashov, SP; Imasheva, ES; Boichenko, VA; Anton, J; Wang, JM; Lanyi, JK			Xanthorhodopsin: A proton pump with a light-harvesting carotenoid antenna	SCIENCE			English	Article							HALOBACTERIUM-HALOBIUM; SALINIBACTER-RUBER; BACTERIORHODOPSIN; IDENTIFICATION; RHODOPSIN; BACTERIA; PROTEIN; COMPLEX; CELLS; ION	Energy transfer from light-harvesting carotenoids to chlorophyll is common in photosynthesis, but such antenna pigments have not been observed in retinal-based ion pumps and photoreceptors. Here we describe xanthorhodopsin, a proton-pumping retinal protein/carotenoid complex in the eubacterium Salinibacter ruber. The wavelength dependence of the rate of pumping and difference absorption spectra measured under a variety of conditions indicate that this protein contains two chromophores, retinal and the carotenoid salinixanthin, in a molar ratio of about 1:1. The two chromophores interact strongly, and light energy absorbed by the carotenoid is transferred to the retinal with a quantum efficiency of similar to 40%. The antenna carotenoid extends the wavelength range of the collection of light for uphill transmembrane proton transport.	Univ Calif Irvine, Irvine, CA 92697 USA; Russian Acad Sci, Inst Basic Biol Problems, Pushchino 142290, Russia; Univ Alicante, E-03080 Alicante, Spain	University of California System; University of California Irvine; Russian Academy of Sciences; Universitat d'Alacant	Balashov, SP (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.	balashov@uci.edu; jlanyi@orion.oac.uci.edu	Lanyi, Janos/C-3808-2011; Anton, Josefa/L-5283-2014	Anton, Josefa/0000-0002-5823-493X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029498, R01GM029498] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM029498, R37 GM029498-24, GM29498] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anton J, 2002, INT J SYST EVOL MICR, V52, P485, DOI 10.1099/00207713-52-2-485; Anton J, 2000, APPL ENVIRON MICROB, V66, P3052, DOI 10.1128/AEM.66.7.3052-3057.2000; Balashov SP, 2001, PHOTOCHEM PHOTOBIOL, V73, P453, DOI 10.1562/0031-8655(2001)073<0453:TASIOT>2.0.CO;2; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Cerullo G, 2002, SCIENCE, V298, P2395, DOI 10.1126/science.1074685; DANON A, 1974, P NATL ACAD SCI USA, V71, P1234, DOI 10.1073/pnas.71.4.1234; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Frank H. A., 1999, ADV PHOTOSYNTHESIS, V8; Kumauchi M, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P43, DOI 10.1002/352760510X.ch3; Lanyi JK, 2003, J MOL BIOL, V328, P439, DOI 10.1016/S0022-2836(03)00263-8; LITVIN FF, 1975, BIOORG KHIM+, V1, P1767; LITVIN FF, 1977, BIOFIZIKA+, V22, P1062; LOZIER RH, 1975, BIOPHYS J, V15, P955, DOI 10.1016/S0006-3495(75)85875-9; Lutnaes BF, 2002, J NAT PROD, V65, P1340, DOI 10.1021/np020125c; Montano GA, 2004, J PHYS CHEM B, V108, P10607, DOI 10.1021/jp047988u; MUKOHATA Y, 1991, PHOTOCHEM PHOTOBIOL, V54, P1039, DOI 10.1111/j.1751-1097.1991.tb02127.x; Mukohata Y, 1999, J BIOCHEM-TOKYO, V125, P649, DOI 10.1093/oxfordjournals.jbchem.a022332; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OESTERHELT D, 1974, FEBS LETT, V44, P257, DOI 10.1016/0014-5793(74)81152-X; OESTERHELT D, 1973, EUR J BIOCHEM, V40, P453, DOI 10.1111/j.1432-1033.1973.tb03214.x; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; Oren A, 2002, EXTREMOPHILES, V6, P491, DOI 10.1007/s00792-002-0286-3; Pena A, 2005, EXTREMOPHILES, V9, P151, DOI 10.1007/s00792-005-0430-y; Polivka T, 2004, CHEM REV, V104, P2021, DOI 10.1021/cr020674n; ROBERT B, 2003, ADV PHOTOSYNTHESIS R, V13, P169; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102	28	242	254	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2061	2064		10.1126/science.1118046	http://dx.doi.org/10.1126/science.1118046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179480	Green Accepted			2022-12-28	WOS:000232181900052
J	Dalgarno, SJ; Tucker, SA; Bassil, DB; Atwood, JL				Dalgarno, SJ; Tucker, SA; Bassil, DB; Atwood, JL			Fluorescent guest molecules report ordered inner phase of host capsules in solution	SCIENCE			English	Article							ENCAPSULATION; ORGANIZATION	Despite recent strides in the synthesis of elaborate nanometer-scale molecular hosts, the internal structure of these self-assembled cages remains ill, characterized. We used fluorescent probe molecules, pyrene butyric acid (PBA), as guests in C-hexylpyrogallol[4]arene capsules to relay information about the chemical environment on the interior of the assemblies. Spectroscopic and single-crystat x-ray diffraction studies show that, in both solution and the solid state, the host can encapsulate two PBA guests and keep them well separated through specific interactions with the capsule watts.	Univ Missouri, Dept Chem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Tucker, SA (corresponding author), Univ Missouri, Dept Chem, 601 S Coll Ave, Columbia, MO 65211 USA.	tuckers@missouri.edu; atwoodj@missouri.edu	atwood, jerry/ABA-8947-2021; Dalgarno, Scott/A-7358-2010	Dalgarno, Scott/0000-0001-7831-012X				Atwood JL, 2002, P NATL ACAD SCI USA, V99, P4837, DOI 10.1073/pnas.082659799; Atwood JL, 2001, CHEM COMMUN, P2376, DOI 10.1039/b106250f; Avram L, 2003, J AM CHEM SOC, V125, P16180, DOI 10.1021/ja0377394; Avram L, 2003, ORG LETT, V5, P3329, DOI 10.1021/ol035211y; BARBOUR LJ, MCAVITY SOFTWARE PAR; Cave GWV, 2004, ANGEW CHEM INT EDIT, V43, P5263, DOI 10.1002/anie.200460711; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; GUPTA D, 1975, J PHOTOCHEM, V4, P307, DOI 10.1016/0047-2670(75)87007-9; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lehn J.-M., 1995, SUPRAMOLECULAR CHEM; MacGillivray LR, 1997, NATURE, V389, P469, DOI 10.1038/38985; MATTAY J, 1999, EUR J ORG CHEM, P2257; MEISSNER RS, 1995, SCIENCE, V270, P1485, DOI 10.1126/science.270.5241.1485; OLSZAK TA, 1989, ACTA CRYSTALLOGR C, V45, P803, DOI 10.1107/S0108270188013496; Orr GW, 1999, SCIENCE, V285, P1049, DOI 10.1126/science.285.5430.1049; Palmer LC, 2005, ORG LETT, V7, P787, DOI 10.1021/ol047673x; RASTON CL, 2004, J AM CHEM SOC, V126, P13170; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Shivanyuk A, 2003, J ORG CHEM, V68, P6489, DOI 10.1021/jo034791+; Shivanyuk A, 2001, CHEM COMMUN, P2374, DOI 10.1039/b106793c; Steed J.W., 2022, SUPRAMOL CHEM	22	174	174	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2037	2039		10.1126/science.1116579	http://dx.doi.org/10.1126/science.1116579			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179474				2022-12-28	WOS:000232181900044
J	Gray, R				Gray, R			Pushing the time barrier in the quest for language roots	SCIENCE			English	Editorial Material									Univ Auckland, Dept Psychol, Auckland 92019, New Zealand	University of Auckland	Gray, R (corresponding author), Univ Auckland, Dept Psychol, Auckland 92019, New Zealand.	rd.gray@auckland.ac.nz	Gray, Russell/H-2078-2015	Gray, Russell/0000-0002-9858-0191				Atkinson QD, 2005, SYST BIOL, V54, P513, DOI 10.1080/10635150590950317; Campbell Lyle, 2003, HIST LINGUISTICS 200, P33; Campbell Lyle, 2003, HDB HIST LINGUISTICS, P262, DOI DOI 10.1002/9780470756393.CH4; Darwin Charles, 1871, DESCENT MAN; Dunn M, 2005, SCIENCE, V309, P2072, DOI 10.1126/science.1114615; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Kirch P., 2001, HAWAIKI ANCESTRAL PO; McMahon A, 2003, T PHILOL SOC, V101, P7, DOI 10.1111/1467-968X.00108; Nichols Johanna, 1992, LINGUISTIC DIVERSITY; Pagel M., 2000, TIME DEPTH HIST LING; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; Ruhlen M., 1994, ORIGIN LANGUAGE TRAC	12	15	15	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2005	309	5743					2007	2008		10.1126/science.1119276	http://dx.doi.org/10.1126/science.1119276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968SF	16179464				2022-12-28	WOS:000232181900033
J	Montarras, D; Morgan, J; Collins, C; Relaix, F; Zaffran, S; Cumano, A; Partridge, T; Buckingham, M				Montarras, D; Morgan, J; Collins, C; Relaix, F; Zaffran, S; Cumano, A; Partridge, T; Buckingham, M			Direct isolation of satellite cells for skeletal muscle regeneration	SCIENCE			English	Article							STEM-CELLS; MYOBLAST TRANSPLANTATION; M-CADHERIN; EXPRESSION; QUIESCENT; CD34; FATE	Muscle satellite cells contribute to muscle regeneration. We have used a Pax3(GFP/+) mouse line to directly isolate (Pax3)(green fluorescent protein)-expressing muscle satellite cells, by flow cytometry from adult skeletal muscles, as, a homogeneous population of small, nongranular, Pax7+, CD34+, CD45-, Sca1-cells. The flow cytometry parameters thus established enabled us to isolate satellite cells from wild-type muscles. Such cells, grafted into muscles of mdx nu/nu mice, contributed both to fiber repair and to the muscle satellite cell compartment. Expansion of these cells in culture before engraftment reduced their regenerative capacity.	Inst Pasteur, Dept Dev Biol, CNRS, Unite Rech Associee 2578, F-75724 Paris, France; Inst Pasteur, INSERM, U668, Unite Dev Lymphocytes, F-75724 Paris, France; Hammersmith Hosp, Dubowitz Neuromuscular Ctr, Imperial Coll Lonson, Dept Paediat, London W12 0NN, England; Univ London Imperial Coll Sci & Technol, Ctr Clin Sci, MRC, Muscle Cell Biol Grp, London W12 0NN, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Imperial College London; University of London; University College London; Imperial College London	Montarras, D (corresponding author), Inst Pasteur, Dept Dev Biol, CNRS, Unite Rech Associee 2578, F-75724 Paris, France.	dmontarr@pasteur.fr; margab@pasteur.fr	Zaffran, Stéphane/S-7454-2019; Morgan, Jennifer/C-6475-2008; Zaffran, Stéphane/I-2955-2016	Zaffran, Stéphane/0000-0002-0811-418X; Zaffran, Stéphane/0000-0002-0811-418X; Cumano, Ana/0000-0002-4578-959X; Relaix, Frederic/0000-0003-1270-1472; Collins, Charlotte/0000-0002-8715-9035				Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; DIMARIO JX, 1995, EXP CELL RES, V216, P431, DOI 10.1006/excr.1995.1054; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; Hollnagel A, 2002, MOL CELL BIOL, V22, P4760, DOI 10.1128/MCB.22.13.4760-4770.2002; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Jankowski RJ, 2002, J CELL SCI, V115, P4361, DOI 10.1242/jcs.00110; MONTARRAS D, UNPUB; MORGAN JE, 1993, J NEUROL SCI, V115, P191, DOI 10.1016/0022-510X(93)90224-M; Morgan JE, 1996, MUSCLE NERVE, V19, P132, DOI 10.1002/(SICI)1097-4598(199602)19:2<132::AID-MUS2>3.0.CO;2-F; Mueller GM, 2002, HUM GENE THER, V13, P1081, DOI 10.1089/104303402753812485; Partridge T, 2004, CELL, V119, P447, DOI 10.1016/j.cell.2004.10.022; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; RELAIX F, UNPUB; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Skuk D, 2002, EXP NEUROL, V175, P112, DOI 10.1006/exnr.2002.7899; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	27	772	813	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2064	2067		10.1126/science.1114758	http://dx.doi.org/10.1126/science.1114758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16141372				2022-12-28	WOS:000232181900053
J	Shaevitz, JW; Lee, JY; Fletcher, DA				Shaevitz, JW; Lee, JY; Fletcher, DA			Spiroplasma swim by a processive change in body helicity	CELL			English	Article							BACTERIAL LINEAR MOTOR; SALMONELLA FLAGELLA; MELLIFERUM BC3; MOTILITY; CHEMOTAXIS; CITRI; MOLLICUTES; SPIROCHETE; PROTEIN; CELLS	Microscopic organisms must rely on very different strategies than their macroscopic counterparts to swim through liquid. To date, the best understood method for prokaryotic swimming employs the rotation of flagella. Here, we show that Spiroplasma, tiny helical bacteria that infect plants and insects, use a very different approach. By measuring cell kinematics during free swimming, we find that propulsion is generated by the propagation of kink pairs down the length of the cell body. A processive change in the helicity of the body creates these waves and enables directional movement.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shaevitz, JW (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, 459 Evans Hall, Berkeley, CA 94720 USA.	jshaevitz@berkeley.edu						Ammar E, 2004, ARCH MICROBIOL, V181, P97, DOI 10.1007/s00203-003-0630-8; ARMITAGE JP, 1987, J BACTERIOL, V169, P514, DOI 10.1128/jb.169.2.514-518.1987; BERG HC, 1979, NATURE, V278, P349, DOI 10.1038/278349a0; Berg HC, 2002, J BACTERIOL, V184, P2063, DOI 10.1128/JB.184.8.2063-2064.2002; BERG HC, 1976, J THEOR BIOL, V56, P269, DOI 10.1016/S0022-5193(76)80074-4; BERG HC, 1978, MICROBES NATURAL ENV, V34, P285; Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; CHARON NW, 1992, RES MICROBIOL, V143, P597, DOI 10.1016/0923-2508(92)90117-7; Chernova AA, 2003, BIOSYSTEMS, V71, P51, DOI 10.1016/S0303-2647(03)00109-6; CHILDRRESS S, 1981, MECH SWIMMING FLYING; DANIELS MJ, 1980, J GEN MICROBIOL, V118, P429; DAVIS RE, 1978, CAN J MICROBIOL, V24, P954, DOI 10.1139/m78-158; DAVIS RE, 1973, PHYTOPATHOLOGY, V63, P403, DOI 10.1094/Phyto-63-403; Gilad R, 2003, MOL MICROBIOL, V47, P657, DOI 10.1046/j.1365-2958.2003.03200.x; Goldstein RE, 2000, PHYS REV LETT, V84, P1631, DOI 10.1103/PhysRevLett.84.1631; GOLDSTEIN SF, 1990, P NATL ACAD SCI USA, V87, P4895, DOI 10.1073/pnas.87.13.4895; HOTANI H, 1976, J MOL BIOL, V106, P151, DOI 10.1016/0022-2836(76)90305-3; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Ludwig W., 1930, Zeitschrift fuer Vergleichende Physiologie, V13, P397; MACNAB RM, 1977, J MOL BIOL, V112, P1, DOI 10.1016/S0022-2836(77)80153-8; MATSUURA S, 1978, J MOL BIOL, V118, P431, DOI 10.1016/0022-2836(78)90237-1; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Schnitzer M. J., 1990, S SOC GEN MICROBIOL, V46, P15; SHIMADA K, 1975, NATURE, V254, P332, DOI 10.1038/254332a0; TAYLOR G, 1951, PROC R SOC LON SER-A, V209, P447, DOI 10.1098/rspa.1951.0218; TOWNSEND R, 1985, J GEN MICROBIOL, V131, P983; TOWNSEND R, 1980, J BACTERIOL, V142, P973, DOI 10.1128/JB.142.3.973-981.1980; Trachtenberg S, 2003, MOL MICROBIOL, V47, P671, DOI 10.1046/j.1365-2958.2003.t01-1-03200.x; Trachtenberg S, 2001, MOL MICROBIOL, V41, P827, DOI 10.1046/j.1365-2958.2001.02527.x; Veneti Z, 2005, SCIENCE, V307, P1461, DOI 10.1126/science.1107182; WATERBURY JB, 1985, SCIENCE, V230, P74, DOI 10.1126/science.230.4721.74; WHITCOMB RF, 1980, ANNU REV MICROBIOL, V34, P677, DOI 10.1146/annurev.mi.34.100180.003333; WILLIAMSON DL, 1991, J BACTERIOL, V173, P4353, DOI 10.1128/JB.173.14.4353-4362.1991; Wolgemuth CW, 2003, BIOPHYS J, V85, P828, DOI 10.1016/S0006-3495(03)74523-8	35	87	94	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 23	2005	122	6					941	945		10.1016/j.cell.2005.07.004	http://dx.doi.org/10.1016/j.cell.2005.07.004			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179261	Bronze			2022-12-28	WOS:000232130200017
J	Taylor, SS; Haste, NM; Ghosh, G				Taylor, SS; Haste, NM; Ghosh, G			PKR and eIF2 alpha: Integration of kinase dimerization, activation, and substrate docking	CELL			English	Editorial Material							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COMPLEX	The antiviral RNA-dependent protein kinase, PKR, binds to viral double-stranded RNA in the cell and halts protein synthesis by phosphorylating the alpha subunit of the translation initiation factor eIF2. In this issue of Cell, two complementary papers Dar et al. (2005) and Dey et al. (2005) address the interaction between PKR and eIF2 alpha. The structures of eIF2 alpha bound to PKR reveal that PKR forms a dimer, the interface of which is essential for kinase activation, and demonstrate how this protein substrate docks to its kinase. The structures, coupled with mutagenesis analysis, also demonstrate how phosphorylation of the activation loop can allosterically couple two distal regions, the dimerization and substrate recognition interfaces.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Chem & Biochem, La Jolla, CA 92093 USA.							Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; NOLAN B, 2004, MOL CELL, V15, P1; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Song HW, 2001, MOL CELL, V7, P615, DOI 10.1016/S1097-2765(01)00208-8; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030	9	96	107	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 23	2005	122	6					823	825		10.1016/j.cell.2005.09.007	http://dx.doi.org/10.1016/j.cell.2005.09.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179248				2022-12-28	WOS:000232130200003
J	Lederberg, J				Lederberg, J			Metaphysical games: An imaginary lecture on crafting Earth's biological future	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Lederberg, J (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	lederberg@mail.rockefeller.edu						ANGERT ER, 1993, NATURE, V362, P239, DOI 10.1038/362239a0; LAROSSA RA, 1996, ESCHERICHIA COLI SAL, V2, P2527; Monod J., 1972, CHANCE NECESSITY ESS	3	2	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1415	1417		10.1001/jama.294.11.1415	http://dx.doi.org/10.1001/jama.294.11.1415			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174705				2022-12-28	WOS:000231987800020
J	Porter, JE				Porter, JE			Federal funding and supportive policies for research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Hogan & Harston LLP, Washington, DC 20004 USA		Porter, JE (corresponding author), Hogan & Harston LLP, 555 13th St NW,No 800E, Washington, DC 20004 USA.	JEporter@hhlaw.com						*AAAS, AAAS AN OUTYEAR PROJ; *AAAS, 2005, 30 AAAS; AGERS T, 2003, SCIENTIST       0714; AUGUSTINE R, 2005, WALL STREET J   0504, pA18; *BIOPH SOC, 2005, BRIDG SCI COAL; *DEP HLTH HUM SERV, 2005, BUDG BRIEF FISC YEAR; HAWKINS AJ, 2005, WASHINGTON FAX  0318; *HR, 1996, 104458 HR, P81; *I MED NAT ACAD, 2003, ENH VIT NIH ORG CHAN; JOHNSTON D, 2004, I LINKAGES ACAD GOVT; *LASK FUND 1ST, 2000, EXC RET EC VAL AM IN; Murphy K, 1999, EC VALUE MED RES; National Science Board, 2004, NSB0407; *NIH, 2000, HIST C APPR 1990 199; *NIH, 2005, CONFL INT INF RES; *NIH, 2005, NIH SUMM FY2003 PRES; *OECD, 2003, OECD SCI TECHN IND S; 2005, AM SPEAKS POLL DATA, V6, P21	18	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1385	1389		10.1001/jama.294.11.1385	http://dx.doi.org/10.1001/jama.294.11.1385			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174698				2022-12-28	WOS:000231987800013
J	Wilson, JF				Wilson, JF			US needs more physicians soon, but how many more is debatable	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; Garber AM, 2004, ANN INTERN MED, V141, P732, DOI 10.7326/0003-4819-141-9-200411020-00018	2	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2005	143	6					469	472		10.7326/0003-4819-143-6-200509200-00020	http://dx.doi.org/10.7326/0003-4819-143-6-200509200-00020			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967OG	16172452				2022-12-28	WOS:000232099900016
J	Munderloh, UG; Kurtti, T				Munderloh, UG; Kurtti, T			The ABCs of Lyme disease spirochaetes in ticks	LANCET			English	Editorial Material							BORRELIA-BURGDORFERI; TEMPERATURE; EXPRESSION; VACCINE		Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Munderloh, UG (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	munde001@umn.edu						deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Fernandez-Soto P, 2001, ANN TROP MED PARASIT, V95, P97, DOI 10.1080/00034980020035960; Fikrig E, 2004, INFECT IMMUN, V72, P1755, DOI 10.1128/IAI.72.3.1755-1759.2004; Munderloh UG, 2005, TICK-BORNE DISEASES OF HUMANS, P37; Obonyo M, 1999, J CLIN MICROBIOL, V37, P2137, DOI 10.1128/JCM.37.7.2137-2141.1999; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Singh SK, 2004, LANCET INFECT DIS, V4, P575; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Willett TA, 2004, P NATL ACAD SCI USA, V101, P1303, DOI 10.1073/pnas.0305680101; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960	11	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					962	964		10.1016/S0140-6736(05)67350-3	http://dx.doi.org/10.1016/S0140-6736(05)67350-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168758				2022-12-28	WOS:000231955900006
J	Petersen, L; Jeppesen, P; Thorup, A; Abel, MJ; Ohlenschlaeger, J; Christensen, TO; Krarup, G; Jorgensen, P; Nordentoft, M				Petersen, L; Jeppesen, P; Thorup, A; Abel, MJ; Ohlenschlaeger, J; Christensen, TO; Krarup, G; Jorgensen, P; Nordentoft, M			A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness	BMJ-BRITISH MEDICAL JOURNAL			English	Article							1ST-EPISODE PSYCHOSIS; SCHIZOPHRENIA; PROGRAM; ONSET; MODEL	Objectives To evaluate the effects of integrated treatment for patients with a first episode of psychotic illness. Design Randomised clinical trial. Setting Copenhagen Hospital Corporation and Psychiatric Hospital Aarhus, Denmark Participants 547 patients With first episode of schizophrenia spectrum disorder. Interventions Integrated treatment and standard treatment. The integrated treatment lasted for two years and consisted of assertive community treatment with programmes for family involvement and social skills training. Standard treatment offered contact With a community mental health centre. Main outcome measures Psychotic and negative symptoms (each scored from 0 to a maximum of 5) at one and two years' follow-up. Results At one year's follow-up, psychotic symptoms changed favourably to a mean of 1.09 (standard deviation 1.27) with an estimated mean difference between groups of -0.31 (95% confidence interval -0.55 to -0.07, P = 0.02) in favour of integrated treatment. Negative symptoms changed favourably with an estimated difference between groups of -0.36 (-0.54 to -0. 17, P < 0.001) in favour of integrated treatment. At two years' follow-up the estimated mean difference between groups in psychotic symptoms was -0.32 (-0.58 to -0.06, P = 0.02) and in negative symptoms was -0.45 (-0.67 to -0.22, P < 0.001), both in favour of integrated treatment. Patients who received integrated treatment had significantly less comorbid substance misuse, better adherence to treatment, and more satisfaction with treatment. Conclusion Integrated treatment improved clinical outcome and adherence to treatment. The improvement in clinical outcome was consistent at one year and two year follow-ups.	Bispebjerg Hosp, Dept Psychiat, DK-2400 Copenhagen, Denmark; Univ Copenhagen Hosp, Rigshosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, DK-2100 Copenhagen, Denmark; Bispebjerg Hosp, Dept Psychiat, Copenhagen NV, Denmark; SCT Hans Mental Hosp, DK-4000 Roskilde, Denmark; Psuchiat Hosp Risskov, DK-8240 Risskov, Denmark	University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Aarhus University	Nordentoft, M (corresponding author), Bispebjerg Hosp, Dept Psychiat, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.	merete.nordentoft@dadlnet.dk	Jeppesen, Pia/L-6716-2016; Nordentoft, Merete/AAH-3253-2019	Jeppesen, Pia/0000-0003-2471-2929; Nordentoft, Merete/0000-0003-4895-7023				ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; ANDREASEN NC, 1995, ARCH GEN PSYCHIAT, V52, P341; [Anonymous], 1998, WHO PSYCH DIS ASS SC; BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; Birchwood M, 1998, BRIT J PSYCHIAT, V172, P53, DOI 10.1192/S0007125000297663; Carbone S, 1999, ACTA PSYCHIAT SCAND, V100, P96, DOI 10.1111/j.1600-0447.1999.tb10830.x; Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; DUNN M, 1990, BRIT J PSYCHIAT, V157, P842, DOI 10.1192/bjp.157.6.842; HAFNER H, 1992, SCHIZOPHR RES, V6, P209, DOI 10.1016/0920-9964(92)90004-O; Jorgensen P, 2000, SOC PSYCH PSYCH EPID, V35, P283, DOI 10.1007/s001270050240; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; LIBERMAN RP, 1986, SCHIZOPHRENIA BULL, V12, P631, DOI 10.1093/schbul/12.4.631; Malla AK, 2002, PSYCHIATR SERV, V53, P458, DOI 10.1176/appi.ps.53.4.458; Marshall M, 2000, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001089, DOI 10.1002/14651858.CD001089]; MCFARLANE WR, 1995, ARCH GEN PSYCHIAT, V52, P679; McGorry PD, 1996, SCHIZOPHRENIA BULL, V22, P305, DOI 10.1093/schbul/22.2.305; MCGREW JH, 1994, J CONSULT CLIN PSYCH, V62, P670, DOI 10.1037/0022-006X.62.4.670; Nordentoft M, 2002, BRIT J PSYCHIAT, V181, pS98, DOI 10.1192/bjp.181.43.s98; Nordentoft M, 2004, BRIT MED J, V329, P261, DOI 10.1136/bmj.38133.622488.63; PHAROAH FM, 2000, COCHRANE DB SYST REV, P88; Pocock S, 1996, CLIN TRIALS PRACTICA; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; STEIN LI, 1980, ARCH GEN PSYCHIAT, V37, P392; *WHO DIV MENT HLTH, 1998, SCHED CLIN ASS NEUR	25	382	388	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2005	331	7517					602	605		10.1136/bmj.38565.415000.E01	http://dx.doi.org/10.1136/bmj.38565.415000.E01			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967EK	16141449	Green Published, Bronze			2022-12-28	WOS:000232074100015
J	Rosenthal, JM; Okie, S				Rosenthal, JM; Okie, S			White coat, mood indigo - Depression in medical school	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Rosenthal, JM (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.							Givens JL, 2002, ACAD MED, V77, P918, DOI 10.1097/00001888-200209000-00024; OPPENHEIMER K, 1987, J MED EDUC, V62, P504; Rosal MC, 1997, ACAD MED, V72, P542, DOI 10.1097/00001888-199706000-00022; Tjia J, 2005, J AM COLL HEALTH, V53, P219, DOI 10.3200/JACH.53.5.219-224	4	116	126	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1085	1088		10.1056/NEJMp058183	http://dx.doi.org/10.1056/NEJMp058183			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	963YG	16162877				2022-12-28	WOS:000231841900001
J	Garssen, B				Garssen, B			No role for extroversion and neuroticism in cancer development	LANCET			English	Editorial Material							PRONE-PERSONALITY; DISEASE		Helen Dowling Inst, NL-3582 JJ Utrecht, Netherlands		Garssen, B (corresponding author), Helen Dowling Inst, NL-3582 JJ Utrecht, Netherlands.	bgarssen@hdi.nl						Faller H, 1996, Z KLIN PSYCHOL PSYCH, V44, P104; Garssen B, 2004, CLIN PSYCHOL REV, V24, P315, DOI 10.1016/j.cpr.2004.01.002; Hansen PE, 2005, CANCER-AM CANCER SOC, V103, P1082, DOI 10.1002/cncr.20871; LINKINS RW, 1990, AM J EPIDEMIOL, V132, P962, DOI 10.1093/oxfordjournals.aje.a115739; Schulz R, 1996, PSYCHOL AGING, V11, P304, DOI 10.1037/0882-7974.11.2.304; SCHWARZ R, 1993, PSYCHOTHER PSYCH MED, V43, P1; SCHWARZ R, 1984, PSYCHOTHER PSYCHOSOM, V41, P195, DOI 10.1159/000287809	7	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 10	2005	366	9489					872	874		10.1016/S0140-6736(05)67295-9	http://dx.doi.org/10.1016/S0140-6736(05)67295-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	962YR	16153997				2022-12-28	WOS:000231770000005
J	Miah, A				Miah, A			Doping and the child: an ethical policy for the vulnerable	LANCET			English	Editorial Material									Univ Paisley, Paisley KA8 0SR, Renfrew, Scotland	University of West Scotland	Miah, A (corresponding author), Univ Paisley, Ayr Campus, Paisley KA8 0SR, Renfrew, Scotland.	email@andymiah.net	Miah, Andy/C-1467-2015	Miah, Andy/0000-0003-0137-674X				BUSH GW, 2004, COMMUNICATION; GOODBODY J, 2005, TIMES LOND      0506; SHIPLEY A, 2004, WASHINGTON POST 1215; Washington RL, 2005, PEDIATRICS, V115, P1103, DOI 10.1542/peds.2005-0085	4	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					874	876		10.1016/S0140-6736(05)67296-0	http://dx.doi.org/10.1016/S0140-6736(05)67296-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16153998				2022-12-28	WOS:000231770000006
J	Morrison, PJ				Morrison, PJ			Insurance, unfair discrimination, and genetic testing	LANCET			English	Editorial Material							HUNTINGTON-DISEASE; CANCER; ONSET; AGE; MANAGEMENT; RISK		Belfast City Hosp Trust, Dept Med Genet, Belfast BT9 7AB, Antrim, North Ireland	Belfast City Hospital	Morrison, PJ (corresponding author), Belfast City Hosp Trust, Dept Med Genet, Belfast BT9 7AB, Antrim, North Ireland.	patrick.morrison@bch.n-i.nhs.uk						*ASS BRIT INS, 2005, WELC INF ZON; Delatycki MB, 2005, LANCET, V366, P314, DOI 10.1016/S0140-6736(05)63012-7; *DEP HLTH, 2001, GOV RESP REP HOUS CO; *DEP HLTH, 2005, CONC MOR GEN INS; *DEP HLTH HUM GEN, 2000, WHOS HANDS YOUR GEN; Devlin L A, 2005, Ulster Med J, V74, P14; Djousse L, 2004, NEUROGENETICS, V5, P109, DOI 10.1007/s10048-004-0175-2; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; Foster C, 2002, BRIT J CANCER, V86, P1209, DOI 10.1038/sj.bjc.6600253; *HC, 2001, HC174 SCI TECHN COMM; *HLTH DEP UK, 2004, 2 GEN INS COMM; Kennedy RD, 2002, LANCET, V360, P1007, DOI 10.1016/S0140-6736(02)11087-7; Li JL, 2003, AM J HUM GENET, V73, P682, DOI 10.1086/378133; Low L, 1998, BRIT MED J, V317, P1632, DOI 10.1136/bmj.317.7173.1632; Lynch HT, 2005, NEW ENGL J MED, V352, P1920, DOI 10.1056/NEJMe058058; Morrison PJ, 1999, DIS MARKERS, V15, P159, DOI 10.1155/1999/748254; Morrison PJ, 2001, ULSTER MED J, V70, P79; Morrison PJ, 1998, LANCET, V352, P1647, DOI 10.1016/S0140-6736(05)61446-8; *NAT I CLIN EXC, 2004, COST CLIN GUID FAM B; Watson M, 2004, BRIT J CANCER, V91, P1787, DOI 10.1038/sj.bjc.6602207	20	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					877	880		10.1016/S0140-6736(05)67298-4	http://dx.doi.org/10.1016/S0140-6736(05)67298-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154000				2022-12-28	WOS:000231770000008
J	Heath, J; Ayres, E; Possell, M; Bardgett, RD; Black, HIJ; Grant, H; Ineson, P; Kerstiens, G				Heath, J; Ayres, E; Possell, M; Bardgett, RD; Black, HIJ; Grant, H; Ineson, P; Kerstiens, G			Rising atmospheric CO2 reduces sequestration of root-derived soil carbon	SCIENCE			English	Article							ORGANIC-MATTER; ELEVATED CO2; DIOXIDE; RESPONSES; FOREST; RESPIRATION; TURNOVER; NITROGEN; OZONE; ECOSYSTEMS	Forests have a key role as carbon sinks, which could potentially mitigate the continuing increase in atmospheric carbon dioxide concentration and associated climate change. We show that carbon dioxide enrichment, although causing short-term growth stimulation in a range of European tree species, also leads to an increase in soil microbial respiration and a marked decline in sequestration of root-derived carbon in the soil. These findings indicate that, should similar processes operate in forest ecosystems, the size of the annual terrestrial carbon sink may be substantially reduced; resulting in a positive feedback on the rate of increase in atmospheric carbon dioxide concentration.	Univ Lancaster, Inst Environm & Nat Sci, Dept Biol Sci, Lancaster LA1 4YQ, England; Univ Lancaster, Inst Environm & Nat Sci, Dept Environm Sci, Lancaster LA1 4YQ, England; Lancaster Environm Ctr, Ctr Ecol & Hydrol, Soil Ecol Grp, Lancaster LA1 4AP, England; Lancaster Environm Ctr, Ctr Ecol & Hydrol, Nat Environm Res Council Life Sci Mass Spectromet, Lancaster LA1 4AP, England; Univ York, Dept Biol, Stockholm Environm Inst, York YO10 5YW, N Yorkshire, England	Lancaster University; Lancaster University; Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); University of York - UK	Heath, J (corresponding author), Univ Lancaster, Inst Environm & Nat Sci, Dept Biol Sci, Lancaster LA1 4YQ, England.	j.heath@lancaster.ac.uk	Kerstiens, Gerhard/B-4728-2008; Possell, Malcolm/A-5043-2009; Ayres, Edward/A-4172-2008	Kerstiens, Gerhard/0000-0001-8767-7791; Possell, Malcolm/0000-0001-5376-8433; Ayres, Edward/0000-0001-5190-258X				Ayres E, 2004, ECOL LETT, V7, P469, DOI 10.1111/j.1461-0248.2004.00604.x; Cardon ZG, 2001, SOIL BIOL BIOCHEM, V33, P365, DOI 10.1016/S0038-0717(00)00151-6; Cheng WX, 1998, PLANT SOIL, V202, P167, DOI 10.1023/A:1004315321332; Gonzelez-Meller MA, 2004, ANN BOT-LONDON, V94, P647, DOI 10.1093/aob/mch189; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; Hoosbeek MR, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002127; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Ineson P, 1996, PLANT SOIL, V187, P345, DOI 10.1007/BF00017099; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; Keeling C. D., 2004, TRENDS COMPENDIUM DA; King JS, 2001, OECOLOGIA, V128, P237, DOI 10.1007/s004420100656; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Krull ES, 2003, FUNCT PLANT BIOL, V30, P207, DOI 10.1071/FP02085; Larson JL, 2002, SOIL SCI SOC AM J, V66, P1848, DOI 10.2136/sssaj2002.1848; Loya WM, 2003, NATURE, V425, P705, DOI 10.1038/nature02047; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Malhi Y, 2002, PHILOS T ROY SOC A, V360, P2925, DOI 10.1098/rsta.2002.1098; Matamala R, 2003, SCIENCE, V302, P1385, DOI 10.1126/science.1089543; Norby RJ, 2004, P NATL ACAD SCI USA, V101, P9689, DOI 10.1073/pnas.0403491101; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pataki DE, 2003, BIOSCIENCE, V53, P805, DOI 10.1641/0006-3568(2003)053[0805:TCIEFU]2.0.CO;2; Phillips RL, 2002, OECOLOGIA, V131, P236, DOI 10.1007/s00442-002-0868-x; Rytter RM, 2001, FOREST ECOL MANAG, V140, P177, DOI 10.1016/S0378-1127(00)00319-4; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Staddon PL, 2004, TRENDS ECOL EVOL, V19, P148, DOI 10.1016/j.tree.2003.12.003; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Watson RT, 2000, LAND USE LAND USE CH; Zak DR, 2000, NEW PHYTOL, V147, P201, DOI 10.1046/j.1469-8137.2000.00687.x	29	115	123	5	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2005	309	5741					1711	1713		10.1126/science.1110700	http://dx.doi.org/10.1126/science.1110700			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151007				2022-12-28	WOS:000231836700040
J	Colchester, ACF; Colchester, NTH				Colchester, ACF; Colchester, NTH			The origin of bovine spongiform encephalopathy: the human prion disease hypothesis	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; VARIANT CJD; BSE; TRANSMISSION; SCRAPIE; EPIDEMIOLOGY; PROTEIN	The cause of the original case or cases of bovine spongiform encephalopathy (BSE) remains an enigma. Sheep scrapie or a previously undetected sporadic bovine transmissible spongiform encephalopathy (TSE) have long been considered as candidates, but no convincing evidence to support these proposals has come to light. We present a new theory, with three related hypotheses: (1) that BSE was acquired from a human TSE (prion disease); (2) that the route of infection was oral, through animal feed containing imported mammalian raw materials contaminated with human remains; and (3) that the origin was the Indian subcontinent, from which large amounts of mammalian material were imported during the relevant time period. Human remains are known to be incorporated into meal made locally, and may still be entering exported material. Further investigations are needed into the sources of animal by-products used in animal feed manufacture, and into the the transmissibility of human TSEs to cattle.	Univ Kent, Kent Inst Med & Hlth Sci, Canterbury CT2 7PD, Kent, England; Univ Edinburgh, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland	University of Kent; University of Edinburgh	Colchester, ACF (corresponding author), Univ Kent, Kent Inst Med & Hlth Sci, Canterbury CT2 7PD, Kent, England.	a.colchester@kent.ac.uk						*AG FRANC PRESS, 2001, HUM SKULLS BON TRAD; Alley KD, 2002, BANKS GANGA; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BROWN P, 1987, NEUROLOGY, V37, P895, DOI 10.1212/WNL.37.6.895; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; BROWN P, 2001, EARLY ONSET DEMENTIA, P361; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Chesebro B, 2004, SCIENCE, V305, P1918, DOI 10.1126/science.1103581; Cohen CH, 1999, INT J EPIDEMIOL, V28, P526, DOI 10.1093/ije/28.3.526; CUTLIP RC, 1994, J INFECT DIS, V169, P814, DOI 10.1093/infdis/169.4.814; Cutlip RC, 2001, CAN J VET RES, V65, P131; DUBOIS G, 1967, AURORE          0917; Ford J, 2005, J NEUROL NEUROSUR PS, V76, P608; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Glatzel M, 2003, LANCET NEUROL, V2, P757, DOI 10.1016/S1474-4422(03)00588-X; *GOV E PAK, 1957, REP MARK BON E PAK, P3; Hainfellner JA, 1999, ANN NEUROL, V45, P812; Head MW, 2005, LANCET, V365, P730; Hope J, 1999, J GEN VIROL, V80, P1, DOI 10.1099/0022-1317-80-1-1; HORN G, 2001, REV ORIGIN BSE, P1; *IND MIN FOOD AGR, 1958, REP MARK BON BON IND, P1; *MAFF, 1969, 287361 MAFF UK NAT A; NARAIN S, 1992, CTR SCI ENV ANN REPO; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Phillips NA, 2000, BSE INQUIRY; Priola SA, 2004, LANCET, V363, P2013, DOI 10.1016/S0140-6736(04)16487-8; RAO PV, 1965, INDIAN PRACT, V16, P439; SATISCHANDRA P, 1997, CREUTZFELDT SYNDROME, P1; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Smith PG, 2003, BRIT MED BULL, V66, P185, DOI 10.1093/bmb/66.1.185; Tateishi J, 1996, SEMIN VIROL, V7, P175, DOI 10.1006/smvy.1996.0022; Taylor DM, 2003, BRIT MED BULL, V66, P293, DOI 10.1093/bmb/66.1.293; Taylor DM, 2003, REV SCI TECH OIE, V22, P297, DOI 10.20506/rst.22.1.1400; Taylor K, 1995, VET REC, V137, P674; WHO, 1998, GLOB SURV DIAGN THER, V2, P1, DOI DOI 10.1016/J.KJMS; WILESMITH JW, 1988, VET REC, V123, P638; 2004, ECOFRIENDS GANGA LIT	38	41	45	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2005	366	9488					856	861		10.1016/S0140-6736(05)67218-2	http://dx.doi.org/10.1016/S0140-6736(05)67218-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139661				2022-12-28	WOS:000231627000031
J	Scott, PG; Tredget, EE				Scott, PG; Tredget, EE			Skin construct or biological bandage?	LANCET			English	Editorial Material							KERATINOCYTES; SUBSTRATE; COLLAGEN; WOUNDS; BURNS		Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Surg, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Scott, PG (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	scottp@ualberta.ca						Boyce ST, 2002, AM J SURG, V183, P445, DOI 10.1016/S0002-9610(02)00813-9; BOYCE ST, 1988, SURGERY, V103, P421; DEMLING RH, 1985, NEW ENGL J MED, V313, P1389, DOI 10.1056/NEJM198511283132205; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; HANSBROUGH JF, 1989, JAMA-J AM MED ASSOC, V262, P2125, DOI 10.1001/jama.262.15.2125; Hohlfeld J, 2005, LANCET, V366, P840, DOI 10.1016/S0140-6736(05)67107-3; MONAFO WW, 2002, TOTAL BURN CARE; Wolf SE, 1997, ANN SURG, V225, P554, DOI 10.1097/00000658-199705000-00012; YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899	10	3	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 3	2005	366	9488					788	790		10.1016/S0140-6736(05)67192-9	http://dx.doi.org/10.1016/S0140-6736(05)67192-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139640				2022-12-28	WOS:000231627000007
J	Zhao, AD; Li, QX; Chen, L; Xiang, HJ; Wang, WH; Pan, S; Wang, B; Xiao, XD; Yang, JL; Hou, JG; Zhu, QS				Zhao, AD; Li, QX; Chen, L; Xiang, HJ; Wang, WH; Pan, S; Wang, B; Xiao, XD; Yang, JL; Hou, JG; Zhu, QS			Controlling the Kondo effect of an adsorbed magnetic ion through its chemical bonding	SCIENCE			English	Article							SCANNING-TUNNELING-MICROSCOPY; QUANTUM-DOT; CARBON NANOTUBES; SPIN; RESONANCE; PHTHALOCYANINE; SPECTROSCOPY; IMPURITY; STATES; ATOM	We report that the Kondo effect exerted by a magnetic ion depends on its chemical environment. A cobalt phthalocyanine molecule adsorbed on an Au(111) surface exhibited no Kondo effect. Cutting away eight hydrogen atoms from the molecule with voltage pulses from a scanning tunneling microscope tip allowed the four orbitals of this molecule to chemically bond to the gold substrate. The localized spin was recovered in this artificial molecular structure, and a clear Kondo resonance was observed near the Fermi surface. We attribute the high Kondo temperature (more than 200 kelvin) to the small on-site Coulomb repulsion and the large half-width of the hybridized d-level.	Univ Sci & Technol China, Hefei Natl lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Yang, JL (corresponding author), Univ Sci & Technol China, Hefei Natl lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	jlyang@ustc.edu.cn; jghou@ustc.edu.cn	Hou, Jianguo/G-5076-2010; pan, shuan/K-8739-2012; Zhao, Aidi/B-1369-2009; Xiang, Hongjun/A-4076-2008; Li, Qunxiang/D-3705-2009; Wang, Bing/D-3535-2009; Chen, Lan/D-3622-2013; Xiang, Hongjun/I-4305-2016; Wang, Weihua/K-1297-2012; Yang, Jinlong/D-3465-2009	Zhao, Aidi/0000-0002-6546-4610; Li, Qunxiang/0000-0003-1988-1971; Wang, Bing/0000-0002-2953-2196; Chen, Lan/0000-0003-4426-9944; Xiang, Hongjun/0000-0002-9396-3214; Wang, Weihua/0000-0002-2269-1952; 				ASSOUR JM, 1965, J AM CHEM SOC, V87, P4701, DOI 10.1021/ja00949a008; Barlow DE, 2004, LANGMUIR, V20, P4413, DOI 10.1021/la035879l; Craig NJ, 2004, SCIENCE, V304, P565, DOI 10.1126/science.1095452; Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Hewson A C, 1993, KONDO PROBLEM HEAVY; Jamneala T, 2000, PHYS REV B, V61, P9990, DOI 10.1103/PhysRevB.61.9990; Jeong H, 2001, SCIENCE, V293, P2221, DOI 10.1126/science.1063182; Ji Y, 2000, SCIENCE, V290, P779, DOI 10.1126/science.290.5492.779; Komeda T, 2004, J CHEM PHYS, V120, P5347, DOI 10.1063/1.1647044; Lauhon LJ, 2000, J PHYS CHEM A, V104, P2463, DOI 10.1021/jp991768c; Li JT, 1998, PHYS REV LETT, V80, P2893, DOI 10.1103/PhysRevLett.80.2893; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; LIN HQ, 1988, PHYS REV B, V37, P1864, DOI 10.1103/PhysRevB.37.1864; Lu X, 1996, J AM CHEM SOC, V118, P7197, DOI 10.1021/ja960874e; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; Nagaoka K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077205; Nygard J, 2000, NATURE, V408, P342, DOI 10.1038/35042545; Odom TW, 2000, SCIENCE, V290, P1549, DOI 10.1126/science.290.5496.1549; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Pasupathy AN, 2004, SCIENCE, V306, P86, DOI 10.1126/science.1102068; REYNOLDS PA, 1991, INORG CHEM, V30, P2294, DOI 10.1021/ic00010a015; ROSA A, 1994, INORG CHEM, V33, P584, DOI 10.1021/ic00081a029; Sasaki S, 2000, NATURE, V405, P764, DOI 10.1038/35015509; TERSOFF J, 1985, PHYS REV B, V31, P805, DOI 10.1103/PhysRevB.31.805; Ujsaghy O, 2000, PHYS REV LETT, V85, P2557, DOI 10.1103/PhysRevLett.85.2557; van der Wiel WG, 2000, SCIENCE, V289, P2105, DOI 10.1126/science.289.5487.2105; Wahl P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.176603; Yu LH, 2004, NANO LETT, V4, P79, DOI 10.1021/nl034893f	32	545	559	14	386	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1542	1544		10.1126/science.1113449	http://dx.doi.org/10.1126/science.1113449			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141069				2022-12-28	WOS:000231715000044
J	Mikkelsen, TS; Hillier, LW; Eichler, EE; Zody, MC; Jaffe, DB; Yang, SP; Enard, W; Hellmann, I; Lindblad-Toh, K; Altheide, TK; Archidiacono, N; Bork, P; Butler, J; Chang, JL; Cheng, Z; Chinwalla, AT; deJong, P; Delehaunty, KD; Fronick, CC; Fulton, LL; Gilad, Y; Glusman, G; Gnerre, S; Graves, TA; Hayakawa, T; Hayden, KE; Huang, XQ; Ji, HK; Kent, WJ; King, MC; Kulbokas, EJ; Lee, MK; Liu, G; Lopez-Otin, C; Makova, KD; Man, O; Mardis, ER; Mauceli, E; Miner, TL; Nash, WE; Nelson, JO; Paabo, S; Patterson, NJ; Pohl, CS; Pollard, KS; Prufer, K; Puente, XS; Reich, D; Rocchi, M; Rosenbloom, K; Ruvolo, M; Richter, DJ; Schaffner, SF; Smit, AFA; Smith, SM; Suyama, M; Taylor, J; Torrents, D; Tuzun, E; Varki, A; Velasco, G; Ventura, M; Wallis, JW; Wendl, MC; Wilson, RK; Lander, ES; Waterston, RH				Mikkelsen, TS; Hillier, LW; Eichler, EE; Zody, MC; Jaffe, DB; Yang, SP; Enard, W; Hellmann, I; Lindblad-Toh, K; Altheide, TK; Archidiacono, N; Bork, P; Butler, J; Chang, JL; Cheng, Z; Chinwalla, AT; deJong, P; Delehaunty, KD; Fronick, CC; Fulton, LL; Gilad, Y; Glusman, G; Gnerre, S; Graves, TA; Hayakawa, T; Hayden, KE; Huang, XQ; Ji, HK; Kent, WJ; King, MC; Kulbokas, EJ; Lee, MK; Liu, G; Lopez-Otin, C; Makova, KD; Man, O; Mardis, ER; Mauceli, E; Miner, TL; Nash, WE; Nelson, JO; Paabo, S; Patterson, NJ; Pohl, CS; Pollard, KS; Prufer, K; Puente, XS; Reich, D; Rocchi, M; Rosenbloom, K; Ruvolo, M; Richter, DJ; Schaffner, SF; Smit, AFA; Smith, SM; Suyama, M; Taylor, J; Torrents, D; Tuzun, E; Varki, A; Velasco, G; Ventura, M; Wallis, JW; Wendl, MC; Wilson, RK; Lander, ES; Waterston, RH		Chimpanzee Sequencing Analysis Consortium	Initial sequence of the chimpanzee genome and comparison with the human genome	NATURE			English	Review							CHROMOSOME FUSION SITE; DNA-SEQUENCES; GREAT APE; ACCELERATED EVOLUTION; DELETERIOUS MUTATIONS; BACKGROUND SELECTION; MOLECULAR EVOLUTION; RECOMBINATION RATES; POSITIVE SELECTION; SUBSTITUTION RATES	Here we present a draft genome sequence of the common chimpanzee ( Pan troglodytes). Through comparison with the human genome, we have generated a largely complete catalogue of the genetic differences that have accumulated since the human and chimpanzee species diverged from our common ancestor, constituting approximately thirty-five million single-nucleotide changes, five million insertion/deletion events, and various chromosomal rearrangements. We use this catalogue to explore the magnitude and regional variation of mutational forces shaping these two genomes, and the strength of positive and negative selection acting on their genes. In particular, we find that the patterns of evolution in human and chimpanzee protein-coding genes are highly correlated and dominated by the fixation of neutral and slightly deleterious alleles. We also use the chimpanzee genome as an outgroup to investigate human population genetics and identify signatures of selective sweeps in recent human evolution.	Univ Washington, Sch Med, Seattle, WA 98195 USA; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Univ Calif San Diego, La Jolla, CA 92093 USA; Univ Bari, Dept Genet & Microbiol, I-70126 Bari, Italy; European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Inst Syst Biol, Seattle, WA 98103 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA; Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Oviedo, Inst Univ Oncol Principado Asturias, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Max Planck Society; University of California System; University of California San Diego; Universita degli Studi di Bari Aldo Moro; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Yale University; Institute for Systems Biology (ISB); Case Western Reserve University; Iowa State University; Harvard University; University of California System; University of California Santa Cruz; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Weizmann Institute of Science; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Waterston, RH (corresponding author), Univ Washington, Sch Med, 1705 NE Pacific St, Seattle, WA 98195 USA.	rwilson@watson.wustl.edu; waterston@gs.washington.edu	Bork, Peer/F-1813-2013; Velasco, Gloria/AAS-5842-2021; Schaffner, Stephen F/D-1189-2011; Puente, Xosé S./ADB-0672-2022; Tuzun, Eray/AAD-7282-2021; Mikkelsen, Tarjei S/A-1306-2007; Wendl, Michael C/A-2741-2008; Wilson, Richard K./AAF-4139-2019; Ventura, Mario/E-6420-2011; Enard, Wolfgang/K-3483-2014; López-Otín, Carlos/AAB-2106-2020; Mardis, Elaine/W-2202-2019; Tuzun, Eray/B-5949-2018; Taylor, James/F-1026-2011; Torrents, David/G-5785-2015	Bork, Peer/0000-0002-2627-833X; Velasco, Gloria/0000-0001-8032-5056; Puente, Xosé S./0000-0001-9525-1483; Tuzun, Eray/0000-0002-5550-7816; Mikkelsen, Tarjei S/0000-0002-8133-3135; Wilson, Richard K./0000-0002-1992-1358; Ventura, Mario/0000-0001-7762-8777; López-Otín, Carlos/0000-0001-6964-1904; Tuzun, Eray/0000-0002-5550-7816; Taylor, James/0000-0001-5079-840X; Suyama, Mikita/0000-0001-9526-3193; Richter, Daniel/0000-0002-9238-5571; Schaffner, Stephen/0000-0001-6699-3568; Torrents, David/0000-0002-6086-9037				Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Angata T, 2004, P NATL ACAD SCI USA, V101, P13251, DOI 10.1073/pnas.0404833101; Arya R, 2004, AM J HUM GENET, V74, P272, DOI 10.1086/381717; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Beales PL, 2001, AM J HUM GENET, V68, P606, DOI 10.1086/318794; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; BIRKY CW, 1988, P NATL ACAD SCI USA, V85, P6414, DOI 10.1073/pnas.85.17.6414; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; BULMER M, 1991, P NATL ACAD SCI USA, V88, P5974, DOI 10.1073/pnas.88.14.5974; CHARLESWORTH B, 1993, GENETICS, V133, P421; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Chen JM, 2001, HUM GENET, V109, P245, DOI 10.1007/s004390100580; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Clee SM, 2001, CIRCULATION, V103, P1198; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; CRAIG JM, 1993, BIOESSAYS, V15, P349, DOI 10.1002/bies.950150510; Cunningham JM, 2001, AM J HUM GENET, V69, P780, DOI 10.1086/323658; Darwin C., 1871, P475; Dennehey BK, 2004, GENOMICS, V83, P493, DOI 10.1016/j.ygeno.2003.08.017; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Duret L, 2002, BIOINFORMATICS, V18, pS91, DOI 10.1093/bioinformatics/18.suppl_2.S91; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; EHRLICH M, 1990, MUTAT RES, V238, P277, DOI 10.1016/0165-1110(90)90019-8; Ellegren H, 2003, CURR OPIN GENET DEV, V13, P562, DOI 10.1016/j.gde.2003.10.008; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2004, ANNU REV GENOM HUM G, V5, P351, DOI 10.1146/annurev.genom.5.061903.180040; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Eyre-Walker A, 2002, MOL BIOL EVOL, V19, P2142, DOI 10.1093/oxfordjournals.molbev.a004039; Fan Y, 2002, GENOME RES, V12, P1651, DOI 10.1101/gr.337602; Fan YX, 2002, GENOME RES, V12, P1663, DOI 10.1101/gr.338402; Fay JC, 2001, GENETICS, V158, P1227; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Frazer KA, 2003, GENOME RES, V13, P341, DOI 10.1101/gr.554603; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujiyama A, 2002, SCIENCE, V295, P131, DOI 10.1126/science.1065199; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Gagneux P, 2005, NATURE, V437, P27, DOI 10.1038/437027a; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; GOODALL J, 1964, NATURE, V201, P1264, DOI 10.1038/2011264a0; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Hardison RC, 2003, COLD SPRING HARB SYM, V68, P335, DOI 10.1101/sqb.2003.68.335; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Hayakawa T, 2005, DEV CELL, V8, P2, DOI 10.1016/j.devcel.2004.12.011; HAYAKAWA T, IN PRESS SCIENCE; Hedges DJ, 2004, GENOME RES, V14, P1068, DOI 10.1101/gr.2530404; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hellmann I, 2003, GENOME RES, V13, P831, DOI 10.1101/gr.944903; Herrmann SM, 2003, J MOL MED, V81, P327, DOI 10.1007/s00109-003-0431-1; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; HUDSON RR, 1995, GENETICS, V141, P1605; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Huxley T., 1863, EVIDENCE MANS PLACE; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Katoh T, 1999, PHARMACOGENETICS, V9, P165; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KHAITOVICH P, IN PRESS SCIENCE; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kitano T, 2003, MOL BIOL EVOL, V20, P1281, DOI 10.1093/molbev/msg134; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kulathinal RJ, 2004, SCIENCE, V306, P1553, DOI 10.1126/science.1100522; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lercher MJ, 2004, GENOME RES, V14, P1002, DOI 10.1101/gr.1597404; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; Lu Jian, 2003, Science, V302, P988; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Makalowski W, 1998, J MOL EVOL, V47, P119, DOI 10.1007/PL00006367; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Marchesani M, 2003, JNCI-J NATL CANCER I, V95, P812, DOI 10.1093/jnci/95.11.812; Mathews LM, 2003, AM J HUM GENET, V72, P739, DOI 10.1086/368275; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; McConkey EH, 2004, CYTOGENET GENOME RES, V105, P157, DOI 10.1159/000078022; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Meloni A, 2002, J CLIN ENDOCR METAB, V87, P841, DOI 10.1210/jc.87.2.841; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Moriyama EN, 1997, J MOL EVOL, V45, P378, DOI 10.1007/PL00006243; Mukhopadhyay A, 2002, MOL VIS, V8, P442; Myers G, 1999, COMPUT SCI ENG, V1, P33, DOI 10.1109/5992.764214; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Navarro A, 2003, SCIENCE, V300, P321, DOI 10.1126/science.1080600; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Ohno S., 1970, P1; OHTA T, 1995, J MOL EVOL, V40, P56, DOI 10.1007/BF00166595; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Ohta T, 1998, GENETICA, V102-3, P83, DOI 10.1023/A:1017007513825; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Pfutzer R, 2002, GUT, V50, P271, DOI 10.1136/gut.50.2.271; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Pizzuti A, 1999, DIABETES, V48, P1881, DOI 10.2337/diabetes.48.9.1881; Pruitt KD, 2003, NUCLEIC ACIDS RES, V31, P34, DOI 10.1093/nar/gkg111; Przeworski M, 2002, GENETICS, V160, P1179; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; ROSENBERG HF, 2002, RELATIONSHIP COALESC; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; SAWYER SA, 1992, GENETICS, V132, P1161; SCHROEDER SA, 1995, NAT MED, V1, P703, DOI 10.1038/nm0795-703; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SEED JR, 1990, J PROTOZOOL, V37, P393, DOI 10.1111/j.1550-7408.1990.tb01163.x; SHARP PM, 1995, PHILOS T R SOC B, V349, P241, DOI 10.1098/rstb.1995.0108; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; SHEN LM, 1994, J BIOL CHEM, V269, P8466; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Sonnenburg JL, 2004, GLYCOBIOLOGY, V14, P339, DOI 10.1093/glycob/cwh039; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stone S, 2002, AM J HUM GENET, V70, P1459, DOI 10.1086/340670; Subramanian S, 2003, GENOME RES, V13, P838, DOI 10.1101/gr.1152803; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; TAYLOR J, UNPUB MOL BIOL EVOL; TEUMER J, 1989, P NATL ACAD SCI USA, V86, P1283, DOI 10.1073/pnas.86.4.1283; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Tuchman M, 2002, HUM MUTAT, V19, P93, DOI 10.1002/humu.10035; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Varki A, 2004, NAT GENET, V36, P1034, DOI 10.1038/ng1004-1034; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wall JD, 2003, GENETICS, V163, P395; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Webster MT, 2004, MOL BIOL EVOL, V21, P1820, DOI 10.1093/molbev/msh181; Weinreich DM, 2001, J MOL EVOL, V52, P40, DOI 10.1007/s002390010132; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Williams EJB, 2000, NATURE, V407, P900, DOI 10.1038/35038066; Yang S, 2004, GENOME RES, V14, P517, DOI 10.1101/gr.1984404; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110; Yu N, 2003, GENETICS, V164, P1511; YUNIS JJ, 1980, SCIENCE, V208, P1145, DOI 10.1126/science.7375922; Zhang JZ, 2004, GENOME RES, V14, P845, DOI 10.1101/gr.1891104; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zhang ZL, 2002, GENOME RES, V12, P1466, DOI 10.1101/gr.331902	172	1195	1299	9	276	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					69	87		10.1038/nature04072	http://dx.doi.org/10.1038/nature04072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136131	Bronze			2022-12-28	WOS:000231560400045
J	Orkin, SH				Orkin, SH			Chipping away at the embryonic stem cell network	CELL			English	Editorial Material							GENE	Critical transcription factors, notably OCT4, SOX2, and NANOG, are necessary to maintain self-renewal and pluripotency, two properties characteristic of embryonic stem (ES) cells. By analyzing the genome-wide localization of these factors at promoter regions in human ES cells, Boyer et al. (2005) demonstrate frequent promoter cooccupancy at numerous target genes. As they discuss in this issue of Cell, their findings indicate the presence of a complex network of autoregulatory and feedforward loops in human ES cells.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.							Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Horak CE, 2002, METHOD ENZYMOL, V350, P469, DOI 10.1016/S0076-6879(02)50979-4; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	10	33	37	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					828	830		10.1016/j.cell.2005.09.002	http://dx.doi.org/10.1016/j.cell.2005.09.002			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179251	Bronze			2022-12-28	WOS:000232130200006
J	Moses, H; Dorsey, ER; Matheson, DHM; Thier, SO				Moses, H; Dorsey, ER; Matheson, DHM; Thier, SO			Financial anatomy of biomedical research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTERS	Context Public and private financial support of biomedical research have increased over the past decade. Few comprehensive analyses of the sources and uses of funds are available. This results in inadequate information on which to base investment decisions because not all sources allow equal latitude to explore hypotheses having scientific or clinical importance and creates a barrier to judging the value of research to society. Objective To quantify funding trends from 1994 to 2004 of basic, translational, and clinical biomedical research by principal sponsors based in the United States. Design Publicly available data were compiled for the federal, state, and local governments; foundations; charities; universities; and industry. Proprietary (by subscription but openly available) databases were used to supplement public sources. Main Outcome Measures Total actual research spending, growth rates, and type of research with inflation adjustment. Results Biomedical research funding increased from $37.1 billion in 1994 to $94.3 billion in 2003 and doubled when adjusted for inflation. Principal research sponsors in 2003 were industry (57%) and the National Institutes of Health (28%). Relative proportions from all public and private sources did not change. Industry sponsorship of clinical trials increased from $4.0 to $14.2 billion (in real terms) while federal proportions devoted to basic and applied research were unchanged. The United States spent an estimated 5.6% of its total health expenditures on biomedical research, more than any other country, but less than 0.1% for health services research. From an economic perspective, biotechnology and medical device companies were most productive, as measured by new diagnostic and therapeutic devices per dollar of research and development cost. Productivity declined for new pharmaceuticals. Conclusions Enhancing research productivity and evaluation of benefit are pressing challenges, requiring (1) more effective translation of basic scientific knowledge to clinical application; (2) critical appraisal of rapidly moving scientific areas to guide investment where clinical need is greatest, not only where commercial opportunity is currently perceived; and (3) more specific information about sources and uses of research funds than is generally available to allow informed investment decisions. Responsibility falls on industry, government, and foundations to bring these changes about with a longer-term view of research value.	Aler Inst, N Garden, VA 22959 USA; Boston Consulting Grp Inc, Bethesda, MD USA; Massachusetts Gen Hosp, Dept Med & Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; Hosp Univ Penn, Philadelphia, PA 19104 USA	Boston Consulting Group (BCG); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Rochester; University of Pennsylvania; Pennsylvania Medicine	Moses, H (corresponding author), Aler Inst, POB 150, N Garden, VA 22959 USA.	hm@alerion.us						[Anonymous], 2005, ECONOMIST       0602; *BIOT IND ORG, BIOT IND FACTS; Booth B, 2004, NAT REV DRUG DISCOV, V3, P451, DOI 10.1038/nrd1384; *BURR CO LLC, 2005, BIOT 2005 LIF SCI MO; Buxton M, 2004, B WORLD HEALTH ORGAN, V82, P733; Callahan D, 2003, CAL MILBANK BOOK HEA, V9, P1; Cohen WM, 2002, MANAGE SCI, V48, P1, DOI 10.1287/mnsc.48.1.1.14273; *CTR MED MED SERV, HLTH ACC; *CTR MED MED SERV, NAT HLTH ACC DEF SOU; *FDN CTR, 2005, FDN GROWTH GIV EST 2; *FDN CTR, 2001, FDN GIV TRENDS 2000; *FDN CTR, 2005, FDN GIV TRENDS 2005; *FDN CTR, 2004, UPD FDN HLTH POL GRA; *FDN CTR, 2005, TOP 50 US FDN AW GRA; HALL P, 1998, INNOVATIVE MILIEU CI; *I MED, 2000, TO ERR IS HUM BUILD; *I MED, 1999, STRENGTH HLTH RES AM; Jones RF, 1996, ACAD MED, V71, P300, DOI 10.1097/00001888-199603000-00027; *KAIS FAM FDN HLTH, 2004, EMPL HLTH BEN 2004 A; Kumar A., 2004, INT J COMPUTER INTER, V12, P81; Lawler A, 2004, SCIENCE, V306, P1662, DOI 10.1126/science.306.5702.1662; LAWRENCE S, 2004, TECHNOL REV      DEC, P68; LAWYER P, 2004, IN VIVO BUSINESS MED, V22, P1; Moses H, 2005, JAMA-J AM MED ASSOC, V293, P1495, DOI 10.1001/jama.293.12.1495; *NAT SCI FDN DIV S, 2004, PUBL NAT SCI FDN DIV; *OFF SCI POL PLANN, BIOM RES DEV PRIC IN; Okie S, 2005, NEW ENGL J MED, V352, P1063, DOI 10.1056/NEJMp058003; OMARA MP, 2004, CITIES KNOWLEDGE COL; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Owen-Smith J, 2002, MANAGE SCI, V48, P24, DOI 10.1287/mnsc.48.1.24.14275; *PHARM RES MAN AM, 2000, PHARM IND PROF 2000; *PHARM RES MAN AM, 1999, PHARM IND PROF 1999; *PHARM RES MAN AM, 2001, PHARM IND PROF 2001; *PHARM RES MAN AM, 2003, PHARM IND PROF 2003; *PHARM RES MAN AM, 1998, PHARM IND PROF 1998; *PHARM RES MAN AM, 2005, PHARM IND PROF 2005; *PHARM RES MAN AM, 2004, PHARM IND PROF 2004; *PHARM RES MAN AM, 1996, PHARM IND PROF 1996; Pharmaceutical Research and Manufacturers of America, 2002, PHARM IND PROF 2002; Rosenberg RN, 2003, JAMA-J AM MED ASSOC, V289, P1305, DOI 10.1001/jama.289.10.1305; Rovner AR, 2003, HEALTH CARE MANAGE R, V28, P319, DOI 10.1097/00004010-200310000-00004; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; *U CAL, 1995, TRENDS US FUND BIOM; *US BUR CENS, 1999, STAT ABSTR US SCI TE; *US FDA, 2004, 2004 ANN REP; Weissman JS, 1999, JAMA-J AM MED ASSOC, V281, P1093, DOI 10.1001/jama.281.12.1093	46	298	306	1	61	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1333	1342		10.1001/jama.294.11.1333	http://dx.doi.org/10.1001/jama.294.11.1333			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965YW	16174691	Bronze			2022-12-28	WOS:000231987800006
J	Chodosh, J; Morton, SC; Mojica, W; Maglione, M; Suttorp, MJ; Hilton, L; Rhodes, S; Shekelle, P				Chodosh, J; Morton, SC; Mojica, W; Maglione, M; Suttorp, MJ; Hilton, L; Rhodes, S; Shekelle, P			Meta-analysis: Chronic disease self-management programs for older adults	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DEPENDENT DIABETES-MELLITUS; LIFE-STYLE MODIFICATION; BLOOD-PRESSURE; PRIMARY-CARE; PATIENT EDUCATION; METABOLIC-CONTROL; GLYCEMIC CONTROL; CHRONIC ILLNESS; CARDIOVASCULAR-DISEASE	Background: Although enthusiasm is growing for self-management programs for chronic conditions, there are conflicting data regarding their effectiveness and no agreement on their essential components. Purpose: To assess the effectiveness and essential components of self-management programs for hypertension, osteoarthritis, and diabetes mellitus. Data Sources: The authors searched multiple sources dated through September 2004, including the Cochrane Library, MEDLINE, PSycINFO, and Nursing and Allied Health databases, and bibliographies of 87 previous reviews. Study Selection: Randomized trials that compared outcomes of self-management interventions with a control or with usual care for diabetes mellitus, osteoarthritis, or hypertension; outcomes included hemoglobin A,c level, fasting blood glucose level, weight, blood pressure, pain, or function. Data Extraction: Two reviewers independently identified trials and extracted data regarding whether the intervention used tailored adjustments to meet individual patient needs, a group setting, feedback, and psychological services, and whether the intervention was provided by the patient's usual physician. Data Synthesis: Of 780 studies screened, 53 studies contributed data to the random-effects meta-analysis (26 diabetes studies, 14 osteoarthritis studies, and 13 hypertension studies). Self-management interventions led to a statistically and clinically significant pooled effect size of -0.36 (95% CI, -0.52 to -0.21) for hemoglobin A,c, equivalent to a reduction in hemoglobin A,, level of about 0.81%. Self-management interventions decreased systolic blood pressure by 5 mm Hg (effect size, -0.39 [CI, -0.51 to -0.28]) and decreased diastolic blood pressure by 4.3 mm Hg (effect size, -0.51 [CI, -0.73 to -0.30]). Pooled effects of self-management interventions were statistically significant but clinically trivial for pain and function outcomes for osteoarthritis. No consistent results supported any of the 5 characteristics examined as essential for program success. Limitations: Studies had variable quality, and possible publication bias was evident. Conclusions: Self-management programs for diabetes mellitus and hypertension probably produce clinically important benefits. The elements of the programs most responsible for benefits cannot be determined from existing data, and this inhibits specification of optimally effective or cost-effective programs. Osteoarthritis self-management programs do not appear to have clinically beneficial effects on pain or function.	Greater Los Angeles Vet Affairs Healthcare Syst, GRECC 11G, Los Angeles, CA 90073 USA; So Calif Evidence Based Practice Ctr, RAND Hlth Div, Santa Monica, CA USA; Univ Calif Los Angeles, Los Angeles, CA USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation; University of California System; University of California Los Angeles	Chodosh, J (corresponding author), Greater Los Angeles Vet Affairs Healthcare Syst, GRECC 11G, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.			Chodosh, Joshua/0000-0001-7784-4306				Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Barlow JH, 2000, HEALTH EDUC RES, V15, P665, DOI 10.1093/her/15.6.665; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Birtwhistle RV, 2004, BMJ-BRIT MED J, V328, P204, DOI 10.1136/bmj.37967.374063.EE; Blixen CE, 2004, J TELEMED TELECARE, V10, P44, DOI 10.1258/135763304322764194; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Brown SA, 2002, DIABETES CARE, V25, P259, DOI 10.2337/diacare.25.2.259; CAMPBELL LV, 1990, DIABETES CARE, V13, P841, DOI 10.2337/diacare.13.8.841; Cappuccio FP, 2004, BMJ-BRIT MED J, V329, P145, DOI 10.1136/bmj.38121.684410.AE; CARNEY N, 2000, ASSESSMENT SELF CARE; *CDCP, 1997, UNR PREV OPP RED HLT; Cooper AR, 2000, BRIT J GEN PRACT, V50, P958; *CTR ADV HLTH, 1996, IND BIBL SELF MAN PE; DERAMOMELKUS GA, 1992, DIABETES CARE, V15, P864, DOI 10.2337/diacare.15.7.864; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edworthy SM, 1999, J RHEUMATOL, V26, P1793; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; ELSHAWS EB, 1994, DIABETES EDUCATOR, V20, P228, DOI 10.1177/014572179402000309; Falkenberg M G, 1986, Scand J Prim Health Care, V4, P157, DOI 10.3109/02813438609014823; FRANSEN M, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004376; Fried LP, 2000, EPIDEMIOL REV, V22, P95, DOI 10.1093/oxfordjournals.epirev.a018031; FROST G, 1994, DIABETIC MED, V11, P397, DOI 10.1111/j.1464-5491.1994.tb00292.x; GIVEN CW, 1984, PATIENT EDUC COUNS, V6, P131, DOI 10.1016/0738-3991(84)90070-3; Glasgow RE, 2001, PATIENT EDUC COUNS, V44, P119, DOI 10.1016/S0738-3991(00)00186-5; GLASGOW RE, 1992, PATIENT EDUC COUNS, V19, P61, DOI 10.1016/0738-3991(92)90102-O; GOEPPINGER J, 1989, ARTHRITIS RHEUM, V32, P706, DOI 10.1002/anr.1780320608; GONZALEZFERNANDEZ RA, 1990, AM J CARDIOL, V65, P1384, DOI 10.1016/0002-9149(90)91332-Z; Goudswaard AN, 2004, DIABETIC MED, V21, P491, DOI 10.1111/j.1464-5491.2004.01153.x; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; GRUMAN J, 2002, MONOGRAPH CTR ADV HL; HAFNER RJ, 1982, BIOFEEDBACK SELF-REG, V7, P305, DOI 10.1007/BF00998923; Hedges LV, 2014, STAT METHODS META AN; HOELSCHER TJ, 1986, J CONSULT CLIN PSYCH, V54, P217, DOI 10.1037/0022-006X.54.2.217; Hopman-Rock M, 2000, J RHEUMATOL, V27, P1947; Hughes SL, 2004, GERONTOLOGIST, V44, P217, DOI 10.1093/geront/44.2.217; Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8; Jaber LA, 1996, ANN PHARMACOTHER, V30, P238, DOI 10.1177/106002809603000305; JACOB RG, 1985, BEHAV MODIF, V9, P32, DOI 10.1177/01454455850091003; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jennings P E, 1987, Diabetes Educ, V13, P390, DOI 10.1177/014572178701300407; JORGENSEN RS, 1981, BEHAV RES THER, V19, P467, DOI 10.1016/0005-7967(81)90073-5; KEEFE FJ, 1990, BEHAV THER, V21, P435, DOI 10.1016/S0005-7894(05)80357-0; Keyserling TC, 2002, DIABETES CARE, V25, P1576, DOI 10.2337/diacare.25.9.1576; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Kim HS, 2003, J ADV NURS, V44, P256, DOI 10.1046/j.1365-2648.2003.02800.x; KORHONEN T, 1983, DIABETES CARE, V6, P256, DOI 10.2337/diacare.6.3.256; KOSTIS JB, 1992, AM HEART J, V123, P466, DOI 10.1016/0002-8703(92)90662-F; Kwon HS, 2004, DIABETES CARE, V27, P478, DOI 10.2337/diacare.27.2.478; LAGRONE R, 1988, J CLIN PSYCHOL, V44, P271, DOI 10.1002/1097-4679(198803)44:2<271::AID-JCLP2270440230>3.0.CO;2-Q; Levetan CS, 2002, DIABETES CARE, V25, P2, DOI 10.2337/diacare.25.1.2; LORIG K, 1989, ARTHRITIS RHEUM, V32, P91, DOI 10.1002/anr.1780320116; LORIG K, 1986, J RHEUMATOL, V13, P763; LORIG K, 1985, ARTHRITIS RHEUM, V28, P680, DOI 10.1002/art.1780280612; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Mazzuca K B, 1997, J Community Health Nurs, V14, P211, DOI 10.1207/s15327655jchn1404_1; MCCULLOCH DK, 1983, BRIT MED J, V287, P1858, DOI 10.1136/bmj.287.6408.1858; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; MOORE H, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004097.PUB3; MUHLHAUSER I, 1993, CLIN EXP HYPERTENS, V15, P125, DOI 10.3109/10641969309041615; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Ravaud P, 2004, ANN RHEUM DIS, V63, P703, DOI 10.1136/ard.2003.009803; RAZ I, 1988, DIABETES CARE, V11, P67, DOI 10.2337/diacare.11.1.67; Ridgeway NA, 1999, SOUTHERN MED J, V92, P667, DOI 10.1097/00007611-199907000-00004; Rosenthal R, 1991, METAANALYTIC PROCEDU; Schroeder K, 2004, ARCH INTERN MED, V164, P722, DOI 10.1001/archinte.164.7.722; Schroeder K., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004804; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; SHEKELLE P, 2005, CHRONIC DIS SELF MAN; SHEKELLE PG, 1999, INTERVENTIONS INCREA; Simmons D, 2004, DIABETIC MED, V21, P214, DOI 10.1111/j.1464-5491.2004.01047.x; Solomon DH, 2002, J RHEUMATOL, V29, P362; SOUTHAM MA, 1982, ARCH GEN PSYCHIAT, V39, P715; Sweeting H L, 1994, J Nurs Manag, V2, P187, DOI 10.1111/j.1365-2834.1994.tb00152.x; TAYLOR CB, 1977, ARCH GEN PSYCHIAT, V34, P339; Tu K S, 1993, Diabetes Educ, V19, P25; VANNINEN E, 1992, DIABETOLOGIA, V35, P340, DOI 10.1007/BF00401201; Victor CR, 2004, J EVAL CLIN PRACT, V10, P63, DOI 10.1111/j.1365-2753.2003.00395.x; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; Warsi A, 2003, ARTHRITIS RHEUM-US, V48, P2207, DOI 10.1002/art.11210; WEINBERER M, 1995, J GEN INTERN MED, V10, P59, DOI 10.1007/BF02600227; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; WHITE N, 1986, DIABETES CARE, V9, P490, DOI 10.2337/diacare.9.5.490; WIERENGA ME, 1994, PATIENT EDUC COUNS, V23, P33	88	539	546	5	85	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2005	143	6					427	438		10.7326/0003-4819-143-6-200509200-00007	http://dx.doi.org/10.7326/0003-4819-143-6-200509200-00007			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967OG	16172441				2022-12-28	WOS:000232099900004
J	Sullivan, F; Wyatt, JC				Sullivan, F; Wyatt, JC			ABC of health informatics - Is a consultation needed?	BRITISH MEDICAL JOURNAL			English	Review							QUALITY; INTERNET; CANCER; MAIL		Univ Dundee, Dundee DD1 4HN, Scotland	University of Dundee	Sullivan, F (corresponding author), Univ Dundee, Dundee DD1 4HN, Scotland.		Wyatt, Jeremy/F-8160-2010; Sullivan, Frank m/A-7767-2009; Sullivan, Frank/L-8286-2019	Wyatt, Jeremy/0000-0001-7008-1473; Sullivan, Frank/0000-0002-6623-4964				Charnock D, 1999, J EPIDEMIOL COMMUN H, V53, P105, DOI 10.1136/jech.53.2.105; Finch TL, 2003, BMJ-BRIT MED J, V327, P1205, DOI 10.1136/bmj.327.7425.1205; Gagliardi A, 2002, BMJ-BRIT MED J, V324, P569, DOI 10.1136/bmj.324.7337.569; Gaster B, 2003, J GEN INTERN MED, V18, P385, DOI 10.1046/j.1525-1497.2003.20627.x; Meric F, 2002, BMJ-BRIT MED J, V324, P577, DOI 10.1136/bmj.324.7337.577; *NAT STAT OFF, 2002, INT ACC HOUS IND; Pagliari Claudia, 2005, J Med Internet Res, V7, pe9, DOI 10.2196/jmir.7.1.e9; Sands DZ, 2004, J AM MED INFORM ASSN, V11, P268, DOI 10.1197/jamia.M1576; Ziebland S, 2004, BMJ-BRIT MED J, V328, P564, DOI 10.1136/bmj.328.7439.564	9	5	5	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 17	2005	331	7517					625	627		10.1136/bmj.331.7517.625	http://dx.doi.org/10.1136/bmj.331.7517.625			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967EK	16166135	Green Published			2022-12-28	WOS:000232074100030
J	Telling, G				Telling, G			Anchors away - Of plaques and pathology in prion disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SCRAPIE INFECTIVITY; PROTEIN		Univ Kentucky, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA	University of Kentucky	Telling, G (corresponding author), Univ Kentucky, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA.		Telling, Glenn C/G-1217-2019	Telling, Glenn C/0000-0002-6294-1805				Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Race R, 1998, NATURE, V392, P770, DOI 10.1038/33834; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; Wille H, 2000, J STRUCT BIOL, V130, P323, DOI 10.1006/jsbi.2000.4242	5	2	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1177	1179		10.1056/NEJMcibr052527	http://dx.doi.org/10.1056/NEJMcibr052527			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963YG	16162891				2022-12-28	WOS:000231841900016
J	Zenz, R; Eferl, R; Kenner, L; Florin, L; Hummerich, L; Mehic, D; Scheuch, H; Angel, P; Tschachler, E; Wagner, EF				Zenz, R; Eferl, R; Kenner, L; Florin, L; Hummerich, L; Mehic, D; Scheuch, H; Angel, P; Tschachler, E; Wagner, EF			Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins	NATURE			English	Article							MICE LACKING JUNB; TRANSGENIC MICE; ACTIVATED KERATINOCYTES; DOWN-REGULATION; GROWTH-FACTOR; MOUSE MODEL; STEM-CELLS; T-CELLS; C-JUN; EXPRESSION	Psoriasis is a frequent, inflammatory disease of skin and joints with considerable morbidity. Here we report that in psoriatic lesions, epidermal keratinocytes have decreased expression of JunB, a gene localized in the psoriasis susceptibility region PSORS6. Likewise, inducible epidermal deletion of JunB and its functional companion c-Jun in adult mice leads ( within two weeks) to a phenotype resembling the histological and molecular hallmarks of psoriasis, including arthritic lesions. In contrast to the skin phenotype, the development of arthritic lesions requires T and B cells and signalling through tumour necrosis factor receptor 1 ( TNFR1). Prior to the disease onset, two chemotactic proteins (S100A8 and S100A9) previously mapped to the psoriasis susceptibility region PSORS4, are strongly induced in mutant keratinocytes in vivo and in vitro. We propose that the abrogation of JunB/activator protein 1 (AP-1) in keratinocytes triggers chemokine/cytokine expression, which recruits neutrophils and macrophages to the epidermis thereby contributing to the phenotypic changes observed in psoriasis. Thus, these data support the hypothesis that epidermal alterations are sufficient to initiate both skin lesions and arthritis in psoriasis.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Deutsch Krebsforschungszentrum, Div Signal Transduct & Growth Control, D-69120 Heidelberg, Germany; Deutsch Krebsforschungszentrum, Div Mol Genet, D-69120 Heidelberg, Germany; Med Univ Vienna, Dept Dermatol, A-1090 Vienna, Austria; Ctr Rech & Invest Epiderm & Sensorielles, F-9251 Neuilly, France	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Vienna	Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	wagner@imp.univie.ac.at		Wagner, Erwin F/0000-0001-7872-0196; Tschachler, Erwin/0000-0002-0248-1798; Kenner, Lukas/0000-0003-2184-1338; Eferl, Robert/0000-0002-6074-7144				Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Black RA, 2004, NAT GENET, V36, P934, DOI 10.1038/ng0904-934; Bonifati C, 1999, INT J DERMATOL, V38, P241, DOI 10.1046/j.1365-4362.1999.00622.x; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Campbell L, 2002, BRIT J DERMATOL, V147, P701, DOI 10.1046/j.1365-2133.2002.05009.x; Carroll JM, 1997, J INVEST DERMATOL, V108, P412, DOI 10.1111/1523-1747.ep12289702; CHENG J, 1992, GENE DEV, V6, P1444, DOI 10.1101/gad.6.8.1444; Cook PW, 1999, J INVEST DERMATOL, V113, P860, DOI 10.1046/j.1523-1747.1999.00753.x; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Elomaa O, 2004, HUM MOL GENET, V13, P1551, DOI 10.1093/hmg/ddh178; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Florin L, 2004, ONCOGENE, V23, P7005, DOI 10.1038/sj.onc.1207938; Galadari H, 2003, INT J DERMATOL, V42, P231, DOI 10.1046/j.1365-4362.2003.01449.x; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; GUO LF, 1993, EMBO J, V12, P973, DOI 10.1002/j.1460-2075.1993.tb05738.x; Hashimoto K, 2000, J DERMATOL SCI, V24, pS46, DOI 10.1016/S0923-1811(00)00141-9; JANCO RL, 1983, TRANSPLANTATION, V35, P501, DOI 10.1097/00007890-198305000-00023; Johansen C, 2004, BRIT J DERMATOL, V151, P600, DOI 10.1111/j.1365-2133.2004.06088.x; Karashima T, 1996, J DERMATOL SCI, V12, P246, DOI 10.1016/0923-1811(95)00480-7; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kong J, 2002, ARCH DERMATOL RES, V294, P370, DOI 10.1007/s00403-002-0348-5; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Namazi MR, 2004, AUTOIMMUNITY, V37, P67, DOI 10.1080/08916930310001637986; Nickoloff BJ, 2000, CUTIS, V65, P110; Nickoloff BJ, 2000, EXP DERMATOL, V9, P359, DOI 10.1034/j.1600-0625.2000.009005359.x; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Schlingemann J, 2003, INT J CANCER, V104, P699, DOI 10.1002/ijc.11008; Schon MP, 1999, J INVEST DERMATOL, V112, P405, DOI 10.1046/j.1523-1747.1999.00538.x; Semprini S, 2002, HUM GENET, V111, P310, DOI 10.1007/s00439-002-0812-5; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; UYEMURA K, 1993, J INVEST DERMATOL, V101, P701, DOI 10.1111/1523-1747.ep12371679; VanBuren V, 2002, GENOME RES, V12, P1999, DOI 10.1101/gr.633802; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Waseem A, 1999, J INVEST DERMATOL, V112, P362, DOI 10.1046/j.1523-1747.1999.00535.x; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793	50	441	482	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					369	375		10.1038/nature03963	http://dx.doi.org/10.1038/nature03963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163348				2022-12-28	WOS:000231849100044
J	Kaiser, C; Brunner-LaRocca, HP; Buser, PT; Bonetti, PO; Osswald, S; Linka, A; Bernheim, A; Zutter, A; Zellweger, M; Grize, L; Pfisterer, ME				Kaiser, C; Brunner-LaRocca, HP; Buser, PT; Bonetti, PO; Osswald, S; Linka, A; Bernheim, A; Zutter, A; Zellweger, M; Grize, L; Pfisterer, ME		BASKET Investigators	Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET)	LANCET			English	Article							CORONARY-ARTERY-DISEASE; LESIONS; REVASCULARIZATION; METAANALYSIS; REGISTRY; SIRIUS	Background No prospective trial-based data are available for incremental cost-effectiveness of drug-eluting stents (DES) compared with bare-metal stents (BMS) in unselected patients, as treated in everyday practice. Methods The Basel stent cost-effectiveness trial (BASKET) included 826 consecutive patients treated with angioplasty and stenting for 1281 de-novo lesions, irrespective of indication for angioplasty. Patients were randomised to one of two DES (Cypher, n=264; Taxus, n=281) or to a cobalt-chromium-based BMS (Vision, n=281) and followed up for 6 months for occurrence of major adverse cardiac events and costs. Analysis was by intention-to-treat. The primary endpoint was cost-effectiveness after 6 months, with effectiveness defined as reduction of major adverse cardiac events. Findings Cardiac death, myocardial infarction, or target vessel revascularisation occurred in 39 of 544 (7.2%) patients with DES and 34 of 280 (12.1%) with BMS (odds ratio 0.56, 95% Cl 0.35-0.91; p=0.02), without significant differences between the two DES. Total costs at 6 months were higher with DES (mean E10544, SD 6849) than with BMS (E9639, 9067; p<0.0001); higher stent costs of DES were not compensated for by lower follow-up costs. incremental cost-effectiveness ratio of DES compared with BMS to avoid one major event was E18311, and costs per quality-adjusted life-year gained were more than E50000. Subgroup analyses showed that DES were more cost-effective for elderly patients in specific high-risk groups. Interpretation In a real-world setting, use of DES in all patients is less cost effective than in studies with selected patients. Use of these stents could be restricted to patients in high-risk groups. Interpretation In a real-world setting, use of DES in all patients is less cost effective than in studies with selected patients. Use of these stents could be restricted to patients in high-risk groups.	Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland; Univ Basel, Inst Social & Prevent Med, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Pfisterer, ME (corresponding author), Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland.	pfisterer@email.ch	Zellweger, Michael/AAB-4859-2022; Brunner-La Rocca, Hans-Peter/AAF-7330-2021; Osswald, Stefan/A-6904-2018; Kaiser, Christoph/AAA-9284-2022	Osswald, Stefan/0000-0002-9240-6731; 				Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; BAGUST A, 2005, HEART; Brophy JM, 2005, CAN MED ASSOC J, V172, P361, DOI 10.1503/cmaj.1041486; Claude J, 2004, EUR HEART J, V25, P2195, DOI 10.1016/j.ehj.2004.09.013; Cohen DJ, 2004, CIRCULATION, V110, P508, DOI 10.1161/01.CIR.0000136821.99814.43; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Glick H A, 2001, Expert Rev Pharmacoecon Outcomes Res, V1, P25, DOI 10.1586/14737167.1.1.25; Greenberg D, 2004, J AM COLL CARDIOL, V43, P513, DOI 10.1016/j.jacc.2003.11.020; Greiner W, 2005, Eur J Health Econ, V6, P124, DOI 10.1007/s10198-004-0264-z; Greiner Wolfgang, 2003, Eur J Health Econ, V4, P222, DOI 10.1007/s10198-003-0182-5; Kastrati A, 2005, JAMA-J AM MED ASSOC, V294, P819, DOI 10.1001/jama.294.7.819; Kereiakes DJ, 2003, AM J CARDIOL, V92, P463, DOI 10.1016/S0002-9149(03)00669-6; Kereiakes DJ, 2003, CIRCULATION, V107, P3012, DOI 10.1161/01.CIR.0000079940.15982.75; Lemos PA, 2004, CIRCULATION, V109, P190, DOI 10.1161/01.CIR.0000109138.84579.FA; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; MORICE MC, 2005, 2005 ANN SCI SESS AM; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; O'Neill WW, 2003, CIRCULATION, V107, P3008, DOI 10.1161/01.CIR.0000079018.84618.0E; Ong ATL, 2005, J AM COLL CARDIOL, V45, P1135, DOI 10.1016/j.jacc.2005.01.008; Polsky D, 1997, HEALTH ECON, V6, P243, DOI 10.1002/(SICI)1099-1050(199705)6:3<243::AID-HEC269>3.0.CO;2-Z; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Shrive FM, 2005, CAN MED ASSOC J, V172, P345, DOI 10.1503/cmaj.1041062; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; THOMAS MR, 2005, HEART; van Hout BA, 2005, HEART, V91, P507, DOI 10.1136/hrt.2004.034454; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175	28	282	299	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					921	929		10.1016/S0140-6736(05)67221-2	http://dx.doi.org/10.1016/S0140-6736(05)67221-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154019				2022-12-28	WOS:000231770000030
J	Taylor, GJ; Wainwright, P				Taylor, GJ; Wainwright, P			Open label extension studies: research or marketing?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Bath, Sch Hlth, Res & Dev Support Unit, Bath BA1 3NG, Avon, England; Kingston Univ, Fac Hlth & Social Care Sci, London, England; St George Hosp, Sch Med, London, England	University of Bath; Kingston University; St Georges University London	Taylor, GJ (corresponding author), Univ Bath, Sch Hlth, Res & Dev Support Unit, Bath BA1 3NG, Avon, England.	G.J.Taylor@bath.ac.uk						Blader JC, 2005, CONTEMP CLIN TRIALS, V26, P290, DOI 10.1016/j.cct.2005.01.003; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; Micetich KC, 1996, CAMB Q HEALTHC ETHIC, V5, P410, DOI 10.1017/S0963180100007210; Wainwright P, 2002, J MED ETHICS, V28, P373, DOI 10.1136/jme.28.6.373	4	38	38	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 10	2005	331	7516					572	574		10.1136/bmj.331.7516.572	http://dx.doi.org/10.1136/bmj.331.7516.572			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965GX	16150772	Green Published, Green Accepted			2022-12-28	WOS:000231939700024
J	Wyatt, JC; Sullivan, F				Wyatt, JC; Sullivan, F			ABC of health informatics - What is health information?	BRITISH MEDICAL JOURNAL			English	Review									Univ Dundee, Dundee DD1 4HN, Scotland	University of Dundee	Wyatt, JC (corresponding author), Univ Dundee, Dundee DD1 4HN, Scotland.		Sullivan, Frank m/A-7767-2009; Sullivan, Frank/L-8286-2019; Wyatt, Jeremy/F-8160-2010	Sullivan, Frank/0000-0002-6623-4964; Wyatt, Jeremy/0000-0001-7008-1473				Brody H., 1987, STORIES SICKNESS; HERSH W, WHAT IS MED INFORMAT; Morris AD, 1997, BMJ-BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524; NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X; Nygren E, 1998, LANCET, V352, P1462, DOI 10.1016/S0140-6736(97)08307-4; PENDLETON D, 1987, CONSULTATION APPROAC; TANENBAUM SJ, 1993, NEW ENGL J MED, V329, P1268, DOI 10.1056/NEJM199310213291713; VANBEMMEL JH, 1997, HDB MED INFORMATICS	8	12	12	3	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 10	2005	331	7516					566	568		10.1136/bmj.331.7516.566	http://dx.doi.org/10.1136/bmj.331.7516.566			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965GX	16150770	Green Published			2022-12-28	WOS:000231939700022
J	Rink, J; Ghigo, E; Kalaidzidis, Y; Zerial, M				Rink, J; Ghigo, E; Kalaidzidis, Y; Zerial, M			Rab conversion as a mechanism of progression from early to late endosomes	CELL			English	Article							ENDOCYTIC PATHWAY; MEMBRANE-FUSION; PHAGOSOME MATURATION; NUCLEOTIDE EXCHANGE; SORTING ENDOSOMES; VACUOLE FUSION; YEAST VACUOLE; LIVING CELLS; TRANSPORT; PROTEIN	The mechanisms of endosome biogenesis and maintenance are largely unknown. The small GTPases Rab5 and Rab7 are key determinants of early and late endosomes, organizing effector proteins into specific membrane subdomains. Whether such Rab machineries ate indefinitely maintained on membranes or can disassemble in the course of cargo transport is an open question. Here, we combined novel image-analysis algorithms with fast live-cell imaging. We found that the level of Rab5 dynamically fluctuates on individual early endosomes, linked by fusion and fission events into a network in time. Within it, degradative cargo concentrates in progressively fewer and larger endosomes that migrate from the cell periphery to the center where Rab5 is rapidly replaced with Rab7. The class C VPS/HOPS complex, an established GEF for Rab7 interacts with Rab5 and is required for Rab5-to-Rab7 conversion. Our results reveal unexpected dynamics of Rab domains and suggest Rab conversion as the mechanism of cargo progression between early and late endosomes.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Fac Med Marseille, CNRS, UPRES A6020, Unite Rickettsies, F-13385 Marseille, France; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Lomonosov Moscow State University	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Eric, Ghigo/N-9427-2016; Kalaidzidis, Yannis/H-3094-2016	Kalaidzidis, Yannis/0000-0002-6137-1193				ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; Griffiths G, 1991, Trends Cell Biol, V1, P5, DOI 10.1016/0962-8924(91)90047-D; GRIFFITHS G, 1989, J CELL BIOL, V109, P2703, DOI 10.1083/jcb.109.6.2703; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; HELENIUS A, 1983, TRENDS BIOCHEM SCI, V8, P245, DOI 10.1016/0968-0004(83)90350-X; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Kim BY, 2001, J BIOL CHEM, V276, P29393, DOI 10.1074/jbc.M101778200; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Murphy R F, 1991, Trends Cell Biol, V1, P77, DOI 10.1016/0962-8924(91)90022-2; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; Rothman JE, 1997, SCIENCE, V276, P1212, DOI 10.1126/science.276.5316.1212; SALZMAN NH, 1989, J CELL BIOL, V109, P2097, DOI 10.1083/jcb.109.5.2097; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Verestoy J., 1999, Machine Graphics & Vision, V8, P553; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	48	1138	1170	3	124	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					735	749		10.1016/j.cell.2005.06.043	http://dx.doi.org/10.1016/j.cell.2005.06.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143105	Bronze			2022-12-28	WOS:000231844300013
J	Beckmann, B; Flogel, S; Hofmann, P; Schulz, M; Wagner, T				Beckmann, B; Flogel, S; Hofmann, P; Schulz, M; Wagner, T			Orbital forcing of Cretaceous river discharge in tropical Africa and ocean response	NATURE			English	Article							SURFACE	The tropics have been suggested as the drivers of global ocean and atmosphere circulation and biogeochemical cycling during the extreme warmth of the Cretaceous period(1,2); but the links between orbital forcing, freshwater runoff and the biogeochemistry of continental margins in extreme greenhouse conditions are not fully understood. Here we present Cretaceous records of geochemical tracers for freshwater runoff obtained from a sediment core off the Ivory Coast that indicate that alternating periods of arid and humid African climate were driven by orbital precession. Our simulations of the precession-driven patterns of river discharge with a global climate model suggest that ocean anoxia and black shale sedimentation were directly caused by high river discharge, and occurred specifically when the northern equinox coincided with perihelion ( the minimum distance between the Sun and the Earth). We conclude that, in a warm climate, the oceans off tropical continental margins respond rapidly and sensitively to even modest changes in river discharge.	Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Bremen, Dept Geosci, D-28357 Bremen, Germany; IFM GEOMAR Leibniz Inst Marine Sci, D-24148 Kiel, Germany; Univ Cologne, Inst Geol & Mineral, D-50674 Cologne, Germany; Univ Bremen, Res Ctr Ocean Margins, D-28357 Bremen, Germany	Newcastle University - UK; University of Bremen; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Cologne; University of Bremen	Wagner, T (corresponding author), Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	thomas.wagner@ncl.ac.uk	Schulz, Michael/P-7276-2016; Flögel, Sascha/AAC-7786-2022; Wagner, Thomas/F-8734-2011	Schulz, Michael/0000-0001-6500-2697; Wagner, Thomas/0000-0001-5006-625X; Hofmann, Peter/0000-0002-9796-0352				ALYCHUNSKAYA NM, 1978, STUDIES REPORTS HYDR, V25, P568; Beckmann B, 2005, SOC SEDIMENT GEOL SP, V82, P125; Bice KL, 1997, GEOLOGY, V25, P951, DOI 10.1130/0091-7613(1997)025<0951:CRAECB>2.3.CO;2; Calvert S.E., 1976, CHEM OCEANOGR, V6, P187, DOI DOI 10.1016/B978-0-12-588606-2.50014-X; DEAN WE, 1984, INITIAL REP DEEP SEA, V75, P819; DeConto RM, 1999, GEOLOGICAL SOC AM SP, V332, P391, DOI DOI 10.1130/0-8137-2332-9.391; DIESTERHAASS L, 1993, MAR GEOL, V114, P233, DOI 10.1016/0025-3227(93)90030-Y; Erlich RN, 1999, CRETACEOUS RES, V20, P547, DOI 10.1006/cres.1999.0167; HAY WW, 1999, EVOLUTION CRETACEOUS; Hofmann P, 2003, GEOLOGY, V31, P135, DOI 10.1130/0091-7613(2003)031<0135:MTCSRO>2.0.CO;2; Holbourn A, 1999, GEOL SOC SPEC PUBL, V153, P195, DOI 10.1144/GSL.SP.1999.153.01.13; KUHNT W, 2004, ODP SCI RES, V159, P389; Norris RD, 2002, GEOLOGY, V30, P299, DOI 10.1130/0091-7613(2002)030<0299:JTTTIT>2.0.CO;2; REY O, 2000, SEDIMENT GEOL, V170, P85; Rusk DC, 2002, AAPG MEMOIR, V74, P429; Shipboard Scientific Party, 2004, P OCEAN DRILL PROGRA, P1, DOI [10.2973/odp.proc.ir.207.105.2004, DOI 10.2973/ODP.PROC.IR.207.105.2004]; THOMPSON SL, 1995, J CLIMATE, V8, P732, DOI 10.1175/1520-0442(1995)008<0732:AGCMWA>2.0.CO;2; Wagner T, 2004, PALEOCEANOGRAPHY, V19, DOI [10.1029/2004PA001087, 10.1029/2003PA000898]; Wagner T, 2002, PALAEOGEOGR PALAEOCL, V179, P113, DOI 10.1016/S0031-0182(01)00415-1; Watkins David K., 1998, Proceedings of the Ocean Drilling Program Scientific Results, V159, P319; Wilson PA, 2001, NATURE, V412, P425, DOI 10.1038/35086553; Yarincik KM, 2000, PALEOCEANOGRAPHY, V15, P593, DOI 10.1029/1999PA000401; Zabel M, 2001, QUATERNARY RES, V56, P207, DOI 10.1006/qres.2001.2261	23	110	114	4	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					241	244		10.1038/nature03976	http://dx.doi.org/10.1038/nature03976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148930				2022-12-28	WOS:000231696900052
J	Collin, D; Ritort, F; Jarzynski, C; Smith, SB; Tinoco, I; Bustamante, C				Collin, D; Ritort, F; Jarzynski, C; Smith, SB; Tinoco, I; Bustamante, C			Verification of the Crooks fluctuation theorem and recovery of RNA folding free energies	NATURE			English	Article							NONEQUILIBRIUM; MOLECULES; ERROR; FORCE	Atomic force microscopes and optical tweezers are widely used to probe the mechanical properties of individual molecules and molecular interactions, by exerting mechanical forces that induce transitions such as unfolding or dissociation. These transitions often occur under nonequilibrium conditions and are associated with hysteresis effects - features usually taken to preclude the extraction of equilibrium information from the experimental data. But fluctuation theorems(1-5) allow us to relate the work along nonequilibrium trajectories to thermodynamic free-energy differences. They have been shown to be applicable to single-molecule force measurements(6) and have already provided information on the folding free energy of a RNA hairpin(7,8). Here we show that the Crooks fluctuation theorem(9) can be used to determine folding free energies for folding and unfolding processes occurring in weak as well as strong nonequilibrium regimes, thereby providing a test of its validity under such conditions. We use optical tweezers(10) to measure repeatedly the mechanical work associated with the unfolding and refolding of a small RNA hairpin(11) and an RNA three-helix junction(12). The resultant work distributions are then analysed according to the theorem and allow us to determine the difference in folding free energy between an RNA molecule and a mutant differing only by one base pair, and the thermodynamic stabilizing effect of magnesium ions on the RNA structure.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Merck & Co Inc, Automated Biotechnol Dept, N Wales, PA 19454 USA; Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain; Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Merck & Company; University of Barcelona; United States Department of Energy (DOE); Los Alamos National Laboratory	Bustamante, C (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	ritort@ffn.ub.es; carlos@alice.berkeley.edu	Jarzynski, Chris/B-4490-2009	Jarzynski, Chris/0000-0002-3464-2920; Bustamante, Carlos/0000-0002-2970-0073	NIGMS NIH HHS [R01 GM010840] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; CARRIONVAZQUEZ M, IN PRESS BIOPHYS MON; Cate JH, 1996, STRUCTURE, V4, P1221, DOI 10.1016/S0969-2126(96)00129-3; Ciliberto S, 1998, J PHYS IV, V8, P215, DOI 10.1051/jp4:1998629; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; EVANS DJ, 1993, PHYS REV LETT, V71, P2401, DOI 10.1103/PhysRevLett.71.2401; Evans DJ, 2002, ADV PHYS, V51, P1529, DOI 10.1080/00018730210155133; GALLAVOTTI G, 1995, PHYS REV LETT, V74, P2694, DOI 10.1103/PhysRevLett.74.2694; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Hummer G, 2001, J CHEM PHYS, V114, P7330, DOI 10.1063/1.1363668; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; LONG DM, 1993, FASEB J, V7, P25, DOI 10.1096/fasebj.7.1.8422971; Manosas M, 2005, BIOPHYS J, V88, P3224, DOI 10.1529/biophysj.104.045344; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Ritort F, 2002, P NATL ACAD SCI USA, V99, P13544, DOI 10.1073/pnas.172525099; RITORT F, 2003, SEMINAIRE POINCARE, V2, P193; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Serganov A, 2001, J MOL BIOL, V305, P785, DOI 10.1006/jmbi.2000.4354; Shirts MR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.140601; Smith SB, 2003, METHOD ENZYMOL, V361, P134; TURNER DH, 2000, NUCL ACIDS STRUCTURE, pCH7; Wang GM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.050601; Zuckerman DM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.180602; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	30	760	766	6	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					231	234		10.1038/nature04061	http://dx.doi.org/10.1038/nature04061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148928	Green Submitted, Green Accepted			2022-12-28	WOS:000231696900050
J	Britz, GW				Britz, GW			ISAT trial: coiling or clipping for intracranial aneurysms?	LANCET			English	Editorial Material							ENDOVASCULAR COILING; EMBOLIZATION; MORTALITY; SURGERY		Univ Washington, Harborview Med Ctr, Dept Neurol Surg & Radiol, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	Britz, GW (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg & Radiol, 325 9th Ave, Seattle, WA 98104 USA.	gbritz@u.washington.edu		Britz, Gavin/0000-0002-2358-3005				Brilstra EH, 1999, STROKE, V30, P470, DOI 10.1161/01.STR.30.2.470; David CA, 1999, J NEUROSURG, V91, P396, DOI 10.3171/jns.1999.91.3.0396; Derdeyn CP, 2003, AM J NEURORADIOL, V24, P1404; Harbaugh RE, 2003, LANCET, V361, P783, DOI 10.1016/S0140-6736(03)12641-4; Lusseveld E, 2002, J NEUROL NEUROSUR PS, V73, P591, DOI 10.1136/jnnp.73.5.591; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Murayama Y, 2003, J NEUROSURG, V98, P959, DOI 10.3171/jns.2003.98.5.0959; Raaymakers TWM, 1998, STROKE, V29, P1531, DOI 10.1161/01.STR.29.8.1531; Regli L, 1999, J NEUROSURG, V90, P1025, DOI 10.3171/jns.1999.90.6.1025; Singh V, 2002, AM J NEURORADIOL, V23, P768; Solomon RA, 1996, STROKE, V27, P13, DOI 10.1161/01.STR.27.1.13; Tang G, 2002, J NEUROSURG, V96, P993, DOI 10.3171/jns.2002.96.6.0993	13	35	38	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 3	2005	366	9488					783	785		10.1016/S0140-6736(05)67190-5	http://dx.doi.org/10.1016/S0140-6736(05)67190-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139637				2022-12-28	WOS:000231627000004
J	Oransky, I				Oransky, I			Marshall S Horwitz - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com						HORWITZ MS, PUBLICATION LIST	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 23	2005	366	9482					286	286		10.1016/S0140-6736(05)66972-3	http://dx.doi.org/10.1016/S0140-6736(05)66972-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16178073	Bronze			2022-12-28	WOS:000230733100015
J	Junghans, C; Feder, G; Hemingway, H; Timmis, A; Jones, M				Junghans, C; Feder, G; Hemingway, H; Timmis, A; Jones, M			Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONSENT; HEALTH; RECORDS	Objective To evaluate the effect of opt-in compared with opt-out recruitment strategies on response rate and selection bias. Design Double blind randomised controlled trial. Setting Two general practices in England. Participants 510 patients with angina. Intervention Patients were randomly allocated to an opt-in (asked to actively signal willingness to participate in research) or opt-out (contacted repeatedly unless they signalled unwillingness to participate) approach for recruitment to an observational prognostic study of patients with angina. Main outcome measures Recruitment rate and clinical characteristics of patients. Results The recruitment rate, defined by clinic attendance, was 38% (96/252) in the opt-in arm and 50% (128/258) in the opt-out arm (P = 0.014). Once an appointment had been made, non-attendance at the clinic was similar (20% opt-in arm v 17% opt-out arm; P = 0.86). Patients in the opt-in arm had fewer risk factors (44% v 60%; P = 0.053), less treatment for angina (69% v 82%; P = 0.01), and less functional impairment (9% v 20%; P = 0.023) than patients in the opt-out arm. Conclusions The opt-in approach to participant recruitment, increasingly required by ethics committees, resulted in lower response rates and a biased sample. We propose that the opt-out approach should be the default recruitment strategy for studies with low risk to participants.	Royal Free & UCL Med Sch, Dept Epidemiol & Publ Hlth, London WC1E 7HD, England; Barts & London Queen Marys Sch Med & Dent, Barts & London, Ctr Gen Practice & Primary Care, London, England; Barts & London NHS Trust, Cardiac Directorate, London, England	University of London; University College London; University of London; Queen Mary University London; Barts Health NHS Trust	Junghans, C (corresponding author), Royal Free & UCL Med Sch, Dept Epidemiol & Publ Hlth, London WC1E 7HD, England.	C.Junghans@ucl.ac.uk	Hemingway, Harry/C-1219-2009; Junghans, Cornelia/ABG-4494-2020; Jones, Melvyn/C-2300-2008	Hemingway, Harry/0000-0003-2279-0624; Junghans, Cornelia/0000-0002-0663-3090; Jones, Melvyn/0000-0002-8766-7443; Feder, Gene/0000-0002-7890-3926				ANDERSON LM, 1995, AM J PUBLIC HEALTH, V85, P840, DOI 10.2105/AJPH.85.6.840; CALDWELL PHY, 2002, INT CLIN TRIALS S SY; Ebrahim S, 2004, BMJ-BRIT MED J, V328, P861, DOI 10.1136/bmj.38034.702836.55; EDWARDS P, 2005, COCHRANE DATABASE ME; Evans GW, 2001, MACROECON DYN, V5, P1, DOI 10.1017/S1365100501018016; EVANS S, MINIM PROGRAMME RAND; Jones AM, 2004, BMJ-BRIT MED J, V329, P280, DOI 10.1136/bmj.329.7460.280; MUTCH L, 1985, ARCH DIS CHILD, V60, P979, DOI 10.1136/adc.60.10.979; Rogers CG, 1998, J PEDIATR-US, V132, P606, DOI 10.1016/S0022-3476(98)70347-6; Sommerville A, 2001, BRIT MED J, V322, P1220; Stanley B, 2003, BMJ-BRIT MED J, V326, P1174, DOI 10.1136/bmj.326.7400.1174; Ward HJT, 2004, BRIT MED J, V329, P277, DOI 10.1136/bmj.329.7460.277; Wilkie T, 2001, BRIT MED J, V322, P1221; Willison DJ, 2003, BRIT MED J, V326, P373, DOI 10.1136/bmj.326.7385.373; Woolf SH, 2000, ARCH FAM MED, V9, P1111, DOI 10.1001/archfami.9.10.1111; Young AF, 2001, AUST NZ J PUBL HEAL, V25, P417, DOI 10.1111/j.1467-842X.2001.tb00284.x	16	184	184	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2005	331	7522					940	942		10.1136/bmj.38583.625613.AE	http://dx.doi.org/10.1136/bmj.38583.625613.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979UR	16157604	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000232970900022
J	Epping, MT; Wang, LM; Edel, MJ; Carlee, L; Hernandez, M; Bernards, R				Epping, MT; Wang, LM; Edel, MJ; Carlee, L; Hernandez, M; Bernards, R			The human tumor antigen repressor of retinoic acid PRAME is a dominant receptor signaling	CELL			English	Article							TERATOCARCINOMA STEM-CELLS; NUCLEAR-RECEPTOR; HISTONE DEACETYLASE; GENE-EXPRESSION; N-COR; TRANSCRIPTIONAL COACTIVATOR; POLYCOMB-M33-DEFICIENT MICE; CELLULAR PROLIFERATION; PROMYELOCYTIC LEUKEMIA; FUSION PROTEINS	Retinoic acid (RA) induces proliferation arrest, differentiation, and apoptosis, and defects in retinoic acid receptor (RAR) signaling have been implicated in cancer. The human tumor antigen PRAME is overexpressed in a variety of cancers, but its function has remained unclear. We identify here PRAME as a dominant repressor of RAR signaling. PRAME binds to RAR in the presence of RA, preventing ligand-induced receptor activation and target gene transcription through recruitment of Polycomb proteins. PRAME is present at RAR target promoters and inhibits RA-induced differentiation, growth arrest, and apoptosis. Conversely, knockdown of PRAME expression by RNA interference in RA-resistant human melanoma restores RAR signaling and reinstates sensitivity to the antiproliferative effects of RA in vitro and in vivo. Our data suggest that overexpression of PRAME frequently observed in human cancers confers growth or survival advantages by antagonizing RAR signaling.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Edel, Michael J/L-1954-2014	Edel, Michael J/0000-0002-5619-8680; Bernards, Rene/0000-0001-8677-3423				Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; ATENCIA R, 1994, EXP CELL RES, V214, P663, DOI 10.1006/excr.1994.1304; Bel-Vialar S, 2000, DEV BIOL, V224, P238, DOI 10.1006/dbio.2000.9791; Boon K, 2003, ONCOGENE, V22, P7687, DOI 10.1038/sj.onc.1207043; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Core N, 1997, DEVELOPMENT, V124, P721; Demary K, 2001, CANCER LETT, V163, P103, DOI 10.1016/S0304-3835(00)00676-5; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Liu M, 1996, J BIOL CHEM, V271, P31723, DOI 10.1074/jbc.271.49.31723; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Oberthuer A, 2004, CLIN CANCER RES, V10, P4307, DOI 10.1158/1078-0432.CCR-03-0813; ONATE SA, 1995, SCIENCE, V270, P1354; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; van Baren N, 1998, BRIT J HAEMATOL, V102, P1376; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDERLEEDE BM, 1993, MOL CARCINOG, V8, P122; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807	49	290	309	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					835	847		10.1016/j.cell.2005.07.003	http://dx.doi.org/10.1016/j.cell.2005.07.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179254	Green Published, Bronze			2022-12-28	WOS:000232130200009
J	Pinn, VW				Pinn, VW			Research on women's health - Progress and opportunities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; PRIMARY PREVENTION; VITAMIN-E; CANCER; ATHEROSCLEROSIS; SUSCEPTIBILITY; ESTROGEN; LUNG; SEX		NIH, Off Res Womens Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Pinn, VW (corresponding author), NIH, Off Res Womens Hlth, Bldg 1,Room 201, Bethesda, MD 20892 USA.	vivian.pinn@nih.gov						Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Anthony M, 2005, J WOMENS HEALTH, V14, P47, DOI 10.1089/jwh.2005.14.47; Anthony Marietta, 2002, J Womens Health Gend Based Med, V11, P617, DOI 10.1089/152460902760360568; Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Cook JD, 2005, P NATL ACAD SCI USA, V102, P8644, DOI 10.1073/pnas.0503218102; Fathman CG, 2005, NATURE, V435, P605, DOI 10.1038/nature03726; Fu JB, 2005, CHEST, V127, P768, DOI 10.1378/chest.127.3.768; Gerberding JL, 2004, EMERG INFECT DIS, V10, P1965, DOI 10.3201/eid1011.040800; Glanz K, 2003, AM J PUBLIC HEALTH, V93, P292, DOI 10.2105/AJPH.93.2.292; GRADY D, 2003, AHRQ PUBLICATION; Hickey M, 2005, LANCET, V366, P409, DOI 10.1016/S0140-6736(05)66519-1; Johnson BD, 2004, CIRCULATION, V109, P2993, DOI 10.1161/01.CIR.0000130642.79868.B2; Johnson MS, 2005, ANN INTERN MED, V142, P855, DOI 10.7326/0003-4819-142-10-200505170-00011; KALTENBACH ML, 2003, XX VS XY, V1, P50; Kerr EA, 2005, ANN INTERN MED, V142, P154, DOI 10.7326/0003-4819-142-2-200501180-00021; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Linfante A, 2004, CIRCULATION, V110, P664; Mattison DR., 2004, PRIMARY CARE WOMEN, P112; McDonald M, 2004, EMERG INFECT DIS, V10, P1963, DOI 10.3201/eid1011.040612; Merz CNB, 2001, AM J MANAG CARE, V7, P959; Narod SA, 2005, WOMENS HEALTH, V1, P27, DOI 10.1517/17455057.1.1.027; National Institutes of Health, NIH GUID INCL WOM MI; National Institutes of Health, NIH ROADM; Nelson LM, 2005, FERTIL STERIL, V83, P1327, DOI 10.1016/j.fertnstert.2004.11.059; *OFF RES WOM HLTH, 1999, NIH PUBL; *OFF RES WOM HLTH, BUILD INT RES CAR WO; Payne Sarah, 2004, Gend Med, V1, P18, DOI 10.1016/S1550-8579(04)80007-X; Pinn VW, 2000, CLIN ORTHOP RELAT R, P9; Pinn VW, 2003, JAMA-J AM MED ASSOC, V289, P397, DOI 10.1001/jama.289.4.397; PINN VW, 2001, ETHNIC DIS, V111, P177; Redberg RF, 2005, JAMA-J AM MED ASSOC, V294, P107, DOI 10.1001/jama.294.1.107; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Spiegel AM, 2005, AM J CLIN NUTR, V82, p211S, DOI 10.1093/ajcn/82.1.221S; Wizemann T. M., 2001, EXPLORING BIOL CONTR	36	19	19	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1407	1410		10.1001/jama.294.11.1407	http://dx.doi.org/10.1001/jama.294.11.1407			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174703				2022-12-28	WOS:000231987800018
J	Yanagi, T; Shimizu, T; Abe, R; Shimizu, H				Yanagi, T; Shimizu, T; Abe, R; Shimizu, H			Zinc dental fillings and palmoplantar pustulosis	LANCET			English	Editorial Material									Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Hokkaido University	Yanagi, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	yanagi@med.hokudai.ac.jp	Yanagi, Teruki/D-4222-2017; Shimizu, Hiroshi/A-5193-2012; Abe, Riichiro/A-5450-2012	Yanagi, Teruki/0000-0003-2196-7600; Shimizu, Tadamichi/0000-0002-3231-0279				Akiyama Tomoko, 1995, Journal of Dermatology (Tokyo), V22, P930; Eriksson MO, 1998, BRIT J DERMATOL, V138, P390; Nakamura K, 2000, J AM ACAD DERMATOL, V42, P1021, DOI 10.1016/S0190-9622(00)90297-4; NAKAYAMA H, 1990, DERMATOL CLIN, V8, P197, DOI 10.1016/S0733-8635(18)30551-5	4	36	40	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 17	2005	366	9490					1050	1050		10.1016/S0140-6736(05)67384-9	http://dx.doi.org/10.1016/S0140-6736(05)67384-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168788				2022-12-28	WOS:000231955900041
J	Du Pasquier, L				Du Pasquier, L			Insects diversify one molecule to serve two systems	SCIENCE			English	Editorial Material							DROSOPHILA DSCAM; RECEPTORS; PLASTICITY; EXPRESSION		Univ Basel, Inst Zool & Evolutionary Biol, CH-4051 Basel, Switzerland	University of Basel	Du Pasquier, L (corresponding author), Univ Basel, Inst Zool & Evolutionary Biol, Vesalgasse 1, CH-4051 Basel, Switzerland.	dupasquier@dial.eunet.ch	Bright, Monika/I-5542-2012; Le Bris, Nadine/E-1381-2014	Le Bris, Nadine/0000-0002-0142-4847				Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; Cannon JP, 2004, CURR BIOL, V14, pR465, DOI 10.1016/j.cub.2004.06.009; Du Pasquier L, 2005, SCAND J IMMUNOL, V62, P39, DOI 10.1111/j.1365-3083.2005.01608.x; Du Pasquier L, 2004, IMMUNOL REV, V198, P233, DOI 10.1111/j.0105-2896.2004.00122.x; HOFFMANN J, 2004, PRIMITIVE IMMUNE SYS; Litman GW, 2005, ADV IMMUNOL, V87, P209, DOI 10.1016/S0065-2776(05)87006-3; Nair SV, 2005, PHYSIOL GENOMICS, V22, P33, DOI 10.1152/physiolgenomics.00052.2005; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Suzuki T, 2005, J IMMUNOL, V174, P2885, DOI 10.4049/jimmunol.174.5.2885; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021	14	34	34	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2005	309	5742					1826	1827		10.1126/science.1118828	http://dx.doi.org/10.1126/science.1118828			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166509				2022-12-28	WOS:000231989500039
J	Webster, PJ; Holland, GJ; Curry, JA; Chang, HR				Webster, PJ; Holland, GJ; Curry, JA; Chang, HR			Changes in tropical cyclone number, duration, and intensity in a warming environment	SCIENCE			English	Article							GLOBAL CLIMATE-CHANGE; HURRICANE INTENSITY; PRECIPITATION; OSCILLATION; FREQUENCY; INCREASE; IMAGERY; IMPACT; MODEL	We examined the number of tropical cyclones and cyclone days as well as tropical cyclone intensity over the past 35 years, in an environment of increasing sea surface temperature. A large increase was seen in the number and proportion of hurricanes reaching categories 4 and 5. The largest increase occurred in the North Pacific, Indian, and Southwest Pacific Oceans, and the smallest percentage increase occurred in the North Atlantic Ocean. These increases have taken place while the number of cyclones and cyclone days has decreased in all basins except the North Atlantic during the past decade.	Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA	University System of Georgia; Georgia Institute of Technology; National Center Atmospheric Research (NCAR) - USA	Webster, PJ (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.							Agudelo PA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020818; Chan JCL, 2004, J CLIMATE, V17, P4590, DOI 10.1175/3240.1; DVORAK VF, 1975, MON WEATHER REV, V103, P420, DOI 10.1175/1520-0493(1975)103<0420:TCIAAF>2.0.CO;2; Elsner JB, 2000, GEOPHYS RES LETT, V27, P129, DOI 10.1029/1999GL010893; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Folland C. K., 1999, EL NINO DECADAL INTE, P73, DOI [10. 1007/978-3-642-58369-8, DOI 10.1007/978-3-642-58369-8_4, DOI 10.1007/978-3-642-58369-8]; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; GRAY WM, 1968, MON WEATHER REV, V96, P669, DOI 10.1175/1520-0493(1968)096<0669:GVOTOO>2.0.CO;2; GRAY WM, 1984, MON WEATHER REV, V112, P1649, DOI 10.1175/1520-0493(1984)112<1649:ASHFPI>2.0.CO;2; Henderson-Sellers A, 1998, B AM METEOROL SOC, V79, P19, DOI 10.1175/1520-0477(1998)079<0019:TCAGCC>2.0.CO;2; HIRSCH RM, 1982, WATER RESOUR RES, V18, P107, DOI 10.1029/WR018i001p00107; Holland GJ, 1997, J ATMOS SCI, V54, P2519, DOI 10.1175/1520-0469(1997)054<2519:TMPIOT>2.0.CO;2; Holland GJ., 1981, AUST METEOROL MAG, V29, P169; HOUGHTON HT, 2001, CLIMATE CHANGE 2001; Knutson TR, 2004, J CLIMATE, V17, P3477, DOI [10.1175/1520-0442(2004)017<3477:IOCWOS>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3477:IOCWOS&gt;2.0.CO;2]; Kossin JP, 2004, MON WEATHER REV, V132, P165, DOI 10.1175/1520-0493(2004)132<0165:APBITC>2.0.CO;2; Lander MA, 1998, MON WEATHER REV, V126, P1163, DOI 10.1175/1520-0493(1998)126<1163:ALAGTC>2.0.CO;2; Landsea CW, 1999, CLIMATIC CHANGE, V42, P89, DOI 10.1023/A:1005416332322; LIGHTHILL J, 1994, B AM METEOROL SOC, V75, P2147; NEUMANN CJ, 1993, GLOBAL GUIDE TROPICA, pCH1; PIELKE RA, IN PRESS B AM METEOR; Royer JF, 1998, CLIMATIC CHANGE, V38, P307, DOI 10.1023/A:1005386312622; Shapiro LJ, 1998, J CLIMATE, V11, P578, DOI 10.1175/1520-0442(1998)011<0578:ASSTAT>2.0.CO;2; Sugi M, 2002, J METEOROL SOC JPN, V80, P249, DOI 10.2151/jmsj.80.249; Trenberth K, 2005, SCIENCE, V308, P1753, DOI 10.1126/science.1112551; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Velden CS, 1998, WEATHER FORECAST, V13, P172, DOI 10.1175/1520-0434(1998)013<0172:DOAOST>2.0.CO;2	28	2058	2211	26	740	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2005	309	5742					1844	1846		10.1126/science.1116448	http://dx.doi.org/10.1126/science.1116448			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166514				2022-12-28	WOS:000231989500046
J	Arrigo, KR				Arrigo, KR			Marine microorganisms and global nutrient cycles	NATURE			English	Review							ANAEROBIC AMMONIUM OXIDATION; NITROGEN-FIXATION; PHYTOPLANKTON GROWTH; N-2 PRODUCTION; CO-LIMITATION; CARBON-CYCLE; PHOSPHORUS; OCEAN; IRON; LIGHT	The way that nutrients cycle through atmospheric, terrestrial, oceanic and associated biotic reservoirs can constrain rates of biological production and help structure ecosystems on land and in the sea. On a global scale, cycling of nutrients also affects the concentration of atmospheric carbon dioxide. Because of their capacity for rapid growth, marine microorganisms are a major component of global nutrient cycles. Understanding what controls their distributions and their diverse suite of nutrient transformations is a major challenge facing contemporary biological oceanographers. What is emerging is an appreciation of the previously unknown degree of complexity within the marine microbial community.	Stanford Univ, Dept Geophys, Stanford, CA 94305 USA	Stanford University	Arrigo, KR (corresponding author), Stanford Univ, Dept Geophys, Stanford, CA 94305 USA.	arrigo@stanford.edu		Arrigo, Kevin/0000-0002-7364-876X				Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Bryant DA, 2003, P NATL ACAD SCI USA, V100, P9647, DOI 10.1073/pnas.1834558100; CAPONE DG, 1982, SCIENCE, V217, P1140, DOI 10.1126/science.217.4565.1140; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; Church MJ, 2005, AQUAT MICROB ECOL, V38, P3, DOI 10.3354/ame038003; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; Devol AH, 2003, NATURE, V422, P575, DOI 10.1038/422575a; Dong ZB, 2000, J SOIL WATER CONSERV, V55, P439; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Dyhrman ST, 2003, J PLANKTON RES, V25, P1215, DOI 10.1093/plankt/fbg086; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 2000, J PHYCOL, V36, P3, DOI 10.1046/j.1529-8817.2000.99161.x; FANNING KA, 1989, NATURE, V339, P460, DOI 10.1038/339460a0; Flynn KJ, 1999, J PHYCOL, V35, P1171, DOI 10.1046/j.1529-8817.1999.3561171.x; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Ganeshram RS, 2002, NATURE, V415, P156, DOI 10.1038/415156a; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Gordon LI, 2000, DEEP-SEA RES PT II, V47, P3095, DOI 10.1016/S0967-0645(00)00060-6; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Hansell DA, 2004, MAR CHEM, V84, P243, DOI 10.1016/j.marchem.2003.08.004; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Klausmeier CA, 2004, LIMNOL OCEANOGR, V49, P1463, DOI 10.4319/lo.2004.49.4_part_2.1463; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; LaRoche J, 2005, J SEA RES, V53, P67, DOI 10.1016/j.seares.2004.05.005; Lipschultz F, 1996, BIOGEOCHEMISTRY, V35, P261, DOI 10.1007/BF02179830; Maldonado MT, 1999, DEEP-SEA RES PT II, V46, P2475, DOI 10.1016/S0967-0645(99)00072-7; MICHAELS AF, 1994, NATURE, V372, P537, DOI 10.1038/372537a0; Michaels D. F., 2001, OCEANOGRAPHY, V14, P68, DOI DOI 10.5670/OCEANOG.2001.08; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Mohan SB, 2004, FEMS MICROBIOL ECOL, V49, P433, DOI 10.1016/j.femsec.2004.04.012; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1111/j.1574-6941.1995.tb00281.x; Niemi A., 1979, ACTA BOT FENN, V110, P57; Pahlow M, 2000, SCIENCE, V287, P831, DOI 10.1126/science.287.5454.831; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; Redfield A. C., 1934, P176; Richards F. A., 1965, CHEM OCEANOGR, V1, P611; Rysgaard S, 2004, LIMNOL OCEANOGR, V49, P86, DOI 10.4319/lo.2004.49.1.0086; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Seppala J, 1999, J MARINE SYST, V23, P107, DOI 10.1016/S0924-7963(99)00053-6; Service RF, 2004, SCIENCE, V305, P1099, DOI 10.1126/science.305.5687.1099; SHAKED Y, IN PRESS LIMNOL OCEA; Shriadah MA, 2004, WATER AIR SOIL POLL, V153, P115, DOI 10.1023/B:WATE.0000019938.57041.21; Smetacek V, 2001, NATURE, V411, P745, DOI 10.1038/35081210; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Suzumura M, 2004, DEEP-SEA RES PT I, V51, P1113, DOI 10.1016/j.dsr.2004.05.001; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Timmermans KR, 2001, MAR ECOL PROG SER, V217, P287, DOI 10.3354/meps217287; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Tyrrell T, 2002, CONT SHELF RES, V22, P2497, DOI 10.1016/S0278-4343(02)00077-8; VANDEGRAAF AA, 1995, APPL ENVIRON MICROB, V61, P1246, DOI 10.1128/AEM.61.4.1246-1251.1995; VENRICK EL, 1974, LIMNOL OCEANOGR, V19, P437, DOI 10.4319/lo.1974.19.3.0437; von Liebig J., 1840, CHEM ITS APPL AGR PH; Voss M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020127; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Yin KD, 2000, MAR ECOL PROG SER, V194, P295, DOI 10.3354/meps194295; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	74	883	955	35	786	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					349	355		10.1038/nature04159	http://dx.doi.org/10.1038/nature04159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163345				2022-12-28	WOS:000231849100041
J	Horne, RB; Thorne, RM; Shprits, YY; Meredith, NP; Glauert, SA; Smith, AJ; Kanekal, SG; Baker, DN; Engebretson, MJ; Posch, JL; Spasojevic, M; Inan, US; Pickett, JS; Decreau, PME				Horne, RB; Thorne, RM; Shprits, YY; Meredith, NP; Glauert, SA; Smith, AJ; Kanekal, SG; Baker, DN; Engebretson, MJ; Posch, JL; Spasojevic, M; Inan, US; Pickett, JS; Decreau, PME			Wave acceleration of electrons in the Van Allen radiation belts	NATURE			English	Article							RELATIVISTIC ELECTRONS; MAGNETOSPHERE; DIFFUSION; CHORUS; STORM	The Van Allen radiation belts(1) are two regions encircling the Earth in which energetic charged particles are trapped inside the Earth's magnetic field. Their properties vary according to solar activity(2,3) and they represent a hazard to satellites and humans in space(4,5). An important challenge has been to explain how the charged particles within these belts are accelerated to very high energies of several million electron volts. Here we show, on the basis of the analysis of a rare event where the outer radiation belt was depleted and then re-formed closer to the Earth(6), that the long established theory of acceleration by radial diffusion is inadequate; the electrons are accelerated more effectively by electromagnetic waves at frequencies of a few kilohertz. Wave acceleration can increase the electron flux by more than three orders of magnitude over the observed timescale of one to two days, more than sufficient to explain the new radiation belt. Wave acceleration could also be important for Jupiter, Saturn and other astrophysical objects with magnetic fields.	British Antarctic Survey, Cambridge CB3 0ET, England; Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; Augsburg Coll, Dept Phys, Minneapolis, MN 55454 USA; Stanford Univ, STAR Lab, Stanford, CA 94305 USA; Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; LPCE, F-45071 Orleans, France	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Boulder; Augsburg University; Stanford University; University of Iowa	Horne, RB (corresponding author), British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England.	R.Horne@bas.ac.uk	Inan, Umran/V-3634-2019; Meredith, Nigel P/C-5806-2018; Horne, Richard B/U-3764-2019	Inan, Umran/0000-0001-5837-5807; Horne, Richard B/0000-0002-0412-6407; Shprits, Yuri/0000-0002-9625-0834; Meredith, Nigel/0000-0001-5032-3463				Baker DN, 2004, NATURE, V432, P878, DOI 10.1038/nature03116; BAKER DN, 1986, J GEOPHYS RES, V91, P4265, DOI 10.1029/JA091iA04p04265; BAKER DN, 1998, EOS T AGU, V79, P477, DOI [10.1029/98EO00359, DOI 10.1029/98E000359]; Brautigam DH, 2000, J GEOPHYS RES-SPACE, V105, P291, DOI 10.1029/1999JA900344; Elkington SR, 1999, GEOPHYS RES LETT, V26, P3273, DOI 10.1029/1999GL003659; FALTHAMM.CG, 1965, J GEOPHYS RES, V70, P2503, DOI 10.1029/JZ070i011p02503; Glauert SA, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010851; HELLIWELL RA, 1967, J GEOPHYS RES, V72, P4773, DOI 10.1029/JZ072i019p04773; Horne RB, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010811; Horne RB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016963; Horne RB, 1998, GEOPHYS RES LETT, V25, P3011, DOI 10.1029/98GL01002; KENNEL CF, 1966, J GEOPHYS RES, V71, P1, DOI 10.1029/JZ071i001p00001; Lanzerotti L. J., 1974, PARTICLE DIFFUSION R, DOI DOI 10.1007/978-3-642-65675-0; Li XL, 2001, GEOPHYS RES LETT, V28, P3827, DOI 10.1029/2001GL013586; LYONS LR, 1973, J GEOPHYS RES, V78, P2142, DOI 10.1029/JA078i013p02142; Meredith NP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017698; Sheeley BW, 2001, J GEOPHYS RES-SPACE, V106, P25631, DOI 10.1029/2000JA000286; Shprits YY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019591; Summers D, 1998, J GEOPHYS RES-SPACE, V103, P20487, DOI 10.1029/98JA01740; TSURUTANI BT, 1974, J GEOPHYS RES, V79, P118, DOI 10.1029/JA079i001p00118; Van Allen J. A., 1997, DISCOVERY MAGNETOSPH, V7; Webb DF, 2004, SPACE WEATHER, V2	22	448	451	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					227	230		10.1038/nature03939	http://dx.doi.org/10.1038/nature03939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148927				2022-12-28	WOS:000231696900049
J	Sharp, D				Sharp, D			Small Latin, even less Greek	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							BELL B, 1999, MINIMUS PUPILS BOOK; BINNIE GAC, 1989, LANCET, P14; Brock W. H., 1992, FONTANA HIST CHEM; CHAMBERLAIN G, 1969, LANCET, V2, P1300; HOGBEN L, 1969, VOCABULARY SCI GREEK	5	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 3	2005	366	9488					794	794		10.1016/S0140-6736(05)67195-4	http://dx.doi.org/10.1016/S0140-6736(05)67195-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139643				2022-12-28	WOS:000231627000010
J	Starr, J				Starr, J			Clostridium difficile associated diarrhoea: diagnosis and treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SACCHAROMYCES-BOULARDII; ELDERLY-PATIENTS; RISK-FACTORS; INFECTION; RECURRENT; DISEASE; COLONIZATION; ANTIBIOTICS; FACILITIES; HOSPITALS		Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh	Starr, J (corresponding author), Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland.	js011q1400@blueyonder.co.uk						AMBROSE NS, 1985, J ANTIMICROB CHEMOTH, V15, P319, DOI 10.1093/jac/15.3.319; ARONSSON B, 1985, J INFECT DIS, V151, P476, DOI 10.1093/infdis/151.3.476; BENDER BS, 1986, LANCET, V2, P11, DOI 10.1016/S0140-6736(86)92559-6; Berild D, 2003, J HOSP INFECT, V54, P202, DOI 10.1016/S0195-6701(03)00149-X; Berrington A, 2004, J HOSP INFECT, V56, P1, DOI 10.1016/j.jhin.2003.10.016; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; Brazier J S, 1998, Commun Dis Public Health, V1, P229; Brazier JS, 1999, J HOSP INFECT, V43, P317, DOI 10.1016/S0195-6701(99)90431-0; Fernandez A, 2004, J CLIN GASTROENTEROL, V38, P414, DOI 10.1097/00004836-200405000-00005; GERDING DN, 1993, CLIN INFECT DIS, V16, pS439, DOI 10.1093/clinids/16.Supplement_4.S439; Geric B, 2003, J CLIN MICROBIOL, V41, P5227, DOI 10.1128/JCM.41.11.5227-5232.2003; Johal SS, 2004, J CLIN PATHOL, V57, P973, DOI 10.1136/jcp.2003.015875; King S, 2004, J HOSP INFECT, V56, pS10, DOI 10.1016/j.jhin.2003.12.025; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Lewis SJ, 1998, J INFECTION, V36, P171, DOI 10.1016/S0163-4453(98)80008-X; McCoubrey J, 2003, J MED MICROBIOL, V52, P573, DOI 10.1099/jmm.0.05179-0; MULLIGAN ME, 1993, CLIN INFECT DIS, V16, pS239, DOI 10.1093/clinids/16.Supplement_4.S239; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; PHILLIPS KD, 1981, J CLIN PATHOL, V34, P642, DOI 10.1136/jcp.34.6.642; Plummer S, 2004, INT MICROBIOL, V7, P59; Starr JM, 2003, AGE AGEING, V32, P657, DOI 10.1093/ageing/afg112; Starr JM, 1997, LANCET, V349, P426, DOI 10.1016/S0140-6736(97)80053-0; Starr JM, 2001, CLIN MICROBIOL INFEC, V7, P432, DOI 10.1046/j.1198-743x.2001.00291.x; Stone SP, 1998, AGE AGEING, V27, P561, DOI 10.1093/ageing/27.5.561; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; Thomas C, 2003, J ANTIMICROB CHEMOTH, V51, P1339, DOI 10.1093/jac/dkg254; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; Wilcox MH, 2004, J ANTIMICROB CHEMOTH, V53, P882, DOI 10.1093/jac/dkh176; Wilcox MH, 2003, J HOSP INFECT, V54, P109, DOI 10.1016/S0195-6701(02)00400-0; Zafar AB, 1998, AM J INFECT CONTROL, V26, P588, DOI 10.1053/ic.1998.v26.a84773; Zimmerman MJ, 1997, ALIMENT PHARM THERAP, V11, P1003, DOI 10.1046/j.1365-2036.1997.00269.x	31	45	50	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2005	331	7515					498	501		10.1136/bmj.331.7515.498	http://dx.doi.org/10.1136/bmj.331.7515.498			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963RA	16141157	Green Submitted, Green Published			2022-12-28	WOS:000231820400024
J	Wilder-Smith, A; Schwartz, E				Wilder-Smith, A; Schwartz, E			Current concepts: Dengue in travelers	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VIRUS-INFECTION; SHOCK SYNDROME; FEVER; EPIDEMIOLOGY; ENHANCEMENT; FEATURES; RISK; TRANSMISSION; DIAGNOSIS; VIREMIA		Travellers Hlth & Vaccinat Ctr, Tan Tock Seng Hosp, Singapore 308433, Singapore; Chaim Sheba Med Ctr, Ctr Geog Med & Trop Dis, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Tan Tock Seng Hospital; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Wilder-Smith, A (corresponding author), Travellers Hlth & Vaccinat Ctr, Tan Tock Seng Hosp, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	epvws@pacific.net.sg	Wilder-Smith, Annelies/F-8751-2015	Wilder-Smith, Annelies/0000-0003-0362-5375				Barrett ADT, 2001, ANN NY ACAD SCI, V951, P262; *CDCP, 2000, WORLD DISTR DENG; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P281; Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807; Cobelens FGJ, 2002, TROP MED INT HEALTH, V7, P331, DOI 10.1046/j.1365-3156.2002.00864.x; Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7; de Wazieres B, 1998, LANCET, V351, P498, DOI 10.1016/S0140-6736(05)78686-4; DOHERTY JF, 1995, QJM-INT J MED, V88, P277; Dung NM, 1999, CLIN INFECT DIS, V29, P787, DOI 10.1086/520435; Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; GUBLER D, 2001, ESSENTIALS TROPICAL, P580; Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; HALSTEAD SB, 1982, PROG ALLERGY, V31, P301; Halstead SB, 1999, LANCET, V353, P1100, DOI 10.1016/S0140-6736(05)76460-6; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Janisch T, 1997, TROP MED INT HEALTH, V2, P934; Jelinek T, 2000, EUR J CLIN MICROBIOL, V19, P555, DOI 10.1007/s100960000318; Jelinek T, 2002, CLIN INFECT DIS, V35, P1047, DOI 10.1086/342906; Jelinek T, 1997, ARCH INTERN MED, V157, P2367, DOI 10.1001/archinte.157.20.2367; Jelinek T, 2000, CLIN INFECT DIS, V31, P144, DOI 10.1086/313889; Jensenius Mogens, 1997, Tidsskrift for den Norske Laegeforening, V117, P4230; Kalaycioglu E, 1999, TURK J CHEM, V23, P1; Lindback H, 2003, EMERG INFECT DIS, V9, P438, DOI 10.3201/eid0904.020267; LopezVelez R, 1996, EUR J CLIN MICROBIOL, V15, P823, DOI 10.1007/BF01701528; Lum L. C. S., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P467; MACLEAN JD, 1994, TRAVEL MED ADVISOR, V5; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; My NV, 2004, AM J TROP MED HYG, V70, P459; NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P392; Norwood C G, 1999, J La State Med Soc, V151, P313; O'Brien D, 2001, CLIN INFECT DIS, V33, P603, DOI 10.1086/322602; O'Leary DR, 2002, AM J TROP MED HYG, V66, P35, DOI 10.4269/ajtmh.2002.66.35; Phuong CXT, 2004, AM J TROP MED HYG, V70, P172, DOI 10.4269/ajtmh.2004.70.172; Potasman I, 1999, EMERG INFECT DIS, V5, P824, DOI 10.3201/eid0506.990615; Rigau-Perez J G, 1997, Rev Panam Salud Publica, V1, P381; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; RODHAIN F, 1993, B SOC PATHOL EXOT, V86, P3; ROSEN L, 1977, AM J TROP MED HYG, V26, P337, DOI 10.4269/ajtmh.1977.26.337; RUSSELL PK, 1967, J IMMUNOL, V99, P285; Schwartz E, 2000, J CLIN VIROL, V19, P169, DOI 10.1016/S1386-6532(00)00114-1; Schwartz E, 2000, EUR J CLIN MICROBIOL, V19, P784, DOI 10.1007/s100960000388; Schwartz E, 1996, AM J MED, V101, P516, DOI 10.1016/S0002-9343(96)00278-1; SCHWARZ TF, 1995, ZBL BAKT-INT J MED M, V282, P533; Sharp, 1995, J Travel Med, V2, P70, DOI 10.1111/j.1708-8305.1995.tb00630.x; SHARP TW, 1995, AM J TROP MED HYG, V53, P89, DOI 10.4269/ajtmh.1995.53.89; STEFFEN R, 1994, JAMA-J AM MED ASSOC, V272, P885, DOI 10.1001/jama.272.11.885; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; Stienlauf S, 2005, J TRAVEL MED, V12, P136, DOI 10.2310/7060.2005.12308; SUMARMO, 1978, LANCET, V1, P449; TASSNIYOM S, 1993, PEDIATRICS, V92, P111; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048; VAUGHN DW, 2000, HUNTERS TROPICAL MED, P240; Wagner D, 2004, EMERG INFECT DIS, V10, P1872, DOI 10.3201/eid1010.031037; Watt G, 2003, AM J TROP MED HYG, V68, P536, DOI 10.4269/ajtmh.2003.68.536; Wichmann O., 2003, Dengue Bulletin, V27, P126; Wichmann O, 2004, J TRAVEL MED, V11, P161, DOI 10.2310/7060.2004.18503; Wilder-Smith A, 2004, CLIN INFECT DIS, V39, P1818, DOI 10.1086/426029; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; WITTESJO B, 1993, SCAND J INFECT DIS, V25, P699, DOI 10.3109/00365549309008566; Yamada K, 1999, JPN J INFECT DIS, V52, P257; 1998, CAN COMMUN DIS REP, V24, P164; 1995, MMWR MORB MORTAL WKL, V44, P353; 1998, CAN COMMUN DIS REP, V24, P168; 1996, MMWR MORB MORTAL WKL, V45, P988; MANAGEMENT DENGUE FE; 2000, MMWR MORB MORTAL WKL, V49, P248	75	283	295	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					924	932		10.1056/NEJMra041927	http://dx.doi.org/10.1056/NEJMra041927			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135837				2022-12-28	WOS:000231551100010
J	Dey, M; Cao, C; Dar, AC; Tamura, T; Ozato, K; Sicheri, F; Dever, TE				Dey, M; Cao, C; Dar, AC; Tamura, T; Ozato, K; Sicheri, F; Dever, TE			Mechanistic link between PKR dimerization, autophosphorylation, and elF2 alpha substrate recognition	CELL			English	Article							DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; INITIATION-FACTOR-2 EIF2-ALPHA; FUNCTIONALLY SUBSTITUTE; INTERFERON ACTION; ALPHA-SUBUNIT; ACTIVATION; BINDING; YEAST	The antiviral protein kinase PKR inhibits protein synthesis by phosphorylating the translation initiation factor eIF2 alpha on Ser51. Binding of double-stranded RNA to the regulatory domains of PKR promotes dimerization, autophosphorylation, and the functional activation of the kinase. Herein, we identify mutations that activate PKR in the absence of its regulatory domains and map the mutations to a recently identified dimerization surface on the kinase catalytic domain. Mutations of other residues on this surface block PKR autophosphorylation and eIF2 alpha phosphorylation, while mutating Thr446, an autophosphorylation site within the catalytic-domain activation segment, impairs eIF2 alpha phosphorylation and viral pseudosubstrate binding. Mutational analysis of catalytic-domain residues preferentially conserved in the eIF2 alpha kinase family identifies helix alpha G as critical for the specific recognition of eIF2 alpha. We propose an ordered mechanism of PKR activation in which catalytic-domain climerization triggers Thr446 autophosphorylation and specific eIF2 alpha substrate recognition.	NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Mol Growth & Regulat, NIH, Bethesda, MD 20892 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Dever, TE (corresponding author), NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	tdever@nih.gov	Dever, Thomas/GSE-0966-2022; Sicheri, Frank/F-8856-2013	Dever, Thomas/0000-0001-7120-9678	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Carpick BW, 1997, J BIOL CHEM, V272, P9510, DOI 10.1074/jbc.272.14.9510; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; COSENTINO GP, 1995, P NATL ACAD SCI USA, V92, P9445, DOI 10.1073/pnas.92.21.9445; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; DeLano WL, 2004, PYMOL USERS MANUAL; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dey M, 2005, MOL CELL BIOL, V25, P3063, DOI 10.1128/MCB.25.8.3063-3075.2005; Dhaliwal S, 2003, J MOL BIOL, V334, P187, DOI 10.1016/j.jmb.2003.09.045; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; HARASHIMA S, 1987, GENETICS, V117, P409; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; KOSTURA M, 1989, MOL CELL BIOL, V9, P1576, DOI 10.1128/MCB.9.4.1576; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; LANGLAND JO, 1992, J BIOL CHEM, V267, P10729; Lemaire PA, 2005, J MOL BIOL, V345, P81, DOI 10.1016/j.jmb.2004.10.031; MELLOR H, 1991, BIOCHEM BIOPH RES CO, V178, P430, DOI 10.1016/0006-291X(91)90125-Q; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Nonato MC, 2002, J BIOL CHEM, V277, P17057, DOI 10.1074/jbc.M111804200; Ortega LG, 1996, VIROLOGY, V215, P31, DOI 10.1006/viro.1996.0004; ROMANO PR, 1995, MOL CELL BIOL, V15, P365, DOI 10.1128/MCB.15.1.365; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Tan SL, 1998, MOL CELL BIOL, V18, P2431, DOI 10.1128/MCB.18.5.2431; THOMIS DC, 1995, J VIROL, V69, P5195, DOI 10.1128/JVI.69.8.5195-5198.1995; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; Wu SY, 1997, J BIOL CHEM, V272, P1291, DOI 10.1074/jbc.272.2.1291; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200	30	262	275	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					901	913		10.1016/j.cell.2005.06.041	http://dx.doi.org/10.1016/j.cell.2005.06.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179259	Bronze			2022-12-28	WOS:000232130200014
J	Lieberman, JA; Stroup, TS; McEvoy, JP; Swartz, MS; Rosenheck, RA; Perkins, DO; Keefe, RSE; Davis, SM; Davis, CE; Lebowitz, BD; Severe, J; Hsiao, JK				Lieberman, JA; Stroup, TS; McEvoy, JP; Swartz, MS; Rosenheck, RA; Perkins, DO; Keefe, RSE; Davis, SM; Davis, CE; Lebowitz, BD; Severe, J; Hsiao, JK		CATIE Investigators	Effectiveness of antipsychotic drugs in patients with chronic schizophrenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEW-GENERATION ANTIPSYCHOTICS; EFFECTIVENESS CATIE PROJECT; 2ND-GENERATION ANTIPSYCHOTICS; CONVENTIONAL ANTIPSYCHOTICS; ATYPICAL ANTIPSYCHOTICS; CLINICAL-TRIALS; DOUBLE-BLIND; METAANALYSIS; HALOPERIDOL; OLANZAPINE	BACKGROUND: The relative effectiveness of second-generation (atypical) antipsychotic drugs as compared with that of older agents has been incompletely addressed, though newer agents are currently used far more commonly. We compared a first-generation antipsychotic, perphenazine, with several newer drugs in a double-blind study. METHODS: A total of 1493 patients with schizophrenia were recruited at 57 U.S. sites and randomly assigned to receive olanzapine (7.5 to 30 mg per day), perphenazine (8 to 32 mg per day), quetiapine (200 to 800 mg per day), or risperidone (1.5 to 6.0 mg per day) for up to 18 months. Ziprasidone (40 to 160 mg per day) was included after its approval by the Food and Drug Administration. The primary aim was to delineate differences in the overall effectiveness of these five treatments. RESULTS: Overall, 74 percent of patients discontinued the study medication before 18 months (1061 of the 1432 patients who received at least one dose): 64 percent of those assigned to olanzapine, 75 percent of those assigned to perphenazine, 82 percent of those assigned to quetiapine, 74 percent of those assigned to risperidone, and 79 percent of those assigned to ziprasidone. The time to the discontinuation of treatment for any cause was significantly longer in the olanzapine group than in the quetiapine (P<0.001) or risperidone (P=0.002) group, but not in the perphenazine (P=0.021) or ziprasidone (P=0.028) group. The times to discontinuation because of intolerable side effects were similar among the groups, but the rates differed (P=0.04); olanzapine was associated with more discontinuation for weight gain or metabolic effects, and perphenazine was associated with more discontinuation for extrapyramidal effects. CONCLUSIONS: The majority of patients in each group discontinued their assigned treatment owing to inefficacy or intolerable side effects or for other reasons. Olanzapine was the most effective in terms of the rates of discontinuation, and the efficacy of the conventional antipsychotic agent perphenazine appeared similar to that of quetiapine, risperidone, and ziprasidone. Olanzapine was associated with greater weight gain and increases in measures of glucose and lipid metabolism.	Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC USA; Univ N Carolina, Sch Publ Hlth, Dept Biostat, Chapel Hill, NC USA; Quintiles, Res Triangle Pk, NC USA; John Umstead Hosp, Dept Biol Psychiat, Butner, NC USA; Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; NIMH, Div Serv & Intervent Res, NIH, Bethesda, MD 20892 USA	Columbia University; New York State Psychiatry Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; IQVIA; Duke University; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Lieberman, JA (corresponding author), Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	jlieberman@columbia.edu	Perkins, Diana O/F-5213-2013; Stroup, Thomas S/F-9188-2014; Keefe, Richard S E/I-3411-2018; Lieberman, Jeffrey/AAY-8239-2020; Young, Alexander/A-1523-2009; Stroup, Thomas/AAB-7780-2019	Stroup, Thomas S/0000-0002-3123-0672; Young, Alexander/0000-0002-9367-9213; Stroup, Thomas/0000-0002-3123-0672; Lebowitz, Barry/0000-0002-6467-646X; Hsiao, John/0000-0003-3471-7539; Thomas, Sonia/0000-0003-1362-5627; Perkins, Diana/0000-0001-9396-2206	NIMH NIH HHS [N01 MH90001] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH090001] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Chakos M, 2001, AM J PSYCHIAT, V158, P518, DOI 10.1176/appi.ajp.158.4.518; Citrome L, 2002, HARVARD REV PSYCHIAT, V10, P280, DOI 10.1080/10673220216279; COX DR, 1972, J R STAT SOC B, V34, P187; Csernansky JG, 2002, NEW ENGL J MED, V346, P16, DOI 10.1056/NEJMoa002028; Csernansky JG, 2002, NEW ENGL J MED, V346, P1424; Davis JM, 2004, J CLIN PSYCHOPHARM, V24, P192, DOI 10.1097/01.jcp.0000117422.05703.ae; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; Davis SM, 2003, SCHIZOPHRENIA BULL, V29, P73, DOI 10.1093/oxfordjournals.schbul.a006993; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Harrington C., 2000, ACCESS UTILIZATION N; Henderson DC, 2005, ARCH GEN PSYCHIAT, V62, P19, DOI 10.1001/archpsyc.62.1.19; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; IMS HLTH, 2002, AT ANT GEN EV INF PO; *INT MED SYST NAT, 2004, IMS HLTH; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Keefe RSE, 1999, SCHIZOPHRENIA BULL, V25, P201, DOI 10.1093/oxfordjournals.schbul.a033374; Keefe RSE, 2003, SCHIZOPHRENIA BULL, V29, P45, DOI 10.1093/oxfordjournals.schbul.a006990; Koro CE, 2002, ARCH GEN PSYCHIAT, V59, P1021, DOI 10.1001/archpsyc.59.11.1021; Lebowitz BD, 2003, SCHIZOPHRENIA BULL, V29, P7, DOI 10.1093/oxfordjournals.schbul.a006992; Lehman AF, 2004, AM J PSYCHIAT, V161, P1; Leucht S, 1999, SCHIZOPHR RES, V35, P51, DOI 10.1016/S0920-9964(98)00105-4; Leucht S, 2003, AM J PSYCHIAT, V160, P1209, DOI 10.1176/appi.ajp.160.7.1209; Leucht S, 2003, LANCET, V361, P1581, DOI 10.1016/S0140-6736(03)13306-5; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Rosenheck R, 2003, SCHIZOPHRENIA BULL, V29, P81, DOI 10.1093/oxfordjournals.schbul.a006994; Rosenheck R, 2003, JAMA-J AM MED ASSOC, V290, P2693, DOI 10.1001/jama.290.20.2693; Rosenheck RA, 2005, PSYCHIAT SERV, V56, P85, DOI 10.1176/appi.ps.56.1.85; Stroup TS, 2003, SCHIZOPHRENIA BULL, V29, P15, DOI 10.1093/oxfordjournals.schbul.a006986; Swartz MS, 2003, SCHIZOPHRENIA BULL, V29, P33, DOI 10.1093/oxfordjournals.schbul.a006989; Tollefson GD, 1998, ARCH GEN PSYCHIAT, V55, P250, DOI 10.1001/archpsyc.55.3.250; Tollefson GD, 1998, ARCH GEN PSYCHIAT, V55, P1052; Tollefson GD, 1997, AM J PSYCHIAT, V154, P466; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Tuunainen A, 2002, SCHIZOPHR RES, V56, P1, DOI 10.1016/S0920-9964(01)00212-2; Wahlbeck K, 1999, AM J PSYCHIAT, V156, P990; Wahlbeck K, 2001, PSYCHOPHARMACOLOGY, V155, P230, DOI 10.1007/s002130100711	37	4180	4422	13	622	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1209	1223		10.1056/NEJMoa051688	http://dx.doi.org/10.1056/NEJMoa051688			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	966DS	16172203	Green Published			2022-12-28	WOS:000232000400005
J	Gutierrez-Macias, A; Lizarralde-Palacios, E; Martinez-Odriozola, P; Miguel-De la Villa, F				Gutierrez-Macias, A; Lizarralde-Palacios, E; Martinez-Odriozola, P; Miguel-De la Villa, F			Lesson of the week - Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Hosp Basurto, Dept Internal Med, Bilbao 48013, Spain	Basurto Hospital	Gutierrez-Macias, A (corresponding author), Hosp Basurto, Dept Internal Med, Ave Montevideo 18, Bilbao 48013, Spain.	alguma@teleline.es	Gutierrez-Macias, Alfonso/AAF-3995-2021	Gutierrez-Macias, Alfonso/0000-0001-7124-9629				Anderson Bryan E, 2002, J Drugs Dermatol, V1, P60; ARELLANO F, 1993, ANN PHARMACOTHER, V27, P337, DOI 10.1177/106002809302700317; Hashimoto K, 2003, CURR OPIN ALLERGY CL, V3, P255, DOI [10.1097/00130832-200308000-00004, 10.1097/01.all.0000083949.99396.af]; Kumar A, 1996, BRIT MED J, V312, P173; LUPTON GP, 1979, J AM ACAD DERMATOL, V1, P365, DOI 10.1016/S0190-9622(79)70031-4; Seamark CJ, 2000, BMJ-BRIT MED J, V320, P1314, DOI 10.1136/bmj.320.7245.1314; SINGER JZ, 1986, ARTHRITIS RHEUM, V29, P82, DOI 10.1002/art.1780290111; Sontheimer RD, 1998, ARCH DERMATOL, V134, P874, DOI 10.1001/archderm.134.7.874; Sullivan JR, 2001, ARCH DERMATOL, V137, P357; ten Holder SM, 2002, ANN PHARMACOTHER, V36, P130, DOI 10.1345/1542-6270(2002)036<0130:CASMOD>2.0.CO;2; Terkeltaub RA, 2003, NEW ENGL J MED, V349, P1647, DOI 10.1056/NEJMcp030733; Wortmann R.L., 1998, HARRISONS PRINCIPLES, V14, P2158	12	62	69	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2005	331	7517					623	624		10.1136/bmj.331.7517.623	http://dx.doi.org/10.1136/bmj.331.7517.623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967EK	16166134	Green Published			2022-12-28	WOS:000232074100029
J	Teare, MD; Barrett, JH				Teare, MD; Barrett, JH			Genetic epidemiology 2 - Genetic linkage studies	LANCET			English	Article							AFFECTED RELATIVE PAIRS; COMPLEX TRAITS; SUSCEPTIBILITY GENES; GENOMEWIDE LINKAGE; QUANTITATIVE-TRAIT; BREAST-CANCER; DISEASE; TESTS; IDENTIFICATION; LOCUS	Linkage analysis is used to map genetic loci by use of observations of related individuals. We provide an introduction to methods commonly used to map loci that predispose to disease. Linkage analysis methods can be applied to both major gene disorders (parametric linkage) and complex diseases (model-free or non-parametric linkage). Evidence for linkage is most commonly expressed as a logarithm of the odds score. We provide a framework for interpretation of these scores and discuss the role of simulation in assessment of statistical significance and estimation of power. Genetic and phenotypic heterogeneity can also affect the success of a study, and several methods exist to address such problems.	Univ Sheffield, Math Modelling & Genet Epidemiol Div, HEnry Wellcome Labs Med Res, Sheffield S10 2RX, S Yorkshire, England; Univ Leeds, Genet Epidemiol Div, Leeds, W Yorkshire, England	University of Sheffield; University of Leeds	Teare, MD (corresponding author), Univ Sheffield, Math Modelling & Genet Epidemiol Div, HEnry Wellcome Labs Med Res, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	m.d.teare@sheffield.ac.uk		Barrett, Jenny/0000-0002-1720-7724; Teare, Marion Dawn/0000-0003-3994-0051				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Arya R, 2002, NAT GENET, V30, P102, DOI 10.1038/ng810; Berger P, 2002, NEUROGENETICS, V4, P1, DOI 10.1007/s10048-002-0130-z; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Burton PR, 2005, LANCET, V366, P941, DOI 10.1016/S0140-6736(05)67322-9; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; Chagnon YC, 2003, OBES RES, V11, P313, DOI 10.1038/oby.2003.47; CHOTAI J, 1984, ANN HUM GENET, V48, P359, DOI 10.1111/j.1469-1809.1984.tb00849.x; CORDELL HJ, IN PRESS LANCET; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Holmans P, 2001, GENET EPIDEMIOL, V20, P44, DOI 10.1002/1098-2272(200101)20:1<44::AID-GEPI5>3.0.CO;2-E; KABACK MM, 1977, TAYSACHS DIS SCREENI; Kennedy G, 2003, AM J HUM GENET, V73, P186; Kennedy JL, 2003, SCIENCE, V302, P822, DOI 10.1126/science.1092132; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; MORTON NE, 1955, AM J HUM GENET, V7, P277; Parrella P, 2003, CANCER RES, V63, P8507; Rahman N, 2003, AM J HUM GENET, V73, P198, DOI 10.1086/376416; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1989, GENET EPIDEMIOL, V6, P143, DOI 10.1002/gepi.1370060127; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6; Sobel E, 1996, AM J HUM GENET, V58, P1323; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Williams NM, 2003, AM J HUM GENET, V73, P1355, DOI 10.1086/380206; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xu JF, 2001, AM J HUM GENET, V68, P1437, DOI 10.1086/320589	49	120	125	1	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 17	2005	366	9490					1036	1044						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168786				2022-12-28	WOS:000231955900039
J	Genovese, MC; Becker, J; Schiff, M; Luggen, M; Sherrer, Y; Kremer, J; Birbara, C; Box, J; Natarajan, K; Nuamah, I; Li, T; Aranda, R; Hagerty, DT; Dougados, M				Genovese, MC; Becker, J; Schiff, M; Luggen, M; Sherrer, Y; Kremer, J; Birbara, C; Box, J; Natarajan, K; Nuamah, I; Li, T; Aranda, R; Hagerty, DT; Dougados, M			Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONCOMITANT METHOTREXATE; COSTIMULATORY BLOCKADE; MONOCLONAL-ANTIBODY; CELL-ACTIVATION; FUSION PROTEIN; DOUBLE-BLIND; DISEASE; PLACEBO; INFLIXIMAB; CRITERIA	BACKGROUND: A substantial number of patients with rheumatoid arthritis have an inadequate or unsustained response to tumor necrosis factor alpha (TNF-alpha) inhibitors. We conducted a randomized, double-blind, phase 3 trial to evaluate the efficacy and safety of abatacept, a selective costimulation modulator, in patients with active rheumatoid arthritis and an inadequate response to at least three months of anti-TNF-alpha therapy. METHODS: Patients with active rheumatoid arthritis and an inadequate response to anti-TNF-alpha therapy were randomly assigned in a 2:1 ratio to receive abatacept or placebo on days 1, 15, and 29 and every 28 days thereafter for 6 months, in addition to at least one disease-modifying antirheumatic drug. Patients discontinued anti-TNF-alpha therapy before randomization. The rates of American College of Rheumatology (ACR) 20 responses (indicating a clinical improvement of 20 percent or greater) and improvement in functional disability, as reflected by scores for the Health Assessment Questionnaire (HAQ) disability index, were assessed. RESULTS: After six months, the rates of ACR 20 responses were 50.4 percent in the abatacept group and 19.5 percent in the placebo group (P<0.001); the respective rates of ACR 50 and ACR 70 responses were also significantly higher in the abatacept group than in the placebo group (20.3 percent vs. 3.8 percent, P<0.001; and 10.2 percent vs. 1.5 percent, P=0.003). At six months, significantly more patients in the abatacept group than in the placebo group had a clinically meaningful improvement in physical function, as reflected by an improvement from baseline of at least 0.3 in the HAQ disability index (47.3 percent vs. 23.3 percent, P<0.001). The incidence of adverse events and peri-infusional adverse events was 79.5 percent and 5.0 percent, respectively, in the abatacept group and 71.4 percent and 3.0 percent, respectively, in the placebo group. The incidence of serious infections was 2.3 percent in each group. CONCLUSIONS: Abatacept produced significant clinical and functional benefits in patients who had had an inadequate response to anti-TNF-alpha therapy.	Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Bristol Myers Squibb Co, Princeton, NJ USA; Denver Arthrit Clin, Denver, CO USA; Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA; Ctr Rheumatol Immunol & Arthrit, Ft Lauderdale, FL USA; Albany Med Coll, Albany, NY 12208 USA; Ctr Rheumatol, Albany, NY USA; Univ Massachusetts, Sch Med, Worcester, MA USA; Carolina Bone & Joint, Charlotte, NC USA; Univ Paris 05, Serv Rhumatol B, Paris, France	Stanford University; Bristol-Myers Squibb; University System of Ohio; University of Cincinnati; Albany Medical College; University of Massachusetts System; University of Massachusetts Worcester; UDICE-French Research Universities; Universite Paris Cite	Genovese, MC (corresponding author), Stanford Univ, Med Ctr, Sch Med, Div Rheumatol & Immunol, 1000 Welch Rd,Suite 203, Palo Alto, CA 94304 USA.	genovese@stanford.edu			NCRR NIH HHS [5 M01 RR000070] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Criscione LG, 2002, CURR OPIN RHEUMATOL, V14, P204, DOI 10.1097/00002281-200205000-00002; Emery P, 2003, EXPERT OPIN INV DRUG, V12, P673, DOI 10.1517/13543784.12.4.673; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fransen J, 2004, RHEUMATOLOGY, V43, P1252, DOI 10.1093/rheumatology/keh297; Kremer JM, 2005, ARTHRITIS RHEUM, V52, P2263, DOI 10.1002/art.21201; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Moreland LW, 2002, ARTHRITIS RHEUM, V46, P1470, DOI 10.1002/art.10294; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; VANRIEL P, USE DAS28; Vrijhoef HJM, 2003, ANN RHEUM DIS, V62, P419, DOI 10.1136/ard.62.5.419; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; WEINBLATT ME, 2004, ARTHRITIS RHEUM, V50, P144; Weisman M, 2004, ANN RHEUM DIS, V63, P138; WELLS GA, 1993, J RHEUMATOL, V20, P557	24	929	1012	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1114	1123		10.1056/NEJMoa050524	http://dx.doi.org/10.1056/NEJMoa050524			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963YG	16162882	Bronze			2022-12-28	WOS:000231841900006
J	Spalding, KL; Buchholz, BA; Bergman, LE; Druid, H; Frisen, J				Spalding, KL; Buchholz, BA; Bergman, LE; Druid, H; Frisen, J			Age written in teeth by nuclear tests	NATURE			English	Editorial Material							C-14		Karolinska Inst, Dept Cell & Mol Biol, Med Nobel Inst, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Forens Med, S-17177 Stockholm, Sweden; Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA	Karolinska Institutet; Karolinska Institutet; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Spalding, KL (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Med Nobel Inst, S-17177 Stockholm, Sweden.	jonas.frisen@cmb.ki.se	Buchholz, Bruce A/G-1356-2011; spalding, kirsty/I-6046-2017; Spalding, Kirsty/CAF-4248-2022	Buchholz, Bruce A/0000-0002-9531-551X; Spalding, Kirsty/0000-0002-5189-7028; Druid, Henrik/0000-0002-9198-023X				Bolanos MV, 2000, FORENSIC SCI INT, V110, P97, DOI 10.1016/S0379-0738(00)00154-7; DEVRIES H, 1958, SCIENCE, V128, P1550, DOI 10.1126/science.128.3338.1550; HARKNESS DD, 1972, NATURE, V240, P302, DOI 10.1038/240302a0; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; LIBBY WF, 1964, SCIENCE, V146, P1171; Nolla CM., 1960, J DENT CHILDREN, V27, P254; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Otlet RL, 1997, J ENVIRON RADIOACTIV, V34, P91, DOI 10.1016/0265-931X(96)00001-X; Ritz-Timme S, 2000, INT J LEGAL MED, V113, P129, DOI 10.1007/s004140050283; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028	10	143	148	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					333	334		10.1038/437333a	http://dx.doi.org/10.1038/437333a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163340				2022-12-28	WOS:000231849100034
J	Sabatine, MS; Cannon, CP; Gibson, CM; Lopez-Sendon, JL; Montalescot, G; Theroux, P; Lewis, BS; Murphy, SA; McCabe, CH; Braunwald, E				Sabatine, MS; Cannon, CP; Gibson, CM; Lopez-Sendon, JL; Montalescot, G; Theroux, P; Lewis, BS; Murphy, SA; McCabe, CH; Braunwald, E		CLARITY TIMI 28 Investigators	Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics - The PCI-CLARITY study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITORS; ANTIPLATELET THERAPY; UNSTABLE ANGINA; PLATELET INHIBITION; ASPIRIN; EVENTS; THROMBOLYSIS; ACTIVATION; TICLOPIDINE; COMBINATION	Context The benefit of clopidogrel pretreatment before percutaneous coronary intervention (PCI) remains debated and its use has not been universally adopted. Objective To determine if clopidogrel pretreatment before PCI in patients with recent ST-segment elevation myocardial infarction (STEMI) is superior to clopidogrel treatment initiated at the time of PCI in preventing major adverse cardiovascular events. Design, Setting, and Participants The PCI-Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY) study was a prospectively planned analysis of the 1863 patients undergoing PCI after mandated angiography in CLARITY-Thrombolysis in Myocardial Infarction (TIMI) 28, a randomized, double-blind, placebo-control led trial of clopidogrel in patients receiving fibrinolytics for STEMI. Patients were enrolled at 319 sites in 23 countries from February 2003 through October 2004. Interventions Patients received aspirin and were randomized to receive either clopidogrel (300 mg loading dose, then 75 mg once daily) or placebo initiated with fibrinolysis and given until coronary angiography, which was performed 2 to 8 days after initiation of the study drug. For patients undergoing coronary artery stenting, it was recommended that open-label clopidogrel (including a loading dose) be administered after the diagnostic angiogram. Main Outcome Measures The primary outcome was the incidence of the composite of cardiovascular death, recurrent MI, or stroke from PCI to 30 days after randomization. Secondary outcomes included MI or stroke before PCI and the aforementioned composite from randomization to 30 days. Results Pretreatment with clopidogrel significantly reduced the incidence of cardiovascular death, MI, or stroke following PCI (34 [3.6%] vs 58 [6.2%]; adjusted odds ratio [OR], 0.54 [95% CI, 0.35-0.85]; P = .008). Pretreatment with clopidogrel also reduced the incidence of MI or stroke prior to PCI (37 [4.0%] vs 58 [6.2%]; OR, 0.62 [95% CI, 0.40-0.95]; P = .03). Overall, pretreatment with clopidogrel resulted in a highly significant reduction in cardiovascular death, MI, or stroke from randomization through 30 days (70 [7.5%] vs 112 [12.0%]; adjusted OR, 0.59 [95% CI, 0.43-0.81]; P = .001; number needed to treat=23). There was no significant excess in the rates of TIMI major or minor bleeding (18 [2.0%] vs 17 [1.9%]; P>.99). Conclusions Clopidogrel pretreatment significantly reduces the incidence of cardiovascular death or ischemic complications both before and after PCI and without a significant increase in major or minor bleeding. These data add further support to the early use of clopidogrel in STEMI and the strategy of routine clopidogrel pretreatment in patients undergoing PCI.	Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Hosp Univ La Paz, Dept Cardiol, Madrid, Spain; Hop La Pitie Salpetriere, Inst Cardiol, Paris, France; Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; Lady Davies Carmel Med Ctr, Dept Cardiovasc Med, Haifa, Israel; Ruth & Bruce Rappaport Sch Med, Haifa, Israel	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Hospital Universitario La Paz; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Montreal; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Sabatine, MS (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Dept Med, 75 Francis St, Boston, MA 02115 USA.	msabatine@partners.org	Gibson, C. Michael/AAE-8212-2019; Sabatine, Marc/AAJ-6751-2020	Sabatine, Marc/0000-0002-0691-3359	NHLBI NIH HHS [R01 HL072879] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072879] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1989, NEW ENGL J MED, V320, P618; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Antman EM, 2004, CIRCULATION, V109, P2480, DOI 10.1161/01.CIR.0000128736.57259.48; Assali AR, 2001, AM J CARDIOL, V88, P884, DOI 10.1016/S0002-9149(01)01897-5; Berger PB, 2002, CIRCULATION, V106, P2284, DOI 10.1161/01.CIR.0000035924.70846.20; BOVILL EG, 1991, ANN INTERN MED, V115, P256, DOI 10.7326/0003-4819-115-4-256; Braunwald E, 2003, CIRCULATION, V108, P28; BRAUNWALD E, 2002, ACC AHA GUIDELINE UP; Cadroy Y, 2000, CIRCULATION, V101, P2823, DOI 10.1161/01.CIR.101.24.2823; Chan AW, 2003, J AM COLL CARDIOL, V42, P1188, DOI 10.1016/S0735-1097(03)00944-6; Chew DP, 2001, AM J CARDIOL, V88, P672, DOI 10.1016/S0002-9149(01)01813-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FITZGERALD DJ, 1986, NEW ENGL J MED, V315, P983, DOI 10.1056/NEJM198610163151602; Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B; Gawaz M, 1996, CIRCULATION, V93, P229, DOI 10.1161/01.CIR.93.2.229; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Gurbel PA, 2003, AM HEART J, V145, P239, DOI 10.1067/mhj.2003.109; Helft G, 2000, ARTERIOSCL THROM VAS, V20, P2316, DOI 10.1161/01.ATV.20.10.2316; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kastrati A, 2004, CIRCULATION, V110, P1916, DOI 10.1161/01.CIR.0000137972.74120.12; KERINS DM, 1989, CIRCULATION, V80, P1718, DOI 10.1161/01.CIR.80.6.1718; KNATTERUD G, 1988, JAMA-J AM MED ASSOC, V260, P2849; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Leopold JA, 2005, CIRCULATION, V111, P1097, DOI 10.1161/01.CIR.0000158691.22229.75; Levine GN, 2003, ANN INTERN MED, V139, P123, DOI 10.7326/0003-4819-139-2-200307150-00012; LEWIS BS, IN PRESS AM HEART J; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; Muller I, 2001, HEART, V85, P92, DOI 10.1136/heart.85.1.92; Quinn MJ, 2004, AM J CARDIOL, V93, P679, DOI 10.1016/j.amjcard.2003.11.048; Quinn MJ, 2002, CIRCULATION, V106, P379, DOI 10.1161/01.CIR.0000019581.22812.B2; Rupprecht HJ, 1998, CIRCULATION, V97, P1046, DOI 10.1161/01.CIR.97.11.1046; Sabatine MS, 2005, AM HEART J, V149, P227, DOI 10.1016/j.ahj.2004.11.006; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Savcic M, 1999, SEMIN THROMB HEMOST, V25, P15; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Saw J, 2004, J AM COLL CARDIOL, V44, P1194, DOI 10.1016/j.jacc.2004.06.049; SCHARF RE, 1992, ARTERIOSCLER THROMB, V12, P1475, DOI 10.1161/01.ATV.12.12.1475; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2001, CIRCULATION, V103, P2572; Steinhubl SR, 2001, CIRCULATION, V103, P1403, DOI 10.1161/01.CIR.103.10.1403; Vivekananthan DP, 2004, AM J CARDIOL, V94, P358, DOI 10.1016/j.amjcard.2004.04.035; Weyrich AS, 2002, CIRCULATION, V106, P1433, DOI 10.1161/01.CIR.0000033634.60453.22; Xiao ZH, 2004, J AM COLL CARDIOL, V43, P1982, DOI 10.1016/j.jacc.2003.10.071	46	541	569	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2005	294	10					1224	1232		10.1001/jama.294.10.1224	http://dx.doi.org/10.1001/jama.294.10.1224			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963UI	16143698	Bronze			2022-12-28	WOS:000231831200019
J	de Crombrugghe, B				de Crombrugghe, B			Osteoblasts clock in for their day job	CELL			English	Editorial Material							SYMPATHETIC-NERVOUS-SYSTEM; BONE-FORMATION	The proteins encoded by clock genes regulate circadian variations of various cellular functions. In this issue of Cell, Fu, Karsenty, and colleagues (Fu et al., 2005) demonstrate that clock genes control the proliferation of osteoblasts, the cells that promote growth of bone. These findings indicate that the homeostatic regulation of bone mass is subject to circadian control.	MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	de Crombrugghe, B (corresponding author), MD Anderson Canc Ctr, Dept Mol Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.							Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; GUNDBERG CM, 1985, J CLIN ENDOCR METAB, V60, P736, DOI 10.1210/jcem-60-4-736; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; SIMMONS DJ, 1966, AM J PHYSIOL, V210, P411, DOI 10.1152/ajplegacy.1966.210.2.411; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8	10	6	6	2	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 9	2005	122	5					651	653		10.1016/j.cell.2005.08.025	http://dx.doi.org/10.1016/j.cell.2005.08.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143097	Bronze			2022-12-28	WOS:000231844300004
J	McWhirter, SM; tenOever, BR; Maniatis, T				McWhirter, SM; tenOever, BR; Maniatis, T			Connecting mitochondria and innate immunity	CELL			English	Editorial Material							NF-KAPPA-B; IDENTIFICATION	Viral infection results in the activation of multiple signaling pathways, but how these pathways are coordinated remains a mystery. Two studies, one published in this issue of Cell (Seth et al., 2005) and the other in Molecular Cell (Xu et al., 2005), identify a new intracellular signaling protein that is required for activating type I interferon expression in response to viral infection. In addition, Seth et al. (2005) show that the function of this protein, which they call MAVS, requires that it be localized to the mitochondria. This observation establishes an unexpected link between innate immunity and an organelle with evolutionary origins in aerobic bacteria.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	McWhirter, SM (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Levy DE, 2004, NAT IMMUNOL, V5, P699, DOI 10.1038/ni0704-699; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	10	79	82	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					645	647		10.1016/j.cell.2005.08.026	http://dx.doi.org/10.1016/j.cell.2005.08.026			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143094	Bronze			2022-12-28	WOS:000231844300001
J	Barzansky, B; Etzel, SI				Barzansky, B; Etzel, SI			Educational programs in US medical schools, 2004-2005	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE LOCATION	Context The educational environment affects the outcomes of medical education, including the characteristics and distribution of medical school graduates. Objective To report the status of variables related to medical education that represent areas that recently have been in flux or have potential impact on health care delivery. Design, Setting, and Participants Descriptive survey study comparing selected results of the Liaison Committee on Medical Education Annual Medical School Questionnaire between 2004-2005 and 1994-1995. The questionnaire was sent to the deans of all 125 LCME-accredited medical schools. Response rate was 100% in both years. Main Outcome Measures Overall trends between 1994-1995 and 2004-2005 in the size and composition of the medical school faculty, the numbers of medical school applicants and students, requirements for passage of the US Medical Licensing Examination, medical student work hours, the use of computers in the educational program, the geographic pipeline from entry to medical school to entry to graduate medical education, and the educational background of medical school deans. Results The number of full-time faculty members increased from 90016 in 19941995 to 119025 in 2004-2005 (a 32% increase) while the number of medical students remained constant at about 67 000. In 2004-2005, 11 % of medical school deans held MID and PhD degrees, 6% held MID and MBA degrees, 4% held MID and MPH degrees, and 2% held an MID and another degree (such as JD). In 2004-2005, 68% of all first-year medical students were residents of the state in which the medical school is located and a mean of 43% of 2005 graduates remained in the same state as the medical school for graduate medical education; results were similar in 1995. In 20042005, 58 schools (46%) required students to have their own computers and 35 (28%) to have their own personal digital assistants. In 2004-2005, night call was less common in the family medicine, internal medicine, pediatrics, and psychiatry clerkships compared with 1994-1995. Conclusions Although most students remain in their home state for medical school, most students leave the medical school state for residency. Factors external to the medical school, such as funding mechanisms and regulations from the public and private sectors, may be having an impact on faculty size and composition, and on the geographic pipeline of students into medical school and residency training.	Amer Med Assoc, Div Undergrad Med Educ Policy & Stand, Chicago, IL 60610 USA; Amer Med Assoc, Div Grad Med Educ, Chicago, IL 60610 USA	American Medical Association; American Medical Association	Barzansky, B (corresponding author), Amer Med Assoc, Div Undergrad Med Educ Policy & Stand, 515 N State St, Chicago, IL 60610 USA.	barbara.barzansky@ama-assn.org						*AAMC DAT BOOK, 2005, STAT INF REL MED ED; *ASS AM MED COLL, 1998, MED SCH ADM REQ US C; BARZANSKY B, 1995, JAMA-J AM MED ASSOC, V274, P716, DOI 10.1001/jama.274.9.716; Barzansky B, 2004, JAMA-J AM MED ASSOC, V292, P1025, DOI 10.1001/jama.292.9.1025; Barzansky B, 2002, JAMA-J AM MED ASSOC, V288, P1067, DOI 10.1001/jama.288.9.1067; Barzansky B, 1997, JAMA-J AM MED ASSOC, V278, P744, DOI 10.1001/jama.278.9.744; Cooksey JA, 1999, ACAD MED, V74, pS114, DOI 10.1097/00001888-199910000-00058; Daugherty RM, 1998, ACAD MED, V73, P649, DOI 10.1097/00001888-199806000-00010; DORNER FH, 1991, ACAD MED, V66, P540, DOI 10.1097/00001888-199109000-00011; Lau F, 2004, J MED SYST, V28, P71, DOI 10.1023/B:JOMS.0000021522.30587.ff; Lieberman Jayme D, 2005, Curr Surg, V62, P231, DOI 10.1016/j.cursur.2004.06.015; PASKO T, 2004, PHYS CHAR DISTR US 2, P29; Rydrych Diane, 2003, Minn Med, V86, P34; SEIFER SD, 1995, JAMA-J AM MED ASSOC, V274, P685, DOI 10.1001/jama.274.9.685; Steele MT, 1998, ANN EMERG MED, V31, P351, DOI 10.1016/S0196-0644(98)70346-4; TRONTELL MC, 1991, J GEN INTERN MED, V6, P445, DOI 10.1007/BF02598169	16	38	38	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2005	294	9					1068	1074		10.1001/jama.294.9.1068	http://dx.doi.org/10.1001/jama.294.9.1068			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XU	16145027				2022-12-28	WOS:000231627300007
J	Fletcher, KE; Underwood, W; Davis, SQ; Mangrulkar, RS; McMahon, LF; Saint, S				Fletcher, KE; Underwood, W; Davis, SQ; Mangrulkar, RS; McMahon, LF; Saint, S			Effects of work hour reduction on residents' lives - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	8th Annual Meeting of the Society-of-Hospital-Medicine	APR 29-30, 2005	Chicago, IL	Soc Hosp Med			NIGHT-FLOAT SYSTEM; NEW-YORK-STATE; INTERNAL-MEDICINE RESIDENTS; SLEEP-DEPRIVATION; DUTY HOURS; PATIENT-CARE; TRAINING-PROGRAMS; IMPACT; PERCEPTIONS; EXPERIENCE	Context The Accreditation Council for Graduate Medical Education implemented mandatory work hour limitations in July 2003, partly out of concern for residents' wellbeing in the setting of sleep deprivation. These limitations are likely to also have an impact on other aspects of the lives of residents. Objective To summarize the literature regarding the effect of interventions to reduce resident work hours on residents' education and quality of life. Data Sources We searched the English-language literature about resident work hours from 1966 through April 2005 using MEDLINE, EMBASE, and Current Contents, supplemented with hand-search of additional journals, reference list review, and review of abstracts from national meetings. Study Selection Studies were included that assessed a system change designed to counteract the effects of resident work hours, fatigue, or sleep deprivation; included an outcome directly related to residents; and were conducted in the United States. Data Extraction For each included study, 2 investigators independently abstracted data related to study quality, subjects, interventions, and findings using a standard data abstraction form. Data Synthesis Fifty-four articles met inclusion criteria. The interventions used to decrease resident work hours varied but included night and day float teams, extra cross-coverage, and physician extenders. Outcomes included measures of resident education (operative experience, test scores, satisfaction) and quality of residents' lives (amount of sleep, well-being). Interventions to reduce resident work hours resulted in mixed effects on both operative experience and on perceived educational quality but generally improved residents' quality of life. Many studies had major limitations in their design or conduct. Conclusions Past interventions suggest that residents' quality of life may improve with work hour limitations, but interpretation of the outcomes of these studies is hampered by suboptimal study design and the use of nonvalidated instruments. The long-term impact of reducing resident work hours on education remains unknown. Current and future interventions should be evaluated with more rigorous methods and should investigate links between residents' quality of life and quality of patient care.	Med Coll Wisconsin, Clement J Zablocki VA Med Ctr, Dept Internal Med, Primary Care Div, Milwaukee, WI 53295 USA; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; Univ Chicago, Pritzker Sch Med, Dept Internal Med, Chicago, IL 60637 USA	Medical College of Wisconsin; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Chicago	Fletcher, KE (corresponding author), Med Coll Wisconsin, Clement J Zablocki VA Med Ctr, Dept Internal Med, Primary Care Div, 5000 W Natl Ave, Milwaukee, WI 53295 USA.	kathlyn.fletcher@med.va.gov	Saint, Sanjay/AAF-5126-2019		AHRQ HHS [P20-HS11540] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011540] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*ACGME, 2003, STAT JUST IMP FIN AP; Akl EA, 2005, J GEN INTERN MED, V20, P150; *AM MED STUD ASS, 2003, RES WORK HOUR ISS; Barden CB, 2002, J AM COLL SURGEONS, V195, P531, DOI 10.1016/S1072-7515(02)01242-5; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Barone JE, 2004, ACAD MED, V79, P379, DOI 10.1097/00001888-200405000-00002; Basu CB, 2004, PLAST RECONSTR SURG, V114, P1878, DOI 10.1097/01.PRS.0000142768.07468.64; BERKOFF K, 1991, J DEV BEHAV PEDIATR, V12, P6; Blanchard MH, 2004, AM J OBSTET GYNECOL, V191, P1746, DOI 10.1016/j.ajog.2004.07.060; BUFF DD, 1995, J GEN INTERN MED, V10, P400, DOI 10.1007/BF02599842; CAREY JC, 1989, OBSTET GYNECOL, V74, P668; Cavallo A, 2003, ERGONOMICS, V46, P653, DOI 10.1080/0014013031000085671; Cavallo A, 2002, CHRONOBIOL INT, V19, P893, DOI 10.1081/CBI-120014106; Chandra RK, 2004, LARYNGOSCOPE, V114, P1394, DOI 10.1097/00005537-200408000-00014; Chung Raphael, 2004, Curr Surg, V61, P609, DOI 10.1016/j.cursur.2004.07.010; *CIR, 2003, WHO WE AR WHAT WE DO; Cockerham WT, 2004, AM SURGEON, V70, P687; COHEN BL, 1991, B NEW YORK ACAD MED, V67, P338; Cohen-Gadol AA, 2005, NEUROSURGERY, V56, P398, DOI 10.1227/01.NEU.0000147999.64356.57; CONIGLIARO J, 1993, J GEN INTERN MED, V8, P502, DOI 10.1007/BF02600112; Converse Jean M., 1986, SURVEY QUESTIONS HAN, V63; Curet MJ, 2003, SURGERY, V134, P158, DOI 10.1067/msy.2003.266; DAIGLER GE, 1990, AM J DIS CHILD, V144, P799, DOI 10.1001/archpedi.1990.02150310067030; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Donabedian A., 1980, DEFINITION QUALITY A, V1; Druss BJ, 1996, ACAD PSYCHIATR, V20, P26, DOI 10.1007/BF03341958; Fassler, 2000, Curr Surg, V57, P373, DOI 10.1016/S0149-7944(00)00274-9; Fink A., 1998, CONDUCT SURVEYS STEP; Fletcher KE, 2005, ACAD MED, V80, P39, DOI 10.1097/00001888-200501000-00010; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; Fowler F.J., 2014, SURV RES METHODS-GER, V5th ed.; Gelfand DV, 2004, ARCH SURG-CHICAGO, V139, P933, DOI 10.1001/archsurg.139.9.933; Godellas CV, 2001, AM J SURG, V181, P294, DOI 10.1016/S0002-9610(01)00576-1; Goldstein Michael J, 2005, Curr Surg, V62, P132, DOI 10.1016/j.cursur.2004.10.013; GOLDSTEIN MJ, 2004, CURR SURG, V61, P4445; GOTTLIEB DJ, 1993, J GEN INTERN MED, V8, P146, DOI 10.1007/BF02599762; GOTTLIEB DJ, 1991, ARCH INTERN MED, V151, P2065, DOI 10.1001/archinte.151.10.2065; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hassett JM, 2002, SURGERY, V132, P635, DOI 10.1067/msy.2002.127542; HILLSON S, 1995, J GEN INTERN MED S1, V10, P89; Hunter A, 2005, J GEN INTERN MED, V20, P182; JACQUES CHM, 1990, J FAM PRACTICE, V30, P223; Jarman Benjamin T, 2004, Curr Surg, V61, P612, DOI 10.1016/j.cursur.2004.06.016; Jasti H, 2004, J GEN INTERN MED, V19, P205; Jasti H, 2004, J GEN INTERN MED, V19, P121; Kaushal H, 2004, J GEN INTERN MED, V19, P145; KELLY A, 1991, OBSTET GYNECOL, V78, P468; Kerfoot BP, 2005, MED EDUC, V39, P528, DOI 10.1111/j.1365-2929.2005.02137.x; Kort KC, 2004, SURGERY, V136, P861, DOI 10.1016/j.surg.2004.07.005; KRIPALANI S, 2001, J GEN INTERN MED S1, V16, P102; Kuo AK, 2004, AMBUL PEDIATR, V4, P332, DOI 10.1367/A03-167R.1; LANDAU C, 1984, P ANN C RES MED ED, V23, P44; Leonard C, 1998, IRISH J MED SCI, V167, P22, DOI 10.1007/BF02937548; LIEBERMAN J, 2004, RES MED ED, P74; LIEU TA, 1992, AM J DIS CHILD, V146, P307, DOI 10.1001/archpedi.1992.02160150047018; LINGENFELSER T, 1994, MED EDUC, V28, P566, DOI 10.1111/j.1365-2923.1994.tb02737.x; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Mathis B, 2004, J GEN INTERN MED, V19, P235; Meltzer DO, 2005, J GEN INTERN MED, V20, P141; Mendoza KA, 2005, ARCH SURG-CHICAGO, V140, P137, DOI 10.1001/archsurg.140.2.137; Mercado JM, 2004, J GEN INTERN MED, V19, P182; NEMES J, 1992, J PEDIATR SURG, V27, P1038, DOI 10.1016/0022-3468(92)90554-K; NICHOLS M, 1994, AM J OBSTET GYNECOL, V170, P1658; Olshausen P, 2005, J GEN INTERN MED, V20, P155; Ozuah PO, 2001, ARCH PEDIAT ADOL MED, V155, P1073; Parekh VI, 2005, J GEN INTERN MED, V20, P165; Peterson CM, 2005, ACAD RADIOL, V12, P373, DOI 10.1016/j.acra.2004.12.014; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Podnos Yale D, 2003, Curr Surg, V60, P529, DOI 10.1016/S0149-7944(03)00004-7; *PUBL CIT HLTH RES, 2003, MED RES WORK HOURS; Reader Douglas W, 2002, Emerg Radiol, V9, P82; Richardson GS, 1996, SLEEP, V19, P718; ROSE MW, 2000, SLEEP, V23, pA253; Rosenbaum JR, 2004, AM J MED, V117, P846, DOI 10.1016/j.amjmed.2004.09.001; ROSENBERG M, 1995, J GEN INTERN MED, V10, P95, DOI 10.1007/BF02600236; Samuels RC, 2005, ACAD MED, V80, P467, DOI 10.1097/00001888-200505000-00013; Saultz JW, 2004, FAM MED, V36, P363; SEELIG CB, 1992, SOUTH MED J, V85, P972, DOI 10.1097/00007611-199210000-00010; SEELIG CB, 1993, J GEN INTERN MED, V8, P610, DOI 10.1007/BF02599716; SELTZER V, 1991, OBSTET GYNECOL, V77, P940; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Spencer AU, 2005, J AM COLL SURGEONS, V200, P670, DOI 10.1016/j.jamcollsurg.2005.01.008; SPISSO J, 1990, J TRAUMA, V30, P660, DOI 10.1097/00005373-199006000-00001; Stamp Thomas, 2005, Curr Surg, V62, P117, DOI 10.1016/j.cursur.2004.09.013; Stern D T, 2001, South Med J, V94, P651; Stone MD, 2000, SURGERY, V128, P465, DOI 10.1067/msy.2000.108048; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Talente GM, 2005, J GEN INTERN MED, V20, P147; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; TRONTELL MC, 1991, J GEN INTERN MED, V6, P445, DOI 10.1007/BF02598169; Victorino GP, 2003, ARCH SURG-CHICAGO, V138, P971, DOI 10.1001/archsurg.138.9.971; Vidyarthi AR, 2004, J GEN INTERN MED, V19, P164; Welling Richard E, 2004, Curr Surg, V61, P241, DOI 10.1016/j.cursur.2003.10.009; Whang EE, 2003, ANN SURG, V237, P449, DOI 10.1097/00000658-200304000-00001; Winslow Emily R, 2004, Curr Surg, V61, P602, DOI 10.1016/j.cursur.2004.06.013; Wong JG, 2004, J GEN INTERN MED, V19, P519, DOI 10.1111/j.1525-1497.2004.30153.x; YEDIDIA MJ, 1993, J GEN INTERN MED, V8, P429, DOI 10.1007/BF02599620; Yu J N, 1994, Fam Med, V26, P163; 2002, STANDARDS BEST PRACT	99	236	244	2	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2005	294	9					1088	1100		10.1001/jama.294.9.1088	http://dx.doi.org/10.1001/jama.294.9.1088			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	960XU	16145030				2022-12-28	WOS:000231627300010
J	Colman, E				Colman, E			Anorectics on trial: A half century of federal regulation of prescription appetite suppressants	ANNALS OF INTERNAL MEDICINE			English	Article							ADIPOSITY	Beginning with the passage of the Federal Food, Drug, and Cosmetic Act in 1938 and escalating with the 1962 Kefauver-Harris amendments, increasing pressure has been placed on pharmaceutical manufacturers to demonstrate that a drug's benefits outweigh its risks. Nowhere has the question of risk versus benefit come under greater scrutiny than with anorectics. After the approval in the 1940s and 1950s of a number of amphetamine and amphetamine-like compounds for the treatment of obesity, the U.S. Food and Drug Administration struggled to define the efficacy and safety of these agents. Labeling restrictions on duration of use and warnings about abuse and addiction ultimately contributed to the reduced use of anorectics. That trend continued until the mid-1990s, when the off-label use of fenfluramine plus phentermine (fen-phen) and the approval of dexfenfluramine gave rise to widespread, long-term use of anorectics to treat obesity. The adverse effects that came to be associated with fenfluramine and dexfenfluramine, leading to their eventual withdrawal from the market, gave pause to regulators, physicians, patients, and drug companies alike. Sibutramine, the latest anorectic to enter the market, is now the focus of a landmark trial that is examining, for the first time, whether drug-induced weight loss reduces the risk for fatal and nonfatal cardiovascular disease.	US FDA, Div Metab & Endocrine Drug Prod, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Colman, E (corresponding author), US FDA, Div Metab & Endocrine Drug Prod, Ctr Drug Evaluat & Res, HFD-510,5600 Fishers Lane, Rockville, MD 20857 USA.	colmane@cder.fda.gov						*ABB LAB, DAT DEM IMP WEIGHT L; *AM MED ASS COUNC, 1946, NEW NON REM, P281; *AM MED ASS COUNC, 1948, NEW NON REM, P228; [Anonymous], 1991, JAMA, V265, P3255; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; DILLON E S, 1951, Trans Assoc Life Insur Med Dir Am, V35, P280; *DRUG EFF STUD PAN, 1969, DRUG EFF STUD IMPL C; DUBLIN L I, 1951, Trans Assoc Life Insur Med Dir Am, V35, P235; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Fricker J, 1997, LANCET, V349, P1374, DOI 10.1016/S0140-6736(05)63217-5; GOLDSTEIN DJ, 1994, AM J CLIN NUTR, V60, P647, DOI 10.1093/ajcn/60.5.647; HALL T, 1992, NY TIMES        1014, pC2; HALL T, 1997, NY TIMES        1125; HALL T, 1992, NY TIMES        0708, pC1; HERWICK RP, 1943, NEW DRUG APPL; *IMS HLTH, 1995, NAT PRESCR AUD PLUS; *IMS HLTH, 1996, NAT PRESCR AUD PLUS; KANNEL WB, 1967, ANN INTERN MED, V67, P48, DOI 10.7326/0003-4819-67-1-48; KNOX R, 1971, COMMUNICATION   0409; KNOX RA, 1997, BOSTON GLOBE    1125; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; LOPEZ M, 1997, STUART NEWS     0121; MECKLER L, 2002, ASS PRESS       0319; *NAT AC SCI NAT RE, 1969, DRUG EFF STUD FIN RE, P6; *NAT AC SCI NAT RE, 1969, DRUG EFF STUD FIN RE, P1; PEDERSEN TR, 1994, LANCET, V344, P1383; RAY H, 1948, AM J DIG DIS, V14, P153; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; ROSS E, 2002, ASS PRESS       0628; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; SCOVILLE B, 1971, COMMUNICATION   0412; SCOVILLE B, 1972, DRUGS CONTROL OVERWE, P92; *US FDA, 1943, NEW DRUG APPL; *US FDA, 1996, MED OFF REV SIB NEW; *US FDA, 1971, P NEUR DRUGS ADV COM; *US FDA, 1996, P END MET DRUGS ADV; *US FDA, 2005, 1996 GUID CLIN EV WE; *US FDAN, 1943, NEW DRUG APPL; US Food and Drug Administration, 1995, P END MET DRUGS ADV; VANWINKLE W, 1943, NEW DRUG APPL; WALKER WJ, 1953, ANN INTERN MED, V39, P705, DOI 10.7326/0003-4819-39-4-705; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P642, DOI 10.1038/clpt.1992.76; WILLAM P, 2002, GUARDIAN        0308; 1973, FED REG, V38, P4249; 1970, FED REG, V35, P12652; 1997, PHYS DESK REFERENCE	47	117	121	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2005	143	5					380	385		10.7326/0003-4819-143-5-200509060-00013	http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00013			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961TE	16144896				2022-12-28	WOS:000231683900007
J	Koretz, RL; Lipman, TO				Koretz, RL; Lipman, TO			Update in gastroenterology and hepatology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; CHRONIC HEPATITIS-C; ACUTE-PANCREATITIS; PARENTERAL-NUTRITION; PLUS RIBAVIRIN; METAANALYSIS; MORTALITY		Olive View UCLA Med Ctr, Dept Med, Sylmar, CA 91342 USA; Vet Affairs Med Ctr, Washington, DC 20422 USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Koretz, RL (corresponding author), Olive View UCLA Med Ctr, Dept Med, 14445 Olive View Dr, Sylmar, CA 91342 USA.	rkoretz@ladhs.org						Calonge N, 2004, ANN INTERN MED, V141, P718, DOI 10.7326/0003-4819-141-9-200411020-00014; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Coon JT, 2002, ALIMENT PHARM THER, V16, P1689, DOI [10.1046/j.0269-2813.2002.01339.x, 10.1046/j.1365-2036.2002.01339.x]; Golub R, 1998, J Gastrointest Surg, V2, P496, DOI 10.1016/S1091-255X(98)80048-6; HYDE D, 1984, GASTROENTEROLOGY, V86, P1119; Koretz RL, 2001, GASTROENTEROLOGY, V121, P970, DOI [10.1053/gast.2001.28031, 10.1016/S0016-5085(01)92000-1]; Koretz RL, 2004, CLIN GASTROENTEROL H, V2, P957, DOI 10.1016/S1542-3565(04)00461-6; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Powell JJ, 2000, BRIT J SURG, V87, P1375, DOI 10.1046/j.1365-2168.2000.01558.x; ROCKEY DC, 1993, NEW ENGL J MED, V329, P1691, DOI 10.1056/NEJM199312023292303; SAX HC, 1987, AM J SURG, V153, P117, DOI 10.1016/0002-9610(87)90211-X; Sharma VK, 2001, PANCREAS, V22, P28, DOI 10.1097/00006676-200101000-00005	13	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2005	143	5					347	354		10.7326/0003-4819-143-5-200509060-00010	http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961TE	16144893				2022-12-28	WOS:000231683900004
J	Solomon, T; Marston, D; Mallewa, M; Felton, T; Shaw, S; McElhinney, LM; Das, K; Mansfield, K; Wainwright, J; Kwong, GNM; Fooks, AR				Solomon, T; Marston, D; Mallewa, M; Felton, T; Shaw, S; McElhinney, LM; Das, K; Mansfield, K; Wainwright, J; Kwong, GNM; Fooks, AR			Lesson of the week - Paralytic rabies after a two week holiday in India	BRITISH MEDICAL JOURNAL			English	Review							ENCEPHALITIS; TRAVEL		Univ Liverpool, Walton Ctr Neurol & Neurosurg, Div Neurol Sci, Viral CNS Infect Grp, Liverpool L9 7LJ, Merseyside, England; Univ Liverpool, Walton Ctr Neurol & Neurosurg, Div Med Microbiol, Viral CNS Infect Grp, Liverpool L9 7LJ, Merseyside, England; Vet Labs Agcy, Rabies & Wildlife Zoonoses Grp, Weybridge KT15 3NB, Surrey, England; Walton Ctr Neurol & Neurosurg NHS Trust, Liverpool, Merseyside, England; Fairfield Hosp, Pennine Acute Hosp NHS Trust, Bury BL9 7TD, Lancs, England	University of Liverpool; Walton Centre; University of Liverpool; Walton Centre; Veterinary Laboratories Agency; Walton Centre	Solomon, T (corresponding author), Univ Liverpool, Walton Ctr Neurol & Neurosurg, Div Neurol Sci, Viral CNS Infect Grp, Liverpool L9 7LJ, Merseyside, England.	tsolomon@liv.ac.uk	Mansfield, Karen L/D-8399-2011; Felton, Tim W/F-1795-2011; Marston, Denise A/D-7993-2011; Felton, Tim/N-5940-2019; Fooks, Anthony R/F-5418-2010	Felton, Tim W/0000-0001-6868-6633; Marston, Denise A/0000-0001-9215-088X; Felton, Tim/0000-0001-6868-6633; Solomon, Tom/0000-0001-7266-6547				Davison KL, 2003, EMERG INFECT DIS, V9, P234; *DEP HLTH, RAB DRAFT UPD CHAPT; Fooks AR, 2003, J MED VIROL, V71, P281, DOI 10.1002/jmv.10481; Fooks AR, 2003, J APPL MICROBIOL, V94, p31S; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Jackson AC, 2003, CLIN INFECT DIS, V36, P60, DOI 10.1086/344905; Johnson N, 2002, J CLIN VIROL, V25, P351, DOI 10.1016/S1386-6532(02)00131-2; Laothamatas J, 2003, AM J NEURORADIOL, V24, P1102; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Sheikh KA, 2005, ANN NEUROL, V57, P768, DOI 10.1002/ana.20482; Smith J, 2003, J MED VIROL, V69, P150, DOI 10.1002/jmv.10253; Solomon T, 2003, CURR OPIN INFECT DIS, V16, P375, DOI 10.1097/00001432-200310000-00002; Srinivasan A, 2005, NEW ENGL J MED, V352, P1103, DOI 10.1056/NEJMoa043018; Wakeley PR, 2005, J CLIN MICROBIOL, V43, P2786, DOI 10.1128/JCM.43.6.2786-2792.2005; Warrell MJ, 2003, MANSONS TROPICAL DIS, P807; *WHO, 2001, WHO RAB FACT SHEET; Wilde H, 2003, CLIN INFECT DIS, V37, P96, DOI 10.1086/375605; Willoughby RE, 2005, NEW ENGL J MED, V352, P2508, DOI 10.1056/NEJMoa050382	18	33	34	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 3	2005	331	7515					501	503		10.1136/bmj.331.7515.501	http://dx.doi.org/10.1136/bmj.331.7515.501			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963RA	16141158	Green Published			2022-12-28	WOS:000231820400025
J	Lu, C; Tej, SS; Luo, SJ; Haudenschild, CD; Meyers, BC; Green, PJ				Lu, C; Tej, SS; Luo, SJ; Haudenschild, CD; Meyers, BC; Green, PJ			Elucidation of the small RNA component of the transcriptome	SCIENCE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; ARABIDOPSIS-THALIANA; INTERFERENCE; MICRORNAS; GENOME; IDENTIFICATION; ANNOTATION; EXPRESSION; MIRNA; MPSS	Small RNAs play important regulatory roles in most eukaryotes, but only a small proportion of these molecules have been identified. We sequenced more than two million small RNAs from seedlings and the inflorescence of the model plant Arabidopsis thaliana. Known and new microRNAs (miRNAs) were among the most abundant of the nonredundant set of more than 75,000 sequences, whereas more than half represented lower abundance small interfering RNAs (siRNAs) that match repetitive sequences, intergenic regions, and genes. Individual or clusters of highly regulated small RNAs were readily observed. Targets of antisense RNA or miRNA did not appear to be preferentially associated with siRNAs. Many genomic regions previously considered featureless were found to be sites of numerous small RNAs.	Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19711 USA; Univ Delaware, Coll Marine Studies, Newark, DE 19711 USA; Solexa Inc, Hayward, CA 94545 USA	University of Delaware; University of Delaware; University of Delaware	Meyers, BC (corresponding author), Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA.	meyers@dbi.udel.edu; green@dbi.udeLedu	Christian, Haudenschild C/D-1602-2009; Meyers, Blake/B-6535-2012	Meyers, Blake/0000-0003-3436-6097	NCRR NIH HHS [P20 RR16472-04] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jen CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r51; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Wortman JR, 2003, PLANT PHYSIOL, V132, P461, DOI 10.1104/pp.103.022251; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	19	471	525	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1567	1569		10.1126/science.1114112	http://dx.doi.org/10.1126/science.1114112			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141074				2022-12-28	WOS:000231715000051
J	Pyle, AM				Pyle, AM			Capping by branching: A new ribozyme makes tiny lariats	SCIENCE			English	Article							RNA; DEOXYRIBOZYME; INTRON	The number of naturally occurring RNA enzymes has just been expanded by the discovery of a new branching ribozyme. But this ribozyme has unexpected relatives: group I introns.	Yale Univ, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Pyle, AM (corresponding author), Yale Univ, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, 266 Whitney Ave,Bass Bldg Room 334, New Haven, CT 06520 USA.							AMBERG AC, 1980, CELL, V19, P313; CECH TR, 1993, RNA WORLD, V1, P239; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Cheng Z, 2004, SCIENCE, V303, P240, DOI 10.1126/science.1087023; Coombes CE, 2005, RNA, V11, P323, DOI 10.1261/rna.7124405; Coppins RL, 2005, J AM CHEM SOC, V127, P2900, DOI 10.1021/ja044881b; JOHANSEN S, 1994, CELL, V76, P725, DOI 10.1016/0092-8674(94)90511-8; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; Nielsen H, 2005, SCIENCE, V309, P1584, DOI 10.1126/science.1113645; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Pratico ED, 2005, NUCLEIC ACIDS RES, V33, P3503, DOI 10.1093/nar/gki656; Tuschl T, 2001, RNA, V7, P29, DOI 10.1017/S1355838201001510; Wang YM, 2003, J AM CHEM SOC, V125, P6880, DOI 10.1021/ja035150z	14	5	6	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1530	1531		10.1126/science.1117957	http://dx.doi.org/10.1126/science.1117957			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141065				2022-12-28	WOS:000231715000040
J	de Waal, FBM				de Waal, FBM			A century of getting to know the chimpanzee	NATURE			English	Article							KIBALE NATIONAL-PARK; INFANTICIDE; PATERNITY	A century of research on chimpanzees, both in their natural habitat and in captivity, has brought these apes socially, emotionally and mentally much closer to us. Parallels and homologues between chimpanzee and human behaviour range from tool-technology and cultural learning to power politics and intercommunity warfare. Few behavioural domains have remained untouched by this increased knowledge, which has dramatically challenged the way we view ourselves. The sequencing of the chimpanzee genome will no doubt bring more surprises and insights. Humans do occupy a special place among the primates, but this place increasingly has to be defined against a backdrop of substantial similarity.	Emory Univ, Yerkes Natl Primate Res Ctr, Living Links, Atlanta, GA 30322 USA	Emory University	de Waal, FBM (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Living Links, 954 N Gatewood Rd, Atlanta, GA 30322 USA.	dewaal@emory.edu						Arcadi AC, 1999, PRIMATES, V40, P337, DOI 10.1007/BF02557557; Aureli F., 2000, NATURAL CONFLICT RES; Boesch C, 2003, ANIMAL SOCIAL COMPLEXITY, P93; Constable JL, 2001, MOL ECOL, V10, P1279, DOI 10.1046/j.1365-294X.2001.01262.x; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; DEWAAL F, 1982, CHIMPANZEE POLITICS; DEWAAL FBM, 1988, ETHOL SOCIOBIOL, V9, P101, DOI 10.1016/0162-3095(88)90016-7; DEWAAL FBM, 1986, ETHOL SOCIOBIOL, V7, P237, DOI 10.1016/0162-3095(86)90051-8; DEWAAL FBM, 1987, NATL GEOGR RES, V3, P318; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Goodall J., 1965, P425; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Goodall J., 1979, GREAT APES, P13; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; HIRAIWAHASEGAWA M, 1994, INFANTICIDE PARENTAL, P137; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Kohler W., 1925, MENTALITY APES; Ladygina-Kohts N. N., 2001, INFANT CHIMPANZEE HU; Menzel EW, 1974, BEHAV NONHUMAN PRIMA, P83; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; NISHIDA T, 1983, Primates, V24, P318, DOI 10.1007/BF02381978; Nishida Toshisada, 1992, P159; Nissen, 1931, COMP PSYCHOL MONOGR, V8, P1; OAKLEY KP, 1957, MAN TOOL MAKER; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; Reno PL, 2003, P NATL ACAD SCI USA, V100, P9404, DOI 10.1073/pnas.1133180100; STANFORD CB, 1998, CHIMPANZEE RED COLUM; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Watts DP, 2004, INT J PRIMATOL, V25, P507, DOI 10.1023/B:IJOP.0000023573.56625.59; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Wittig RM, 2003, BEHAV ECOL SOCIOBIOL, V54, P491, DOI 10.1007/s00265-003-0654-8; Yerkes RM., 1943, CHIMPANZEES LAB COLO	34	29	34	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					56	59		10.1038/nature03999	http://dx.doi.org/10.1038/nature03999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	960AC	16136128				2022-12-28	WOS:000231560400042
J	[Anonymous]				[Anonymous]			Timeline: A brief history of chimps	NATURE			English	Article																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					48	49		10.1038/437048a	http://dx.doi.org/10.1038/437048a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136125				2022-12-28	WOS:000231560400039
J	A'Hearn, MF; Belton, MJS; Delamere, WA; Kissel, J; Klaasen, KP; McFadden, LA; Meech, KJ; Melosh, HJ; Schultz, PH; Sunshine, JM; Thomas, PC; Veverka, J; Yeomans, DK; Baca, MW; Busko, I; Crockett, CJ; Collins, SM; Desnoyer, M; Eberhardy, CA; Ernst, CM; Farnham, TL; Feaga, L; Groussin, O; Hampton, D; Ipatov, SI; Li, JY; Lindler, D; Lisse, CM; Mastrodemos, N; Owen, WM; Richardson, JE; Wellnitz, DD; White, RL				A'Hearn, MF; Belton, MJS; Delamere, WA; Kissel, J; Klaasen, KP; McFadden, LA; Meech, KJ; Melosh, HJ; Schultz, PH; Sunshine, JM; Thomas, PC; Veverka, J; Yeomans, DK; Baca, MW; Busko, I; Crockett, CJ; Collins, SM; Desnoyer, M; Eberhardy, CA; Ernst, CM; Farnham, TL; Feaga, L; Groussin, O; Hampton, D; Ipatov, SI; Li, JY; Lindler, D; Lisse, CM; Mastrodemos, N; Owen, WM; Richardson, JE; Wellnitz, DD; White, RL			Deep Impact: Excavating comet Tempel 1	SCIENCE			English	Article							P/WILD 2; NUCLEUS; EVOLUTION; MISSION; SURFACE	Deep Impact collided with comet Tempel 1, excavating a crater controlled by gravity. The comet's outer layer is composed of 1- to 100-micrometer fine particles with negligible strength (<65 pascals). Local gravitational field and average nucleus density (600 kilograms per cubic meter) are estimated from ejecta fallback. Initial ejecta were hot (>1000 kelvins). A large increase in organic material occurred during and after the event, with smaller changes in carbon dioxide relative to water. On approach, the spacecraft observed frequent natural outbursts, a mean radius of 3.0 +/- 0.1 kilometers, smooth and rough terrain, scarps, and impact craters. A thermal map indicates a surface in equilibrium with sunlight.	Univ Maryland, College Pk, MD 20742 USA; Belton Space Explorat Initiat, Tucson, AZ 85716 USA; Delamere Support Serv, Boulder, CO 80301 USA; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Hawaii, Honolulu, HI 96822 USA; Univ Arizona, Tucson, AZ 85721 USA; Brown Univ, Providence, RI USA; SAIC, Chantilly, VA 20151 USA; Cornell Univ, Ithaca, NY 14853 USA; Space Telescope Sci Inst, Baltimore, MD 21218 USA; Ball Aerosp & Technol Corp, Boulder, CO 80301 USA; Sigma Sci, Greenbelt, MD 20771 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	University System of Maryland; University of Maryland College Park; Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Hawaii System; University of Arizona; Brown University; Science Applications International Corporation (SAIC); Cornell University; Space Telescope Science Institute; Ball Aerospace & Technologies; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	A'Hearn, MF (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	ma@astro.umd.edu	Ипатов, Сергей/O-2302-2014; Lisse, Carey M/B-7772-2016; McFadden, Lucy-Ann/I-4902-2013; Meech, Karen/CAH-1412-2022; Wellnitz, Dennis/B-4080-2012; White, Richard L/A-8143-2012; Ernst, Carolyn M/I-4902-2012	Ипатов, Сергей/0000-0002-1413-9180; Lisse, Carey M/0000-0002-9548-1526; McFadden, Lucy-Ann/0000-0002-0537-9975; Ernst, Carolyn M/0000-0002-9434-7886; White, Richard/0000-0002-9194-2807; Sunshine, Jessica/0000-0002-9413-8785; Li, Jian-Yang/0000-0003-3841-9977; Meech, Karen/0000-0002-2058-5670; Feaga, Lori/0000-0002-4230-6759				A'Hearn MF, 2005, SPACE SCI REV, V117, P1, DOI 10.1007/s11214-005-3387-3; Anderson JLB, 2004, METEORIT PLANET SCI, V39, P303, DOI 10.1111/j.1945-5100.2004.tb00342.x; Belton MJ, 2005, SPACE SCI REV, V117, P137, DOI 10.1007/s11214-005-3389-1; Blume WH, 2005, SPACE SCI REV, V117, P23, DOI 10.1007/s11214-005-3386-4; Britt DT, 2004, ICARUS, V167, P45, DOI 10.1016/j.icarus.2003.09.004; Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; Fernandez YR, 2002, ASTRON J, V123, P1050, DOI 10.1086/338436; Groussin O, 2004, ASTRON ASTROPHYS, V413, P1163, DOI 10.1051/0004-6361:20031564; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; Housen KR, 1999, NATURE, V402, P155, DOI 10.1038/45985; Kolokolova L, 2004, SPACE SCI S, P577; LEBOFSKY LA, 1989, ASTEROIDS II, P128; Lisse C, 2002, EARTH MOON PLANETS, V90, P497, DOI 10.1023/A:1021519408600; Lisse CM, 2005, ASTROPHYS J, V625, pL139, DOI 10.1086/431238; Meech KJ, 2005, SCIENCE, V310, P265, DOI 10.1126/science.1118978; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Richardson JE, 2005, SPACE SCI REV, V117, P241, DOI 10.1007/s11214-005-3393-5; Schmidt R.M., 1987, INT J IMPACT ENG, V5, P543, DOI [DOI 10.1016/0734-743X(87)90069-8, 10.1016/0734-743X(87)90069-8]; Schultz PH, 2005, SPACE SCI REV, V117, P207, DOI 10.1007/s11214-005-3383-7; Schultz PH, 1996, J GEOPHYS RES-PLANET, V101, P21117, DOI 10.1029/96JE02266; Sekanina Z, 2004, SCIENCE, V304, P1769, DOI 10.1126/science.1098388; SPENCER JR, 1989, ICARUS, V78, P337, DOI 10.1016/0019-1035(89)90182-6; ULICH BL, 1974, NATURE, V248, P121, DOI 10.1038/248121a0	23	581	587	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					258	264		10.1126/science.1118923	http://dx.doi.org/10.1126/science.1118923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16150978				2022-12-28	WOS:000232670100037
J	Webster, AC; Woodroffe, RC; Taylor, RS; Chapman, JR; Craig, JC				Webster, AC; Woodroffe, RC; Taylor, RS; Chapman, JR; Craig, JC			Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RENAL-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; FOLLOW-UP; CARDIOVASCULAR-DISEASE; RECEIVING TACROLIMUS; COMPARING TACROLIMUS; ACUTE REJECTION; END-POINTS; MULTICENTER; MICROEMULSION	Objective To compare the positive and negative effects of tacrolimus and ciclosporin as initial treatment for renal transplant recipients. Design Systematic review. Data sources and study selection Reports of comparative randomised trials of tacrolimus and ciclosporin identified by searches of Medline, Embase, the Cochrane Register of Controlled Trials, the Cochrane Renal Group Specialist Register, and conference proceedings. Data extraction and synthesis Two reviewers assessed trials for eligibility and quality and extracted data independently. Data were synthesised (random effects model) and results expressed as relative risk (RR), with values < 1 favouring tacrolimus. Subgroup analysis and meta-regression were used to examine potential effect modification by differences in trial design and immunosuppressive co-interventions. Results 123 reports from 30 trials (4102 patients) were included. At six months, graft loss was significantly reduced in tacrolimus treated recipients (RR=0.56, 951% confidence interval 0.36 to 0.86), and this effect persisted up to three years. The relative reduction in graft loss with tacrolimus diminished with higher concentrations of tacrolimus (P = 0.04) but did not vary with ciclosporin formulation (P = 0.97) or ciclosporin concentration (P = 0.38). At one year, tacrolimus treated patients had less acute rejection (RR = 0.69, 0.60 to 0.79) and less steroid resistant rejection (RR=0.49, 0.37 to 0.64) but more diabetes mellitus requiring insulin (RR=1.86, 1.11 to 3.09), tremor, headache, diarrhoea, dyspepsia, and vomiting. The relative excess of diabetes increased with higher concentrations of tacrolimus (P=0.003). Ciclosporin treated recipients had significantly more constipation and cosmetic side effects. No differences were seen in infection or malignancy. Conclusions Treating 100 recipients with tacrolimus instead of ciclosporin for the first year after transplantation avoids 12 patients having acute rejection and two losing their graft but causes an extra five patients to develop insulin dependent diabetes. Optimal drug choice may vary between patients.	Childrens Hosp Westmead, Ctr Kidney Res, Cochrane Renal Grp, Westmead, NSW 2145, Australia; Westmead Hosp, Dept Renal Med, Ctr Transplant & Renal Res, Westmead, NSW 2145, Australia; Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Sydney; University of Sydney; University of Sydney; University of Birmingham	Webster, AC (corresponding author), Childrens Hosp Westmead, Ctr Kidney Res, Cochrane Renal Grp, Westmead, NSW 2145, Australia.	angela.webster@gmad.com	Craig, Jonathan/E-2813-2013; Webster, Angela/J-2186-2012	Craig, Jonathan/0000-0002-2548-4035; Webster, Angela/0000-0001-7509-0512				Agha I, 2001, J AM SOC NEPHROL, V12, p847A; BASKIN E, 2002, 19 INT C TRANSPL SOC; Berlin JA, 2002, STAT MED, V21, P371, DOI 10.1002/sim.1023; Busque S, 2001, TRANSPLANT P, V33, P1266, DOI 10.1016/S0041-1345(00)02471-4; Campos HH, 2002, TRANSPL P, V34, P1656, DOI 10.1016/S0041-1345(02)02968-8; Cecka J M, 1997, Pediatr Transplant, V1, P55; CHADBAN S, 2003, TRANSPLANTATION ANZD, P65; Charpentier B, 2002, TRANSPLANT P, V34, P1625, DOI 10.1016/S0041-1345(02)03048-8; Cosio FG, 2003, AM J TRANSPLANT, V3, P915, DOI 10.1034/j.1600-6143.2003.00183.x; Cuervo LG, 2003, BMJ-BRIT MED J, V327, P65, DOI 10.1136/bmj.327.7406.65; de Mattos AM, 2000, AM J KIDNEY DIS, V35, P333, DOI 10.1016/S0272-6386(00)70348-9; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Denton MD, 1999, LANCET, V353, P1083, DOI 10.1016/S0140-6736(98)07493-5; Egfjord M, 2002, 19 INT C TRANSPL SOC; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2008, SYSTEMATIC REV HLTH; El Haggan W, 2002, TRANSPLANT P, V34, P1817, DOI 10.1016/S0041-1345(02)03094-4; Gourishankar S, 2002, CURR OPIN IMMUNOL, V14, P576, DOI 10.1016/S0952-7915(02)00386-2; Hariharan S, 2003, AM J TRANSPLANT, V3, P933, DOI 10.1034/j.1600-6143.2003.00176.x; Heering P, 1998, CLIN TRANSPLANT, V12, P465; Heisel O, 2004, AM J TRANSPLANT, V4, P583, DOI 10.1046/j.1600-6143.2003.00372.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong JC, 2000, SEMIN NEPHROL, V20, P108; Ichimaru N, 2001, ATHEROSCLEROSIS, V158, P417, DOI 10.1016/S0021-9150(01)00438-5; Johnson C, 2000, TRANSPLANTATION, V69, P834; Kasiske BL, 2000, SEMIN NEPHROL, V20, P176; Knoll GA, 1999, BRIT MED J, V318, P1104, DOI 10.1136/bmj.318.7191.1104; Lachenbruch PA, 2004, AM J TRANSPLANT, V4, P451, DOI 10.1111/j.1600-6143.2004.00386.x; LASKOW DA, 1995, TRANSPLANT P, V27, P809; Liu B, 2003, TRANSPLANT P, V35, P87, DOI 10.1016/S0041-1345(02)04003-4; Margreiter R, 2002, LANCET, V359, P741, DOI 10.1016/S0140-6736(02)07875-3; Mayer AD, 1997, TRANSPLANTATION, V64, P436, DOI 10.1097/00007890-199708150-00012; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Miller J, 2002, 19 INT C TRANSPL SOC; Morris-Stiff G, 1998, TRANSPLANT INT, V11, P204; Nankivell BJ, 2004, TRANSPLANTATION, V78, P557, DOI 10.1097/01.TP.0000128636.70499.6E; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; *NAT I CLIN EXC, 2004, IMM THER REN TRANSPL; National Institute for Health and Care Excellence (NICE), 2004, IMM THER REN TRANSPL, pTA85; Nichelle L, 2002, TRANSPLANT P, V34, P2824, DOI 10.1016/S0041-1345(02)03530-3; OJO AO, 1995, KIDNEY INT, V48, P1592, DOI 10.1038/ki.1995.452; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Radermacher J, 1998, TRANSPLANT INT, V11, P3, DOI 10.1111/j.1432-2277.1998.tb00948.x; Raofi V, 1999, AM J SURG, V177, P299, DOI 10.1016/S0002-9610(99)00042-2; SHAPIRO R, 1991, TRANSPLANT P, V23, P3065; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Toz Huseyin, 2001, Journal of the American Society of Nephrology, V12, p950A; Trompeter R, 2002, PEDIATR NEPHROL, V17, P141, DOI 10.1007/s00467-001-0795-9; TSINALIS D, 2000, 13 INT C TRANSPL SOC; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; *US ORG PROC TRANS, 2004, IMM 2004 ANN REP US; Van Duijnhoven EM, 2002, J AM SOC NEPHROL, V13, P213, DOI 10.1681/ASN.V131213; Wang XH, 2000, TRANSPLANT P, V32, P1702, DOI 10.1016/S0041-1345(00)01408-1; Weimer R, 2002, TRANSPLANT P, V34, P2377, DOI 10.1016/S0041-1345(02)03278-5; White SA, 2000, TRANSPLANT P, V32, P19, DOI 10.1016/S0041-1345(99)00856-8; Yang HC, 1999, TRANSPLANT P, V31, P1121, DOI 10.1016/S0041-1345(98)01929-0; Yu L, 2000, TRANSPLANT P, V32, P1709, DOI 10.1016/S0041-1345(00)01405-6	58	383	398	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2005	331	7520					810	+		10.1136/bmj.38569.471007.AE	http://dx.doi.org/10.1136/bmj.38569.471007.AE			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	974BC	16157605	Green Published, Bronze			2022-12-28	WOS:000232565300019
J	Boyer, LA; Lee, TI; Cole, MF; Johnstone, SE; Levine, SS; Zucker, JR; Guenther, MG; Kumar, RM; Murray, HL; Jenner, RG; Gifford, DK; Melton, DA; Jaenisch, R; Young, RA				Boyer, LA; Lee, TI; Cole, MF; Johnstone, SE; Levine, SS; Zucker, JR; Guenther, MG; Kumar, RM; Murray, HL; Jenner, RG; Gifford, DK; Melton, DA; Jaenisch, R; Young, RA			Core transcriptional regulatory circuitry in human embryonic stem cells	CELL			English	Article							GENE-EXPRESSION; ESCHERICHIA-COLI; RNA INTERFERENCE; NETWORK MOTIFS; MOUSE; PLURIPOTENCY; SOX2; DIFFERENTIATION; ENHANCER; NANOG	The transcription factors OCT4, SOX2, and NANOG have essential roles in early development and are required for the propagation of undifferentiated embryonic stem (ES) cells in culture. To gain insights into transcriptional regulation of human ES cells, we have identified OCT4, SOX2, and NANOG target genes using genome-scale location analysis. We found, surprisingly, that OCT4, SOX2, and NANOG co-occupy a substantial portion of their target genes. These target genes frequently encode transcription factors, many of which are developmentally important homeodomain proteins. Our data also indicate that OCT4, SOX2, and NANOG collaborate to form regulatory circuitry consisting of autoregulatory and feedforward loops. These results provide new insights into the transcriptional regulation of stem cells and reveal how OCT4, SOX2, and NANOG contribute to pluripotency and self-renewal.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; MIT, CSAIL, Cambridge, MA 02139 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Jenner, Richard/J-8683-2012; Young, Richard A/F-6495-2012	Jenner, Richard/0000-0002-2946-6811; Young, Richard A/0000-0001-8855-8647; Levine, Stuart/0000-0001-7363-562X	NATIONAL CANCER INSTITUTE [F32CA094664] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM068273, R01GM069400] Funding Source: NIH RePORTER; NCI NIH HHS [CA094664, F32 CA094664] Funding Source: Medline; NHGRI NIH HHS [R01 HG002668, R01 HG002668-02, HG002668] Funding Source: Medline; NIGMS NIH HHS [R01 GM069400, F32 GM068273, GM068273, GM069400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Dailey L, 2001, J CELL PHYSIOL, V186, P315, DOI 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1046>3.0.CO;2-Y; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Hombria JCG, 2003, DIFFERENTIATION, V71, P461, DOI 10.1046/j.1432-0436.2003.7108004.x; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Resendis-Antonio O, 2005, TRENDS GENET, V21, P16, DOI 10.1016/j.tig.2004.11.010; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; RODDA DJ, 2005, IN PRESS J BIOL CHEM, V18; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thieffry D, 1998, BIOINFORMATICS, V14, P391, DOI 10.1093/bioinformatics/14.5.391; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	56	3303	3513	5	370	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					947	956		10.1016/j.cell.2005.08.020	http://dx.doi.org/10.1016/j.cell.2005.08.020			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16153702	Green Accepted, Bronze			2022-12-28	WOS:000232130200018
J	Fisk, LA				Fisk, LA			Journey into the unknown beyond	SCIENCE			English	Editorial Material							COSMIC-RAYS; ENHANCEMENTS; SHOCK	The Voyager 1 spacecraft has passed an important milestone. As is reported in papers in this issue, Voyager 1 has crossed the termination shock of the solar wind, where the wind abruptly decelerates to begin its merger into the local interstellar medium. The termination shock provided surprises; the region beyond is truly uncharted territory.	Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fisk, LA (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA.	lafisk@umich.edu						Burlaga LF, 2005, SCIENCE, V309, P2027, DOI 10.1126/science.1117542; BURLAGA LF, 2003, GEOPHYS RES LETT, V30; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; FISK LA, 1974, ASTROPHYS J, V190, pL35, DOI 10.1086/181498; Gurnett DA, 2005, SCIENCE, V309, P2025, DOI 10.1126/science.1117425; Krimigis SM, 2003, NATURE, V426, P45, DOI 10.1038/nature02068; McDonald FB, 2003, NATURE, V426, P48, DOI 10.1038/nature02066; PESSES ME, 1981, ASTROPHYS J, V246, pL85, DOI 10.1086/183559; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684	9	34	34	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2005	309	5743					2016	2017		10.1126/science.1118762	http://dx.doi.org/10.1126/science.1118762			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179467				2022-12-28	WOS:000232181900037
J	Le Fevre, O; Paltani, S; Arnouts, S; Charlot, S; Foucaud, S; Ilbert, O; McCracken, HJ; Zamorani, G; Bottini, D; Garilli, B; Le Brun, V; Maccagni, D; Picat, JP; Scaramella, R; Scodeggio, M; Tresse, L; Vettolani, G; Zanichelli, A; Adami, C; Bardelli, S; Bolzonella, M; Cappi, A; Ciliegi, P; Contini, T; Franzetti, P; Gavignaud, I; Guzzo, L; Iovino, A; Marano, B; Marinoni, C; Mazure, A; Meneux, B; Merighi, R; Pello, R; Pollo, A; Pozzetti, L; Radovich, M; Zucca, E; Arnaboldi, M; Bondi, M; Bongiorno, A; Busarello, G; Gregorini, L; Lamareille, F; Mathez, G; Mellier, Y; Merluzzi, P; Ripepi, V; Rizzo, D				Le Fevre, O; Paltani, S; Arnouts, S; Charlot, S; Foucaud, S; Ilbert, O; McCracken, HJ; Zamorani, G; Bottini, D; Garilli, B; Le Brun, V; Maccagni, D; Picat, JP; Scaramella, R; Scodeggio, M; Tresse, L; Vettolani, G; Zanichelli, A; Adami, C; Bardelli, S; Bolzonella, M; Cappi, A; Ciliegi, P; Contini, T; Franzetti, P; Gavignaud, I; Guzzo, L; Iovino, A; Marano, B; Marinoni, C; Mazure, A; Meneux, B; Merighi, R; Pello, R; Pollo, A; Pozzetti, L; Radovich, M; Zucca, E; Arnaboldi, M; Bondi, M; Bongiorno, A; Busarello, G; Gregorini, L; Lamareille, F; Mathez, G; Mellier, Y; Merluzzi, P; Ripepi, V; Rizzo, D			A large population of galaxies 9 to 12 billion years back in the history of the Universe	NATURE			English	Article							LYMAN-BREAK GALAXIES; ULTRAVIOLET LUMINOSITY DENSITY; FRANCE REDSHIFT SURVEY; FORMING GALAXIES; STAR-FORMATION; BRIGHT	To understand the evolution of galaxies, we need to know as accurately as possible how many galaxies were present in the Universe at different epochs(1). Galaxies in the young Universe have hitherto mainly been identified using their expected optical colours(2 - 4), but this leaves open the possibility that a significant population remains undetected because their colours are the result of a complex mix of stars, gas, dust or active galactic nuclei. Here we report the results of a flux- limited I- band survey of galaxies at look- back times of 9 to 12 billion years. We find 970 galaxies with spectroscopic redshifts between 1.4 and 5. This population is 1.6 to 6.2 times larger than previous estimates(2 - 4), with the difference increasing towards brighter magnitudes. Strong ultraviolet continua ( in the rest frame of the galaxies) indicate vigorous star formation rates of more than 10 - 100 solar masses per year. As a consequence, the cosmic star formation rate representing the volume- averaged production of stars is higher than previously measured at redshifts of 3 to 4.	Univ Aix Marseille 1, CNRS, UMR 6110, OAMP,Lab Astrophys Marseille, F-13376 Marseille, France; Max Planck Inst Astrophys, D-85741 Garching, Germany; Inst Astrophys, UMR 7095, F-75014 Paris, France; IASF INAF, I-20133 Milan, Italy; Univ Bologna, Dipartimento Astron, I-40127 Bologna, Italy; Osservatorio Astron Bologna, INAF, I-40127 Bologna, Italy; Observ Midi Pyrenees, UMR 5572, Astrophys Lab, F-31400 Toulouse, France; IRA INAF, I-40129 Bologna, Italy; European So Observ, D-85748 Garching, Germany; Osserv Astron Brera, INAF, Milan, Italy; Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; Observ Paris, LERMA, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Istituto Nazionale Astrofisica (INAF); University of Bologna; Istituto Nazionale Astrofisica (INAF); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Istituto Nazionale Astrofisica (INAF); European Southern Observatory; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	Le Fevre, O (corresponding author), Univ Aix Marseille 1, CNRS, UMR 6110, OAMP,Lab Astrophys Marseille, BP8, F-13376 Marseille, France.	Olivier.LeFevre@oamp.fr	Merighi, Roberto/O-9360-2015; Bardelli, Sandro/O-9369-2015; Bolzonella, Micol/O-9495-2015; McCracken, Henry Joy/AAA-1489-2019; Guzzo, Luigi/R-4939-2017; Pello, Roser/G-4754-2010; Zucca, Elena/O-9396-2015; Cappi, Alberto/O-9391-2015; Ilbert, Olivier/AAK-4578-2020; Pozzetti, Lucia/ABC-8644-2021; Le Fevre, Olivier/G-7389-2011; Contini, Thierry/AAQ-1509-2021; Merighi, Roberto/Q-3993-2019	Merighi, Roberto/0000-0003-2490-1834; Bardelli, Sandro/0000-0002-8900-0298; Bolzonella, Micol/0000-0003-3278-4607; McCracken, Henry Joy/0000-0002-9489-7765; Guzzo, Luigi/0000-0001-8264-5192; Zucca, Elena/0000-0002-5845-8132; Cappi, Alberto/0000-0002-9200-7167; Ilbert, Olivier/0000-0002-7303-4397; Merighi, Roberto/0000-0003-2490-1834; Bongiorno, Angela/0000-0002-0101-6624; bottini, dario/0000-0001-6917-041X; Merluzzi, Paola/0000-0003-3966-2397; Tresse, Laurence/0000-0001-8776-0958; Iovino, Angela/0000-0001-6958-0304; Garilli, Bianca/0000-0001-7455-8750; Zanichelli, Alessandra/0000-0002-2893-023X; Pollo, Agnieszka/0000-0003-3358-0665; Zamorani, Giovanni/0000-0002-2318-301X; Radovich, Mario/0000-0002-3585-866X; Contini, Thierry/0000-0003-0275-938X; Scodeggio, Marco/0000-0002-2282-5850; Busarello, Giovanni/0000-0002-4253-7100; Pozzetti, Lucia/0000-0001-7085-0412; Franzetti, Paolo/0000-0002-6986-0127; Scaramella, Roberto/0000-0003-2229-193X; Ciliegi, Paolo/0000-0002-0447-4620; Arnaboldi, Magda/0000-0001-7214-3009				Ando M, 2004, ASTROPHYS J, V610, P635, DOI 10.1086/421900; Bentz MC, 2004, ASTROPHYS J, V600, pL19, DOI 10.1086/381531; Bunker AJ, 2004, MON NOT R ASTRON SOC, V355, P374, DOI 10.1111/j.1365-2966.2004.08326.x; Chapman SC, 2003, NATURE, V422, P695, DOI 10.1038/nature01540; Cimatti A, 2002, ASTRON ASTROPHYS, V381, pL68, DOI 10.1051/0004-6361:20011696; COWIE LL, 1995, NATURE, V377, P603, DOI 10.1038/377603a0; Foucaud S, 2003, ASTRON ASTROPHYS, V409, P835, DOI 10.1051/0004-6361:20031181; Giavalisco M, 2004, ASTROPHYS J, V600, pL103, DOI 10.1086/381244; GLAZEBROOK K, 1995, MON NOT R ASTRON SOC, V273, P157, DOI 10.1093/mnras/273.1.157; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; LEFEVRE O, 1995, ASTROPHYS J, V455, P60, DOI 10.1086/176556; LEFEVRE O, 2004, VIMOS VLT DEEP SURVE; Lehnert MD, 2003, ASTROPHYS J, V593, P630, DOI 10.1086/376729; LILLY SJ, 1995, ASTROPHYS J, V455, P50, DOI 10.1086/176555; Pascarelle SM, 1998, ASTROPHYS J, V508, pL1, DOI 10.1086/311708; Schreiber NMF, 2004, ASTROPHYS J, V616, P40, DOI 10.1086/424838; Somerville RS, 2004, ASTROPHYS J, V600, pL171, DOI 10.1086/378628; Steidel CC, 1999, ASTROPHYS J, V519, P1, DOI 10.1086/307363; Steidel CC, 2004, ASTROPHYS J, V604, P534, DOI 10.1086/381960; Steidel CC, 1996, ASTROPHYS J, V462, pL17, DOI 10.1088/1538-4357/462/1/L17	21	53	53	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					519	521		10.1038/nature03979	http://dx.doi.org/10.1038/nature03979			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177783	Green Submitted			2022-12-28	WOS:000232004800042
J	Young, EA; Coryell, W				Young, EA; Coryell, W			Suicide and the hypothalamic-pituitary-adrenal axis	LANCET			English	Editorial Material							DEXAMETHASONE-SUPPRESSION TEST; GLUCOCORTICOID-RECEPTOR GENE; PARAVENTRICULAR NUCLEUS; UNIPOLAR DEPRESSION; MESSENGER-RNA; VICTIMS; POLYMORPHISM; ASSOCIATION; BEHAVIOR		Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA; Roy J & Lucille A Carver Coll Med, Dept Psychiat, Iowa City, IA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Young, EA (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	eayoung@umich.edu		coryell, william/0000-0003-3989-7276				ARATO M, 1989, BIOL PSYCHIAT, V25, P355, DOI 10.1016/0006-3223(89)90183-2; Black Donald W, 2002, Ann Clin Psychiatry, V14, P83, DOI 10.1023/A:1016839404032; CARROLL B, 1980, RECENT ADV NEUROPSYC; Coryell W, 2005, J CLIN PSYCHIAT, V66, P412, DOI 10.4088/JCP.v66n0401; Coryell W, 2001, AM J PSYCHIAT, V158, P748, DOI 10.1176/appi.ajp.158.5.748; CORYELL W, 1981, AM J PSYCHIAT, V138, P1120; DOROVINIZIS K, 1987, AM J PSYCHIAT, V144, P1214; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P83, DOI 10.1016/S0306-4530(02)00146-4; LESTER D, 1992, PHARMACOPSYCHIATRY, V25, P265, DOI 10.1055/s-2007-1014419; LOPEZ JF, 1992, NEUROENDOCRINOLOGY, V56, P491, DOI 10.1159/000126266; NEMEROFF CB, 1988, ARCH GEN PSYCHIAT, V45, P577; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; NIELSEN J, IN PRESS MAYO CLIN P; NORMAN WH, 1990, ACTA PSYCHIAT SCAND, V81, P120, DOI 10.1111/j.1600-0447.1990.tb06463.x; Pfennig A, 2005, BIOL PSYCHIAT, V57, P336, DOI 10.1016/j.biopsych.2004.11.017; RAADSHEER FC, 1995, AM J PSYCHIAT, V152, P1372; RAADSHEER FC, 1994, NEUROENDOCRINOLOGY, V60, P436, DOI 10.1159/000126778; van Rossum EFC, 2004, AM J MED, V117, P158, DOI 10.1016/j.amjmed.2004.01.027; van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x; Yerevanian BI, 2004, J AFFECT DISORDERS, V83, P103, DOI 10.1016/j.jad.2004.08.009	21	9	9	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 17	2005	366	9490					959	961		10.1016/S0140-6736(05)67348-5	http://dx.doi.org/10.1016/S0140-6736(05)67348-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168756				2022-12-28	WOS:000231955900004
J	Cherian, A; Seena, S; Bullock, RK; Antony, AC				Cherian, A; Seena, S; Bullock, RK; Antony, AC			Incidence of neural tube defects in the least-developed area of India: a population-based study	LANCET			English	Article							COBALAMIN DEFICIENCY	Hospital-based records from major cities of India, where roughly a quarter of the population resides, identified the frequency of neural tube defects (NTDS) as ranging from 3.9 to 8.8 per 1000 births, but the incidence in rural areas is unknown. We did a population-based door-to-door survey of mothers living in remote dusters of villages in Balrampur District in Uttar Pradesh, a region ranked as the least-developed area in India. The data showed that the incidence of NTDs was 6.57-8.21 per 1000 livebirths, which is among the highest worldwide. India's Ministry of Health needs to produce a strategy to reduce the incidence of such defects.	Emmanuel Hosp, Assoc Prem Sewa Hosp, Balrampur, Uttar Pradesh, India; Indiana Univ, Sch Nursing, Indianapolis, IN USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Antony, AC (corresponding author), 1044 W Walnut St,R4-266, Indianapolis, IN 46202 USA.	aantony@iupui.edu						Antony AC, 2003, AM J CLIN NUTR, V78, P3, DOI 10.1093/ajcn/78.1.3; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Busby A, 2005, BMJ-BRIT MED J, V330, P574, DOI 10.1136/bmj.330.7491.574; GOPALAN C, 2004, NFI B, V25, P1; *GOV IND, NAT COMM POP REP; KULKARNI ML, 1987, LANCET, V1, P1260; Refsum H, 2001, AM J CLIN NUTR, V74, P233; VERMA IC, 1978, LANCET, V1, P879; XIAO KZ, 1990, INT J EPIDEMIOL, V19, P978	9	71	72	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					930	931		10.1016/S0140-6736(05)67319-9	http://dx.doi.org/10.1016/S0140-6736(05)67319-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154020				2022-12-28	WOS:000231770000031
J	Evans, PD; Gilbert, SL; Mekel-Bobrov, N; Vallender, EJ; Anderson, JR; Vaez-Azizi, LM; Tishkoff, SA; Hudson, RR; Lahn, BT				Evans, PD; Gilbert, SL; Mekel-Bobrov, N; Vallender, EJ; Anderson, JR; Vaez-Azizi, LM; Tishkoff, SA; Hudson, RR; Lahn, BT			Microcephalin, a gene regulating brain size, continues to evolve adaptively in humans	SCIENCE			English	Article							RECENT POSITIVE SELECTION; MAJOR DETERMINANT; HAPLOTYPE RECONSTRUCTION; MOLECULAR EVOLUTION; STATISTICAL-METHOD; MAPS; POPULATION; SIGNATURES; LOCUS; ASPM	The gene Microcephalin (MCPH1) regulates brain size and has evolved under strong positive selection in the human evolutionary lineage. We show that one genetic variant of Microcephalin in modern humans, which arose 37,000 years ago, increased in frequency too rapidly to be compatible with neutral drift. This indicates that it has spread under strong positive selection, although the exact nature of the selection is unknown. The finding that an important brain gene has continued to evolve adaptively in anatomically modern humans suggests the ongoing evolutionary plasticity of the human brain. It also makes Microcephalin an attractive candidate locus for studying the genetics of human variation in brain-related phenotypes.	Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University System of Maryland; University of Maryland College Park	Lahn, BT (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, 5841 S Maryland Ave, Chicago, IL 60637 USA.	blahn@bsd.uchicago.edu	Vallender, Eric/A-2450-2008	Vallender, Eric/0000-0003-3506-0540				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Dobyns WB, 2002, AM J MED GENET, V112, P315, DOI 10.1002/ajmg.10580; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Evans PD, 2004, HUM MOL GENET, V13, P1139, DOI 10.1093/hmg/ddh126; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huyton T, 2000, MUTAT RES-DNA REPAIR, V460, P319, DOI 10.1016/S0921-8777(00)00034-3; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Jerison J. H, 1973, EVOLUTION BRAIN INTE; Klein R. G., 1999, HUMAN CAREER HUMAN B; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SPUHLER JN, 1959, EVOLUTION MANS CAPAC; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tang H, 2002, GENETICS, V161, P447; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Wang YQ, 2004, HUM MOL GENET, V13, P1131, DOI 10.1093/hmg/ddh127; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Wright S., 1978, EVOLUTION GENETICS P; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Zhang JZ, 2003, GENETICS, V165, P2063; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	49	322	331	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1717	1720		10.1126/science.1113722	http://dx.doi.org/10.1126/science.1113722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151009				2022-12-28	WOS:000231836700042
J	Satpute-Krishnan, P; Serio, TR				Satpute-Krishnan, P; Serio, TR			Prion protein remodelling confers an immediate phenotypic switch	NATURE			English	Article							CHAIN RELEASE FACTOR; YEAST SUP35 PROTEIN; SACCHAROMYCES-CEREVISIAE; IN-VITRO; SCRAPIE; PROPAGATION; REPLICATION; DETERMINANT; INHERITANCE; MECHANISM	In a variety of systems, proteins have been linked to processes historically limited to nucleic acids, such as infectivity and inheritance(1,2). These atypical proteins, termed prions(3), lack sequence homology but are collectively defined by their capacity to adopt multiple physical and therefore functional states in vivo. Newly synthesized prion protein generally adopts the form already present in the cell, and this in vivo folding bias directs the near faithful transmission of the corresponding phenotypic state(1,2). Switches between the prion and non-prion phenotypes can occur in vivo(2); however, the fate of existing protein during these transitions and its effects on the emergence of new traits remain major unanswered questions. Here, we determine the changes in protein-state that induce phenotypic switching for the yeast prion Sup35/[PSI+]. We show that the prion form does not need to be specified by an alternate misfolding pathway initiated during Sup35 synthesis but instead can be accessed by mature protein. This remodelling of protein from one stable form to another is accompanied by the loss of Sup35 activity, evoking a rapid change in cellular phenotype within a single cell cycle.	Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University	Serio, TR (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	Tricia_Serio@Brown.edu	Serio, Tricia/GPP-7129-2022; Satpute-Krishnan, Prasanna/ABE-5421-2020	Serio, Tricia/0000-0003-2687-7372				Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Dagkesamanskaya AR, 1997, GENETIKA+, V33, P610; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Frolova L, 1996, RNA, V2, P334; GALGOCZY DJ, 2004, P NATL ACAD SCI USA, V108, P18069; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; TUITE MF, 1981, GENETICS, V98, P691; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025	30	71	74	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					262	265		10.1038/nature03981	http://dx.doi.org/10.1038/nature03981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148935				2022-12-28	WOS:000231696900057
J	Pandya, KJ; Morrow, GR; Roscoe, JA; Zhao, HW; Hickok, JT; Pajon, E; Sweeney, TJ; Banerjee, TK; Flynn, PJ				Pandya, KJ; Morrow, GR; Roscoe, JA; Zhao, HW; Hickok, JT; Pajon, E; Sweeney, TJ; Banerjee, TK; Flynn, PJ			Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial	LANCET			English	Article							POSTMENOPAUSAL WOMEN; TAMOXIFEN; HYPOTHESIS; CLONIDINE; SUBUNIT	Background Most women receiving systemic therapy for breast cancer experience hot flashes. We undertook a randomised, double-blind, placebo-controlled, multi-institutional trial to assess the efficacy of gabapentin in controlling hot flashes in women with breast cancer. Methods 420 women with breast cancer who were having two or more hot flashes per day were randomly assigned placebo, gabapentin 300 mg/day, or gabapentin 900 mg/day by mouth in three divided doses for 8 weeks. Each patient kept a 1-week, self-report diary on the frequency, severity, and duration of hot flashes before the start of the study and during weeks 4 and 8 of treatment. Analyses were by intention to treat. Findings Evaluable data were available on 371 participants at 4 weeks (119 placebo, 123 gabapentin 300 mg, and 129 gabapentin 900 mg) and 347 at 8 weeks (113 placebo, 114 gabapentin 300 mg, and 120 gabapentin 900 mg). The percentage decreases in hot-flash severity score between baseline and weeks 4 and 8, respectively were: 21% (95% CI 12 to 30) and 15% (1 to 29) in the placebo group; 33% (23 to 43) and 31% (16 to 46) in the group assigned gabapentin 300 mg; and 49% (42 to 56) and 46% (34 to 58) in the group assigned gabapentin 900 mg. The differences between the groups were significant (p=0.0001 at 4 weeks and p=0.007 at 8 weeks by ANCOVA for overall treatment effect, adjusted for baseline values); only the higher dose of gabapentin was associated with significant decreases in hot-flash frequency and severity. Interpretation Gabapentin is effective in the control of hot flashes at a dose of 900 mg/day, but not at a dose of 300 mg/day. This drug should be considered for treatment of hot flashes in women with breast cancer.	Univ Rochester, Ctr Canc, Community Clin Oncol Program Res Base, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; Colorado Canc Res Program Community Clin Oncol Pr, Denver, CO USA; Columbus Community Clin Oncol Program, Columbus, OH USA; Marshfield Clin Res Fdn Community Clin Oncol Prog, Marshfield, WI USA; Metro Minnesota Community Clin Oncol Program, Minneapolis, MN USA	University of Rochester; University of Rochester	Pandya, KJ (corresponding author), Univ Rochester, Ctr Canc, Community Clin Oncol Program Res Base, 601 Elmwood Ave,Box 704, Rochester, NY 14642 USA.	Kishan_Pandya@urmc.rochester.edu			NATIONAL CANCER INSTITUTE [U10CA037420, R25CA102618] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Carpenter JS, 1998, CANCER-AM CANCER SOC, V82, P1682, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.3.CO;2-8; CASPER RF, 1985, CLIN ENDOCRINOL, V22, P293, DOI 10.1111/j.1365-2265.1985.tb03243.x; Cleeland CS, 2000, CANCER-AM CANCER SOC, V89, P1634, DOI 10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V; Creasman WT, 2002, GYNECOL ONCOL, V86, P1, DOI 10.1006/gyno.2001.6499; Freedman RR, 1999, AM J OBSTET GYNECOL, V181, P66, DOI 10.1016/S0002-9378(99)70437-0; FREEDMAN RR, 1995, J CLIN ENDOCR METAB, V80, P2354, DOI 10.1210/jc.80.8.2354; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; GOLDBERG RM, 1994, J CLIN ONCOL, V12, P155, DOI 10.1200/JCO.1994.12.1.155; Guttuso T, 2003, OBSTET GYNECOL, V101, P337, DOI 10.1016/S0029-7844(02)02712-6; Guttuso TJ, 2000, NEUROLOGY, V54, P2161, DOI 10.1212/WNL.54.11.2161; Holmberg L, 2004, LANCET, V363, P453, DOI 10.1016/S0140-6736(04)15493-7; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; KRONENBERG F, 1987, CAN J PHYSIOL PHARM, V65, P1312, DOI 10.1139/y87-208; Leonetti HB, 1999, OBSTET GYNECOL, V94, P225, DOI 10.1016/S0029-7844(99)00266-5; Loprinzi CL, 2002, J CLIN ONCOL, V20, P1578, DOI 10.1200/JCO.20.6.1578; Loprinzi CL, 2000, LANCET, V356, P2059, DOI 10.1016/S0140-6736(00)03403-6; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; MCKINLAY SM, 1974, BRIT J PREV SOC MED, V28, P108; MCNAMARA JO, 2001, GOODMAN GILMANS PHAR, P521; OMEARA ES, 2004, JNCI-J NATL CANCER I, V93, P754; Pandya KJ, 2000, ANN INTERN MED, V132, P788, DOI 10.7326/0003-4819-132-10-200005160-00004; Pandya KJ, 2004, BREAST CANCER RES TR, V83, P87, DOI 10.1023/B:BREA.0000010676.54597.22; Quella SK, 1998, CANCER, V82, P1784, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1789::AID-CNCR27>3.0.CO;2-#; ROSENBERG J, 1991, MED HYPOTHESES, V35, P349, DOI 10.1016/0306-9877(91)90282-4; Shanafelt TD, 2002, MAYO CLIN PROC, V77, P1207, DOI 10.4065/77.11.1207; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Stearns V, 2003, JAMA-J AM MED ASSOC, V289, P2827, DOI 10.1001/jama.289.21.2827; Stefani A, 1998, NEUROPHARMACOLOGY, V37, P83, DOI 10.1016/S0028-3908(97)00189-5	29	213	222	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2005	366	9488					818	824		10.1016/S0140-6736(05)67215-7	http://dx.doi.org/10.1016/S0140-6736(05)67215-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139656	Green Accepted			2022-12-28	WOS:000231627000026
J	Rougier, GW; Forasiepi, AM; Martinelli, AG				Rougier, GW; Forasiepi, AM; Martinelli, AG			Comment on "Independent origins of middle ear bones in monotremes and therians" (II)	SCIENCE			English	Editorial Material									Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; Museo Argentino Ciencias Nat Bernardino Rivadavia, Dept Vertebrate Paleontol, RA-1405 Buenos Aires, DF, Argentina	University of Louisville; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	Rougier, GW (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	grougier@louisville.edu	Martinelli, Agustin G./D-4632-2015					ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; CHOW M, 1982, Australian Mammalogy, V5, P127; de Beer G., 1937, DEV VERTEBRATE SKULL; Forasiepi A, 2004, J VERTEBR PALEONTOL, V24, p59A; FOURIE S, 1974, Annals of the South African Museum, V65, P337; Gaupp E., 1913, ARCH ANATOMIE ENTWIC, P1; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Moore W.J., 1981, MAMMALIAN SKULL; Rauhut OWM, 2002, NATURE, V416, P165, DOI 10.1038/416165a; Rich TH, 2005, SCIENCE, V307, P910, DOI 10.1126/science.1105717; Zeller U., 1989, ABHANDLUNGEN SENCKEN, V545, P1	11	17	17	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740								10.1126/science.1111294	http://dx.doi.org/10.1126/science.1111294			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141051				2022-12-28	WOS:000231715000024
J	Ahlberg, PE; Clack, JA; Blom, H				Ahlberg, PE; Clack, JA; Blom, H			The axial skeleton of the Devonian tetrapod Ichthyostega	NATURE			English	Article							ACANTHOSTEGA-GUNNARI; EVOLUTION	Ichthyostega was the first Devonian tetrapod to be subject to a whole-body reconstruction(1-3). It remains, together with Acanthostega(4), one of only two Devonian tetrapods for which near-complete postcranial material is available. It is thus crucially important for our understanding of the earliest stages of tetrapod evolution and terrestrialization. Here we show a new reconstruction of Ichthyostega based on extensive re-examination of original material and augmented by recently collected specimens. Our reconstruction differs substantially from those previously published and reveals hitherto unrecognized regionalization in the vertebral column. Ichthyostega is the earliest vertebrate to show obvious adaptations for non-swimming locomotion. Uniquely among early tetrapods, the presacral vertebral column shows pronounced regionalization of neural arch morphology, suggesting that it was adapted for dorsoventral rather than lateral flexion.	Uppsala Univ, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, S-75236 Uppsala, Sweden; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Uppsala University; University of Cambridge	Ahlberg, PE (corresponding author), Uppsala Univ, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	per.ahlberg@ebc.uu.se	Ahlberg, Per/E-8086-2013	Ahlberg, Per/0000-0001-9054-2900				Blom H., 2005, MEDDELELSER GRONLAND, p[43, 4]; Clack JA, 2003, J VERTEBR PALEONTOL, V23, p41A; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA, 2002, NATURE, V418, P72, DOI 10.1038/nature00824; Clack JA, 2002, T ROY SOC EDIN-EARTH, V93, P17, DOI 10.1017/S0263593300000304; Clack JA., 2005, J SYST PALAEONTOL, V2, P311, DOI [10.1017/S1477201904001506, DOI 10.1017/S1477201904001506]; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; COATES MI, 1995, STUDIES EARLY VERTEB, P373; HOLMES R, 1984, PHILOS T ROY SOC B, V306, P431, DOI 10.1098/rstb.1984.0103; Jarvik E., 1952, Meddelelser om Gronland, V114, P1; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Jarvik Erik, 1996, Fossils and Strata, V40, P1; Jarvik E, 1955, SCI MON, V80, P141; LOMBARD RE, 1995, PALAEONTOLOGY, V38, P471; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103	16	95	97	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					137	140		10.1038/nature03893	http://dx.doi.org/10.1038/nature03893			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136143				2022-12-28	WOS:000231560400057
J	Hill, RS; Walsh, CA				Hill, RS; Walsh, CA			Molecular insights into human brain evolution	NATURE			English	Article							CEREBRAL CORTICAL SIZE; MAJOR DETERMINANT; MAMMALIAN NEOCORTEX; HOMO-SAPIENS; GREAT APES; CELL-CYCLE; GENE; LANGUAGE; SPEECH; CORTEX	Rapidly advancing knowledge of genome structure and sequence enables new means for the analysis of specific DNA changes associated with the differences between the human brain and that of other mammals. Recent studies implicate evolutionary changes in messenger RNA and protein expression levels, as well as DNA changes that alter amino acid sequences. We can anticipate having a systematic catalogue of DNA changes in the lineage leading to humans, but an ongoing challenge will be relating these changes to the anatomical and functional differences between our brain and that of our ancient and more recent ancestors.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Neurogenet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Neurogenet, Room 266,New Res Bldg,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu		Walsh, Christopher/0000-0002-0156-2238				Allman J, 2002, NEUROSCIENTIST, V8, P335, DOI 10.1177/107385840200800409; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Broadfield DC, 2001, ANAT RECORD, V262, P369, DOI 10.1002/ar.1047; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; CAJAL SRY, 1917, RECUERDOS VIDA, V2, P345; Cantalupo C, 2001, NATURE, V414, P505, DOI 10.1038/35107134; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Evans PD, 2004, HUM MOL GENET, V13, P1139, DOI 10.1093/hmg/ddh126; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Hopkins WD, 2004, BEHAV NEUROSCI, V118, P1176, DOI 10.1037/0735-7044.118.6.1176; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MARINPADILLA M, 1992, J COMP NEUROL, V321, P223, DOI 10.1002/cne.903210205; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tics.2004.05.009; Semendeferi K, 2002, NAT NEUROSCI, V5, P272, DOI 10.1038/nn814; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Zhang JZ, 2003, GENETICS, V165, P2063	30	150	151	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					64	67		10.1038/nature04103	http://dx.doi.org/10.1038/nature04103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136130				2022-12-28	WOS:000231560400044
J	Linardopoulou, EV; Williams, EM; Fan, YX; Friedman, C; Young, JM; Trask, BJ				Linardopoulou, EV; Williams, EM; Fan, YX; Friedman, C; Young, JM; Trask, BJ			Human subtelomeres are hot spots of interchromosomal recombination and segmental duplication	NATURE			English	Article							STRAND BREAK REPAIR; OLFACTORY RECEPTOR GENE; DNA; EVOLUTION; POLYMORPHISM; REGIONS; EXPANSION; SEQUENCES; REVEALS; REPEATS	Human subtelomeres are polymorphic patchworks of interchromosomal segmental duplications at the ends of chromosomes. Here we provide evidence that these patchworks arose recently through repeated translocations between chromosome ends. We assess the relative contribution of the principal mechanisms of ectopic DNA repair to the formation of subtelomeric duplications and find that non-homologous end-joining predominates. Once subtelomeric duplications arise, they are prone to homology-based sequence transfers as shown by the incongruent phylogenetic relationships of neighbouring sections. Interchromosomal recombination of subtelomeres is a potent force for recent change. Cytogenetic and sequence analyses reveal that pieces of the subtelomeric patchwork have changed location and copy number with unprecedented frequency during primate evolution. Half of the known subtelomeric sequence has formed recently, through human-specific sequence transfers and duplications. Subtelomeric dynamics result in a gene duplication rate significantly higher than the genome average and could have both advantageous and pathological consequences in human biology. More generally, our analyses suggest an evolutionary cycle between segmental polymorphisms and genome rearrangements.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Trask, BJ (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1100 Fairview Ave N C3-168, Seattle, WA 98109 USA.	btrask@fhcrc.org		Williams, Eleanor/0000-0002-0851-7990	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004209] Funding Source: Medline; NIGMS NIH HHS [R01 GM057070] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bass HW, 2003, CELL MOL LIFE SCI, V60, P2319, DOI 10.1007/s00018-003-3312-4; Bray N, 2003, NUCLEIC ACIDS RES, V31, P3525, DOI 10.1093/nar/gkg623; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cornforth MN, 2001, MUTAGENESIS, V16, P85, DOI 10.1093/mutage/16.1.85; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Der-Sarkissian H, 2002, GENOME RES, V12, P1673, DOI 10.1101/gr.322802; Eichler EE, 1999, GENOME RES, V9, P1048, DOI 10.1101/gr.9.11.1048; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Fan Y, 2002, GENOME RES, V12, P1651, DOI 10.1101/gr.337602; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; *GEN PUBL POL CTR, 2004, GEN INF TRANSL; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Hansen TF, 2000, J THEOR BIOL, V207, P495, DOI 10.1006/jtbi.2000.2189; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Knight SJL, 2004, METHOD CELL BIOL, V75, P799; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Linardopoulou E, 2001, HUM MOL GENET, V10, P2373, DOI 10.1093/hmg/10.21.2373; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Martin CL, 2002, AM J HUM GENET, V70, P972, DOI 10.1086/339768; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Mefford HC, 2001, HUM MOL GENET, V10, P2363, DOI 10.1093/hmg/10.21.2363; Monfouilloux S, 1998, GENOMICS, V51, P165, DOI 10.1006/geno.1998.5358; Nergadze SG, 2004, GENOME RES, V14, P1704, DOI 10.1101/gr.2778904; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Ricchetti M, 2003, J MOL BIOL, V328, P847, DOI 10.1016/S0022-2836(03)00315-2; Riethman H, 2004, GENOME RES, V14, P18, DOI 10.1101/gr.1245004; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WONG Z, 1990, GENOMICS, V7, P222, DOI 10.1016/0888-7543(90)90544-5; Zhou Y, 2005, P NATL ACAD SCI USA, V102, P4051, DOI 10.1073/pnas.0407957102; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207	49	279	289	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					94	100		10.1038/nature04029	http://dx.doi.org/10.1038/nature04029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136133	Green Accepted			2022-12-28	WOS:000231560400047
J	Morgan, SG; Bassett, KL; Wright, JM; Evans, RG; Barer, ML; Caetano, PA; Black, CD				Morgan, SG; Bassett, KL; Wright, JM; Evans, RG; Barer, ML; Caetano, PA; Black, CD			"Breakthrough" drugs and growth in expenditure on prescription drugs in Canada	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ British Columbia, Ctr Hlth Serv & Policy Res, Dept Family Practice, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Hlth Serv & Policy Res, Dept Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Morgan, SG (corresponding author), Univ British Columbia, Ctr Hlth Serv & Policy Res, Dept Family Practice, 429-2194 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	morgan@chspr.ubc.ca	Morgan, Steven/J-8814-2015	Morgan, Steven/0000-0002-7529-0028				*CAN I HLTH INF, 2005, DRUG EXP CAN 1985 20; Davis Peter, 2004, Aust Health Rev, V28, P171; *IMS, 2005, GLOB PHARM SAL REG 1; *PAT MED PRIC REV, 2004, ANN REP 2003, P49; World Health Organization, 2004, GUID ATC CLASS DDD A	5	57	57	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2005	331	7520					815	816		10.1136/bmj.38582.703866.AE	http://dx.doi.org/10.1136/bmj.38582.703866.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	974BC	16141448	Green Published, Bronze			2022-12-28	WOS:000232565300020
J	Guttmacher, AE; Collins, FS				Guttmacher, AE; Collins, FS			Realizing the promise of genomics in biomedical research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FACTOR-H POLYMORPHISM; FAMILY-HISTORY; LUNG-CANCER; MUTATIONS; SEQUENCE; GENETICS; BREAST; GENES		NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Guttmacher, AE (corresponding author), NHGRI, NIH, Room 4B09,31 Ctr Dr, Bethesda, MD 20892 USA.	guttmach@mail.nih.gov						Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Collado-Vides Julio, 2003, Genome Biol, V4, P328, DOI 10.1186/gb-2003-4-7-328; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Coppel RL, 2004, TRENDS PARASITOL, V20, P553, DOI 10.1016/j.pt.2004.10.002; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; *ELSI RES, 2001, J LAW MED ETHICS S, V29, P1; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; Guttmacher AE, 2003, NEW ENGL J MED, V349, P996, DOI 10.1056/NEJMe038132; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hall MA, 2000, GENET MED, V2, P214, DOI 10.1097/00125817-200007000-00003; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jenkins J, 2001, GENET MED, V3, P155, DOI 10.1097/00125817-200103000-00011; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; *NAT COAL HLTH PRO, NCHPEG; *NAT HUM GEN RES I, INT HAPMAP PROJ; National Center for Biotechnology Information, PUBCHEM PROJ; National Human Genome Research Institute, ENCODE PROJ ENCY DNA; *NCAB WORK GROUP B, 2005, REP NAT CANC ADV BOA; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Service RF, 2003, SCIENCE, V300, P236, DOI 10.1126/science.300.5617.236; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; Sulston J, 2003, LANCET, V362, P400, DOI 10.1016/S0140-6736(03)14030-5; Trent RJA, 2003, MED J AUSTRALIA, V178, P406, DOI 10.5694/j.1326-5377.2003.tb05262.x; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WHO, 2002, GEN WORLD HLTH REP A; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	38	94	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1399	1402		10.1001/jama.294.11.1399	http://dx.doi.org/10.1001/jama.294.11.1399			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174701				2022-12-28	WOS:000231987800016
J	Bradley, P; Misura, KMS; Baker, D				Bradley, P; Misura, KMS; Baker, D			Toward high-resolution de novo structure prediction for small proteins	SCIENCE			English	Article							CHAIN; SEQUENCES; DOCKING; DESIGN	The prediction of protein structure from amino acid sequence is a grand challenge of computational molecular biology. By using a combination of improved low- and high-resolution conformational sampling methods, improved atomically detailed potential functions that capture the jigsaw puzzle-like packing of protein cores, and high-performance computing, high-resolution structure prediction (<1.5 angstroms) can be achieved for small protein domains (<85 residues). The primary bottleneck to consistent high-resolution prediction appears to be conformational sampling.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217				ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Misura KMS, 2005, PROTEINS, V59, P15, DOI 10.1002/prot.20376; Moult J, 2003, PROTEINS, V53, P334, DOI 10.1002/prot.10556; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905	15	618	663	6	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1868	1871		10.1126/science.1113801	http://dx.doi.org/10.1126/science.1113801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166519				2022-12-28	WOS:000231989500053
J	Blumenthal, D; Hsiao, W				Blumenthal, D; Hsiao, W			Privatization and its discontents - The evolving Chinese health care system	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MARKET; REFORM		Massachusetts Gen Hosp, Partners Hlth Care Syst, Inst Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health	Blumenthal, D (corresponding author), Massachusetts Gen Hosp, Partners Hlth Care Syst, Inst Hlth Policy, Boston, MA 02114 USA.							Bloom G, 1997, SOC SCI MED, V45, P351, DOI 10.1016/S0277-9536(96)00350-4; *CHIN MIN HLTH, 2004, CHIN HLTH YB 2004; Cyranoski D, 2003, NATURE, V425, P442, DOI 10.1038/425442b; Cyranoski D, 2003, NATURE, V425, P333, DOI 10.1038/425333a; HELPRIN N, 2004, WALL STREET J   1213, pA16; Hesketh T, 1997, BRIT MED J, V314, P1543, DOI 10.1136/bmj.314.7093.1543; Hesketh T, 1997, BMJ-BRIT MED J, V314, P1616, DOI 10.1136/bmj.314.7094.1616; Hsiao William C., 2004, HARVARD CHINA REV, V5, P64; HUTZLER C, 2005, WALL STREET J   0124, pA2; KAHN J, 2004, NY TIMES        0703, pA1; Lim MK, 2004, HEALTH AFFAIR, V23, P222, DOI 10.1377/hlthaff.23.6.222; Liu XZ, 2000, HEALTH POLICY PLANN, V15, P157, DOI 10.1093/heapol/15.2.157; Liu Y., 2003, PEOPLES REPUBLIC CHI; Liu YL, 1998, HEALTH POLICY, V44, P103, DOI 10.1016/S0168-8510(98)00010-4; Liu YL, 2004, B WORLD HEALTH ORGAN, V82, P532; Liu YL, 2004, HEALTH POLICY PLANN, V19, P159, DOI 10.1093/heapol/czh019; Liu YL, 2003, J HEALTH POPUL NUTR, V21, P216; *NAT INT COUNC, 2004, MAPP GLOB FUT REP NA; SCHMITT E, 2005, NY TIMES        0218, pA9; Smith C, 2005, HEALTH AFFAIR, V24, P185, DOI 10.1377/hlthaff.24.1.185; YARDLEY J, 2004, NY TIMES        1208, pA1; YARDLEY J, 2005, NY TIMES        0121, pA4	22	395	406	5	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1165	1170		10.1056/NEJMhpr051133	http://dx.doi.org/10.1056/NEJMhpr051133			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	963YG	16162889				2022-12-28	WOS:000231841900014
J	Smetacek, V; Nicol, S				Smetacek, V; Nicol, S			Polar ocean ecosystems in a changing world	NATURE			English	Review							KRILL EUPHAUSIA-SUPERBA; SEA-ICE EXTENT; SOUTHERN-OCEAN; ANTARCTIC KRILL; MARINE ECOSYSTEMS; CLIMATE-CHANGE; PACK-ICE; ABUNDANCE; IRON; DECLINE	Polar organisms have adapted their seasonal cycles to the dynamic interface between ice and water. This interface ranges from the micrometre-sized brine channels within sea ice to the planetary-scale advance and retreat of sea ice. Polar marine ecosystems are particularly sensitive to climate change because small temperature differences can have large effects on the extent and thickness of sea ice. Little is known about the interactions between large, long-lived organisms and their planktonic food supply. Disentangling the effects of human exploitation of upper trophic levels from basin-wide, decade-scale climate cycles to identify long-term, global trends is a daunting challenge facing polar bio-oceanography.	Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; Australian Antarctic Div, Dept Environm & Heritage, Kingston, Tas 7050, Australia	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Australian Antarctic Division	Smetacek, V (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.	vsmetacek@awi-bremerhaven.de						Anderson RF, 2002, DEEP-SEA RES PT II, V49, P1909, DOI 10.1016/S0967-0645(02)00018-8; Arrigo KR, 2004, ANTARCT SCI, V16, P471, DOI 10.1017/S0954102004002263; Ashjian CJ, 2003, DEEP-SEA RES PT I, V50, P1235, DOI 10.1016/S0967-0637(03)00129-8; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Atkinson A, 1998, J MARINE SYST, V15, P289, DOI 10.1016/S0924-7963(97)00081-X; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Brierley AS, 2002, ADV MAR BIOL, V43, P171, DOI 10.1016/S0065-2881(02)43005-2; Brook BW, 2004, J BIOGEOGR, V31, P517, DOI 10.1046/j.1365-2699.2003.01028.x; Clarke A, 2003, ENVIRON CONSERV, V30, P1, DOI 10.1017/S0376892903000018; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Constable AJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001270; Croxall JP, 2004, ANTARCT SCI, V16, P569, DOI 10.1017/S0954102004002330; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; Curran MAJ, 2003, SCIENCE, V302, P1203, DOI 10.1126/science.1087888; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FRASER WR, 1992, POLAR BIOL, V11, P525; Gersonde R, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000809; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; GONZALEZ HE, 1992, POLAR BIOL, V12, P81; Hamner WM, 2000, CAN J FISH AQUAT SCI, V57, P192, DOI 10.1139/cjfas-57-S3-192; Hart T. J., 1942, Discovery Reports Cambridge, V21, P261; Hewitt RP, 2003, AQUAT LIVING RESOUR, V16, P205, DOI 10.1016/S0990-7440(03)00019-6; Hunt GL, 2002, PROG OCEANOGR, V55, P5, DOI 10.1016/S0079-6611(02)00067-8; HUNT GL, 2005, 19 GLOBEC; HUNTLEY ME, 1991, SCIENCE, V253, P64, DOI 10.1126/science.1905841; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johannessen OM, 2004, TELLUS A, V56, P328, DOI 10.1111/j.1600-0870.2004.00060.x; Jones CD, 2004, DEEP-SEA RES PT II, V51, P1421, DOI 10.1016/j.dsr2.2004.06.009; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; KNOX GA, 1994, BIOL SO OCEAN; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; MACDONALD RW, 2003, ARCTIC CARBON CYCLE, P7; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; MARSCHALL HP, 1988, POLAR BIOL, V9, P129, DOI 10.1007/BF00442041; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Murphy E. J., 1995, DEEP-SEA RES, V42, P1; Nicol S, 2003, MAR FRESHW BEHAV PHY, V36, P191, DOI 10.1080/10236240310001614420; Nicol S, 2000, CCAMLR SCI, V7, P87; Orlova LA, 2004, RADIOCARBON, V46, P301, DOI 10.1017/S0033822200039618; Parkinson CL, 2004, ANTARCT SCI, V16, P387, DOI 10.1017/S0954102004002214; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; PAULY D, 2003, PERFECT OCEAN; Priddle J, 1998, J MARINE SYST, V17, P275, DOI 10.1016/S0924-7963(98)00043-8; Ray G., 2004, COASTAL MARINE CONSE; REID K, 2001, PHIL T R SOC LOND B, V286, P377; ROSS RM, 1989, J EXP MAR BIOL ECOL, V133, P103, DOI 10.1016/0022-0981(89)90161-5; Sakshaug E., 2003, ARCTIC CARBON CYCLE, P58; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Sedwick PN, 1997, GEOPHYS RES LETT, V24, P2515, DOI 10.1029/97GL02596; Sherr BF, 2003, DEEP-SEA RES PT I, V50, P529, DOI 10.1016/S0967-0637(03)00030-X; SIEGEL V, 1995, MAR ECOL PROG SER, V123, P45, DOI 10.3354/meps123045; Smetacek V, 2004, ANTARCT SCI, V16, P541, DOI 10.1017/S0954102004002317; SMETACEK V, 2005, BER POLARFORSCH MEER, V500, P3; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; Southwell C, 2004, MAR MAMMAL SCI, V20, P602, DOI 10.1111/j.1748-7692.2004.tb01182.x; TURNER DR, 1995, DEEP-SEA RES PT II, V42, P907, DOI 10.1016/0967-0645(95)00056-V; von Bodungen B., 1987, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V62, P243; Voronina NM, 1998, J MARINE SYST, V17, P375, DOI 10.1016/S0924-7963(98)00050-5; ZIMOV SA, 1995, AM NAT, V146, P765, DOI 10.1086/285824; [No title captured]	62	345	363	3	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					362	368		10.1038/nature04161	http://dx.doi.org/10.1038/nature04161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163347				2022-12-28	WOS:000231849100043
J	Lee, DS; Tu, JV; Juurlink, DN; Alter, DA; Ko, DT; Austin, PC; Chong, A; Stukel, TA; Levy, D; Laupacis, A				Lee, DS; Tu, JV; Juurlink, DN; Alter, DA; Ko, DT; Austin, PC; Chong, A; Stukel, TA; Levy, D; Laupacis, A			Risk-treatment mismatch in the pharmacotherapy of heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVERTING ENZYME-INHIBITORS; ACUTE CORONARY SYNDROMES; QUALITY-OF-CARE; ELDERLY-PATIENTS; BETA-BLOCKERS; MYOCARDIAL-INFARCTION; TASK-FORCE; UNSTABLE ANGINA; OLDER PATIENTS; MORTALITY	Context Patients with heart failure have a wide spectrum of mortality risks. To maximize the benefit of available pharmacotherapies, patients with high mortality risk should receive high rates of drug therapy. Objective To examine patterns of drug therapy and underlying mortality risk in patients with heart failure. Design, Setting, and Patients In the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) population-based cohort (1999-2001) of 9942 patients with heart failure hospitalized in Ontario, Canada, we evaluated 1418 patients with documented left ventricular ejection fraction of 40% or less and aged 79 years or younger with low-, average-, and high-predicted risk of death within 1 year; all patients survived to hospital discharge. Administration of angiotensin-converting enzyme (ACE) inhibitors, ACE inhibitors or angiotensin II receptor blockers (ARBs), and beta-adrenoreceptor antagonists was evaluated according to predicted risk of death. Main Outcome Measure Heart failure drug administration rates at time of discharge and 90 days after hospital discharge. Results At hospital discharge, prescription rates for patients in the low-, average-, and high-risk groups were 81%, 73%, 60%, respectively, for ACE inhibitors; 86%, 80%, 65%, respectively, for ACE inhibitors or ARBs; and 40%, 33%, 24%, respectively, for beta-adrenoreceptor antagonists (all P<.001 for trend). Within 90 days following hospital discharge, the rates were 83%, 76%, and 61% for ACE inhibitors; 89%, 83%, and 67% for ACE inhibitors or ARBs; and 43%, 36%, and 28% for beta-adrenoreceptor antagonists for the 3 risk groups, respectively (all P<.001 for trend). The pattern of lower rates of drug administration in those patients at increasing risk was maintained up to 1 year postdischarge (P<.001). After accounting for varying survival time and potential contraindications to therapy, low-risk patients were more likely to receive ACE inhibitors or ARBs (adjusted hazard ratio [HR], 1.61; 95% confidence interval [CI], 1.49-1.74) and beta-adrenoreceptor antagonists (HR, 1.80; 95% CI, 1.60-2.01) compared with high-risk patients (both P<.001). Conclusions Patients with heart failure at greatest risk of death are least likely to receive ACE inhibitors, ACE inhibitors or ARBs, and beta-adrenoreceptor antagonists. Understanding the reasons underlying this mismatch may facilitate improvements in care and outcomes for patients with heart failure.	Univ Toronto, Inst Clin Evaluat Sci, Dept Hlth Policy Management & Evaluat, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada; NHLBI, Framingham Heart Study, NIH, Framingham, MA USA	University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Laupacis, A (corresponding author), Univ Toronto, Inst Clin Evaluat Sci, Dept Hlth Policy Management & Evaluat, Room G-106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	alaupacis@ices.on.ca	Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021	Levy, Daniel/0000-0003-1843-8724; Lee, Douglas/0000-0001-7078-745X; Ko, Dennis/0000-0001-6840-8051; Tu, Jack/0000-0003-0111-722X; Austin, Peter/0000-0003-3337-233X; Stukel, Therese/0000-0002-2951-1360				Ahmed A, 2002, J AM GERIATR SOC, V50, P1659, DOI 10.1046/j.1532-5415.2002.50457.x; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Alter DA, 2004, AM J MED, V116, P540, DOI 10.1016/j.amjmed.2003.10.039; American Heart Association, 2005, HEART DIS STROKE STA; Barakat K, 1999, LANCET, V353, P955, DOI 10.1016/S0140-6736(98)07114-1; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Bouzamondo A, 2003, EUR J HEART FAIL, V5, P281, DOI 10.1016/S1388-9842(03)00042-4; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; Califf RM, 1996, J AM COLL CARDIOL, V27, P1007, DOI 10.1016/0735-1097(96)87733-3; Deedwania PC, 2004, EUR HEART J, V25, P1300, DOI 10.1016/j.ehj.2004.05.022; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Furberg CD, 1996, J AM COLL CARDIOL, V27, P976, DOI 10.1016/0735-1097(96)87730-8; Gambassi G, 2000, ARCH INTERN MED, V160, P53, DOI 10.1001/archinte.160.1.53; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Good P, 2000, PERMUTATION TESTS PR; Halon DA, 2004, J AM COLL CARDIOL, V43, P346, DOI 10.1016/j.jacc.2003.08.044; Havranek EP, 1998, ARCH INTERN MED, V158, P2024, DOI 10.1001/archinte.158.18.2024; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Johnson D, 2003, J AM COLL CARDIOL, V42, P1438, DOI 10.1016/S0735-1097(03)01058-1; Jong P, 2002, J AM COLL CARDIOL, V39, P463, DOI 10.1016/S0735-1097(01)01775-2; Juurlink DN, 2001, CAN MED ASSOC J, V165, P27; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Komajda M, 2003, EUR HEART J, V24, P464, DOI 10.1016/S0195-668X(02)00700-5; Kotlyar E, 2002, J HEART LUNG TRANSPL, V21, P1290, DOI 10.1016/S1053-2498(02)00459-X; Krum H, 2003, JAMA-J AM MED ASSOC, V289, P712, DOI 10.1001/jama.289.6.712; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Lee DS, 2003, CAN J CARDIOL, V19, P357; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; LEE WH, 1986, CIRCULATION, V73, P257, DOI 10.1161/01.CIR.73.2.257; Liu P, 2003, CAN J CARDIOL, V19, P347; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; Masoudi FA, 2004, CIRCULATION, V110, P724, DOI 10.1161/01.CIR.0000138934.28340.ED; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McMurray JJV, 1998, EUR HEART J, V19, pP9; Morris AD, 1997, DIABETES CARE, V20, P1363, DOI 10.2337/diacare.20.9.1363; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Rathore SS, 2003, AM J MED, V114, P307, DOI 10.1016/S0002-9343(02)01531-0; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rochon PA, 2000, LANCET, V356, P639, DOI 10.1016/S0140-6736(00)02606-4; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Rouleau JL, 2004, J AM COLL CARDIOL, V43, P1423, DOI 10.1016/j.jacc.2003.11.037; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Shibata MC, 2001, EUR J HEART FAIL, V3, P351, DOI 10.1016/S1388-9842(01)00144-1; Sin DD, 2002, AM J MED, V113, P650, DOI 10.1016/S0002-9343(02)01346-3; Smith NL, 2004, AM HEART J, V148, P710, DOI 10.1016/j.ahj.2004.04.002; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Tonkin AM, 2000, LANCET, V356, P1871, DOI 10.1016/S0140-6736(00)03257-8; Tu JV, 2001, JAMA-J AM MED ASSOC, V285, P3116, DOI 10.1001/jama.285.24.3116; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	52	178	182	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2005	294	10					1240	1247		10.1001/jama.294.10.1240	http://dx.doi.org/10.1001/jama.294.10.1240			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963UI	16160132	Bronze			2022-12-28	WOS:000231831200021
J	Stone, GW; Ellis, SG; Cannon, L; Mann, JT; Greenberg, JD; Spriggs, D; O'Shaughnessy, CD; DeMaio, S; Hall, P; Popma, JJ; Koglin, J; Russell, ME				Stone, GW; Ellis, SG; Cannon, L; Mann, JT; Greenberg, JD; Spriggs, D; O'Shaughnessy, CD; DeMaio, S; Hall, P; Popma, JJ; Koglin, J; Russell, ME		TAXUS V Investigators	Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BALLOON ANGIOPLASTY; ANGIOGRAPHIC PREDICTORS; BENESTENT II; RESTENOSIS; IMPLANTATION; METAANALYSIS; LESIONS	Context Compared with bare metal stents, drug-eluting stents reduce restenosis in noncomplex lesions. The utility of drug-eluting stents has not been evaluated in more difficult stenoses. Objective To investigate the safety and efficacy of the polymer-based, slow-release paclitaxel-eluting stent in a patient population with more complex lesions than previously studied. Design, Setting, and Patients Prospective, placebo-controlled, double-blind, multicenter randomized trial conducted from February 2003 to March 2004 at 66 academic and community-based institutions with 1156 patients who underwent stent implantation in a single coronary artery stenosis (vessel diameter, 2.25-4.0 mm; lesion length, 10-46 mm), including 664 patients (57.4%) with complex or previously unstudied lesions (requiring 2.25-mm, 4.0-mm, and/or multiple stents) and 9-month clinical and angiographic follow-up. Interventions Patients were randomly assigned to receive 1 or more bare metal stents (n = 579) or identical-appearing paclitaxel-eluting stents (n = 577). Main Outcome Measure Ischemia-driven target vessel revascularization at 9 months. Results Baseline characteristics were well matched. Diabetes was present in 31% of patients. The mean (SD) reference vessel diameter was 2.69 (0.57) mm, the reference lesion length was 17.2 (9.2) mm, and 78% of lesions were type B-2/C. A mean (SD) of 1.38 (0.58) stents (total mean [SD] length, 28.4 [13.1] mm) were implanted per lesion; 33% of lesions required multiple stents. Stents that were 2.25 mm and 4.0 mm in diameter were used in 18% and 17% of lesions, respectively. Compared with bare metal stents, paclitaxel-eluting stents reduced the 9-month rate of target lesion revascularization from 15.7% to 8.6% (P<.001) and target vessel revascularization from 17.3% to 12.1% (P = .02). Similar rates were observed for cardiac death or myocardial infarction (5.5% for bare metal stent group vs 5.7% for paclitaxel-eluting stent group) and stent thrombosis (0.7% in both groups). Angiographic restenosis was reduced from 33.9% to 18.9% in the entire study cohort (P<.001), including among patients receiving 2.25-mm stents (49.4% vs 31.2%; P = .01), 4.0-mm stents (14.4% vs 3.5%; P = .02), and multiple stents (57.8% vs 27.2%; P<.001). Conclusion Compared with a bare metal stent, implantation of the paclitaxel-eluting stent in a patient population with complex lesions effectively reduces clinical and angiographic restenosis.	Columbia Univ, Med Ctr, Dept Cardiol, New York, NY 10032 USA; Cardiovasc Res Fdn, New York, NY USA; Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; No Michigan Hosp, Dept Cardiol, Petoskey, MI USA; WakeMed, Raleigh, NC USA; Florida Heart Inst, Dept Cardiol, Orlando, FL USA; Morton Plant Hosp, Dept Cardiol, Clearwater, FL USA; Elyria Mem Hosp, Dept Cardiol, Elyria, OH USA; S Austin Hosp, Dept Cardiol, Austin, TX USA; S Carolina Heart Ctr, Dept Cardiol, Columbia, SC USA; Brigham & Womens Hosp, Dept Cardiol, Boston, MA 02115 USA; Boston Sci Corp, Natick, MA USA	Columbia University; Cardiovascular Research Foundation (CRF); Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Boston Scientific	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Dept Cardiol, Herbert Irving Pavil,5th Floor,161 Ft Washington, New York, NY 10032 USA.	gs2184@columbia.edu						Agostoni P, 2005, EUR HEART J, V26, P881, DOI 10.1093/eurheartj/ehi116; Aliabadi D, 1997, AM J CARDIOL, V80, P994, DOI 10.1016/S0002-9149(97)00591-2; Ardissino D, 2004, JAMA-J AM MED ASSOC, V292, P2727, DOI 10.1001/jama.292.22.2727; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Cutlip DE, 2002, J AM COLL CARDIOL, V40, P2082, DOI 10.1016/S0735-1097(02)02597-4; Kasaoka S, 1998, J AM COLL CARDIOL, V32, P1630, DOI 10.1016/S0735-1097(98)00404-5; Kastrati A, 1997, J AM COLL CARDIOL, V30, P1428, DOI 10.1016/S0735-1097(97)00334-3; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Mercado N, 2001, J AM COLL CARDIOL, V38, P645, DOI 10.1016/S0735-1097(01)01431-0; *MILL RES GROUP, 2005, MARK AN; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Orlic D, 2004, J AM COLL CARDIOL, V43, P1154, DOI 10.1016/j.jacc.2003.10.052; Serruys PW, 1999, J AM COLL CARDIOL, V34, P1067, DOI 10.1016/S0735-1097(99)00308-3; Serruys PW, 2002, J AM COLL CARDIOL, V39, P393, DOI 10.1016/S0735-1097(01)01760-0; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; SERRUYS PW, 2005, ANN SCI SESS AM COLL; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; VANDERZWET PMJ, 1994, J AM COLL CARDIOL, V24, P216, DOI 10.1016/0735-1097(94)90566-5	19	627	671	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2005	294	10					1215	1223		10.1001/jama.294.10.1215	http://dx.doi.org/10.1001/jama.294.10.1215			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963UI	16160130	Bronze			2022-12-28	WOS:000231831200018
J	Orford, J				Orford, J		UKATT Res Team	Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIMITATIONS; DEPENDENCE; OUTCOMES; THERAPY	Objective To compare the effectiveness of social behaviour and network therapy, a new treatment for alcohol problems, with that of the proved motivational enhancement therapy. Design Pragmatic randomised trial. Setting Seven treatment sites around Birmingham, Cardiff, and Leeds. Participants 742 clients with alcohol problems; 689 (93.0%) were interviewed at three months and 617 (83.2%) at 12 months. Interventions Social behaviour and network therapy and motivational enhancement therapy. Main outcome measures Changes in alcohol consumption, alcohol dependence, and alcohol related problems over 12 months. Results Both groups reported substantial reductions in alcohol consumption, dependence, and problems and better mental health related quality of life over 12 months. Between groups we found only one significant difference in outcome, probably due to chance: the social network group showed significantly better physical health at three months. Non-significant differences at 12 months in the motivational group relative to the social network group included: the number of drinks consumed per drinking day had decreased by an extra 1.1 (95% confidence interval - 1.0 to 3.2); scores on the Leeds dependence questionnaire had improved by an extra 0.6 (- 0.7 to 2.0); scores on the alcohol problems questionnaire had improved by an extra 0.5 (- 0.4 to 1.4); but the Dumber of days abstinent from drinking had increased by 1.2% less (- 4.5% to 6.9%). Conclusion The novel social behaviour and network therapy for alcohol problems did not differ significantly in effectiveness from the proved motivational enhancement therapy.	Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Orford, J (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	j.f.orford@bham.ac.uk	Russell, Ian T/H-1181-2012	Parrott, Steven James/0000-0002-0165-1150				*ALC CONC, 2002, REP MAPP ALC SERV EN; Allen J, 1998, ALCOHOL CLIN EXP RES, V22, P1300; Allen JP, 1997, J STUD ALCOHOL, V58, P7; Babor TF, 2000, J STUD ALCOHOL, V61, P55, DOI 10.15288/jsa.2000.61.55; *BOEHR MANNH DIAGN, 1989, REFL CLIENT MAN SYST; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; CHICK J, 1988, BRIT J ADDICT, V83, P159; Copello A, 2002, ADDICT BEHAV, V27, P345, DOI 10.1016/S0306-4603(01)00176-9; Copello A, 2001, ALCOHOL ALCOHOLISM, V36, P11; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; DRUMMOND DC, 1990, BRIT J ADDICT, V85, P357; Finney JW, 2000, ADDICTION, V95, P1491, DOI 10.1046/j.1360-0443.2000.951014914.x; Godfrey C, 2005, BMJ-BRIT MED J, V331, P544; GOLDBERG DP, 1972, DETECTIONS PSYCHIAT; Hillman A, 1998, ALCOHOL ALCOHOLISM, V33, P626, DOI 10.1093/alcalc/33.6.626; Leontaridi R., 2003, ALCOHOL MISUSE MUCH; Millard N, 2001, J INST BRIT TELECOMM, V2, P92; Miller W., 1998, TREATING ADDICTIVE B, V2, P203, DOI [10.1007/978-1-4899-1934-2_15, DOI 10.1007/978-1-4899-1934-2_15]; Miller W. R., 1996, PROJECT MATCH MONOGR, V5; MILLER WR, 1992, DHHS PUBLICATION; RAISTRICK D, 1994, ADDICTION, V89, P563, DOI 10.1111/j.1360-0443.1994.tb03332.x; Sellman JD, 2001, J STUD ALCOHOL, V62, P389, DOI 10.15288/jsa.2001.62.389; Singleton N., 2001, PSYCHIAT MORBIDITY A; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weisner C, 2003, ADDICTION, V98, P901, DOI 10.1046/j.1360-0443.2003.00438.x	26	175	176	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2005	331	7516					541	544						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965GX	16150764				2022-12-28	WOS:000231939700015
J	Adams, JS				Adams, JS			"Bound" to work: The free hormone hypothesis revisited	CELL			English	Editorial Material								Megalin is a member of the low-density lipoprotein receptor-related protein (LRP) family. The plasma membrane-anchored LRPs serve as receptors for a wide variety of extracellular ligands, promoting their entry into cells by endocytosis of the receptor-ligand complex. In this issue of Cell, Hammes et al. (2005) show that resistance (insensitivity) to sex steroid hormones is encountered in animals lacking megalin. These data provide important insights into an endocytic mechanism for the uptake of sex steroids by mammalian cells.	Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Burns & Allen Res Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Adams, JS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Burns & Allen Res Inst, Los Angeles, CA 90048 USA.		Adams, John S/I-3365-2013	Adams, John S/0000-0001-9607-5020				Adams JS, 2004, J STEROID BIOCHEM, V89-90, P461, DOI 10.1016/j.jsbmb.2004.03.016; Gekle M, 2005, ANNU REV PHYSIOL, V67, P573, DOI 10.1146/annurev.physiol.67.031103.154845; GRIFFIN JE, 1982, AM J PHYSIOL, V243, pE81, DOI 10.1152/ajpendo.1982.243.2.E81; Hammes A, 2005, CELL, V122, P751, DOI 10.1016/j.cell.2005.06.032; Hijazi RA, 2005, ANNU REV MED, V56, P117, DOI 10.1146/annurev.med.56.082103.104518; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Nagai J, 2005, AM J PHYSIOL-RENAL, V289, pF569, DOI 10.1152/ajprenal.00292.2004; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5	10	28	28	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					647	649		10.1016/j.cell.2005.08.024	http://dx.doi.org/10.1016/j.cell.2005.08.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143095	Bronze			2022-12-28	WOS:000231844300002
J	Bell, DR; Jorgensen, P; Christophel, EM; Palmer, KL				Bell, DR; Jorgensen, P; Christophel, EM; Palmer, KL			Malaria risk - Estimation of the malaria burden	NATURE			English	Letter							PLASMODIUM-FALCIPARUM		World Hlth Org, Reg Off Western Pacific, Malaria Other Vector Borne & Parasit Dis Unit, Manila, Philippines	World Health Organization	Bell, DR (corresponding author), World Hlth Org, Reg Off Western Pacific, Malaria Other Vector Borne & Parasit Dis Unit, POB 2932, Manila, Philippines.	belld@wpro.who.int						Anthony TG, 2005, J INFECT DIS, V191, P1558, DOI 10.1086/429338; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Gillies M. T., 1988, Malaria: principles and practice of malariology. Volume 1., P453; Lysenko A.J., 1968, MEDICINSKAJA GEOGRAF, P25; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Socheat Doung, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P1; Torres EP, 1997, ACTA TROP, V63, P209, DOI 10.1016/S0001-706X(96)00622-5; *UN ENV PROGR, 2001, AS PAC ENV OUTL, V2; *WHO, 2005, MAL OTH VECT PAR DIS; *WHO EXP COMM, 2000, 20 WHO EXP COMM	10	24	25	1	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					E3	E4		10.1038/nature04179	http://dx.doi.org/10.1038/nature04179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148887				2022-12-28	WOS:000231696900044
J	Cullen, M; Steven, N; Billingham, L; Gaunt, C; Hastings, M; Simmonds, P; Stuart, N; Rea, D; Bower, M; Fernando, I; Huddart, R; Gollins, S; Stanley, A				Cullen, M; Steven, N; Billingham, L; Gaunt, C; Hastings, M; Simmonds, P; Stuart, N; Rea, D; Bower, M; Fernando, I; Huddart, R; Gollins, S; Stanley, A		SIGNIFICANT Trial Grp	Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEUTROPENIC CANCER-PATIENTS; CONTROLLED PHASE-III; ANTIBIOTIC-PROPHYLAXIS; METAANALYSIS; ASSOCIATION; INFECTIONS; GUIDELINES; RESISTANCE; THERAPY; FEVER	BACKGROUND: The role of prophylactic antibacterial agents after chemotherapy remains controversial. METHODS: We conducted a randomized, double-blind, placebo-controlled trial in patients who were receiving cyclic chemotherapy for solid tumors or lymphoma and who were at risk for temporary, severe neutropenia (fewer than 500 neutrophils per cubic millimeter). Patients were randomly assigned to receive either 500 mg of levofloxacin once daily or matching placebo for seven days during the expected neutropenic period. The primary outcome was the incidence of clinically documented febrile episodes (temperature of more than 38 degreesC) attributed to infection. Secondary outcomes included the incidence of all probable infections, severe infections, and hospitalization but did not include a systematic evaluation of antibacterial resistance. RESULTS: A total of 1565 patients underwent randomization (784 to placebo and 781 to levofloxacin). The tumors included breast cancer (35.4 percent), lung cancer (22.5 percent), testicular cancer (14.4 percent), and lymphoma (12.8 percent). During the first cycle of chemotherapy, 3.5 percent of patients in the levofloxacin group had at least one febrile episode, as compared with 7.9 percent in the placebo group (P<0.001). During the entire chemotherapy course, 10.8 percent of patients in the levofloxacin group had at least one febrile episode, as compared with 15.2 percent of patients in the placebo group (P=0.01); the respective rates of probable infection were 34.2 percent and 41.5 percent (P=0.004). Hospitalization was required for the treatment of infection in 15.7 percent of patients in the levofloxacin group and 21.6 percent of patients in the placebo group (P=0.004). The respective rate of severe infection was 1.0 percent and 2.0 percent (P=0.15), with four infection-related deaths in each group. An organism was isolated in 9.2 percent of probable infections. CONCLUSIONS: Among patients receiving chemotherapy for solid tumors or lymphoma, the prophylactic use of levofloxacin reduces the incidence of fever, probable infection, and hospitalization.	Univ Hosp Birmingham, Ctr Canc, Birmingham, W Midlands, England; Ysbyty Gwynedd, Bangor, Gwynedd, Wales; Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham, W Midlands, England; Natl Publ Hlth Serv Wales, Cardiff, Wales; Royal S Hampshire Hosp, Southampton, Hants, England; Glan Clwyd, Rhyl, Wales; Chelsea & Westminster Hosp, London, England; Royal Marsden Hosp, London SW3 6JJ, England; City Hosp, Birmingham, W Midlands, England	University of Birmingham; Cancer Research UK; University of Birmingham; Imperial College London; Royal Marsden NHS Foundation Trust; University of Birmingham	Cullen, M (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2TH, W Midlands, England.	cullen@uhb.nhs.uk		Billingham, Lucinda/0000-0001-8581-4262; huddart, robert/0000-0003-3604-1990; Bower, Mark/0000-0002-4077-6351				Bucaneve G, 2005, NEW ENGL J MED, V353, P977, DOI 10.1056/NEJMoa044097; Cruciani M, 1996, CLIN INFECT DIS, V23, P795, DOI 10.1093/clinids/23.4.795; Engels EA, 1998, J CLIN ONCOL, V16, P1179, DOI 10.1200/JCO.1998.16.3.1179; Freifeld A, 1999, NEW ENGL J MED, V341, P305, DOI 10.1056/NEJM199907293410501; FREIFELD A, 2004, P AN M AM SOC CLIN, V23, P747; FU KP, 1992, ANTIMICROB AGENTS CH, V36, P860, DOI 10.1128/AAC.36.4.860; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hughes WT, 1997, CLIN INFECT DIS, V25, P551, DOI 10.1086/513764; Kern WV, 1999, NEW ENGL J MED, V341, P312, DOI 10.1056/NEJM199907293410502; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Leonard RCF, 2003, BRIT J CANCER, V89, P2062, DOI 10.1038/sj.bjc.6601279; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Ozer H, 2000, J CLIN ONCOL, V18, P3558, DOI 10.1200/JCO.2000.18.20.3558; SPIERS ASD, 1974, BMJ-BRIT MED J, V4, P440, DOI 10.1136/bmj.4.5942.440; SULLIVAN KM, 2001, PREVENTING OPPORTUNI, P392; Tjan-Heijnen VCG, 2001, ANN ONCOL, V12, P1359, DOI 10.1023/A:1012545507920; Tjan-Heijnen VCG, 2003, ANN ONCOL, V14, P248, DOI 10.1093/annonc/mdg073; VERHOEF J, 1993, CLIN INFECT DIS, V17, pS359, DOI 10.1093/clinids/17.Supplement_2.S359	18	271	290	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					988	998		10.1056/NEJMoa050078	http://dx.doi.org/10.1056/NEJMoa050078			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148284				2022-12-28	WOS:000231698200004
J	Nutt, JG; Wooten, GF				Nutt, JG; Wooten, GF			Diagnosis and initial management of Parkinson's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY STANDARDS SUBCOMMITTEE; RANDOMIZED CONTROLLED-TRIAL; AMERICAN ACADEMY; HEART-DISEASE; FOLLOW-UP; LEVODOPA; PROGRESSION; PERGOLIDE; THERAPY; PRAMIPEXOLE		Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; Univ Virginia, Dept Neurol, Charlottesville, VA USA	Oregon Health & Science University; University of Virginia	Nutt, JG (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nuttj@ohsu.edu						Agarwal P, 2004, MOVEMENT DISORD, V19, P699, DOI 10.1002/mds.20200; Agid Y, 1998, LANCET, V351, P851, DOI 10.1016/S0140-6736(05)70285-3; Baseman DG, 2004, NEUROLOGY, V63, P301, DOI 10.1212/01.WNL.0000129842.49926.07; Bower JH, 1999, NEUROLOGY, V52, P1214, DOI 10.1212/WNL.52.6.1214; Clarke CE, 2000, J NEUROL NEUROSUR PS, V69, P590, DOI 10.1136/jnnp.69.5.590; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; Dupont E, 1996, ACTA NEUROL SCAND, V93, P14; Ellis T, 2005, ARCH PHYS MED REHAB, V86, P626, DOI 10.1016/j.apmr.2004.08.008; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fahn S, 1996, NEUROLOGY, V47, pS184, DOI 10.1212/WNL.47.6_Suppl_3.184S; Fall PA, 2003, MOVEMENT DISORD, V18, P1312, DOI 10.1002/mds.10537; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; GOETZ CG, 2002, MOV DISORD S4, V17, pS1; Healy DG, 2004, LANCET NEUROL, V3, P652, DOI 10.1016/S1474-4422(04)00905-6; Hirsch MA, 2003, ARCH PHYS MED REHAB, V84, P1109, DOI 10.1016/S0003-9993(03)00046-7; Holloway RG, 2005, ARCH NEUROL-CHICAGO, V62, P430; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jennings DL, 2004, ARCH NEUROL-CHICAGO, V61, P1224, DOI 10.1001/archneur.61.8.1224; KEYSER DL, 1991, ARCH INTERN MED, V151, P794, DOI 10.1001/archinte.151.4.794; Koller WC, 1999, NEUROLOGY, V53, P1012, DOI 10.1212/WNL.53.5.1012; Lees AJ, 2001, NEUROLOGY, V57, P1687, DOI 10.1212/WNL.57.9.1687; Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653; Marshall V, 2003, MOVEMENT DISORD, V18, P1415, DOI 10.1002/mds.10592; Meara J, 1999, AGE AGEING, V28, P99, DOI 10.1093/ageing/28.2.99; Miyasaki JM, 2002, NEUROLOGY, V58, P11, DOI 10.1212/WNL.58.1.11; Olanow CW, 2004, MOVEMENT DISORD, V19, P997, DOI 10.1002/mds.20243; PAULSON G, 1993, NEUROLOGY, V43, P1296; PAYAMI H, 1994, ANN NEUROL, V36, P659, DOI 10.1002/ana.410360417; Pritchett AM, 2002, MAYO CLIN PROC, V77, P1280, DOI 10.4065/77.12.1280; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Ravina BM, 2003, NEUROLOGY, V60, P1234, DOI 10.1212/01.WNL.0000058760.13152.1A; RILEY D, 1989, J NEUROL NEUROSUR PS, V52, P63, DOI 10.1136/jnnp.52.1.63; Shoulson I, 2002, ANN NEUROL, V51, P604, DOI 10.1002/ana.10191; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Siderowf A, 2004, ARCH NEUROL-CHICAGO, V61, P561; Tanner C. M., 2004, MOVEMENT DISORDERS N, P177; United States Census Bureau, 2004, US INT PROJ AG SEX R; Van Camp G, 2004, LANCET, V363, P1179, DOI 10.1016/S0140-6736(04)15945-X; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982	44	209	221	3	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					1021	1027		10.1056/NEJMcp043908	http://dx.doi.org/10.1056/NEJMcp043908			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148287				2022-12-28	WOS:000231698200007
J	Littlejohns, P; Kelly, M				Littlejohns, P; Kelly, M			The changing face of NICE: the same but different	LANCET			English	Editorial Material							PUBLIC-HEALTH		Natl Inst Hlth & Clin Excellence, London WC1V 6NA, England	National Institute for Health & Care Excellence	Littlejohns, P (corresponding author), Natl Inst Hlth & Clin Excellence, London WC1V 6NA, England.	peter.littlejohns@nice.org.uk						Beaglehole R, 2004, LANCET, V363, P2084, DOI 10.1016/S0140-6736(04)16461-1; *DEP HLTH, 2004, REC DEP HLTH ARMS LE; Department of Health, 2004, CHOOS HLTH MAK HLTH; Heath I, 2005, BRIT MED J, V330, P954, DOI 10.1136/bmj.330.7497.954; *NAT I HLTH CLIN E, CIT COUNC; Rawlins MD, 2005, BRIT MED J, V330, P376, DOI 10.1136/bmj.330.7488.376; Roberts M, 2002, LANCET, V359, P1055, DOI 10.1016/S0140-6736(02)08097-2; Wanless, 2002, SECURING OUR FUTURE; Wanless D., 2004, SECURING GOOD HLTH W	9	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 3	2005	366	9488					791	794		10.1016/S0140-6736(05)67194-2	http://dx.doi.org/10.1016/S0140-6736(05)67194-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139642				2022-12-28	WOS:000231627000009
J	Bever, GS; Rowe, T; Ekdale, EG; Macrini, TE; Colbert, MW; Balanoff, AM				Bever, GS; Rowe, T; Ekdale, EG; Macrini, TE; Colbert, MW; Balanoff, AM			Comment on "Independent origins of middle ear bones in monotremes and therians" (I)	SCIENCE			English	Editorial Material							EVOLUTION		Univ Texas, Jackson Sch Geosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bever, GS (corresponding author), Univ Texas, Jackson Sch Geosci, 1 Univ Stn C1140, Austin, TX 78712 USA.	gsbever@mail.utexas.edu						Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Rich TH, 2005, SCIENCE, V307, P910, DOI 10.1126/science.1105717; Rich TH, 2001, ACTA PALAEONTOL POL, V46, P113; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; ROWE T, 1987, SYST ZOOL, V36, P208, DOI 10.2307/2413270; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; ROWE T, 1996, NEW PERSPECTIVES HIS, P71; Woodburne Michael O., 2003, Journal of Mammalian Evolution, V10, P195, DOI 10.1023/B:JOMM.0000015104.29857.f0; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1	11	13	13	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740								10.1126/science.1112248	http://dx.doi.org/10.1126/science.1112248			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141050				2022-12-28	WOS:000231715000023
J	Bintanja, R; van de Wal, RSW; Oerlemans, J				Bintanja, R; van de Wal, RSW; Oerlemans, J			Modelled atmospheric temperatures and global sea levels over the past million years	NATURE			English	Article							LAST GLACIAL MAXIMUM; ICE-AGE CYCLE; INTERGLACIAL PERIOD; CLIMATE-CHANGE; SHEET; WATER; GREENLAND; HOLOCENE; HISTORY; RECORDS	Marine records of sediment oxygen isotope compositions show that the Earth's climate has gone through a succession of glacial and interglacial periods during the past million years. But the interpretation of the oxygen isotope records is complicated because both isotope storage in ice sheets and deep-water temperature affect the recorded isotopic composition(1-5). Separating these two effects would require long records of either sea level or deep-ocean temperature, which are currently not available. Here we use a coupled model of the Northern Hemisphere ice sheets(6) and ocean temperatures, forced to match an oxygen isotope record for the past million years compiled from 57 globally distributed sediment cores, to quantify both contributions simultaneously. We find that the ice-sheet contribution to the variability in oxygen isotope composition varied from ten per cent in the beginning of glacial periods to sixty per cent at glacial maxima, suggesting that strong ocean cooling preceded slow ice-sheet build-up. The model yields mutually consistent time series of continental mean surface temperatures between 40 and 80 degrees N, ice volume and global sea level. We find that during extreme glacial stages, air temperatures were 17 +/- 1.8 degrees C lower than present, with a 120 +/- 10 m sea level equivalent of continental ice present.	Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3584 CC Utrecht, Netherlands	Utrecht University	Bintanja, R (corresponding author), Univ Utrecht, Inst Marine & Atmospher Res Utrecht, Princetonpl 5, NL-3584 CC Utrecht, Netherlands.	R.Bintanja@phys.uu.nl	van de wal, roderik/D-1705-2011; Oerlemans, Johannes/G-3802-2011	van de wal, roderik/0000-0003-2543-3892; 				Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Bintanja R, 2005, CLIM DYNAM, V24, P197, DOI 10.1007/s00382-004-0486-x; Bintanja R, 1996, CLIM DYNAM, V12, P523, DOI 10.1007/BF00207936; Bintanja R, 2002, QUATERN INT, V95-6, P11, DOI 10.1016/S1040-6182(02)00023-X; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; Clarke GKC, 2002, QUATERNARY SCI REV, V21, P419, DOI 10.1016/S0277-3791(01)00111-1; CORTIJO E, 1994, NATURE, V372, P446, DOI 10.1038/372446a0; CUFFEY KM, 1995, SCIENCE, V270, P455, DOI 10.1126/science.270.5235.455; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; Duplessy JC, 2002, QUATERNARY SCI REV, V21, P315, DOI 10.1016/S0277-3791(01)00107-X; DWYER GS, 1995, SCIENCE, V270, P1347, DOI 10.1126/science.270.5240.1347; Fricke HC, 1999, EARTH PLANET SC LETT, V170, P181, DOI 10.1016/S0012-821X(99)00105-3; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; Jouzel J, 2002, QUATERNARY SCI REV, V21, P307, DOI 10.1016/S0277-3791(01)00106-8; Kageyama M, 2001, CLIM DYNAM, V17, P23, DOI 10.1007/s003820000095; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Lea DW, 2002, QUATERNARY SCI REV, V21, P283, DOI 10.1016/S0277-3791(01)00081-6; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20; MIX AC, 1984, QUATERNARY RES, V21, P1, DOI 10.1016/0033-5894(84)90085-1; Paillard D, 2001, REV GEOPHYS, V39, P325, DOI 10.1029/2000RG000091; SCHRAGG DP, 1996, SCIENCE, V372, P1930; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; SHACKLETON NJ, 1974, METHODES QUANTITATIV, P203; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Tarasov L, 1997, J GEOPHYS RES-ATMOS, V102, P21665, DOI 10.1029/97JD01766; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9	30	515	543	2	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					125	128		10.1038/nature03975	http://dx.doi.org/10.1038/nature03975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136140				2022-12-28	WOS:000231560400054
J	Yin, LK; Mohamed, AL				Yin, LK; Mohamed, AL			Dextrocardia with situs inversus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Int Med Univ Malaysia, Seremban 70300, Malaysia	International Medical University Malaysia	Yin, LK (corresponding author), Int Med Univ Malaysia, Seremban 70300, Malaysia.		ABDEL-LATIF, Mohamed E./N-3372-2018	ABDEL-LATIF, Mohamed E./0000-0003-4306-2933					0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					933	933		10.1056/NEJMicm040398	http://dx.doi.org/10.1056/NEJMicm040398			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135838				2022-12-28	WOS:000231551100011
J	Ferey, G; Mellot-Draznieks, C; Serre, C; Millange, F; Dutour, J; Surble, S; Margiolaki, I				Ferey, G; Mellot-Draznieks, C; Serre, C; Millange, F; Dutour, J; Surble, S; Margiolaki, I			A chromium terephthalate-based solid with unusually large pore volumes and surface area	SCIENCE			English	Article							COMPUTATIONAL DESIGN; INORGANIC FRAMEWORKS; BUILDING UNITS; GIANT PORES; CHEMISTRY; ROUTE		Univ Versailles, Inst Lavoisier, CNRS, Unite Mixte Rech 8637, F-78035 Versailles, France; Inst Univ France, F-75005 Paris, France; UCL Royal Inst Great Britain, London W1S 4BS, England; European Synchrotron Radiat Facil, F-38042 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut Universitaire de France; University of London; University College London; European Synchrotron Radiation Facility (ESRF)	Ferey, G (corresponding author), Univ Versailles, Inst Lavoisier, CNRS, Unite Mixte Rech 8637, 45 Ave Etats Unis, F-78035 Versailles, France.	ferey@chimie.uvsq.fr	Serre, Christian/AAJ-3990-2020; Surblé, Suzy/B-5652-2014	Serre, Christian/0000-0003-3040-2564; Surblé, Suzy/0000-0001-6228-5919				Batten SR, 1998, ANGEW CHEM INT EDIT, V37, P1460, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1460::AID-ANIE1460>3.0.CO;2-Z; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; ESTERMANN M, 1991, NATURE, V352, P320, DOI 10.1038/352320a0; Ferey G, 2000, J SOLID STATE CHEM, V152, P37, DOI 10.1006/jssc.2000.8667; Ferey G, 2004, ANGEW CHEM INT EDIT, V43, P6296, DOI 10.1002/anie.200460592; Ferey G, 2003, CHEM COMMUN, P2976, DOI 10.1039/b308903g; Ferey G, 2005, ACCOUNTS CHEM RES, V38, P217, DOI 10.1021/ar040163i; GIRARD S, 2001, STUD SURF SCI CATAL, V135, P254; Hong BH, 2001, SCIENCE, V294, P348, DOI 10.1126/science.1062126; Mellot-Draznieks C, 2004, Z ANORG ALLG CHEM, V630, P2599, DOI 10.1002/zaac.200400416; Mellot-Draznieks C, 2004, ANGEW CHEM INT EDIT, V43, P6290, DOI 10.1002/anie.200454251; Mellot-Draznieks C, 2002, J AM CHEM SOC, V124, P15326, DOI 10.1021/ja020999l; Mellot-Draznieks C, 2002, CHEM-EUR J, V8, P4103, DOI 10.1002/1521-3765(20020916)8:18<4102::AID-CHEM4102>3.0.CO;2-3; MELLOTDRAZNIEKS C, 2000, ANGEW CHEM INT EDIT, V39, P2271; Muller A, 2000, ANGEW CHEM INT EDIT, V39, P3414; Rowsell JLC, 2004, J AM CHEM SOC, V126, P5666, DOI 10.1021/ja049408c; SCHUTH F, 2002, HDB POROUS SOLIDS, V3, P563; Seo JS, 2000, NATURE, V404, P982, DOI 10.1038/35010088; Serre C, 2004, ANGEW CHEM INT EDIT, V43, P6286, DOI 10.1002/anie.200454250	19	3992	4155	154	3441	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2040	2042		10.1126/science.1116275	http://dx.doi.org/10.1126/science.1116275			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179475	Green Submitted			2022-12-28	WOS:000232181900045
J	Habenicht, A; Olapinski, M; Burmeister, F; Leiderer, P; Boneberg, J				Habenicht, A; Olapinski, M; Burmeister, F; Leiderer, P; Boneberg, J			Jumping, nanodroplets	SCIENCE			English	Article							LIQUID-DROP; DYNAMICS; SURFACE; IMPACT	Flat gold nanostructures on inert substrates like glass or graphite were illuminated by single intensive laser pulses with fluences above the gold. melting threshold. The liquid structures produced in this way are far from their equilibrium shape, and a dewetting process sets in. On a time scale of a few nanoseconds, the liquid contracted toward a sphere. During this contraction, the center of mass moved upward, which could lead to detachment of droplets from the surface due to inertia. The resulting velocities were on the order of 10 meters per second for droplets with radii in the range of 100 nanometers.	Univ Konstanz, Dept Phys, D-78457 Constance, Germany; Univ Munich, Dept Phys, D-80539 Munich, Germany; Univ Munich, Ctr Nano Sci, D-80539 Munich, Germany; Fraunhofer Inst Mech Mat, D-79108 Freiburg, Germany	University of Konstanz; University of Munich; University of Munich; Fraunhofer Gesellschaft	Habenicht, A (corresponding author), Univ Konstanz, Dept Phys, Univ Str 10, D-78457 Constance, Germany.							Bischof J, 1996, PHYS REV LETT, V77, P1536, DOI 10.1103/PhysRevLett.77.1536; BROCHARDWYART F, 1993, J PHYS II, V3, P21, DOI 10.1051/jp2:1993108; Burmeister F, 1997, LANGMUIR, V13, P2983, DOI 10.1021/la9621123; Burmeister F, 1999, APPL SURF SCI, V144-45, P461, DOI 10.1016/S0169-4332(98)00840-X; EGRY I, 1995, PHYS REV LETT, V75, P4043, DOI 10.1103/PhysRevLett.75.4043; GANGOPADHYAY U, 1994, MATER RES SOC SYMP P, V318, P393; Herminghaus S, 1998, SCIENCE, V282, P916, DOI 10.1126/science.282.5390.916; Klein J, 2000, NATURE, V405, P745, DOI 10.1038/35015645; Naidich YV, 1981, PROG SURF MEMBR SCI, P353, DOI DOI 10.1016/B978-0-12-571814-1.50011-7; REIN M, 1993, FLUID DYN RES, V12, P61, DOI 10.1016/0169-5983(93)90106-K; Richard D, 2000, EUROPHYS LETT, V50, P769, DOI 10.1209/epl/i2000-00547-6; Rioboo R, 2002, EXP FLUIDS, V33, P112, DOI [10.1007/s00348-002-0431-X, 10.1007/s00348-002-0431-x]; Roisman IV, 2002, P ROY SOC A-MATH PHY, V458, P1411, DOI 10.1098/rspa.2001.0923; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; Ukiwe C, 2005, LANGMUIR, V21, P666, DOI 10.1021/la0481288; Worthington AM., 1877, P R SOC LOND, V25, P261, DOI [10.1098/rspl.1876.0048, DOI 10.1098/RSPL.1876.0073, DOI 10.1098/RSPL.1876.0048]	16	165	170	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2043	2045		10.1126/science.1116505	http://dx.doi.org/10.1126/science.1116505			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179476	Green Submitted			2022-12-28	WOS:000232181900046
J	Riedner, G; Rusizoka, M; Todd, J; Maboko, L; Hoelscher, M; Mmbando, D; Samky, E; Lyamuya, E; Mabey, D; Grosskurth, H; Hayes, R				Riedner, G; Rusizoka, M; Todd, J; Maboko, L; Hoelscher, M; Mmbando, D; Samky, E; Lyamuya, E; Mabey, D; Grosskurth, H; Hayes, R			Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TREPONEMA-PALLIDUM; TRIAL; CEFTRIAXONE; INFECTION	BACKGROUND: Pilot studies suggest that a single, 2-g oral dose of azithromycin may be an alternative to a 2.4-MU intramuscular dose of penicillin G benzathine in the prevention and treatment of syphilis. We evaluated the efficacy of treatment with azithromycin in a developing country. METHODS: A total of 328 subjects, 25 with primary and 303 with high-titer (a titer of at least 1:8 on a rapid plasmin reagin [RPR] test) latent syphilis, were recruited through screening of high-risk populations in Mbeya, Tanzania, and randomly assigned to receive 2 g of azithromycin orally (163 subjects) or 2.4 million units of penicillin G benzathine intramuscularly (165 subjects). The primary outcome was treatment efficacy, with cure defined serologically (a decline in the RPR titer of at least two dilutions by nine months after treatment) and, in primary syphilis, by epithelialization of ulcers within one or two weeks. RESULTS: The average age of participants was 27.0 years, 235 (71.6 percent) were female, and 171 (52.1 percent) were seropositive for human immunodeficiency virus. Cure rates were 97.7 percent (95 percent confidence interval, 94.0 to 99.4) in the azithromycin group and 95.0 percent (95 percent confidence interval, 90.6 to 97.8) in the penicillin G benzathine group (95 percent confidence interval for the difference, -1.7 to 7.1 percent), achieving prespecified criteria for equivalence. Cure rates were also similar three and six months after treatment in the two groups and in all subgroups. Cure rates at three months were 59.4 percent (95 percent confidence interval, 51.8 to 67.1) in the azithromycin group and 59.5 percent (95 percent confidence interval, 51.8 to 67.3) in the penicillin G benzathine group and at six months were 85.5 percent (95 percent confidence interval, 79.4 to 90.6) and 81.5 percent (95 percent confidence interval, 74.8 to 87.4), respectively. CONCLUSIONS: Single-dose oral azithromycin is effective in treating syphilis and may be particularly useful in developing countries in which the use of penicillin G benzathine injections is problematic. However, recent reports of azithromycin-resistant Treponema pallidum in the United States indicate the importance of continued monitoring for resistance.	London Sch Hyg & Trop Med, London, England; Reg Med Off, Mbeya, Tanzania; Mbeya Med Res Programme, Mbeya, Tanzania; Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany; Mbeya Consultant Hosp, Mbeya, Tanzania; Muhimbili Univ, Coll Hlth Sci, Dar Es Salaam, Tanzania; Uganda Virus Res Inst, Med Res Council Programme AIDS, Entebbe, Uganda	University of London; London School of Hygiene & Tropical Medicine; University of Munich; Uganda Virus Research Institute	Riedner, G (corresponding author), Adul Razzak Al Sanhouri St,POB 7068, Cairo 11371, Egypt.	riednerg@emro.who.int	Hoelscher, Michael/D-3436-2012	Grosskurth, Heiner/0000-0001-9960-7280; Hayes, Richard/0000-0002-1729-9892; Mabey, David/0000-0002-0031-8276; Todd, Jim/0000-0001-5918-4914	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		HANDSFIELD HH, 1994, SEX TRANSM DIS, V21, P107, DOI 10.1097/00007435-199403000-00010; HART G, 1986, ANN INTERN MED, V104, P368, DOI 10.7326/0003-4819-104-3-368; Hook EW, 1999, ANN INTERN MED, V131, P434, DOI 10.7326/0003-4819-131-6-199909210-00007; Hook EW, 2002, SEX TRANSM DIS, V29, P486, DOI 10.1097/00007435-200208000-00010; HOPKINS S, 1991, AM J MED, V91, pS40, DOI 10.1016/0002-9343(91)90401-I; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; MARTIN DH, 1992, NEW ENGL J MED, V327, P921, DOI 10.1056/NEJM199209243271304; MARTIN DH, 1995, CLIN INFECT DIS, V21, P409, DOI 10.1093/clinids/21.2.409; MUSHER DM, 1990, ANN INTERN MED, V113, P872, DOI 10.7326/0003-4819-113-11-872; Orle KA, 1996, J CLIN MICROBIOL, V34, P49, DOI 10.1128/JCM.34.1.49-54.1996; Parkes R, 2004, INT J STD AIDS, V15, P73, DOI 10.1258/095646204322764253; Rolfs RT, 1997, NEW ENGL J MED, V337, P307, DOI 10.1056/NEJM199707313370504; 2004, MMWR MORB MORTAL WKL, V53, P197	13	173	186	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1236	1244		10.1056/NEJMoa044284	http://dx.doi.org/10.1056/NEJMoa044284			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	966DS	16177249	Green Accepted			2022-12-28	WOS:000232000400007
J	Robinson, JC				Robinson, JC			Health savings accounts - The ownership society in health care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Robinson, JC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA.							DOE J, 2005, AIS REPORT BLUE CROS; Frist WH, 2005, NEW ENGL J MED, V352, P267, DOI 10.1056/NEJMsa045011; RIDDLE C, 2005, COSUMER DRIVEN GUIDE; Robinson JC, 2004, JAMA-J AM MED ASSOC, V291, P1880, DOI 10.1001/jama.291.15.1880; UYOO H, 2005, NUMBERS HSA PLANS EX	5	35	35	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1199	1202		10.1056/NEJMp058097	http://dx.doi.org/10.1056/NEJMp058097			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	966DS	16177245	Green Submitted			2022-12-28	WOS:000232000400002
J	McLellan, F				McLellan, F			Hurricane Katrina: "a speaking sight", or, washday in Durant	LANCET			English	Editorial Material									The Lancet, New York, NY 10010 USA		McLellan, F (corresponding author), The Lancet, New York, NY 10010 USA.			McLellan, Faith/0000-0003-0744-1450				Defoe D., 2004, J PLAGUE YEAR; Loewenberg S, 2005, LANCET, V366, P881, DOI 10.1016/S0140-6736(05)67300-X; *US PUBL HLTH, 2005, LANCET, V366, P867	3	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 17	2005	366	9490					968	969		10.1016/S0140-6736(05)67353-9	http://dx.doi.org/10.1016/S0140-6736(05)67353-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965MZ	16168761				2022-12-28	WOS:000231955900009
J	DeLong, EF; Karl, DM				DeLong, EF; Karl, DM			Genomic perspectives in microbial oceanography	NATURE			English	Review							SURFACE WATERS; SARGASSO SEA; MARINE; SEQUENCE; BACTERIOPLANKTON; OCEAN; BACTERIUM; DIVERSITY; EVOLUTION; COMMUNITY	The global ocean is an integrated living system where energy and matter transformations are governed by interdependent physical, chemical and biotic processes. Although the fundamentals of ocean physics and chemistry are well established, comprehensive approaches to describing and interpreting oceanic microbial diversity and processes are only now emerging. In particular, the application of genomics to problems in microbial oceanography is significantly expanding our understanding of marine microbial evolution, metabolism and ecology. Integration of these new genome-enabled insights into the broader framework of ocean science represents one of the great contemporary challenges for microbial oceanographers.	MIT 48 427, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; MIT 48 427, Div Biol Engn, Cambridge, MA 02139 USA; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Hawaii System	DeLong, EF (corresponding author), MIT 48 427, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.	delong@mit.edu	Karl, David/AFP-3837-2022	Karl, David/0000-0002-6660-6721				Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Doney SC, 2004, FRONT ECOL ENVIRON, V2, P457, DOI 10.2307/3868334; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Hou SB, 2004, P NATL ACAD SCI USA, V101, P18036, DOI 10.1073/pnas.0407638102; JOHNSON PW, 1979, LIMNOL OCEANOGR, V24, P928, DOI 10.4319/lo.1979.24.5.0928; KARL DM, 1994, MICROBIAL ECOL, V28, P147, DOI 10.1007/BF00166802; KARL DM, 1980, MICROBIOL REV, V44, P739, DOI 10.1128/MMBR.44.4.739-796.1980; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; KARL DM, 1979, APPL ENVIRON MICROB, V38, P850, DOI 10.1128/AEM.38.5.850-860.1979; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Paul JH, 2002, COMP BIOCHEM PHYS B, V133, P463, DOI 10.1016/S1096-4959(02)00168-9; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Rabus R, 2004, ENVIRON MICROBIOL, V6, P887, DOI 10.1111/j.1462-2920.2004.00665.x; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Ruby EG, 2005, P NATL ACAD SCI USA, V102, P3004, DOI 10.1073/pnas.0409900102; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Stahl D., 2002, MICROBIAL ECOLOGY GE; STAHL DA, 1984, SCIENCE, V224, P409, DOI 10.1126/science.224.4647.409; Stein JL, 1996, J BACTERIOL, V178, P591, DOI 10.1128/jb.178.3.591-599.1996; Suzuki MT, 2001, AQUAT MICROB ECOL, V24, P117, DOI 10.3354/ame024117; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0; YAYANOS AA, 1981, P NATL ACAD SCI-BIOL, V78, P5212, DOI 10.1073/pnas.78.8.5212	51	189	202	5	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2005	437	7057					336	342		10.1038/nature04157	http://dx.doi.org/10.1038/nature04157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163343				2022-12-28	WOS:000231849100039
J	Fox, KAA; Poole-Wilson, P; Clayton, TC; Henderson, RA; Shaw, TRD; Wheatley, DJ; Knight, R; Pocock, SJ				Fox, KAA; Poole-Wilson, P; Clayton, TC; Henderson, RA; Shaw, TRD; Wheatley, DJ; Knight, R; Pocock, SJ			5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial	LANCET			English	Article							ARTERY-DISEASE; MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; SOCIETY	Background The long-term outcome of an interventional strategy in patients with non-ST-elevation acute coronary syndrome is unknown. We tested whether an interventional strategy (routine angiography followed by revascularisation) was better than a conservative, strategy (ischaemia-driven or symptom-driven angiography) over 5 years' follow-up. Methods in a multicentre randomised trial, 1810 patients (from 45 hospitals in England and Scotland, UK) with non-ST-elevation acute coronary syndrome were randomly assigned to receive an early intervention (n=895) or a conservative strategy (n=915) within 48 h of the index episode of cardiac pain. In each group, the aim was to provide the best medical treatment, and also to undertake coronary arteriography within 72 h in the interventional strategy with subsequent management guided by the angiographic findings. Analysis was by intention to treat and the primary outcome (composite of death or non-fatal myocardial infarction) had masked independent adjudication. RITA 3 has been assigned the International Standard Randomised Control Trial Number ISRCTN07752711. Findings At 1-year follow-up, rates of death or non-fatal myocardial infarction. were similar. However, at a median of 5 years' follow-up (IQR 4.6-5.0), 142 (16.6%) patients with intervention treatment and 178 (20.0%) with conservative treatment died or had non-fatal myocardial infarction (odds ratio 0.78, 95% CI 0.61-0.99, p=0.044), with a similar benefit for cardiovascular death or myocardial infarction (0.74, 0.56-0.97, p=0.030). 234 (102[12%] intervention, 132 [15%] conservative) patients died during follow-up (0.76, 0.58-1.00, p=0.054). The benefits of an intervention strategy were mainly seen in patients at high risk of death or myocardial, infarction (p=0.004), and for the highest risk group, the odds ratio of death or non-fatal myocardial infarction was 0.44 (0.25-0.76). Interpretation In patients with non-ST-elevation acute coronary syndrome, a routine invasive strategy leads to long-term reduction in risk of death or non-fatal myocardial infarction, and this benefit is mainly in high-risk patients. The findings provide support for national and international guidelines in the need for more robust risk stratification in acute coronary syndrome.	Univ Edinburgh, Ctr Cardiovasc Sci, Dept Med & Radiol Sci, Edinburgh EH16 4SB, Midlothian, Scotland; Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Dept Cardiac Med, London, England; Nottingham City Hosp HHS Trust, Nottingham, England; London Sch Hyg & Trop Med, Med Stat Unit, London WC1, England; Western Gen Hosp, Dept Cardiol, Edinburgh EH4 2XU, Midlothian, Scotland; Glasgow Royal Infirm, Dept Cardiac Surg, Glasgow G4 0SF, Lanark, Scotland	University of Edinburgh; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh; University of Glasgow	Fox, KAA (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, Dept Med & Radiol Sci, Edinburgh EH16 4SB, Midlothian, Scotland.	k.a.a.fox@ed.ac.uk	Fox, keith A A/I-3742-2013	Fox, Keith/0000-0002-0140-2752; Clayton, Tim/0000-0002-1266-3288				Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Clayton TC, 2004, EUR HEART J, V25, P1641, DOI 10.1016/j.ehj.2004.07.032; Davies MJ, 2000, HEART, V83, P361, DOI 10.1136/heart.83.3.361; Diderholm E, 2002, AM HEART J, V143, P760, DOI 10.1067/mhj.2002.121733; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Lagerqvist B, 2005, HEART, V91, P1047, DOI 10.1136/hrt.2003.031369; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	14	274	297	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					914	920		10.1016/S0140-6736(05)67222-4	http://dx.doi.org/10.1016/S0140-6736(05)67222-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154018				2022-12-28	WOS:000231770000029
J	Ryan, ND				Ryan, ND			Treatment of depression in. children and adolescents	LANCET			English	Article							STRESSFUL LIFE EVENTS; PLACEBO-CONTROLLED TRIAL; MAJOR DEPRESSION; INTERPERSONAL PSYCHOTHERAPY; DOUBLE-BLIND; ANTIDEPRESSANT MEDICATION; FLUOXETINE TREATMENT; GENETIC ETIOLOGY; MOOD DISORDERS; JUVENILE-ONSET	Depressive disorders during youth occur frequently, are chronic and recurrent, and are associated with significant functional impairment, morbidity, and mortality. Two psychotherapeutic approaches-cognitive behavioural therapy and interpersonal therapy-are each better than wait-list or treatment-as-usual approaches. Several antidepressants have proven efficacious compared with placebo; however, more than half the studies comparing antidepressant treatment with placebo in children and adolescents with depression have not shown any benefit of the active compounds. Suicide rates are decreasing overall in adolescents, and there seems to be a correlation between the use of selective serotonin reuptake inhibitors (SSRIs) and a decrease in completed suicide. However, there was a signal for increase in suicide attempts and suicidal ideation in patients on acute antidepressant treatment when all antidepressants were assessed as a single group. Thus, there is substantial debate about the best approach to treat this serious disorder. Here, we discuss the treatment options for depression in children and adolescents.	Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ryan, ND (corresponding author), Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA.	ryannd@upmc.edu	anand, amit/A-7222-2009					Angold A, 1999, PSYCHOL MED, V29, P1043, DOI 10.1017/S0033291799008946; Angold A, 1998, PSYCHOL MED, V28, P51, DOI 10.1017/S003329179700593X; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1017/S0021963098003448; Birmaher B, 2000, ARCH GEN PSYCHIAT, V57, P29, DOI 10.1001/archpsyc.57.1.29; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; Birmaher B, 2004, J AM ACAD CHILD PSY, V43, P63, DOI 10.1097/00004583-200401000-00015; Birmaher B, 2003, J AM ACAD CHILD PSY, V42, P415, DOI 10.1097/01.CHI.0000037049.04952.9F; Blomhoff S, 2001, BRIT J PSYCHIAT, V179, P23, DOI 10.1192/bjp.179.1.23; Brent DA, 1997, ARCH GEN PSYCHIAT, V54, P877; Carlsten A, 2001, PHARMACOEPIDEM DR S, V10, P525, DOI 10.1002/pds.618; Clarke GN, 2001, ARCH GEN PSYCHIAT, V58, P1127, DOI 10.1001/archpsyc.58.12.1127; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Dubitsky GM, 2004, REV EVALUATION CLIN; EMSLIE G, 2004, AACAP M WASH DC US O; EMSLIE G, 2004, AACAP ANN M WASH DC; Emslie G J, 1998, Depress Anxiety, V7, P32, DOI 10.1002/(SICI)1520-6394(1998)7:1<32::AID-DA4>3.0.CO;2-7; Emslie GJ, 2002, J AM ACAD CHILD PSY, V41, P1205, DOI 10.1097/00004583-200210000-00010; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; Emslie GJ, 2004, J AM ACAD CHILD PSY, V43, P1397, DOI 10.1097/01.chi.0000140453.89323.57; Emslie GJ, 2002, J CHILD ADOL PSYCHOP, V12, P299; EMSLIE GJ, 2000, FLUOXETINE ACUTE TRE; FLAMENT MF, 1985, ARCH GEN PSYCHIAT, V42, P977; FLEMING JE, 1990, J AM ACAD CHILD PSY, V29, P571, DOI 10.1097/00004583-199007000-00010; GELLER B, 1994, J AM ACAD CHILD PSY, V33, P461, DOI 10.1097/00004583-199405000-00003; Glowinski AL, 2003, J CHILD PSYCHOL PSYC, V44, P988, DOI 10.1111/1469-7610.00183; GRAY D, 2003, UTAH YOUTH SUICIDE S; *GSK, 2004, PAR PED AD PAT; HAGNELL O, 1982, PSYCHOL MED, V12, P279, DOI 10.1017/S0033291700046614; Hammad, 2004, REV EVALUATION CLIN; Harrington R, 1998, BRIT J PSYCHIAT, V173, P291, DOI 10.1192/bjp.173.4.291; Harrington R, 1998, J AM ACAD CHILD PSY, V37, P1005; HARRINGTON R, 1990, ARCH GEN PSYCHIAT, V47, P465; HAZELL P, 2000, COCHRANE DB SYST REV, V3; Jaffee SR, 2002, ARCH GEN PSYCHIAT, V59, P215, DOI 10.1001/archpsyc.59.3.215; Judd LL, 2000, ARCH GEN PSYCHIAT, V57, P375, DOI 10.1001/archpsyc.57.4.375; KANN L, 1999, MMWR-MORBID MORTAL W, V49, P1; KAPUR S, 1992, JAMA-J AM MED ASSOC, V268, P3441, DOI 10.1001/jama.268.24.3441; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Kendler KS, 2000, AM J PSYCHIAT, V157, P1243, DOI 10.1176/appi.ajp.157.8.1243; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kendler KS, 2001, AM J PSYCHIAT, V158, P587, DOI 10.1176/appi.ajp.158.4.587; Kessler R C, 1998, Depress Anxiety, V7, P3, DOI 10.1002/(SICI)1520-6394(1998)7:1<3::AID-DA2>3.0.CO;2-F; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; Klein DN, 2001, ARCH GEN PSYCHIAT, V58, P13, DOI 10.1001/archpsyc.58.1.13; KOVACS M, 1984, ARCH GEN PSYCHIAT, V41, P643, DOI 10.1001/archpsyc.1984.01790180013001; KOVACS M, 1994, J PSYCHIATR RES, V28, P319, DOI 10.1016/0022-3956(94)90014-0; KOVACS M, 1984, ARCH GEN PSYCHIAT, V41, P229; Leon AC, 2004, J CLIN PSYCHIAT, V65, P915; Lewinsohn P M, 1998, Depress Anxiety, V7, P47, DOI 10.1002/(SICI)1520-6394(1998)7:1<47::AID-DA6>3.0.CO;2-2; Lewinsohn PM, 1999, CLIN PSYCHOL REV, V19, P329, DOI 10.1016/S0272-7358(98)00055-5; LEWINSOHN PM, 1993, J ABNORM PSYCHOL, V102, P110, DOI 10.1037/0021-843X.102.1.110; Lewinsohn PM, 1998, CLIN PSYCHOL REV, V18, P765, DOI 10.1016/S0272-7358(98)00010-5; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; MASAND P, 1991, NEW ENGL J MED, V324, P420; MILIN R, 1999, AACAP ANN M CHIC US; MONTGOMERY SA, 1995, EUR NEUROPSYCHOPHARM, V5, P5, DOI 10.1016/0924-977X(94)00131-T; Mufson L, 1996, J AM ACAD CHILD PSY, V35, P1145, DOI 10.1097/00004583-199609000-00012; Mufson L, 2004, ARCH GEN PSYCHIAT, V61, P577, DOI 10.1001/archpsyc.61.6.577; Mufson L, 1999, ARCH GEN PSYCHIAT, V56, P573, DOI 10.1001/archpsyc.56.6.573; Mufson Laura, 2004, American Journal of Psychotherapy, V58, P220; Neuman RJ, 1997, J AM ACAD CHILD PSY, V36, P466, DOI 10.1097/00004583-199704000-00008; Ohberg A, 1998, J AFFECT DISORDERS, V50, P225, DOI 10.1016/S0165-0327(98)00114-1; Olfson M, 2003, ARCH GEN PSYCHIAT, V60, P978, DOI 10.1001/archpsyc.60.9.978; POST RM, 1992, AM J PSYCHIAT, V149, P999; PUIGANTICH J, 1985, ARCH GEN PSYCHIAT, V42, P511; PUIGANTICH J, 1985, ARCH GEN PSYCHIAT, V42, P500, DOI 10.1001/archpsyc.1985.01790280082008; PUIGANTICH J, 1993, J AM ACAD CHILD PSY, V32, P244, DOI 10.1097/00004583-199303000-00003; PUIGANTICH J, 1989, ARCH GEN PSYCHIAT, V46, P406; RAO U, 1995, J AM ACAD CHILD PSY, V34, P566, DOI 10.1097/00004583-199505000-00009; Rice F, 2003, J CHILD PSYCHOL PSYC, V44, P977, DOI 10.1111/1469-7610.00182; Rice F, 2002, J CHILD PSYCHOL PSYC, V43, P65, DOI 10.1111/1469-7610.00004; Rossello J, 1999, J CONSULT CLIN PSYCH, V67, P734, DOI 10.1037/0022-006X.67.5.734; RYAN ND, 1992, J AM ACAD CHILD PSY, V31, P600, DOI 10.1097/00004583-199207000-00004; Ryan ND, 2003, INT J METH PSYCH RES, V12, P44, DOI 10.1002/mpr.141; Shaffer D, 1999, J CLIN PSYCHIAT, V60, P70; Silberg J, 1999, ARCH GEN PSYCHIAT, V56, P225, DOI 10.1001/archpsyc.56.3.225; SIMEON JG, 1990, PROG NEURO-PSYCHOPH, V14, P791, DOI 10.1016/0278-5846(90)90050-Q; TEICHER MH, 1990, AM J PSYCHIAT, V147, P207; THAPAR A, 1994, BRIT J PSYCHIAT, V165, P259, DOI 10.1192/bjp.165.2.259; Thapar A, 1996, DEV PSYCHOPATHOL, V8, P751, DOI 10.1017/S0954579400007409; Thapar A, 1998, J CHILD PSYCHOL PSYC, V39, P1153, DOI 10.1017/S0021963098003229; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; WAGNER K, 2004, AACAP M WASH DC US O; Wagner KD, 2004, AM J PSYCHIAT, V161, P1079, DOI 10.1176/appi.ajp.161.6.1079; Wagner KD, 2003, JAMA-J AM MED ASSOC, V290, P1033, DOI 10.1001/jama.290.8.1033; Walkup JT, 2001, NEW ENGL J MED, V344, P1279, DOI 10.1056/NEJM200104263441703; Weissman MM, 1999, ARCH GEN PSYCHIAT, V56, P794, DOI 10.1001/archpsyc.56.9.794; WEISSMAN MM, 1984, ARCH GEN PSYCHIAT, V41, P1136; Weissman MM, 1999, JAMA-J AM MED ASSOC, V281, P1707, DOI 10.1001/jama.281.18.1707; Weissman MM, 2002, ARCH GEN PSYCHIAT, V59, P223, DOI 10.1001/archpsyc.59.3.223; WILLIAMSON DE, 1995, J AM ACAD CHILD PSY, V34, P1596, DOI 10.1097/00004583-199512000-00010	91	116	120	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					933	940		10.1016/S0140-6736(05)67321-7	http://dx.doi.org/10.1016/S0140-6736(05)67321-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	962YR	16154022				2022-12-28	WOS:000231770000033
J	Wysocka, J; Milne, TA; Allis, CD				Wysocka, J; Milne, TA; Allis, CD			Taking LSD1 to a new high	CELL			English	Editorial Material							METHYLTRANSFERASES; CANCER	Histone modifications mediate changes in gene expression by altering the underlying chromatin structure or by serving as a binding platform to recruit other proteins. One such modification, histone methylation, was thought to be irreversible until last year when Shi and coworkers broke new ground with their discovery of a lysine-specific histone demethylase (LSD1). They showed that LSD1, a nuclear amine oxidase homolog, is a bona fide histone H3 lysine 4 demethylase (Shi et al., 2004). Now, a new study from Shi et al. (2005) published in a recent issue of Molecular Cell, together with two studies recently published by Metzger et al. (2005) and Lee et al. (2005) in Nature, reveal that LSD1's specificity and activity is in fact regulated by associated protein cofactors.	Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA	Rockefeller University	Wysocka, J (corresponding author), Rockefeller Univ, Lab Chromatin Biol, 1230 York Ave, New York, NY 10021 USA.		Milne, Tom/E-1872-2016	Milne, Tom/0000-0002-0413-4271				Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Grant PA, 1999, SEMIN CELL DEV BIOL, V10, P169, DOI 10.1006/scdb.1999.0298; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; LEE MG, 2005, IN PRESS NATURE; METZGER E, 2005, IN PRESS NATURE; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; SHI Y, 2005, IN PRESS MOL CELL, V19; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Yu JJ, 2003, EMBO J, V22, P3403, DOI 10.1093/emboj/cdg326	12	33	38	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 9	2005	122	5					654	658		10.1016/j.cell.2005.08.022	http://dx.doi.org/10.1016/j.cell.2005.08.022			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143099	Bronze			2022-12-28	WOS:000231844300006
J	Moore, MJ				Moore, MJ			From birth to death: The complex lives of eukaryotic mRNAs	SCIENCE			English	Review							PROCESSING BODIES; GENE-EXPRESSION; NUCLEAR EXPORT; PROTEINS; LOCALIZATION; DECAY; MRNP; RECOGNITION; TRANSLATION; YEAST	Recent work indicates that the posttranscriptional control of eukaryotic gene expression is much more elaborate and extensive than previously thought, with essentially every step of messenger RNA (mRNA) metabolism being subject to regulation in an mRNA-specific manner. Thus, a comprehensive understanding of eukaryotic gene expression requires an appreciation for how the lives of mRNAs are influenced by a wide array of diverse regulatory mechanisms.	Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute	Moore, MJ (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, 415 South St, Waltham, MA 02454 USA.	mmoore@brandeis.edu						Abruzzi KC, 2004, EMBO J, V23, P2620, DOI 10.1038/sj.emboj.7600261; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Anderson P, 2002, J CELL SCI, V115, P3227; Condeelis J, 2005, BIOL CELL, V97, P97; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Daneholt B, 2001, CHROMOSOMA, V110, P173, DOI 10.1007/s004120000127; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gonsalvez GB, 2005, BIOL CELL, V97, P75; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; HUTVAGNER G, 2005, SCIENCE, V309, P1518; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Maquat LE, 2002, SCIENCE, V295, P2221, DOI 10.1126/science.1071285; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Messias AC, 2004, ACCOUNTS CHEM RES, V37, P279, DOI 10.1021/ar030034m; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; STONTHEIMER EJ, 2005, CELL, V122, P9; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhao J, 2002, EMBO J, V21, P1177, DOI 10.1093/emboj/21.5.1177	44	762	789	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1514	1518		10.1126/science.1111443	http://dx.doi.org/10.1126/science.1111443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141059				2022-12-28	WOS:000231715000035
J	Cheng, Z; Ventura, M; She, XW; Khaitovich, P; Graves, T; Osoegawa, K; Church, D; DeJong, P; Wilson, RK; Paabo, S; Rocchi, M; Eichler, EE				Cheng, Z; Ventura, M; She, XW; Khaitovich, P; Graves, T; Osoegawa, K; Church, D; DeJong, P; Wilson, RK; Paabo, S; Rocchi, M; Eichler, EE			A genome-wide comparison of recent chimpanzee and human segmental duplications	NATURE			English	Article							HUMAN-CHROMOSOMES; GENE FAMILY; EVOLUTION; REGIONS; REARRANGEMENTS; SELECTION; PATTERNS; SEQUENCE; LINEAGE; MOUSE	We present a global comparison of differences in content of segmental duplication between human and chimpanzee, and determine that 33% of human duplications (>94% sequence identity) are not duplicated in chimpanzee, including some human disease-causing duplications. Combining experimental and computational approaches, we estimate a genomic duplication rate of 4 - 5 megabases per million years since divergence. These changes have resulted in gene expression differences between the species. In terms of numbers of base pairs affected, we determine that de novo duplication has contributed most significantly to differences between the species, followed by deletion of ancestral duplications. Post-speciation gene conversion accounts for less than 10% of recent segmental duplication. Chimpanzee-specific hyperexpansion (. 100 copies) of particular segments of DNA have resulted in marked quantitative differences and alterations in the genome landscape between chimpanzee and human. Almost all of the most extreme differences relate to changes in chromosome structure, including the emergence of African great ape subterminal heterochromatin. Nevertheless, base per base, large segmental duplication events have had a greater impact (2.7%) in altering the genomic landscape of these two species than single-base-pair substitution (1.2%).	Univ Washington, Sch Med, Dept Genome Sci, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Bari, Dept Genet & Microbiol, I-70126 Bari, Italy; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Washington Univ, Sch Med, St Louis, MO 63108 USA; Childrens Hosp Oakland, Res Inst, BACPAC Resources, Oakland, CA 94609 USA; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Universita degli Studi di Bari Aldo Moro; Max Planck Society; Washington University (WUSTL); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Howard Hughes Med Inst, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Ventura, Mario/E-6420-2011; Wilson, Richard K./AAF-4139-2019; Khaitovich, Philipp/HGC-8520-2022	Ventura, Mario/0000-0001-7762-8777; Wilson, Richard K./0000-0002-1992-1358; Rocchi, Mariano/0000-0002-9451-5616	NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Armengol L, 2003, HUM MOL GENET, V12, P2201, DOI 10.1093/hmg/ddg223; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Courseaux A, 2001, SCIENCE, V291, P1293, DOI 10.1126/science.1057284; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Fan Y, 2002, GENOME RES, V12, P1651, DOI 10.1101/gr.337602; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; KHAITOVICH P, IN PRESS SCIENCE; ROYLE NJ, 1994, NAT GENET, V6, P52, DOI 10.1038/ng0194-52; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Tuzun E, 2004, GENOME RES, V14, P493, DOI 10.1101/gr.1907504; Ventura M, 2003, GENOME RES, V13, P2059, DOI 10.1101/gr.1155103; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zhang LQ, 2005, MOL BIOL EVOL, V22, P135, DOI 10.1093/molbev/msh262	30	281	301	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					88	93		10.1038/nature04000	http://dx.doi.org/10.1038/nature04000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136132				2022-12-28	WOS:000231560400046
J	Corbit, KC; Aanstad, P; Singla, V; Norman, AR; Stainier, DYR; Reiter, JF				Corbit, KC; Aanstad, P; Singla, V; Norman, AR; Stainier, DYR; Reiter, JF			Vertebrate Smoothened functions at the primary cilium	NATURE			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; INTRAFLAGELLAR TRANSPORT PROTEINS; OLFACTORY CILIA; NEURONAL CILIA; LOCALIZATION; DROSOPHILA; BETA-ARRESTIN-2; CYCLOPAMINE; INHIBITION; RECEPTORS	The unanticipated involvement of several intraflagellar transport proteins in the mammalian Hedgehog (Hh) pathway has hinted at a functional connection between cilia and Hh signal transduction(1,2). Here we show that mammalian Smoothened (Smo), a seven-transmembrane protein essential for Hh signalling(3), is expressed on the primary cilium. This ciliary expression is regulated by Hh pathway activity; Sonic hedgehog or activating mutations in Smo promote ciliary localization, whereas the Smo antagonist cyclopamine inhibits ciliary localization. The translocation of Smo to primary cilia depends upon a conserved hydrophobic and basic residue sequence homologous to a domain previously shown to be required for the ciliary localization of seven-transmembrane proteins in Caenorhabditis elegans(4). Mutation of this domain not only prevents ciliary localization but also eliminates Smo activity both in cultured cells and in zebrafish embryos. Thus, Hh-dependent translocation to cilia is essential for Smo activity, suggesting that Smo acts at the primary cilium.	Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reiter, JF (corresponding author), Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA.	jreiter@diabetes.ucsf.edu		Aanstad, Pia/0000-0003-3893-2973; Singla, Veena/0000-0002-5107-0717; Stainier, Didier/0000-0002-0382-0026				Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen WB, 2001, DEVELOPMENT, V128, P2385; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Salisbury JL, 2004, CURR BIOL, V14, pR765, DOI 10.1016/j.cub.2004.09.016; SULIK K, 1994, DEV DYNAM, V201, P260, DOI 10.1002/aja.1002010309; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; TAKEMOTO DJ, 1990, CELL SIGNAL, V2, P99, DOI 10.1016/0898-6568(90)90013-Z; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	29	1045	1075	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2005	437	7061					1018	1021		10.1038/nature04117	http://dx.doi.org/10.1038/nature04117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16136078				2022-12-28	WOS:000232496100044
J	Cecconi, C; Shank, EA; Bustamante, C; Marqusee, S				Cecconi, C; Shank, EA; Bustamante, C; Marqusee, S			Direct observation of the three-state folding of a single protein molecule	SCIENCE			English	Article							RIBONUCLEASE-H; MOLTEN GLOBULE; RNASE-H; FORCE; KINETICS; COOPERATIVITY; INTERMEDIATE; SPECTROSCOPY; EQUILIBRIUM; UBIQUITIN	We used force-measuring optical tweezers to induce complete mechanical unfolding and refolding of individual Escherichia-coli ribonuclease H (RNase H) molecules. The protein unfolds in a two-state manner and refolds through an intermediate that correlates with the transient molten globule-like intermediate observed in bulk studies. This intermediate displays unusual mechanical compliance and unfolds at substantially lower forces than the native state. In a narrow range of forces, the molecule hops between the unfolded and intermediate states in real time. Occasionally, hopping was observed to stop as the molecule crossed the folding barrier directly from the intermediate, demonstrating that the intermediate is on-pathway. These studies allow us to map the energy landscape of RNase H.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Inst Quantitat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu; marqusee@berkeley.edu	Cecconi, Ciro/K-5028-2016; Shank, Elizabeth A./AAV-9050-2021	Cecconi, Ciro/0000-0002-6101-2609; Shank, Elizabeth A./0000-0002-4804-1966; Bustamante, Carlos/0000-0002-2970-0073	NIGMS NIH HHS [GM50945, GM32543, GM008295] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050945, R37GM032543, R01GM050945, R01GM032543] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Chamberlain AK, 1996, NAT STRUCT BIOL, V3, P782, DOI 10.1038/nsb0996-782; Chan HS, 1998, PROTEINS, V30, P2, DOI 10.1002/(SICI)1097-0134(19980101)30:1<2::AID-PROT2>3.0.CO;2-R; DABORA JM, 1994, PROTEIN SCI, V3, P1401, DOI 10.1002/pro.5560030906; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kellermayer MSZ, 1998, J STRUCT BIOL, V122, P197, DOI 10.1006/jsbi.1998.3988; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.3.CO;2-D; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Parker MJ, 1999, J MOL BIOL, V293, P1195, DOI 10.1006/jmbi.1999.3204; Raschke TM, 1999, NAT STRUCT BIOL, V6, P825; Raschke TM, 1997, NAT STRUCT BIOL, V4, P298, DOI 10.1038/nsb0497-298; Rhoades E, 2004, J AM CHEM SOC, V126, P14686, DOI 10.1021/ja046209k; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Roder H, 1997, CURR OPIN STRUC BIOL, V7, P15, DOI 10.1016/S0959-440X(97)80004-8; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Spudich GM, 2004, J MOL BIOL, V335, P609, DOI 10.1016/j.jmb.2003.10.052; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1	27	473	485	1	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2057	2060		10.1126/science.1116702	http://dx.doi.org/10.1126/science.1116702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179479				2022-12-28	WOS:000232181900051
J	O'Doherty, A; Ruf, S; Mulligan, C; Hildreth, V; Errington, ML; Cooke, S; Sesay, A; Modino, S; Vanes, L; Hernandez, D; Linehan, JM; Sharpe, PT; Brandner, S; Bliss, TVP; Henderson, DJ; Nizetic, D; Tybulewicz, VLJ; Fisher, EMC				O'Doherty, A; Ruf, S; Mulligan, C; Hildreth, V; Errington, ML; Cooke, S; Sesay, A; Modino, S; Vanes, L; Hernandez, D; Linehan, JM; Sharpe, PT; Brandner, S; Bliss, TVP; Henderson, DJ; Nizetic, D; Tybulewicz, VLJ; Fisher, EMC			An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes	SCIENCE			English	Article							LONG-TERM POTENTIATION; HUMAN-CHROMOSOME FRAGMENTS; TS65DN MOUSE; GERMLINE TRANSMISSION; CEREBELLAR PHENOTYPES; RECOGNITION MEMORY; CHIMERIC MICE; MODEL; HIPPOCAMPUS; TRISOMY	Aneuploidies are common chromosomal defects that result in growth and developmental deficits and high levels of lethality in humans'. To gain insight into the biology of aneuploidies, we manipulated mouse embryonic stem cells and generated a trans-species aneuploid mouse line that stably transmits a freely segregating, almost complete human chromosome 21 (Hsa21). This "'transchromosomic" mouse line, TO, is a model of trisomy 21, which manifests as Down syndrome (DS) in humans, and has phenotypic alterations in behavior, synaptic plasticity, cerebellar neuronal number, heart development, and mandible size that relate to human DS. Transchromosomic mouse lines such as Tc1 may represent useful genetic tools for dissecting other human aneupioidies.	Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; Natl Inst Med Res, London NW7 1AA, England; Queen Marys Sch Med, Barts & London, Inst Cell & Mol Sci, Ctr Haematol, London E1 2AT, England; Newcastle Univ, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Guys Hosp, Univ London Kings Coll, Dept Craniofacial Dev, London SE1 9RT, England	University of London; University College London; University of London; University College London; MRC National Institute for Medical Research; University of London; Queen Mary University London; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Tybulewicz, VLJ (corresponding author), Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England.	vtybule@nimr.mrc.ac.uk; e.fisher@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014; Fisher, Elizabeth MC/C-2168-2008; Hernandez, Diana/AAE-4613-2021; Nizetic, Dean/F-9509-2015	Brandner, Sebastian/0000-0002-9821-0342; Fisher, Elizabeth MC/0000-0003-2850-9936; cooke, samuel/0000-0002-4876-6502; Tybulewicz, Victor/0000-0003-2439-0798; Hernandez, Diana/0000-0002-1353-2175; Sharpe, Paul/0000-0003-2116-9561; Nizetic, Dean/0000-0001-5486-5761; Henderson, Deborah/0000-0002-2705-5998	Medical Research Council [MC_U117512674] Funding Source: Medline; Wellcome Trust [076700] Funding Source: Medline; MRC [MC_U117512674] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Aylward EH, 1997, ARCH NEUROL-CHICAGO, V54, P209, DOI 10.1001/archneur.1997.00550140077016; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Chrast R, 2000, HUM MOL GENET, V9, P1853, DOI 10.1093/hmg/9.12.1853; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Devlin L, 2004, ARCH DIS CHILD, V89, P1177, DOI 10.1136/adc.2003.031765; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hernandez D, 1999, TRENDS GENET, V15, P241, DOI 10.1016/S0168-9525(99)01743-6; Hernandez D, 1999, HUM MOL GENET, V8, P923, DOI 10.1093/hmg/8.5.923; Hsu LYF, 1998, GENETIC DISORDERS FE, V4th, P179; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P529, DOI 10.1001/archneur.1990.00530050049011; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kazuki Y, 2001, J HUM GENET, V46, P600, DOI 10.1007/s100380170028; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Maslen CL, 2004, CURR OPIN CARDIOL, V19, P205, DOI 10.1097/00001573-200405000-00003; Nelson DL, 2004, SCIENCE, V306, P619, DOI 10.1126/science.1105226; Olson LE, 2004, DEV DYNAM, V230, P581, DOI 10.1002/dvdy.20079; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; RAZ N, 1995, NEUROLOGY, V45, P356, DOI 10.1212/WNL.45.2.356; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Scotese I, 1998, PEDIATR RES, V44, P252, DOI 10.1203/00006450-199808000-00019; Shinohara T, 2001, HUM MOL GENET, V10, P1163, DOI 10.1093/hmg/10.11.1163; Shinohara T, 2000, CHROMOSOME RES, V8, P713, DOI 10.1023/A:1026741321193; Siarey RJ, 1997, NEUROPHARMACOLOGY, V36, P1549, DOI 10.1016/S0028-3908(97)00157-3; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Tomizuka K, 2000, P NATL ACAD SCI USA, V97, P722, DOI 10.1073/pnas.97.2.722; Voss AK, 1997, EXP CELL RES, V230, P45, DOI 10.1006/excr.1996.3418; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227	39	309	316	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2033	2037		10.1126/science.1114535	http://dx.doi.org/10.1126/science.1114535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179473	Green Accepted			2022-12-28	WOS:000232181900043
J	Feigin, RD				Feigin, RD			Prospects for the future of child health through research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENE-THERAPY; AUTISM; ADOLESCENTS; ORIGINS; OBESITY	Improvements in child health through research will be made at an increasingly accelerated pace during the post-genomic era. Advances made possible through genomics, proteomics, and the application of nanosystem technology, coupled with a greater understanding of the influence of the environment on human genes, will enhance our ability to prevent, modify, or cure numerous childhood disorders. This article reviews some of the more pressing and important causes of morbidity and mortality in children, discusses the manner in which some of the newer technologies may be applied to investigations of these disorders, and offers predictions concerning the effect that new discoveries may have in ameliorating the morbid consequences of childhood diseases. The need to design and implement prospective long-term studies to determine the most effective ways to reduce the burden of preventable problems, which are rooted in societal issues (child abuse, alcoholism, drug abuse, and homicide) is highlighted. Physician-scientists also must address the ethical, political, and social questions already raised by recent advances in medicine.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Feigin, RD (corresponding author), Baylor Coll Med, Dept Pediat, 1 Baylor Plaza, Houston, TX 77030 USA.	rfeigin@bcm.tmc.edu						Aygun AD, 2005, MEDIAT INFLAMM, P180, DOI 10.1155/MI.2005.180; BARKER DJP, 1993, ACTA PAEDIATR, V82, P93, DOI 10.1111/j.1651-2227.1993.tb12938.x; Barker DJP, 1998, MOTHERS BABIES HLTH; Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Chen YC, 2004, P NATL ACAD SCI USA, V101, P15782, DOI 10.1073/pnas.0403975101; *COMM AUSTR, NHMRC CLIN PRACT GUI; Flodmark CE, 2004, INT J OBESITY, V28, P1189, DOI 10.1038/sj.ijo.0802787; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Galbiati S, 2005, HUM GENET, V117, P243, DOI 10.1007/s00439-005-1330-z; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gottschalk S, 2001, BLOOD, V97, P835, DOI 10.1182/blood.V97.4.835; GUNNELL D, IN PRESS PEDIATRICS; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Halaz A, 2003, ALLERGY ASTHMA PROC, V24, P111; Inge TH, 2004, PEDIATRICS, V114, P217, DOI 10.1542/peds.114.1.217; Jiang YH, 2004, AM J MED GENET A, V131A, P1, DOI 10.1002/ajmg.a.30297; Jobe AH, 1998, AM J OBSTET GYNECOL, V178, P880, DOI 10.1016/S0002-9378(98)70518-6; Kahn RS, 2003, J PEDIATR-US, V143, P104, DOI 10.1016/S0022-3476(03)00208-7; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Lobstein T., 2004, OBES REV S1, V5, P4, DOI [https://doi.org/10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; *NAT HUM GEN RES I, COMPR GEN AN CANC RE; Nathan DG, 2001, JAMA-J AM MED ASSOC, V285, P533, DOI 10.1001/jama.285.5.533; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Peggs KS, 2002, BLOOD, V99, P4642, DOI 10.1182/blood.V99.12.4642; Peters C, 2003, BONE MARROW TRANSPL, V31, P229, DOI 10.1038/sj.bmt.1703839; Rinaldo P, 2004, CURR OPIN PEDIATR, V16, P427, DOI 10.1097/01.mop.0000133635.79661.84; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; Tempany CMC, 2001, JAMA-J AM MED ASSOC, V285, P562, DOI 10.1001/jama.285.5.562; Wang GJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e81; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weinreb L, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e41; Weissleder R, 1999, RADIOLOGY, V212, P609, DOI 10.1148/radiology.212.3.r99se18609; *WHO, 2000, ANN 6 ROLL BACK MAL; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	42	8	8	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1373	1379		10.1001/jama.294.11.1373	http://dx.doi.org/10.1001/jama.294.11.1373			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174696				2022-12-28	WOS:000231987800011
J	Brooks, WA; Santosham, M; Naheed, A; Goswami, D; Wahed, MA; Diener-West, M; Faruque, ASG; Black, RE				Brooks, WA; Santosham, M; Naheed, A; Goswami, D; Wahed, MA; Diener-West, M; Faruque, ASG; Black, RE			Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial	LANCET			English	Article							DEVELOPING-COUNTRIES; DOUBLE-BLIND; RESPIRATORY-INFECTIONS; POOLED ANALYSIS; OTITIS-MEDIA; MORBIDITY; MORTALITY; INFANTS; GROWTH; DEATHS	Background Pneumonia and diarrhoea cause much morbidity and mortality in children younger than 5 years. Most deaths occur during infancy and in developing countries. Daily regimens of zinc have been reported to prevent acute lower respiratory tract infection and diarrhoea, and to reduce child mortality. We aimed to examine whether giving zinc weekly could prevent clinical pneumonia and diarrhoea in children younger than 2 years. Methods 1665 poor, urban children aged 60 days to 12 months were randomly assigned zinc (70 mg) or placebo orally once weekly for 12 months. Children were assessed every week by field research assistants. Our primary outcomes were the rate of pneumonia and diarrhoea. The rates of other respiratory tract infections were the secondary outcomes. Growth, final serum copper, and final haemoglobin were also measured. Analysis was by intention to treat. Findings 34 children were excluded before random assignment to treatment group because they had tuberculosis. 809 children were assigned zinc, and 812 placebo. After treatment assignment, 103 children in the treatment group and 44 in the control group withdrew. There were significantly fewer incidents of pneumonia in the zinc group than the control group (199 vs 286; relative risk 0.83, 95% CI 0.73-0.95), and a small but significant effect on incidence of diarrhoea (1881 cases vs 2407; 0.94, 0.88-0.99). There were two deaths in the zinc group and 14 in the placebo group (p=0.013). There were no pneumonia-related deaths in the zinc group, but ten in the placebo group (p=0.013). The zinc group had a small gain in height, but not weight at 10 months compared with the placebo group. Serum copper and haemoglobin concentrations were not adversely affected after 10 months of zinc supplementation. Interpretation 70 mg of zinc weekly reduces pneumonia and mortality in young children. However, compliance with weekly intake might be problematic outside a research programme.	Int Ctr Diarrhoeal Dis Res, Ctr Hlth & Populat Res, Mohakhali Dhaka 1000, Bangladesh; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Johns Hopkins Univ, Dept Biostat, Baltimore, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Brooks, WA (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Hlth & Populat Res, Mohakhali Dhaka 1000, Bangladesh.	abrooks@icddrb.org	A, Naheed/AHB-2941-2022; Brooks, W. Abdullah/AAD-3876-2021; A, Naheed/AHB-2940-2022	A, Naheed/0000-0002-6016-5603; Brooks, W. Abdullah/0000-0001-9871-5546; A, Naheed/0000-0002-6016-5603; Black, Robert/0000-0001-9926-7984				[Anonymous], 2000, MAN CHILD SER INF SE, P162; Attallah M S, 1996, Otolaryngol Pol, V50, P145; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Baqui AH, 2003, J NUTR, V133, P4150, DOI 10.1093/jn/133.12.4150; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; BERMAN S, 1995, PEDIATRICS, V96, P126; Bhandari N, 2002, BRIT MED J, V324, P1358, DOI 10.1136/bmj.324.7350.1358; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Black RE, 2001, BRIT J NUTR, V85, pS125, DOI 10.1079/BJN2000304; Brooks WA, 2004, LANCET, V363, P1683, DOI 10.1016/S0140-6736(04)16252-1; BROOKS WA, IN PRESS AM J CLIN N; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; Brown KH, 1998, BIBL NUTR DIET, P76; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; FESTA MD, 1985, AM J CLIN NUTR, V41, P285, DOI 10.1093/ajcn/41.2.285; FOSMIRE GJ, 1990, AM J CLIN NUTR, V51, P225, DOI 10.1093/ajcn/51.2.225; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; HATCHER J, 1995, INT J PEDIATR OTORHI, V33, P197, DOI 10.1016/0165-5876(95)01209-5; Ledwith M, 2001, CURR OPIN PEDIATR, V13, P70, DOI 10.1097/00008480-200102000-00013; Ninh NX, 1996, AM J CLIN NUTR, V63, P514, DOI 10.1093/ajcn/63.4.514; ROSADO JL, 1995, FASEB J, V9, P157; Roy SK, 1997, ARCH DIS CHILD, V77, P196, DOI 10.1136/adc.77.3.196; Rutka J, 1998, J OTOLARYNGOL, V27, P43; Sazawal S, 1998, PEDIATRICS, V102, P1, DOI 10.1542/peds.102.1.1; Sazawal S, 2001, PEDIATRICS, V108, P1280, DOI 10.1542/peds.108.6.1280; Smith A, 1992, Afr Health, V15, P33; Smith AW, 1996, LANCET, V348, P1128, DOI 10.1016/S0140-6736(96)09388-9; *STATACORP, 2003, STAT STAT SOFTW REL; *UNICEF WHO, 2004, WHO UNICEF JOINT STA, P1; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0	31	174	178	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					999	1004		10.1016/S0140-6736(05)67109-7	http://dx.doi.org/10.1016/S0140-6736(05)67109-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168782				2022-12-28	WOS:000231955900035
J	Mancoff, FB; Rizzo, ND; Engel, BN; Tehrani, S				Mancoff, FB; Rizzo, ND; Engel, BN; Tehrani, S			Phase-locking in double-point-contact spin-transfer devices	NATURE			English	Article							INDUCED MAGNETIZATION REVERSAL; POLARIZED CURRENT; TUNNEL-JUNCTIONS; CO/CU/CO PILLARS; DRIVEN; NANOMAGNET; DEPENDENCE; VALVE	Spin-transfer(1,2) in nanometre-scale magnetic devices results from the torque on a ferromagnet owing to its interaction with a spin-polarized current and the electrons' spin angular momentum. Experiments have detected either a reversal(3-16) or high-frequency (GHz) steady-state precession(17-23) of the magnetization in giant magnetoresistance spin valves and magnetic tunnel junctions with current densities of more than 10(7) A cm(-2). Spin-transfer devices may enable high-density, low-power magnetic random access memory(24,25) or direct-current-driven nanometre-sized microwave oscillators. Here we show that the magnetization oscillations induced by spin-transfer in two 80-nm-diameter giant-magneto-resistance point contacts in close proximity to each other can phase-lock into a single resonance over a frequency range from approximately < 10 to > 24 GHz for contact spacings of less than about similar to 200 nm. The output power from these contact pairs with small spacing is approximately twice the total power from more widely spaced (similar to 400 nm and greater) contact pairs that undergo separate resonances, indicating that the closely spaced pairs are phase-locked with zero phase shift. Phase-locking may enable control of large arrays of coupled spin-transfer devices with increased power output for microwave oscillator applications.	Freescale Semicond Inc, Technol Solut Org, Chandler, AZ 85224 USA	NXP Semiconductors; Freescale Semiconductor	Mancoff, FB (corresponding author), Freescale Semicond Inc, Technol Solut Org, Chandler, AZ 85224 USA.	fred.mancoff@freescale.com						Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Chen TY, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.026601; Covington M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.184406; Engel BN, 2005, IEEE T MAGN, V41, P132, DOI 10.1109/TMAG.2004.840847; Grollier J, 2001, APPL PHYS LETT, V78, P3663, DOI 10.1063/1.1374230; Huai YM, 2004, APPL PHYS LETT, V84, P3118, DOI 10.1063/1.1707228; Jiang Y, 2004, NAT MATER, V3, P361, DOI 10.1038/nmat1120; Katine JA, 2000, PHYS REV LETT, V84, P3149, DOI 10.1103/PhysRevLett.84.3149; Kiselev SI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036601; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; Krivorotov IN, 2005, SCIENCE, V307, P228, DOI 10.1126/science.1105722; Lacour D, 2004, APPL PHYS LETT, V85, P4681, DOI 10.1063/1.1819516; Lee KJ, 2004, J APPL PHYS, V95, P7423, DOI 10.1063/1.1682872; Mancoff FB, 2003, APPL PHYS LETT, V83, P1596, DOI 10.1063/1.1604936; Myers EB, 1999, SCIENCE, V285, P867, DOI 10.1126/science.285.5429.867; Ozyilmaz B, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.067203; Parkin SSP, 1999, J APPL PHYS, V85, P5828, DOI 10.1063/1.369932; Rippard WH, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.100406; Russek SE, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.104425; SLONCZEWSKI JC, 1996, J MAGN MAGN MATER, V159, P1; Sun JZ, 2002, APPL PHYS LETT, V81, P2202, DOI 10.1063/1.1506794; Tsoi M, 2000, NATURE, V406, P46, DOI 10.1038/35017512; Urazhdin S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.146803; Wegrowe JE, 1999, EUROPHYS LETT, V45, P626, DOI 10.1209/epl/i1999-00213-1; Yagami K, 2004, APPL PHYS LETT, V85, P5634, DOI 10.1063/1.1829140	26	419	447	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2005	437	7057					393	395		10.1038/nature04036	http://dx.doi.org/10.1038/nature04036			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163352				2022-12-28	WOS:000231849100049
J	Asplin, BR; Rhodes, KV; Levy, H; Lurie, N; Crain, AL; Carlin, BP; Kellermann, AL				Asplin, BR; Rhodes, KV; Levy, H; Lurie, N; Crain, AL; Carlin, BP; Kellermann, AL			Insurance status and access to urgent ambulatory care follow-up appointments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY; MEDICAID	Context There is growing pressure to avoid hospitalizing emergency department patients who can be treated safely as outpatients, but this strategy depends on timely access to follow-up care. Objective To determine the association between reported insurance status and access to follow-up appointments for serious conditions that are commonly identified during an emergency department visit. Design, Setting, and Participants Eight research assistants called 499 randomly selected ambulatory clinics in 9 US cities (May 2002-February 2003) and identified themselves as new patients who had been seen in an emergency department and needed an urgent follow-up appointment (within 1 week) for 1 of 3 clinical vignettes (pneumonia, hypertension, or possible ectopic pregnancy). The same person called each clinic twice using the same clinical vignette but different insurance status. Main Outcome Measure Proportion of callers who were offered an appointment within a week. Results Of 499 clinics contacted in the final sample, 430 completed the study protocol. Four hundred six (47.2%) of 860 total callers and 277 (64.4%) of 430 privately insured callers were offered appointments within a week. Callers who claimed to have private insurance were more likely to receive appointments than those who claimed to have Medicaid coverage (63.6% [147/231] vs 34.2% [79/231]; difference, 29.4 percentage points; 95% confidence interval, 21.2-37.6, P<.001). Callers reporting private insurance coverage had higher appointment rates than callers who reported that they were uninsured but offered to pay $20 and arrange payment of the balance (65.3% [130/199] vs 25.1% [50/199]; difference, 40.2; 95% confidence interval, 31.4-49.1; P<.001). There were no differences in appointment rates between callers who claimed to have private insurance coverage and those who reportedly were uninsured but willing to pay cash for the entire visit fee (66.3 % [132/199] vs 62.8% [125/199]; difference, 3.5; 95% confidence interval -3.7 to 10.8; P=.31). The median charge was $100 (range, $25-$600). Seventy-two percent of clinics did not attempt to determine the severity of the caller's condition. Conclusions Reported insurance status is associated with access to timely follow-up ambulatory care for potentially serious conditions. Having private insurance and being willing to pay cash may not eliminate the difficulty in obtaining urgent follow-up appointments.	Reg Hosp, Dept Emergency Med, St Paul, MN 55101 USA; HealthPartners Res Fdn, St Paul, MN USA; Univ Chicago Hosp, Dept Med, Sect Emergency Med, Chicago, IL 60637 USA; Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; RAND Corp, Arlington, VA USA; HealthPartners Res Fdn, Minneapolis, MN USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA	University of Chicago; University of Illinois System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; RAND Corporation; HealthPartners Institute for Education & Research; University of Minnesota System; University of Minnesota Twin Cities; Emory University	Asplin, BR (corresponding author), Reg Hosp, Dept Emergency Med, 640 Jackson St, St Paul, MN 55101 USA.	Brent.R.Asplin@HealthPartners.com			AHRQ HHS [K08-HS13007] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS013007] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], ADV DATA; CURRIE J, 1995, AM ECON REV, V85, P106; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; *I MED COMM CONS U, 2002, CAR COV TO LITTL TOO; Institute of Medicine Committee on the Consequences of Uninsurance, 2002, HLTH INS IS FAM MATT; Institute of Medicine (US) Committee on the Consequences of Uninsurance, 2003, SHAR DEST COMM EFF U; Institute of Medicine (US) Committee on the Consequences of Uninsurance, 2001, COV MATT INS HLTH CA; Johnson LA, 2001, ANN EMERG MED, V37, P495, DOI 10.1067/mem.2001.115173; KELLERMANN AL, 1994, NEW ENGL J MED, V330, P1426; KNAPP RG, 1992, CLIN EPIDEMIOLOGY BI, P116; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1035, DOI 10.1001/jama.289.8.1035; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1042, DOI 10.1001/jama.289.8.1042; Sarver JH, 2002, ACAD EMERG MED, V9, P916, DOI 10.1197/aemj.9.9.916; Skaggs DL, 2001, PEDIATRICS, V107, P1405, DOI 10.1542/peds.107.6.1405; Solberg LI, 2004, AM J MANAG CARE, V10, P717; Weber EJ, 2005, ANN EMERG MED, V45, P4, DOI 10.1016/j.annemergmed.2004.06.023	16	203	203	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2005	294	10					1248	1254		10.1001/jama.294.10.1248	http://dx.doi.org/10.1001/jama.294.10.1248			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963UI	16160133	Bronze			2022-12-28	WOS:000231831200022
J	Leunissen, ME; Christova, CG; Hynninen, AP; Royall, CP; Campbell, AI; Imhof, A; Dijkstra, M; van Roij, R; van Blaaderen, A				Leunissen, ME; Christova, CG; Hynninen, AP; Royall, CP; Campbell, AI; Imhof, A; Dijkstra, M; van Roij, R; van Blaaderen, A			Ionic colloidal crystals of oppositely charged particles	NATURE			English	Article							HARD-SPHERE; MODEL SYSTEM; PHASE; MONODISPERSE; FLUORESCENT; TRANSITION; MIXTURES	Colloidal suspensions are widely used to study processes such as melting, freezing(1-3) and glass transitions(4,5). This is because they display the same phase behaviour as atoms or molecules, with the nano- to micrometre size of the colloidal particles making it possible to observe them directly in real space(3,4). Another attractive feature is that different types of colloidal interactions, such as long-range repulsive(1,3), short-range attractive(5), hard-sphere-like(2-4) and dipolar(3), can be realized and give rise to equilibrium phases. However, spherically symmetric, long-range attractions ( that is, ionic interactions) have so far always resulted in irreversible colloidal aggregation(6). Here we show that the electrostatic interaction between oppositely charged particles can be tuned such that large ionic colloidal crystals form readily, with our theory and simulations confirming the stability of these structures. We find that in contrast to atomic systems, the stoichiometry of our colloidal crystals is not dictated by charge neutrality; this allows us to obtain a remarkable diversity of new binary structures. An external electric field melts the crystals, confirming that the constituent particles are indeed oppositely charged. Colloidal model systems can thus be used to study the phase behaviour of ionic species. We also expect that our approach to controlling opposite-charge interactions will facilitate the production of binary crystals of micrometre-sized particles, which could find use as advanced materials for photonic applications(7).	Univ Utrecht, Debye Inst, NL-3584 CC Utrecht, Netherlands; Univ Utrecht, Inst Theoret Phys, NL-3584 CE Utrecht, Netherlands	Utrecht University; Utrecht University	Leunissen, ME (corresponding author), Univ Utrecht, Debye Inst, Princetonpl 5, NL-3584 CC Utrecht, Netherlands.	M.E.Leunissen@phys.uu.nl; A.vanBlaaderen@phys.uu.nl	Imhof, Arnout/B-6655-2009; van Blaaderen, Alfons/B-6304-2009; van Roij, René/E-5163-2011; Campbell, Andrew I/F-7690-2013; van Blaaderen, Alfons/ABB-1370-2020; Dijkstra, Marjolein/B-6656-2009; van Roij, Rene/AAU-1721-2020	Imhof, Arnout/0000-0002-7445-1360; van Blaaderen, Alfons/0000-0003-3090-2753; van Roij, René/0000-0002-2221-294X; Campbell, Andrew I/0000-0001-6213-0757; van Blaaderen, Alfons/0000-0003-3090-2753; Dijkstra, Marjolein/0000-0002-9166-6478; van Roij, Rene/0000-0002-2221-294X; Royall, C. Patrick/0000-0001-7247-8685				BARTLETT P, IN PRESS PHYS REV LE; Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; Bosma G, 2002, J COLLOID INTERF SCI, V245, P292, DOI 10.1006/jcis.2001.7986; Bresme F, 2000, PHYS REV LETT, V85, P3217, DOI 10.1103/PhysRevLett.85.3217; Caballero JB, 2004, J CHEM PHYS, V121, P2428, DOI 10.1063/1.1767995; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Dzubiella J, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021402; FRENKEL D, 2002, UNDERSTANDING MOL SI, pCH5; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; HACHISU S, 1973, J COLLOID INTERF SCI, V42, P342, DOI 10.1016/0021-9797(73)90298-1; HACHISU S, 1987, PHYSICS COMPLEX SUPE, P221; Hunt N, 2000, PHYS REV E, V62, P900, DOI 10.1103/PhysRevE.62.900; HUNTER RJ, 1981, ZETA POTENTIAL COLLO, pCH4; Islam AM, 1995, ADV COLLOID INTERFAC, V62, P109, DOI 10.1016/0001-8686(95)00276-V; Kegel WK, 2000, SCIENCE, V287, P290, DOI 10.1126/science.287.5451.290; Lowen H, 2003, FARADAY DISCUSS, V123, P99, DOI 10.1039/b202892c; Maskaly G. R., 2005, THESIS MIT; OBRIEN RW, 1978, J CHEM SOC FARAD T 2, V74, P1607, DOI 10.1039/f29787401607; Petekidis G, 2003, FARADAY DISCUSS, V123, P287, DOI 10.1039/b207343a; Pham KN, 2002, SCIENCE, V296, P104, DOI 10.1126/science.1068238; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; Redl FX, 2003, NATURE, V423, P968, DOI 10.1038/nature01702; Royall CP, 2003, J PHYS-CONDENS MAT, V15, pS3581, DOI 10.1088/0953-8984/15/48/017; Saunders AE, 2005, CHEMPHYSCHEM, V6, P61, DOI 10.1002/cphc.200400382; Schofield AB, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051403; UNDERWOOD SM, 1995, PHYSICA A, V221, P438, DOI 10.1016/0378-4371(95)00207-X; VANBLAADEREN A, 1992, LANGMUIR, V8, P2921, DOI 10.1021/la00048a013; Velikov KP, 2002, SCIENCE, V296, P106, DOI 10.1126/science.1067141; Vlasov YA, 2001, NATURE, V414, P289, DOI 10.1038/35104529; WEISS JA, 1995, J CHEM PHYS, V103, P1180, DOI 10.1063/1.469828; Yethiraj A, 2003, NATURE, V421, P513, DOI 10.1038/nature01328	31	807	823	11	422	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					235	240		10.1038/nature03946	http://dx.doi.org/10.1038/nature03946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148929	Green Published			2022-12-28	WOS:000231696900051
J	Morgan, AD; Gandon, S; Buckling, A				Morgan, AD; Gandon, S; Buckling, A			The effect of migration on local adaptation in a coevolving host-parasite system	NATURE			English	Article							GENE-FOR-GENE; COEVOLUTION; VIRULENCE; MALADAPTATION; DIVERGENCE; EVOLUTION; FLOW	Antagonistic coevolution between hosts and parasites in spatially structured populations can result in local adaptation of parasites(1-5); that is, the greater infectivity of local parasites than foreign parasites on local hosts(1). Such parasite specialization on local hosts has implications for human health and agriculture. By contrast with classic single-species population-genetic models(6,7), theory indicates that parasite migration between subpopulations might increase parasite local adaptation, as long as migration does not completely homogenize populations(8-11). To test this hypothesis we developed a system-specific mathematical model and then coevolved replicate populations of the bacterium Pseudomonas fluorescens and a parasitic bacteriophage with parasite only, with host only or with no migration. Here we show that patterns of local adaptation have considerable temporal and spatial variation and that, in the absence of migration, parasites tend to be locally maladapted. However, in accord with our model, parasite migration results in parasite local adaptation, but host migration alone has no significant effect.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; CNRS, UMR 2724, IRD, F-34394 Montpellier, France	University of Oxford; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Morgan, AD (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	andrew.morgan@zoo.ox.ac.uk	Morgan, Andrew D/C-4948-2008; GANDON, Sylvain/AHC-0976-2022	GANDON, Sylvain/0000-0003-2624-7856; Buckling, Angus/0000-0003-1170-4604				Agrawal A, 2002, EVOL ECOL RES, V4, P79; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; CRAWLEY MJ, GLIM ECOLOGISTS, P93; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; Frank SA, 1996, EVOL ECOL, V10, P307, DOI 10.1007/BF01237687; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kaltz O, 1999, EVOLUTION, V53, P395, DOI [10.1111/j.1558-5646.1999.tb03775.x, 10.2307/2640776]; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1984, J THEOR BIOL, V108, P319, DOI 10.1016/S0022-5193(84)80035-1; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; LIVELY CM, 1989, EVOLUTION, V43, P1663, DOI [10.2307/2409382, 10.1111/j.1558-5646.1989.tb02616.x]; McCoy KD, 2002, EVOL ECOL RES, V4, P441; Miralles R, 1999, J GEN VIROL, V80, P2051, DOI 10.1099/0022-1317-80-8-2051; Morand S, 1996, P ROY SOC B-BIOL SCI, V263, P119, DOI 10.1098/rspb.1996.0019; Mutikainen P, 2000, EVOLUTION, V54, P433; Oppliger A, 1999, J EVOLUTION BIOL, V12, P951, DOI 10.1046/j.1420-9101.1999.00101.x; PARKER MA, 1985, EVOLUTION, V39, P713, DOI 10.1111/j.1558-5646.1985.tb00414.x; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116	29	211	211	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					253	256		10.1038/nature03913	http://dx.doi.org/10.1038/nature03913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148933				2022-12-28	WOS:000231696900055
J	van Wijk, JPH; de Koning, EJP; Cabezas, MC; Roodt, JO; Joven, J; Rabelink, TJ; Hoepelman, AI				van Wijk, JPH; de Koning, EJP; Cabezas, MC; Roodt, JO; Joven, J; Rabelink, TJ; Hoepelman, AI			Comparison of rosiglitazone and metformin for treating HIV lipodystrophy - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							FLOW-MEDIATED DILATION; CORONARY-HEART-DISEASE; IMMUNODEFICIENCY-VIRUS-INFECTION; TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR RISK; ENDOTHELIAL DYSFUNCTION; PROTEASE INHIBITORS; FAT REDISTRIBUTION	Background: The use of antiretroviral combination therapy in HIV has been associated with lipodystrophy and cardiovascular risk factors. Objective: To compare the effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone and metformin for treating HIV lipodystrophy. Design: An open, randomized, 6-month clinical trial. Setting: University Medical Center, Utrecht, the Netherlands. Patients: 39 HIV-infected men with lipodystrophy. Intervention: Rosiglitazone, 8 mg/d, or metformin, 2 mg/d. Measurements: insulin sensitivity estimated by the oral glucose tolerance test, subcutaneous and visceral abdominal fat measured by single-slice computed tomography, endothelial function measured by flow-mediated vasodilation, and fasting plasma measurements. Two patients in the metformin group withdrew from the study. Complete case analysis was performed. Results: Compared with metformin, rosiglitazone increased subcutaneous abdominal fat (between-treatment change from baseline, 27 cm(2) [95% CI, 7 cm(2) to 46 cm(2)]) and visceral abdominal fat (between-treatment change from baseline, 24 cm(2) [CI, 6 cm(2) to 51 cm(2)]). The area under the curve for insulin after the oral glucose tolerance test decreased similarly with both agents, but only rosiglitazone increased adiponectin levels. Metformin showed greater benefits on fasting lipid profile than rosiglitazone. Flow-mediated vasodilation statistically significantly increased with metformin (mean change, 1.5% [CI, 0.4% to 3.3%]) and not with rosiglitazone (mean change, 0.7% [CI, -1.1% to 2.7%]). The metformin versus rosiglitazone increases did not statistically differ. Rosiglitazone and metformin did not change C-reactive protein levels. Limitations: This small trial was not blinded or placebo-controlled and did not measure clinical outcomes. Conclusions: The findings emphasize the importance of individualized care in HIV-Infected patients. Although rosiglitazone may partly correct lipoatrophy, metformin improves visceral fat accumulation, fasting lipid profile, and endothelial function.	Univ Utrecht, Med Ctr, Dept Infect Dis & Internal Med, NL-3508 GA Utrecht, Netherlands; Leiden Univ, Med Ctr, Leiden, Netherlands; St Franciscus Gasthuis, Rotterdam, Netherlands; Hosp Univ Sant Joan, Ctr Rec Biomed, Reus, Spain	Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Franciscus Gasthuis	van Wijk, JPH (corresponding author), Univ Utrecht, Med Ctr, Dept Infect Dis & Internal Med, Room G02-402,POB 85500, NL-3508 GA Utrecht, Netherlands.	j.p.h.vanwijk@azu.nl	Joven, Jorge/B-3360-2016; Rabelink, Ton J./A-5316-2008; de Koning, Eelco JP/H-6030-2011	Joven, Jorge/0000-0003-2749-4541; Rabelink, Ton J./0000-0001-6780-5186; de Koning, Eelco JP/0000-0002-1232-7022; op 't Roodt, Jos/0000-0003-3535-6894				Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Bertran N, 2005, J LAB CLIN MED, V145, P41, DOI 10.1016/j.lab.2004.11.002; Borch-Johnsen K, 1999, LANCET, V354, P617; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Brevetti G, 2003, CIRCULATION, V108, P2093, DOI 10.1161/01.CIR.0000095273.92468.D9; Caron M, 2001, DIABETES, V50, P1378, DOI 10.2337/diabetes.50.6.1378; Carr A, 2002, JAMA-J AM MED ASSOC, V288, P207, DOI 10.1001/jama.288.2.207; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; Carr A, 2003, AIDS, V17, pS141, DOI 10.1097/00002030-200304001-00017; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2004, LANCET, V363, P429, DOI 10.1016/S0140-6736(04)15489-5; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Grinspoon S, 2003, CLIN INFECT DIS, V37, pS85, DOI 10.1086/375885; Hadigan C, 2004, ANN INTERN MED, V140, P786, DOI 10.7326/0003-4819-140-10-200405180-00008; Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541; Hadigan C, 2000, JAMA-J AM MED ASSOC, V284, P472, DOI 10.1001/jama.284.4.472; Hadigan C, 2002, J CLIN ENDOCR METAB, V87, P4611, DOI 10.1210/jc.2002-020709; Hadigan C, 2001, J CLIN ENDOCR METAB, V86, P939, DOI 10.1210/jc.86.2.939; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Hijmering ML, 2001, ATHEROSCLEROSIS, V157, P369, DOI 10.1016/S0021-9150(00)00748-6; Hookman P, 2003, AM J GASTROENTEROL, V98, P2330; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001; John M, 2003, JAIDS-J ACQ IMM DEF, V33, P29, DOI 10.1097/00126334-200305010-00005; Lindegaard B, 2004, CLIN EXP IMMUNOL, V135, P273, DOI 10.1111/j.1365-2249.2004.02367.x; Mather KJ, 2001, J AM COLL CARDIOL, V37, P1344, DOI 10.1016/S0735-1097(01)01129-9; Mercie P, 2002, ANN MED, V34, P55, DOI 10.1080/078538902317338652; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Mooser V, 2001, CURR OPIN LIPIDOL, V12, P313, DOI 10.1097/00041433-200106000-00011; Natali A, 2004, DIABETES CARE, V27, P1349, DOI 10.2337/diacare.27.6.1349; Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Patti G, 2005, CIRCULATION, V111, P70, DOI 10.1161/01.CIR.0000151308.06673.D2; Pistrosch F, 2004, DIABETES CARE, V27, P484, DOI 10.2337/diacare.27.2.484; Pyorala M, 1998, CIRCULATION, V98, P398, DOI 10.1161/01.CIR.98.5.398; Saint-Marc T, 1999, AIDS, V13, P1000, DOI 10.1097/00002030-199905280-00023; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; Stein JH, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.018; Stein JH, 2001, CIRCULATION, V104, P257, DOI 10.1161/01.CIR.104.3.257; Sutinen J, 2003, ANTIVIR THER, V8, P199; Sutinen J, 2002, AIDS, V16, P2183, DOI 10.1097/00002030-200211080-00011; Tong Q, 2003, J CLIN ENDOCR METAB, V88, P1559, DOI 10.1210/jc.2002-021600; Van Wijk JPH, 2005, DIABETES CARE, V28, P844, DOI 10.2337/diacare.28.4.844; van Wijk JPH, 2004, ARTERIOSCL THROM VAS, V24, P798, DOI 10.1161/01.ATV.0000127311.38703.1f; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zar JH., 1999, BIOSTAT ANAL, V663rd	50	88	97	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2005	143	5					337	346		10.7326/0003-4819-143-5-200509060-00009	http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961TE	16144892				2022-12-28	WOS:000231683900003
J	Deftos, LJ				Deftos, LJ			Treatment of Paget's disease - Taming the wild osteoclast	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Diego, La Jolla, CA 92093 USA; San Diego Vet Affairs Med Ctr, San Diego, CA USA; Calif Western Sch Law, San Diego, CA USA	University of California System; University of California San Diego	Deftos, LJ (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.							FLEISCH H, 2002, PRINCIPLES BONE BIOL, V2, P1361; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; POTTS JT, 1974, DUNCANS DIS METABOLI, P904; Vaananen K, 2005, ADV DRUG DELIVER REV, V57, P959, DOI 10.1016/j.addr.2004.12.018	5	17	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					872	875		10.1056/NEJMp058184	http://dx.doi.org/10.1056/NEJMp058184			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135831				2022-12-28	WOS:000231551100004
J	Richter, A; Burrows, JP; Nuss, H; Granier, C; Niemeier, U				Richter, A; Burrows, JP; Nuss, H; Granier, C; Niemeier, U			Increase in tropospheric nitrogen dioxide over China observed from space	NATURE			English	Article							OZONE MONITORING EXPERIMENT; GOME MEASUREMENTS; EMISSIONS; MODEL; NO2; RETRIEVAL; TRANSPORT; NO(X); ASIA	Emissions from fossil fuel combustion and biomass burning reduce local air quality and affect global tropospheric chemistry. Nitrogen oxides are emitted by all combustion processes and play a key part in the photochemically induced catalytic production of ozone, which results in summer smog and has increased levels of tropospheric ozone globally(1). Release of nitrogen oxide also results in nitric acid deposition, and - at least locally - increases radiative forcing effects due to the absorption of downward propagating visible light(2). Nitrogen oxide concentrations in many industrialized countries are expected to decrease(3), but rapid economic development has the potential to increase significantly the emissions of nitrogen oxides(4-7) in parts of Asia. Here we present the tropospheric column amounts of nitrogen dioxide retrieved from two satellite instruments GOME(8,9) and SCIAMACHY(10) over the years 1996 - 2004. We find substantial reductions in nitrogen dioxide concentrations over some areas of Europe and the USA, but a highly significant increase of about 50 per cent - with an accelerating trend in annual growth rate - over the industrial areas of China, more than recent bottom-up inventories suggest(6).	Univ Bremen, Inst Environm Phys, D-28359 Bremen, Germany; Max Planck Inst Meteorol, D-20146 Hamburg, Germany; Univ Paris 06, IPSL, Serv Aeron, F-75005 Paris, France; NOAA, CIRES, Aeron Lab, Boulder, CO 80305 USA	University of Bremen; Max Planck Society; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Richter, A (corresponding author), Univ Bremen, Inst Environm Phys, Otto Hahn Allee 1, D-28359 Bremen, Germany.	richter@iup.physik.uni-bremen.de	Burrows, John P/B-6199-2014; Richter, Andreas/C-4971-2008; Burrows, John Philip/AAF-8468-2019; Granier, Claire/D-5360-2013	Burrows, John P/0000-0002-6821-5580; Richter, Andreas/0000-0003-3339-212X; Burrows, John Philip/0000-0002-6821-5580; Granier, Claire/0000-0001-7344-7995				Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Beirle S, 2003, ATMOS CHEM PHYS, V3, P2225, DOI 10.5194/acp-3-2225-2003; Boersma KF, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003962; Bovensmann H, 1999, J ATMOS SCI, V56, P127, DOI 10.1175/1520-0469(1999)056<0127:SMOAMM>2.0.CO;2; Burrows JP, 1999, J ATMOS SCI, V56, P151, DOI 10.1175/1520-0469(1999)056<0151:TGOMEG>2.0.CO;2; Chipperfield MP, 1999, J GEOPHYS RES-ATMOS, V104, P1781, DOI 10.1029/98JD02597; *EUR SPAC AG, 1995, ESA; Horowitz LW, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002853; Jaegle L, 2005, FARADAY DISCUSS, V130, P407, DOI 10.1039/b502128f; Koelemeijer RBA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002429; Koelemeijer RBA, 2001, J GEOPHYS RES-ATMOS, V106, P3475, DOI 10.1029/2000JD900657; Kunhikrishnan T, 2004, ATMOS ENVIRON, V38, P581, DOI 10.1016/j.atmosenv.2003.09.074; Leue C, 2001, J GEOPHYS RES-ATMOS, V106, P5493, DOI 10.1029/2000JD900572; LOVBLAD G, 2004, EMEP ASSESSMENT 1, P48; Martin RV, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003453; Martin RV, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002622; Martin RV, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001027; Massie ST, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004620; OLIVIER J, 2003, POET, P4; Petritoli A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004547; Richter A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020822; Richter A, 2002, ADV SPACE RES, V29, P1673, DOI 10.1016/S0273-1177(02)00100-X; Rozanov VV, 1997, J GEOPHYS RES-ATMOS, V102, P16683, DOI 10.1029/96JD01535; Solomon S, 1999, J GEOPHYS RES-ATMOS, V104, P12047, DOI 10.1029/1999JD900035; Streets DG, 2000, ATMOS ENVIRON, V34, P363, DOI 10.1016/S1352-2310(99)00167-3; Streets DG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003093; van Aardenne JA, 1999, ATMOS ENVIRON, V33, P633, DOI 10.1016/S1352-2310(98)00110-1; VOLZ A, 1988, NATURE, V332, P240, DOI 10.1038/332240a0; ZHAO J, 2003, SINOSPHERE J, V6, P20	29	998	1129	33	524	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					129	132		10.1038/nature04092	http://dx.doi.org/10.1038/nature04092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136141				2022-12-28	WOS:000231560400055
J	Whiten, A				Whiten, A			The second inheritance system of chimpanzees and humans	NATURE			English	Article							GROOMING HAND-CLASP; CHILDREN; EVOLUTION; CULTURES; INSIGHTS; APES	Half a century of dedicated field research has brought us from ignorance of our closest relatives to the discovery that chimpanzee communities resemble human cultures in possessing suites of local traditions that uniquely identify them. The collaborative effort required to establish this picture parallels the one set up to sequence the chimpanzee genome, and has revealed a complex social inheritance system that complements the genetic picture we are now developing.	Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9JP, Fife, Scotland; Univ St Andrews, Sch Psychol, Scottish Primate Res Grp, St Andrews KY16 9JP, Fife, Scotland	University of St Andrews; University of St Andrews	Whiten, A (corresponding author), Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9JP, Fife, Scotland.	a.whiten@st-and.ac.uk		Whiten, Andrew/0000-0003-2426-5890	Biotechnology and Biological Sciences Research Council [S16447] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Boesch C, 2003, EVOL ANTHROPOL, V12, P82, DOI 10.1002/evan.10106; Boesch Christophe, 2002, BEHAV DIVERSITY CHIM; Byrne RW, 2004, TRENDS COGN SCI, V8, P341, DOI 10.1016/j.tics.2004.06.002; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; Call J, 2005, ANIM COGN, V8, P151, DOI 10.1007/s10071-004-0237-8; Fragaszy D.M., 2003, BIOL TRADITIONS MODE; Galef B G, 1992, Hum Nat, V3, P157, DOI 10.1007/BF02692251; GOODALL J, 1964, NATURE, V201, P1264, DOI 10.1038/2011264a0; Goodall J., 1986, CHIMPANZEES GOMBE PA; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Huffman MA, 2004, PRIMATES, V45, P113, DOI 10.1007/s10329-003-0065-5; Lefebvre Louis, 2000, P311; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; MATSUZAWA T, 2002, CHIMPANZEES BOSSAU N; Mc Grew WC, 2001, CURR ANTHROPOL, V42, P148, DOI 10.1086/318441; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew William, 2004, CULTURED CHIMPANZEE; Nakamura M, 2004, CURR ANTHROPOL, V45, P108, DOI 10.1086/381007; Nielsen M, 2005, ANIM COGN, V8, P31, DOI 10.1007/s10071-004-0232-0; Nishida T, 2004, FOLIA PRIMATOL, V75, P31, DOI 10.1159/000073429; Nishida T, 1999, ANTHROPOL SCI, V107, P141, DOI 10.1537/ase.107.141; Perry Susan, 2003, P391, DOI 10.1017/CBO9780511584022.015; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Reynolds V., 2005, CHIMPANZEES BUDONGO; RICHERSON PJ, 2005, NOT GENES CULTURE TR; Sanz C, 2004, AM NAT, V164, P567, DOI 10.1086/424803; Suddendorf T, 2001, PSYCHOL BULL, V127, P629, DOI 10.1037//0033-2909.127.5.629; Tomasello M., 1987, HUM EVOL, V2, P175, DOI DOI 10.1007/BF02436405; Tomasello Michael, 1996, P319, DOI 10.1016/B978-012273965-1/50016-9; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 2003, EVOL ANTHROPOL, V12, P92, DOI 10.1002/evan.10107; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WHITEN A, 2005, NATURE          0821, DOI DOI 10.1038/NATURE04047; Wrangham R. W., 1994, CHIMPANZEE CULTURES	39	182	186	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					52	55		10.1038/nature04023	http://dx.doi.org/10.1038/nature04023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	960AC	16136127				2022-12-28	WOS:000231560400041
J	Calvano, SE; Xiao, WZ; Richards, DR; Felciano, RM; Baker, HV; Cho, RJ; Chen, RO; Brownstein, BH; Cobb, JP; Tschoeke, SK; Miller-Graziano, C; Moldawer, LL; Mindrinos, MN; Davis, RW; Tompkins, RG; Lowry, SF				Calvano, SE; Xiao, WZ; Richards, DR; Felciano, RM; Baker, HV; Cho, RJ; Chen, RO; Brownstein, BH; Cobb, JP; Tschoeke, SK; Miller-Graziano, C; Moldawer, LL; Mindrinos, MN; Davis, RW; Tompkins, RG; Lowry, SF		Inflammation Host Response Injury	A network-based analysis of systemic inflammation in humans	NATURE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; MOLECULAR CLASSIFICATION; ENDOTOXIN TOLERANCE; CELL-DEATH; EXPRESSION; DISEASE; DYSFUNCTION; MICROARRAYS; PREDICTION; MECHANISM	Oligonucleotide and complementary DNA microarrays are being used to subclassify histologically similar tumours, monitor disease progress, and individualize treatment regimens(1-5). However, extracting new biological insight from high-throughput genomic studies of human diseases is a challenge, limited by difficulties in recognizing and evaluating relevant biological processes from huge quantities of experimental data. Here we present a structured network knowledge-base approach to analyse genome-wide transcriptional responses in the context of known functional interrelationships among proteins, small molecules and phenotypes. This approach was used to analyse changes in blood leukocyte gene expression patterns in human subjects receiving an inflammatory stimulus ( bacterial endotoxin). We explore the known genome-wide interaction network to identify significant functional modules perturbed in response to this stimulus. Our analysis reveals that the human blood leukocyte response to acute systemic inflammation includes the transient dysregulation of leukocyte bioenergetics and modulation of translational machinery. These findings provide insight into the regulation of global leukocyte activities as they relate to innate immune system tolerance and increased susceptibility to infection in humans.	Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08903 USA; Ingenuity Syst Inc, Mountain View, CA 94043 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA; Washington Univ, Dept Surg, St Louis, MO 63110 USA; Univ Rochester, Sch Med, Dept Surg, Rochester, NY 14642 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA	Stanford University; Rutgers State University New Brunswick; Rutgers State University Medical Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington University (WUSTL); University of Rochester; Harvard University; Harvard Medical School; Massachusetts General Hospital	Davis, RW (corresponding author), Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	dbowe@stanford.edu	Cho, Raymond/AAO-8125-2020; Califano, Andrea/F-7239-2012	Cho, Raymond/0000-0001-6090-6603; Moldawer, Lyle/0000-0002-9041-9838; xiao, wenzhong/0000-0003-4944-6380; Baker, Henry/0000-0002-8273-5320	NIGMS NIH HHS [U54 GM062119] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; FONG YM, 1990, J CLIN INVEST, V85, P1896, DOI 10.1172/JCI114651; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Kalil AC, 2004, SHOCK, V21, P222, DOI 10.1097/01.shk.0000116778.27924.79; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Padfield KE, 2005, P NATL ACAD SCI USA, V102, P5368, DOI 10.1073/pnas.0501211102; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wolk K, 2000, BLOOD, V96, P218, DOI 10.1182/blood.V96.1.218.013k04_218_223; Wolk K, 2003, J BIOL CHEM, V278, P18030, DOI 10.1074/jbc.M207714200	24	1114	1178	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2005	437	7061					1032	1037		10.1038/nature03985	http://dx.doi.org/10.1038/nature03985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16136080				2022-12-28	WOS:000232496100047
J	Pattingre, S; Tassa, A; Qu, XP; Garuti, R; Liang, XH; Mizushima, N; Packer, M; Schneider, MD; Levine, B				Pattingre, S; Tassa, A; Qu, XP; Garuti, R; Liang, XH; Mizushima, N; Packer, M; Schneider, MD; Levine, B			Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy	CELL			English	Article							CELL-DEATH; APOPTOSIS; MACROAUTOPHAGY; PHOSPHORYLATION; TUMORIGENESIS; DISSECTION	Apoptosis and autophagy are both tightly regulated biological processes that play a central role in tissue homeostasis, development, and disease. The antiapoptotic protein, Bcl-2, interacts with the evolutionarily conserved autophagy protein, Beclin 1. However, little is known about the functional significance of this interaction. Here, we show that wild-type Bcl-2 antiapoptotic proteins, but not Beclin 1 binding defective mutants of Bcl-2, inhibit Beclin 1-dependent autophagy in yeast and mammalian cells and that cardiac Bcl-2 transgenic expression inhibits autophagy in mouse heart muscle. Furthermore, Beclin 1 mutants that cannot bind to Bcl-2 induce more autophagy than wild-type Beclin 1 and, unlike wild-type Beclin 1, promote cell death. Thus, Bcl-2 not only functions as an antiapoptotic protein, but also as an antiautophagy protein via its inhibitory interaction with Beclin 1. This antiautophagy function of Bcl-2 may help maintain autophagy at levels that are compatible with cell survival, rather than cell death.	Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Biostat & Clin Sci, Dallas, TX 75390 USA; Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Tokyo 1138613, Japan; Japan Sci & Technol Agcy, Precursory Res Embryol Sci & Technol, Kawaguchi 3320012, Japan; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Columbia University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Baylor College of Medicine	Levine, B (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA.	beth.levine@utsouthwestern.edu	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Pattingre, Sophie/0000-0001-6284-6050; Schneider, Michael/0000-0001-9645-1938	NATIONAL CANCER INSTITUTE [R01CA084254, R56CA109618, R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044157] Funding Source: NIH RePORTER; NCI NIH HHS [CA084254, R01 CA109618, CA109618] Funding Source: Medline; NIAID NIH HHS [R01 AI151367, AI44157] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asnaghi L, 2004, ONCOGENE, V23, P5781, DOI 10.1038/sj.onc.1207698; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; GERMAIN M, 2003, SCI STKE, V173, pPE10; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; Imahashi K, 2004, CIRC RES, V95, P734, DOI 10.1161/01.RES.0000143898.67182.4c; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lacour S, 2003, ONCOGENE, V22, P1807, DOI 10.1038/sj.onc.1206127; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; LEVINE B, 2005, IN PRESS J CLIN INVE; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Poommipanit PB, 1999, J BIOL CHEM, V274, P1033, DOI 10.1074/jbc.274.2.1033; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	39	2790	2942	6	364	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					927	939		10.1016/j.cell.2005.07.002	http://dx.doi.org/10.1016/j.cell.2005.07.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179260	Bronze			2022-12-28	WOS:000232130200016
J	Janssen, BJC; Huizinga, EG; Raaijmakers, HCA; Roos, A; Daha, MR; Nilsson-Ekdahl, K; Nilsson, B; Gros, P				Janssen, BJC; Huizinga, EG; Raaijmakers, HCA; Roos, A; Daha, MR; Nilsson-Ekdahl, K; Nilsson, B; Gros, P			Structures of complement component C3 provide insights into the function and evolution of immunity	NATURE			English	Article							INITIAL C-3 CONVERTASE; RAY CRYSTAL-STRUCTURE; 3RD COMPONENT; FACTOR-H; INTERNAL THIOESTER; DIFFRACTION DATA; PROTEIN C3; BINDING; CLEAVAGE; FRAGMENT	The mammalian complement system is a phylogenetically ancient cascade system that has a major role in innate and adaptive immunity. Activation of component C3 ( 1,641 residues) is central to the three complement pathways and results in inflammation and elimination of self and non- self targets. Here we present crystal structures of native C3 and its final major proteolytic fragment C3c. The structures reveal thirteen domains, nine of which were unpredicted, and suggest that the proteins of the alpha 2- macroglobulin family evolved from a core of eight homologous domains. A double mechanism prevents hydrolysis of the thioester group, essential for covalent attachment of activated C3 to target surfaces. Marked conformational changes in the alpha- chain, including movement of a critical interaction site through a ring formed by the domains of the beta- chain, indicate an unprecedented, conformation- dependent mechanism of activation, regulation and biological function of C3.	Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands; Univ Hosp, Dept Clin Immunol, SE-75185 Uppsala, Sweden; Univ Kalmar, Dept Chem & Biomed Sci, SE-39182 Kalmar, Sweden	Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Uppsala University; Uppsala University Hospital; Linnaeus University; University of Kalmar	Gros, P (corresponding author), Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	p.gros@chem.uu.nl	Gros, Piet/I-5569-2016; Ekdahl, Kristina Nilsson/B-5301-2012; Gros, Piet/AAD-6452-2019; Janssen, Bert/I-3338-2016; Nilsson, Bo/B-3102-2012	Gros, Piet/0000-0002-7782-2585; Gros, Piet/0000-0002-7782-2585; Janssen, Bert/0000-0002-8101-8370; Nilsson, Bo/0000-0003-0057-2730; raaijmakers, hans/0000-0002-2567-7363				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOKISCH VA, 1969, J EXP MED, V129, P1109, DOI 10.1084/jem.129.5.1109; Bramham J, 2005, J BIOL CHEM, V280, P10636, DOI 10.1074/jbc.M413126200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budd A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r38; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; DAOUDAKI ME, 1988, J IMMUNOL, V140, P1577; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; FISHELSON Z, 1984, J IMMUNOL, V132, P1430; Gadjeva M, 1998, J IMMUNOL, V161, P985; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; HARRISON RA, 1980, MOL IMMUNOL, V17, P219, DOI 10.1016/0161-5890(80)90074-7; HUBER R, 1980, H-S Z PHYSIOL CHEM, V361, P1389, DOI 10.1515/bchm2.1980.361.2.1389; ISENMAN DE, 1981, BIOCHEMISTRY-US, V20, P4458, DOI 10.1021/bi00518a034; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jenner L, 1998, STRUCTURE, V6, P595, DOI 10.1016/S0969-2126(98)00061-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; LACHMANN PJ, 1982, J EXP MED, V156, P205, DOI 10.1084/jem.156.1.205; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; LAMBRIS JD, 1988, IMMUNOL TODAY, V9, P387, DOI 10.1016/0167-5699(88)91240-6; Lambris JD, 1996, J IMMUNOL, V156, P4821; LAW SK, 1979, J IMMUNOL, V123, P1388; Law SKA, 1997, PROTEIN SCI, V6, P263; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; MULLEREBERHARD HJ, 1972, J EXP MED, V135, P1003, DOI 10.1084/jem.135.4.1003; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANGBURN MK, 1992, J BIOL CHEM, V267, P8584; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Qazi U, 1998, J BIOL CHEM, V273, P8987, DOI 10.1074/jbc.273.15.8987; ROSS GD, 1982, J IMMUNOL, V129, P2051; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Solomon KR, 2004, GENE, V327, P171, DOI 10.1016/j.gene.2003.11.025; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; TACK BF, 1980, P NATL ACAD SCI-BIOL, V77, P5764, DOI 10.1073/pnas.77.10.5764; TANIGUCHISIDLE A, 1994, J IMMUNOL, V153, P5285; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMAS ML, 1982, P NATL ACAD SCI-BIOL, V79, P1054, DOI 10.1073/pnas.79.4.1054; van den Elsen JMH, 2002, J MOL BIOL, V322, P1103, DOI 10.1016/S0022-2836(02)00854-9; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Winters MS, 2005, J IMMUNOL, V174, P3469, DOI 10.4049/jimmunol.174.6.3469	51	405	419	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					505	511		10.1038/nature04005	http://dx.doi.org/10.1038/nature04005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177781	Green Published			2022-12-28	WOS:000232004800040
J	Messerli, FH; Messerli, AW; Luscher, TF				Messerli, FH; Messerli, AW; Luscher, TF			Eisenhower's billion-dollar heart attack - 50 years later	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, St Lukes Roosevelt Hosp Ctr, Hypertens Program, New York, NY 10027 USA; St Josephs Hosp, Catheterizat Lab, Lexington, KY USA; Univ Spital Zurich, Herz Kreislauf Zentrum, Zurich, Switzerland	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; University of Zurich; University Zurich Hospital	Messerli, FH (corresponding author), Columbia Univ, St Lukes Roosevelt Hosp Ctr, Hypertens Program, New York, NY 10027 USA.		Messerli, Franz/AAR-4783-2021; Messerli, Adrian W/O-8672-2018	Messerli, Adrian W/0000-0001-9025-6023				Ginzberg E, 1999, JAMA-J AM MED ASSOC, V282, P1665, DOI 10.1001/jama.282.17.1665; NIXON RM, 1962, 6 CRISES, P138; ONEILL MJ, 1955, WASHINGTON POST 0925, pA8; WHITE PD, 1955, WASHINGTON POST 1030, pE1; HLTH MED HIST PRESID	5	24	24	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1205	1207		10.1056/NEJMp058162	http://dx.doi.org/10.1056/NEJMp058162			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	966DS	16177247				2022-12-28	WOS:000232000400004
J	Brody, BA; McCullough, LB; Sharp, RR				Brody, BA; McCullough, LB; Sharp, RR			Consensus and controversy in clinical research ethics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THERAPEUTIC MISCONCEPTION; INTERNATIONAL-COMMITTEE; STATEMENT; TRIALS; RISKS		Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA	Baylor College of Medicine	Brody, BA (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, 1 Baylor Plaza, Houston, TX 77030 USA.	bbrody@bcm.tmc.edu						[Anonymous], 1995, Pediatrics, V95, P286; Brody BA, 1998, ETHICS BIOMEDICAL RE; Casarett D, 2000, JAMA-J AM MED ASSOC, V283, P2275, DOI 10.1001/jama.283.17.2275; Christian MC, 2002, NEW ENGL J MED, V346, P1405, DOI 10.1056/NEJM200205023461814; De Angelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2927, DOI 10.1001/jama.293.23.jed50037; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dickert N, 1999, NEW ENGL J MED, V341, P198, DOI 10.1056/NEJM199907153410312; Dresser R, 1996, JAMA-J AM MED ASSOC, V276, P67, DOI 10.1001/jama.276.1.67; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Emanuel EJ, 2003, ETHICAL REGULATORY A; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Foster MW, 2000, TRENDS GENET, V16, P93, DOI 10.1016/S0168-9525(99)01895-8; Frader JE, 1998, SURG ETHICS, P216; FREEDMAN LS, 1995, CONTROL CLIN TRIALS, V16, P277, DOI 10.1016/0197-2456(95)00048-8; Juengst ET, 1998, KENNEDY INST ETHIC J, V8, P183, DOI 10.1353/ken.1998.0010; Levine RJ, 1986, ETHICS REGULATION CL, V2nd; Lidz CW, 2004, SOC SCI MED, V58, P1689, DOI 10.1016/S0277-9536(03)00338-1; Macklin R., 2004, DOUBLE STANDARDS MED; McCrary SV, 2000, NEW ENGL J MED, V343, P1621, DOI 10.1056/NEJM200011303432207; Miller FG, 2003, HASTINGS CENT REP, V33, P19, DOI 10.2307/3528434; *NIH, GUID RES INV REC DNA; SUGARMAN J, 1998, ETHICS RES HUMAN SUB, P209; United States Department of Health and Human Services, 1998, OEI019700193 US DEP; US Department of Health and Human Services, PROT HUM SUBJ; Weijer C, 1999, CAMB Q HEALTHC ETHIC, V8, P501, DOI 10.1017/S0963180199004120; Weir RF, 2004, STORED TISSUE ISSUE; WHITE LJ, 1989, ANN INTERN MED, V111, P843, DOI 10.7326/0003-4819-111-10-843; World Medical Association, DECL HELS ETH PRINC	28	51	52	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1411	1414		10.1001/jama.294.11.1411	http://dx.doi.org/10.1001/jama.294.11.1411			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174704				2022-12-28	WOS:000231987800019
J	Edwards, RG				Edwards, RG			The Lasker Foundation and recognition of scientific excellence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Reprod Biomed Online, Duck End Farm, Cambridge CB3 8DB, England; Univ Cambridge, Cambridge, England	University of Cambridge	Edwards, RG (corresponding author), Reprod Biomed Online, Duck End Farm, Dry Drayton, Cambridge CB3 8DB, England.							ROBERT EDWARDS AND PATRICK STEPTOE, 1980, MATTER LIFE; Verlinsky Y, 2005, REPROD BIOMED ONLINE, V10, P24, DOI 10.1016/S1472-6483(10)62200-6	2	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1422	1423		10.1001/jama.294.11.1422	http://dx.doi.org/10.1001/jama.294.11.1422			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174709				2022-12-28	WOS:000231987800024
J	Ley, TJ; Rosenberg, LE				Ley, TJ; Rosenberg, LE			The physician-scientist career pipeline in 2005 - Build it, and they will come	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PATIENT-ORIENTED RESEARCH; CLINICAL-RESEARCH; MEDICAL-STUDENTS; INVESTIGATOR; CHALLENGES; GAP	Context Physician-scientists play a unique and critical role in medical research. Nonetheless, a number of trends followed during the 1980s and 1990s revealed that this career pathway was in serious jeopardy. Physician-scientists were declining in number and were getting older. A variety of factors were thought to contribute to this problem, including increasing indebtedness of medical school graduates caused by rapidly rising medical school tuition costs. Objective To evaluate the impact of recently initiated programs from the National Institutes of Health (NIH) and several not-for-profit institutions designed to revitalize the physician-scientist career pipeline. Design We assessed recent trends in the physician-scientist career pipeline using data obtained from the NIH, the American Medical Association, the Association of American Medical Colleges, and other sources. Main Outcome Measures Total numbers of physicians performing research, grant application numbers and success rates for MDs, MD-PhDs, and PhDs at various stages in their careers, interest in research among medical students, medical school tuitions and postgraduate salaries, numbers and composition of applicants for NIH loan repayment programs, and gender distribution of young physician-scientists. Results The number of physician-scientists in the United States has been in a steady state for the past decade, but funded physician-scientists are significantly older than they were 2 decades ago. However, the study of early career markers over the past 7 to 10 years has demonstrated increasing interest in research careers by medical students, steady growth of the MD-PhD pool, and a new burst of activity in the "late bloomer" pool of MDs (individuals who choose research careers in medical school or in residency training), fueled by loan repayment programs that were created by the NIH in 2002. Several recent trends for more established physician-scientists have also suggested improvement. Conclusions Although it is too early to assess the impact of these indicators on the long-term career pathway, the recent growth in activity in the physician-scientist career pipeline is an encouraging development. Continued funding of these new programs, coupled with sustained support for physician-scientists committed to the pathway, will be required to maintain these positive trends.	Washington Univ, Sch Med, Div Oncol, Sect Stem Cell Biol,Dept Med,Siteman Canc Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Siteman Canc Ctr, Dept Genet, St Louis, MO USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Siteman Cancer Center; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Princeton University; Princeton University	Ley, TJ (corresponding author), Washington Univ, Sch Med, Div Oncol, Sect Stem Cell Biol,Dept Med,Siteman Canc Ctr, Campus Box 8007,660 S Euclid Ave, St Louis, MO 63110 USA.	tley@im.wustl.edu						Ahrens E.H., 1992, CRISIS CLIN RES OVER; Andrews NC, 2002, NAT MED, V8, P439, DOI 10.1038/nm0502-439; ARIAS IM, 1989, NEW ENGL J MED, V321, P972, DOI 10.1056/NEJM198910053211412; Cech TR, 2001, SCIENCE, V293, P573, DOI 10.1126/science.293.5530.573; Gallin EK, 2005, J INVEST MED, V53, P73, DOI 10.2310/6650.2005.00202; GILL GN, 1984, AM SCHOLAR, V53, P353; Goldstein JL, 1997, J CLIN INVEST, V99, P2803, DOI 10.1172/JCI119470; Guelich JM, 2002, J INVEST MED, V50, P412, DOI 10.1136/jim-50-06-01; Heinig SJ, 1999, ACAD MED, V74, P726, DOI 10.1097/00001888-199906000-00024; Jolly P, 2005, HEALTH AFFAIR, V24, P527, DOI 10.1377/hlthaff.24.2.527; Ley TJ, 2002, NEW ENGL J MED, V346, P368, DOI 10.1056/NEJM200201313460515; Mark AL, 2001, J INVEST MED, V49, P486, DOI 10.2310/6650.2001.33624; Morrison G, 2005, NEW ENGL J MED, V352, P117, DOI 10.1056/NEJMp048089; Nathan DG, 2002, NEW ENGL J MED, V346, P372, DOI 10.1056/NEJM200201313460516; Nathan DG, 1998, JAMA-J AM MED ASSOC, V280, P1427, DOI 10.1001/jama.280.16.1427; Nathan DG, 2003, NEW ENGL J MED, V349, P1860, DOI 10.1056/NEJMsb035066; Neilson EG, 2003, J CLIN INVEST, V111, P765, DOI 10.1172/JCI200318116; Rosenberg LE, 2000, ANN INTERN MED, V133, P831, DOI 10.7326/0003-4819-133-10-200011210-00017; Rosenberg LE, 1999, J CLIN INVEST, V103, P1621, DOI 10.1172/JCI7304; Schechter AN, 1998, JAMA-J AM MED ASSOC, V280, P1440, DOI 10.1001/jama.280.16.1440; Shaywitz DA, 2000, AM J MED, V109, P136, DOI 10.1016/S0002-9343(00)00452-6; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Thompson JN, 1997, JAMA-J AM MED ASSOC, V278, P241, DOI 10.1001/jama.278.3.241; Varki A, 2002, NAT MED, V8, P437, DOI 10.1038/nm0502-437; Williams GH, 1997, JAMA-J AM MED ASSOC, V278, P227, DOI 10.1001/jama.278.3.227; WYNGAARDEN JB, 1979, NEW ENGL J MED, V301, P1254, DOI 10.1056/NEJM197912063012303; Zemlo TR, 2000, FASEB J, V14, P221, DOI 10.1096/fasebj.14.2.221; [No title captured]	28	271	280	1	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1343	1351		10.1001/jama.294.11.1343	http://dx.doi.org/10.1001/jama.294.11.1343			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174692	Bronze			2022-12-28	WOS:000231987800007
J	Woolley, M; Propst, SM				Woolley, M; Propst, SM			Public attitudes and perceptions about health-related research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Health-related research in the United States is funded by US citizens, either as taxpayers or as consumers. Public support is critical to the success of the research enterprise, and it is essential for stakeholders in research to pay attention to the public's views about the investment level in research and the nature of its conduct, as well as to understand the public's level of awareness and opinions about research to improve health. This article reviews key results from surveys concerning public attitudes and perceptions toward health-related research. Collectively, these data demonstrate that Americans rate research as a high national priority, and they strongly support greater investment by public and private funders.	Res Amer, Alexandria, VA 22314 USA		Propst, SM (corresponding author), Res Amer, 1101 King St, Alexandria, VA 22314 USA.	spropst@researchamerica.org						*ASS AM MED COLL, 2004, WHAT AM SAY NAT MED; *HARR INT, 2000, MAJ SURV REV CANC PA; Kaiser Family Foundation, 2004, NAT SURV CONS EXP PA; *M TWAIN HOUS MUS, BIOGR; *NAT SCI FDN, 2004, SCI ENG IND REP; *WIK, MARG ERR; 2005, CNN USA TODAY GA MAY; 2004, TAKING OUR PULSE MAR; 2004, TAKING OUR PULSE APR; 2003, RES AM AM SPEAKS POL, V5; 2004, RES AM AM PUBLIC OCT; 2004, RES AM AM SPEAKS POL, V6; 2004, ONLINE NEWS HOUR TRA; 2005, PARADE RES AM HL JUN; 2005, RES AM RES AM NA JAN	15	30	32	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1380	1384		10.1001/jama.294.11.1380	http://dx.doi.org/10.1001/jama.294.11.1380			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174697				2022-12-28	WOS:000231987800012
J	Bringa, EM; Caro, A; Wang, YM; Victoria, M; McNaney, JM; Remington, BA; Smith, RF; Torralva, BR; Van Swygenhoven, H				Bringa, EM; Caro, A; Wang, YM; Victoria, M; McNaney, JM; Remington, BA; Smith, RF; Torralva, BR; Van Swygenhoven, H			Ultrahigh strength in nanocrystalline materials under shock loading	SCIENCE			English	Article							PLASTIC-DEFORMATION; BEHAVIOR; METALS; ASYMMETRY; PRESSURE; ALUMINUM; COPPER	Molecular dynamics simulations of nanocrystalline copper under shock loading show an unexpected ultrahigh strength behind the shock front, with values Lip to twice those at low pressure. Partial and perfect dislocations, twinning, and debris from dislocation interactions are found behind the shock front. Results are interpreted in terms of the pressure dependence of both deformation mechanisms active at these grain sizes, namely dislocation-based plasticity and grain boundary sliding. These simulations, together with new shock experiments on nanocrystalline nickel, raise the possibility of achieving ultrahard materials during and after shock loading.	Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Paul Scherrer Inst, CH-5232 Villigen, Switzerland	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Bringa, EM (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	ebringa@llnl.gov	Bringa, Eduardo/F-8918-2011; McNaney, James/F-5258-2013; Van Swygenhoven, Helena/GZL-0225-2022; Wang, Yinmin (Morris)/F-2249-2010	Bringa, Eduardo/0000-0002-1403-1954; Wang, Yinmin (MORRIS)/0000-0003-0393-5154; McNaney, James/0000-0003-3526-9379; Wang, Yinmin (Morris)/0000-0002-7161-2034				Bringa EM, 2004, J APPL PHYS, V96, P3793, DOI 10.1063/1.1789266; Budrovic Z, 2004, SCIENCE, V304, P273, DOI 10.1126/science.1095071; Chen MW, 2003, SCIENCE, V299, P1563, DOI 10.1126/science.1080819; Cheng S, 2003, ACTA MATER, V51, P4505, DOI 10.1016/S1359-6454(03)00286-6; Dalla Torre F, 2002, ACTA MATER, V50, P3957, DOI 10.1016/S1359-6454(02)00198-2; Davila LP, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1906307; Dittrich TR, 1999, LASER PART BEAMS, V17, P217, DOI 10.1017/S0263034699172070; Holian BL, 1998, SCIENCE, V280, P2085, DOI 10.1126/science.280.5372.2085; Jia D, 2001, SCRIPTA MATER, V45, P613, DOI 10.1016/S1359-6462(01)01071-5; Jiang B, 2004, J MECH PHYS SOLIDS, V52, P1125, DOI 10.1016/j.jmps.2003.09.002; Kadau K, 2002, SCIENCE, V296, P1681, DOI 10.1126/science.1070375; Lu L, 2001, SCRIPTA MATER, V45, P1163, DOI 10.1016/S1359-6462(01)01138-1; Lund AC, 2005, ACTA MATER, V53, P3193, DOI 10.1016/j.actamat.2005.03.023; Madec R, 2003, SCIENCE, V301, P1879, DOI 10.1126/science.1085477; McNaney JM, 2004, METALL MATER TRANS A, V35A, P2625, DOI 10.1007/s11661-004-0208-3; Meyers M.A., 1999, MECH BEHAV MAT; Meyers MA, 2003, ACTA MATER, V51, P1211, DOI 10.1016/S1359-6454(02)00420-2; Remington BA, 2004, METALL MATER TRANS A, V35A, P2587, DOI 10.1007/s11661-004-0205-6; Sapozhnikov FA, 2003, J PHYS IV, V110, P323, DOI 10.1051/jp4:20030714; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328; Schuh CA, 2003, NAT MATER, V2, P449, DOI 10.1038/nmat918; Van Swygenhoven H, 1998, PHYS REV B, V58, P11246, DOI 10.1103/PhysRevB.58.11246; Van Swygenhoven H, 2004, NAT MATER, V3, P399, DOI 10.1038/nmat1136; Van Swygenhoven H, 1999, PHYS REV B, V60, P22, DOI 10.1103/PhysRevB.60.22; Weertman Jr, 2002, MA SC PR TE, P397; Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700	27	277	289	2	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1838	1841		10.1126/science.1116723	http://dx.doi.org/10.1126/science.1116723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166512	Green Submitted			2022-12-28	WOS:000231989500044
J	Khaitovich, P; Hellmann, I; Enard, W; Nowick, K; Leinweber, M; Franz, H; Weiss, G; Lachmann, M; Paabo, S				Khaitovich, P; Hellmann, I; Enard, W; Nowick, K; Leinweber, M; Franz, H; Weiss, G; Lachmann, M; Paabo, S			Parallel patterns of evolution in the genomes and transcriptomes of humans and chimpanzees	SCIENCE			English	Article							PROTEIN-INTERACTION NETWORK; GENE-EXPRESSION LEVELS; TISSUE-SPECIFIC GENES; RAPID EVOLUTION; DUPLICATE GENES; HUMAN BRAIN; DROSOPHILA; SELECTION; DIVERGENCE; SEQUENCE	The determination of the chimpanzee genome sequence provides a means to study both structural and functional aspects of the evolution of the human genome. Here we compare humans and chimpanzees with respect to differences in expression levels and protein-coding sequences for genes active in brain, heart, liver, kidney, and testis. We find that the patterns of differences in gene expression and gene sequences are markedly similar. In particular, there is a gradation of selective constraints among the tissues so that the brain shows the [east differences between the species whereas liver shows the most. Furthermore, expression levels as well as amino acid sequences of genes active in more tissues have diverged less between the species than have genes active in fewer tissues. In general, these patterns are consistent with a model of neutral evolution with negative selection. However, for X-chromosomal genes expressed in testis, patterns suggestive of positive selection on sequence changes as well as expression changes are seen. Furthermore, although genes expressed in the brain have changed less than have genes expressed in other tissues, in agreement with previous work we find that genes active in brain have accumulated more changes on the human than on the chimpanzee lineage.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Univ Dusseldorf, WE Informat Bioinformat, D-40225 Dusseldorf, Germany	Max Planck Society; Heinrich Heine University Dusseldorf	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutscher Pl 6, D-04103 Leipzig, Germany.	paabo@eva.mpg.de	Nowick, Katja/J-8270-2014; Khaitovich, Philipp/HGC-8520-2022; Enard, Wolfgang/K-3483-2014	Nowick, Katja/0000-0003-3993-4479; Leinweber, Marcus/0000-0002-6583-7739; Weiss, Guenter/0000-0003-0709-2158; Franz, Henriette/0000-0001-9358-7442				Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Dixson AF, 1998, PRIMATE SEXUALITY; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Enard W, 2004, ANNU REV GENOM HUM G, V5, P351, DOI 10.1146/annurev.genom.5.061903.180040; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fay JC, 2003, ANNU REV GENOM HUM G, V4, P213, DOI 10.1146/annurev.genom.4.020303.162528; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Gu JY, 2003, TRENDS GENET, V19, P63, DOI 10.1016/S0168-9525(02)00040-9; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Hsieh WP, 2003, GENETICS, V165, P747; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Khaitovich P, 2005, GENETICS, V170, P929, DOI 10.1534/genetics.104.037135; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Kimura M., 1983, NEUTRAL THEORY MOL E; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Klein R.G., 1999, HUMAN CAREER; KUMA K, 1995, MOL BIOL EVOL, V12, P123, DOI 10.1093/oxfordjournals.molbev.a040181; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Lemos B, 2004, NAT GENET, V36, P1059, DOI 10.1038/ng1427; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tomasello M, 1997, PRIMATE COGNITION; TURELLI M, 1988, EVOLUTION, V42, P1085, DOI [10.2307/2408923, 10.1111/j.1558-5646.1988.tb02526.x]; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Wagner A, 2000, P NATL ACAD SCI USA, V97, P6579, DOI 10.1073/pnas.110147097; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Wistuba J, 2003, BIOL REPROD, V69, P582, DOI 10.1095/biolreprod.103.015925; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	37	431	442	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2005	309	5742					1850	1854		10.1126/science.1108296	http://dx.doi.org/10.1126/science.1108296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16141373				2022-12-28	WOS:000231989500048
J	de Beur, SMJ				de Beur, SMJ			Tumor-induced osteomalacia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FIBROBLAST GROWTH FACTOR-23; ONCOGENIC OSTEOMALACIA; HYPOPHOSPHATEMIC RICKETS; MESENCHYMAL TUMORS; PROTEOLYTIC CLEAVAGE; PHOSPHATE-TRANSPORT; FGF-23; PHEX; BONE; GENE	Tumor-induced osteomalacia (TIO) is a rare paraneoplastic form of renal phosphate wasting that results in severe hypophosphatemia, a defect in vitamin D metabolism, and osteomalacia. This debilitating disorder is illustrated by the clinical presentation of a 55-year-old woman with progressive fatigue, weakness, and muscle and bone pain with fractures. After a protracted clinical course and extensive laboratory evaluation, tumor-induced osteomalacia was identified as the basis of her clinical presentation. In this article, the distinctive clinical characteristics of this syndrome, the advances in diagnosis of TIO, and new insights into the pathophysiology of this disorder are discussed.	Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Dept Med, Baltimore, MD 21224 USA; Johns Hopkins Bayview Med Ctr, Dept Endocrinol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	de Beur, SMJ (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Dept Med, 4940 Eastern Ave,B114, Baltimore, MD 21224 USA.	sjandebe@jhmi.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002652] Funding Source: NIH RePORTER; NIDDK NIH HHS [R03DK0602944, K08DK02652] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Avila NA, 1996, AM J ROENTGENOL, V167, P343, DOI 10.2214/ajr.167.2.8686600; Bai XY, 2003, J BIOL CHEM, V278, P9843, DOI 10.1074/jbc.M210490200; Berndt T, 2003, J CLIN INVEST, V112, P785, DOI 10.1172/JC1200318563; BIJVOET OLM, 1969, CLIN CHIM ACTA, V26, P15, DOI 10.1016/0009-8981(69)90280-0; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; CAI Q, 1994, NEW ENGL J MED, V330, P1645, DOI 10.1056/NEJM199406093302304; Campos M, 2003, BIOCHEM J, V373, P271, DOI 10.1042/BJ20030287; De Beur SMJ, 2002, J BONE MINER RES, V17, P1102, DOI 10.1359/jbmr.2002.17.6.1102; de Beur SMJ, 2002, J CLIN ENDOCR METAB, V87, P2467, DOI 10.1210/jc.87.6.2467; de Beur SMJ, 2002, LANCET, V359, P761, DOI 10.1016/S0140-6736(02)07846-7; DREZNER MK, 1977, J CLIN INVEST, V60, P1046, DOI 10.1172/JCI108855; Dupond JL, 2005, BONE, V36, P375, DOI 10.1016/j.bone.2005.01.001; Folpe AL, 2004, AM J SURG PATHOL, V28, P1, DOI 10.1097/00000478-200401000-00001; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; Guo R, 2001, AM J PHYSIOL-ENDOC M, V281, pE837, DOI 10.1152/ajpendo.2001.281.4.E837; Jan de Beur SM, 2003, PRIMER METABOLIC BON, P418; Jonsson KB, 2001, J ENDOCRINOL, V169, P613, DOI 10.1677/joe.0.1690613; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Kumar R, 2000, BONE, V27, P333, DOI 10.1016/S8756-3282(00)00334-3; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; MCCANCE RA, 1947, Q J MED, V16, P33; MIYAUCHI A, 1988, J CLIN ENDOCR METAB, V67, P46, DOI 10.1210/jcem-67-1-46; Nelson AE, 1996, MOL CELL ENDOCRINOL, V124, P17, DOI 10.1016/S0303-7207(96)03928-7; POPOVTZER MM, 1981, CLIN RES, V29, pA418; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Reubi JC, 1996, CANCER RES, V56, P1922; Riminucci M, 2003, J CLIN INVEST, V112, P683, DOI 10.1172/JC120031899; Rowe PSN, 2004, BONE, V34, P303, DOI 10.1016/j.bone.2003.10.005; Rowe PSN, 1996, BONE, V18, P159, DOI 10.1016/8756-3282(95)00458-0; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; Saito H, 2003, J BIOL CHEM, V278, P2206, DOI 10.1074/jbc.M207872200; Schiavi SC, 2002, CURR OPIN NEPHROL HY, V11, P423, DOI 10.1097/00041552-200207000-00009; Seufert J, 2001, NEW ENGL J MED, V345, P1883, DOI 10.1056/NEJMoa010839; Shane E, 1997, J BONE MINER RES, V12, P1502, DOI 10.1359/jbmr.1997.12.9.1502; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Takeuchi Y, 2004, J CLIN ENDOCR METAB, V89, P3979, DOI 10.1210/jc.2004-0406; WEIDNER N, 1987, CANCER, V59, P1442, DOI 10.1002/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; WILKINS GE, 1995, J CLIN ENDOCR METAB, V80, P1628, DOI 10.1210/jc.80.5.1628; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105	50	146	147	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2005	294	10					1260	1267						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963UI	16160135				2022-12-28	WOS:000231831200024
J	Menzies, D; Scholey, G				Menzies, D; Scholey, G			Welsh rarebits	LANCET			English	Editorial Material									Morriston Hosp, Swansea NHS Trust, Dept Med, Swansea SA6 6NL, W Glam, Wales	Morriston Hospital	Menzies, D (corresponding author), Morriston Hosp, Swansea NHS Trust, Dept Med, Swansea SA6 6NL, W Glam, Wales.	Daniel@menzies98.fsnet.co.uk							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					932	932		10.1016/S0140-6736(05)67320-5	http://dx.doi.org/10.1016/S0140-6736(05)67320-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154021				2022-12-28	WOS:000231770000032
J	Nakatsuji, S; Nambu, Y; Tonomura, H; Sakai, O; Jonas, S; Broholm, C; Tsunetsugu, H; Qiu, YM; Maeno, Y				Nakatsuji, S; Nambu, Y; Tonomura, H; Sakai, O; Jonas, S; Broholm, C; Tsunetsugu, H; Qiu, YM; Maeno, Y			Spin disorder on a triangular lattice	SCIENCE			English	Article							PHASE-TRANSITION; NEEL ORDER; FRUSTRATION	As liquids crystallize into solids on cooling, spins in magnets generally form periodic order. However, three decades ago, it was theoretically proposed that spins on a triangular lattice form a liquidlike disordered state at low temperatures. Whether or not a spin liquid is stabilized by geometrical frustration has remained an active point of inquiry ever since. Our thermodynamic and neutron measurements on NiGa2S4, a rare example of a two-dimensional triangular lattice antiferromagnet, demonstrate that geometrical frustration stabilizes a low-temperature spin-disordered state with coherence beyond the two-spin correlation length. Spin liquid formation may be an origin of such behavior.	Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068502, Japan; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Natl Inst Stand & Technol, Ctr Neutron Res, Gaithersburg, MD 20899 USA; Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA; Kyoto Univ, Int Innovat Ctr, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Johns Hopkins University; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; Kyoto University	Nakatsuji, S (corresponding author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.	nakatsuji@scphys.kyoto-u.ac.jp	Broholm, Collin Leslie/E-8228-2011; Nambu, Yusuke/C-3863-2012	Broholm, Collin Leslie/0000-0002-1569-9892; Nambu, Yusuke/0000-0003-1167-7124				AFFLECK I, 1989, J PHYS-CONDENS MAT, V1, P3047, DOI 10.1088/0953-8984/1/19/001; BEATTIE JA, 1926, J MATH PHYS, V6, P1; BERNU B, 1992, PHYS REV LETT, V69, P2590, DOI 10.1103/PhysRevLett.69.2590; Capriotti L, 1999, PHYS REV LETT, V82, P3899, DOI 10.1103/PhysRevLett.82.3899; CHANDRA P, 1991, PHYS REV LETT, V66, P100, DOI 10.1103/PhysRevLett.66.100; Collins MF, 1997, CAN J PHYS, V75, P605, DOI 10.1139/cjp-75-9-605; HUSE DA, 1988, PHYS REV LETT, V60, P2531, DOI 10.1103/PhysRevLett.60.2531; Ishida K, 1997, PHYS REV LETT, V79, P3451, DOI 10.1103/PhysRevLett.79.3451; Kashima T, 2001, J PHYS SOC JPN, V70, P3052, DOI 10.1143/JPSJ.70.3052; KAWAMURA H, 1984, J PHYS SOC JPN, V53, P4138, DOI 10.1143/JPSJ.53.4138; LUTZ HD, 1986, Z ANORG ALLG CHEM, V533, P118, DOI 10.1002/zaac.19865330215; Misguich G, 2005, FRUSTRATED SPIN SYSTEMS, P229, DOI 10.1142/9789812567819_0005; Morita H, 2002, J PHYS SOC JPN, V71, P2109, DOI 10.1143/JPSJ.71.2109; Mydosh J. A., 1993, SPIN GLASSES EXPT IN; RAMIREZ AP, 1990, PHYS REV LETT, V64, P2070, DOI 10.1103/PhysRevLett.64.2070; Ramirez AP, 2000, PHYS REV LETT, V84, P2957, DOI 10.1103/PhysRevLett.84.2957; Ramirez AP., 2001, HDB MAGNETIC MAT, Vvol 13, P423, DOI DOI 10.1016/S1567-2719(01)13008-8; Shimizu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107001; Sindzingre P, 2000, PHYS REV LETT, V84, P2953, DOI 10.1103/PhysRevLett.84.2953; Takada K, 2003, NATURE, V422, P53, DOI 10.1038/nature01450; TAKEDA K, 1992, J PHYS SOC JPN, V61, P2156, DOI 10.1143/JPSJ.61.2156; WANNIER GH, 1950, PHYS REV, V79, P357, DOI 10.1103/PhysRev.79.357; Wills AS, 1998, EUROPHYS LETT, V42, P325, DOI 10.1209/epl/i1998-00250-2; Wilson J. A., 1985, METALLIC NONMETALLIC, P215	25	410	410	3	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1697	1700		10.1126/science.1114727	http://dx.doi.org/10.1126/science.1114727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151004				2022-12-28	WOS:000231836700036
J	Zhang, K; Lin, WC; Latham, JA; Riefler, GM; Schumacher, JM; Chan, C; Tatchell, K; Hawke, DH; Kobayashi, R; Dent, SYR				Zhang, K; Lin, WC; Latham, JA; Riefler, GM; Schumacher, JM; Chan, C; Tatchell, K; Hawke, DH; Kobayashi, R; Dent, SYR			The set1 methyltransferase orwoses IpI1 aurora kinase functions in chromosome segregation	CELL			English	Article							H3 LYSINE-4 METHYLATION; TYPE-1 PROTEIN PHOSPHATASE; HISTONE H3; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC PHOSPHORYLATION; COVALENT MODIFICATIONS; KINETOCHORE; COMPLEX; ACETYLATION	A balance in the activities of the Ipl1 Aurora kinase and the Glc7 phosphatase is essential for normal chromosome segregation in yeast. We report here that this balance is modulated by the Set1 methyltransferase. Deletion of SET1 suppresses chromosome loss in ipl1-2 cells. Conversely, combination of SET1 and GLC7 mutations is lethal. Strikingly, these effects are independent of previously defined functions for Set1 in transcription initiation and histone H3 methylation. We find that Set1 is required for methylation of conserved lysines in a kinetochore protein, Dam1. Biochemical and genetic experiments indicate that Dam1 methylation inhibits Ipl1-mediated phosphorylation of flanking serines. Our studies demonstrate that Set1 has important, unexpected functions in mitosis. Moreover, our findings suggest that antagonism between lysine methylation and serine phosphorylation is a fundamental mechanism for controlling protein function.	Univ Texas, MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Proteom Facil, Houston, TX 77030 USA; Univ Texas, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Dent, SYR (corresponding author), Univ Texas, MD Anderson Canc Ctr, Program Genes & Dev, 1515 Holcombe Blvd, Houston, TX 77030 USA.	syr@mdacc.tmc.edu	Tatchell, Kelly/A-9643-2009; Dent, Sharon YR/F-1746-2011; Schumacher, Jill/B-2932-2012	Dent, Sharon YR/0000-0002-4824-3269; Hawke, David/0000-0002-6102-7843	NCI NIH HHS [CA16672, P30 CA016672] Funding Source: Medline; NICHD NIH HHS [T32 HD007325, T32 HD07325] Funding Source: Medline; NIGMS NIH HHS [R01GM62181, R01 GM062181-03, R01 GM062181-04, R01 GM062181, R01 GM062181-05] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007325] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bloecher A, 1999, GENE DEV, V13, P517, DOI 10.1101/gad.13.5.517; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; CHAN CSM, 1993, GENETICS, V135, P677; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Corda Y, 1999, NAT GENET, V21, P204, DOI 10.1038/5991; Courtwright AM, 2002, DEV CELL, V3, P610, DOI 10.1016/S1534-5807(02)00332-5; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Edmondson DG, 2002, J BIOL CHEM, V277, P29496, DOI 10.1074/jbc.M200651200; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; FRANCISCO L, 1994, CELL MOL BIOL RES, V40, P207; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; Hong G, 2000, ARCH BIOCHEM BIOPHYS, V376, P288, DOI 10.1006/abbi.2000.1715; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Peggie MW, 2002, J CELL SCI, V115, P195; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schramke V, 2001, GENE DEV, V15, P1845, DOI 10.1101/gad.193901; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; SIKORSKI RS, 1989, GENETICS, V122, P19; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wu XL, 2001, BIOCHEMISTRY-US, V40, P7410, DOI 10.1021/bi002796k; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	53	117	119	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					723	734		10.1016/j.cell.2005.06.021	http://dx.doi.org/10.1016/j.cell.2005.06.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143104	Green Accepted, Bronze			2022-12-28	WOS:000231844300012
J	Thomas, PC; Parker, JW; McFadden, LA; Russell, CT; Stern, SA; Sykes, MV; Young, EF				Thomas, PC; Parker, JW; McFadden, LA; Russell, CT; Stern, SA; Sykes, MV; Young, EF			Differentiation of the asteroid Ceresas revealed by its shape	NATURE			English	Article							4 VESTA; AQUEOUS ALTERATION; ADAPTIVE OPTICS; SATELLITES; WATER; TOPOGRAPHY; EVOLUTION; MINERALS; SURFACES; DENSITY	The accretion of bodies in the asteroid belt was halted nearly 4.6 billion years ago by the gravitational influence of the newly formed giant planet Jupiter. The asteroid belt therefore preserves a record of both this earliest epoch of Solar System formation and variation of conditions within the solar nebula. Spectral features in reflected sunlight indicate that some asteroids have experienced sufficient thermal evolution to differentiate into layered structures(1). The second most massive asteroid - 4 Vesta - has differentiated to a crust, mantle and core(2,3). 1 Ceres, the largest and most massive asteroid, has in contrast been presumed to be homogeneous, in part because of its low density, low albedo and relatively featureless visible reflectance spectrum, similar to carbonaceous meteorites that have suffered minimal thermal processing(4). Here we show that Ceres has a shape and smoothness indicative of a gravitationally relaxed object. Its shape is significantly less flattened than that expected for a homogeneous object, but is consistent with a central mass concentration indicative of differentiation. Possible interior configurations include water-ice-rich mantles over a rocky core.	Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; SwRI, Dept Space Studies, Boulder, CO 80302 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Univ Calif Los Angeles, IGPP & ESS, Los Angeles, CA 90095 USA; Planetary Sci Inst, Tucson, AZ 85719 USA	Cornell University; Southwest Research Institute; University System of Maryland; University of Maryland College Park; University of California System; University of California Los Angeles	Thomas, PC (corresponding author), Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA.	thomas@baritone.astro.cornell.edu	Russell, Christopher T/E-7745-2012; McFadden, Lucy-Ann/I-4902-2013	Russell, Christopher T/0000-0003-1639-8298; McFadden, Lucy-Ann/0000-0002-0537-9975; Parker, Joel/0000-0002-3672-0603				Britt DT, 2003, METEORIT PLANET SCI, V38, P1161, DOI 10.1111/j.1945-5100.2003.tb00305.x; Chandrasekhar S., 1969, Ellipsoidal figures of equilibrium; DERMOTT SF, 1979, ICARUS, V37, P575, DOI 10.1016/0019-1035(79)90015-0; Drummond JD, 1998, ICARUS, V132, P80, DOI 10.1006/icar.1997.5882; FANALE FP, 1989, ICARUS, V82, P97, DOI 10.1016/0019-1035(89)90026-2; FARINELLA P, 1992, ASTRON ASTROPHYS, V253, P604; FEIERBERG MA, 1981, GEOCHIM COSMOCHIM AC, V45, P971, DOI 10.1016/0016-7037(81)90121-6; Ghosh A, 1998, ICARUS, V134, P187, DOI 10.1006/icar.1998.5956; GRIMM RE, 1989, ICARUS, V82, P244, DOI 10.1016/0019-1035(89)90038-9; HESTROFFER D, 2004, B AM ASTRON SOC, V36, P861; JOHNSON TV, 1973, ICARUS, V18, P612, DOI 10.1016/0019-1035(73)90064-X; KING TVV, 1992, SCIENCE, V255, P1551, DOI 10.1126/science.255.5051.1551; LEBOFSKY LA, 1981, ICARUS, V48, P453, DOI 10.1016/0019-1035(81)90055-5; McCord TB, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002244; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; McSween H. Y., 2002, ASTEROIDS, P559; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Michalak G, 2000, ASTRON ASTROPHYS, V360, P363; MILLIS RL, 1987, ICARUS, V72, P507, DOI 10.1016/0019-1035(87)90048-0; PARKER J, IN PRESS ADV SPACE R; PAVLOVSKY C, 2004, ACS INSTRUMENT HDB V; Rivkin A.S., 1997, THESIS U ARIZONA; SAINTPE O, 1993, ICARUS, V105, P263, DOI 10.1006/icar.1993.1124; SCHENK PM, 1989, J GEOPHYS RES-SOLID, V94, P3813, DOI 10.1029/JB094iB04p03813; Thomas PC, 1997, SCIENCE, V277, P1492, DOI 10.1126/science.277.5331.1492; Thomas PC, 1998, ICARUS, V135, P175, DOI 10.1006/icar.1998.5987; THOMAS PC, 1993, ICARUS, V105, P326, DOI 10.1006/icar.1993.1130; Veverka J, 1997, SCIENCE, V278, P2109, DOI 10.1126/science.278.5346.2109; Viateau B, 2001, ASTRON ASTROPHYS, V370, P602, DOI 10.1051/0004-6361:20010222; Wilson L, 1999, METEORIT PLANET SCI, V34, P541, DOI 10.1111/j.1945-5100.1999.tb01362.x	30	198	199	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2005	437	7056					224	226		10.1038/nature03938	http://dx.doi.org/10.1038/nature03938			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148926				2022-12-28	WOS:000231696900048
J	Fleming, VM; Schindler, N; Martin, GJ; DaRosa, DA				Fleming, VM; Schindler, N; Martin, GJ; DaRosa, DA			Separate and equitable promotion tracks for clinician-educators	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACADEMIC PROMOTION; FACULTY TRACKS; SCHOLARSHIP; APPOINTMENT; MEDICINE; TENURE; CRITERIA; POLICIES; COLLEGE; SUCCESS		Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Fleming, VM (corresponding author), Northwestern Univ, Feinberg Sch Med, 251 E Huron St,Galter 3-150, Chicago, IL 60611 USA.	vfleming@northwestern.edu						ALXEANDER H, 2005, REPORT FACULTY TRACK; Association of American Medical Colleges, MEDEDPORTAL; Atasoylu AA, 2003, J GEN INTERN MED, V18, P711, DOI 10.1046/j.1525-1497.2003.10425.x; Barchi RL, 2000, ACAD MED, V75, P899, DOI 10.1097/00001888-200009000-00011; Boyer EL, 1990, SCHOLARSHIP RECONSID; Buckley LM, 2000, ARCH INTERN MED, V160, P2625, DOI 10.1001/archinte.160.17.2625; Glassick CE, 2000, ACAD MED, V75, P877, DOI 10.1097/00001888-200009000-00007; Hafler JP, 2000, ACAD MED, V75, P649, DOI 10.1097/00001888-200006000-00018; Howell LP, 2004, ACAD MED, V79, P250, DOI 10.1097/00001888-200403000-00012; JACOBS MB, 1992, ACAD MED, V67, P623, DOI 10.1097/00001888-199210000-00001; Jones RF, 1998, ACAD MED, V73, P212, DOI 10.1097/00001888-199802000-00023; Jones RF, 2001, ACAD MED, V76, P993, DOI 10.1097/00001888-200110000-00006; KELLEY WN, 1992, ANN INTERN MED, V116, P654, DOI 10.7326/0003-4819-116-8-654; Larson RJ, 2005, ARCH INTERN MED, V165, P645, DOI 10.1001/archinte.165.6.645; Levinson W, 1999, NEW ENGL J MED, V341, P840, DOI 10.1056/NEJM199909093411111; Lubitz RM, 1997, J GEN INTERN MED, V12, pS71, DOI 10.1046/j.1525-1497.12.s2.10.x; Lucey CR, 2003, J GEN INTERN MED, V18, P768, DOI 10.1046/j.1525-1497.2003.30701.x; Nora LM, 2000, ACAD MED, V75, P913, DOI 10.1097/00001888-200009000-00014; PARRIS M, 1984, J MED EDUC, V59, P465; Sherertz EF, 2000, ACAD MED, V75, P954, DOI 10.1097/00001888-200009000-00022; Shulman L., 1999, CHANGE, V31, P11; Simpson D, 2004, ACAD MED, V79, P783, DOI 10.1097/00001888-200408000-00014; Simpson DE, 2000, ACAD MED, V75, P930, DOI 10.1097/00001888-200009000-00016; Thomas PA, 2004, ACAD MED, V79, P258, DOI 10.1097/00001888-200403000-00013; Waldman JD, 2004, HEALTH CARE MANAGE R, V29, P2, DOI 10.1097/00004010-200401000-00002	25	74	74	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2005	294	9					1101	1104		10.1001/jama.294.9.1101	http://dx.doi.org/10.1001/jama.294.9.1101			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XU	16145031				2022-12-28	WOS:000231627300011
J	Ludmerer, KM; Johns, MME				Ludmerer, KM; Johns, MME			Reforming graduate medical education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESIDENT WORK HOURS; NEW-MODEL; PHYSICIAN; REGULATIONS	Because of the traditional subordination of education to service, graduate medical education (GME) in the United States has never realized its full educational potential. This article suggests 4 strategies for reasserting the primacy of education in GME: limit the number of patients house officers manage at one time, relieve the resident staff of noneducational chores, improve educational content, and ease emotional stresses. Achieving these goals will require regulatory reform, adequate funding, and institutional competency in the use of educational resources. Modern medicine grows ever more complex. The need to address the deficiencies of GME is urgent.	Washington Univ, Dept Med, St Louis, MO 63110 USA; Washington Univ, Dept Hist, St Louis, MO 63110 USA; Emory Univ, Robert W Woodruff Hlth Sci Ctr, Atlanta, GA 30322 USA	Washington University (WUSTL); Washington University (WUSTL); Emory University	Ludmerer, KM (corresponding author), Washington Univ, Dept Med, 660 S Euclid Ave,Campus Box 8066, St Louis, MO 63110 USA.	kludmere@im.wustl.edu						*AD HOC COMM DEANS, 2004, ED DOCT PROV HIGH QU; Barone JE, 2004, ACAD MED, V79, P379, DOI 10.1097/00001888-200405000-00002; Boex JR, 2003, ACAD MED, V78, P939, DOI 10.1097/00001888-200309000-00022; Charap M, 2004, ANN INTERN MED, V140, P814, DOI 10.7326/0003-4819-140-10-200405180-00011; Citizens Commission on Graduate Medical Education, 1966, GRAD ED PHYS; Coggeshall LT, 1966, PLANNING MED PROGR E; Cohen JJ, 1999, ACAD MED, V74, P108, DOI 10.1097/00001888-199902000-00009; *COMM FUND TASK FO, 2002, TRAIN TOM DOCT; Commission on Graduate Medical Education, 1940, GRAD MED ED REP COMM; *COUNC GRAD MED ED, 1999, 13 US DEP HHS COUNC; DARVES B, 2003, ACP OBSERVER, V1, P8; Drazen JM, 2004, NEW ENGL J MED, V351, P1884, DOI 10.1056/NEJMe048276; Fischer JE, 2004, ACAD MED, V79, P381, DOI 10.1097/00001888-200405000-00004; Flexner A, 1925, MED ED COMP STUDY; Flexner A., 1910, FLEXNER REPORT; Glines ME, 2004, ANN INTERN MED, V140, P818, DOI 10.7326/0003-4819-140-10-200405180-00013; Goroll AH, 2004, ANN INTERN MED, V140, P902, DOI 10.7326/0003-4819-140-11-200406010-00012; *I MED, 2003, AC HLTH CTR LEAD CHA; Institute of Medicine, 2003, HLTH PROF ED BRIDG Q; Johns MME, 2001, JAMA-J AM MED ASSOC, V286, P1075, DOI 10.1001/jama.286.9.1075; Ludmerer K., 1999, TIME HEAL AM MED ED; Ludmerer KM, 2004, NEW ENGL J MED, V351, P1163, DOI 10.1056/NEJMp048112; Mukherjee S, 2004, NEW ENGL J MED, V351, P1822, DOI 10.1056/NEJMp048085; Nishimura RA, 2004, ACAD MED, V79, P426, DOI 10.1097/00001888-200405000-00011; Ofri D, 2004, NEW ENGL J MED, V351, P1824, DOI 10.1056/NEJMp038251; Schroeder SA, 2004, ANN INTERN MED, V140, P838, DOI 10.7326/0003-4819-140-10-200405180-00017; Skeff KM, 2004, ANN INTERN MED, V140, P816, DOI 10.7326/0003-4819-140-10-200405180-00012; The Blue Ridge Academic Health Group, 2003, 7 EM U BLUE RIDG AC; WILLIAMS S, 2002, ACAD PHYS SCI    SEP, P1	29	64	65	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2005	294	9					1083	1087		10.1001/jama.294.9.1083	http://dx.doi.org/10.1001/jama.294.9.1083			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XU	16145029				2022-12-28	WOS:000231627300009
J	Shankar, SK; Satishchandra, P				Shankar, SK; Satishchandra, P			Did BSE in the UK originate from the Indian subcontinent?	LANCET			English	Editorial Material							CREUTZFELDT-JAKOB-DISEASE		Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India	National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India	Shankar, SK (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India.	shankar@nimhans.kar.nic.in						Alley KD, 2002, BANKS GANGA; Colchester ACF, 2005, LANCET, V366, P856, DOI 10.1016/S0140-6736(05)67218-2; Donnelly CA, 2002, CR BIOL, V325, P793, DOI 10.1016/S1631-0691(02)01486-5; Donnelly CA, 2002, P ROY SOC B-BIOL SCI, V269, P2179, DOI 10.1098/rspb.2002.2156; DONNELLY CA, 1997, APPL STAT, V4, P321; Johnson RT, 1998, NEW ENGL J MED, V339, P1994, DOI 10.1056/NEJM199812313392707; Mahadevan A, 2002, NEUROPATH APPL NEURO, V28, P314, DOI 10.1046/j.1365-2990.2002.00399.x; MASTERS CL, 1979, ANN NEUROL, V5, P177, DOI 10.1002/ana.410050212; SATISHCHANDRA P, 1991, NEUROEPIDEMIOLOGY, V10, P27, DOI 10.1159/000110244; SHANKAR SK, 2005, REPORT CREUTZFELDTJA; ZOLTNIK I, 1961, VET REC, V73, P543; 2005, BSE COMPILATION REPO	12	10	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2005	366	9488					790	791		10.1016/S0140-6736(05)67193-0	http://dx.doi.org/10.1016/S0140-6736(05)67193-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139641				2022-12-28	WOS:000231627000008
J	Mears, CA; Wentz, FJ				Mears, CA; Wentz, FJ			The effect of diurnal correction on satellite-derived lower tropospheric temperature	SCIENCE			English	Article							TEMPORAL HOMOGENIZATION; TRENDS; SURFACE	Satellite-based measurements of decadal-scale temperature change in the tower troposphere have indicated cooling relative to Earth's surface in the tropics. Such measurements need a diurnal correction to prevent drifts in the satellites' measurement time from causing spurious trends. We have derived a diurnal correction that, in the tropics, is of the opposite sign from that previously applied. When we use this correction in the calculation of lower tropospheric temperature from satellite microwave measurements, we find tropical warming consistent with that found at the surface and in our satellite-derived version of middie/upper tropospheric temperature.	Remote Sensing Syst, Alameda, CA 94501 USA		Mears, CA (corresponding author), Remote Sensing Syst, 438 1st St,Suite 200, Alameda, CA 94501 USA.							Christy JR, 2000, J ATMOS OCEAN TECH, V17, P1153, DOI 10.1175/1520-0426(2000)017<1153:MTTDCA>2.0.CO;2; Christy JR, 2003, J ATMOS OCEAN TECH, V20, P613, DOI 10.1175/1520-0426(2003)20<613:EEOVOM>2.0.CO;2; Fu Q, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022266; Fu Q, 2004, J CLIMATE, V17, P4636, DOI 10.1175/JCLI-3267.1; Fu Q, 2004, NATURE, V429, P55, DOI 10.1038/nature02524; Gaffen DJ, 2000, J CLIMATE, V13, P1776, DOI 10.1175/1520-0442(2000)013<1776:SOTAST>2.0.CO;2; Grody NC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005079; Hansen J, 2001, J GEOPHYS RES-ATMOS, V106, P23947, DOI 10.1029/2001JD000354; HOUGHTON JT, 2001, 3 INT PAN CLIM CHANG; Hurrell JW, 1998, J CLIMATE, V11, P945, DOI 10.1175/1520-0442(1998)011<0945:DIORTT>2.0.CO;2; Huurell JW, 2000, B AM METEOROL SOC, V81, P2165, DOI 10.1175/1520-0477(2000)081<2165:COTTFR>2.3.CO;2; Lanzante JR, 2003, J CLIMATE, V16, P224, DOI 10.1175/1520-0442(2003)016<0224:THOMRT>2.0.CO;2; Lanzante JR, 2003, J CLIMATE, V16, P241, DOI 10.1175/1520-0442(2003)016<0241:THOMRT>2.0.CO;2; Mears CA, 2003, J CLIMATE, V16, P3650, DOI 10.1175/1520-0442(2003)016<3650:AROTMC>2.0.CO;2; MEARS CA, 2002, P INT GEOPH REM SENS, V3, P1839; Prabhakara C, 2000, GEOPHYS RES LETT, V27, P3517, DOI 10.1029/2000GL011719; Santer BD, 2005, SCIENCE, V309, P1551, DOI 10.1126/science.1114867; Santer BD, 2003, SCIENCE, V300, P1280, DOI 10.1126/science.1082393; Santer BD, 2000, SCIENCE, V287, P1227, DOI 10.1126/science.287.5456.1227; Seidel DJ, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005526; Smith TM, 2005, J CLIMATE, V18, P2021, DOI 10.1175/JCLI3362.1; SPENCER RW, 1992, J CLIMATE, V5, P858, DOI 10.1175/1520-0442(1992)005<0858:PARVOS>2.0.CO;2; Tett S, 2004, NATURE, V432, DOI 10.1038/nature03208; THORNE PW, IN PRESS J GEOPHYS R; Trenberth KE, 2005, CLIM DYNAM, V24, P741, DOI 10.1007/s00382-005-0017-4; Vinnikov KY, 2003, SCIENCE, V302, P269, DOI 10.1126/science.1087910; WALLACE JM, 2000, RECONCILING OBSERVAT; Wentz FJ, 2000, NATURE, V403, P414, DOI 10.1038/35000184; Wentz FJ, 1998, NATURE, V394, P661, DOI 10.1038/29267	29	132	138	4	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1548	1551		10.1126/science.1114772	http://dx.doi.org/10.1126/science.1114772			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141071				2022-12-28	WOS:000231715000046
J	Meyer, JC; Paillet, M; Roth, S				Meyer, JC; Paillet, M; Roth, S			Single-molecule torsional pendulum	SCIENCE			English	Article							CARBON NANOTUBES	We have built a torsional pendulum based on an individual single-waited carbon nanotube, which is used as a torsional spring and mechanical support for the moving part. The moving part can be rotated by an electric field, resulting in large but fully elastic torsional deformations of the nanotube. As a result of the extremely small restoring force associated with the torsional deformation of a single molecule, unusually large oscillations are excited by the thermal energy of the pendulum. By diffraction analysis, we are able to determine the handedness of the molecule in our device. Mechanical devices with molecular-scale components are potential building blocks for nanoelectromechanical systems and may also serve as sensors or actuators.	Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; Univ Montpellier 2, Lab Colloides Verres & Nanomat, F-34095 Montpellier, France	Max Planck Society; Universite de Montpellier	Meyer, JC (corresponding author), Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany.	j.meyer@fkf.mpg.de	Meyer, Jannik C/H-8541-2012	Meyer, Jannik C/0000-0003-4023-0778				Bourlon B, 2004, NANO LETT, V4, P709, DOI 10.1021/nl035217g; Carr DW, 1999, APPL PHYS LETT, V75, P920, DOI 10.1063/1.124554; Fennimore AM, 2003, NATURE, V424, P408, DOI 10.1038/nature01823; Gao M, 2003, APPL PHYS LETT, V82, P2703, DOI 10.1063/1.1569418; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Lu JP, 1997, PHYS REV LETT, V79, P1297, DOI 10.1103/PhysRevLett.79.1297; Meyer JC, 2004, APPL PHYS LETT, V85, P2911, DOI 10.1063/1.1805701; MEYER JC, IN PRESS ULTRAMICROS; Paillet M, 2004, J PHYS CHEM B, V108, P17112, DOI 10.1021/jp0471711; Pantano A, 2004, J APPL PHYS, V96, P6756, DOI 10.1063/1.1809252; Papadakis SJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.146101; Williams PA, 2003, APPL PHYS LETT, V82, P805, DOI 10.1063/1.1538346	13	127	129	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1539	1541		10.1126/science.1115067	http://dx.doi.org/10.1126/science.1115067			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141068				2022-12-28	WOS:000231715000043
J	Jiang, ZB; Tamura, M; Fukagawa, M; Hough, J; Lucas, P; Suto, H; Ishii, M; Yang, J				Jiang, ZB; Tamura, M; Fukagawa, M; Hough, J; Lucas, P; Suto, H; Ishii, M; Yang, J			A circumstellar disk associated with a massive protostellar object	NATURE			English	Article							BECKLIN-NEUGEBAUER OBJECT; YOUNG STELLAR OBJECTS; IMAGING POLARIMETRY; MAGNETIC-FIELD; INFRARED POLARIMETRY; MOLECULAR CLOUD; STAR FORMATION; ORION-NEBULA; REGION; TELESCOPE	The formation process for stars with masses several times that of the Sun is still unclear. The two main theories are mergers of several low-mass young stellar objects(1), which requires a high stellar density, or mass accretion from circumstellar disks in the same way as low-mass stars are formed(2), accompanied by outflows during the process of gravitational infall. Although a number of disks have been discovered around low- and intermediate-mass young stellar objects(3,4), the presence of disks around massive young stellar objects is still uncertain and the mass of the disk system detected around one such object(5), M17, is disputed(6). Here we report near-infrared imaging polarimetry that reveals an outflow/ disk system around the Becklin - Neugebauer protostellar object, which has a mass of at least seven solar masses (M-.). This strongly supports the theory that stars with masses of at least 7M(.) form in the same way as lower mass stars.	Chinese Acad Sci, Purple Mt Observ, Nanjing 210008, Peoples R China; Natl Astron Observ Japan, Tokyo 1818588, Japan; Univ Hertfordshire, Dept Phys Astron & Math, Hatfield AL10 9AB, Herts, England	Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Hertfordshire	Jiang, ZB (corresponding author), Chinese Acad Sci, Purple Mt Observ, Nanjing 210008, Peoples R China.	zbjiang@pmo.ac.cn		Fukagawa, Misato/0000-0003-1117-9213; Fukagawa, Masafumi/0000-0002-7832-2339; Lucas, Philip/0000-0002-8872-4462				BECKLIN EE, 1967, ASTROPHYS J, V147, P799, DOI 10.1086/149055; Blum RD, 2004, ASTROPHYS J, V617, P1167, DOI 10.1086/425680; Bonnell IA, 1998, MON NOT R ASTRON SOC, V298, P93, DOI 10.1046/j.1365-8711.1998.01590.x; Chini R, 2004, NATURE, V429, P155, DOI 10.1038/nature02507; CHRYSOSTOMOU A, 1994, MON NOT R ASTRON SOC, V268, P325, DOI 10.1093/mnras/268.2.325; COHEN RJ, 1984, MON NOT R ASTRON SOC, V210, P425, DOI 10.1093/mnras/210.2.425; DAVIS L, 1951, ASTROPHYS J, V114, P206, DOI 10.1086/145464; GENZEL R, 1989, ANNU REV ASTRON ASTR, V27, P41, DOI 10.1146/annurev.aa.27.090189.000353; Gezari DY, 1998, ASTROPHYS J, V509, P283, DOI 10.1086/306462; Hillenbrand LA, 2001, ASTROPHYS J, V547, pL53, DOI 10.1086/318884; HOUGH JH, 1986, MON NOT R ASTRON SOC, V222, P629, DOI 10.1093/mnras/222.4.629; JONES TJ, 1989, ASTROPHYS J, V346, P728, DOI 10.1086/168054; Krumholz MR, 2005, ASTROPHYS J, V618, pL33, DOI 10.1086/427555; Lucas PW, 2004, MON NOT R ASTRON SOC, V352, P1347, DOI 10.1111/j.1365-2966.2004.08026.x; Matsumoto T, 2004, ASTROPHYS J, V616, P266, DOI 10.1086/424897; MINCHIN NR, 1991, MON NOT R ASTRON SOC, V248, P715, DOI 10.1093/mnras/248.4.715; ODELL CR, 1994, ASTROPHYS J, V436, P194, DOI 10.1086/174892; Perrin MD, 2004, SCIENCE, V303, P1345, DOI 10.1126/science.1094602; Sako S, 2005, NATURE, V434, P995, DOI 10.1038/nature03471; Schultz ASB, 1999, ASTROPHYS J, V511, P282, DOI 10.1086/306680; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; Shuping RY, 2004, ASTRON J, V128, P363, DOI 10.1086/421373; TAMURA M, 1988, MON NOT R ASTRON SOC, V231, P445, DOI 10.1093/mnras/231.2.445; Tamura M, 2003, P SOC PHOTO-OPT INS, V4843, P190, DOI 10.1117/12.458839; Tamura M, 2000, P SOC PHOTO-OPT INS, V4008, P1153, DOI 10.1117/12.395434; Tan JC, 2004, ASTROPHYS J, V607, pL47, DOI 10.1086/421721; WOLFIRE MG, 1987, ASTROPHYS J, V319, P850, DOI 10.1086/165503; Yorke HW, 2002, ASTROPHYS J, V569, P846, DOI 10.1086/339264	28	42	45	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					112	115		10.1038/nature04012	http://dx.doi.org/10.1038/nature04012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136137				2022-12-28	WOS:000231560400051
J	Srinivasan, M; Ruina, A				Srinivasan, M; Ruina, A			Computer optimization of a minimal biped model discovers walking and running	NATURE			English	Article							LOCOMOTION; ENERGETICS; GAITS; TRANSITION; SPEED	Although people's legs are capable of a broad range of muscle-use and gait patterns, they generally prefer just two. They walk, swinging their body over a relatively straight leg with each step, or run, bouncing up off a bent leg between aerial phases. Walking feels easiest when going slowly, and running feels easiest when going faster. More unusual gaits seem more tiring. Perhaps this is because walking and running use the least energy(1-7). Addressing this classic(1) conjecture with experiments(2,3) requires comparing walking and running with many other strange and unpractised gaits. As an alternative, a basic understanding of gait choice might be obtained by calculating energy cost by using mechanics-based models. Here we use a minimal model that can describe walking and running as well as an infinite variety of other gaits. We use computer optimization to find which gaits are indeed energetically optimal for this model. At low speeds the optimization discovers the classic inverted-pendulum walk(8-13), at high speeds it discovers a bouncing run(12,13), even without springs, and at intermediate speeds it finds a new pendular-running gait that includes walking and running as extreme cases.	Cornell Univ, Biorobot & Locomot Lab, Ithaca, NY 14853 USA	Cornell University	Srinivasan, M (corresponding author), Cornell Univ, Biorobot & Locomot Lab, 306 Kimball Hall, Ithaca, NY 14853 USA.	ms285@cornell.edu	Srinivasan, Manoj/E-8751-2011; Ruina, Andy L/A-8725-2018	Srinivasan, Manoj/0000-0002-7811-3617; Ruina, Andy L/0000-0001-5493-6048				ALEXANDER RM, 1992, PHILOS T ROY SOC B, V338, P189, DOI 10.1098/rstb.1992.0138; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; ALEXANDER RM, 1980, J ZOOL, V192, P97, DOI 10.1111/j.1469-7998.1980.tb04222.x; ALEXANDER RM, 2003, APPL MECH REV, V48, P461; Alexander RM., 1976, PERSPECTIVES EXPT BI, P493; Alexander RM., 1988, ELASTIC MECH ANIMAL; Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; Bertram JEA, 2002, J MOTOR BEHAV, V34, P309, DOI 10.1080/00222890209601949; BLICKHAN R, 1993, J COMP PHYSIOL A, V173, P509; BORELLI GA, 1680, MOTU ANIMALIUM PARS; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Bryson A.E., 2018, APPL OPTIMAL CONTROL, P90, DOI 10.1201/9781315137667-3; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; FARLEY CT, 2005, J APPL PHYSL    0728, DOI DOI 10.1152/JAPPLPHYSIOL.00103.2005; Gill PE, 2002, SIAM J OPTIMIZ, V12, P979, DOI 10.1137/S1052623499350013; Gordon K. E, 2003, P 27 ANN M AM SOC BI; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Margaria R., 1977, BIOMECHANICS ENERGET; Marsh RL, 2004, SCIENCE, V303, P80, DOI 10.1126/science.1090704; MCMAHON TA, 1990, J BIOMECH, V23, P65, DOI 10.1016/0021-9290(90)90042-2; MINETTI AE, 1994, ACTA PHYSIOL SCAND, V150, P315, DOI 10.1111/j.1748-1716.1994.tb09692.x; Minetti AE, 1997, J THEOR BIOL, V186, P467, DOI 10.1006/jtbi.1997.0407; Minetti AE, 1998, P ROY SOC B-BIOL SCI, V265, P1227, DOI 10.1098/rspb.1998.0424; Rashevsky N., 1944, BULL MATH BIO PHYS, V6, P1, DOI 10.1007/BF02478284; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; THORSTENSSON A, 1987, ACTA PHYSIOL SCAND, V131, P211, DOI 10.1111/j.1748-1716.1987.tb08228.x	30	382	395	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					72	75		10.1038/nature04113	http://dx.doi.org/10.1038/nature04113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16155564	Green Submitted			2022-12-28	WOS:000234378700036
J	Ayad, NG				Ayad, NG			CDKs give Cdc6 a license to drive into S phase	CELL			English	Editorial Material							ANAPHASE-PROMOTING COMPLEX; DESTRUCTION BOX; CELL-CYCLE; MITOSIS; REPLICATION; PROTEOLYSIS; DNA	The accumulation of Cdc6 promotes the initiation of DNA replication. In this issue of Cell, Mailand and Diffley (2005) show that phosphorylation of Cdc6 by cyclin-dependent kinases prevents its destruction by the anaphase promoting complex (APC). This simple mechanism explains how the APC simultaneously spares Cdc6 while targeting for destruction suppressors of DNA replication during the transition from quiescence to cell cycle reentry.	Scripps Florida, Dept Biomed Sci, Jupiter, FL 33458 USA	State University System of Florida; University of Florida	Ayad, NG (corresponding author), Scripps Florida, Dept Biomed Sci, 5353 Parkside Dr RF2, Jupiter, FL 33458 USA.							Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Wirth KG, 2004, GENE DEV, V18, P88, DOI 10.1101/gad.285404	15	14	15	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 23	2005	122	6					825	827		10.1016/j.cell.2005.09.001	http://dx.doi.org/10.1016/j.cell.2005.09.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179249	Bronze			2022-12-28	WOS:000232130200004
J	Gurnett, DA; Kurth, WS				Gurnett, DA; Kurth, WS			Electron plasma oscillations upstream of the solar wind termination shock	SCIENCE			English	Article							WAVE OBSERVATIONS; VOYAGER-1; HELIOSHEATH; FREQUENCY; FORESHOCK	Electron plasma oscillations have been detected upstream of the solar wind termination shock by the plasma wave instrument on the Voyager 1 spacecraft. These waves were first observed on 11 February 2004, at a heliocentric radial distance of 91.0 astronomical units, and continued sporadically with a gradually increasing occurrence rate for nearly a year. The last event occurred on 15 December 2004, at 94.1 astronomical units, just before the spacecraft crossed the termination shock. Since then, no further electron plasma oscillations have been observed, consistent with the spacecraft having crossed the termination shock into the heliosheath.	Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA	University of Iowa	Gurnett, DA (corresponding author), Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA.	donaid-gurnett@uiowa.edu	Kurth, William/AAA-7334-2019	Kurth, William/0000-0002-5471-6202				Burlaga LF, 2005, SCIENCE, V309, P2027, DOI 10.1126/science.1117542; CAIRNS IH, 1987, J GEOPHYS RES, V92, P2329, DOI 10.1029/JA092iA03p02329; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; FILBERT PC, 1979, J GEOPHYS RES-SPACE, V84, P1369, DOI 10.1029/JA084iA04p01369; GURNETT DA, 1981, SCIENCE, V212, P235, DOI 10.1126/science.212.4491.235; GURNETT DA, 1986, SCIENCE, V233, P106, DOI 10.1126/science.233.4759.106; GURNETT DA, 1989, SCIENCE, V246, P1494, DOI 10.1126/science.246.4936.1494; GURNETT DA, 2005, INTRO PLASMA PHYS, P328; HUNDHAUSEN AJ, 1972, CORONAL EXPANSION SO, P11; KURTH WS, 1993, J GEOPHYS RES-SPACE, V98, P15129, DOI 10.1029/93JA01176; REINER MJ, 1992, COSPAR COLL, V3, P657; RICHARDSON JD, IN PRESS J GEOPHYS R; SCARF FL, 1979, SCIENCE, V204, P991, DOI 10.1126/science.204.4396.991; SCARF FL, 1971, J GEOPHYS RES, V76, P5162, DOI 10.1029/JA076i022p05162; SCARF FL, 1979, SCIENCE, V203, P748, DOI 10.1126/science.203.4382.748; SCARF FL, 1977, SPACE SCI REV, V21, P5162; Stix T. H., 1962, THEORY PLASMA WAVES, P10; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; Tonks L, 1929, PHYS REV, V33, P195, DOI 10.1103/PhysRev.33.195	19	70	71	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2005	309	5743					2025	2027		10.1126/science.1117425	http://dx.doi.org/10.1126/science.1117425			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179470				2022-12-28	WOS:000232181900040
J	Pimenta, BVS; Haddad, CFB; Nascimento, LB; Cruz, CAG; Pombal, JP				Pimenta, BVS; Haddad, CFB; Nascimento, LB; Cruz, CAG; Pombal, JP			Comment on "Status and trends of amphibian declines and extinctions worldwide"	SCIENCE			English	Editorial Material									Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, BR-20940040 Rio de Janeiro, Brazil; Univ Estadual Paulista, Inst Biociencias, Dept Zool, BR-13506900 Rio Claro, SP, Brazil; Pontificia Univ Catolica Minas Gerais, Dept Ciencias Biol, Museu Cienciias Nat, BR-30535610 Belo Horizonte, MG, Brazil	Universidade Federal do Rio de Janeiro; Universidade Estadual Paulista; Pontificia Universidade Catolica de Minas Gerais	Pimenta, BVS (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Quinta Boa Vista, BR-20940040 Rio de Janeiro, Brazil.	brunopimenta@mn.ufrj.br	Pombal, Jose P/C-6365-2015; Nascimento, Luciana B/B-8190-2013; Haddad, Célio F. B./C-4267-2012	Pombal, Jose P/0000-0003-4900-630X; Haddad, Célio F. B./0000-0002-7044-5764				Baillie J. E., 2004, GLOBAL SPECIES ASSES; CARAMASCHI U, 2004, ARQ MUS NAC, V62, P191; Cruz C.A.G., 2000, B MUSEU NACL, V434, P1; Dixo Marianna, 2004, Phyllomedusa, V3, P77; Feio RN, 2003, AMPHIBIA-REPTILIA, V24, P108; FROST DR, 2004, AMPHIBIAN SPECIES WO; Gardenfors U, 2001, TRENDS ECOL EVOL, V16, P511, DOI 10.1016/S0169-5347(01)02214-5; Haddad CFB, 2004, ZOOTAXA, P1; IUCN CONSERVATION INTERNATIONAL AND NATURESERVE, 2004, GLOB AMPH ASS; *IUCN WORLD CONS U, 2001, IUCN RED LIST CATEGO; Lutz B., 1973, BRAZILIAN SPECIES HY; Nascimento LB, 2001, J ZOOL, V254, P421, DOI 10.1017/S0952836901000917; Peixoto O.L., 1987, Senckenbergiana Biologica, V68, P1; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Pugliese A, 2004, ZOOTAXA, P1; *SOC BRAS HERP, 2004, LIST ESP ANF BRAS; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Young B.E., 2004, DISAPPEARING JEWELS; ZAHER H, IN PRESS ARQ MUS NAC	19	48	54	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743								10.1126/science.1112996	http://dx.doi.org/10.1126/science.1112996			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179460				2022-12-28	WOS:000232181900025
J	Yamamoto, J; Nishiyama, I; Inoue, M; Yokoyama, H				Yamamoto, J; Nishiyama, I; Inoue, M; Yokoyama, H			Optical isotropy and iridescence in a smectic 'blue phase'	NATURE			English	Article							LIQUID-CRYSTAL	When liquid crystal molecules are chiral, the twisted structure competes with spatially uniform liquid crystalline orders, resulting in a variety of modulated liquid crystal phases, such as the cholesteric blue phase(1), twist grain boundary(2 - 4) and smectic blue phases(5). Here we report a liquid crystal smectic blue phase ( SmBPiso), formed from a two- component mixture containing a chiral monomer and a ' twin' containing two repeat units of the first molecule connected by a linear hydrocarbon spacer. The phase exhibits the simultaneous presence of finite local- order parameters of helices and smectic layers, without any discontinuity on a mesoscopic length scale. The anomalous softening of elasticity due to a strong reduction in entropy caused by mixing the monomer and the twin permits the seamless coexistence of these two competing liquid crystal orders. The new phase spontaneously exhibits an optically isotropic but uniformly iridescent colour and automatically acquires spherical symmetry, so that the associated photonic band gap(6 - 9) maintains the same symmetry despite the local liquid crystalline order. We expect a range of unusual optical transmission properties based on this three-dimensional isotropic structure, and complete tunability due to the intrinsic softness and responsiveness of the liquid crystalline order against external fields.	ERATO, Yokoyama Nanostruct Liquid Crystal Project, JST, Tsukuba, Ibaraki 3002635, Japan; AIST, Nanotechnol Res Inst, Tsukuba, Ibaraki 3058568, Japan	Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Yamamoto, J (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan.	jun@junyamamoto.jp						Busch K, 1999, PHYS REV LETT, V83, P967, DOI 10.1103/PhysRevLett.83.967; DiDonna BA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215504; Dierking I, 1999, LIQ CRYST, V26, P83, DOI 10.1080/026782999205588; GOODBY JW, 1989, NATURE, V337, P449, DOI 10.1038/337449a0; JOHN S, 1984, PHYS REV LETT, V53, P2169, DOI 10.1103/PhysRevLett.53.2169; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; KETZEROW HS, 2002, CHIRALITY LIQUID CRY, P186; MACKINTOSH FC, 1991, PHYS REV LETT, V67, P1169, DOI 10.1103/PhysRevLett.67.1169; Niori T, 1996, J MATER CHEM, V6, P1231, DOI 10.1039/jm9960601231; Nishiyama I, 2001, J MATER CHEM, V11, P2690, DOI 10.1039/b105268n; Pansu B, 2000, PHYS REV E, V62, P658, DOI 10.1103/PhysRevE.62.658; RENN SR, 1988, PHYS REV A, V38, P2132, DOI 10.1103/PhysRevA.38.2132; Thisayukta J, 2001, JPN J APPL PHYS 1, V40, P3277, DOI 10.1143/JJAP.40.3277; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; YAMAMOTO J, 1991, JPN J APPL PHYS 1, V30, P754, DOI 10.1143/JJAP.30.754; Yamamoto J, 2001, NATURE, V409, P321, DOI 10.1038/35053035; Zhong-can O.-Y., 1990, PHYS REV LETT, V65, P1679	17	48	49	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					525	528		10.1038/nature04034	http://dx.doi.org/10.1038/nature04034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177785				2022-12-28	WOS:000232004800044
J	Roberts, JM; Gammill, H				Roberts, JM; Gammill, H			Pre-eclampsia and cardiovascular disease in later life	LANCET			English	Editorial Material							WOMEN; RISK; PREGNANCY; ECLAMPSIA; HISTORY		Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roberts, JM (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15213 USA.	rsijmr@mail.magee.edu	Roberts, James/AAI-3283-2020	Roberts, James/0000-0002-2671-3207				Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Chesley LC, 2000, AM J OBSTET GYNECOL, V182, P249, DOI 10.1016/S0002-9378(00)70521-7; DAVIES AM, 1969, ISRAEL J MED SCI, V5, P1095; Funai EF, 2005, PAEDIATR PERINAT EP, V19, P59, DOI 10.1111/j.1365-3016.2004.00623.x; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Laivuori H, 1996, J CLIN ENDOCR METAB, V81, P2908, DOI 10.1210/jc.81.8.2908; LORENTZEN B, 1994, HYPERTENS PREGNANCY, V13, P103, DOI 10.3109/10641959409084177; Sattar N, 2003, HYPERTENSION, V42, P39, DOI 10.1161/01.HYP.0000074428.11168.EE; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P1011, DOI 10.1016/0002-9378(86)90336-4	10	44	47	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					961	962		10.1016/S0140-6736(05)67349-7	http://dx.doi.org/10.1016/S0140-6736(05)67349-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168757				2022-12-28	WOS:000231955900005
J	O'Donovan, P; Perrett, CM; Zhang, XH; Montaner, B; Xu, YZ; Harwood, CA; McGregor, JM; Walker, SL; Hanaoka, F; Karran, P				O'Donovan, P; Perrett, CM; Zhang, XH; Montaner, B; Xu, YZ; Harwood, CA; McGregor, JM; Walker, SL; Hanaoka, F; Karran, P			Azathioprine and UVA light generate mutagenic oxidative DNA damage	SCIENCE			English	Article							NONMELANOMA SKIN-CANCER; ORGAN-TRANSPLANTATION; MAMMALIAN-CELLS; REPLICATION; POLYMERASE; THERAPY; REPAIR; ULTRAVIOLET; RISK	Oxidative stress and mutagenic DNA lesions formed by reactive oxygen species (ROS) are linked to human malignancy. Clinical treatments inducing chronic oxidative stress may therefore carry a risk of therapy-related cancer. We suggest that immunosuppression by azathioprine (Aza) may be one such treatment. Aza causes the accumulation of 6-thioguanine (6-TG) in patients' DNA. Here we demonstrate that biologically relevant doses of ultraviolet A (UVA) generate ROS in cultured cells with 6-TG-substituted DNA and that 6-TG and UVA are synergistically mutagenic. A replication-blocking DNA 6-TG photoproduct, guanine sulfonate, was bypassed by error-prone, Y-family DNA polymerases in vitro. A preliminary analysis revealed that in five of five cases, Aza treatment was associated with a selective UVA photosensitivity. These findings may partly explain the prevalence of skin cancer in long-term survivors of organ transplantation.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Open Univ, Dept Chem, Milton Keynes MK7 6AA, Bucks, England; Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, Ctr Cutaneous Res, London E1 2AT, England; Kings Coll London, Guys Kings & St Thomas Sch Med, St Johns Inst Dermatol, Dept Photobiol, London SE1 7EH, England; RIKEN, Discovery Res Inst, Wako, Saitama 3510198, Japan	Cancer Research UK; Open University - UK; University of London; Queen Mary University London; University of London; King's College London; RIKEN	Karran, P (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	peter.karran@cancer.org.uk	Xu, Yao/A-7700-2010	Harwood, Catherine/0000-0002-1375-0965; Montaner, Beatriz/0000-0001-9877-7317; Xu, Yao/0000-0002-5713-8030	Cancer Research UK [A6695] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Berg RJW, 1998, J INVEST DERMATOL, V110, P405, DOI 10.1111/j.1523-1747.1998.00173.x; Branch P, 2000, ONCOGENE, V19, P3138, DOI 10.1038/sj.onc.1203668; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Cuffari C, 2004, DIGEST DIS SCI, V49, P133, DOI 10.1023/B:DDAS.0000011614.88494.ee; DOERR IL, 1961, J ORG CHEM, V26, P3401, DOI 10.1021/jo01067a093; DRISCOLL CMH, 2002, SOLAR RAD MEASUREMEN; DROBETSKY EA, 1995, P NATL ACAD SCI USA, V92, P2350, DOI 10.1073/pnas.92.6.2350; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; FINKEL JM, 1975, J PHARM SCI, V64, P121, DOI 10.1002/jps.2600640126; Glover MT, 1997, LANCET, V349, P398, DOI 10.1016/S0140-6736(97)80015-3; Gruz P, 2001, J BIOL CHEM, V276, P47394, DOI 10.1074/jbc.M107213200; HEMMENS VJ, 1986, PHOTOCHEM PHOTOBIOL, V43, P247, DOI 10.1111/j.1751-1097.1986.tb05601.x; Karran P, 2001, CARCINOGENESIS, V22, P1931, DOI 10.1093/carcin/22.12.1931; Lehmann AR, 2002, MUTAT RES-FUND MOL M, V509, P23, DOI 10.1016/S0027-5107(02)00227-0; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Massey A, 2001, CURR BIOL, V11, P1142, DOI 10.1016/S0960-9822(01)00272-X; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; PHEAR G, 1989, J MOL BIOL, V209, P577, DOI 10.1016/0022-2836(89)90595-0; RACKWITZ HR, 1974, CHEM BER-RECL, V107, P2284, DOI 10.1002/cber.19741070713; Ramsay HM, 2002, BRIT J DERMATOL, V147, P950, DOI 10.1046/j.1365-2133.2002.04976.x; RAPPAPORT HP, 1993, BIOCHEMISTRY-US, V32, P3047, DOI 10.1021/bi00063a016; Relling MV, 2001, NAT REV CANCER, V1, P99, DOI 10.1038/35101056; WARREN DJ, 1995, CANCER RES, V55, P1670; Young AR, 2000, J INVEST DERMATOL, V115, P37, DOI 10.1046/j.1523-1747.2000.00012.x	26	468	475	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2005	309	5742					1871	1874		10.1126/science.1114233	http://dx.doi.org/10.1126/science.1114233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166520	Green Accepted			2022-12-28	WOS:000231989500054
J	Abbott, A				Abbott, A			Paper, paper, everywhere ...	NATURE			English	News Item																			0	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2005	437	7057					310	310						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16173121				2022-12-28	WOS:000231849100014
J	Lobov, IB; Rao, S; Carroll, TJ; Vallance, JE; Ito, M; Ondr, JK; Kurup, S; Glass, DA; Patel, MS; Shu, WG; Morrisey, EE; McMahon, AP; Karsenty, G; Lang, RA				Lobov, IB; Rao, S; Carroll, TJ; Vallance, JE; Ito, M; Ondr, JK; Kurup, S; Glass, DA; Patel, MS; Shu, WG; Morrisey, EE; McMahon, AP; Karsenty, G; Lang, RA			WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature	NATURE			English	Article							RECEPTOR-RELATED PROTEIN-5; COLORECTAL-CANCER; MOUSE; EYE; PROLIFERATION; PROGRESSION; REGRESSION; ELEGANS; CATENIN; ROLES	Macrophages have a critical role in inflammatory and immune responses through their ability to recognize and engulf apoptotic cells(1). Here we show that macrophages initiate a cell-death programme in target cells by activating the canonical WNT pathway. We show in mice that macrophage WNT7b is a short-range paracrine signal required for WNT-pathway responses and programmed cell death in the vascular endothelial cells of the temporary hyaloid vessels of the developing eye. These findings indicate that macrophages can use WNT ligands to influence cell-fate decisions - including cell death - in adjacent cells, and raise the possibility that they do so in many different cellular contexts.	Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45229 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Natl Def Med Coll, Dept Anat, Tokorozawa, Saitama 3598513, Japan; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Mol Cardiol Res Ctr, Philadelphia, PA 19104 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Harvard University; National Defense Medical College - Japan; Baylor College of Medicine; University of Pennsylvania; University of Pennsylvania	Lang, RA (corresponding author), Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA.	Richard.Lang@cchmc.org	McMahon, Andrew P/ABE-7520-2020; Glass, Donald A/A-1908-2013; Lang, Richard/E-5578-2011; Glass, Donald/AGI-6735-2022	Glass, Donald/0000-0003-0866-770X; Lang, Richard/0000-0002-5212-254X; /0000-0001-7061-6837; Vallance, Jefferson/0000-0001-6473-3623	NATIONAL EYE INSTITUTE [R01EY015766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087825, U01HL100405] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY015766-02, R01 EY015766] Funding Source: Medline; NHLBI NIH HHS [R01 HL087825, U01 HL100405] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Diez-Roux G, 1999, DEVELOPMENT, V126, P2141; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Perrimon N, 1996, CELL, V86, P513, DOI 10.1016/S0092-8674(00)80124-5; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Shu WG, 2002, DEVELOPMENT, V129, P4831; Smith K, 1999, BRIT J CANCER, V81, P496, DOI 10.1038/sj.bjc.6690721; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	29	318	331	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					417	421		10.1038/nature03928	http://dx.doi.org/10.1038/nature03928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163358	Green Accepted			2022-12-28	WOS:000231849100055
J	Nicholson, S				Nicholson, S			Commentary: The benefits of aptitude testing for selecting medical students	BRITISH MEDICAL JOURNAL			English	Editorial Material									Queen Marys Sch Med & Dent, Inst Hlth Sci Educ, London E1 4NS, England	University of London; Queen Mary University London	Nicholson, S (corresponding author), Queen Marys Sch Med & Dent, Inst Hlth Sci Educ, London E1 4NS, England.	s.nicholson@qmul.ac.uk						Department of Health, 2004, MED SCH DEL DOCT FUT; Lumsden MA, 2005, MED EDUC, V39, P258, DOI 10.1111/j.1365-2929.2005.02087.x; McManus IC, 2005, BRIT MED J, V331, P555, DOI 10.1136/bmj.331.7516.555; Ross, 2003, HIGHER ED SOCIAL CLA; Schwartz, 2004, FAIR ADMISSIONS HIGH	5	23	23	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 10	2005	331	7516					559	560		10.1136/bmj.331.7516.559	http://dx.doi.org/10.1136/bmj.331.7516.559			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965GX	16150767	Green Published, Bronze			2022-12-28	WOS:000231939700020
J	Brotherton, SE; Rockey, PH; Etzel, SI				Brotherton, SE; Rockey, PH; Etzel, SI			US Graduate Medical Education, 2004-2005 - Trends in primary care specialties	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTETRICIAN-GYNECOLOGISTS	Context Over the last decade, the primary care specialties have experienced an ebb and flow in popularity. A description of the future primary care workforce may inform planning for the health care needs of our population. Objectives To describe characteristics of physicians training in primary care specialties over the past 9 years and to monitor trends in the characteristics of the entire residency population. Design, Setting, and Participants Descriptive survey study of the National GME Census, conducted by the American Medical Association and Association of American Medical Colleges, which jointly surveyed 8246 allopathic graduate medical education (GME) programs during the academic year 2004-2005 about active, transferred, and graduated residents, as well as about program characteristics. Program directors confirmed the status of 97.3% of active residents. The accompanying program survey was completed by 7163 (87%) of the program directors. Main Outcome Measures General trends in the numbers and characteristics of all residents, fellows, and training programs, with specific trends for residents and fellows training in the primary care specialties and subspecialties over the past 9 years. Results The census counted 101291 physicians-in-training during the 2004-2005 academic year, the largest number ever recorded by this survey. The number of osteopathic medical school graduates (DOS) in allopathic GME decreased from 5838 in 2003-2004 to 5,675, following many years of annual increases. The number of residents in primary care specialties reached a peak in the mid 1990s. The number of family medicine residents who are graduates of US allopathic medical schools (USMDs) has fallen from 8232 (77.6%) in 1998-1999 to 4848 (51.7%) in 2004-2005. The number of primary care residents who are graduates of foreign medical schools and US citizens (USIMGs) nearly doubled between 1995-1996 (n=1768) and 2004-2005 (n=3304). The number of USIMGs training in internal medicine or pediatrics subspecialties increased by 45.7% between 1995-1996 (n=622) and 2004-2005 (n=906). The number of pediatric subspecialty fellows grew 55.7%, mostly because of the near doubling of USMDs, from 813 to 1617. More than half of primary care residents are women (52.5%). All primary care specialties and subspecialties experienced gains in the proportion of female residents, with the greatest in obstetrics/gynecology, which increased by 28.7% (57.9% in 1995-1996 vs 74.5% in 2004-2005). Conclusions An increasing proportion of physicians are pursuing subspecialty training, while the number in primary care specialties has leveled off. Trends in GME suggest that the primary care medical workforce of the future will include more women, more IMGs, and more DOS.	Amer Med Assoc, Div Grad Med Educ, Chicago, IL 60610 USA	American Medical Association	Brotherton, SE (corresponding author), Amer Med Assoc, Div Grad Med Educ, 515 N State St, Chicago, IL 60610 USA.	sarah.brotherton@ama-assn.org						*AM MED ASS, FREIDA ONL FELL RES; Andriole DA, 2003, ACAD MED, V78, pS6, DOI 10.1097/00001888-200310001-00003; *ASS AM MED COLL, 2005, PHYS WORKF POS STAT; *ASS AM MED COLL, 2005, RES DAT 2005 MATCH; Association of American Medical Colleges, GME TRACK; Brotherton SE, 2004, JAMA-J AM MED ASSOC, V292, P1032, DOI 10.1001/jama.292.9.1032; Brotherton SE, 2002, JAMA-J AM MED ASSOC, V288, P1073, DOI 10.1001/jama.288.9.1073; Brotherton SE, 2003, JAMA-J AM MED ASSOC, V290, P1197, DOI 10.1001/jama.290.9.1197; Chan BTB, 2004, OBSTET GYNECOL, V103, P493, DOI 10.1097/01.AOG.0000113616.49207.dd; *COUNC GRAD MED ED, 1992, 3 US DEP HHS COUNC G; Council on Graduate Medical Education, 2005, PHYS WORKF POL GUID; Cull WL, 2002, PEDIATRICS, V109, P1015, DOI 10.1542/peds.109.6.1015; Dunn MR, 1998, JAMA-J AM MED ASSOC, V280, P809, DOI 10.1001/jama.280.9.809; Graduate medical education, 1996, JAMA-J AM MED ASSOC, V276, P739; *HLTH RES SERV ADM, HLTH PROF SHORT AR P; Obradovic Joyce L., 2004, Journal of the American Osteopathic Association, V104, P468; PASKO T, 2001, PHYS CHAR DISTR US 2; Promecene PA, 2003, AM J OBSTET GYNECOL, V189, P631, DOI 10.1067/S0002-9378(03)00888-3; SINGER AM, 2005, 2004 ANN REP OST MED	19	73	75	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2005	294	9					1075	1082		10.1001/jama.294.9.1075	http://dx.doi.org/10.1001/jama.294.9.1075			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XU	16145028				2022-12-28	WOS:000231627300008
J	Aasbo, JD; Lawrence, AT; Krishnan, K; Kim, MH; Trohman, RG				Aasbo, JD; Lawrence, AT; Krishnan, K; Kim, MH; Trohman, RG			Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: A meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Article							POSTOPERATIVE ATRIAL-FIBRILLATION; OPEN-HEART-SURGERY; ORAL AMIODARONE; INTRAVENOUS AMIODARONE; HISTORICAL DEVELOPMENT; SUPPRESSION TRIAL; PREVENTION; PLACEBO; MORTALITY; THERAPY	Background: Although evidence supports the prophylactic use of beta-blockade in cardiac surgery, postoperative atrial fibrillation or flutter occurs in 40% to 60% of patients. Trials that assessed whether amiodarone prophylaxis decreases the incidence of postoperative atrial tachyarrhythmias have had mixed results and were not specifically powered to detect changes in cardiovascular morbidity, length of stay, or mortality. Purpose: To see whether prophylactic administration of amiodarone decreases the incidence of major cardiovascular events, length of stay, and mortality after cardiac surgery. Data Sources: English-language and non-English-language publications listed in the MEDLINE, EMBASE, and CINAHL databases and the Cochrane Central Register of Controlled Trials, and bibliographies of published reviews. Sources were searched from the earliest possible dates through February 2005. Study Selection: Double-blind, randomized studies comparing amiodarone with placebo that reported the incidence of supraventricular arrhythmia, atrial fibrillation, or atrial flutter as the primary end point. Data Extraction: Two investigators independently collected all data. Discrepancies were resolved by consensus. Data Synthesis: After DerSimonian-Laird random-effects models were used to combine data from 10 trials involving 1744 patients, amiodarone therapy was found to decrease the incidence of atrial fibrillation or flutter (relative risk, 0.64 [95% CI, 0.55 to 0.75]), ventricular tachycardia and fibrillation (relative risk, 0.42 [Cl, 0.28 to 0.63]), stroke (relative risk, 0.39 [CI, 0.21 to 0.76]), and length of stay (weighted mean difference, -0.63 day [Cl, -1.03 to -0.23 days]). All studies reported adverse events, but none indicated how these events were assessed. Three studies found significantly more adverse events with amiodarone therapy, including nausea permitting continuation of therapy, bradycardia of unclear clinical significance, and increased intensive care monitoring and support. Limitations: Not all studies used beta-blockade, and regimens were not uniform among trials. Few trials met the stringent inclusion criteria, some did not report each type of cardiovascular event, and none reported completeness of follow-up. Conclusions: Amiodarone prophylaxis decreases the occurrence of atrial fibrillation, ventricular tachyarrhythmias, and stroke and length of stay after cardiac surgery. To further evaluate the potential benefits of concomitant prophylaxis with beta-blockers and amiodarone, a multicenter, randomized, double-blind trial with cardiovascular outcomes that compares amiodarone with placebo in patients already receiving beta-blocker prophylaxis is needed.	Rush Univ, Med Ctr, Chicago, IL 60612 USA	Rush University	Trohman, RG (corresponding author), Rush Univ, Med Ctr, 1750 W Harrison Suite 983 Jelke, Chicago, IL 60612 USA.	rtrohman@rush.edu		Kim, Michael/0000-0002-1458-8234				Abreu JE, 1999, AM J CARDIOL, V83, P775, DOI 10.1016/S0002-9149(98)00988-6; Almassi GH, 1997, ANN SURG, V226, P501, DOI 10.1097/00000658-199710000-00011; ANDREWS TC, 1981, CIRCULATION S, V84, P236; [Anonymous], 2001, CIRCULATION, V104, P2118; ARNOLD AZ, 1992, J AM COLL CARDIOL, V19, P851, DOI 10.1016/0735-1097(92)90530-Z; BUTLER J, 1993, BRIT HEART J, V70, P56; Cagli K, 2000, AM J CARDIOL, V85, P1259, DOI 10.1016/S0002-9149(00)00742-6; CHARLIER R, 1969, Bruxelles Medical, V49, P543; Crystal E, 2002, CIRCULATION, V106, P75, DOI 10.1161/01.CIR.0000021113.44111.3E; Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501; DAUDON P, 1986, AM J CARDIOL, V58, P933, DOI 10.1016/S0002-9149(86)80014-5; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dorge H, 2000, ANN THORAC SURG, V69, P1358, DOI 10.1016/S0003-4975(00)01081-X; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Giri S, 2001, LANCET, V357, P830, DOI 10.1016/S0140-6736(00)04196-9; Guarnieri T, 1999, J AM COLL CARDIOL, V34, P343, DOI 10.1016/S0735-1097(99)00212-0; Harahsheh BS, 2001, SAUDI MED J, V22, P797; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOHNLOSER SH, 1991, AM HEART J, V121, P89, DOI 10.1016/0002-8703(91)90960-P; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kerstein J, 2004, CHEST, V126, P716, DOI 10.1378/chest.126.3.716; Kim MH, 2001, AM J CARDIOL, V87, P881, DOI 10.1016/S0002-9149(00)01530-7; KODAMA I, 1992, BRIT J PHARMACOL, V107, P502, DOI 10.1111/j.1476-5381.1992.tb12774.x; Kodama I, 1997, CARDIOVASC RES, V35, P13, DOI 10.1016/S0008-6363(97)00114-4; Kodama I, 1996, JPN HEART J, V37, P719; Lee SH, 2000, ANN THORAC SURG, V70, P157, DOI 10.1016/S0003-4975(00)01308-4; Maras D, 2001, Am Heart J, V141, pE8, DOI 10.1067/mhj.2001.114201; MASON JW, 1987, NEW ENGL J MED, V316, P455; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nattel Stanley, 1994, P207; Ommen SR, 1997, NEW ENGL J MED, V336, P1429, DOI 10.1056/NEJM199705153362006; PODRID PJ, 1995, ANN INTERN MED, V122, P689, DOI 10.7326/0003-4819-122-9-199505010-00008; Redle JD, 1999, AM HEART J, V138, P144, DOI 10.1016/S0002-8703(99)70260-7; SARABU MR, 1987, ANN THORAC SURG, V44, P199, DOI 10.1016/S0003-4975(10)62041-3; SINGH BN, 1989, PROG CARDIOVASC DIS, V31, P249, DOI 10.1016/0033-0620(89)90033-9; SINGH BN, 1983, AM HEART J, V106, P788, DOI 10.1016/0002-8703(83)90002-9; SINGH BN, 1970, BRIT J PHARMACOL, V39, P657, DOI 10.1111/j.1476-5381.1970.tb09891.x; Solomon AJ, 2001, AM HEART J, V142, P811, DOI 10.1067/mhj.2001.118738; Treggiari-Venzi MM, 2000, BRIT J ANAESTH, V85, P690, DOI 10.1093/bja/85.5.690; Villareal RP, 2004, J AM COLL CARDIOL, V43, P742, DOI 10.1016/j.jacc.2003.11.023; VONSEGESSER L, 1987, THORAC CARDIOV SURG, V35, P352; VONSEGESSER LK, 1989, ANN THORAC SURG, V47, P575, DOI 10.1016/0003-4975(89)90436-0; White CM, 2003, CIRCULATION, V108, P200, DOI 10.1161/01.cir.0000087445.59819.6f; White CM, 2002, ANN THORAC SURG, V74, P69, DOI 10.1016/S0003-4975(02)03593-2; Wurdeman RL, 2002, CHEST, V121, P1203, DOI 10.1378/chest.121.4.1203; Yagdi T, 2003, J THORAC CARDIOV SUR, V125, P1420, DOI 10.1016/S0022-5223(02)73292-3; Yazigi A, 2002, J CARDIOTHOR VASC AN, V16, P603, DOI 10.1053/jcan.2002.126956; Zimmer J, 2003, AM J CARDIOL, V91, P1137, DOI 10.1016/S0002-9149(03)00168-1	48	70	81	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2005	143	5					327	336		10.7326/0003-4819-143-5-200509060-00008	http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961TE	16144891				2022-12-28	WOS:000231683900002
J	Lee, TH; Zapert, K				Lee, TH; Zapert, K			Do high-deductible health plans threaten quality of care?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Partners Healthcare Syst, Boston, MA 02199 USA; Harris Interact, New York, NY USA	Partners Healthcare System	Lee, TH (corresponding author), Partners Healthcare Syst, Boston, MA 02199 USA.							BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; Lohr K N, 1986, Med Care, V24, pS1; Wong MD, 2001, AM J PUBLIC HEALTH, V91, P1889, DOI 10.2105/AJPH.91.11.1889	4	44	44	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1202	1204		10.1056/NEJMp058209	http://dx.doi.org/10.1056/NEJMp058209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	966DS	16177246				2022-12-28	WOS:000232000400003
J	Weis, SM; Cheresh, DA				Weis, SM; Cheresh, DA			Pathophysiological consequences of VEGF-induced vascular permeability	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; FOCAL ADHESION KINASE; CADHERIN TYROSINE PHOSPHORYLATION; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INDUCED ANGIOGENESIS; FACTOR EXPRESSION; DIABETIC-RETINOPATHY; TUMOR VASCULATURE; REDUCING EDEMA; BETA-CATENIN	Although vascular endothelial growth factor ( VEGF) induces angiogenesis, it also disrupts vascular barrier function in diseased tissues. Accordingly, VEGF expression in cancer and ischaemic disease has unexpected pathophysiological consequences. By uncoupling endothelial cell - cell junctions VEGF causes vascular permeability and oedema, resulting in extensive injury to ischaemic tissues after stroke or myocardial infarction. In cancer, VEGF- mediated disruption of the vascular barrier may potentiate tumour cell extravasation, leading to widespread metastatic disease. Therefore, by blocking the vascular permeability promoting effects of VEGF it may be feasible to reduce tissue injury after ischaemic disease and minimize the invasive properties of circulating tumour cells.	Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu						Akiyama C, 2003, ACTA NEUROCHIR SUPPL, V86, P421; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Avizienyte E, 2004, MOL BIOL CELL, V15, P2794, DOI 10.1091/mbc.E03-12-0879; Baish JW, 1997, MICROVASC RES, V53, P128, DOI 10.1006/mvre.1996.2005; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; Bates DO, 1999, MICROCIRCULATION, V6, P83, DOI 10.1038/sj.mn.7300054; Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BROWN LF, 1989, AM REV RESPIR DIS, V140, P1104, DOI 10.1164/ajrccm/140.4.1104; Caldwelll RB, 2003, DIABETES-METAB RES, V19, P442, DOI 10.1002/dmrr.415; Cao ZX, 2004, CLIN CANCER RES, V10, P5253, DOI 10.1158/1078-0432.CCR-03-0588; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chang YS, 2000, MICROVASC RES, V59, P265, DOI 10.1006/mvre.1999.2225; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3; Cohen AW, 1999, AM J PHYSIOL-HEART C, V277, pH2038, DOI 10.1152/ajpheart.1999.277.5.H2038; Conklin BS, 2002, AM J PATHOL, V160, P413, DOI 10.1016/S0002-9440(10)64859-6; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; DVORAK HF, 1990, PROG CLIN BIOL RES, V354, P317; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Esser S, 1998, J CELL SCI, V111, P1853; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Fedor-Chaiken M, 2003, CELL COMMUN ADHES, V10, P105, DOI 10.1080/714040416; Feng D, 1999, MICROCIRCULATION, V6, P23, DOI 10.1080/713773925; Feng D, 2000, MICROVASC RES, V59, P24, DOI 10.1006/mvre.1999.2207; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Fukuda S, 2004, J MOL CELL CARDIOL, V36, P547, DOI 10.1016/j.yjmcc.2004.02.002; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hormbrey E, 2002, CLIN EXP METASTAS, V19, P651, DOI 10.1023/A:1021379811308; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Ishida A, 2001, J CELL PHYSIOL, V188, P359, DOI 10.1002/jcp.1121; Izumi Y, 2002, NATURE, V416, P279, DOI 10.1038/416279b; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kawamoto A, 2004, CIRCULATION, V110, P1398, DOI 10.1161/01.CIR.0000141563.71410.64; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kevil CG, 2001, AM J PHYSIOL-CELL PH, V281, pC1940, DOI 10.1152/ajpcell.2001.281.6.C1940; Kimura Y, 2001, J NUTR, V131, P1844, DOI 10.1093/jn/131.6.1844; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Kuroi K, 2001, INT J BIOL MARKER, V16, P5, DOI 10.1177/172460080101600102; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Langille BL, 2001, MICROCIRCULATION, V8, P195, DOI 10.1038/sj.mn.7800085; Lee RJ, 2000, CIRCULATION, V102, P898; Li J, 1996, AM J PHYSIOL-HEART C, V270, pH1803, DOI 10.1152/ajpheart.1996.270.5.H1803; Liao F, 2002, CANCER RES, V62, P2567; Liao HF, 2003, J AGR FOOD CHEM, V51, P7907, DOI 10.1021/jf034729d; Lin MT, 2003, MOL PHARMACOL, V64, P1029, DOI 10.1124/mol.64.5.1029; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; McDonald DM, 1999, MICROCIRCULATION, V6, P7; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Monsky WL, 1999, CANCER RES, V59, P4129; Moore TM, 2000, AM J PHYSIOL-LUNG C, V279, pL691, DOI 10.1152/ajplung.2000.279.4.L691; Mukhopadhyay D, 2004, SEMIN CANCER BIOL, V14, P123, DOI 10.1016/j.semcancer.2003.09.019; MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161; Mura M, 2004, J APPL PHYSIOL, V97, P1605, DOI 10.1152/japplphysiol.00202.2004; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nwariaku FE, 2002, SURGERY, V132, P180, DOI 10.1067/msy.2002.125305; Ozawa M, 2001, J CELL SCI, V114, P503; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Pedram A, 2002, J BIOL CHEM, V277, P44385, DOI 10.1074/jbc.M202391200; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Robinson SD, 2004, ARTERIOSCL THROM VAS, V24, P2108, DOI 10.1161/01.ATV.0000143857.27408.de; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Salgado Roberto, 2001, Angiogenesis, V4, P37, DOI 10.1023/A:1016611230747; Sasaki H, 2002, J MOL CELL CARDIOL, V34, P335, DOI 10.1006/jmcc.2001.1516; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shyu KG, 2002, CARDIOVASC RES, V54, P576, DOI 10.1016/S0008-6363(02)00259-6; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Suarez S, 2001, J CELL SCI, V114, P1229; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Takahashi N, 1999, CIRC RES, V84, P1194, DOI 10.1161/01.RES.84.10.1194; Tang FY, 2003, INT J CANCER, V106, P871, DOI 10.1002/ijc.11325; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tsuzuki Y, 2000, CANCER RES, V60, P6248; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Vaquero Javier, 2003, Ann Hepatol, V2, P12; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/j.ccr.2004.10.011; Wu HM, 1999, AM J PHYSIOL-HEART C, V276, pH535, DOI 10.1152/ajpheart.1999.276.2.H535; Wu MH, 2003, J PHYSIOL-LONDON, V552, P691, DOI 10.1113/jphysiol.2003.048405; Xie KP, 2004, CYTOKINE GROWTH F R, V15, P297, DOI 10.1016/j.cytogfr.2004.04.003; Xu YR, 1999, J CELL BIOCHEM, V75, P264; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765; Yue XP, 1999, DEV DYNAM, V216, P28, DOI 10.1002/(SICI)1097-0177(199909)216:1<28::AID-DVDY5>3.3.CO;2-L; Zhu BQ, 2003, CANCER CELL, V4, P191, DOI 10.1016/S1535-6108(03)00219-8	100	650	677	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					497	504		10.1038/nature03987	http://dx.doi.org/10.1038/nature03987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177780				2022-12-28	WOS:000232004800039
J	Cech, TR				Cech, TR			Fostering innovation and discovery in biomedical research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NOBEL LECTURE; TETRAHYMENA; ANGIOGENESIS; RNA		Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Howard Hughes Medical Institute	Cech, TR (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.	president@hhmi.org						*AM CANC SOC, RES SPEND FY 2003 AC; Benderly BL, 2005, SCIENCE, V308, P717, DOI 10.1126/science.308.5722.717; Brenner S, 2003, BIOSCIENCE REP, V23, P225, DOI 10.1023/B:BIRE.0000019186.48208.f3; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Cech TR, 2004, NAT STRUCT MOL BIOL, V11, P1166, DOI 10.1038/nsmb1204-1166; *DTSCH FORSCH, 2005, DTSCH FORSCH BUDG CU; Goldstein JL, 1997, J CLIN INVEST, V99, P2803, DOI 10.1172/JCI119470; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; *H HUGH MED I, 2004, INN BIOM ANN REP; Horvitz HR, 2003, CHEMBIOCHEM, V4, P697, DOI 10.1002/cbic.200300614; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; *MED RES COUNC, 2005, MED RES COUNC BUDG C; *NAT SCI FDN, 2005, NAT SCI FDN EST FY 2; Nathan DG, 2000, NAT MED, V6, P1201, DOI 10.1038/81282; National Research Council, 2005, BRIDG IND; Ng EWM, 2005, CAN J OPHTHALMOL, V40, P352, DOI 10.1016/S0008-4182(05)80078-X; *NIH, FISC YEAR 2004 BUDG; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Sulston JE, 2003, CHEMBIOCHEM, V4, P688, DOI 10.1002/cbic.200300577; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121	24	21	21	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1390	1393		10.1001/jama.294.11.1390	http://dx.doi.org/10.1001/jama.294.11.1390			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174699				2022-12-28	WOS:000231987800014
J	Abasolo, L; Blanco, M; Bachiller, J; Candelas, G; Collado, P; Lajas, C; Revenga, M; Ricci, P; Lazaro, P; Aguilar, D; Vargas, E; Fernandez-Gutierrez, B; Hernandez-Garcia, C; Carmona, L; Jover, JA				Abasolo, L; Blanco, M; Bachiller, J; Candelas, G; Collado, P; Lajas, C; Revenga, M; Ricci, P; Lazaro, P; Aguilar, D; Vargas, E; Fernandez-Gutierrez, B; Hernandez-Garcia, C; Carmona, L; Jover, JA			A health system program to reduce work disability related to musculoskeletal disorders	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-BACK-PAIN; RHEUMATIC-DISEASES; COST-EFFECTIVENESS; SICKNESS ABSENCE; CARE; PREVENTION; INTERVENTION; MANAGEMENT; ARTHRITIS; IMPACT	Background: Musculoskeletal disorders (MSDs) are a frequent cause of work disability, accounting for productivity losses in industrialized societies equivalent to 1.3% of the U.S. gross national product. Objective: To evaluate whether a population-based clinical program offered to patients with recent-inset work disability caused by MSDs is cost-effective. Design: Randomized controlled intervention study. The inclusion and follow-up periods each lasted 12 months. Setting: Three health districts in Madrid, Spain. Patients: All patients with MSD-related temporary work disability in 1998 and 1999. Intervention: The control group received standard primary care management, wit referral to specialized care if needed. The intervention group received a specific program, administered by rheumatologists, in which care was delivered during regular visits and included 3 main elements: education, protocol-based clinical management, and administrative duties. Measurements: Efficacy variables were 1) days of temporary work disability and 2) number of patients with permanent work disability. All analyses were done on an intention-to-treat basis. Results: 13 077 patients were included in the study, 7805 in the control group and 5272 in the intervention group, generating 16 297 episodes of MSD-related temporary work disability. These episodes were shorter in the intervention group than in the control group (man, 26 days compared with 41 days; P < 0.001), and the groups had similar numbers of episodes per patient. Fewer patients received long-term disability compensation in the intervention group (n = 38 [0.7%]) than in the control group (n = 99 [1.3%]) (P < 0.005). Direct and indirect costs were lower in the intervention group than in the control group. To save 1 day of temporary work disability, $6.00 had to be invested in the program. Each dollar invested generated a benefit of $11.00. The program's net benefit was in excess of $5 million. Limitations: The study was unblinded. Conclusions: Implementation of the program, offered to the general population, improves short- and long-term work disability outcomes and is cost-effective.	Hosp Clin San Carlos, Serv Reumatol, Madrid 28040, Spain; Hosp Ramon & Cajal, E-28034 Madrid, Spain; Hosp Severo Ochoa, Madrid, Spain	Hospital Clinico San Carlos; Hospital Universitario Ramon y Cajal; Severo Ochoa University Hospital	Jover, JA (corresponding author), Hosp Clin San Carlos, Serv Reumatol, Calle Prof Martin Lagos S-N, Madrid 28040, Spain.	jjover.hcsc@salud.madrid.org	Martínez, Marcelino Revenga/T-1168-2017; Vargas-Castrillón, Emilio/AAZ-7621-2021; Carmona, Loreto/A-2748-2014; Fernandez-Gutierrez, Benjamin/AAM-9063-2020; Bachiller Corral, Javier/AGX-7411-2022	Martínez, Marcelino Revenga/0000-0002-7350-8214; Vargas-Castrillón, Emilio/0000-0003-4828-6004; Carmona, Loreto/0000-0002-4401-2551; Bachiller Corral, Javier/0000-0001-8954-209X; Candelas, Gloria/0000-0001-7759-5127; Fernandez-Gutierrez, Benjamin/0000-0002-6126-8786				[Anonymous], 1996, JAMA, V276, P241; BADLEY EM, 1994, J RHEUMATOL, V21, P505; BADLEY EM, 1994, J RHEUMATOL, V21, P515; BADLEY EM, 1995, J RHEUMATOL, V22, P204; Borestein DG, 1995, LOW BACK PAIN MED DI; Buchbinder R, 2001, BRIT MED J, V322, P1516, DOI 10.1136/bmj.322.7301.1516; CANOSO J J, 1990, Current Opinion in Rheumatology, V2, P276; CANOSO JJ, 1997, RHEUMATOLOGY PRIMARY; DALTON SE, 1994, BRIT J RHEUMATOL, V33, P663; Daltroy LH, 1997, NEW ENGL J MED, V337, P322, DOI 10.1056/NEJM199707313370507; Fautrel B, 2002, CURR OPIN RHEUMATOL, V14, P121, DOI 10.1097/00002281-200203000-00008; FELTS W, 1989, J RHEUMATOL, V16, P867; FEUERSTEIN M, 1993, J OCCUP ENVIRON MED, V35, P396; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Frank J, 1998, CAN MED ASSOC J, V158, P1625; Frank JW, 1996, SPINE, V21, P2918, DOI 10.1097/00007632-199612150-00025; GLAZIER R, 1995, ARTHRITIS RHEUM, V38, P533, DOI 10.1002/art.1780380412; Hadler NM., 1999, OCCUPATIONAL MUSCULO; INDAHL A, 1995, SPINE, V20, P473, DOI 10.1097/00007632-199502001-00011; Kelly W, 1996, TXB RHEUMATOLOGY; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Kivimaki M, 2004, J EPIDEMIOL COMMUN H, V58, P710, DOI 10.1136/jech.2003.015842; Korthals-de Bos IBC, 2003, BRIT MED J, V326, P911; LAHAD A, 1994, JAMA-J AM MED ASSOC, V272, P1286, DOI 10.1001/jama.272.16.1286; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LEHMANN TR, 1993, SPINE, V18, P1103, DOI 10.1097/00007632-199306150-00023; Loisel P, 2002, OCCUP ENVIRON MED, V59, P807, DOI 10.1136/oem.59.12.807; MALMIVAARA A, 1995, NEW ENGL J MED, V332, P351, DOI 10.1056/NEJM199502093320602; McNeil JM, 2001, JAMA-J AM MED ASSOC, V285, P1571; MEENAN RF, 1988, J RHEUMATOL, V15, P1693; Meerding WJ, 1998, BRIT MED J, V317, P111, DOI 10.1136/bmj.317.7151.111; Mutchler JE, 1997, J GERONTOL B-PSYCHOL, V52, pS4, DOI 10.1093/geronb/52B.1.S4; *NIOSH, ERG MUSC DIS; Nordin M, 1997, MUSCULOSKELETAL DISO; PARISEK R, 1994, ARTHRITIS RHEUM S, V37, P356; REYNOLDS DL, 1992, J RHEUMATOL, V19, P1020; Robin MP., 1983, TREAT YOUR OWN NECK; Sheon RP, 1996, SOFT TISSUE RHEUMATI; Sinclair SJ, 1997, SPINE, V22, P2919, DOI 10.1097/00007632-199712150-00015; STROSBERG MA, 1980, J RHEUMATOL, V7, P923; *SUBD GEN COORD AD, 1997, MAN GEST INC TEMP; VANSCHAARDENBURG D, 1994, ANN RHEUM DIS, V53, P807, DOI 10.1136/ard.53.12.807; WARD MM, 1993, ARCH INTERN MED, V153, P2229, DOI 10.1001/archinte.153.19.2229; Warhold LG, 1993, J MUSCULOSKELETAL ME, V10, P55; WHO, 2001, WHO INT CLASS FUNCT; YELIN E, 1987, ARTHRITIS RHEUM, V30, P507, DOI 10.1002/art.1780300504; YELIN EH, 1990, ARTHRITIS RHEUM, V33, P750, DOI 10.1002/art.1780330520; YELIN EH, 1986, ARTHRITIS RHEUM, V29, P1322, DOI 10.1002/art.1780291104; Young T, 2004, BRIT MED J, V328, P162, DOI 10.1136/bmj.328.7432.162	49	42	46	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2005	143	6					404	414		10.7326/0003-4819-143-6-200509200-00005	http://dx.doi.org/10.7326/0003-4819-143-6-200509200-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967OG	16172439				2022-12-28	WOS:000232099900002
J	Troger, U; Lins, H; Scherrmann, JM; Wallesch, CW; Bode-Boger, SM				Troger, U; Lins, H; Scherrmann, JM; Wallesch, CW; Bode-Boger, SM			Tetraparesis associated with colchicine is probably due to inhibition by verapamil of the P-glycoprotein efflux pump, in the blood-brain barrier	BRITISH MEDICAL JOURNAL			English	Article									Univ Magdeburg, Inst Clin Pharmacol, D-39120 Magdeburg, Germany; Univ Magdeburg, Dept Neurol, D-39120 Magdeburg, Germany; Univ Paris 07, Univ Paris 05, Hop Fernand Widal, CNRS,UMR 7157,INSERM,U705, F-75475 Paris, France	Otto von Guericke University; Otto von Guericke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Troger, U (corresponding author), Univ Magdeburg, Inst Clin Pharmacol, Leipzigr Str 44, D-39120 Magdeburg, Germany.	uwe.troeger@medizin.uni-magdeburg.de	Scherrmann, Jean-Michel/I-1865-2017	Bode-Boger, Stefanie/0000-0002-5132-6591				Drion N, 1997, J NEUROSCI RES, V49, P80; KUNCL RW, 1987, NEW ENGL J MED, V316, P1562, DOI 10.1056/NEJM198706183162502; Pauli-Magnus C, 2000, J PHARMACOL EXP THER, V293, P376; ROCHDI I, 1994, EUR J CLIN PHARMACOL, V46, P351	4	14	16	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 17	2005	331	7517					613	613		10.1136/bmj.38568.639688.F7	http://dx.doi.org/10.1136/bmj.38568.639688.F7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967EK	16148013	Green Published, Bronze			2022-12-28	WOS:000232074100018
J	Stahl, SS				Stahl, SS			Palladium-catalyzed oxidation of organic chemicals with O-2	SCIENCE			English	Editorial Material							AEROBIC OXIDATION; MOLECULAR-OXYGEN; ALCOHOLS; WATER		Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Stahl, SS (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	stahl@chem.wisc.edu						Bianchi D, 1999, ANGEW CHEM INT EDIT, V38, P706, DOI 10.1002/(SICI)1521-3773(19990301)38:5<706::AID-ANIE706>3.0.CO;2-G; Brice JL, 2005, J AM CHEM SOC, V127, P2868, DOI 10.1021/ja0433020; Ferreira EM, 2001, J AM CHEM SOC, V123, P7725, DOI 10.1021/ja015791z; Iwasawa T, 2004, J AM CHEM SOC, V126, P6554, DOI 10.1021/ja031936l; Jensen DR, 2003, ANGEW CHEM INT EDIT, V42, P3810, DOI 10.1002/anie.200351997; Jensen DR, 2001, J AM CHEM SOC, V123, P7475, DOI 10.1021/ja015827n; LAROCK RC, 1993, J ORG CHEM, V58, P5298, DOI 10.1021/jo00072a004; Nishimura T, 2004, SYNLETT, P201, DOI 10.1055/s-2004-815412; Paavola S, 2004, ADV SYNTH CATAL, V346, P237, DOI 10.1002/adsc.200303166; Schultz MJ, 2002, CHEM COMMUN, P3034, DOI 10.1039/b209344h; SMIDT J, 1959, ANGEW CHEM INT EDIT, V71, P176, DOI 10.1002/ange.19590710503; Stahl SS, 2004, ANGEW CHEM INT EDIT, V43, P3400, DOI 10.1002/anie.200300630; ten Brink GJ, 2000, SCIENCE, V287, P1636; Toyota M, 2002, SYNLETT, P1211, DOI 10.1055/s-2002-32946; VANBENTHEM RATM, 1994, J CHEM SOC CHEM COMM, P357, DOI 10.1039/c39940000357; VISION 2020 CATALYSI	16	433	436	0	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2005	309	5742					1824	1826		10.1126/science.1114666	http://dx.doi.org/10.1126/science.1114666			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166508				2022-12-28	WOS:000231989500038
J	Magain, P; Letawe, G; Courbin, F; Jablonka, P; Jahnke, K; Meylan, G; Wisotzki, L				Magain, P; Letawe, G; Courbin, F; Jablonka, P; Jahnke, K; Meylan, G; Wisotzki, L			Discovery of a bright quasar without a massive host galaxy	NATURE			English	Article							IMAGES; DECONVOLUTION; SPECTROSCOPY; BULGE	A quasar is thought to be powered by the infall of matter onto a supermassive black hole at the centre of a massive galaxy(1,2). Because the optical luminosity of quasars exceeds that of their host galaxy, disentangling the two components can be difficult. This led in the 1990s to the controversial claim of the discovery of 'naked' quasars(3-7). Since then, the connection between quasars and galaxies has been well established(8). Here we report the discovery of a quasar lying at the edge of a gas cloud, whose size is comparable to that of a small galaxy, but whose spectrum shows no evidence for stars. The gas in the cloud is excited by the quasar itself. If a host galaxy is present, it is at least six times fainter than would normally be expected(8,9) for such a bright quasar. The quasar is interacting dynamically with a neighbouring galaxy, whose gas might be feeding the black hole.	Univ Liege, Inst Astrophys & Geophys, B-4000 Liege, Belgium; Ecole Polytech Fed Lausanne, Astrophys Lab, CH-1290 Sauverny, Switzerland; Univ Geneve Observ, CH-1290 Sauverny, Switzerland; Observ Paris, UMR 8111, GEPI, F-75014 Paris, France; Astrophys Inst Potsdam, D-14482 Potsdam, Germany	University of Liege; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite	Magain, P (corresponding author), Univ Liege, Inst Astrophys & Geophys, Allee 6 Aout,17,Bat B5C, B-4000 Liege, Belgium.	Pierre.Magain@ulg.ac.be		Jahnke, Knud/0000-0003-3804-2137				BAHCALL JN, 1994, ASTROPHYS J, V435, pL11, DOI 10.1086/187582; Bahcall JN, 1997, ASTROPHYS J, V479, P642, DOI 10.1086/303926; Boyce PJ, 1996, ASTROPHYS J, V473, P760, DOI 10.1086/178187; Boyce PJ, 1999, MON NOT R ASTRON SOC, V302, pL39, DOI 10.1046/j.1365-8711.1999.02281.x; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Canalizo G, 2001, ASTROPHYS J, V555, P719, DOI 10.1086/321520; Courbin F, 2000, ASTROPHYS J, V529, P1136, DOI 10.1086/308291; Courbin F, 2002, ASTRON ASTROPHYS, V394, P863, DOI [10.1051/0004-6361:20021246, 10.1051/0004-6361:2UUZIL40]; DEGRIJP MHK, 1987, ASTRON ASTROPHYS SUP, V70, P95; DISNEY MJ, 1995, NATURE, V376, P150, DOI 10.1038/376150a0; Dunlop JS, 2003, MON NOT R ASTRON SOC, V340, P1095, DOI 10.1046/j.1365-8711.2003.06333.x; Ferrarese L, 2002, ASTROPHYS J, V578, P90, DOI 10.1086/342308; Floyd DJE, 2004, MON NOT R ASTRON SOC, V355, P196, DOI 10.1111/j.1365-2966.2004.08315.x; HUTCHINGS JB, 1995, NATURE, V376, P118; Kaspi S, 2000, ASTROPHYS J, V533, P631, DOI 10.1086/308704; Letawe G, 2004, ASTRON ASTROPHYS, V424, P455, DOI 10.1051/0004-6361:20040481; LOW FJ, 1988, ASTROPHYS J, V327, pL41, DOI 10.1086/185136; Magain P, 1998, ASTROPHYS J, V494, P472, DOI 10.1086/305187; McLure RJ, 2002, MON NOT R ASTRON SOC, V331, P795, DOI 10.1046/j.1365-8711.2002.05236.x; McLure RJ, 1999, MON NOT R ASTRON SOC, V308, P377, DOI 10.1046/j.1365-8711.1999.02676.x; Richstone D, 1998, NATURE, V395, pA14	21	62	62	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					381	384		10.1038/nature04013	http://dx.doi.org/10.1038/nature04013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163349	Green Submitted			2022-12-28	WOS:000231849100046
J	Osborne, LC; Lisberger, SG; Bialek, W				Osborne, LC; Lisberger, SG; Bialek, W			A sensory source for motor variation	NATURE			English	Article							PERCEPTUAL DECISIONS; EYE-MOVEMENT; DIRECTION; AREA; INFORMATION; NEURONS	Suppose that the variability in our movements(1-9) is caused not by noise in the motor system itself, nor by fluctuations in our intentions or plans, but rather by errors in our sensory estimates of the external parameters that define the appropriate action. For tasks in which precision is at a premium, performance would be optimal if no noise were added in movement planning and execution: motor output would be as accurate as possible given the quality of sensory inputs. Here we use visually guided smooth-pursuit eye movements in primates(10) as a testing ground for this notion of optimality. In response to repeated presentations of identical target motions, nearly 92% of the variance in eye trajectory can be accounted for as a consequence of errors in sensory estimates of the speed, direction and timing of target motion, plus a small background noise that is observed both during eye movements and during fixations. The magnitudes of the inferred sensory errors agree with the observed thresholds for sensory discrimination by perceptual systems, suggesting that the very different neural processes of perception and action are limited by the same sources of noise.	Univ Calif San Francisco, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Princeton University; Princeton University	Osborne, LC (corresponding author), Univ Calif San Francisco, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, Sloan Swartz Ctr Theoret Neurobiol, Box 0444, San Francisco, CA 94143 USA.	osborne@phy.ucsf.edu		Osborne, Leslie/0000-0002-6080-5279	NATIONAL EYE INSTITUTE [R01EY003878] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY003878-25, R01 EY003878] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BIALEK W, 2002, PHYS BIOMOLECULES CE, P485; Carpenter RHS, 1981, EYE MOVEMENTS COGNIT, P237; d'Avella A, 1998, P NATL ACAD SCI USA, V95, P7711, DOI 10.1073/pnas.95.13.7711; DEBRUYN B, 1988, VISION RES, V28, P1323, DOI 10.1016/0042-6989(88)90064-8; Donchin O, 2003, J NEUROSCI, V23, P9032; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FUCHS AF, 1970, J NEUROPHYSIOL, V33, P382, DOI 10.1152/jn.1970.33.3.382; Gegenfurtner KR, 2003, J VISION, V3, P865, DOI 10.1167/3.11.19; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Green DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; KOWLER E, 1987, VISION RES, V27, P993, DOI 10.1016/0042-6989(87)90014-9; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Roitman JD, 2002, J NEUROSCI, V22, P9475; Ross J, 2001, TRENDS NEUROSCI, V24, P317, DOI 10.1016/S0166-2236(00)01827-0; Sanger TD, 2000, J NEUROSCI, V20, P1066, DOI 10.1523/JNEUROSCI.20-03-01066.2000; Santello M, 1998, J NEUROSCI, V18, P10105; Stone LS, 2003, J VISION, V3, P725, DOI 10.1167/3.11.7; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Watamaniuk SNJ, 1999, VISION RES, V39, P59, DOI 10.1016/S0042-6989(98)00128-X	29	196	196	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					412	416		10.1038/nature03961	http://dx.doi.org/10.1038/nature03961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163357	Green Accepted			2022-12-28	WOS:000231849100054
J	Latimer, AM; Silander, JA; Cowling, RM				Latimer, AM; Silander, JA; Cowling, RM			Neutral ecological theory reveals isolation and rapid speciation in a biodiversity hot spot	SCIENCE			English	Article							CAPE FLORISTIC REGION; PLANT DIVERSITY; SOUTH-AFRICA; FLORA; FOREST; PROTEACEAE; DISPERSAL; ABUNDANCE; ENDEMISM; CLIMATE	South Africa's Mediterranean-climate fynbos shrubland is a hot spot of species diversity, but its diversity patterns contrast strongly with other high-diversity areas, including the Amazon rain forest. With its extremely high levels of endemism and species turnover, fynbos is made up of dissimilar local communities that are species-rich but relatively poor in rare species. Using neutral ecological theory, we show that the relative species-abundance distributions in fynbos can be explained by migration rates that are two orders of magnitude lower than they are in tropical rain forests. Speciation rates, which are indexed by the "biodiversity parameter" Theta, are estimated to be higher than they are in any previously examined plant system.	Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; Nelson Mandela Metropolitan Univ, Dept Bot, Terr Ecol Res Unit, ZA-6031 Port Elizabeth, South Africa	University of Connecticut; Nelson Mandela University	Latimer, AM (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, 75 N Eagleville Rd, Storrs, CT 06269 USA.	latimer@uconn.edu	Cowling, Richard/AFU-6261-2022	Latimer, Andrew/0000-0001-8098-0448				Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; [Anonymous], 2000, STRELITZIA; BOUCHER C, 1978, Bothalia, V12, P455; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cowling RM, 1998, AUST J BOT, V46, P335, DOI 10.1071/BT97040; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; COWLING RM, 1992, BIOL J LINN SOC, V47, P367, DOI 10.1111/j.1095-8312.1992.tb00675.x; COWLING RM, 2005, PLANT DIVERSITY COMP, V55, P273; Hardy OJ, 2004, FOREST ECOL MANAG, V197, P191, DOI 10.1016/j.foreco.2004.05.014; Hubbell Stephen P., 2001, V32, pi; Linder HP, 2004, PHILOS T R SOC B, V359, P1623, DOI 10.1098/rstb.2004.1534; Linder R, 1992, ECOLOGY FYNBOS; MCDONALD DJ, 1995, PLANT SYST EVOL, V195, P137, DOI 10.1007/BF00989290; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; SLINGSBY P, 1985, S AFR J BOT, V51, P30, DOI 10.1016/S0254-6299(16)31698-2; Taylor H.C, 1996, CEDERBERG VEGETATION; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; VANWYK BE, 1988, BOTHALIA, V18, P211, DOI 10.4102/abc.v18i2.1048; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; WERGER M J A, 1974, Bothalia, V11, P309; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	27	103	106	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1722	1725		10.1126/science.1115576	http://dx.doi.org/10.1126/science.1115576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151011				2022-12-28	WOS:000231836700044
J	Malterud, K				Malterud, K			Humiliation instead of care?	LANCET			English	Editorial Material							SHAME		Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5018 Bergen, Norway; Univ Copenhagen, Res Unit, Copenhagen, Denmark; Univ Copenhagen, Dept Gen Practice, Copenhagen, Denmark	University of Bergen; University of Copenhagen; University of Copenhagen	Malterud, K (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Kalfarveien 31, N-5018 Bergen, Norway.	Kirsti.malterud@isf.uib.no						Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Foucault Michel, 1994, BIRTH CLIN ARCHAEOLO; LAZARE A, 1987, ARCH INTERN MED, V147, P1653, DOI 10.1001/archinte.147.9.1653; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Malterud Kirsti, 2004, NORA, V12, P8; Mishler EG, 1984, DISCOURSE MED DIALEC; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; THESEN J, IN PRESS SCAND J PUB; Waitzkin H., 1991, POLITICS MED ENCOUNT; Weed M., 2005, FORUM QUALITATIVE SO, V6; Werner A, 2004, SOC SCI MED, V59, P1035, DOI 10.1016/j.socscimed.2003.12.001	12	16	16	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 3	2005	366	9488					785	786		10.1016/S0140-6736(05)67031-6	http://dx.doi.org/10.1016/S0140-6736(05)67031-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139638				2022-12-28	WOS:000231627000005
J	Cundy, T; Davidson, J; Rutland, MD; Stewart, C; DePaoli, AM				Cundy, T; Davidson, J; Rutland, MD; Stewart, C; DePaoli, AM			Brief report: Recombinant osteoprotegerin for juvenile Paget's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC HYPERPHOSPHATASIA; POSTMENOPAUSAL WOMEN; BONE; OSTEOPOROSIS; PHENOTYPE; THERAPY	Juvenile Paget's disease, a genetic bone disease characterized by accelerated bone turn-over, results from inactivating mutations in the gene encoding osteoprotegerin - a key regulator of osteoclastogenesis. The effects of recombinant osteoprotegerin were investigated in two adult siblings with juvenile Paget's disease. Bone resorption ( assessed by N-telopeptide excretion) was suppressed by once-weekly subcutaneous doses of 0.3 to 0.4 mg per kilogram of body weight. After 15 months of treatment, radial bone mass increased in one patient by 9 percent and in the other by 30 percent, skeletal bisphosphonate retention decreased by 37 percent and 55 percent, respectively, and there was radiographic improvement. Apart from mild hypocalcemia and hypophosphatemia, no apparent adverse events occurred.	Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland 1, New Zealand; LabPlus, Dept Biochem, Auckland, New Zealand; Auckland City Hosp, Dept Nucl Med, Auckland, New Zealand; Amgen Inc, Thousand Oaks, CA USA	University of Auckland; Auckland City Hospital; Amgen	Cundy, T (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland 1, New Zealand.			Cundy, Timothy/0000-0003-4890-9400				Bekker PJ, 2001, J BONE MINER RES, V16, P348, DOI 10.1359/jbmr.2001.16.2.348; Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Body JJ, 2003, CANCER-AM CANCER SOC, V97, P887, DOI 10.1002/cncr.11138; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; CASSINELLI HR, 1992, BONE MINER, V19, P175, DOI 10.1016/0169-6009(92)90924-3; Chong B, 2003, J BONE MINER RES, V18, P2095, DOI 10.1359/jbmr.2003.18.12.2095; Cundy T, 2002, HUM MOL GENET, V11, P2119, DOI 10.1093/hmg/11.18.2119; Cundy T, 2004, J BONE MINER RES, V19, P703, DOI 10.1359/JBMR.040127; DOYLE FH, 1974, BRIT J RADIOL, V47, P9, DOI 10.1259/0007-1285-47-553-9; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Tau C, 2004, BONE, V35, P210, DOI 10.1016/j.bone.2004.03.013; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329	15	63	66	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					918	923		10.1056/NEJMoa050893	http://dx.doi.org/10.1056/NEJMoa050893			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135836				2022-12-28	WOS:000231551100009
J	Fraser, WD; Hofmeyr, J; Lede, R; Faron, G; Alexander, S; Goffinet, F; Ohlsson, A; Goulet, C; Turcot-Lemay, L; Prendiville, W; Marcoux, S; Laperriere, L; Roy, C; Petrou, S; Xu, HR; Wei, B; Nicolaou, E; Nguekeng, E; Parker, C; Mlokoti, Z; Qolohle, D; Thomas, L; Barabini, N; Morin, V; Berube, J; Castaldi, J; Bertin, M; Mendoza, S; Aguilera, E; Breccia, G; Werbicki, E; Sosa, C; Godoy, L; Alonso, J; Nikodem, C; Calvert, H; Benjamin, U; Ferreira, S; Jafta, Z; Mangesi, L; Singata, M; Makinana, N; How, HY; Recht, KR; Walkinshaw, S; Yoxall, B; Chari, RS; Demianczuk, N; Pentinnen, E; Delisle, MF; Poposvka, V; Vokaer, A; Dreyfus, M; Denoual-Ziad, C; Bazin, S; Paradis, G; Blackwell, SC; Sorokin, Y; Russel, E; Gratton, R; Watson, M; Ramanna, R; Kopatch, S; Kirkpatrick, C; Lami, C; Petit, A; Craig, C; Fanning, C; Arsenault, MY; Poirier, C; Ymayo, MR; Ymayo, F; Tsatsaris, V; Dubois, S; Boudreault, A; Tawagi, G; Meeker, T; Pollard, JK; Swaby, C; Helewa, ME; Kenny-Lodewsky, D; Magnin, G; Sarfati, R; Fawcus, S; Linley, L; Khairi, H; Darraji, F; Audibert, F; Simon, B; Meirinho, M; Casal, ME; McNamara, H; Benjamin, A; Ritter, J; Treisser, A; Viville, B; Langer, B; Degueldre, M; Barlow, P; Lebbi, I; Chelli, H; Boutroy, JL; Thiebeaugeorges, O; Eason, EL; Hunter, N; Dumminy, P; October, L; Hubinont, C; Yamgnane, A; Velazquez, H; Comas, JP; Crosland, H; Brown, R; Boulvain, M; Irion, O; Fatur, D; Palermo, M; Thomas, D; Perrotin, F; Potin, J; Windrim, R; Saleniecks, ME; Golfier, F; Vaudoyer, F; Matt, C; Poulin, P; Lassel, L; Thoumsin, H; Vendittelli, F; Leduc, L; Ferland, S; Marceau, S; Houle, N; St Onges, O; Latulippe, D; Senecal, J; Marc, I; Poulin, P; Fraser, W; Goulet, C; Xu, HR; Wei, B; Roy, C; Turcot-Lemay, L; Marcoux, S; Morin, V; Hofmeyr, J; Lede, R; Faron, G; Alexander, S; Goffinet, F; Ohlsson, A; Petrou, S; Prendiville, W				Fraser, WD; Hofmeyr, J; Lede, R; Faron, G; Alexander, S; Goffinet, F; Ohlsson, A; Goulet, C; Turcot-Lemay, L; Prendiville, W; Marcoux, S; Laperriere, L; Roy, C; Petrou, S; Xu, HR; Wei, B; Nicolaou, E; Nguekeng, E; Parker, C; Mlokoti, Z; Qolohle, D; Thomas, L; Barabini, N; Morin, V; Berube, J; Castaldi, J; Bertin, M; Mendoza, S; Aguilera, E; Breccia, G; Werbicki, E; Sosa, C; Godoy, L; Alonso, J; Nikodem, C; Calvert, H; Benjamin, U; Ferreira, S; Jafta, Z; Mangesi, L; Singata, M; Makinana, N; How, HY; Recht, KR; Walkinshaw, S; Yoxall, B; Chari, RS; Demianczuk, N; Pentinnen, E; Delisle, MF; Poposvka, V; Vokaer, A; Dreyfus, M; Denoual-Ziad, C; Bazin, S; Paradis, G; Blackwell, SC; Sorokin, Y; Russel, E; Gratton, R; Watson, M; Ramanna, R; Kopatch, S; Kirkpatrick, C; Lami, C; Petit, A; Craig, C; Fanning, C; Arsenault, MY; Poirier, C; Ymayo, MR; Ymayo, F; Tsatsaris, V; Dubois, S; Boudreault, A; Tawagi, G; Meeker, T; Pollard, JK; Swaby, C; Helewa, ME; Kenny-Lodewsky, D; Magnin, G; Sarfati, R; Fawcus, S; Linley, L; Khairi, H; Darraji, F; Audibert, F; Simon, B; Meirinho, M; Casal, ME; McNamara, H; Benjamin, A; Ritter, J; Treisser, A; Viville, B; Langer, B; Degueldre, M; Barlow, P; Lebbi, I; Chelli, H; Boutroy, JL; Thiebeaugeorges, O; Eason, EL; Hunter, N; Dumminy, P; October, L; Hubinont, C; Yamgnane, A; Velazquez, H; Comas, JP; Crosland, H; Brown, R; Boulvain, M; Irion, O; Fatur, D; Palermo, M; Thomas, D; Perrotin, F; Potin, J; Windrim, R; Saleniecks, ME; Golfier, F; Vaudoyer, F; Matt, C; Poulin, P; Lassel, L; Thoumsin, H; Vendittelli, F; Leduc, L; Ferland, S; Marceau, S; Houle, N; St Onges, O; Latulippe, D; Senecal, J; Marc, I; Poulin, P; Fraser, W; Goulet, C; Xu, HR; Wei, B; Roy, C; Turcot-Lemay, L; Marcoux, S; Morin, V; Hofmeyr, J; Lede, R; Faron, G; Alexander, S; Goffinet, F; Ohlsson, A; Petrou, S; Prendiville, W		Amnioinfusion Trial Grp	Amnioinfusion for the prevention of the meconium aspiration syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAINED AMNIOTIC-FLUID; PROPHYLACTIC AMNIOINFUSION; CONTROLLED TRIALS; INTRAPARTUM; LABOR; METAANALYSES; MULTICENTER; MANAGEMENT; DELIVERY; FAILURE	Background: It is uncertain whether amnioinfusion (infusion of saline into the amniotic cavity) in women who have thick meconium staining of the amniotic fluid reduces the risk of perinatal death, moderate or severe meconium aspiration syndrome, or both. Methods: We performed a multicenter trial in which 1998 pregnant women in labor at 36 or more weeks of gestation who had thick meconium staining of the amniotic fluid were stratified according to the presence or absence of variable decelerations in fetal heart rate and then randomly assigned to amnioinfusion or to standard care. The composite primary outcome measure was perinatal death, moderate or severe meconium aspiration syndrome, or both. Results: Perinatal death, moderate or severe meconium aspiration syndrome, or both occurred in 44 infants (4.5 percent) of women in the amnioinfusion group and 35 infants (3.5 percent) of women in the control group (relative risk, 1.26; 95 percent confidence interval, 0.82 to 1.95). Five perinatal deaths occurred in the amnioinfusion group and five in the control group. The rate of cesarean delivery was 31.8 percent in the amnioinfusion group and 29.0 percent in the control group (relative risk, 1.10; 95 percent confidence interval, 0.96 to 1.25). Conclusions: For women in labor who have thick meconium staining of the amniotic fluid, amnioinfusion did not reduce the risk of moderate or severe meconium aspiration syndrome, perinatal death, or other major maternal or neonatal disorders.	Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Hop St Justine, Montreal, PQ H3T 1C5, Canada; Univ Witwatersrand, E London, South Africa; Inst Argentino Med Basada Evidencias, Buenos Aires, DF, Argentina; Ctr Hosp Univ Brugmann, Dept Obstet & Gynecol, Brussels, Belgium; Univ Libre Bruxelles, Dept Prevent & Social Med, Brussels, Belgium; Hop Cochin, Dept Obstet Matern Port Royal, F-75674 Paris, France; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Laval, Hop Saint Francois Assise, Quebec City, PQ G1K 7P4, Canada; Univ Laval, Dept Social & Prevent Med, Quebec City, PQ G1K 7P4, Canada; Coombe Lying In Hosp, Dept Obstet & Gynaecol, Dublin 8, Ireland; Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England	Universite de Montreal; Universite de Montreal; University of Witwatersrand; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Toronto; Laval University; Laval University; Trinity College Dublin; University of Oxford	Fraser, WD (corresponding author), Univ Montreal, Dept Obstet & Gynecol, 3175 Chemin Cote Sainte Catherine, Montreal, PQ H3T 1C5, Canada.	william.fraser@umontreal.ca	Windrim, Rory/AAC-6038-2020; Windrim, Rory/ABD-6799-2021; Audibert, François/AAL-1265-2020; Perrotin, Franck/AAL-8833-2021; Petrou, Stavros/ABD-8323-2021	Perrotin, Franck/0000-0001-9694-6658; Petrou, Stavros/0000-0003-3121-6050; GOFFINET, Francois/0000-0001-9643-0299				Adam K, 1989, P 9 ANN M SOC PER OB, P438; BROWN BL, 1981, OBSTET GYNECOL, V57, P26; CIALONE PR, 1994, AM J OBSTET GYNECOL, V170, P842, DOI 10.1016/S0002-9378(94)70296-9; Cleary GM, 1998, PEDIATR CLIN N AM, V45, P511, DOI 10.1016/S0031-3955(05)70025-0; COLTART TM, 1989, BRIT J OBSTET GYNAEC, V96, P411, DOI 10.1111/j.1471-0528.1989.tb02414.x; DAVIS RO, 1985, AM J OBSTET GYNECOL, V151, P731, DOI 10.1016/0002-9378(85)90506-X; DRAGICH DA, 1991, ANESTH ANALG, V72, P549; ERIKSEN NL, 1994, AM J OBSTET GYNECOL, V171, P1026, DOI 10.1016/0002-9378(94)90027-2; FALCIGLIA HS, 1988, OBSTET GYNECOL, V71, P349; FUJIKURA T, 1975, AM J OBSTET GYNECOL, V121, P45, DOI 10.1016/0002-9378(75)90973-4; Ghidini A, 2001, AM J OBSTET GYNECOL, V185, P931, DOI 10.1067/mob.2001.116828; HERNANDEZ C, 1993, AM J OBSTET GYNECOL, V169, P61, DOI 10.1016/0002-9378(93)90132-3; Hofmeyr GJ, 2002, COCHRANE DB SYST REV, V1; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; MACDONALD D, 1985, AM J OBSTET GYNECOL, V152, P524, DOI 10.1016/0002-9378(85)90619-2; MAHER JE, 1994, OBSTET GYNECOL, V83, P851; Mahomed K, 1998, BRIT J OBSTET GYNAEC, V105, P309, DOI 10.1111/j.1471-0528.1998.tb10092.x; Pierce J, 2000, OBSTET GYNECOL, V95, P1051, DOI 10.1016/S0029-7844(99)00629-8; ROSSI EM, 1989, AM J OBSTET GYNECOL, V161, P1106, DOI 10.1016/0002-9378(89)90643-1; SPONG CY, 1994, AM J OBSTET GYNECOL, V171, P931, DOI 10.1016/S0002-9378(94)70061-3; Urbaniak KJ, 1996, AUST NZ J OBSTET GYN, V36, P401, DOI 10.1111/j.1479-828X.1996.tb02180.x; Vain NE, 2004, LANCET, V364, P597, DOI 10.1016/S0140-6736(04)16852-9; VILLAR J, 1995, LANCET, V345, P772, DOI 10.1016/S0140-6736(95)90646-0; WENSTROM K, 1995, OBSTET GYNECOL, V86, P572, DOI 10.1016/0029-7844(95)00235-J; WENSTROM KD, 1989, OBSTET GYNECOL, V73, P647; Wiswell TE, 2000, PEDIATRICS, V105, P1, DOI 10.1542/peds.105.1.1; WISWELL TE, 1990, PEDIATRICS, V85, P7715; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	28	86	88	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					909	917		10.1056/NEJMoa050223	http://dx.doi.org/10.1056/NEJMoa050223			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135835				2022-12-28	WOS:000231551100008
J	Tanzilli, S; Tittel, W; Halder, M; Alibart, O; Baldi, P; Gisin, N; Zbinden, H				Tanzilli, S; Tittel, W; Halder, M; Alibart, O; Baldi, P; Gisin, N; Zbinden, H			A photonic quantum information interface	NATURE			English	Article							BELLS-INEQUALITY; WAVE-GUIDE; ENTANGLEMENT; VIOLATION; REALIZATION	Quantum communication requires the transfer of quantum states(1), or quantum bits of information (qubits), from one place to another. From a fundamental perspective, this allows the distribution of entanglement and the demonstration of quantum non-locality over significant distances(2-6). Within the context of applications, quantum cryptography offers a provably secure way to establish a confidential key between distant partners(7). Photons represent the natural flying qubit carriers for quantum communication, and the presence of telecommunications optical fibres makes the wavelengths of 1,310 nm and 1,550 nm particularly suitable for distribution over long distances. However, qubits encoded into alkaline atoms that absorb and emit at wavelengths around 800 nm have been considered for the storage and processing of quantum information(8,9). Hence, future quantum information networks made of telecommunications channels and alkaline memories will require interfaces that enable qubit transfers between these useful wavelengths, while preserving quantum coherence and entanglement(9-11). Here we report a demonstration of qubit transfer between photons of wavelength 1,310 nm and 710 nm. The mechanism is a nonlinear up-conversion process, with a success probability of greater than 5 per cent. In the event of a successful qubit transfer, we observe strong two-photon interference between the 710 nm photon and a third photon at 1,550 nm, initially entangled with the 1,310 nm photon, although they never directly interacted. The corresponding fidelity is higher than 98 per cent.	Univ Geneva, Appl Phys Grp, CH-1211 Geneva, Switzerland; Univ Nice, Phys Mat Condensee Lab, F-06108 Nice, France	University of Geneva; UDICE-French Research Universities; Universite Cote d'Azur	Tanzilli, S (corresponding author), Univ Geneva, Appl Phys Grp, CH-1211 Geneva, Switzerland.	sebastien.tanzilli@physics.unige.ch	Zbinden, Hugo/AAE-7258-2019; Tittel, Wolfgang/A-1600-2011; Tittel, Wolfgang/AAW-7332-2020	Tittel, Wolfgang/0000-0003-3136-8919				Albota MA, 2004, OPT LETT, V29, P1449, DOI 10.1364/OL.29.001449; ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Aspect A, 1999, NATURE, V398, P189, DOI 10.1038/18296; Banaszek K, 2001, OPT LETT, V26, P1367, DOI 10.1364/OL.26.001367; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; FRANSON JD, 1989, PHYS REV LETT, V62, P2205, DOI 10.1103/PhysRevLett.62.2205; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; HUANG JM, 1992, PHYS REV LETT, V68, P2153, DOI 10.1103/PhysRevLett.68.2153; Julsgaard B, 2004, NATURE, V432, P482, DOI 10.1038/nature03064; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Kuklewicz CE, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.013807; Kwiat PG, 1999, PHYS REV A, V60, pR773, DOI 10.1103/PhysRevA.60.R773; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; LLOYD S, 2001, PHYS REV LETT, V87; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; Marcikic I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180502; Mataloni P, 2003, FORTSCHR PHYS, V51, P435, DOI 10.1002/prop.200310059; Peng CZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.150501; Resch KJ, 2005, OPT EXPRESS, V13, P202, DOI 10.1364/OPEX.13.000202; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Schmidt-Kaler F, 2003, NATURE, V422, P408, DOI 10.1038/nature01494; Tanzilli S, 2002, EUR PHYS J D, V18, P155, DOI 10.1140/epjd/e20020019; Tittel W, 1998, PHYS REV LETT, V81, P3563, DOI 10.1103/PhysRevLett.81.3563; Tittel W, 2001, QUANTUM INF COMPUT, V1, P3; Vandevender AP, 2004, J MOD OPTIC, V51, P1433, DOI 10.1080/09500340410001670884; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0	29	304	310	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					116	120		10.1038/nature04009	http://dx.doi.org/10.1038/nature04009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136138	Green Submitted			2022-12-28	WOS:000231560400052
J	VandeBerg, JL; Zola, SM; Fritz, J; Lee, DR; Rowell, TJ; Satterfield, WC				VandeBerg, JL; Zola, SM; Fritz, J; Lee, DR; Rowell, TJ; Satterfield, WC			A unique biomedical resource at risk	NATURE			English	Editorial Material							MONOCLONAL-ANTIBODIES		SW Natl Primate Res Ctr, San Antonio, TX 78245 USA; Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; Primate Fdn Arizona, Mesa, AZ USA; Alamogordo Primate Facil, Alamogordo, NM USA; Univ Louisiana, Lafayette, LA USA; MD Anderson Canc Ctr, Bastrop, TX USA	Texas Biomedical Research Institute; University of Louisiana Lafayette; University of Texas System; UTMD Anderson Cancer Center	VandeBerg, JL (corresponding author), SW Natl Primate Res Ctr, San Antonio, TX 78245 USA.							Berger M, 2002, AM J MED SCI, V324, P14, DOI 10.1097/00000441-200207000-00004; Brent L, 2004, LAB ANIMAL, V33, P37, DOI 10.1038/laban0104-37; Desgranges C, 2004, PATHOL BIOL, V52, P351, DOI 10.1016/j.patbio.2003.09.017; GEARING M, 1994, P NATL ACAD SCI USA, V91, P9382, DOI 10.1073/pnas.91.20.9382; Murthy KK, 1998, AIDS RES HUM RETROV, V14, pS271; National Research Council, 1997, CHIMP RES STRAT THEI; Smith KA, 2004, J CLIN PATHOL, V57, P912, DOI 10.1136/jcp.2003.014407; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stern M, 2005, CRIT REV ONCOL HEMAT, V54, P11, DOI 10.1016/j.critrevonc.2004.10.011; Wong H, 2004, DRUG METAB DISPOS, V32, P1359, DOI 10.1124/dmd.104.000943	10	30	30	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					30	32		10.1038/437030a	http://dx.doi.org/10.1038/437030a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136112				2022-12-28	WOS:000231560400024
